<SEC-DOCUMENT>0001628280-22-028255.txt : 20221103
<SEC-HEADER>0001628280-22-028255.hdr.sgml : 20221103
<ACCEPTANCE-DATETIME>20221103165148
ACCESSION NUMBER:		0001628280-22-028255
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		54
CONFORMED PERIOD OF REPORT:	20220930
FILED AS OF DATE:		20221103
DATE AS OF CHANGE:		20221103

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			MEDIFAST INC
		CENTRAL INDEX KEY:			0000910329
		STANDARD INDUSTRIAL CLASSIFICATION:	MISCELLANEOUS FOOD PREPARATIONS & KINDRED PRODUCTS [2090]
		IRS NUMBER:				133714405
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-31573
		FILM NUMBER:		221358817

	BUSINESS ADDRESS:	
		STREET 1:		11445 CRONHILL DRIVE
		CITY:			OWINGS MILLS
		STATE:			MD
		ZIP:			21117
		BUSINESS PHONE:		7327640619

	MAIL ADDRESS:	
		STREET 1:		11445 CRONHILL DRIVE
		CITY:			OWINGS MILLS
		STATE:			MD
		ZIP:			21117

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	HEALTHRITE INC
		DATE OF NAME CHANGE:	19951120

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	XX
		DATE OF NAME CHANGE:	19950619

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	00
		DATE OF NAME CHANGE:	19950619
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>med-20220930.htm
<DESCRIPTION>10-Q
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2022 Workiva--><!--r:1ae599f9-ff00-4d75-90b9-110349ab0236,g:6d08fa26-e8d0-4031-9c9e-a858e7464a0f,d:c8ae413b3ff34d56976502c585fa6ab3--><html xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:dei="http://xbrl.sec.gov/dei/2021q4" xmlns:med="http://www.medifast1.com/20220930" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns="http://www.w3.org/1999/xhtml" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>med-20220930</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180L2ZyYWc6OGJhOGUzMWM0NGMxNGE4Mjk1OWJhMjYyMjYxN2QxZWQvdGFibGU6OGJhNjQ3MGEwZDU0NDVlY2JiNmQyYWRlM2E5Nzc4NjIvdGFibGVyYW5nZTo4YmE2NDcwYTBkNTQ0NWVjYmI2ZDJhZGUzYTk3Nzg2Ml8yNi0xLTEtMS00Mjc5Mg_f2e92489-7f46-4f21-b9d6-55376ff33fb1">0000910329</ix:nonNumeric><ix:nonNumeric contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930" name="dei:CurrentFiscalYearEndDate" format="ixt:date-month-day" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180L2ZyYWc6OGJhOGUzMWM0NGMxNGE4Mjk1OWJhMjYyMjYxN2QxZWQvdGFibGU6OGJhNjQ3MGEwZDU0NDVlY2JiNmQyYWRlM2E5Nzc4NjIvdGFibGVyYW5nZTo4YmE2NDcwYTBkNTQ0NWVjYmI2ZDJhZGUzYTk3Nzg2Ml8yNy0xLTEtMS00Mjc5Mg_c66bc7d7-36da-4a8c-9930-9ab7e338ba66">12-31</ix:nonNumeric><ix:nonNumeric contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180L2ZyYWc6OGJhOGUzMWM0NGMxNGE4Mjk1OWJhMjYyMjYxN2QxZWQvdGFibGU6OGJhNjQ3MGEwZDU0NDVlY2JiNmQyYWRlM2E5Nzc4NjIvdGFibGVyYW5nZTo4YmE2NDcwYTBkNTQ0NWVjYmI2ZDJhZGUzYTk3Nzg2Ml8yOC0xLTEtMS00Mjc5Mg_81a20340-410e-45db-a0cc-b4da1574b98f">2022</ix:nonNumeric><ix:nonNumeric contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180L2ZyYWc6OGJhOGUzMWM0NGMxNGE4Mjk1OWJhMjYyMjYxN2QxZWQvdGFibGU6OGJhNjQ3MGEwZDU0NDVlY2JiNmQyYWRlM2E5Nzc4NjIvdGFibGVyYW5nZTo4YmE2NDcwYTBkNTQ0NWVjYmI2ZDJhZGUzYTk3Nzg2Ml8yOS0xLTEtMS00Mjc5Mg_ef0d0d7b-138d-4ded-aba6-23053c5a155b">Q3</ix:nonNumeric><ix:nonNumeric contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930" name="dei:AmendmentFlag" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180L2ZyYWc6OGJhOGUzMWM0NGMxNGE4Mjk1OWJhMjYyMjYxN2QxZWQvdGFibGU6OGJhNjQ3MGEwZDU0NDVlY2JiNmQyYWRlM2E5Nzc4NjIvdGFibGVyYW5nZTo4YmE2NDcwYTBkNTQ0NWVjYmI2ZDJhZGUzYTk3Nzg2Ml8zMC0xLTEtMS00Mjc5Mg_86122db8-41f7-44f5-a43c-3657c780e950">FALSE</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="med-20220930.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7165f9e7627148d7b4334bd7c0b51707_I20221026"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-10-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="i2f3a96a832ab4b0ca374599d1c3e9bce_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="i3bb5592686d74afab4f7004818fd6f9b_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic431430d1ab24120b4507025a722d73a_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="i5de311f5948148cda49342e2cea83715_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i47f09f18839440ffae0cf05a475aa7fe_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i03d902ffc72e4d98b5eeb6fb903f405b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifb5de6f6a1b842d59a7c6674c3095ce8_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i77931d79ec4a440094a82f9812ccc722_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4daa9b081467438bab4674c0946e08cd_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id19243f3c67e4c9db2d2085c6f295c96_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic425e1f1f3a24303b14c8132e098ec51_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i87d2a4b91677497c84867fb9eb0d1fe3_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4c296c25c3154c589996445b02c8b46f_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i35ec1b88d067414ebdd617a1caddf764_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9d58012ea00c40debc6e3821ba8c53e8_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifef10a2343ba477a98a2732ea2e3188d_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifcda0fa259164bf4a392c5cadde798d0_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iedb06a9ecbbd425b9ff4de89c5ec443c_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1aa514aadcf045659a010e7c7dff59d4_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9b72febc917d4ba4a54ef5179a1ddbbf_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id441c59bc18c4d6faf4dc590c7376782_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6b8a276003b3422d87146a73aca9877e_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5d8f60be441544f9a5706ed808193db4_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ife6dd959a81f4995b5e17747ce77289e_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i825be310f0914f779c3296901da45216_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6a350b34ff224fcfb66d3b6986b8d85d_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i31e2c05019204ecc9f2b00f8685ed1de_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7c04a52245ee4a18af7538a5b3926bd8_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3fe461be5d8a4b1d8f4f96a4471aae50_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4b731dc434c94dbca7470032b562d581_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i44dccac463fc4d3d841cabd5924e0d7b_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1a26a14e2dc041cc84ce9b142e145c9e_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i74ad881c792442baa75df8b807911f09_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7bf72d1c8e9744c19c58f817cb47d391_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i913ea3b7a1e249509ae836a1357f94f2_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9c92e926af9e4d908021e1a185782db8_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i46cc59e8b81644bfa9c00742166adce3_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5a90f297c41946ada6274ba46fe40700_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i543db287df984eccb3551d94073d122d_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2a8af11f752e4e7cb2dba522b9ad74d2_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5c1aea55f14840448c42fb7a08b519b6_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i86b6fd23b7b042e2ba7777c1c5d29391_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0c74a76f5cb04d3896ad8481dd40c875_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib4e37db708e64812ac81e983938b61df_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i45eff40e381645728b84813044e661c6_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i82d77786c5f844c8a6ad979988ec850e_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1163d3352fc648fabd60e9dbcf073a70_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if34e8b84444d41ce8edf53d30fe4aa32_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i19f7e6a88c8d41818d290843acae9d96_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2b15d638707f47c0b49ae2a29db046e6_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i52670ec43ed94ac3b4d465333938624b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id4f9149bb4104ee2963222e63eef1ac9_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i68572f7de11f487eb008f9ea31479d93_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i470e4e9ecca64945928eff798199788e_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia13ecf3f80ad40c2a77b77116d4ed43c_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i38351930dc7542bba71c26ab68521fec_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7ffa4de1d96a472385d9f446aded3673_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i926bcd92e3394962b4b7831cda0ea157_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i593139faed924dd193120eb4e1bcaeec_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4149861d44464055b0906f38bd8c72e2_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i53d4071f311c4bc6a78da6c7fb1ca3da_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i432fec2efa784910b40e24a63bb087c5_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i36a8ff01ce244ad6a7aaa930257b4d4f_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia82656c7830f478dbef5fdc6935f568d_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8148576927e64d0f8fda8e31eb6b529b_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i02db23a8737b4985815005662095656a_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9224eb8da52e48a886d66dcac0ff9f06_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7a3770d9964c4b419436e67fc0ef4044_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i581ec4205b3c47a0a164d6c0e54036f6_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9e9dcffbe0354e98962551a32828abc2_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idfb0b0b879244ae7862113b2345aa1e6_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9cea7aaedf6e484b95020ab9ac02f011_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic4a2d943c8664242a544b6294ec6c7c8_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib6dc7945bf0e400099cdcc1fed80fb2c_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i059d81e5005e42788c673ccfaf1058e5_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i73d2ec22c05b4c4fbe6a550f139a59ae_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibd26354982214044ae591432e82c800d_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1aab3bd0f0be43baa5e0bc44e70a5a28_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4218dcf5ff3845e68993eb267c5fbe10_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i64699db86ad54ac8a14806cd578d3cf7_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib9edd1f9ecfe40139a3c3fbfe3370644_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i25169b23871e46eca074903e07db728c_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9c3f2304fd3c47c18b9051b19c7301ea_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i00844f75496c44e194d293f567033a2d_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0e33dd9737fd44d6ab51db5290fd1254_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8c40ccc203fe40598b003eaa16fd683f_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i44833e234c5b420caed39d2dbc002f2b_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ide51255203a64d54b830864bda6b2f1f_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i873b1283e7f24f0c80ef84c8a9e20c76_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if96bd90ed63041fc85fb7929f8aa69cf_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie17f9491af104b57837e5277e79f0dee_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id337c0920a144e0c91a6bed2853c1d7b_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia06f0db3dd8146e097bef1502f9f86af_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i64e1421ab00c4da49c0547bb9f5f234a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if58da46cc9354a8eadc10f9e4f114ac2_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iee1cf11574cc42609fde6f9c8aee4073_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic65b09ecdbb7426eb38e93fcf8817112_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if99f41a5e55c4b58ab6b630db3712adb_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="i0ecdbda19ca5476b9e392faeaca89725_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id883036fe81d4fbd9ce98760bd9584d6_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibadc66af627d4a50adc5b6a3602689c5_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">med:OptionsAndRestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i12f18bce76824fa181f9d54c1673be9d_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">med:OptionsAndRestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i95d94f4202144399b49c964c8368ac37_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">med:MarketAndPerformanceSharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">med:GrantedIn2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0901c79f16de41bea38c2f269bd6bd08_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">med:MarketAndPerformanceSharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">med:GrantedIn2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0a41616804a64fe39e2eb14b59e5df17_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">med:GrantedIn2021Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie5d960394d1f4239b6b22f78b99ccbfd_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">med:GrantedIn2021Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia7b71491bfda423a9b849e5ba3c9591d_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">med:GrantedIn2020Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i840318db555b44f1929d580be8e92f97_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">med:GrantedIn2020Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i86506a2c9bb242aab0a78a2c5c61556e_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">med:GrantedIn2019Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9f1fb4440c1a44f78177fa769579f56b_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">med:GrantedIn2019Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic07f86d9e5da4afd87e67a65fb6f4791_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">med:OptionsAndRestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie5f97af31c054e3788ba0bc81976a278_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">med:OptionsAndRestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icf2b50e3ab554624b26461e34b8f1ca1_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">med:MarketAndPerformanceSharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">med:GrantedIn2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i69d71c00111f4c31a670e455a0400e4b_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">med:MarketAndPerformanceSharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">med:GrantedIn2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8836599f5719436f91aef628c5b33be0_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">med:GrantedIn2021Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if982f76b88b6470b88a0ed0c16c942e8_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">med:GrantedIn2021Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaf70d20a80bb4d1aa9e3337f77338213_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">med:GrantedIn2020Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iec911248646e4fb08207555f658d9df7_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">med:GrantedIn2020Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2b5cd09c8d0d42ac95d3ad2f1003faf4_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">med:GrantedIn2019Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i22b57c2d55054a9da3152d65a3fac12e_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">med:GrantedIn2019Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0d192144959640fd8d222d1f8b709e6b_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2fe34b3f982747e1929ba94579cd75e3_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6694abec73714bcba4d3d84d55594c48_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ice458ff158834dc8b920eafada15a08c_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">med:OperatingLeaseArrangementForRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic37ce3f978074bddbfb14a6e5f911b56_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">med:OperatingLeaseArrangementForRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0399caeb91d24d5b95af603648d72cb4_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">med:OperatingLeaseArrangementForEquipmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie6bff7e9e26a4002b1c59b59832b37a2_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">med:OperatingLeaseArrangementForEquipmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9072f45fffaa474fb85e95c07d3eeec4_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if1f1d1f963874bf9a839c3e7d4c9af87_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i097ff6133d214f6bb8b7dc45eed5eed7_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8729459526e94e28ad22588635f7ca5e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2441f967061c4361b6837702e3fee167_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CashMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iea299389245a4a8b89c2066eaf7399d6_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1ce2f0d8655c4a7da2f77d8aa8960f46_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CashMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1b9d5d43ca6d4d0a8b8eba73d75d9cd6_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8dd60027e0b14536ba3bfa6e34c9dfae_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">med:GovernmentAgencySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i23259e7a55774035a3ea3e0ab04e7338_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">med:GovernmentAgencySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if41dd7900bc54c728b2f679f78ab8cf8_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i64b67de4322349efbcaab405308f4973_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i51ae42d5ac59407da626249ef44365c7_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i89429fed7a924252aaa74342106dea93_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifaa46d08341a4f5db42a3cfd1e77e968_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib975abad8363400482246009fad4070e_I20220531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">med:CreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-05-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9f7c21a6e6a1463a8de2e4295c68b795_I20220531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">med:CreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-05-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibea5baeea8b840488104a7e63ceeb4bc_D20220531-20220531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">med:CreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-31</xbrli:startDate><xbrli:endDate>2022-05-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie586fdb4b2b04c1f83bcdaff0af594c8_D20220531-20220531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">med:CreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-31</xbrli:startDate><xbrli:endDate>2022-05-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i56c008dd01b046dda5a8ab4c98daf9d7_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">med:CreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:EurodollarMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i761b85a615a044a28a135126fe49dca4_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">med:CreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1572f54925ef49918ea7d21b949a4e18_I20220531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">med:CreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-05-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i116efaf8269843e38b3d65a462979897_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">med:CreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0b400b25989d44b2afb02aff99c3fc41_D20220531-20220531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-31</xbrli:startDate><xbrli:endDate>2022-05-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i614062ec1b3741b0a8c6fc4b23ffa70c_D20220808-20220808"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-08-08</xbrli:startDate><xbrli:endDate>2022-08-08</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="ic8ae413b3ff34d56976502c585fa6ab3_1"></div><div style="min-height:45pt;width:100%"><div style="margin-top:21.6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#ic8ae413b3ff34d56976502c585fa6ab3_7">Table of Contents</a></span></div></div><div style="margin-top:21.6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:4pt"><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"></td></tr></table></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">WASHINGTON, D.C. 20549</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xL2ZyYWc6MjNlYzlhNDY1OTg4NDgyMWFkOWE4ODRmNWJiMGI2NWUvdGV4dHJlZ2lvbjoyM2VjOWE0NjU5ODg0ODIxYWQ5YTg4NGY1YmIwYjY1ZV8yMzI0_a78b224a-e2b5-46e7-9800-389ee435e21d">10-Q</ix:nonNumeric></span></div><div style="margin-top:6pt;padding-left:9pt;padding-right:9pt;text-align:center;text-indent:-18pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930" name="dei:DocumentQuarterlyReport" format="ixt:fixed-true" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xL2ZyYWc6MjNlYzlhNDY1OTg4NDgyMWFkOWE4ODRmNWJiMGI2NWUvdGV4dHJlZ2lvbjoyM2VjOWE0NjU5ODg0ODIxYWQ5YTg4NGY1YmIwYjY1ZV8yMzIx_84f861ee-ffd0-44f8-b2f9-dba16572fc2b">x</ix:nonNumeric></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></div><div style="margin-top:6pt;padding-left:9pt;padding-right:9pt;text-align:center;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">For the quarterly period ended <ix:nonNumeric contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xL2ZyYWc6MjNlYzlhNDY1OTg4NDgyMWFkOWE4ODRmNWJiMGI2NWUvdGV4dHJlZ2lvbjoyM2VjOWE0NjU5ODg0ODIxYWQ5YTg4NGY1YmIwYjY1ZV81NDk3NTU4MTYyNzU_ef8a5a93-31a4-4825-bb56-d81214346466">September&#160;30, 2022</ix:nonNumeric></span></div><div style="margin-top:6pt;padding-left:9pt;padding-right:9pt;text-align:center;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">OR</span></div><div style="margin-top:6pt;padding-left:9pt;padding-right:9pt;text-align:center;text-indent:-18pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930" name="dei:DocumentTransitionReport" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xL2ZyYWc6MjNlYzlhNDY1OTg4NDgyMWFkOWE4ODRmNWJiMGI2NWUvdGV4dHJlZ2lvbjoyM2VjOWE0NjU5ODg0ODIxYWQ5YTg4NGY1YmIwYjY1ZV8yMzE0_6b799bb2-837f-4113-a908-1cacd9a7b8aa">o</ix:nonNumeric></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></div><div style="margin-top:6pt;padding-left:9pt;padding-right:9pt;text-align:center;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">For the transition period from________ to ________.</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Commission File Number: <ix:nonNumeric contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xL2ZyYWc6MjNlYzlhNDY1OTg4NDgyMWFkOWE4ODRmNWJiMGI2NWUvdGV4dHJlZ2lvbjoyM2VjOWE0NjU5ODg0ODIxYWQ5YTg4NGY1YmIwYjY1ZV8yMzI4_819f0b41-dd64-40df-ac0b-a93f0ff4d1ed">001-31573</ix:nonNumeric></span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xL2ZyYWc6MjNlYzlhNDY1OTg4NDgyMWFkOWE4ODRmNWJiMGI2NWUvdGV4dHJlZ2lvbjoyM2VjOWE0NjU5ODg0ODIxYWQ5YTg4NGY1YmIwYjY1ZV8yMzE1_5407a282-c640-4b7f-a548-ec1ce12915ca">Medifast, Inc.</ix:nonNumeric></span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.607%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.609%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"><ix:nonNumeric contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xL2ZyYWc6MjNlYzlhNDY1OTg4NDgyMWFkOWE4ODRmNWJiMGI2NWUvdGFibGU6NzYwZWY3MTUwODIxNDU3MmJhYzgwYWI4M2JiYjY2NzMvdGFibGVyYW5nZTo3NjBlZjcxNTA4MjE0NTcyYmFjODBhYjgzYmJiNjY3M18wLTAtMS0xLTQyNzky_6a5b0262-b9da-4d16-a25f-880b9ddecbc3">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"><ix:nonNumeric contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xL2ZyYWc6MjNlYzlhNDY1OTg4NDgyMWFkOWE4ODRmNWJiMGI2NWUvdGFibGU6NzYwZWY3MTUwODIxNDU3MmJhYzgwYWI4M2JiYjY2NzMvdGFibGVyYW5nZTo3NjBlZjcxNTA4MjE0NTcyYmFjODBhYjgzYmJiNjY3M18wLTItMS0xLTQyNzky_ee5fd4cf-b482-4c93-8ccf-66b141c99a92">13-3714405</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:114%">(State or other jurisdiction of incorporation or organization)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:114%">(I.R.S. Employer Identification No.)</span></td></tr></table></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xL2ZyYWc6MjNlYzlhNDY1OTg4NDgyMWFkOWE4ODRmNWJiMGI2NWUvdGV4dHJlZ2lvbjoyM2VjOWE0NjU5ODg0ODIxYWQ5YTg4NGY1YmIwYjY1ZV8yMzIy_64b87af1-a627-49d8-9b48-b0f6654466fa">100 International Drive</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xL2ZyYWc6MjNlYzlhNDY1OTg4NDgyMWFkOWE4ODRmNWJiMGI2NWUvdGV4dHJlZ2lvbjoyM2VjOWE0NjU5ODg0ODIxYWQ5YTg4NGY1YmIwYjY1ZV8yMzI3_49f85d6c-2e51-490c-bea9-c85f5ba88d1b">Baltimore</ix:nonNumeric>, <ix:nonNumeric contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xL2ZyYWc6MjNlYzlhNDY1OTg4NDgyMWFkOWE4ODRmNWJiMGI2NWUvdGV4dHJlZ2lvbjoyM2VjOWE0NjU5ODg0ODIxYWQ5YTg4NGY1YmIwYjY1ZV8yMzIz_69e58803-f738-4828-82f9-ba0183d54fe5">Maryland</ix:nonNumeric> <ix:nonNumeric contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xL2ZyYWc6MjNlYzlhNDY1OTg4NDgyMWFkOWE4ODRmNWJiMGI2NWUvdGV4dHJlZ2lvbjoyM2VjOWE0NjU5ODg0ODIxYWQ5YTg4NGY1YmIwYjY1ZV8yMzI1_3d70c88c-09f2-4faf-a489-bee2d0f818df">21202</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Telephone Number: (<ix:nonNumeric contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xL2ZyYWc6MjNlYzlhNDY1OTg4NDgyMWFkOWE4ODRmNWJiMGI2NWUvdGV4dHJlZ2lvbjoyM2VjOWE0NjU5ODg0ODIxYWQ5YTg4NGY1YmIwYjY1ZV8yMzI2_1c743ce2-590e-4407-af26-048328a63f5b">410</ix:nonNumeric>) <ix:nonNumeric contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xL2ZyYWc6MjNlYzlhNDY1OTg4NDgyMWFkOWE4ODRmNWJiMGI2NWUvdGV4dHJlZ2lvbjoyM2VjOWE0NjU5ODg0ODIxYWQ5YTg4NGY1YmIwYjY1ZV8yMzE2_d1d5af12-8c2b-4ea2-a91f-6f8df2202ea9">581-8042</ix:nonNumeric></span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(Address of Principal Executive Offices, Zip Code and Telephone Number, Including Area Code)</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:39.543%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.443%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.546%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 3.28pt;text-align:center;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Title of each class</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Trading Symbol</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 3.28pt;text-align:center;text-indent:-7.2pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonNumeric contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xL2ZyYWc6MjNlYzlhNDY1OTg4NDgyMWFkOWE4ODRmNWJiMGI2NWUvdGFibGU6NGVlMGNkYmU5NjIwNGU5NjkxNGIzZWE5OWNkNWZiYjYvdGFibGVyYW5nZTo0ZWUwY2RiZTk2MjA0ZTk2OTE0YjNlYTk5Y2Q1ZmJiNl8xLTAtMS0xLTQyNzky_41b67bdf-c8f6-4663-b226-871d214b67b0">Common Stock, par value $0.001 per share</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonNumeric contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xL2ZyYWc6MjNlYzlhNDY1OTg4NDgyMWFkOWE4ODRmNWJiMGI2NWUvdGFibGU6NGVlMGNkYmU5NjIwNGU5NjkxNGIzZWE5OWNkNWZiYjYvdGFibGVyYW5nZTo0ZWUwY2RiZTk2MjA0ZTk2OTE0YjNlYTk5Y2Q1ZmJiNl8xLTItMS0xLTQyNzky_1b980732-663b-44fa-acc6-57e7ff050976">MED</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonNumeric contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xL2ZyYWc6MjNlYzlhNDY1OTg4NDgyMWFkOWE4ODRmNWJiMGI2NWUvdGFibGU6NGVlMGNkYmU5NjIwNGU5NjkxNGIzZWE5OWNkNWZiYjYvdGFibGVyYW5nZTo0ZWUwY2RiZTk2MjA0ZTk2OTE0YjNlYTk5Y2Q1ZmJiNl8xLTQtMS0xLTQyNzky_080d864f-6b6c-44ec-8071-1ce2e731d494">New York Stock Exchange</ix:nonNumeric></span></td></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Indicate by checkmark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15 (d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. </span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xL2ZyYWc6MjNlYzlhNDY1OTg4NDgyMWFkOWE4ODRmNWJiMGI2NWUvdGV4dHJlZ2lvbjoyM2VjOWE0NjU5ODg0ODIxYWQ5YTg4NGY1YmIwYjY1ZV8yMzE3_b05f279c-f328-4daa-9060-196cd22a3f20">Yes</ix:nonNumeric> </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%">x</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> No </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%">o</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). </span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xL2ZyYWc6MjNlYzlhNDY1OTg4NDgyMWFkOWE4ODRmNWJiMGI2NWUvdGV4dHJlZ2lvbjoyM2VjOWE0NjU5ODg0ODIxYWQ5YTg4NGY1YmIwYjY1ZV8yMzE4_b2d89e4b-1a86-4e95-9f7d-118e5129d090">Yes</ix:nonNumeric> </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%">x</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> No </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%">o</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:23.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonNumeric contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xL2ZyYWc6MjNlYzlhNDY1OTg4NDgyMWFkOWE4ODRmNWJiMGI2NWUvdGFibGU6Mjk5OWY0Y2U4NDg3NDA4Yzg0NjdkNGQyYzEyYWM0NGIvdGFibGVyYW5nZToyOTk5ZjRjZTg0ODc0MDhjODQ2N2Q0ZDJjMTJhYzQ0Yl8wLTAtMS0xLTQyNzky_e3a02346-a7ea-4b5f-a285-1937e1bc669b">Large accelerated filer</ix:nonNumeric> </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">&#9746;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#9744;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Non-accelerated filer </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">&#9744;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Smaller reporting company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonNumeric contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930" name="dei:EntitySmallBusiness" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xL2ZyYWc6MjNlYzlhNDY1OTg4NDgyMWFkOWE4ODRmNWJiMGI2NWUvdGFibGU6Mjk5OWY0Y2U4NDg3NDA4Yzg0NjdkNGQyYzEyYWM0NGIvdGFibGVyYW5nZToyOTk5ZjRjZTg0ODc0MDhjODQ2N2Q0ZDJjMTJhYzQ0Yl8xLTMtMS0xLTQyNzky_82a60286-5c69-4216-8105-1733f56e2c36">&#9744;</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Emerging growth company </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonNumeric contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930" name="dei:EntityEmergingGrowthCompany" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xL2ZyYWc6MjNlYzlhNDY1OTg4NDgyMWFkOWE4ODRmNWJiMGI2NWUvdGFibGU6Mjk5OWY0Y2U4NDg3NDA4Yzg0NjdkNGQyYzEyYWM0NGIvdGFibGVyYW5nZToyOTk5ZjRjZTg0ODc0MDhjODQ2N2Q0ZDJjMTJhYzQ0Yl8yLTEtMS0xLTQyNzky_3b6dfb82-6d5d-4d85-b400-e01d1f1aa05d">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%">o</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Indicate by checkmark whether the Registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). </span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Yes </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%">o</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> No </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930" name="dei:EntityShellCompany" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xL2ZyYWc6MjNlYzlhNDY1OTg4NDgyMWFkOWE4ODRmNWJiMGI2NWUvdGV4dHJlZ2lvbjoyM2VjOWE0NjU5ODg0ODIxYWQ5YTg4NGY1YmIwYjY1ZV8yMzIw_333b23ea-009f-423a-b889-5aa7eeb55c8d">x</ix:nonNumeric></span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Indicate the number of shares outstanding of each of the issuer&#8217;s classes of common stock, as of the latest practicable date.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">The number of shares of the registrant&#8217;s common stock outstanding at October&#160;26, 2022 was <ix:nonFraction unitRef="shares" contextRef="i7165f9e7627148d7b4334bd7c0b51707_I20221026" decimals="INF" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xL2ZyYWc6MjNlYzlhNDY1OTg4NDgyMWFkOWE4ODRmNWJiMGI2NWUvdGV4dHJlZ2lvbjoyM2VjOWE0NjU5ODg0ODIxYWQ5YTg4NGY1YmIwYjY1ZV8yMzEw_d17a4045-8cd3-4408-ae70-26565293af3b">10,926,989</ix:nonFraction>.</span></div><div style="margin-top:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:4pt"><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> </span></div></div></div><div id="ic8ae413b3ff34d56976502c585fa6ab3_7"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:21.6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#ic8ae413b3ff34d56976502c585fa6ab3_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Medifast, Inc. and Subsidiaries</span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Index</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:93.052%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.748%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:none" href="#ic8ae413b3ff34d56976502c585fa6ab3_10">Part 1 &#8211; Financial Information</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#ic8ae413b3ff34d56976502c585fa6ab3_13">Item 1 &#8211; Financial Statements</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic8ae413b3ff34d56976502c585fa6ab3_16">Condensed Consolidated Statements of Income (unaudited) for the Three and Nine Months Ended September 30, 2022 and 2021</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#ic8ae413b3ff34d56976502c585fa6ab3_16">2</a></span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic8ae413b3ff34d56976502c585fa6ab3_19">Condensed Consolidated Statements of Comprehensive Income (unaudited) for the Three and Nine Months Ended September 30, 2022 and 2021</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#ic8ae413b3ff34d56976502c585fa6ab3_19">3</a></span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic8ae413b3ff34d56976502c585fa6ab3_22">Condensed Consolidated Balance Sheets (unaudited) as of September 30, 2022 and December 31, 2021</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#ic8ae413b3ff34d56976502c585fa6ab3_22">4</a></span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic8ae413b3ff34d56976502c585fa6ab3_25">Condensed Consolidated Statements of Cash Flows (unaudited) for the Nine Months Ended September 30, 2022 and 2021</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#ic8ae413b3ff34d56976502c585fa6ab3_25">5</a></span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic8ae413b3ff34d56976502c585fa6ab3_28">Condensed Consolidated Statements of Changes in Stockholders&#8217; Equity (unaudited) for the </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic8ae413b3ff34d56976502c585fa6ab3_28">Nine Months Ended September 30, 2022 and 2021</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#ic8ae413b3ff34d56976502c585fa6ab3_28">6</a></span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic8ae413b3ff34d56976502c585fa6ab3_31">Notes to Condensed Consolidated Financial Statements (unaudited)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#ic8ae413b3ff34d56976502c585fa6ab3_31">8</a></span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic8ae413b3ff34d56976502c585fa6ab3_61">Item 2 &#8211; Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#ic8ae413b3ff34d56976502c585fa6ab3_61">15</a></span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic8ae413b3ff34d56976502c585fa6ab3_85">Item 3 &#8211; Quantitative and Qualitative Disclosures about Market Risk</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#ic8ae413b3ff34d56976502c585fa6ab3_85">23</a></span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic8ae413b3ff34d56976502c585fa6ab3_88">Item 4 &#8211; Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#ic8ae413b3ff34d56976502c585fa6ab3_88">23</a></span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ic8ae413b3ff34d56976502c585fa6ab3_91">Part II &#8211; Other Information</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic8ae413b3ff34d56976502c585fa6ab3_94">Item 1 &#8211; Legal Proceedings</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#ic8ae413b3ff34d56976502c585fa6ab3_94">24</a></span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic8ae413b3ff34d56976502c585fa6ab3_97">Item 1A &#8211; Risk Factors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#ic8ae413b3ff34d56976502c585fa6ab3_97">24</a></span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic8ae413b3ff34d56976502c585fa6ab3_100">Item 2 &#8211; Unregistered Sales of Equity Securities and Use of Proceeds</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#ic8ae413b3ff34d56976502c585fa6ab3_100">24</a></span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic8ae413b3ff34d56976502c585fa6ab3_103">Item 6 &#8211; Exhibits</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#ic8ae413b3ff34d56976502c585fa6ab3_103">25</a></span></div></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">1</span></div></div></div><div id="ic8ae413b3ff34d56976502c585fa6ab3_10"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:21.6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#ic8ae413b3ff34d56976502c585fa6ab3_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:115%"> </span></div><div id="ic8ae413b3ff34d56976502c585fa6ab3_13"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:115%"> </span></div><div id="ic8ae413b3ff34d56976502c585fa6ab3_16"></div><div style="text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">MEDIFAST, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF INCOME (UNAUDITED)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(U.S. dollars in thousands, except per share amounts &amp; dividend data)</span></div><div style="margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:38.666%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.525%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Three months ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Nine months ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Revenue</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f3a96a832ab4b0ca374599d1c3e9bce_D20220701-20220930" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xNi9mcmFnOjZjYzAzOTMyMGFhZjRjYmQ5M2QwZTYxZTBlY2Q5NTViL3RhYmxlOjM5NWNhYWJhZDg1MzQ3NGQ5ZGI5Y2M1NTI5NzU2YTJlL3RhYmxlcmFuZ2U6Mzk1Y2FhYmFkODUzNDc0ZDlkYjljYzU1Mjk3NTZhMmVfMy0xLTEtMS00Mjc5Mg_38d99f09-9919-42b3-94f7-9f2d41f5ff49">390,398</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bb5592686d74afab4f7004818fd6f9b_D20210701-20210930" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xNi9mcmFnOjZjYzAzOTMyMGFhZjRjYmQ5M2QwZTYxZTBlY2Q5NTViL3RhYmxlOjM5NWNhYWJhZDg1MzQ3NGQ5ZGI5Y2M1NTI5NzU2YTJlL3RhYmxlcmFuZ2U6Mzk1Y2FhYmFkODUzNDc0ZDlkYjljYzU1Mjk3NTZhMmVfMy0zLTEtMS00Mjc5Mg_ebfb0475-f09d-4a88-bcc0-10fc818ec083">413,395</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xNi9mcmFnOjZjYzAzOTMyMGFhZjRjYmQ5M2QwZTYxZTBlY2Q5NTViL3RhYmxlOjM5NWNhYWJhZDg1MzQ3NGQ5ZGI5Y2M1NTI5NzU2YTJlL3RhYmxlcmFuZ2U6Mzk1Y2FhYmFkODUzNDc0ZDlkYjljYzU1Mjk3NTZhMmVfMy01LTEtMS00Mjc5Mg_3b510e77-74b9-4101-b14f-5d9b0ee1a977">1,261,332</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic431430d1ab24120b4507025a722d73a_D20210101-20210930" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xNi9mcmFnOjZjYzAzOTMyMGFhZjRjYmQ5M2QwZTYxZTBlY2Q5NTViL3RhYmxlOjM5NWNhYWJhZDg1MzQ3NGQ5ZGI5Y2M1NTI5NzU2YTJlL3RhYmxlcmFuZ2U6Mzk1Y2FhYmFkODUzNDc0ZDlkYjljYzU1Mjk3NTZhMmVfMy03LTEtMS00Mjc5Mg_e8dac241-fabf-4b35-878a-2651de3655d9">1,148,253</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Cost of sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f3a96a832ab4b0ca374599d1c3e9bce_D20220701-20220930" decimals="-3" name="us-gaap:CostOfRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xNi9mcmFnOjZjYzAzOTMyMGFhZjRjYmQ5M2QwZTYxZTBlY2Q5NTViL3RhYmxlOjM5NWNhYWJhZDg1MzQ3NGQ5ZGI5Y2M1NTI5NzU2YTJlL3RhYmxlcmFuZ2U6Mzk1Y2FhYmFkODUzNDc0ZDlkYjljYzU1Mjk3NTZhMmVfNC0xLTEtMS00Mjc5Mg_bc7aba9d-edce-4eb0-bdf3-0f042ad62b09">107,549</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bb5592686d74afab4f7004818fd6f9b_D20210701-20210930" decimals="-3" name="us-gaap:CostOfRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xNi9mcmFnOjZjYzAzOTMyMGFhZjRjYmQ5M2QwZTYxZTBlY2Q5NTViL3RhYmxlOjM5NWNhYWJhZDg1MzQ3NGQ5ZGI5Y2M1NTI5NzU2YTJlL3RhYmxlcmFuZ2U6Mzk1Y2FhYmFkODUzNDc0ZDlkYjljYzU1Mjk3NTZhMmVfNC0zLTEtMS00Mjc5Mg_c8f76e06-cd93-416b-a5de-9bcca24a98ee">106,338</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930" decimals="-3" name="us-gaap:CostOfRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xNi9mcmFnOjZjYzAzOTMyMGFhZjRjYmQ5M2QwZTYxZTBlY2Q5NTViL3RhYmxlOjM5NWNhYWJhZDg1MzQ3NGQ5ZGI5Y2M1NTI5NzU2YTJlL3RhYmxlcmFuZ2U6Mzk1Y2FhYmFkODUzNDc0ZDlkYjljYzU1Mjk3NTZhMmVfNC01LTEtMS00Mjc5Mg_5f398335-4177-483d-9c12-c7d77c69b52d">354,515</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic431430d1ab24120b4507025a722d73a_D20210101-20210930" decimals="-3" name="us-gaap:CostOfRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xNi9mcmFnOjZjYzAzOTMyMGFhZjRjYmQ5M2QwZTYxZTBlY2Q5NTViL3RhYmxlOjM5NWNhYWJhZDg1MzQ3NGQ5ZGI5Y2M1NTI5NzU2YTJlL3RhYmxlcmFuZ2U6Mzk1Y2FhYmFkODUzNDc0ZDlkYjljYzU1Mjk3NTZhMmVfNC03LTEtMS00Mjc5Mg_cb152896-80ad-49a0-8380-cb41658221d7">298,942</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Gross profit</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f3a96a832ab4b0ca374599d1c3e9bce_D20220701-20220930" decimals="-3" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xNi9mcmFnOjZjYzAzOTMyMGFhZjRjYmQ5M2QwZTYxZTBlY2Q5NTViL3RhYmxlOjM5NWNhYWJhZDg1MzQ3NGQ5ZGI5Y2M1NTI5NzU2YTJlL3RhYmxlcmFuZ2U6Mzk1Y2FhYmFkODUzNDc0ZDlkYjljYzU1Mjk3NTZhMmVfNS0xLTEtMS00Mjc5Mg_547362ab-fe50-4c8d-b9ec-61d6d6d0be11">282,849</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bb5592686d74afab4f7004818fd6f9b_D20210701-20210930" decimals="-3" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xNi9mcmFnOjZjYzAzOTMyMGFhZjRjYmQ5M2QwZTYxZTBlY2Q5NTViL3RhYmxlOjM5NWNhYWJhZDg1MzQ3NGQ5ZGI5Y2M1NTI5NzU2YTJlL3RhYmxlcmFuZ2U6Mzk1Y2FhYmFkODUzNDc0ZDlkYjljYzU1Mjk3NTZhMmVfNS0zLTEtMS00Mjc5Mg_40d1f606-5ea9-40c7-be5b-76bf91d68529">307,057</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930" decimals="-3" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xNi9mcmFnOjZjYzAzOTMyMGFhZjRjYmQ5M2QwZTYxZTBlY2Q5NTViL3RhYmxlOjM5NWNhYWJhZDg1MzQ3NGQ5ZGI5Y2M1NTI5NzU2YTJlL3RhYmxlcmFuZ2U6Mzk1Y2FhYmFkODUzNDc0ZDlkYjljYzU1Mjk3NTZhMmVfNS01LTEtMS00Mjc5Mg_70895429-6ba7-4b1f-b5ad-01664e7b4373">906,817</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic431430d1ab24120b4507025a722d73a_D20210101-20210930" decimals="-3" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xNi9mcmFnOjZjYzAzOTMyMGFhZjRjYmQ5M2QwZTYxZTBlY2Q5NTViL3RhYmxlOjM5NWNhYWJhZDg1MzQ3NGQ5ZGI5Y2M1NTI5NzU2YTJlL3RhYmxlcmFuZ2U6Mzk1Y2FhYmFkODUzNDc0ZDlkYjljYzU1Mjk3NTZhMmVfNS03LTEtMS00Mjc5Mg_1eb56662-c1eb-4d0c-a720-c70412db3fb2">849,311</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Selling, general, and administrative</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f3a96a832ab4b0ca374599d1c3e9bce_D20220701-20220930" decimals="-3" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xNi9mcmFnOjZjYzAzOTMyMGFhZjRjYmQ5M2QwZTYxZTBlY2Q5NTViL3RhYmxlOjM5NWNhYWJhZDg1MzQ3NGQ5ZGI5Y2M1NTI5NzU2YTJlL3RhYmxlcmFuZ2U6Mzk1Y2FhYmFkODUzNDc0ZDlkYjljYzU1Mjk3NTZhMmVfNy0xLTEtMS00Mjc5Mg_9ae7a2d0-7896-408f-b623-04bd21e6515d">234,693</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bb5592686d74afab4f7004818fd6f9b_D20210701-20210930" decimals="-3" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xNi9mcmFnOjZjYzAzOTMyMGFhZjRjYmQ5M2QwZTYxZTBlY2Q5NTViL3RhYmxlOjM5NWNhYWJhZDg1MzQ3NGQ5ZGI5Y2M1NTI5NzU2YTJlL3RhYmxlcmFuZ2U6Mzk1Y2FhYmFkODUzNDc0ZDlkYjljYzU1Mjk3NTZhMmVfNy0zLTEtMS00Mjc5Mg_55fa7b2a-81fd-4386-91f6-9c2374bec3de">251,886</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930" decimals="-3" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xNi9mcmFnOjZjYzAzOTMyMGFhZjRjYmQ5M2QwZTYxZTBlY2Q5NTViL3RhYmxlOjM5NWNhYWJhZDg1MzQ3NGQ5ZGI5Y2M1NTI5NzU2YTJlL3RhYmxlcmFuZ2U6Mzk1Y2FhYmFkODUzNDc0ZDlkYjljYzU1Mjk3NTZhMmVfNy01LTEtMS00Mjc5Mg_dd1503ef-1e50-4d0b-9123-fadcdef0236b">754,610</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic431430d1ab24120b4507025a722d73a_D20210101-20210930" decimals="-3" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xNi9mcmFnOjZjYzAzOTMyMGFhZjRjYmQ5M2QwZTYxZTBlY2Q5NTViL3RhYmxlOjM5NWNhYWJhZDg1MzQ3NGQ5ZGI5Y2M1NTI5NzU2YTJlL3RhYmxlcmFuZ2U6Mzk1Y2FhYmFkODUzNDc0ZDlkYjljYzU1Mjk3NTZhMmVfNy03LTEtMS00Mjc5Mg_a5a27ef7-f500-481d-ac45-d10860eb4981">679,907</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Income from operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f3a96a832ab4b0ca374599d1c3e9bce_D20220701-20220930" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xNi9mcmFnOjZjYzAzOTMyMGFhZjRjYmQ5M2QwZTYxZTBlY2Q5NTViL3RhYmxlOjM5NWNhYWJhZDg1MzQ3NGQ5ZGI5Y2M1NTI5NzU2YTJlL3RhYmxlcmFuZ2U6Mzk1Y2FhYmFkODUzNDc0ZDlkYjljYzU1Mjk3NTZhMmVfOS0xLTEtMS00Mjc5Mg_41174499-04fe-482c-bb13-de35c598ad61">48,156</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bb5592686d74afab4f7004818fd6f9b_D20210701-20210930" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xNi9mcmFnOjZjYzAzOTMyMGFhZjRjYmQ5M2QwZTYxZTBlY2Q5NTViL3RhYmxlOjM5NWNhYWJhZDg1MzQ3NGQ5ZGI5Y2M1NTI5NzU2YTJlL3RhYmxlcmFuZ2U6Mzk1Y2FhYmFkODUzNDc0ZDlkYjljYzU1Mjk3NTZhMmVfOS0zLTEtMS00Mjc5Mg_4a189f56-c8fa-40d8-acf0-29455ba112bc">55,171</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xNi9mcmFnOjZjYzAzOTMyMGFhZjRjYmQ5M2QwZTYxZTBlY2Q5NTViL3RhYmxlOjM5NWNhYWJhZDg1MzQ3NGQ5ZGI5Y2M1NTI5NzU2YTJlL3RhYmxlcmFuZ2U6Mzk1Y2FhYmFkODUzNDc0ZDlkYjljYzU1Mjk3NTZhMmVfOS01LTEtMS00Mjc5Mg_f72758a3-7e23-4c9b-b0cf-5e09161db4da">152,207</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic431430d1ab24120b4507025a722d73a_D20210101-20210930" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xNi9mcmFnOjZjYzAzOTMyMGFhZjRjYmQ5M2QwZTYxZTBlY2Q5NTViL3RhYmxlOjM5NWNhYWJhZDg1MzQ3NGQ5ZGI5Y2M1NTI5NzU2YTJlL3RhYmxlcmFuZ2U6Mzk1Y2FhYmFkODUzNDc0ZDlkYjljYzU1Mjk3NTZhMmVfOS03LTEtMS00Mjc5Mg_140669f1-2f84-410e-88b7-71adbc08ae97">169,404</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Other income (expense)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Interest expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2f3a96a832ab4b0ca374599d1c3e9bce_D20220701-20220930" decimals="-3" sign="-" name="us-gaap:InterestIncomeExpenseNonoperatingNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xNi9mcmFnOjZjYzAzOTMyMGFhZjRjYmQ5M2QwZTYxZTBlY2Q5NTViL3RhYmxlOjM5NWNhYWJhZDg1MzQ3NGQ5ZGI5Y2M1NTI5NzU2YTJlL3RhYmxlcmFuZ2U6Mzk1Y2FhYmFkODUzNDc0ZDlkYjljYzU1Mjk3NTZhMmVfMTItMS0xLTEtNDI3OTI_88fdb537-99fb-4ead-9950-f8c98b13d954">261</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3bb5592686d74afab4f7004818fd6f9b_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:InterestIncomeExpenseNonoperatingNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xNi9mcmFnOjZjYzAzOTMyMGFhZjRjYmQ5M2QwZTYxZTBlY2Q5NTViL3RhYmxlOjM5NWNhYWJhZDg1MzQ3NGQ5ZGI5Y2M1NTI5NzU2YTJlL3RhYmxlcmFuZ2U6Mzk1Y2FhYmFkODUzNDc0ZDlkYjljYzU1Mjk3NTZhMmVfMTItMy0xLTEtNDI3OTI_df3f366f-fcb6-4268-8b33-0bd0cb97ca9e">94</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:InterestIncomeExpenseNonoperatingNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xNi9mcmFnOjZjYzAzOTMyMGFhZjRjYmQ5M2QwZTYxZTBlY2Q5NTViL3RhYmxlOjM5NWNhYWJhZDg1MzQ3NGQ5ZGI5Y2M1NTI5NzU2YTJlL3RhYmxlcmFuZ2U6Mzk1Y2FhYmFkODUzNDc0ZDlkYjljYzU1Mjk3NTZhMmVfMTItNS0xLTEtNDI3OTI_7c514816-ae6d-4594-ba8c-bd82b0a295c9">519</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic431430d1ab24120b4507025a722d73a_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:InterestIncomeExpenseNonoperatingNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xNi9mcmFnOjZjYzAzOTMyMGFhZjRjYmQ5M2QwZTYxZTBlY2Q5NTViL3RhYmxlOjM5NWNhYWJhZDg1MzQ3NGQ5ZGI5Y2M1NTI5NzU2YTJlL3RhYmxlcmFuZ2U6Mzk1Y2FhYmFkODUzNDc0ZDlkYjljYzU1Mjk3NTZhMmVfMTItNy0xLTEtNDI3OTI_f3583b37-de98-4f34-aa78-3d6c4ff77bd1">138</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Other income (expense)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2f3a96a832ab4b0ca374599d1c3e9bce_D20220701-20220930" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xNi9mcmFnOjZjYzAzOTMyMGFhZjRjYmQ5M2QwZTYxZTBlY2Q5NTViL3RhYmxlOjM5NWNhYWJhZDg1MzQ3NGQ5ZGI5Y2M1NTI5NzU2YTJlL3RhYmxlcmFuZ2U6Mzk1Y2FhYmFkODUzNDc0ZDlkYjljYzU1Mjk3NTZhMmVfMTMtMS0xLTEtNDI3OTI_de7fc987-c7d5-465f-86b6-d1b246c7d425">17</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bb5592686d74afab4f7004818fd6f9b_D20210701-20210930" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xNi9mcmFnOjZjYzAzOTMyMGFhZjRjYmQ5M2QwZTYxZTBlY2Q5NTViL3RhYmxlOjM5NWNhYWJhZDg1MzQ3NGQ5ZGI5Y2M1NTI5NzU2YTJlL3RhYmxlcmFuZ2U6Mzk1Y2FhYmFkODUzNDc0ZDlkYjljYzU1Mjk3NTZhMmVfMTMtMy0xLTEtNDI3OTI_4fbf4db5-3b8d-4e83-aefc-e7c39eefa2e5">115</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xNi9mcmFnOjZjYzAzOTMyMGFhZjRjYmQ5M2QwZTYxZTBlY2Q5NTViL3RhYmxlOjM5NWNhYWJhZDg1MzQ3NGQ5ZGI5Y2M1NTI5NzU2YTJlL3RhYmxlcmFuZ2U6Mzk1Y2FhYmFkODUzNDc0ZDlkYjljYzU1Mjk3NTZhMmVfMTMtNS0xLTEtNDI3OTI_ac952459-53ce-4250-8612-3bcba4a72c7c">37</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic431430d1ab24120b4507025a722d73a_D20210101-20210930" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xNi9mcmFnOjZjYzAzOTMyMGFhZjRjYmQ5M2QwZTYxZTBlY2Q5NTViL3RhYmxlOjM5NWNhYWJhZDg1MzQ3NGQ5ZGI5Y2M1NTI5NzU2YTJlL3RhYmxlcmFuZ2U6Mzk1Y2FhYmFkODUzNDc0ZDlkYjljYzU1Mjk3NTZhMmVfMTMtNy0xLTEtNDI3OTI_cc597800-677b-436e-8643-90ea5f106b95">112</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2f3a96a832ab4b0ca374599d1c3e9bce_D20220701-20220930" decimals="-3" sign="-" name="us-gaap:NonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xNi9mcmFnOjZjYzAzOTMyMGFhZjRjYmQ5M2QwZTYxZTBlY2Q5NTViL3RhYmxlOjM5NWNhYWJhZDg1MzQ3NGQ5ZGI5Y2M1NTI5NzU2YTJlL3RhYmxlcmFuZ2U6Mzk1Y2FhYmFkODUzNDc0ZDlkYjljYzU1Mjk3NTZhMmVfMTQtMS0xLTEtNDI3OTI_81b1d080-8ef5-451c-84a8-484d69d055c1">278</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bb5592686d74afab4f7004818fd6f9b_D20210701-20210930" decimals="-3" name="us-gaap:NonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xNi9mcmFnOjZjYzAzOTMyMGFhZjRjYmQ5M2QwZTYxZTBlY2Q5NTViL3RhYmxlOjM5NWNhYWJhZDg1MzQ3NGQ5ZGI5Y2M1NTI5NzU2YTJlL3RhYmxlcmFuZ2U6Mzk1Y2FhYmFkODUzNDc0ZDlkYjljYzU1Mjk3NTZhMmVfMTQtMy0xLTEtNDI3OTI_0f64cb07-6a09-45f7-8ff4-53965f5c4618">21</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:NonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xNi9mcmFnOjZjYzAzOTMyMGFhZjRjYmQ5M2QwZTYxZTBlY2Q5NTViL3RhYmxlOjM5NWNhYWJhZDg1MzQ3NGQ5ZGI5Y2M1NTI5NzU2YTJlL3RhYmxlcmFuZ2U6Mzk1Y2FhYmFkODUzNDc0ZDlkYjljYzU1Mjk3NTZhMmVfMTQtNS0xLTEtNDI3OTI_0f3fa899-ba1b-494f-a6be-4deee977da63">556</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic431430d1ab24120b4507025a722d73a_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:NonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xNi9mcmFnOjZjYzAzOTMyMGFhZjRjYmQ5M2QwZTYxZTBlY2Q5NTViL3RhYmxlOjM5NWNhYWJhZDg1MzQ3NGQ5ZGI5Y2M1NTI5NzU2YTJlL3RhYmxlcmFuZ2U6Mzk1Y2FhYmFkODUzNDc0ZDlkYjljYzU1Mjk3NTZhMmVfMTQtNy0xLTEtNDI3OTI_7e7ff5e7-03d9-4504-b377-97656f632ef8">26</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Income from operations before income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f3a96a832ab4b0ca374599d1c3e9bce_D20220701-20220930" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xNi9mcmFnOjZjYzAzOTMyMGFhZjRjYmQ5M2QwZTYxZTBlY2Q5NTViL3RhYmxlOjM5NWNhYWJhZDg1MzQ3NGQ5ZGI5Y2M1NTI5NzU2YTJlL3RhYmxlcmFuZ2U6Mzk1Y2FhYmFkODUzNDc0ZDlkYjljYzU1Mjk3NTZhMmVfMTYtMS0xLTEtNDI3OTI_238b6f9e-9726-4039-ae6d-0399d8082f9f">47,878</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bb5592686d74afab4f7004818fd6f9b_D20210701-20210930" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xNi9mcmFnOjZjYzAzOTMyMGFhZjRjYmQ5M2QwZTYxZTBlY2Q5NTViL3RhYmxlOjM5NWNhYWJhZDg1MzQ3NGQ5ZGI5Y2M1NTI5NzU2YTJlL3RhYmxlcmFuZ2U6Mzk1Y2FhYmFkODUzNDc0ZDlkYjljYzU1Mjk3NTZhMmVfMTYtMy0xLTEtNDI3OTI_5c750045-2afc-4278-9c58-8d2eec871d3b">55,192</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xNi9mcmFnOjZjYzAzOTMyMGFhZjRjYmQ5M2QwZTYxZTBlY2Q5NTViL3RhYmxlOjM5NWNhYWJhZDg1MzQ3NGQ5ZGI5Y2M1NTI5NzU2YTJlL3RhYmxlcmFuZ2U6Mzk1Y2FhYmFkODUzNDc0ZDlkYjljYzU1Mjk3NTZhMmVfMTYtNS0xLTEtNDI3OTI_0cca4fd9-54e7-4c8d-91ff-5fc428281faf">151,651</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic431430d1ab24120b4507025a722d73a_D20210101-20210930" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xNi9mcmFnOjZjYzAzOTMyMGFhZjRjYmQ5M2QwZTYxZTBlY2Q5NTViL3RhYmxlOjM5NWNhYWJhZDg1MzQ3NGQ5ZGI5Y2M1NTI5NzU2YTJlL3RhYmxlcmFuZ2U6Mzk1Y2FhYmFkODUzNDc0ZDlkYjljYzU1Mjk3NTZhMmVfMTYtNy0xLTEtNDI3OTI_0353e287-e4f0-4db2-91fe-8533f1642ba0">169,378</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Provision for income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f3a96a832ab4b0ca374599d1c3e9bce_D20220701-20220930" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xNi9mcmFnOjZjYzAzOTMyMGFhZjRjYmQ5M2QwZTYxZTBlY2Q5NTViL3RhYmxlOjM5NWNhYWJhZDg1MzQ3NGQ5ZGI5Y2M1NTI5NzU2YTJlL3RhYmxlcmFuZ2U6Mzk1Y2FhYmFkODUzNDc0ZDlkYjljYzU1Mjk3NTZhMmVfMTgtMS0xLTEtNDI3OTI_37333495-cab2-4095-b2fb-99e8afb13582">11,723</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bb5592686d74afab4f7004818fd6f9b_D20210701-20210930" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xNi9mcmFnOjZjYzAzOTMyMGFhZjRjYmQ5M2QwZTYxZTBlY2Q5NTViL3RhYmxlOjM5NWNhYWJhZDg1MzQ3NGQ5ZGI5Y2M1NTI5NzU2YTJlL3RhYmxlcmFuZ2U6Mzk1Y2FhYmFkODUzNDc0ZDlkYjljYzU1Mjk3NTZhMmVfMTgtMy0xLTEtNDI3OTI_b3551f54-2735-470a-bf94-38b0e31efbe4">13,210</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xNi9mcmFnOjZjYzAzOTMyMGFhZjRjYmQ5M2QwZTYxZTBlY2Q5NTViL3RhYmxlOjM5NWNhYWJhZDg1MzQ3NGQ5ZGI5Y2M1NTI5NzU2YTJlL3RhYmxlcmFuZ2U6Mzk1Y2FhYmFkODUzNDc0ZDlkYjljYzU1Mjk3NTZhMmVfMTgtNS0xLTEtNDI3OTI_e3c0507a-be8a-4091-a798-e54568896850">34,601</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic431430d1ab24120b4507025a722d73a_D20210101-20210930" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xNi9mcmFnOjZjYzAzOTMyMGFhZjRjYmQ5M2QwZTYxZTBlY2Q5NTViL3RhYmxlOjM5NWNhYWJhZDg1MzQ3NGQ5ZGI5Y2M1NTI5NzU2YTJlL3RhYmxlcmFuZ2U6Mzk1Y2FhYmFkODUzNDc0ZDlkYjljYzU1Mjk3NTZhMmVfMTgtNy0xLTEtNDI3OTI_e8972e8c-46ec-4446-897a-6b2490812549">39,370</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Net income</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f3a96a832ab4b0ca374599d1c3e9bce_D20220701-20220930" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xNi9mcmFnOjZjYzAzOTMyMGFhZjRjYmQ5M2QwZTYxZTBlY2Q5NTViL3RhYmxlOjM5NWNhYWJhZDg1MzQ3NGQ5ZGI5Y2M1NTI5NzU2YTJlL3RhYmxlcmFuZ2U6Mzk1Y2FhYmFkODUzNDc0ZDlkYjljYzU1Mjk3NTZhMmVfMjAtMS0xLTEtNDI3OTI_a8dda91d-2175-496c-9f08-a26d7da54d28">36,155</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bb5592686d74afab4f7004818fd6f9b_D20210701-20210930" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xNi9mcmFnOjZjYzAzOTMyMGFhZjRjYmQ5M2QwZTYxZTBlY2Q5NTViL3RhYmxlOjM5NWNhYWJhZDg1MzQ3NGQ5ZGI5Y2M1NTI5NzU2YTJlL3RhYmxlcmFuZ2U6Mzk1Y2FhYmFkODUzNDc0ZDlkYjljYzU1Mjk3NTZhMmVfMjAtMy0xLTEtNDI3OTI_1debcfff-fbe8-498c-aa9f-09b9030d2bca">41,982</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xNi9mcmFnOjZjYzAzOTMyMGFhZjRjYmQ5M2QwZTYxZTBlY2Q5NTViL3RhYmxlOjM5NWNhYWJhZDg1MzQ3NGQ5ZGI5Y2M1NTI5NzU2YTJlL3RhYmxlcmFuZ2U6Mzk1Y2FhYmFkODUzNDc0ZDlkYjljYzU1Mjk3NTZhMmVfMjAtNS0xLTEtNDI3OTI_80832123-86c4-453b-95cf-1adedabcc4d8">117,050</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic431430d1ab24120b4507025a722d73a_D20210101-20210930" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xNi9mcmFnOjZjYzAzOTMyMGFhZjRjYmQ5M2QwZTYxZTBlY2Q5NTViL3RhYmxlOjM5NWNhYWJhZDg1MzQ3NGQ5ZGI5Y2M1NTI5NzU2YTJlL3RhYmxlcmFuZ2U6Mzk1Y2FhYmFkODUzNDc0ZDlkYjljYzU1Mjk3NTZhMmVfMjAtNy0xLTEtNDI3OTI_613b68c5-10ac-4dab-8b25-62d4a8bef4e3">130,008</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Earnings per share - basic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i2f3a96a832ab4b0ca374599d1c3e9bce_D20220701-20220930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xNi9mcmFnOjZjYzAzOTMyMGFhZjRjYmQ5M2QwZTYxZTBlY2Q5NTViL3RhYmxlOjM5NWNhYWJhZDg1MzQ3NGQ5ZGI5Y2M1NTI5NzU2YTJlL3RhYmxlcmFuZ2U6Mzk1Y2FhYmFkODUzNDc0ZDlkYjljYzU1Mjk3NTZhMmVfMjItMS0xLTEtNDI3OTI_f779a94b-ce2b-4784-a0d9-d8551bea32dc">3.30</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i3bb5592686d74afab4f7004818fd6f9b_D20210701-20210930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xNi9mcmFnOjZjYzAzOTMyMGFhZjRjYmQ5M2QwZTYxZTBlY2Q5NTViL3RhYmxlOjM5NWNhYWJhZDg1MzQ3NGQ5ZGI5Y2M1NTI5NzU2YTJlL3RhYmxlcmFuZ2U6Mzk1Y2FhYmFkODUzNDc0ZDlkYjljYzU1Mjk3NTZhMmVfMjItMy0xLTEtNDI3OTI_a680f3d5-ff6b-4e4d-ad85-e6aaa347b2f8">3.59</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xNi9mcmFnOjZjYzAzOTMyMGFhZjRjYmQ5M2QwZTYxZTBlY2Q5NTViL3RhYmxlOjM5NWNhYWJhZDg1MzQ3NGQ5ZGI5Y2M1NTI5NzU2YTJlL3RhYmxlcmFuZ2U6Mzk1Y2FhYmFkODUzNDc0ZDlkYjljYzU1Mjk3NTZhMmVfMjItNS0xLTEtNDI3OTI_0beb3564-2177-493c-8520-7781c4d83775">10.37</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ic431430d1ab24120b4507025a722d73a_D20210101-20210930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xNi9mcmFnOjZjYzAzOTMyMGFhZjRjYmQ5M2QwZTYxZTBlY2Q5NTViL3RhYmxlOjM5NWNhYWJhZDg1MzQ3NGQ5ZGI5Y2M1NTI5NzU2YTJlL3RhYmxlcmFuZ2U6Mzk1Y2FhYmFkODUzNDc0ZDlkYjljYzU1Mjk3NTZhMmVfMjItNy0xLTEtNDI3OTI_e7ffab24-513c-49a0-a6e3-3c22d450c7fb">11.07</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Earnings per share - diluted</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i2f3a96a832ab4b0ca374599d1c3e9bce_D20220701-20220930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xNi9mcmFnOjZjYzAzOTMyMGFhZjRjYmQ5M2QwZTYxZTBlY2Q5NTViL3RhYmxlOjM5NWNhYWJhZDg1MzQ3NGQ5ZGI5Y2M1NTI5NzU2YTJlL3RhYmxlcmFuZ2U6Mzk1Y2FhYmFkODUzNDc0ZDlkYjljYzU1Mjk3NTZhMmVfMjQtMS0xLTEtNDI3OTI_284aa335-cd1c-4a90-abba-cb4db81aece0">3.27</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i3bb5592686d74afab4f7004818fd6f9b_D20210701-20210930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xNi9mcmFnOjZjYzAzOTMyMGFhZjRjYmQ5M2QwZTYxZTBlY2Q5NTViL3RhYmxlOjM5NWNhYWJhZDg1MzQ3NGQ5ZGI5Y2M1NTI5NzU2YTJlL3RhYmxlcmFuZ2U6Mzk1Y2FhYmFkODUzNDc0ZDlkYjljYzU1Mjk3NTZhMmVfMjQtMy0xLTEtNDI3OTI_7630d1ab-db8c-48a4-a4d8-71d495566801">3.56</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xNi9mcmFnOjZjYzAzOTMyMGFhZjRjYmQ5M2QwZTYxZTBlY2Q5NTViL3RhYmxlOjM5NWNhYWJhZDg1MzQ3NGQ5ZGI5Y2M1NTI5NzU2YTJlL3RhYmxlcmFuZ2U6Mzk1Y2FhYmFkODUzNDc0ZDlkYjljYzU1Mjk3NTZhMmVfMjQtNS0xLTEtNDI3OTI_6fdcb574-4b2b-41bd-8740-30541ba9e5ad">10.30</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ic431430d1ab24120b4507025a722d73a_D20210101-20210930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xNi9mcmFnOjZjYzAzOTMyMGFhZjRjYmQ5M2QwZTYxZTBlY2Q5NTViL3RhYmxlOjM5NWNhYWJhZDg1MzQ3NGQ5ZGI5Y2M1NTI5NzU2YTJlL3RhYmxlcmFuZ2U6Mzk1Y2FhYmFkODUzNDc0ZDlkYjljYzU1Mjk3NTZhMmVfMjQtNy0xLTEtNDI3OTI_83e55467-43c8-4ea0-b605-65fbbc041180">10.98</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Weighted average shares outstanding </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Basic</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2f3a96a832ab4b0ca374599d1c3e9bce_D20220701-20220930" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xNi9mcmFnOjZjYzAzOTMyMGFhZjRjYmQ5M2QwZTYxZTBlY2Q5NTViL3RhYmxlOjM5NWNhYWJhZDg1MzQ3NGQ5ZGI5Y2M1NTI5NzU2YTJlL3RhYmxlcmFuZ2U6Mzk1Y2FhYmFkODUzNDc0ZDlkYjljYzU1Mjk3NTZhMmVfMjctMS0xLTEtNDI3OTI_f898d3ca-f97f-4e85-983a-deb6e6fd412c">10,964</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3bb5592686d74afab4f7004818fd6f9b_D20210701-20210930" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xNi9mcmFnOjZjYzAzOTMyMGFhZjRjYmQ5M2QwZTYxZTBlY2Q5NTViL3RhYmxlOjM5NWNhYWJhZDg1MzQ3NGQ5ZGI5Y2M1NTI5NzU2YTJlL3RhYmxlcmFuZ2U6Mzk1Y2FhYmFkODUzNDc0ZDlkYjljYzU1Mjk3NTZhMmVfMjctMy0xLTEtNDI3OTI_4a9b94b8-a6e9-4989-b54c-3efaffe200c8">11,692</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xNi9mcmFnOjZjYzAzOTMyMGFhZjRjYmQ5M2QwZTYxZTBlY2Q5NTViL3RhYmxlOjM5NWNhYWJhZDg1MzQ3NGQ5ZGI5Y2M1NTI5NzU2YTJlL3RhYmxlcmFuZ2U6Mzk1Y2FhYmFkODUzNDc0ZDlkYjljYzU1Mjk3NTZhMmVfMjctNS0xLTEtNDI3OTI_5b0062bc-29de-40ee-8380-519244f7cbfc">11,290</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic431430d1ab24120b4507025a722d73a_D20210101-20210930" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xNi9mcmFnOjZjYzAzOTMyMGFhZjRjYmQ5M2QwZTYxZTBlY2Q5NTViL3RhYmxlOjM5NWNhYWJhZDg1MzQ3NGQ5ZGI5Y2M1NTI5NzU2YTJlL3RhYmxlcmFuZ2U6Mzk1Y2FhYmFkODUzNDc0ZDlkYjljYzU1Mjk3NTZhMmVfMjctNy0xLTEtNDI3OTI_53a9fe20-f7b4-440a-932c-59fe5edf5cf4">11,739</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Diluted</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2f3a96a832ab4b0ca374599d1c3e9bce_D20220701-20220930" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xNi9mcmFnOjZjYzAzOTMyMGFhZjRjYmQ5M2QwZTYxZTBlY2Q5NTViL3RhYmxlOjM5NWNhYWJhZDg1MzQ3NGQ5ZGI5Y2M1NTI5NzU2YTJlL3RhYmxlcmFuZ2U6Mzk1Y2FhYmFkODUzNDc0ZDlkYjljYzU1Mjk3NTZhMmVfMjgtMS0xLTEtNDI3OTI_84cb14e3-f772-485f-8732-41831c32018f">11,042</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3bb5592686d74afab4f7004818fd6f9b_D20210701-20210930" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xNi9mcmFnOjZjYzAzOTMyMGFhZjRjYmQ5M2QwZTYxZTBlY2Q5NTViL3RhYmxlOjM5NWNhYWJhZDg1MzQ3NGQ5ZGI5Y2M1NTI5NzU2YTJlL3RhYmxlcmFuZ2U6Mzk1Y2FhYmFkODUzNDc0ZDlkYjljYzU1Mjk3NTZhMmVfMjgtMy0xLTEtNDI3OTI_2aff0e75-9228-4ea3-9954-217c28edb259">11,785</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xNi9mcmFnOjZjYzAzOTMyMGFhZjRjYmQ5M2QwZTYxZTBlY2Q5NTViL3RhYmxlOjM5NWNhYWJhZDg1MzQ3NGQ5ZGI5Y2M1NTI5NzU2YTJlL3RhYmxlcmFuZ2U6Mzk1Y2FhYmFkODUzNDc0ZDlkYjljYzU1Mjk3NTZhMmVfMjgtNS0xLTEtNDI3OTI_29f83474-b0d0-4714-87bc-f322e657534f">11,369</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic431430d1ab24120b4507025a722d73a_D20210101-20210930" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xNi9mcmFnOjZjYzAzOTMyMGFhZjRjYmQ5M2QwZTYxZTBlY2Q5NTViL3RhYmxlOjM5NWNhYWJhZDg1MzQ3NGQ5ZGI5Y2M1NTI5NzU2YTJlL3RhYmxlcmFuZ2U6Mzk1Y2FhYmFkODUzNDc0ZDlkYjljYzU1Mjk3NTZhMmVfMjgtNy0xLTEtNDI3OTI_86928965-7a7c-43de-8636-bee6945313b6">11,840</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Cash dividends declared per share</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i2f3a96a832ab4b0ca374599d1c3e9bce_D20220701-20220930" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xNi9mcmFnOjZjYzAzOTMyMGFhZjRjYmQ5M2QwZTYxZTBlY2Q5NTViL3RhYmxlOjM5NWNhYWJhZDg1MzQ3NGQ5ZGI5Y2M1NTI5NzU2YTJlL3RhYmxlcmFuZ2U6Mzk1Y2FhYmFkODUzNDc0ZDlkYjljYzU1Mjk3NTZhMmVfMzAtMS0xLTEtNDI3OTI_0f6f5ae2-516b-44ae-8a62-74073969d4c9">1.64</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i3bb5592686d74afab4f7004818fd6f9b_D20210701-20210930" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xNi9mcmFnOjZjYzAzOTMyMGFhZjRjYmQ5M2QwZTYxZTBlY2Q5NTViL3RhYmxlOjM5NWNhYWJhZDg1MzQ3NGQ5ZGI5Y2M1NTI5NzU2YTJlL3RhYmxlcmFuZ2U6Mzk1Y2FhYmFkODUzNDc0ZDlkYjljYzU1Mjk3NTZhMmVfMzAtMy0xLTEtNDI3OTI_04efb8ad-6d52-478e-87e8-cf3cd9030819">1.42</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xNi9mcmFnOjZjYzAzOTMyMGFhZjRjYmQ5M2QwZTYxZTBlY2Q5NTViL3RhYmxlOjM5NWNhYWJhZDg1MzQ3NGQ5ZGI5Y2M1NTI5NzU2YTJlL3RhYmxlcmFuZ2U6Mzk1Y2FhYmFkODUzNDc0ZDlkYjljYzU1Mjk3NTZhMmVfMzAtNS0xLTEtNDI3OTI_2c70e941-3712-4174-9737-b54556c0cca2">4.92</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ic431430d1ab24120b4507025a722d73a_D20210101-20210930" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xNi9mcmFnOjZjYzAzOTMyMGFhZjRjYmQ5M2QwZTYxZTBlY2Q5NTViL3RhYmxlOjM5NWNhYWJhZDg1MzQ3NGQ5ZGI5Y2M1NTI5NzU2YTJlL3RhYmxlcmFuZ2U6Mzk1Y2FhYmFkODUzNDc0ZDlkYjljYzU1Mjk3NTZhMmVfMzAtNy0xLTEtNDI3OTI_66d402ed-c5a7-4621-a509-ebecb27e1b85">4.26</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these condensed consolidated financial statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">2</span></div></div></div><div id="ic8ae413b3ff34d56976502c585fa6ab3_19"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:21.6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#ic8ae413b3ff34d56976502c585fa6ab3_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">MEDIFAST, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (UNAUDITED)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(U.S. dollars in thousands)</span></div><div style="margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.607%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.303%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine months ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Net income</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f3a96a832ab4b0ca374599d1c3e9bce_D20220701-20220930" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xOS9mcmFnOjBhMzgwODEwMmVmMjQxNjFhNjQxNDgwMjQ5MGRjZjNlL3RhYmxlOjI4M2VkZmNkZjU3MjQxNjU5ODA3MGMxNWQ3NmVkMmYxL3RhYmxlcmFuZ2U6MjgzZWRmY2RmNTcyNDE2NTk4MDcwYzE1ZDc2ZWQyZjFfMy0xLTEtMS00Mjc5Mg_3951fec1-2c4e-4289-882e-e623ae4bde4d">36,155</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bb5592686d74afab4f7004818fd6f9b_D20210701-20210930" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xOS9mcmFnOjBhMzgwODEwMmVmMjQxNjFhNjQxNDgwMjQ5MGRjZjNlL3RhYmxlOjI4M2VkZmNkZjU3MjQxNjU5ODA3MGMxNWQ3NmVkMmYxL3RhYmxlcmFuZ2U6MjgzZWRmY2RmNTcyNDE2NTk4MDcwYzE1ZDc2ZWQyZjFfMy0zLTEtMS00Mjc5Mg_5c8c19ea-df2f-4e1b-8744-b891f6d1fa4b">41,982</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xOS9mcmFnOjBhMzgwODEwMmVmMjQxNjFhNjQxNDgwMjQ5MGRjZjNlL3RhYmxlOjI4M2VkZmNkZjU3MjQxNjU5ODA3MGMxNWQ3NmVkMmYxL3RhYmxlcmFuZ2U6MjgzZWRmY2RmNTcyNDE2NTk4MDcwYzE1ZDc2ZWQyZjFfMy01LTEtMS00Mjc5Mg_5f2d8789-0c10-4075-aaaa-ee3bc16ad713">117,050</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic431430d1ab24120b4507025a722d73a_D20210101-20210930" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xOS9mcmFnOjBhMzgwODEwMmVmMjQxNjFhNjQxNDgwMjQ5MGRjZjNlL3RhYmxlOjI4M2VkZmNkZjU3MjQxNjU5ODA3MGMxNWQ3NmVkMmYxL3RhYmxlcmFuZ2U6MjgzZWRmY2RmNTcyNDE2NTk4MDcwYzE1ZDc2ZWQyZjFfMy03LTEtMS00Mjc5Mg_98041895-14f6-4055-8e4f-47c4b383463b">130,008</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Other comprehensive income (loss), net of tax:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Foreign currency translation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f3a96a832ab4b0ca374599d1c3e9bce_D20220701-20220930" decimals="-3" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xOS9mcmFnOjBhMzgwODEwMmVmMjQxNjFhNjQxNDgwMjQ5MGRjZjNlL3RhYmxlOjI4M2VkZmNkZjU3MjQxNjU5ODA3MGMxNWQ3NmVkMmYxL3RhYmxlcmFuZ2U6MjgzZWRmY2RmNTcyNDE2NTk4MDcwYzE1ZDc2ZWQyZjFfNi0xLTEtMS00Mjc5Mg_5d036f59-ec23-4879-845c-44d898833a14">123</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bb5592686d74afab4f7004818fd6f9b_D20210701-20210930" decimals="-3" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xOS9mcmFnOjBhMzgwODEwMmVmMjQxNjFhNjQxNDgwMjQ5MGRjZjNlL3RhYmxlOjI4M2VkZmNkZjU3MjQxNjU5ODA3MGMxNWQ3NmVkMmYxL3RhYmxlcmFuZ2U6MjgzZWRmY2RmNTcyNDE2NTk4MDcwYzE1ZDc2ZWQyZjFfNi0zLTEtMS00Mjc5Mg_0a6dcb24-c766-4b67-92d2-7ee1d6712bf3">63</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930" decimals="-3" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xOS9mcmFnOjBhMzgwODEwMmVmMjQxNjFhNjQxNDgwMjQ5MGRjZjNlL3RhYmxlOjI4M2VkZmNkZjU3MjQxNjU5ODA3MGMxNWQ3NmVkMmYxL3RhYmxlcmFuZ2U6MjgzZWRmY2RmNTcyNDE2NTk4MDcwYzE1ZDc2ZWQyZjFfNi01LTEtMS00Mjc5Mg_191eae13-0cb9-4d34-8995-2278cf0e9684">300</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic431430d1ab24120b4507025a722d73a_D20210101-20210930" decimals="-3" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xOS9mcmFnOjBhMzgwODEwMmVmMjQxNjFhNjQxNDgwMjQ5MGRjZjNlL3RhYmxlOjI4M2VkZmNkZjU3MjQxNjU5ODA3MGMxNWQ3NmVkMmYxL3RhYmxlcmFuZ2U6MjgzZWRmY2RmNTcyNDE2NTk4MDcwYzE1ZDc2ZWQyZjFfNi03LTEtMS00Mjc5Mg_8f9a1971-ab4c-413a-8ae2-8dd2628f3e2b">130</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Unrealized losses on investment securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f3a96a832ab4b0ca374599d1c3e9bce_D20220701-20220930" decimals="-3" name="us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xOS9mcmFnOjBhMzgwODEwMmVmMjQxNjFhNjQxNDgwMjQ5MGRjZjNlL3RhYmxlOjI4M2VkZmNkZjU3MjQxNjU5ODA3MGMxNWQ3NmVkMmYxL3RhYmxlcmFuZ2U6MjgzZWRmY2RmNTcyNDE2NTk4MDcwYzE1ZDc2ZWQyZjFfNy0xLTEtMS00Mjc5Mg_9c99dbcc-d625-4489-bcff-8a0956ab483b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3bb5592686d74afab4f7004818fd6f9b_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xOS9mcmFnOjBhMzgwODEwMmVmMjQxNjFhNjQxNDgwMjQ5MGRjZjNlL3RhYmxlOjI4M2VkZmNkZjU3MjQxNjU5ODA3MGMxNWQ3NmVkMmYxL3RhYmxlcmFuZ2U6MjgzZWRmY2RmNTcyNDE2NTk4MDcwYzE1ZDc2ZWQyZjFfNy0zLTEtMS00Mjc5Mg_7e4a5d2e-6264-46ee-b8a0-5cfb41e918da">16</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xOS9mcmFnOjBhMzgwODEwMmVmMjQxNjFhNjQxNDgwMjQ5MGRjZjNlL3RhYmxlOjI4M2VkZmNkZjU3MjQxNjU5ODA3MGMxNWQ3NmVkMmYxL3RhYmxlcmFuZ2U6MjgzZWRmY2RmNTcyNDE2NTk4MDcwYzE1ZDc2ZWQyZjFfNy01LTEtMS00Mjc5Mg_1f65e53a-f135-490f-98c7-99b79b8e6bed">21</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic431430d1ab24120b4507025a722d73a_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xOS9mcmFnOjBhMzgwODEwMmVmMjQxNjFhNjQxNDgwMjQ5MGRjZjNlL3RhYmxlOjI4M2VkZmNkZjU3MjQxNjU5ODA3MGMxNWQ3NmVkMmYxL3RhYmxlcmFuZ2U6MjgzZWRmY2RmNTcyNDE2NTk4MDcwYzE1ZDc2ZWQyZjFfNy03LTEtMS00Mjc5Mg_23aa749d-59ed-452d-a9ab-18972a552db7">49</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f3a96a832ab4b0ca374599d1c3e9bce_D20220701-20220930" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xOS9mcmFnOjBhMzgwODEwMmVmMjQxNjFhNjQxNDgwMjQ5MGRjZjNlL3RhYmxlOjI4M2VkZmNkZjU3MjQxNjU5ODA3MGMxNWQ3NmVkMmYxL3RhYmxlcmFuZ2U6MjgzZWRmY2RmNTcyNDE2NTk4MDcwYzE1ZDc2ZWQyZjFfOC0xLTEtMS00Mjc5Mg_ee7e9b48-c671-4224-a66d-da3958391922">123</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bb5592686d74afab4f7004818fd6f9b_D20210701-20210930" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xOS9mcmFnOjBhMzgwODEwMmVmMjQxNjFhNjQxNDgwMjQ5MGRjZjNlL3RhYmxlOjI4M2VkZmNkZjU3MjQxNjU5ODA3MGMxNWQ3NmVkMmYxL3RhYmxlcmFuZ2U6MjgzZWRmY2RmNTcyNDE2NTk4MDcwYzE1ZDc2ZWQyZjFfOC0zLTEtMS00Mjc5Mg_41e4df67-2aa7-45e1-89e2-94b66acdda56">47</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xOS9mcmFnOjBhMzgwODEwMmVmMjQxNjFhNjQxNDgwMjQ5MGRjZjNlL3RhYmxlOjI4M2VkZmNkZjU3MjQxNjU5ODA3MGMxNWQ3NmVkMmYxL3RhYmxlcmFuZ2U6MjgzZWRmY2RmNTcyNDE2NTk4MDcwYzE1ZDc2ZWQyZjFfOC01LTEtMS00Mjc5Mg_90e056db-ed12-4193-8758-61648cf1ab9c">279</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic431430d1ab24120b4507025a722d73a_D20210101-20210930" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xOS9mcmFnOjBhMzgwODEwMmVmMjQxNjFhNjQxNDgwMjQ5MGRjZjNlL3RhYmxlOjI4M2VkZmNkZjU3MjQxNjU5ODA3MGMxNWQ3NmVkMmYxL3RhYmxlcmFuZ2U6MjgzZWRmY2RmNTcyNDE2NTk4MDcwYzE1ZDc2ZWQyZjFfOC03LTEtMS00Mjc5Mg_7b16a58b-aa5b-429f-b468-2d0c0c612aa8">81</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Comprehensive income</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f3a96a832ab4b0ca374599d1c3e9bce_D20220701-20220930" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xOS9mcmFnOjBhMzgwODEwMmVmMjQxNjFhNjQxNDgwMjQ5MGRjZjNlL3RhYmxlOjI4M2VkZmNkZjU3MjQxNjU5ODA3MGMxNWQ3NmVkMmYxL3RhYmxlcmFuZ2U6MjgzZWRmY2RmNTcyNDE2NTk4MDcwYzE1ZDc2ZWQyZjFfMTAtMS0xLTEtNDI3OTI_df535255-b848-4680-994e-0a3a946e14f6">36,278</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bb5592686d74afab4f7004818fd6f9b_D20210701-20210930" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xOS9mcmFnOjBhMzgwODEwMmVmMjQxNjFhNjQxNDgwMjQ5MGRjZjNlL3RhYmxlOjI4M2VkZmNkZjU3MjQxNjU5ODA3MGMxNWQ3NmVkMmYxL3RhYmxlcmFuZ2U6MjgzZWRmY2RmNTcyNDE2NTk4MDcwYzE1ZDc2ZWQyZjFfMTAtMy0xLTEtNDI3OTI_34ac9587-cd6a-4f49-b762-64f0b5561290">42,029</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xOS9mcmFnOjBhMzgwODEwMmVmMjQxNjFhNjQxNDgwMjQ5MGRjZjNlL3RhYmxlOjI4M2VkZmNkZjU3MjQxNjU5ODA3MGMxNWQ3NmVkMmYxL3RhYmxlcmFuZ2U6MjgzZWRmY2RmNTcyNDE2NTk4MDcwYzE1ZDc2ZWQyZjFfMTAtNS0xLTEtNDI3OTI_e303f13f-cd97-4a4c-9710-d98aa820f8d3">117,329</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic431430d1ab24120b4507025a722d73a_D20210101-20210930" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xOS9mcmFnOjBhMzgwODEwMmVmMjQxNjFhNjQxNDgwMjQ5MGRjZjNlL3RhYmxlOjI4M2VkZmNkZjU3MjQxNjU5ODA3MGMxNWQ3NmVkMmYxL3RhYmxlcmFuZ2U6MjgzZWRmY2RmNTcyNDE2NTk4MDcwYzE1ZDc2ZWQyZjFfMTAtNy0xLTEtNDI3OTI_b720d72d-75b4-4efa-be08-a1ba1564fb01">130,089</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these condensed consolidated financial statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">3</span></div></div></div><div id="ic8ae413b3ff34d56976502c585fa6ab3_22"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:21.6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#ic8ae413b3ff34d56976502c585fa6ab3_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">MEDIFAST, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(U.S. dollars in thousands, except par value)</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.660%"><tr><td style="width:1.0%"></td><td style="width:58.780%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.109%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.398%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.213%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yMi9mcmFnOjYwNmIyYmE0ZmEyOTQxNDBhNGQ5Njk4ODFlNmFlZjA0L3RhYmxlOjMwOWU2MjUwZDA1NzRiNTk5ZTBjZjRjMWIyOTc3ZjE0L3RhYmxlcmFuZ2U6MzA5ZTYyNTBkMDU3NGI1OTllMGNmNGMxYjI5NzdmMTRfMC0xLTEtMS00Mjc5Mg_75cfbe1e-17ec-4442-ae34-fd999dbe9ec2">September 30,<br/>2022</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">December 31,<br/>2021</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">ASSETS</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Current Assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5de311f5948148cda49342e2cea83715_I20220930" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yMi9mcmFnOjYwNmIyYmE0ZmEyOTQxNDBhNGQ5Njk4ODFlNmFlZjA0L3RhYmxlOjMwOWU2MjUwZDA1NzRiNTk5ZTBjZjRjMWIyOTc3ZjE0L3RhYmxlcmFuZ2U6MzA5ZTYyNTBkMDU3NGI1OTllMGNmNGMxYjI5NzdmMTRfNC0xLTEtMS00Mjc5Mg_fce2aa72-9790-4ccb-aff5-f6375007c9b7">69,710</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47f09f18839440ffae0cf05a475aa7fe_I20211231" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yMi9mcmFnOjYwNmIyYmE0ZmEyOTQxNDBhNGQ5Njk4ODFlNmFlZjA0L3RhYmxlOjMwOWU2MjUwZDA1NzRiNTk5ZTBjZjRjMWIyOTc3ZjE0L3RhYmxlcmFuZ2U6MzA5ZTYyNTBkMDU3NGI1OTllMGNmNGMxYjI5NzdmMTRfNC0zLTEtMS00Mjc5Mg_1564c355-c962-4b5a-a949-00cc4e38c3ce">104,183</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Inventories</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5de311f5948148cda49342e2cea83715_I20220930" decimals="-3" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yMi9mcmFnOjYwNmIyYmE0ZmEyOTQxNDBhNGQ5Njk4ODFlNmFlZjA0L3RhYmxlOjMwOWU2MjUwZDA1NzRiNTk5ZTBjZjRjMWIyOTc3ZjE0L3RhYmxlcmFuZ2U6MzA5ZTYyNTBkMDU3NGI1OTllMGNmNGMxYjI5NzdmMTRfNS0xLTEtMS00Mjc5Mg_a405ee8c-a8c2-4412-858d-f84da4793fe1">145,279</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47f09f18839440ffae0cf05a475aa7fe_I20211231" decimals="-3" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yMi9mcmFnOjYwNmIyYmE0ZmEyOTQxNDBhNGQ5Njk4ODFlNmFlZjA0L3RhYmxlOjMwOWU2MjUwZDA1NzRiNTk5ZTBjZjRjMWIyOTc3ZjE0L3RhYmxlcmFuZ2U6MzA5ZTYyNTBkMDU3NGI1OTllMGNmNGMxYjI5NzdmMTRfNS0zLTEtMS00Mjc5Mg_8cc134d5-597b-40ed-ab0b-16deef41d0e8">180,043</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Investment securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5de311f5948148cda49342e2cea83715_I20220930" decimals="-3" name="us-gaap:ShortTermInvestments" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yMi9mcmFnOjYwNmIyYmE0ZmEyOTQxNDBhNGQ5Njk4ODFlNmFlZjA0L3RhYmxlOjMwOWU2MjUwZDA1NzRiNTk5ZTBjZjRjMWIyOTc3ZjE0L3RhYmxlcmFuZ2U6MzA5ZTYyNTBkMDU3NGI1OTllMGNmNGMxYjI5NzdmMTRfNi0xLTEtMS00Mjc5Mg_0f3abab3-f26b-4fa5-9874-1d9f24d5fd52">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47f09f18839440ffae0cf05a475aa7fe_I20211231" decimals="-3" name="us-gaap:ShortTermInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yMi9mcmFnOjYwNmIyYmE0ZmEyOTQxNDBhNGQ5Njk4ODFlNmFlZjA0L3RhYmxlOjMwOWU2MjUwZDA1NzRiNTk5ZTBjZjRjMWIyOTc3ZjE0L3RhYmxlcmFuZ2U6MzA5ZTYyNTBkMDU3NGI1OTllMGNmNGMxYjI5NzdmMTRfNi0zLTEtMS00Mjc5Mg_af182fff-048e-49d4-a559-b83a7d53802a">5,361</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Income taxes, prepaid</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5de311f5948148cda49342e2cea83715_I20220930" decimals="-3" name="us-gaap:PrepaidTaxes" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yMi9mcmFnOjYwNmIyYmE0ZmEyOTQxNDBhNGQ5Njk4ODFlNmFlZjA0L3RhYmxlOjMwOWU2MjUwZDA1NzRiNTk5ZTBjZjRjMWIyOTc3ZjE0L3RhYmxlcmFuZ2U6MzA5ZTYyNTBkMDU3NGI1OTllMGNmNGMxYjI5NzdmMTRfNy0xLTEtMS00Mjc5Mg_687757cd-9fe3-48a1-9f9b-c7477802589b">150</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47f09f18839440ffae0cf05a475aa7fe_I20211231" decimals="-3" name="us-gaap:PrepaidTaxes" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yMi9mcmFnOjYwNmIyYmE0ZmEyOTQxNDBhNGQ5Njk4ODFlNmFlZjA0L3RhYmxlOjMwOWU2MjUwZDA1NzRiNTk5ZTBjZjRjMWIyOTc3ZjE0L3RhYmxlcmFuZ2U6MzA5ZTYyNTBkMDU3NGI1OTllMGNmNGMxYjI5NzdmMTRfNy0zLTEtMS00Mjc5Mg_498100ee-cc4f-403b-a0b8-004a93a21bc6">945</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5de311f5948148cda49342e2cea83715_I20220930" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yMi9mcmFnOjYwNmIyYmE0ZmEyOTQxNDBhNGQ5Njk4ODFlNmFlZjA0L3RhYmxlOjMwOWU2MjUwZDA1NzRiNTk5ZTBjZjRjMWIyOTc3ZjE0L3RhYmxlcmFuZ2U6MzA5ZTYyNTBkMDU3NGI1OTllMGNmNGMxYjI5NzdmMTRfOC0xLTEtMS00Mjc5Mg_23a44577-a43e-4615-8d9a-2f95489b4b2b">14,445</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47f09f18839440ffae0cf05a475aa7fe_I20211231" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yMi9mcmFnOjYwNmIyYmE0ZmEyOTQxNDBhNGQ5Njk4ODFlNmFlZjA0L3RhYmxlOjMwOWU2MjUwZDA1NzRiNTk5ZTBjZjRjMWIyOTc3ZjE0L3RhYmxlcmFuZ2U6MzA5ZTYyNTBkMDU3NGI1OTllMGNmNGMxYjI5NzdmMTRfOC0zLTEtMS00Mjc5Mg_93d47478-045d-414d-9680-178b6b3575e2">16,334</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Total current assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5de311f5948148cda49342e2cea83715_I20220930" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yMi9mcmFnOjYwNmIyYmE0ZmEyOTQxNDBhNGQ5Njk4ODFlNmFlZjA0L3RhYmxlOjMwOWU2MjUwZDA1NzRiNTk5ZTBjZjRjMWIyOTc3ZjE0L3RhYmxlcmFuZ2U6MzA5ZTYyNTBkMDU3NGI1OTllMGNmNGMxYjI5NzdmMTRfOS0xLTEtMS00Mjc5Mg_51ca2728-eee5-4a99-815f-f1efae33b32b">229,584</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47f09f18839440ffae0cf05a475aa7fe_I20211231" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yMi9mcmFnOjYwNmIyYmE0ZmEyOTQxNDBhNGQ5Njk4ODFlNmFlZjA0L3RhYmxlOjMwOWU2MjUwZDA1NzRiNTk5ZTBjZjRjMWIyOTc3ZjE0L3RhYmxlcmFuZ2U6MzA5ZTYyNTBkMDU3NGI1OTllMGNmNGMxYjI5NzdmMTRfOS0zLTEtMS00Mjc5Mg_75eb677c-8e4e-48d7-9a82-8b36732e4b47">306,866</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Property, plant and equipment - net of accumulated depreciation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5de311f5948148cda49342e2cea83715_I20220930" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yMi9mcmFnOjYwNmIyYmE0ZmEyOTQxNDBhNGQ5Njk4ODFlNmFlZjA0L3RhYmxlOjMwOWU2MjUwZDA1NzRiNTk5ZTBjZjRjMWIyOTc3ZjE0L3RhYmxlcmFuZ2U6MzA5ZTYyNTBkMDU3NGI1OTllMGNmNGMxYjI5NzdmMTRfMTEtMS0xLTEtNDI3OTI_e47a9e72-a2b4-4510-855d-8da0566602c8">58,107</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47f09f18839440ffae0cf05a475aa7fe_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yMi9mcmFnOjYwNmIyYmE0ZmEyOTQxNDBhNGQ5Njk4ODFlNmFlZjA0L3RhYmxlOjMwOWU2MjUwZDA1NzRiNTk5ZTBjZjRjMWIyOTc3ZjE0L3RhYmxlcmFuZ2U6MzA5ZTYyNTBkMDU3NGI1OTllMGNmNGMxYjI5NzdmMTRfMTEtMy0xLTEtNDI3OTI_33626c32-c15e-42b4-b12d-4078803a7a4e">56,131</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Right-of-use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5de311f5948148cda49342e2cea83715_I20220930" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yMi9mcmFnOjYwNmIyYmE0ZmEyOTQxNDBhNGQ5Njk4ODFlNmFlZjA0L3RhYmxlOjMwOWU2MjUwZDA1NzRiNTk5ZTBjZjRjMWIyOTc3ZjE0L3RhYmxlcmFuZ2U6MzA5ZTYyNTBkMDU3NGI1OTllMGNmNGMxYjI5NzdmMTRfMTItMS0xLTEtNDI3OTI_c27b15d2-dde4-4408-bc54-57d404a36312">19,819</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47f09f18839440ffae0cf05a475aa7fe_I20211231" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yMi9mcmFnOjYwNmIyYmE0ZmEyOTQxNDBhNGQ5Njk4ODFlNmFlZjA0L3RhYmxlOjMwOWU2MjUwZDA1NzRiNTk5ZTBjZjRjMWIyOTc3ZjE0L3RhYmxlcmFuZ2U6MzA5ZTYyNTBkMDU3NGI1OTllMGNmNGMxYjI5NzdmMTRfMTItMy0xLTEtNDI3OTI_eb4d522c-734d-42ea-b5d1-2069d88c1ccc">24,457</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5de311f5948148cda49342e2cea83715_I20220930" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yMi9mcmFnOjYwNmIyYmE0ZmEyOTQxNDBhNGQ5Njk4ODFlNmFlZjA0L3RhYmxlOjMwOWU2MjUwZDA1NzRiNTk5ZTBjZjRjMWIyOTc3ZjE0L3RhYmxlcmFuZ2U6MzA5ZTYyNTBkMDU3NGI1OTllMGNmNGMxYjI5NzdmMTRfMTMtMS0xLTEtNDI3OTI_32cb0416-931d-4c85-b3bf-6eb75a967555">12,691</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47f09f18839440ffae0cf05a475aa7fe_I20211231" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yMi9mcmFnOjYwNmIyYmE0ZmEyOTQxNDBhNGQ5Njk4ODFlNmFlZjA0L3RhYmxlOjMwOWU2MjUwZDA1NzRiNTk5ZTBjZjRjMWIyOTc3ZjE0L3RhYmxlcmFuZ2U6MzA5ZTYyNTBkMDU3NGI1OTllMGNmNGMxYjI5NzdmMTRfMTMtMy0xLTEtNDI3OTI_6f85ffcb-0f9e-41f6-b5d4-93e43f778387">6,468</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Deferred tax assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5de311f5948148cda49342e2cea83715_I20220930" decimals="-3" name="us-gaap:DeferredIncomeTaxAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yMi9mcmFnOjYwNmIyYmE0ZmEyOTQxNDBhNGQ5Njk4ODFlNmFlZjA0L3RhYmxlOjMwOWU2MjUwZDA1NzRiNTk5ZTBjZjRjMWIyOTc3ZjE0L3RhYmxlcmFuZ2U6MzA5ZTYyNTBkMDU3NGI1OTllMGNmNGMxYjI5NzdmMTRfMTQtMS0xLTEtNDI3OTI_406c3785-49fc-4a30-b963-cef891032a96">6,150</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47f09f18839440ffae0cf05a475aa7fe_I20211231" decimals="-3" name="us-gaap:DeferredIncomeTaxAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yMi9mcmFnOjYwNmIyYmE0ZmEyOTQxNDBhNGQ5Njk4ODFlNmFlZjA0L3RhYmxlOjMwOWU2MjUwZDA1NzRiNTk5ZTBjZjRjMWIyOTc3ZjE0L3RhYmxlcmFuZ2U6MzA5ZTYyNTBkMDU3NGI1OTllMGNmNGMxYjI5NzdmMTRfMTQtMy0xLTEtNDI3OTI_82a2b6c2-285e-4407-8ead-26ff88dd80f6">4,404</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">TOTAL ASSETS</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5de311f5948148cda49342e2cea83715_I20220930" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yMi9mcmFnOjYwNmIyYmE0ZmEyOTQxNDBhNGQ5Njk4ODFlNmFlZjA0L3RhYmxlOjMwOWU2MjUwZDA1NzRiNTk5ZTBjZjRjMWIyOTc3ZjE0L3RhYmxlcmFuZ2U6MzA5ZTYyNTBkMDU3NGI1OTllMGNmNGMxYjI5NzdmMTRfMTctMS0xLTEtNDI3OTI_960e6299-cb45-4860-a023-0c432ee91191">326,351</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47f09f18839440ffae0cf05a475aa7fe_I20211231" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yMi9mcmFnOjYwNmIyYmE0ZmEyOTQxNDBhNGQ5Njk4ODFlNmFlZjA0L3RhYmxlOjMwOWU2MjUwZDA1NzRiNTk5ZTBjZjRjMWIyOTc3ZjE0L3RhYmxlcmFuZ2U6MzA5ZTYyNTBkMDU3NGI1OTllMGNmNGMxYjI5NzdmMTRfMTctMy0xLTEtNDI3OTI_fcf779a5-7ccc-4dcd-967c-6c039e5ce84f">398,326</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">LIABILITIES AND STOCKHOLDERS' EQUITY</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Current Liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;Accounts payable and accrued expenses</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5de311f5948148cda49342e2cea83715_I20220930" decimals="-3" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yMi9mcmFnOjYwNmIyYmE0ZmEyOTQxNDBhNGQ5Njk4ODFlNmFlZjA0L3RhYmxlOjMwOWU2MjUwZDA1NzRiNTk5ZTBjZjRjMWIyOTc3ZjE0L3RhYmxlcmFuZ2U6MzA5ZTYyNTBkMDU3NGI1OTllMGNmNGMxYjI5NzdmMTRfMjEtMS0xLTEtNDI3OTI_dae2dd66-326c-4ff0-bbcd-7a8576ef8045">148,129</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47f09f18839440ffae0cf05a475aa7fe_I20211231" decimals="-3" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yMi9mcmFnOjYwNmIyYmE0ZmEyOTQxNDBhNGQ5Njk4ODFlNmFlZjA0L3RhYmxlOjMwOWU2MjUwZDA1NzRiNTk5ZTBjZjRjMWIyOTc3ZjE0L3RhYmxlcmFuZ2U6MzA5ZTYyNTBkMDU3NGI1OTllMGNmNGMxYjI5NzdmMTRfMjEtMy0xLTEtNDI3OTI_4a8b2be3-bace-4b25-b539-6d13fa3fc69a">163,309</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Revolving credit facility</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5de311f5948148cda49342e2cea83715_I20220930" decimals="-3" name="us-gaap:LinesOfCreditCurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yMi9mcmFnOjYwNmIyYmE0ZmEyOTQxNDBhNGQ5Njk4ODFlNmFlZjA0L3RhYmxlOjMwOWU2MjUwZDA1NzRiNTk5ZTBjZjRjMWIyOTc3ZjE0L3RhYmxlcmFuZ2U6MzA5ZTYyNTBkMDU3NGI1OTllMGNmNGMxYjI5NzdmMTRfMjItMS0xLTEtNDI3OTI_faa8c2da-b981-4db1-ac11-0fc99ec0e6e1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47f09f18839440ffae0cf05a475aa7fe_I20211231" decimals="-3" name="us-gaap:LinesOfCreditCurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yMi9mcmFnOjYwNmIyYmE0ZmEyOTQxNDBhNGQ5Njk4ODFlNmFlZjA0L3RhYmxlOjMwOWU2MjUwZDA1NzRiNTk5ZTBjZjRjMWIyOTc3ZjE0L3RhYmxlcmFuZ2U6MzA5ZTYyNTBkMDU3NGI1OTllMGNmNGMxYjI5NzdmMTRfMjItMy0xLTEtNDI3OTI_952e2b62-67be-41d7-bd25-d53226fefa82">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;Current lease obligations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5de311f5948148cda49342e2cea83715_I20220930" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yMi9mcmFnOjYwNmIyYmE0ZmEyOTQxNDBhNGQ5Njk4ODFlNmFlZjA0L3RhYmxlOjMwOWU2MjUwZDA1NzRiNTk5ZTBjZjRjMWIyOTc3ZjE0L3RhYmxlcmFuZ2U6MzA5ZTYyNTBkMDU3NGI1OTllMGNmNGMxYjI5NzdmMTRfMjMtMS0xLTEtNDI3OTI_28b2bf50-6b7f-4dc5-b638-7cd06db645cc">6,126</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47f09f18839440ffae0cf05a475aa7fe_I20211231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yMi9mcmFnOjYwNmIyYmE0ZmEyOTQxNDBhNGQ5Njk4ODFlNmFlZjA0L3RhYmxlOjMwOWU2MjUwZDA1NzRiNTk5ZTBjZjRjMWIyOTc3ZjE0L3RhYmxlcmFuZ2U6MzA5ZTYyNTBkMDU3NGI1OTllMGNmNGMxYjI5NzdmMTRfMjMtMy0xLTEtNDI3OTI_ebc6bab9-c691-4a01-a17d-abac6c654cd3">6,523</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Total current liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5de311f5948148cda49342e2cea83715_I20220930" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yMi9mcmFnOjYwNmIyYmE0ZmEyOTQxNDBhNGQ5Njk4ODFlNmFlZjA0L3RhYmxlOjMwOWU2MjUwZDA1NzRiNTk5ZTBjZjRjMWIyOTc3ZjE0L3RhYmxlcmFuZ2U6MzA5ZTYyNTBkMDU3NGI1OTllMGNmNGMxYjI5NzdmMTRfMjQtMS0xLTEtNDI3OTI_b00b7b33-ff00-4a4a-83fd-7a9f1fdb0d4a">154,255</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47f09f18839440ffae0cf05a475aa7fe_I20211231" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yMi9mcmFnOjYwNmIyYmE0ZmEyOTQxNDBhNGQ5Njk4ODFlNmFlZjA0L3RhYmxlOjMwOWU2MjUwZDA1NzRiNTk5ZTBjZjRjMWIyOTc3ZjE0L3RhYmxlcmFuZ2U6MzA5ZTYyNTBkMDU3NGI1OTllMGNmNGMxYjI5NzdmMTRfMjQtMy0xLTEtNDI3OTI_86838a45-c509-462a-8453-5ddcac5dc7cc">169,832</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;Lease obligations, net of current lease obligations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5de311f5948148cda49342e2cea83715_I20220930" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yMi9mcmFnOjYwNmIyYmE0ZmEyOTQxNDBhNGQ5Njk4ODFlNmFlZjA0L3RhYmxlOjMwOWU2MjUwZDA1NzRiNTk5ZTBjZjRjMWIyOTc3ZjE0L3RhYmxlcmFuZ2U6MzA5ZTYyNTBkMDU3NGI1OTllMGNmNGMxYjI5NzdmMTRfMjYtMS0xLTEtNDI3OTI_fc0615d9-1509-488a-bfa7-b40a6cbe57b0">21,574</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47f09f18839440ffae0cf05a475aa7fe_I20211231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yMi9mcmFnOjYwNmIyYmE0ZmEyOTQxNDBhNGQ5Njk4ODFlNmFlZjA0L3RhYmxlOjMwOWU2MjUwZDA1NzRiNTk5ZTBjZjRjMWIyOTc3ZjE0L3RhYmxlcmFuZ2U6MzA5ZTYyNTBkMDU3NGI1OTllMGNmNGMxYjI5NzdmMTRfMjYtMy0xLTEtNDI3OTI_4e58bd40-2fab-4192-bbba-9acd0208748e">26,020</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Total liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5de311f5948148cda49342e2cea83715_I20220930" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yMi9mcmFnOjYwNmIyYmE0ZmEyOTQxNDBhNGQ5Njk4ODFlNmFlZjA0L3RhYmxlOjMwOWU2MjUwZDA1NzRiNTk5ZTBjZjRjMWIyOTc3ZjE0L3RhYmxlcmFuZ2U6MzA5ZTYyNTBkMDU3NGI1OTllMGNmNGMxYjI5NzdmMTRfMjktMS0xLTEtNDI3OTI_7bcd01f1-3c15-42df-a8b4-859f286d4b4f">175,829</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47f09f18839440ffae0cf05a475aa7fe_I20211231" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yMi9mcmFnOjYwNmIyYmE0ZmEyOTQxNDBhNGQ5Njk4ODFlNmFlZjA0L3RhYmxlOjMwOWU2MjUwZDA1NzRiNTk5ZTBjZjRjMWIyOTc3ZjE0L3RhYmxlcmFuZ2U6MzA5ZTYyNTBkMDU3NGI1OTllMGNmNGMxYjI5NzdmMTRfMjktMy0xLTEtNDI3OTI_b4125600-ddba-44d1-a772-f2306c9a06b0">195,852</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Stockholders' Equity</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Common stock, par value $<ix:nonFraction unitRef="usdPerShare" contextRef="i47f09f18839440ffae0cf05a475aa7fe_I20211231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yMi9mcmFnOjYwNmIyYmE0ZmEyOTQxNDBhNGQ5Njk4ODFlNmFlZjA0L3RhYmxlOjMwOWU2MjUwZDA1NzRiNTk5ZTBjZjRjMWIyOTc3ZjE0L3RhYmxlcmFuZ2U6MzA5ZTYyNTBkMDU3NGI1OTllMGNmNGMxYjI5NzdmMTRfMzItMC0xLTEtNDI3OTIvdGV4dHJlZ2lvbjoxNGFkYjg0Y2Y3NzY0ODczODM2ZjUwN2VjODQ4MGM1OV8yOA_5029a283-ae4e-43d7-8a6e-f10c565c8577"><ix:nonFraction unitRef="usdPerShare" contextRef="i5de311f5948148cda49342e2cea83715_I20220930" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yMi9mcmFnOjYwNmIyYmE0ZmEyOTQxNDBhNGQ5Njk4ODFlNmFlZjA0L3RhYmxlOjMwOWU2MjUwZDA1NzRiNTk5ZTBjZjRjMWIyOTc3ZjE0L3RhYmxlcmFuZ2U6MzA5ZTYyNTBkMDU3NGI1OTllMGNmNGMxYjI5NzdmMTRfMzItMC0xLTEtNDI3OTIvdGV4dHJlZ2lvbjoxNGFkYjg0Y2Y3NzY0ODczODM2ZjUwN2VjODQ4MGM1OV8yOA_d1ef4535-b396-4cf7-a660-442971bf45ce">0.001</ix:nonFraction></ix:nonFraction> per share: <ix:nonFraction unitRef="shares" contextRef="i5de311f5948148cda49342e2cea83715_I20220930" decimals="-3" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yMi9mcmFnOjYwNmIyYmE0ZmEyOTQxNDBhNGQ5Njk4ODFlNmFlZjA0L3RhYmxlOjMwOWU2MjUwZDA1NzRiNTk5ZTBjZjRjMWIyOTc3ZjE0L3RhYmxlcmFuZ2U6MzA5ZTYyNTBkMDU3NGI1OTllMGNmNGMxYjI5NzdmMTRfMzItMC0xLTEtNDI3OTIvdGV4dHJlZ2lvbjoxNGFkYjg0Y2Y3NzY0ODczODM2ZjUwN2VjODQ4MGM1OV80Mg_762678db-cdcf-4745-9af9-e0297dc5397e"><ix:nonFraction unitRef="shares" contextRef="i47f09f18839440ffae0cf05a475aa7fe_I20211231" decimals="-3" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yMi9mcmFnOjYwNmIyYmE0ZmEyOTQxNDBhNGQ5Njk4ODFlNmFlZjA0L3RhYmxlOjMwOWU2MjUwZDA1NzRiNTk5ZTBjZjRjMWIyOTc3ZjE0L3RhYmxlcmFuZ2U6MzA5ZTYyNTBkMDU3NGI1OTllMGNmNGMxYjI5NzdmMTRfMzItMC0xLTEtNDI3OTIvdGV4dHJlZ2lvbjoxNGFkYjg0Y2Y3NzY0ODczODM2ZjUwN2VjODQ4MGM1OV80Mg_bba9a21b-93a0-4bd8-9f42-f2b9f5e7b604">20,000</ix:nonFraction></ix:nonFraction> shares authorized;</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="i5de311f5948148cda49342e2cea83715_I20220930" decimals="-3" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yMi9mcmFnOjYwNmIyYmE0ZmEyOTQxNDBhNGQ5Njk4ODFlNmFlZjA0L3RhYmxlOjMwOWU2MjUwZDA1NzRiNTk5ZTBjZjRjMWIyOTc3ZjE0L3RhYmxlcmFuZ2U6MzA5ZTYyNTBkMDU3NGI1OTllMGNmNGMxYjI5NzdmMTRfMzMtMC0xLTEtNDI3OTIvdGV4dHJlZ2lvbjo1NWQ3OWI0MWVjMjM0MDU3YTJmZDI4NDc5YjE1ZThhMF80_1bdfe5db-ebad-4de3-8dae-5152506d950d">10,929</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="i47f09f18839440ffae0cf05a475aa7fe_I20211231" decimals="-3" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yMi9mcmFnOjYwNmIyYmE0ZmEyOTQxNDBhNGQ5Njk4ODFlNmFlZjA0L3RhYmxlOjMwOWU2MjUwZDA1NzRiNTk5ZTBjZjRjMWIyOTc3ZjE0L3RhYmxlcmFuZ2U6MzA5ZTYyNTBkMDU3NGI1OTllMGNmNGMxYjI5NzdmMTRfMzMtMC0xLTEtNDI3OTIvdGV4dHJlZ2lvbjo1NWQ3OWI0MWVjMjM0MDU3YTJmZDI4NDc5YjE1ZThhMF8xMQ_c50d2001-b820-4926-891f-14395dfabda1">11,594</ix:nonFraction> issued and <ix:nonFraction unitRef="shares" contextRef="i5de311f5948148cda49342e2cea83715_I20220930" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yMi9mcmFnOjYwNmIyYmE0ZmEyOTQxNDBhNGQ5Njk4ODFlNmFlZjA0L3RhYmxlOjMwOWU2MjUwZDA1NzRiNTk5ZTBjZjRjMWIyOTc3ZjE0L3RhYmxlcmFuZ2U6MzA5ZTYyNTBkMDU3NGI1OTllMGNmNGMxYjI5NzdmMTRfMzMtMC0xLTEtNDI3OTIvdGV4dHJlZ2lvbjo1NWQ3OWI0MWVjMjM0MDU3YTJmZDI4NDc5YjE1ZThhMF8yNQ_3ed1cb26-063d-4281-99d5-97dd3d450f9d">10,928</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="i47f09f18839440ffae0cf05a475aa7fe_I20211231" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yMi9mcmFnOjYwNmIyYmE0ZmEyOTQxNDBhNGQ5Njk4ODFlNmFlZjA0L3RhYmxlOjMwOWU2MjUwZDA1NzRiNTk5ZTBjZjRjMWIyOTc3ZjE0L3RhYmxlcmFuZ2U6MzA5ZTYyNTBkMDU3NGI1OTllMGNmNGMxYjI5NzdmMTRfMzMtMC0xLTEtNDI3OTIvdGV4dHJlZ2lvbjo1NWQ3OWI0MWVjMjM0MDU3YTJmZDI4NDc5YjE1ZThhMF8zMg_0b86542c-b56a-4887-9e5d-1183f971d88d">11,593</ix:nonFraction> outstanding</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">at <ix:nonNumeric contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yMi9mcmFnOjYwNmIyYmE0ZmEyOTQxNDBhNGQ5Njk4ODFlNmFlZjA0L3RhYmxlOjMwOWU2MjUwZDA1NzRiNTk5ZTBjZjRjMWIyOTc3ZjE0L3RhYmxlcmFuZ2U6MzA5ZTYyNTBkMDU3NGI1OTllMGNmNGMxYjI5NzdmMTRfMzQtMC0xLTEtNDI3OTIvdGV4dHJlZ2lvbjphZWVjYzQyODE5NzQ0NjNlYTViNmQ0OTI0NTA0MjZiN183_75cfbe1e-17ec-4442-ae34-fd999dbe9ec2">September&#160;30, 2022</ix:nonNumeric> and December&#160;31, 2021, respectively</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5de311f5948148cda49342e2cea83715_I20220930" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yMi9mcmFnOjYwNmIyYmE0ZmEyOTQxNDBhNGQ5Njk4ODFlNmFlZjA0L3RhYmxlOjMwOWU2MjUwZDA1NzRiNTk5ZTBjZjRjMWIyOTc3ZjE0L3RhYmxlcmFuZ2U6MzA5ZTYyNTBkMDU3NGI1OTllMGNmNGMxYjI5NzdmMTRfMzQtMS0xLTEtNDI3OTI_431d86ae-0acf-456b-bc4c-005ab7536ba4">11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47f09f18839440ffae0cf05a475aa7fe_I20211231" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yMi9mcmFnOjYwNmIyYmE0ZmEyOTQxNDBhNGQ5Njk4ODFlNmFlZjA0L3RhYmxlOjMwOWU2MjUwZDA1NzRiNTk5ZTBjZjRjMWIyOTc3ZjE0L3RhYmxlcmFuZ2U6MzA5ZTYyNTBkMDU3NGI1OTllMGNmNGMxYjI5NzdmMTRfMzQtMy0xLTEtNDI3OTI_ae584758-0f15-4848-b21f-faf4eea813e0">12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Additional paid-in capital</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5de311f5948148cda49342e2cea83715_I20220930" decimals="-3" name="us-gaap:AdditionalPaidInCapital" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yMi9mcmFnOjYwNmIyYmE0ZmEyOTQxNDBhNGQ5Njk4ODFlNmFlZjA0L3RhYmxlOjMwOWU2MjUwZDA1NzRiNTk5ZTBjZjRjMWIyOTc3ZjE0L3RhYmxlcmFuZ2U6MzA5ZTYyNTBkMDU3NGI1OTllMGNmNGMxYjI5NzdmMTRfMzUtMS0xLTEtNDI3OTI_5b7a9dcf-61c6-4a06-9cbf-ce6fc1085324">18,617</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47f09f18839440ffae0cf05a475aa7fe_I20211231" decimals="-3" name="us-gaap:AdditionalPaidInCapital" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yMi9mcmFnOjYwNmIyYmE0ZmEyOTQxNDBhNGQ5Njk4ODFlNmFlZjA0L3RhYmxlOjMwOWU2MjUwZDA1NzRiNTk5ZTBjZjRjMWIyOTc3ZjE0L3RhYmxlcmFuZ2U6MzA5ZTYyNTBkMDU3NGI1OTllMGNmNGMxYjI5NzdmMTRfMzUtMy0xLTEtNDI3OTI_193c25b3-8cc2-4e3d-9963-82fa22897066">12,018</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Accumulated other comprehensive income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5de311f5948148cda49342e2cea83715_I20220930" decimals="-3" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yMi9mcmFnOjYwNmIyYmE0ZmEyOTQxNDBhNGQ5Njk4ODFlNmFlZjA0L3RhYmxlOjMwOWU2MjUwZDA1NzRiNTk5ZTBjZjRjMWIyOTc3ZjE0L3RhYmxlcmFuZ2U6MzA5ZTYyNTBkMDU3NGI1OTllMGNmNGMxYjI5NzdmMTRfMzYtMS0xLTEtNDI3OTI_c8981ce3-f53d-4f8f-ba23-de049969fa14">391</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47f09f18839440ffae0cf05a475aa7fe_I20211231" decimals="-3" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yMi9mcmFnOjYwNmIyYmE0ZmEyOTQxNDBhNGQ5Njk4ODFlNmFlZjA0L3RhYmxlOjMwOWU2MjUwZDA1NzRiNTk5ZTBjZjRjMWIyOTc3ZjE0L3RhYmxlcmFuZ2U6MzA5ZTYyNTBkMDU3NGI1OTllMGNmNGMxYjI5NzdmMTRfMzYtMy0xLTEtNDI3OTI_b0717347-d8bf-4259-8c0f-b6600499e628">111</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Retained earnings </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5de311f5948148cda49342e2cea83715_I20220930" decimals="-3" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yMi9mcmFnOjYwNmIyYmE0ZmEyOTQxNDBhNGQ5Njk4ODFlNmFlZjA0L3RhYmxlOjMwOWU2MjUwZDA1NzRiNTk5ZTBjZjRjMWIyOTc3ZjE0L3RhYmxlcmFuZ2U6MzA5ZTYyNTBkMDU3NGI1OTllMGNmNGMxYjI5NzdmMTRfMzctMS0xLTEtNDI3OTI_3580446e-4a3b-4d27-add3-51a2cd9ff4d0">131,503</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47f09f18839440ffae0cf05a475aa7fe_I20211231" decimals="-3" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yMi9mcmFnOjYwNmIyYmE0ZmEyOTQxNDBhNGQ5Njk4ODFlNmFlZjA0L3RhYmxlOjMwOWU2MjUwZDA1NzRiNTk5ZTBjZjRjMWIyOTc3ZjE0L3RhYmxlcmFuZ2U6MzA5ZTYyNTBkMDU3NGI1OTllMGNmNGMxYjI5NzdmMTRfMzctMy0xLTEtNDI3OTI_d4119757-fbb5-4c94-a2ac-5cb01d45cfb1">190,333</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Total stockholders' equity</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5de311f5948148cda49342e2cea83715_I20220930" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yMi9mcmFnOjYwNmIyYmE0ZmEyOTQxNDBhNGQ5Njk4ODFlNmFlZjA0L3RhYmxlOjMwOWU2MjUwZDA1NzRiNTk5ZTBjZjRjMWIyOTc3ZjE0L3RhYmxlcmFuZ2U6MzA5ZTYyNTBkMDU3NGI1OTllMGNmNGMxYjI5NzdmMTRfMzktMS0xLTEtNDI3OTI_9a3dba30-0dbe-43a3-a946-dc669cf73246">150,522</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47f09f18839440ffae0cf05a475aa7fe_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yMi9mcmFnOjYwNmIyYmE0ZmEyOTQxNDBhNGQ5Njk4ODFlNmFlZjA0L3RhYmxlOjMwOWU2MjUwZDA1NzRiNTk5ZTBjZjRjMWIyOTc3ZjE0L3RhYmxlcmFuZ2U6MzA5ZTYyNTBkMDU3NGI1OTllMGNmNGMxYjI5NzdmMTRfMzktMy0xLTEtNDI3OTI_ae0dec76-72b0-43fe-978f-00478b28c208">202,474</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5de311f5948148cda49342e2cea83715_I20220930" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yMi9mcmFnOjYwNmIyYmE0ZmEyOTQxNDBhNGQ5Njk4ODFlNmFlZjA0L3RhYmxlOjMwOWU2MjUwZDA1NzRiNTk5ZTBjZjRjMWIyOTc3ZjE0L3RhYmxlcmFuZ2U6MzA5ZTYyNTBkMDU3NGI1OTllMGNmNGMxYjI5NzdmMTRfNDEtMS0xLTEtNDI3OTI_eea47f96-36fe-49d6-98a4-3eeed1642e17">326,351</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47f09f18839440ffae0cf05a475aa7fe_I20211231" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yMi9mcmFnOjYwNmIyYmE0ZmEyOTQxNDBhNGQ5Njk4ODFlNmFlZjA0L3RhYmxlOjMwOWU2MjUwZDA1NzRiNTk5ZTBjZjRjMWIyOTc3ZjE0L3RhYmxlcmFuZ2U6MzA5ZTYyNTBkMDU3NGI1OTllMGNmNGMxYjI5NzdmMTRfNDEtMy0xLTEtNDI3OTI_149cbb0d-3547-4135-bb7f-5bda61bb1b2c">398,326</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these condensed consolidated financial statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">4</span></div></div></div><div id="ic8ae413b3ff34d56976502c585fa6ab3_25"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:21.6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#ic8ae413b3ff34d56976502c585fa6ab3_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">MEDIFAST, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(U.S. dollar in thousands)</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.245%"><tr><td style="width:1.0%"></td><td style="width:57.828%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.286%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.395%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.991%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine months ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Operating Activities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Net income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yNS9mcmFnOmE1MmJkOGZiZTY1ZjQ3ZWI4ZmVhNTIzNjZjZjJiM2NmL3RhYmxlOjEwZjViZTk1NjExOTQ5NzlhODdhYjVjZTdmZTgyYTIxL3RhYmxlcmFuZ2U6MTBmNWJlOTU2MTE5NDk3OWE4N2FiNWNlN2ZlODJhMjFfNC0xLTEtMS00Mjc5Mg_51affeed-2e8e-4c9b-a2f8-7f244fd8e430">117,050</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic431430d1ab24120b4507025a722d73a_D20210101-20210930" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yNS9mcmFnOmE1MmJkOGZiZTY1ZjQ3ZWI4ZmVhNTIzNjZjZjJiM2NmL3RhYmxlOjEwZjViZTk1NjExOTQ5NzlhODdhYjVjZTdmZTgyYTIxL3RhYmxlcmFuZ2U6MTBmNWJlOTU2MTE5NDk3OWE4N2FiNWNlN2ZlODJhMjFfNC0zLTEtMS00Mjc5Mg_95a1e57d-8e63-418d-93ed-a2a5e878a312">130,008</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Adjustments to reconcile net income to cash provided by operating activities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 17.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Depreciation and amortization </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yNS9mcmFnOmE1MmJkOGZiZTY1ZjQ3ZWI4ZmVhNTIzNjZjZjJiM2NmL3RhYmxlOjEwZjViZTk1NjExOTQ5NzlhODdhYjVjZTdmZTgyYTIxL3RhYmxlcmFuZ2U6MTBmNWJlOTU2MTE5NDk3OWE4N2FiNWNlN2ZlODJhMjFfNi0xLTEtMS00Mjc5Mg_de32e084-78a9-4f07-b457-f57823afbd57">8,026</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic431430d1ab24120b4507025a722d73a_D20210101-20210930" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yNS9mcmFnOmE1MmJkOGZiZTY1ZjQ3ZWI4ZmVhNTIzNjZjZjJiM2NmL3RhYmxlOjEwZjViZTk1NjExOTQ5NzlhODdhYjVjZTdmZTgyYTIxL3RhYmxlcmFuZ2U6MTBmNWJlOTU2MTE5NDk3OWE4N2FiNWNlN2ZlODJhMjFfNi0zLTEtMS00Mjc5Mg_07711508-a324-4862-b58e-28af884f9b93">3,767</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 17.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Non-cash lease expense</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930" decimals="-3" name="med:OperatingLeaseExpenseNonCash" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yNS9mcmFnOmE1MmJkOGZiZTY1ZjQ3ZWI4ZmVhNTIzNjZjZjJiM2NmL3RhYmxlOjEwZjViZTk1NjExOTQ5NzlhODdhYjVjZTdmZTgyYTIxL3RhYmxlcmFuZ2U6MTBmNWJlOTU2MTE5NDk3OWE4N2FiNWNlN2ZlODJhMjFfNy0xLTEtMS00Mjc5Mg_affa4d46-3e12-4186-a2b8-bdf10a0c3fe6">4,740</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic431430d1ab24120b4507025a722d73a_D20210101-20210930" decimals="-3" name="med:OperatingLeaseExpenseNonCash" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yNS9mcmFnOmE1MmJkOGZiZTY1ZjQ3ZWI4ZmVhNTIzNjZjZjJiM2NmL3RhYmxlOjEwZjViZTk1NjExOTQ5NzlhODdhYjVjZTdmZTgyYTIxL3RhYmxlcmFuZ2U6MTBmNWJlOTU2MTE5NDk3OWE4N2FiNWNlN2ZlODJhMjFfNy0zLTEtMS00Mjc5Mg_c6c813de-7093-4cf1-8011-780a0493209c">3,508</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 17.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Share-based compensation</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yNS9mcmFnOmE1MmJkOGZiZTY1ZjQ3ZWI4ZmVhNTIzNjZjZjJiM2NmL3RhYmxlOjEwZjViZTk1NjExOTQ5NzlhODdhYjVjZTdmZTgyYTIxL3RhYmxlcmFuZ2U6MTBmNWJlOTU2MTE5NDk3OWE4N2FiNWNlN2ZlODJhMjFfOC0xLTEtMS00Mjc5Mg_f06fb114-7b90-4c7f-ad68-ace1a63f12ed">8,103</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic431430d1ab24120b4507025a722d73a_D20210101-20210930" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yNS9mcmFnOmE1MmJkOGZiZTY1ZjQ3ZWI4ZmVhNTIzNjZjZjJiM2NmL3RhYmxlOjEwZjViZTk1NjExOTQ5NzlhODdhYjVjZTdmZTgyYTIxL3RhYmxlcmFuZ2U6MTBmNWJlOTU2MTE5NDk3OWE4N2FiNWNlN2ZlODJhMjFfOC0zLTEtMS00Mjc5Mg_9ebbd387-5510-4d96-8f79-46f3c7fc0107">6,613</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 17.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Amortization of premium on investment securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930" decimals="-3" name="med:AmortizationOfPremiumOnInvestmentSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yNS9mcmFnOmE1MmJkOGZiZTY1ZjQ3ZWI4ZmVhNTIzNjZjZjJiM2NmL3RhYmxlOjEwZjViZTk1NjExOTQ5NzlhODdhYjVjZTdmZTgyYTIxL3RhYmxlcmFuZ2U6MTBmNWJlOTU2MTE5NDk3OWE4N2FiNWNlN2ZlODJhMjFfMTAtMS0xLTEtNDI3OTI_39a88ea6-9601-4d54-8764-a728b3255b7b">14</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic431430d1ab24120b4507025a722d73a_D20210101-20210930" decimals="-3" name="med:AmortizationOfPremiumOnInvestmentSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yNS9mcmFnOmE1MmJkOGZiZTY1ZjQ3ZWI4ZmVhNTIzNjZjZjJiM2NmL3RhYmxlOjEwZjViZTk1NjExOTQ5NzlhODdhYjVjZTdmZTgyYTIxL3RhYmxlcmFuZ2U6MTBmNWJlOTU2MTE5NDk3OWE4N2FiNWNlN2ZlODJhMjFfMTAtMy0xLTEtNDI3OTI_1845a214-57f9-4da6-8fba-490748ccced3">70</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 17.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Deferred income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yNS9mcmFnOmE1MmJkOGZiZTY1ZjQ3ZWI4ZmVhNTIzNjZjZjJiM2NmL3RhYmxlOjEwZjViZTk1NjExOTQ5NzlhODdhYjVjZTdmZTgyYTIxL3RhYmxlcmFuZ2U6MTBmNWJlOTU2MTE5NDk3OWE4N2FiNWNlN2ZlODJhMjFfMTEtMS0xLTEtNDI3OTI_e60ceaaa-f28f-44a3-87e2-140263af3017">1,746</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic431430d1ab24120b4507025a722d73a_D20210101-20210930" decimals="-3" name="us-gaap:DeferredIncomeTaxExpenseBenefit" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yNS9mcmFnOmE1MmJkOGZiZTY1ZjQ3ZWI4ZmVhNTIzNjZjZjJiM2NmL3RhYmxlOjEwZjViZTk1NjExOTQ5NzlhODdhYjVjZTdmZTgyYTIxL3RhYmxlcmFuZ2U6MTBmNWJlOTU2MTE5NDk3OWE4N2FiNWNlN2ZlODJhMjFfMTEtMy0xLTEtNDI3OTI_92a94342-a034-407f-be1d-44427af07d63">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 17.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Change in operating assets and liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 23.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Inventories</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInInventories" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yNS9mcmFnOmE1MmJkOGZiZTY1ZjQ3ZWI4ZmVhNTIzNjZjZjJiM2NmL3RhYmxlOjEwZjViZTk1NjExOTQ5NzlhODdhYjVjZTdmZTgyYTIxL3RhYmxlcmFuZ2U6MTBmNWJlOTU2MTE5NDk3OWE4N2FiNWNlN2ZlODJhMjFfMTQtMS0xLTEtNDI3OTI_d680cc76-7326-4837-bfc3-a4d86ce3e7e1">34,764</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic431430d1ab24120b4507025a722d73a_D20210101-20210930" decimals="-3" name="us-gaap:IncreaseDecreaseInInventories" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yNS9mcmFnOmE1MmJkOGZiZTY1ZjQ3ZWI4ZmVhNTIzNjZjZjJiM2NmL3RhYmxlOjEwZjViZTk1NjExOTQ5NzlhODdhYjVjZTdmZTgyYTIxL3RhYmxlcmFuZ2U6MTBmNWJlOTU2MTE5NDk3OWE4N2FiNWNlN2ZlODJhMjFfMTQtMy0xLTEtNDI3OTI_dee37617-4e97-4aa5-b452-fc0357ae93e4">76,222</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 23.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Income taxes, prepaid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInPrepaidTaxes" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yNS9mcmFnOmE1MmJkOGZiZTY1ZjQ3ZWI4ZmVhNTIzNjZjZjJiM2NmL3RhYmxlOjEwZjViZTk1NjExOTQ5NzlhODdhYjVjZTdmZTgyYTIxL3RhYmxlcmFuZ2U6MTBmNWJlOTU2MTE5NDk3OWE4N2FiNWNlN2ZlODJhMjFfMTUtMS0xLTEtNDI3OTI_252704f3-0b50-4d34-9358-c7a269931e57">795</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic431430d1ab24120b4507025a722d73a_D20210101-20210930" decimals="-3" name="us-gaap:IncreaseDecreaseInPrepaidTaxes" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yNS9mcmFnOmE1MmJkOGZiZTY1ZjQ3ZWI4ZmVhNTIzNjZjZjJiM2NmL3RhYmxlOjEwZjViZTk1NjExOTQ5NzlhODdhYjVjZTdmZTgyYTIxL3RhYmxlcmFuZ2U6MTBmNWJlOTU2MTE5NDk3OWE4N2FiNWNlN2ZlODJhMjFfMTUtMy0xLTEtNDI3OTI_f2aad2e5-d38d-4550-88eb-2b01cd49283b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 23.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yNS9mcmFnOmE1MmJkOGZiZTY1ZjQ3ZWI4ZmVhNTIzNjZjZjJiM2NmL3RhYmxlOjEwZjViZTk1NjExOTQ5NzlhODdhYjVjZTdmZTgyYTIxL3RhYmxlcmFuZ2U6MTBmNWJlOTU2MTE5NDk3OWE4N2FiNWNlN2ZlODJhMjFfMTYtMS0xLTEtNDI3OTI_72e6553b-8444-4f6a-8b6d-c8e784cdaaac">1,889</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic431430d1ab24120b4507025a722d73a_D20210101-20210930" decimals="-3" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yNS9mcmFnOmE1MmJkOGZiZTY1ZjQ3ZWI4ZmVhNTIzNjZjZjJiM2NmL3RhYmxlOjEwZjViZTk1NjExOTQ5NzlhODdhYjVjZTdmZTgyYTIxL3RhYmxlcmFuZ2U6MTBmNWJlOTU2MTE5NDk3OWE4N2FiNWNlN2ZlODJhMjFfMTYtMy0xLTEtNDI3OTI_369cd9cd-d6f8-4f2b-a259-a3b303936710">5,094</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 23.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yNS9mcmFnOmE1MmJkOGZiZTY1ZjQ3ZWI4ZmVhNTIzNjZjZjJiM2NmL3RhYmxlOjEwZjViZTk1NjExOTQ5NzlhODdhYjVjZTdmZTgyYTIxL3RhYmxlcmFuZ2U6MTBmNWJlOTU2MTE5NDk3OWE4N2FiNWNlN2ZlODJhMjFfMTctMS0xLTEtNDI3OTI_fdc8725a-d2dd-4ce1-a0a1-a986f9ab7583">8,545</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic431430d1ab24120b4507025a722d73a_D20210101-20210930" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yNS9mcmFnOmE1MmJkOGZiZTY1ZjQ3ZWI4ZmVhNTIzNjZjZjJiM2NmL3RhYmxlOjEwZjViZTk1NjExOTQ5NzlhODdhYjVjZTdmZTgyYTIxL3RhYmxlcmFuZ2U6MTBmNWJlOTU2MTE5NDk3OWE4N2FiNWNlN2ZlODJhMjFfMTctMy0xLTEtNDI3OTI_21f6e395-fb4f-4394-9523-cda2525787af">3,393</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 23.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Accounts payable and accrued expenses </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yNS9mcmFnOmE1MmJkOGZiZTY1ZjQ3ZWI4ZmVhNTIzNjZjZjJiM2NmL3RhYmxlOjEwZjViZTk1NjExOTQ5NzlhODdhYjVjZTdmZTgyYTIxL3RhYmxlcmFuZ2U6MTBmNWJlOTU2MTE5NDk3OWE4N2FiNWNlN2ZlODJhMjFfMTgtMS0xLTEtNDI3OTI_2656f10c-7f37-417f-b899-5999036f66b2">22,259</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic431430d1ab24120b4507025a722d73a_D20210101-20210930" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yNS9mcmFnOmE1MmJkOGZiZTY1ZjQ3ZWI4ZmVhNTIzNjZjZjJiM2NmL3RhYmxlOjEwZjViZTk1NjExOTQ5NzlhODdhYjVjZTdmZTgyYTIxL3RhYmxlcmFuZ2U6MTBmNWJlOTU2MTE5NDk3OWE4N2FiNWNlN2ZlODJhMjFfMTgtMy0xLTEtNDI3OTI_b1abe8ed-ee93-49c0-9b51-2915b5f098ab">42,747</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Net cash flow provided by operating activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930" decimals="-3" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yNS9mcmFnOmE1MmJkOGZiZTY1ZjQ3ZWI4ZmVhNTIzNjZjZjJiM2NmL3RhYmxlOjEwZjViZTk1NjExOTQ5NzlhODdhYjVjZTdmZTgyYTIxL3RhYmxlcmFuZ2U6MTBmNWJlOTU2MTE5NDk3OWE4N2FiNWNlN2ZlODJhMjFfMTktMS0xLTEtNDI3OTI_618b955d-daa1-4725-b1c2-44460833526a">142,831</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic431430d1ab24120b4507025a722d73a_D20210101-20210930" decimals="-3" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yNS9mcmFnOmE1MmJkOGZiZTY1ZjQ3ZWI4ZmVhNTIzNjZjZjJiM2NmL3RhYmxlOjEwZjViZTk1NjExOTQ5NzlhODdhYjVjZTdmZTgyYTIxL3RhYmxlcmFuZ2U6MTBmNWJlOTU2MTE5NDk3OWE4N2FiNWNlN2ZlODJhMjFfMTktMy0xLTEtNDI3OTI_06c974aa-c992-45e5-81a6-c37abc5e1c80">102,004</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Investing Activities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Sale and maturities of investment securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930" decimals="-3" name="us-gaap:ProceedsFromSaleOfShortTermInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yNS9mcmFnOmE1MmJkOGZiZTY1ZjQ3ZWI4ZmVhNTIzNjZjZjJiM2NmL3RhYmxlOjEwZjViZTk1NjExOTQ5NzlhODdhYjVjZTdmZTgyYTIxL3RhYmxlcmFuZ2U6MTBmNWJlOTU2MTE5NDk3OWE4N2FiNWNlN2ZlODJhMjFfMjItMS0xLTEtNDI3OTI_5a16e06a-02be-4501-a6e9-13d8b53685dc">5,267</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic431430d1ab24120b4507025a722d73a_D20210101-20210930" decimals="-3" name="us-gaap:ProceedsFromSaleOfShortTermInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yNS9mcmFnOmE1MmJkOGZiZTY1ZjQ3ZWI4ZmVhNTIzNjZjZjJiM2NmL3RhYmxlOjEwZjViZTk1NjExOTQ5NzlhODdhYjVjZTdmZTgyYTIxL3RhYmxlcmFuZ2U6MTBmNWJlOTU2MTE5NDk3OWE4N2FiNWNlN2ZlODJhMjFfMjItMy0xLTEtNDI3OTI_e465f417-d180-4cd1-9185-30810886cf9c">5,145</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Purchase of property and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yNS9mcmFnOmE1MmJkOGZiZTY1ZjQ3ZWI4ZmVhNTIzNjZjZjJiM2NmL3RhYmxlOjEwZjViZTk1NjExOTQ5NzlhODdhYjVjZTdmZTgyYTIxL3RhYmxlcmFuZ2U6MTBmNWJlOTU2MTE5NDk3OWE4N2FiNWNlN2ZlODJhMjFfMjMtMS0xLTEtNDI3OTI_0520a961-789f-439a-a40f-bcec527eedfc">7,617</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic431430d1ab24120b4507025a722d73a_D20210101-20210930" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yNS9mcmFnOmE1MmJkOGZiZTY1ZjQ3ZWI4ZmVhNTIzNjZjZjJiM2NmL3RhYmxlOjEwZjViZTk1NjExOTQ5NzlhODdhYjVjZTdmZTgyYTIxL3RhYmxlcmFuZ2U6MTBmNWJlOTU2MTE5NDk3OWE4N2FiNWNlN2ZlODJhMjFfMjMtMy0xLTEtNDI3OTI_2c822ac3-d1cb-4422-84be-ad1080c95f47">22,585</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Net cash flow used in investing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yNS9mcmFnOmE1MmJkOGZiZTY1ZjQ3ZWI4ZmVhNTIzNjZjZjJiM2NmL3RhYmxlOjEwZjViZTk1NjExOTQ5NzlhODdhYjVjZTdmZTgyYTIxL3RhYmxlcmFuZ2U6MTBmNWJlOTU2MTE5NDk3OWE4N2FiNWNlN2ZlODJhMjFfMjQtMS0xLTEtNDI3OTI_ffef3d0c-3411-4110-86fc-d1ec3cec85cb">2,350</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic431430d1ab24120b4507025a722d73a_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yNS9mcmFnOmE1MmJkOGZiZTY1ZjQ3ZWI4ZmVhNTIzNjZjZjJiM2NmL3RhYmxlOjEwZjViZTk1NjExOTQ5NzlhODdhYjVjZTdmZTgyYTIxL3RhYmxlcmFuZ2U6MTBmNWJlOTU2MTE5NDk3OWE4N2FiNWNlN2ZlODJhMjFfMjQtMy0xLTEtNDI3OTI_b6f7d4a6-c95c-4201-9608-ebcf336b228b">17,440</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Financing Activities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Options exercised by executives and directors</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930" decimals="-3" name="us-gaap:ProceedsFromStockOptionsExercised" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yNS9mcmFnOmE1MmJkOGZiZTY1ZjQ3ZWI4ZmVhNTIzNjZjZjJiM2NmL3RhYmxlOjEwZjViZTk1NjExOTQ5NzlhODdhYjVjZTdmZTgyYTIxL3RhYmxlcmFuZ2U6MTBmNWJlOTU2MTE5NDk3OWE4N2FiNWNlN2ZlODJhMjFfMjgtMS0xLTEtNDI3OTI_057e3ca4-42f0-4ea3-a041-788e273656f8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic431430d1ab24120b4507025a722d73a_D20210101-20210930" decimals="-3" name="us-gaap:ProceedsFromStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yNS9mcmFnOmE1MmJkOGZiZTY1ZjQ3ZWI4ZmVhNTIzNjZjZjJiM2NmL3RhYmxlOjEwZjViZTk1NjExOTQ5NzlhODdhYjVjZTdmZTgyYTIxL3RhYmxlcmFuZ2U6MTBmNWJlOTU2MTE5NDk3OWE4N2FiNWNlN2ZlODJhMjFfMjgtMy0xLTEtNDI3OTI_601ba0b5-537b-4e94-b548-97d54c73b63e">811</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Net shares repurchased for taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930" decimals="-3" name="us-gaap:PaymentsForRepurchaseOfOtherEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yNS9mcmFnOmE1MmJkOGZiZTY1ZjQ3ZWI4ZmVhNTIzNjZjZjJiM2NmL3RhYmxlOjEwZjViZTk1NjExOTQ5NzlhODdhYjVjZTdmZTgyYTIxL3RhYmxlcmFuZ2U6MTBmNWJlOTU2MTE5NDk3OWE4N2FiNWNlN2ZlODJhMjFfMjktMS0xLTEtNDI3OTI_3f40b894-672c-4d1d-b5bf-0317983a405f">1,504</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic431430d1ab24120b4507025a722d73a_D20210101-20210930" decimals="-3" name="us-gaap:PaymentsForRepurchaseOfOtherEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yNS9mcmFnOmE1MmJkOGZiZTY1ZjQ3ZWI4ZmVhNTIzNjZjZjJiM2NmL3RhYmxlOjEwZjViZTk1NjExOTQ5NzlhODdhYjVjZTdmZTgyYTIxL3RhYmxlcmFuZ2U6MTBmNWJlOTU2MTE5NDk3OWE4N2FiNWNlN2ZlODJhMjFfMjktMy0xLTEtNDI3OTI_e0961cb3-5979-42b6-8f7d-267c45b673d9">1,867</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Cash dividends paid to stockholders</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930" decimals="-3" name="us-gaap:PaymentsOfDividends" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yNS9mcmFnOmE1MmJkOGZiZTY1ZjQ3ZWI4ZmVhNTIzNjZjZjJiM2NmL3RhYmxlOjEwZjViZTk1NjExOTQ5NzlhODdhYjVjZTdmZTgyYTIxL3RhYmxlcmFuZ2U6MTBmNWJlOTU2MTE5NDk3OWE4N2FiNWNlN2ZlODJhMjFfMzAtMS0xLTEtNDI3OTI_de811a30-3009-4609-b172-e02a9e3ceb56">53,698</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic431430d1ab24120b4507025a722d73a_D20210101-20210930" decimals="-3" name="us-gaap:PaymentsOfDividends" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yNS9mcmFnOmE1MmJkOGZiZTY1ZjQ3ZWI4ZmVhNTIzNjZjZjJiM2NmL3RhYmxlOjEwZjViZTk1NjExOTQ5NzlhODdhYjVjZTdmZTgyYTIxL3RhYmxlcmFuZ2U6MTBmNWJlOTU2MTE5NDk3OWE4N2FiNWNlN2ZlODJhMjFfMzAtMy0xLTEtNDI3OTI_237eaf91-24dd-4387-8a2d-5d609e6f2256">46,845</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Stock repurchases</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930" decimals="-3" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yNS9mcmFnOmE1MmJkOGZiZTY1ZjQ3ZWI4ZmVhNTIzNjZjZjJiM2NmL3RhYmxlOjEwZjViZTk1NjExOTQ5NzlhODdhYjVjZTdmZTgyYTIxL3RhYmxlcmFuZ2U6MTBmNWJlOTU2MTE5NDk3OWE4N2FiNWNlN2ZlODJhMjFfMzEtMS0xLTEtNDI3OTI_7ad717b9-3666-4cb0-874d-621566f41543">120,048</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic431430d1ab24120b4507025a722d73a_D20210101-20210930" decimals="-3" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yNS9mcmFnOmE1MmJkOGZiZTY1ZjQ3ZWI4ZmVhNTIzNjZjZjJiM2NmL3RhYmxlOjEwZjViZTk1NjExOTQ5NzlhODdhYjVjZTdmZTgyYTIxL3RhYmxlcmFuZ2U6MTBmNWJlOTU2MTE5NDk3OWE4N2FiNWNlN2ZlODJhMjFfMzEtMy0xLTEtNDI3OTI_0a35d764-411a-4906-810c-74fbbe99a9f8">46,000</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Net cash flow used in financing activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yNS9mcmFnOmE1MmJkOGZiZTY1ZjQ3ZWI4ZmVhNTIzNjZjZjJiM2NmL3RhYmxlOjEwZjViZTk1NjExOTQ5NzlhODdhYjVjZTdmZTgyYTIxL3RhYmxlcmFuZ2U6MTBmNWJlOTU2MTE5NDk3OWE4N2FiNWNlN2ZlODJhMjFfMzMtMS0xLTEtNDI3OTI_f929402f-d405-4b71-8a55-fc50c2c74dc1">175,250</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic431430d1ab24120b4507025a722d73a_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yNS9mcmFnOmE1MmJkOGZiZTY1ZjQ3ZWI4ZmVhNTIzNjZjZjJiM2NmL3RhYmxlOjEwZjViZTk1NjExOTQ5NzlhODdhYjVjZTdmZTgyYTIxL3RhYmxlcmFuZ2U6MTBmNWJlOTU2MTE5NDk3OWE4N2FiNWNlN2ZlODJhMjFfMzMtMy0xLTEtNDI3OTI_924b235d-a564-477f-944e-bce8abda89f2">93,901</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Foreign currency impact</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930" decimals="-3" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yNS9mcmFnOmE1MmJkOGZiZTY1ZjQ3ZWI4ZmVhNTIzNjZjZjJiM2NmL3RhYmxlOjEwZjViZTk1NjExOTQ5NzlhODdhYjVjZTdmZTgyYTIxL3RhYmxlcmFuZ2U6MTBmNWJlOTU2MTE5NDk3OWE4N2FiNWNlN2ZlODJhMjFfMzUtMS0xLTEtNDI3OTI_6eea6b9e-3d75-4aee-b8b6-90f2294501a1">296</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic431430d1ab24120b4507025a722d73a_D20210101-20210930" decimals="-3" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yNS9mcmFnOmE1MmJkOGZiZTY1ZjQ3ZWI4ZmVhNTIzNjZjZjJiM2NmL3RhYmxlOjEwZjViZTk1NjExOTQ5NzlhODdhYjVjZTdmZTgyYTIxL3RhYmxlcmFuZ2U6MTBmNWJlOTU2MTE5NDk3OWE4N2FiNWNlN2ZlODJhMjFfMzUtMy0xLTEtNDI3OTI_8ea56dcb-1d40-400a-9f8d-9ecfd6efdcf4">130</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Decrease in cash and cash equivalents</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yNS9mcmFnOmE1MmJkOGZiZTY1ZjQ3ZWI4ZmVhNTIzNjZjZjJiM2NmL3RhYmxlOjEwZjViZTk1NjExOTQ5NzlhODdhYjVjZTdmZTgyYTIxL3RhYmxlcmFuZ2U6MTBmNWJlOTU2MTE5NDk3OWE4N2FiNWNlN2ZlODJhMjFfMzctMS0xLTEtNDI3OTI_9f833e61-f2a8-4398-ad42-e3bdc310eebe">34,473</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic431430d1ab24120b4507025a722d73a_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yNS9mcmFnOmE1MmJkOGZiZTY1ZjQ3ZWI4ZmVhNTIzNjZjZjJiM2NmL3RhYmxlOjEwZjViZTk1NjExOTQ5NzlhODdhYjVjZTdmZTgyYTIxL3RhYmxlcmFuZ2U6MTBmNWJlOTU2MTE5NDk3OWE4N2FiNWNlN2ZlODJhMjFfMzctMy0xLTEtNDI3OTI_0ee3a712-6291-4b18-994c-d2bb238ac0b8">9,207</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Cash and cash equivalents - beginning of the period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47f09f18839440ffae0cf05a475aa7fe_I20211231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yNS9mcmFnOmE1MmJkOGZiZTY1ZjQ3ZWI4ZmVhNTIzNjZjZjJiM2NmL3RhYmxlOjEwZjViZTk1NjExOTQ5NzlhODdhYjVjZTdmZTgyYTIxL3RhYmxlcmFuZ2U6MTBmNWJlOTU2MTE5NDk3OWE4N2FiNWNlN2ZlODJhMjFfMzgtMS0xLTEtNDI3OTI_bbe1d34d-8656-4674-a5e2-a4f2f4c416f4">104,183</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03d902ffc72e4d98b5eeb6fb903f405b_I20201231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yNS9mcmFnOmE1MmJkOGZiZTY1ZjQ3ZWI4ZmVhNTIzNjZjZjJiM2NmL3RhYmxlOjEwZjViZTk1NjExOTQ5NzlhODdhYjVjZTdmZTgyYTIxL3RhYmxlcmFuZ2U6MTBmNWJlOTU2MTE5NDk3OWE4N2FiNWNlN2ZlODJhMjFfMzgtMy0xLTEtNDI3OTI_ec7efb2a-ed20-455e-a52a-d9dbcbc87006">163,723</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Cash and cash equivalents - end of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5de311f5948148cda49342e2cea83715_I20220930" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yNS9mcmFnOmE1MmJkOGZiZTY1ZjQ3ZWI4ZmVhNTIzNjZjZjJiM2NmL3RhYmxlOjEwZjViZTk1NjExOTQ5NzlhODdhYjVjZTdmZTgyYTIxL3RhYmxlcmFuZ2U6MTBmNWJlOTU2MTE5NDk3OWE4N2FiNWNlN2ZlODJhMjFfMzktMS0xLTEtNDI3OTI_9a56f374-df4a-4987-8980-c32ea0f928b9">69,710</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb5de6f6a1b842d59a7c6674c3095ce8_I20210930" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yNS9mcmFnOmE1MmJkOGZiZTY1ZjQ3ZWI4ZmVhNTIzNjZjZjJiM2NmL3RhYmxlOjEwZjViZTk1NjExOTQ5NzlhODdhYjVjZTdmZTgyYTIxL3RhYmxlcmFuZ2U6MTBmNWJlOTU2MTE5NDk3OWE4N2FiNWNlN2ZlODJhMjFfMzktMy0xLTEtNDI3OTI_211efb01-8c22-43d2-947a-2f9486b668ee">154,516</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Supplemental disclosure of cash flow information:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Income taxes paid</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930" decimals="-3" name="us-gaap:IncomeTaxesPaidNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yNS9mcmFnOmE1MmJkOGZiZTY1ZjQ3ZWI4ZmVhNTIzNjZjZjJiM2NmL3RhYmxlOjEwZjViZTk1NjExOTQ5NzlhODdhYjVjZTdmZTgyYTIxL3RhYmxlcmFuZ2U6MTBmNWJlOTU2MTE5NDk3OWE4N2FiNWNlN2ZlODJhMjFfNDItMS0xLTEtNDI3OTI_28e41871-7ba6-42a0-8130-8a3240254ccb">33,906</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic431430d1ab24120b4507025a722d73a_D20210101-20210930" decimals="-3" name="us-gaap:IncomeTaxesPaidNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yNS9mcmFnOmE1MmJkOGZiZTY1ZjQ3ZWI4ZmVhNTIzNjZjZjJiM2NmL3RhYmxlOjEwZjViZTk1NjExOTQ5NzlhODdhYjVjZTdmZTgyYTIxL3RhYmxlcmFuZ2U6MTBmNWJlOTU2MTE5NDk3OWE4N2FiNWNlN2ZlODJhMjFfNDItMy0xLTEtNDI3OTI_33569e70-b3ea-4d11-9b34-d0e270d89d2c">41,302</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Dividends declared included in accounts payable</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930" decimals="-3" name="us-gaap:DividendsCash" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yNS9mcmFnOmE1MmJkOGZiZTY1ZjQ3ZWI4ZmVhNTIzNjZjZjJiM2NmL3RhYmxlOjEwZjViZTk1NjExOTQ5NzlhODdhYjVjZTdmZTgyYTIxL3RhYmxlcmFuZ2U6MTBmNWJlOTU2MTE5NDk3OWE4N2FiNWNlN2ZlODJhMjFfNDMtMS0xLTEtNDI3OTI_97098aae-503c-4a0a-9799-a2fafd7fe6bf">19,395</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic431430d1ab24120b4507025a722d73a_D20210101-20210930" decimals="-3" name="us-gaap:DividendsCash" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yNS9mcmFnOmE1MmJkOGZiZTY1ZjQ3ZWI4ZmVhNTIzNjZjZjJiM2NmL3RhYmxlOjEwZjViZTk1NjExOTQ5NzlhODdhYjVjZTdmZTgyYTIxL3RhYmxlcmFuZ2U6MTBmNWJlOTU2MTE5NDk3OWE4N2FiNWNlN2ZlODJhMjFfNDMtMy0xLTEtNDI3OTI_f99cf643-225a-40cc-8f1a-ad8875768514">17,351</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these condensed consolidated financial statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">5</span></div></div></div><div id="ic8ae413b3ff34d56976502c585fa6ab3_28"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:21.6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#ic8ae413b3ff34d56976502c585fa6ab3_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">MEDIFAST, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS&#8217; EQUITY (UNAUDITED)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(U.S. dollars in thousands)</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:30.030%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.710%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.387%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.563%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.387%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.710%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.387%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.675%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.387%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.444%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.387%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.563%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.387%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.983%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Nine months ended September 30, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Number of<br/>Shares Issued</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Common Stock</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Additional Paid-In <br/>Capital</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Accumulated Other <br/>Comprehensive Income</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Retained <br/>Earnings</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Treasury Stock</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Total</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Balance, December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i77931d79ec4a440094a82f9812ccc722_I20211231" decimals="-3" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOmYwOWZlYWUyNmU5OTQ5Mzk4MDk5NmU5MjgzMzdkZDZiL3RhYmxlcmFuZ2U6ZjA5ZmVhZTI2ZTk5NDkzOTgwOTk2ZTkyODMzN2RkNmJfMy0xLTEtMS00Mjc5Mg_86976645-d4e7-48b2-b036-ebaf4c9aedd9">11,594</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77931d79ec4a440094a82f9812ccc722_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOmYwOWZlYWUyNmU5OTQ5Mzk4MDk5NmU5MjgzMzdkZDZiL3RhYmxlcmFuZ2U6ZjA5ZmVhZTI2ZTk5NDkzOTgwOTk2ZTkyODMzN2RkNmJfMy0zLTEtMS00Mjc5Mg_285b6b2d-1ee3-4dfa-9d20-c353695d9ab6">12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4daa9b081467438bab4674c0946e08cd_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOmYwOWZlYWUyNmU5OTQ5Mzk4MDk5NmU5MjgzMzdkZDZiL3RhYmxlcmFuZ2U6ZjA5ZmVhZTI2ZTk5NDkzOTgwOTk2ZTkyODMzN2RkNmJfMy01LTEtMS00Mjc5Mg_bcd54ed4-280b-438b-a7f4-9d51796b4cd5">12,018</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id19243f3c67e4c9db2d2085c6f295c96_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOmYwOWZlYWUyNmU5OTQ5Mzk4MDk5NmU5MjgzMzdkZDZiL3RhYmxlcmFuZ2U6ZjA5ZmVhZTI2ZTk5NDkzOTgwOTk2ZTkyODMzN2RkNmJfMy03LTEtMS00Mjc5Mg_2b3c046b-42af-4fc1-9403-cd395350a58d">111</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic425e1f1f3a24303b14c8132e098ec51_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOmYwOWZlYWUyNmU5OTQ5Mzk4MDk5NmU5MjgzMzdkZDZiL3RhYmxlcmFuZ2U6ZjA5ZmVhZTI2ZTk5NDkzOTgwOTk2ZTkyODMzN2RkNmJfMy05LTEtMS00Mjc5Mg_a06ebfd8-d47b-4860-b99e-60803a29c44d">190,333</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87d2a4b91677497c84867fb9eb0d1fe3_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOmYwOWZlYWUyNmU5OTQ5Mzk4MDk5NmU5MjgzMzdkZDZiL3RhYmxlcmFuZ2U6ZjA5ZmVhZTI2ZTk5NDkzOTgwOTk2ZTkyODMzN2RkNmJfMy0xMS0xLTEtNDI3OTI_bc0478aa-bc29-4f5e-8e96-241b369a0761">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47f09f18839440ffae0cf05a475aa7fe_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOmYwOWZlYWUyNmU5OTQ5Mzk4MDk5NmU5MjgzMzdkZDZiL3RhYmxlcmFuZ2U6ZjA5ZmVhZTI2ZTk5NDkzOTgwOTk2ZTkyODMzN2RkNmJfMy0xMy0xLTEtNDI3OTI_d46079a6-4935-494c-b542-1861b8279402">202,474</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Net income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c296c25c3154c589996445b02c8b46f_D20220101-20220331" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOmYwOWZlYWUyNmU5OTQ5Mzk4MDk5NmU5MjgzMzdkZDZiL3RhYmxlcmFuZ2U6ZjA5ZmVhZTI2ZTk5NDkzOTgwOTk2ZTkyODMzN2RkNmJfNC05LTEtMS00Mjc5Mg_5fd9cee4-2253-48c0-a892-95535b0bcdb9">41,781</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35ec1b88d067414ebdd617a1caddf764_D20220101-20220331" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOmYwOWZlYWUyNmU5OTQ5Mzk4MDk5NmU5MjgzMzdkZDZiL3RhYmxlcmFuZ2U6ZjA5ZmVhZTI2ZTk5NDkzOTgwOTk2ZTkyODMzN2RkNmJfNC0xMy0xLTEtNDI3OTI_44ce9256-173c-4dc2-88b2-b397bdbef6d8">41,781</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Share-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9d58012ea00c40debc6e3821ba8c53e8_D20220101-20220331" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOmYwOWZlYWUyNmU5OTQ5Mzk4MDk5NmU5MjgzMzdkZDZiL3RhYmxlcmFuZ2U6ZjA5ZmVhZTI2ZTk5NDkzOTgwOTk2ZTkyODMzN2RkNmJfNS0xLTEtMS00Mjc5Mg_d4af9c93-c6f9-499e-bdcf-17b5ec49fb8b">18</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifef10a2343ba477a98a2732ea2e3188d_D20220101-20220331" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOmYwOWZlYWUyNmU5OTQ5Mzk4MDk5NmU5MjgzMzdkZDZiL3RhYmxlcmFuZ2U6ZjA5ZmVhZTI2ZTk5NDkzOTgwOTk2ZTkyODMzN2RkNmJfNS01LTEtMS00Mjc5Mg_9dfd3af8-bbe7-4622-abac-e8c7370eb64e">2,275</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35ec1b88d067414ebdd617a1caddf764_D20220101-20220331" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOmYwOWZlYWUyNmU5OTQ5Mzk4MDk5NmU5MjgzMzdkZDZiL3RhYmxlcmFuZ2U6ZjA5ZmVhZTI2ZTk5NDkzOTgwOTk2ZTkyODMzN2RkNmJfNS0xMy0xLTEtNDI3OTI_994adb5f-d7dc-405a-aaa5-9e6d65c64752">2,275</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Net shares repurchased for taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i9d58012ea00c40debc6e3821ba8c53e8_D20220101-20220331" decimals="-3" name="us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOmYwOWZlYWUyNmU5OTQ5Mzk4MDk5NmU5MjgzMzdkZDZiL3RhYmxlcmFuZ2U6ZjA5ZmVhZTI2ZTk5NDkzOTgwOTk2ZTkyODMzN2RkNmJfNi0xLTEtMS00Mjc5Mg_e9ddcbe9-bbb5-4bc0-af96-27a02fb013e7">8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifef10a2343ba477a98a2732ea2e3188d_D20220101-20220331" decimals="-3" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOmYwOWZlYWUyNmU5OTQ5Mzk4MDk5NmU5MjgzMzdkZDZiL3RhYmxlcmFuZ2U6ZjA5ZmVhZTI2ZTk5NDkzOTgwOTk2ZTkyODMzN2RkNmJfNi01LTEtMS00Mjc5Mg_fc2e5ab2-ab3f-4c2a-a483-ec6b78e50f2f">1,459</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i35ec1b88d067414ebdd617a1caddf764_D20220101-20220331" decimals="-3" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOmYwOWZlYWUyNmU5OTQ5Mzk4MDk5NmU5MjgzMzdkZDZiL3RhYmxlcmFuZ2U6ZjA5ZmVhZTI2ZTk5NDkzOTgwOTk2ZTkyODMzN2RkNmJfNi0xMy0xLTEtNDI3OTI_b047598d-8a8d-4458-851f-5d119e3d907f">1,459</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Treasury stock from stock repurchases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifcda0fa259164bf4a392c5cadde798d0_D20220101-20220331" decimals="-3" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOmYwOWZlYWUyNmU5OTQ5Mzk4MDk5NmU5MjgzMzdkZDZiL3RhYmxlcmFuZ2U6ZjA5ZmVhZTI2ZTk5NDkzOTgwOTk2ZTkyODMzN2RkNmJfNy0xMS0xLTEtNDI3OTI_30d09897-82e5-44ba-bf66-c51592848663">10,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i35ec1b88d067414ebdd617a1caddf764_D20220101-20220331" decimals="-3" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOmYwOWZlYWUyNmU5OTQ5Mzk4MDk5NmU5MjgzMzdkZDZiL3RhYmxlcmFuZ2U6ZjA5ZmVhZTI2ZTk5NDkzOTgwOTk2ZTkyODMzN2RkNmJfNy0xMy0xLTEtNDI3OTI_81a7b37b-975a-477e-861f-4421c3cc03b8">10,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Treasury stock retired from stock repurchases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i9d58012ea00c40debc6e3821ba8c53e8_D20220101-20220331" decimals="-3" name="us-gaap:TreasuryStockSharesRetired" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOmYwOWZlYWUyNmU5OTQ5Mzk4MDk5NmU5MjgzMzdkZDZiL3RhYmxlcmFuZ2U6ZjA5ZmVhZTI2ZTk5NDkzOTgwOTk2ZTkyODMzN2RkNmJfOC0xLTEtMS00Mjc5Mg_c2bd1c78-60b1-480d-9c18-4a7492c10460">51</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4c296c25c3154c589996445b02c8b46f_D20220101-20220331" decimals="-3" name="us-gaap:TreasuryStockRetiredCostMethodAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOmYwOWZlYWUyNmU5OTQ5Mzk4MDk5NmU5MjgzMzdkZDZiL3RhYmxlcmFuZ2U6ZjA5ZmVhZTI2ZTk5NDkzOTgwOTk2ZTkyODMzN2RkNmJfOC05LTEtMS00Mjc5Mg_d8b97f36-2627-4175-a7ae-c5f577a29b21">10,000</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifcda0fa259164bf4a392c5cadde798d0_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:TreasuryStockRetiredCostMethodAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOmYwOWZlYWUyNmU5OTQ5Mzk4MDk5NmU5MjgzMzdkZDZiL3RhYmxlcmFuZ2U6ZjA5ZmVhZTI2ZTk5NDkzOTgwOTk2ZTkyODMzN2RkNmJfOC0xMS0xLTEtNDI3OTI_99c0cad7-449c-4386-aa36-b0e76f04a652">10,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35ec1b88d067414ebdd617a1caddf764_D20220101-20220331" decimals="-3" name="us-gaap:TreasuryStockRetiredCostMethodAmount" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOmYwOWZlYWUyNmU5OTQ5Mzk4MDk5NmU5MjgzMzdkZDZiL3RhYmxlcmFuZ2U6ZjA5ZmVhZTI2ZTk5NDkzOTgwOTk2ZTkyODMzN2RkNmJfOC0xMy0xLTEtNDI3OTI_ebbb8c5c-a2e0-4ce5-a899-9d7cc4dfed2d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Other comprehensive income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iedb06a9ecbbd425b9ff4de89c5ec443c_D20220101-20220331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOmYwOWZlYWUyNmU5OTQ5Mzk4MDk5NmU5MjgzMzdkZDZiL3RhYmxlcmFuZ2U6ZjA5ZmVhZTI2ZTk5NDkzOTgwOTk2ZTkyODMzN2RkNmJfOS03LTEtMS00Mjc5Mg_b16c1351-3d64-44be-aecb-9774f6e6082f">16</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35ec1b88d067414ebdd617a1caddf764_D20220101-20220331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOmYwOWZlYWUyNmU5OTQ5Mzk4MDk5NmU5MjgzMzdkZDZiL3RhYmxlcmFuZ2U6ZjA5ZmVhZTI2ZTk5NDkzOTgwOTk2ZTkyODMzN2RkNmJfOS0xMy0xLTEtNDI3OTI_9ed6eee9-418f-4d7f-a5ca-83091bb5914d">16</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Cash dividends declared to stockholders</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4c296c25c3154c589996445b02c8b46f_D20220101-20220331" decimals="-3" name="us-gaap:DividendsCommonStockCash" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOmYwOWZlYWUyNmU5OTQ5Mzk4MDk5NmU5MjgzMzdkZDZiL3RhYmxlcmFuZ2U6ZjA5ZmVhZTI2ZTk5NDkzOTgwOTk2ZTkyODMzN2RkNmJfMTAtOS0xLTEtNDI3OTI_ab160f31-d67e-4127-8b85-ee1085ca1370">19,063</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i35ec1b88d067414ebdd617a1caddf764_D20220101-20220331" decimals="-3" name="us-gaap:DividendsCommonStockCash" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOmYwOWZlYWUyNmU5OTQ5Mzk4MDk5NmU5MjgzMzdkZDZiL3RhYmxlcmFuZ2U6ZjA5ZmVhZTI2ZTk5NDkzOTgwOTk2ZTkyODMzN2RkNmJfMTAtMTMtMS0xLTQyNzky_bf1bd379-ec8b-4c39-94b4-2d30fc80213f">19,063</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Balance, March 31, 2022</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1aa514aadcf045659a010e7c7dff59d4_I20220331" decimals="-3" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOmYwOWZlYWUyNmU5OTQ5Mzk4MDk5NmU5MjgzMzdkZDZiL3RhYmxlcmFuZ2U6ZjA5ZmVhZTI2ZTk5NDkzOTgwOTk2ZTkyODMzN2RkNmJfMTItMS0xLTEtNDI3OTI_9cf606a6-f4d3-4a4b-aa68-cd61be7367ac">11,553</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1aa514aadcf045659a010e7c7dff59d4_I20220331" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOmYwOWZlYWUyNmU5OTQ5Mzk4MDk5NmU5MjgzMzdkZDZiL3RhYmxlcmFuZ2U6ZjA5ZmVhZTI2ZTk5NDkzOTgwOTk2ZTkyODMzN2RkNmJfMTItMy0xLTEtNDI3OTI_352a75f0-83d5-40c4-981e-57d8db0367a6">12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b72febc917d4ba4a54ef5179a1ddbbf_I20220331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOmYwOWZlYWUyNmU5OTQ5Mzk4MDk5NmU5MjgzMzdkZDZiL3RhYmxlcmFuZ2U6ZjA5ZmVhZTI2ZTk5NDkzOTgwOTk2ZTkyODMzN2RkNmJfMTItNS0xLTEtNDI3OTI_dd70086b-bfa8-4b08-b6ec-707aadf2fb7d">12,834</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id441c59bc18c4d6faf4dc590c7376782_I20220331" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOmYwOWZlYWUyNmU5OTQ5Mzk4MDk5NmU5MjgzMzdkZDZiL3RhYmxlcmFuZ2U6ZjA5ZmVhZTI2ZTk5NDkzOTgwOTk2ZTkyODMzN2RkNmJfMTItNy0xLTEtNDI3OTI_11ba3119-736d-4531-80fa-23b28efe8d05">127</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b8a276003b3422d87146a73aca9877e_I20220331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOmYwOWZlYWUyNmU5OTQ5Mzk4MDk5NmU5MjgzMzdkZDZiL3RhYmxlcmFuZ2U6ZjA5ZmVhZTI2ZTk5NDkzOTgwOTk2ZTkyODMzN2RkNmJfMTItOS0xLTEtNDI3OTI_9ea22545-114d-4725-aebd-eb61dffa1f84">203,051</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5d8f60be441544f9a5706ed808193db4_I20220331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOmYwOWZlYWUyNmU5OTQ5Mzk4MDk5NmU5MjgzMzdkZDZiL3RhYmxlcmFuZ2U6ZjA5ZmVhZTI2ZTk5NDkzOTgwOTk2ZTkyODMzN2RkNmJfMTItMTEtMS0xLTQyNzky_c0402550-7d80-495b-a711-d2dafc0a3500">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife6dd959a81f4995b5e17747ce77289e_I20220331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOmYwOWZlYWUyNmU5OTQ5Mzk4MDk5NmU5MjgzMzdkZDZiL3RhYmxlcmFuZ2U6ZjA5ZmVhZTI2ZTk5NDkzOTgwOTk2ZTkyODMzN2RkNmJfMTItMTMtMS0xLTQyNzky_f1bbe1b7-60c3-4a4c-b92b-08b00ee76693">216,024</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Net income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i825be310f0914f779c3296901da45216_D20220401-20220630" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOmYwOWZlYWUyNmU5OTQ5Mzk4MDk5NmU5MjgzMzdkZDZiL3RhYmxlcmFuZ2U6ZjA5ZmVhZTI2ZTk5NDkzOTgwOTk2ZTkyODMzN2RkNmJfMTMtOS0xLTEtNDI3OTI_134c5d6f-339f-46c1-aec8-8c4dbd2e8afd">39,113</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a350b34ff224fcfb66d3b6986b8d85d_D20220401-20220630" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOmYwOWZlYWUyNmU5OTQ5Mzk4MDk5NmU5MjgzMzdkZDZiL3RhYmxlcmFuZ2U6ZjA5ZmVhZTI2ZTk5NDkzOTgwOTk2ZTkyODMzN2RkNmJfMTMtMTMtMS0xLTQyNzky_efee6062-6a9e-40c5-8d3b-430fdd09d64e">39,113</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Share-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i31e2c05019204ecc9f2b00f8685ed1de_D20220401-20220630" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOmYwOWZlYWUyNmU5OTQ5Mzk4MDk5NmU5MjgzMzdkZDZiL3RhYmxlcmFuZ2U6ZjA5ZmVhZTI2ZTk5NDkzOTgwOTk2ZTkyODMzN2RkNmJfMTQtMS0xLTEtNDI3OTI_92112386-0da4-4783-b9ce-09f47af45778">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c04a52245ee4a18af7538a5b3926bd8_D20220401-20220630" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOmYwOWZlYWUyNmU5OTQ5Mzk4MDk5NmU5MjgzMzdkZDZiL3RhYmxlcmFuZ2U6ZjA5ZmVhZTI2ZTk5NDkzOTgwOTk2ZTkyODMzN2RkNmJfMTQtNS0xLTEtNDI3OTI_8d36cfd6-1c21-47a6-bafe-d70378f3f2e2">2,865</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a350b34ff224fcfb66d3b6986b8d85d_D20220401-20220630" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOmYwOWZlYWUyNmU5OTQ5Mzk4MDk5NmU5MjgzMzdkZDZiL3RhYmxlcmFuZ2U6ZjA5ZmVhZTI2ZTk5NDkzOTgwOTk2ZTkyODMzN2RkNmJfMTQtMTMtMS0xLTQyNzky_2fecf6ad-fcfa-41d5-98a7-b93244a9392f">2,865</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Net shares repurchased for taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7c04a52245ee4a18af7538a5b3926bd8_D20220401-20220630" decimals="-3" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOmYwOWZlYWUyNmU5OTQ5Mzk4MDk5NmU5MjgzMzdkZDZiL3RhYmxlcmFuZ2U6ZjA5ZmVhZTI2ZTk5NDkzOTgwOTk2ZTkyODMzN2RkNmJfMTUtNS0xLTEtNDI3OTI_b6e0c757-eb7f-4eb2-ad55-29b52934a967">20</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6a350b34ff224fcfb66d3b6986b8d85d_D20220401-20220630" decimals="-3" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOmYwOWZlYWUyNmU5OTQ5Mzk4MDk5NmU5MjgzMzdkZDZiL3RhYmxlcmFuZ2U6ZjA5ZmVhZTI2ZTk5NDkzOTgwOTk2ZTkyODMzN2RkNmJfMTUtMTMtMS0xLTQyNzky_6e27534e-9af5-4c5b-9437-6999bb1bbdc2">20</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Treasury stock from stock repurchases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3fe461be5d8a4b1d8f4f96a4471aae50_D20220401-20220630" decimals="-3" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOmYwOWZlYWUyNmU5OTQ5Mzk4MDk5NmU5MjgzMzdkZDZiL3RhYmxlcmFuZ2U6ZjA5ZmVhZTI2ZTk5NDkzOTgwOTk2ZTkyODMzN2RkNmJfMTYtMTEtMS0xLTQyNzky_88defd38-7015-4b0c-97ec-de5f6d1aef77">90,038</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6a350b34ff224fcfb66d3b6986b8d85d_D20220401-20220630" decimals="-3" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOmYwOWZlYWUyNmU5OTQ5Mzk4MDk5NmU5MjgzMzdkZDZiL3RhYmxlcmFuZ2U6ZjA5ZmVhZTI2ZTk5NDkzOTgwOTk2ZTkyODMzN2RkNmJfMTYtMTMtMS0xLTQyNzky_711672e3-7e11-4732-8b45-c592f2f4763b">90,038</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Treasury stock retired from stock repurchases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i31e2c05019204ecc9f2b00f8685ed1de_D20220401-20220630" decimals="-3" name="us-gaap:TreasuryStockSharesRetired" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOmYwOWZlYWUyNmU5OTQ5Mzk4MDk5NmU5MjgzMzdkZDZiL3RhYmxlcmFuZ2U6ZjA5ZmVhZTI2ZTk5NDkzOTgwOTk2ZTkyODMzN2RkNmJfMTctMS0xLTEtNDI3OTI_f266dec4-29e2-4d76-97f0-08aca6a5ca6f">535</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i31e2c05019204ecc9f2b00f8685ed1de_D20220401-20220630" decimals="-3" name="us-gaap:TreasuryStockRetiredCostMethodAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOmYwOWZlYWUyNmU5OTQ5Mzk4MDk5NmU5MjgzMzdkZDZiL3RhYmxlcmFuZ2U6ZjA5ZmVhZTI2ZTk5NDkzOTgwOTk2ZTkyODMzN2RkNmJfMTctMy0xLTEtNDI3OTI_d022abf6-bca2-4c6d-a249-9a2955a7d0d7">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i825be310f0914f779c3296901da45216_D20220401-20220630" decimals="-3" name="us-gaap:TreasuryStockRetiredCostMethodAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOmYwOWZlYWUyNmU5OTQ5Mzk4MDk5NmU5MjgzMzdkZDZiL3RhYmxlcmFuZ2U6ZjA5ZmVhZTI2ZTk5NDkzOTgwOTk2ZTkyODMzN2RkNmJfMTctOS0xLTEtNDI3OTI_9d09d5ba-ba4d-47d3-b18d-6604160363ef">90,038</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3fe461be5d8a4b1d8f4f96a4471aae50_D20220401-20220630" decimals="-3" sign="-" name="us-gaap:TreasuryStockRetiredCostMethodAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOmYwOWZlYWUyNmU5OTQ5Mzk4MDk5NmU5MjgzMzdkZDZiL3RhYmxlcmFuZ2U6ZjA5ZmVhZTI2ZTk5NDkzOTgwOTk2ZTkyODMzN2RkNmJfMTctMTEtMS0xLTQyNzky_371cc47f-ae0d-41bc-9359-ad151253b0cc">90,038</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6a350b34ff224fcfb66d3b6986b8d85d_D20220401-20220630" decimals="-3" name="us-gaap:TreasuryStockRetiredCostMethodAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOmYwOWZlYWUyNmU5OTQ5Mzk4MDk5NmU5MjgzMzdkZDZiL3RhYmxlcmFuZ2U6ZjA5ZmVhZTI2ZTk5NDkzOTgwOTk2ZTkyODMzN2RkNmJfMTctMTMtMS0xLTQyNzky_4757ded8-a717-4ade-8916-fd4a67c7181e">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Stock repurchases, not yet settled</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7c04a52245ee4a18af7538a5b3926bd8_D20220401-20220630" decimals="-3" name="med:AdjustmentsToPaidInCapitalShareRepurchasesNotYetSettled" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOmYwOWZlYWUyNmU5OTQ5Mzk4MDk5NmU5MjgzMzdkZDZiL3RhYmxlcmFuZ2U6ZjA5ZmVhZTI2ZTk5NDkzOTgwOTk2ZTkyODMzN2RkNmJfMTgtNS0xLTEtNDI3OTI_e622db32-1dc5-4111-814f-c8162a1e8793">15,679</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i825be310f0914f779c3296901da45216_D20220401-20220630" decimals="-3" name="med:AdjustmentsToPaidInCapitalShareRepurchasesNotYetSettled" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOmYwOWZlYWUyNmU5OTQ5Mzk4MDk5NmU5MjgzMzdkZDZiL3RhYmxlcmFuZ2U6ZjA5ZmVhZTI2ZTk5NDkzOTgwOTk2ZTkyODMzN2RkNmJfMTgtOS0xLTEtNDI3OTI_ae9de390-9706-443c-b847-0c3dc26a6ab1">4,331</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6a350b34ff224fcfb66d3b6986b8d85d_D20220401-20220630" decimals="-3" name="med:AdjustmentsToPaidInCapitalShareRepurchasesNotYetSettled" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOmYwOWZlYWUyNmU5OTQ5Mzk4MDk5NmU5MjgzMzdkZDZiL3RhYmxlcmFuZ2U6ZjA5ZmVhZTI2ZTk5NDkzOTgwOTk2ZTkyODMzN2RkNmJfMTgtMTMtMS0xLTQyNzky_cec1efb8-8488-4a0e-b807-1ccaf5d2c6b6">20,010</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Other comprehensive income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b731dc434c94dbca7470032b562d581_D20220401-20220630" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOmYwOWZlYWUyNmU5OTQ5Mzk4MDk5NmU5MjgzMzdkZDZiL3RhYmxlcmFuZ2U6ZjA5ZmVhZTI2ZTk5NDkzOTgwOTk2ZTkyODMzN2RkNmJfMTktNy0xLTEtNDI3OTI_e1aa1062-9227-4e5c-b9bc-bfedfdf92757">141</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a350b34ff224fcfb66d3b6986b8d85d_D20220401-20220630" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOmYwOWZlYWUyNmU5OTQ5Mzk4MDk5NmU5MjgzMzdkZDZiL3RhYmxlcmFuZ2U6ZjA5ZmVhZTI2ZTk5NDkzOTgwOTk2ZTkyODMzN2RkNmJfMTktMTMtMS0xLTQyNzky_0c75dc2e-84a6-438d-909b-9792e04213a2">141</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Cash dividends declared to stockholders</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i825be310f0914f779c3296901da45216_D20220401-20220630" decimals="-3" name="us-gaap:DividendsCommonStockCash" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOmYwOWZlYWUyNmU5OTQ5Mzk4MDk5NmU5MjgzMzdkZDZiL3RhYmxlcmFuZ2U6ZjA5ZmVhZTI2ZTk5NDkzOTgwOTk2ZTkyODMzN2RkNmJfMjAtOS0xLTEtNDI3OTI_d92a381f-4b3e-49a5-8161-aeea2fdee961">18,598</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6a350b34ff224fcfb66d3b6986b8d85d_D20220401-20220630" decimals="-3" name="us-gaap:DividendsCommonStockCash" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOmYwOWZlYWUyNmU5OTQ5Mzk4MDk5NmU5MjgzMzdkZDZiL3RhYmxlcmFuZ2U6ZjA5ZmVhZTI2ZTk5NDkzOTgwOTk2ZTkyODMzN2RkNmJfMjAtMTMtMS0xLTQyNzky_963bc6ac-5606-416b-81d5-31b9b9d19bb9">18,598</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance, June 30, 2022</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i44dccac463fc4d3d841cabd5924e0d7b_I20220630" decimals="-3" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOmYwOWZlYWUyNmU5OTQ5Mzk4MDk5NmU5MjgzMzdkZDZiL3RhYmxlcmFuZ2U6ZjA5ZmVhZTI2ZTk5NDkzOTgwOTk2ZTkyODMzN2RkNmJfMjItMS0xLTEtNDI3OTI_5871e0ba-765b-4f34-ba8e-28bfe193d8ad">11,019</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44dccac463fc4d3d841cabd5924e0d7b_I20220630" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOmYwOWZlYWUyNmU5OTQ5Mzk4MDk5NmU5MjgzMzdkZDZiL3RhYmxlcmFuZ2U6ZjA5ZmVhZTI2ZTk5NDkzOTgwOTk2ZTkyODMzN2RkNmJfMjItMy0xLTEtNDI3OTI_3444bf3a-d474-481c-ab93-6741f6a04ff8">11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a26a14e2dc041cc84ce9b142e145c9e_I20220630" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOmYwOWZlYWUyNmU5OTQ5Mzk4MDk5NmU5MjgzMzdkZDZiL3RhYmxlcmFuZ2U6ZjA5ZmVhZTI2ZTk5NDkzOTgwOTk2ZTkyODMzN2RkNmJfMjItNS0xLTEtNDI3OTI_824242a7-80f9-4e00-aa32-9ece44f0b3d2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74ad881c792442baa75df8b807911f09_I20220630" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOmYwOWZlYWUyNmU5OTQ5Mzk4MDk5NmU5MjgzMzdkZDZiL3RhYmxlcmFuZ2U6ZjA5ZmVhZTI2ZTk5NDkzOTgwOTk2ZTkyODMzN2RkNmJfMjItNy0xLTEtNDI3OTI_05b62759-7778-4318-86f0-89fc2ffad6ba">268</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7bf72d1c8e9744c19c58f817cb47d391_I20220630" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOmYwOWZlYWUyNmU5OTQ5Mzk4MDk5NmU5MjgzMzdkZDZiL3RhYmxlcmFuZ2U6ZjA5ZmVhZTI2ZTk5NDkzOTgwOTk2ZTkyODMzN2RkNmJfMjItOS0xLTEtNDI3OTI_a7103553-c92f-4672-9519-5832bbfd6df6">129,197</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i913ea3b7a1e249509ae836a1357f94f2_I20220630" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOmYwOWZlYWUyNmU5OTQ5Mzk4MDk5NmU5MjgzMzdkZDZiL3RhYmxlcmFuZ2U6ZjA5ZmVhZTI2ZTk5NDkzOTgwOTk2ZTkyODMzN2RkNmJfMjItMTEtMS0xLTQyNzky_e1c55e6c-c547-4349-a8bb-f520046d6656">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c92e926af9e4d908021e1a185782db8_I20220630" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOmYwOWZlYWUyNmU5OTQ5Mzk4MDk5NmU5MjgzMzdkZDZiL3RhYmxlcmFuZ2U6ZjA5ZmVhZTI2ZTk5NDkzOTgwOTk2ZTkyODMzN2RkNmJfMjItMTMtMS0xLTQyNzky_0002422d-2b17-4662-b666-b4bbee7ad859">129,476</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46cc59e8b81644bfa9c00742166adce3_D20220701-20220930" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOmYwOWZlYWUyNmU5OTQ5Mzk4MDk5NmU5MjgzMzdkZDZiL3RhYmxlcmFuZ2U6ZjA5ZmVhZTI2ZTk5NDkzOTgwOTk2ZTkyODMzN2RkNmJfMjMtOS0xLTEtNDM3Mzg_cdeb2bd1-34b6-4039-8aa2-76e06809cc80">36,155</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f3a96a832ab4b0ca374599d1c3e9bce_D20220701-20220930" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOmYwOWZlYWUyNmU5OTQ5Mzk4MDk5NmU5MjgzMzdkZDZiL3RhYmxlcmFuZ2U6ZjA5ZmVhZTI2ZTk5NDkzOTgwOTk2ZTkyODMzN2RkNmJfMjMtMTMtMS0xLTQzNzM4_7ab0f95c-2934-41cb-8a94-ad1ef1d884ef">36,155</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5a90f297c41946ada6274ba46fe40700_D20220701-20220930" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOmYwOWZlYWUyNmU5OTQ5Mzk4MDk5NmU5MjgzMzdkZDZiL3RhYmxlcmFuZ2U6ZjA5ZmVhZTI2ZTk5NDkzOTgwOTk2ZTkyODMzN2RkNmJfMjQtMS0xLTEtNDM3Mzg_5d9c1420-953f-4826-86b3-cdf676586f2e">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i543db287df984eccb3551d94073d122d_D20220701-20220930" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOmYwOWZlYWUyNmU5OTQ5Mzk4MDk5NmU5MjgzMzdkZDZiL3RhYmxlcmFuZ2U6ZjA5ZmVhZTI2ZTk5NDkzOTgwOTk2ZTkyODMzN2RkNmJfMjQtNS0xLTEtNDM3Mzg_21804b6d-04dd-467b-8c56-531f3c2b7abf">2,963</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f3a96a832ab4b0ca374599d1c3e9bce_D20220701-20220930" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOmYwOWZlYWUyNmU5OTQ5Mzk4MDk5NmU5MjgzMzdkZDZiL3RhYmxlcmFuZ2U6ZjA5ZmVhZTI2ZTk5NDkzOTgwOTk2ZTkyODMzN2RkNmJfMjQtMTMtMS0xLTQzNzM4_805cbf03-3e19-4967-b535-fdbe061914e0">2,963</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net shares repurchased for taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i543db287df984eccb3551d94073d122d_D20220701-20220930" decimals="-3" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOmYwOWZlYWUyNmU5OTQ5Mzk4MDk5NmU5MjgzMzdkZDZiL3RhYmxlcmFuZ2U6ZjA5ZmVhZTI2ZTk5NDkzOTgwOTk2ZTkyODMzN2RkNmJfMjUtNS0xLTEtNDM3Mzg_6e115ea1-8e8e-4548-8368-4f38f9fa2afe">25</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2f3a96a832ab4b0ca374599d1c3e9bce_D20220701-20220930" decimals="-3" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOmYwOWZlYWUyNmU5OTQ5Mzk4MDk5NmU5MjgzMzdkZDZiL3RhYmxlcmFuZ2U6ZjA5ZmVhZTI2ZTk5NDkzOTgwOTk2ZTkyODMzN2RkNmJfMjUtMTMtMS0xLTQzNzM4_63199886-3a2e-44cb-bea5-d59b5003b96a">25</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Treasury stock from stock repurchases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2a8af11f752e4e7cb2dba522b9ad74d2_D20220701-20220930" decimals="-3" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOmYwOWZlYWUyNmU5OTQ5Mzk4MDk5NmU5MjgzMzdkZDZiL3RhYmxlcmFuZ2U6ZjA5ZmVhZTI2ZTk5NDkzOTgwOTk2ZTkyODMzN2RkNmJfMjYtMTEtMS0xLTQzNzM4_418119b8-e05b-47ee-866f-92f6d0fb710c">20,010</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2f3a96a832ab4b0ca374599d1c3e9bce_D20220701-20220930" decimals="-3" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOmYwOWZlYWUyNmU5OTQ5Mzk4MDk5NmU5MjgzMzdkZDZiL3RhYmxlcmFuZ2U6ZjA5ZmVhZTI2ZTk5NDkzOTgwOTk2ZTkyODMzN2RkNmJfMjYtMTMtMS0xLTQzNzM4_0d517971-d40e-49d3-aef9-c0b5f90569b4">20,010</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Treasury stock retired from stock repurchases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i5a90f297c41946ada6274ba46fe40700_D20220701-20220930" decimals="-3" name="us-gaap:TreasuryStockSharesRetired" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOmYwOWZlYWUyNmU5OTQ5Mzk4MDk5NmU5MjgzMzdkZDZiL3RhYmxlcmFuZ2U6ZjA5ZmVhZTI2ZTk5NDkzOTgwOTk2ZTkyODMzN2RkNmJfMjctMS0xLTEtNDM3Mzg_fb01778c-6b14-4699-896e-08524535f041">91</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i46cc59e8b81644bfa9c00742166adce3_D20220701-20220930" decimals="-3" name="us-gaap:TreasuryStockRetiredCostMethodAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOmYwOWZlYWUyNmU5OTQ5Mzk4MDk5NmU5MjgzMzdkZDZiL3RhYmxlcmFuZ2U6ZjA5ZmVhZTI2ZTk5NDkzOTgwOTk2ZTkyODMzN2RkNmJfMjctOS0xLTEtNDM3Mzg_d717af47-9686-419b-a7c3-666e1a4c73a3">20,010</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a8af11f752e4e7cb2dba522b9ad74d2_D20220701-20220930" decimals="-3" sign="-" name="us-gaap:TreasuryStockRetiredCostMethodAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOmYwOWZlYWUyNmU5OTQ5Mzk4MDk5NmU5MjgzMzdkZDZiL3RhYmxlcmFuZ2U6ZjA5ZmVhZTI2ZTk5NDkzOTgwOTk2ZTkyODMzN2RkNmJfMjctMTEtMS0xLTQzNzM4_ca893898-4b18-4067-b146-2e7cb9453667">20,010</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f3a96a832ab4b0ca374599d1c3e9bce_D20220701-20220930" decimals="-3" name="us-gaap:TreasuryStockRetiredCostMethodAmount" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOmYwOWZlYWUyNmU5OTQ5Mzk4MDk5NmU5MjgzMzdkZDZiL3RhYmxlcmFuZ2U6ZjA5ZmVhZTI2ZTk5NDkzOTgwOTk2ZTkyODMzN2RkNmJfMjctMTMtMS0xLTQzNzM4_39d74a7e-0b30-4698-bb56-35621f9b8d9e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Settlement of accelerated share repurchase agreement</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i543db287df984eccb3551d94073d122d_D20220701-20220930" decimals="-3" name="us-gaap:AcceleratedShareRepurchaseProgramAdjustment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOmYwOWZlYWUyNmU5OTQ5Mzk4MDk5NmU5MjgzMzdkZDZiL3RhYmxlcmFuZ2U6ZjA5ZmVhZTI2ZTk5NDkzOTgwOTk2ZTkyODMzN2RkNmJfMjgtNS0xLTEtNDM3Mzg_23595ba5-4142-483f-9b79-f10121625321">15,679</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46cc59e8b81644bfa9c00742166adce3_D20220701-20220930" decimals="-3" name="us-gaap:AcceleratedShareRepurchaseProgramAdjustment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOmYwOWZlYWUyNmU5OTQ5Mzk4MDk5NmU5MjgzMzdkZDZiL3RhYmxlcmFuZ2U6ZjA5ZmVhZTI2ZTk5NDkzOTgwOTk2ZTkyODMzN2RkNmJfMjgtOS0xLTEtNDM3Mzg_164f4164-1181-4cd3-8720-b0604d8969d7">4,331</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f3a96a832ab4b0ca374599d1c3e9bce_D20220701-20220930" decimals="-3" name="us-gaap:AcceleratedShareRepurchaseProgramAdjustment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOmYwOWZlYWUyNmU5OTQ5Mzk4MDk5NmU5MjgzMzdkZDZiL3RhYmxlcmFuZ2U6ZjA5ZmVhZTI2ZTk5NDkzOTgwOTk2ZTkyODMzN2RkNmJfMjgtMTMtMS0xLTQzNzM4_f049c699-d689-4057-b669-82654230a43e">20,010</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c1aea55f14840448c42fb7a08b519b6_D20220701-20220930" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOmYwOWZlYWUyNmU5OTQ5Mzk4MDk5NmU5MjgzMzdkZDZiL3RhYmxlcmFuZ2U6ZjA5ZmVhZTI2ZTk5NDkzOTgwOTk2ZTkyODMzN2RkNmJfMjktNy0xLTEtNDM3Mzg_60ac6cd5-ce67-4aad-b805-0fe0e6e54fb7">123</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f3a96a832ab4b0ca374599d1c3e9bce_D20220701-20220930" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOmYwOWZlYWUyNmU5OTQ5Mzk4MDk5NmU5MjgzMzdkZDZiL3RhYmxlcmFuZ2U6ZjA5ZmVhZTI2ZTk5NDkzOTgwOTk2ZTkyODMzN2RkNmJfMjktMTMtMS0xLTQzNzM4_7fc5e4ff-44d6-4dbf-ae4c-2d01f0a50588">123</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash dividends declared to stockholders</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i46cc59e8b81644bfa9c00742166adce3_D20220701-20220930" decimals="-3" name="us-gaap:DividendsCommonStockCash" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOmYwOWZlYWUyNmU5OTQ5Mzk4MDk5NmU5MjgzMzdkZDZiL3RhYmxlcmFuZ2U6ZjA5ZmVhZTI2ZTk5NDkzOTgwOTk2ZTkyODMzN2RkNmJfMzAtOS0xLTEtNDM3Mzg_e1c995b7-5257-4f92-b1ff-7db45fe1c3c8">18,170</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2f3a96a832ab4b0ca374599d1c3e9bce_D20220701-20220930" decimals="-3" name="us-gaap:DividendsCommonStockCash" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOmYwOWZlYWUyNmU5OTQ5Mzk4MDk5NmU5MjgzMzdkZDZiL3RhYmxlcmFuZ2U6ZjA5ZmVhZTI2ZTk5NDkzOTgwOTk2ZTkyODMzN2RkNmJfMzAtMTMtMS0xLTQzNzM4_6628677b-04df-4a07-a71c-6f0290697039">18,170</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance, September 30, 2022</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i86b6fd23b7b042e2ba7777c1c5d29391_I20220930" decimals="-3" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOmYwOWZlYWUyNmU5OTQ5Mzk4MDk5NmU5MjgzMzdkZDZiL3RhYmxlcmFuZ2U6ZjA5ZmVhZTI2ZTk5NDkzOTgwOTk2ZTkyODMzN2RkNmJfMzItMS0xLTEtNDM3Mzg_1a1a1dc6-904f-4c3d-bfa3-a4a4a2f749d5">10,929</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i86b6fd23b7b042e2ba7777c1c5d29391_I20220930" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOmYwOWZlYWUyNmU5OTQ5Mzk4MDk5NmU5MjgzMzdkZDZiL3RhYmxlcmFuZ2U6ZjA5ZmVhZTI2ZTk5NDkzOTgwOTk2ZTkyODMzN2RkNmJfMzItMy0xLTEtNDM3Mzg_edb4567d-c0a6-44a6-b52f-5c71e7d65990">11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c74a76f5cb04d3896ad8481dd40c875_I20220930" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOmYwOWZlYWUyNmU5OTQ5Mzk4MDk5NmU5MjgzMzdkZDZiL3RhYmxlcmFuZ2U6ZjA5ZmVhZTI2ZTk5NDkzOTgwOTk2ZTkyODMzN2RkNmJfMzItNS0xLTEtNDM3Mzg_7de96e79-d3c4-4e2b-a108-1e292790964c">18,617</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4e37db708e64812ac81e983938b61df_I20220930" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOmYwOWZlYWUyNmU5OTQ5Mzk4MDk5NmU5MjgzMzdkZDZiL3RhYmxlcmFuZ2U6ZjA5ZmVhZTI2ZTk5NDkzOTgwOTk2ZTkyODMzN2RkNmJfMzItNy0xLTEtNDM3Mzg_d8082385-98f9-45eb-a1d0-9353c8104f22">391</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45eff40e381645728b84813044e661c6_I20220930" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOmYwOWZlYWUyNmU5OTQ5Mzk4MDk5NmU5MjgzMzdkZDZiL3RhYmxlcmFuZ2U6ZjA5ZmVhZTI2ZTk5NDkzOTgwOTk2ZTkyODMzN2RkNmJfMzItOS0xLTEtNDM3Mzg_2469cd4f-2ee4-46fe-9776-eb05c671da45">131,503</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i82d77786c5f844c8a6ad979988ec850e_I20220930" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOmYwOWZlYWUyNmU5OTQ5Mzk4MDk5NmU5MjgzMzdkZDZiL3RhYmxlcmFuZ2U6ZjA5ZmVhZTI2ZTk5NDkzOTgwOTk2ZTkyODMzN2RkNmJfMzItMTEtMS0xLTQzNzM4_2ba6cb03-b8cd-4324-9996-4e85942088fc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5de311f5948148cda49342e2cea83715_I20220930" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOmYwOWZlYWUyNmU5OTQ5Mzk4MDk5NmU5MjgzMzdkZDZiL3RhYmxlcmFuZ2U6ZjA5ZmVhZTI2ZTk5NDkzOTgwOTk2ZTkyODMzN2RkNmJfMzItMTMtMS0xLTQzNzM4_f620b1e8-319e-47af-8c01-1bcbefc25fce">150,522</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these condensed consolidated financial statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">6</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:21.6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#ic8ae413b3ff34d56976502c585fa6ab3_7">Table of Contents</a></span></div></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:29.455%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.242%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Nine months ended September 30, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Number of <br/>Shares Issued</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Common Stock</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Additional Paid-In <br/>Capital</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Accumulated Other<br/>Comprehensive Income</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Retained <br/>Earnings</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Treasury Stock</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Total</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Balance, December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1163d3352fc648fabd60e9dbcf073a70_I20201231" decimals="-3" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOjhhNjMyYmY5MWYyZDQwNTA4OTU4ZmM0YTliM2I0NTY3L3RhYmxlcmFuZ2U6OGE2MzJiZjkxZjJkNDA1MDg5NThmYzRhOWIzYjQ1NjdfMy0xLTEtMS00Mjc5Mg_6e17216c-cf7b-435d-8f43-f8ac4fc1cda4">11,822</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1163d3352fc648fabd60e9dbcf073a70_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOjhhNjMyYmY5MWYyZDQwNTA4OTU4ZmM0YTliM2I0NTY3L3RhYmxlcmFuZ2U6OGE2MzJiZjkxZjJkNDA1MDg5NThmYzRhOWIzYjQ1NjdfMy0zLTEtMS00Mjc5Mg_a44e5146-0235-4c35-8d6f-1a918f05cd26">12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if34e8b84444d41ce8edf53d30fe4aa32_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOjhhNjMyYmY5MWYyZDQwNTA4OTU4ZmM0YTliM2I0NTY3L3RhYmxlcmFuZ2U6OGE2MzJiZjkxZjJkNDA1MDg5NThmYzRhOWIzYjQ1NjdfMy01LTEtMS00Mjc5Mg_384aecba-aaa3-48aa-bd08-47f5d70a0924">7,842</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19f7e6a88c8d41818d290843acae9d96_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOjhhNjMyYmY5MWYyZDQwNTA4OTU4ZmM0YTliM2I0NTY3L3RhYmxlcmFuZ2U6OGE2MzJiZjkxZjJkNDA1MDg5NThmYzRhOWIzYjQ1NjdfMy03LTEtMS00Mjc5Mg_da56578a-982a-4a9d-b6b8-1ae711266693">41</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b15d638707f47c0b49ae2a29db046e6_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOjhhNjMyYmY5MWYyZDQwNTA4OTU4ZmM0YTliM2I0NTY3L3RhYmxlcmFuZ2U6OGE2MzJiZjkxZjJkNDA1MDg5NThmYzRhOWIzYjQ1NjdfMy05LTEtMS00Mjc5Mg_59c94016-2556-4d91-86d1-b9e738fbc80f">154,351</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i52670ec43ed94ac3b4d465333938624b_I20201231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOjhhNjMyYmY5MWYyZDQwNTA4OTU4ZmM0YTliM2I0NTY3L3RhYmxlcmFuZ2U6OGE2MzJiZjkxZjJkNDA1MDg5NThmYzRhOWIzYjQ1NjdfMy0xMS0xLTEtNDI3OTI_f05336d2-1224-4015-8435-1bd6c5fde69e">5,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03d902ffc72e4d98b5eeb6fb903f405b_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOjhhNjMyYmY5MWYyZDQwNTA4OTU4ZmM0YTliM2I0NTY3L3RhYmxlcmFuZ2U6OGE2MzJiZjkxZjJkNDA1MDg5NThmYzRhOWIzYjQ1NjdfMy0xMy0xLTEtNDI3OTI_76b4ce07-000f-4997-aa07-955c0c4d3d2a">157,246</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Net income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4f9149bb4104ee2963222e63eef1ac9_D20210101-20210331" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOjhhNjMyYmY5MWYyZDQwNTA4OTU4ZmM0YTliM2I0NTY3L3RhYmxlcmFuZ2U6OGE2MzJiZjkxZjJkNDA1MDg5NThmYzRhOWIzYjQ1NjdfNC05LTEtMS00Mjc5Mg_927f2191-71a8-4e67-ab52-f72a5020f461">41,063</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68572f7de11f487eb008f9ea31479d93_D20210101-20210331" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOjhhNjMyYmY5MWYyZDQwNTA4OTU4ZmM0YTliM2I0NTY3L3RhYmxlcmFuZ2U6OGE2MzJiZjkxZjJkNDA1MDg5NThmYzRhOWIzYjQ1NjdfNC0xMy0xLTEtNDI3OTI_9ec78792-7df3-4432-a5cc-9b0381c684ea">41,063</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Share-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i470e4e9ecca64945928eff798199788e_D20210101-20210331" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOjhhNjMyYmY5MWYyZDQwNTA4OTU4ZmM0YTliM2I0NTY3L3RhYmxlcmFuZ2U6OGE2MzJiZjkxZjJkNDA1MDg5NThmYzRhOWIzYjQ1NjdfNS0xLTEtMS00Mjc5Mg_421132df-c984-456e-ac39-dcc49da9f31a">13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia13ecf3f80ad40c2a77b77116d4ed43c_D20210101-20210331" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOjhhNjMyYmY5MWYyZDQwNTA4OTU4ZmM0YTliM2I0NTY3L3RhYmxlcmFuZ2U6OGE2MzJiZjkxZjJkNDA1MDg5NThmYzRhOWIzYjQ1NjdfNS01LTEtMS00Mjc5Mg_79725253-d5e3-47b1-b43f-e44d45386c0e">2,198</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68572f7de11f487eb008f9ea31479d93_D20210101-20210331" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOjhhNjMyYmY5MWYyZDQwNTA4OTU4ZmM0YTliM2I0NTY3L3RhYmxlcmFuZ2U6OGE2MzJiZjkxZjJkNDA1MDg5NThmYzRhOWIzYjQ1NjdfNS0xMy0xLTEtNDI3OTI_d7755134-fc6f-4144-baa0-8bebc63ec5b0">2,198</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Options exercised by executives and directors</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i470e4e9ecca64945928eff798199788e_D20210101-20210331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOjhhNjMyYmY5MWYyZDQwNTA4OTU4ZmM0YTliM2I0NTY3L3RhYmxlcmFuZ2U6OGE2MzJiZjkxZjJkNDA1MDg5NThmYzRhOWIzYjQ1NjdfNi0xLTEtMS00Mjc5Mg_1fbc8e1d-bd11-4039-86b7-0b2cd0266ada">11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia13ecf3f80ad40c2a77b77116d4ed43c_D20210101-20210331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOjhhNjMyYmY5MWYyZDQwNTA4OTU4ZmM0YTliM2I0NTY3L3RhYmxlcmFuZ2U6OGE2MzJiZjkxZjJkNDA1MDg5NThmYzRhOWIzYjQ1NjdfNi01LTEtMS00Mjc5Mg_6d3c0c74-5806-45d2-ab69-7c3d7f942443">481</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68572f7de11f487eb008f9ea31479d93_D20210101-20210331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOjhhNjMyYmY5MWYyZDQwNTA4OTU4ZmM0YTliM2I0NTY3L3RhYmxlcmFuZ2U6OGE2MzJiZjkxZjJkNDA1MDg5NThmYzRhOWIzYjQ1NjdfNi0xMy0xLTEtNDI3OTI_a9affc05-531b-4e16-87e8-404dc48e0bd7">481</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Net shares repurchased for taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i470e4e9ecca64945928eff798199788e_D20210101-20210331" decimals="-3" name="us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOjhhNjMyYmY5MWYyZDQwNTA4OTU4ZmM0YTliM2I0NTY3L3RhYmxlcmFuZ2U6OGE2MzJiZjkxZjJkNDA1MDg5NThmYzRhOWIzYjQ1NjdfNy0xLTEtMS00Mjc5Mg_2e19acd9-10f2-4e25-8671-96cde4cc0fbe">7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia13ecf3f80ad40c2a77b77116d4ed43c_D20210101-20210331" decimals="-3" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOjhhNjMyYmY5MWYyZDQwNTA4OTU4ZmM0YTliM2I0NTY3L3RhYmxlcmFuZ2U6OGE2MzJiZjkxZjJkNDA1MDg5NThmYzRhOWIzYjQ1NjdfNy01LTEtMS00Mjc5Mg_b18b87b0-78d1-4f2d-ae3a-985a35a27149">1,807</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a8af11f752e4e7cb2dba522b9ad74d2_D20220701-20220930" decimals="-3" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOjhhNjMyYmY5MWYyZDQwNTA4OTU4ZmM0YTliM2I0NTY3L3RhYmxlcmFuZ2U6OGE2MzJiZjkxZjJkNDA1MDg5NThmYzRhOWIzYjQ1NjdfNy0xMS0xLTEtNDI3OTI_d9311e7c-6197-4894-99c9-0e950538afa9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i68572f7de11f487eb008f9ea31479d93_D20210101-20210331" decimals="-3" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOjhhNjMyYmY5MWYyZDQwNTA4OTU4ZmM0YTliM2I0NTY3L3RhYmxlcmFuZ2U6OGE2MzJiZjkxZjJkNDA1MDg5NThmYzRhOWIzYjQ1NjdfNy0xMy0xLTEtNDI3OTI_1dd52895-5c3d-42d1-9644-b8e2a23d0456">1,807</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Treasury stock from stock repurchases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i38351930dc7542bba71c26ab68521fec_D20210101-20210331" decimals="-3" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOjhhNjMyYmY5MWYyZDQwNTA4OTU4ZmM0YTliM2I0NTY3L3RhYmxlcmFuZ2U6OGE2MzJiZjkxZjJkNDA1MDg5NThmYzRhOWIzYjQ1NjdfOC0xMS0xLTEtNDI3OTI_f3b444fd-228b-422f-97e5-7a480ae50553">7,500</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i68572f7de11f487eb008f9ea31479d93_D20210101-20210331" decimals="-3" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOjhhNjMyYmY5MWYyZDQwNTA4OTU4ZmM0YTliM2I0NTY3L3RhYmxlcmFuZ2U6OGE2MzJiZjkxZjJkNDA1MDg5NThmYzRhOWIzYjQ1NjdfOC0xMy0xLTEtNDI3OTI_8e61a680-2818-4388-be1e-2a29e24a10ac">7,500</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Other comprehensive income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ffa4de1d96a472385d9f446aded3673_D20210101-20210331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOjhhNjMyYmY5MWYyZDQwNTA4OTU4ZmM0YTliM2I0NTY3L3RhYmxlcmFuZ2U6OGE2MzJiZjkxZjJkNDA1MDg5NThmYzRhOWIzYjQ1NjdfOS03LTEtMS00Mjc5Mg_4ecd1543-4466-4bcf-b536-9544ed2702d0">62</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68572f7de11f487eb008f9ea31479d93_D20210101-20210331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOjhhNjMyYmY5MWYyZDQwNTA4OTU4ZmM0YTliM2I0NTY3L3RhYmxlcmFuZ2U6OGE2MzJiZjkxZjJkNDA1MDg5NThmYzRhOWIzYjQ1NjdfOS0xMy0xLTEtNDI3OTI_4012f26a-1457-4c51-b00e-5f9e6ab895bf">62</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Cash dividends declared to stockholders</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id4f9149bb4104ee2963222e63eef1ac9_D20210101-20210331" decimals="-3" name="us-gaap:DividendsCommonStockCash" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOjhhNjMyYmY5MWYyZDQwNTA4OTU4ZmM0YTliM2I0NTY3L3RhYmxlcmFuZ2U6OGE2MzJiZjkxZjJkNDA1MDg5NThmYzRhOWIzYjQ1NjdfMTAtOS0xLTEtNDI3OTI_7a5a5aec-279b-48e3-b807-dca5022a6b8b">16,852</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i68572f7de11f487eb008f9ea31479d93_D20210101-20210331" decimals="-3" name="us-gaap:DividendsCommonStockCash" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOjhhNjMyYmY5MWYyZDQwNTA4OTU4ZmM0YTliM2I0NTY3L3RhYmxlcmFuZ2U6OGE2MzJiZjkxZjJkNDA1MDg5NThmYzRhOWIzYjQ1NjdfMTAtMTMtMS0xLTQyNzky_097f125e-aee1-4052-9a55-181d0ba8d4be">16,852</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Balance, March 31, 2021</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i926bcd92e3394962b4b7831cda0ea157_I20210331" decimals="-3" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOjhhNjMyYmY5MWYyZDQwNTA4OTU4ZmM0YTliM2I0NTY3L3RhYmxlcmFuZ2U6OGE2MzJiZjkxZjJkNDA1MDg5NThmYzRhOWIzYjQ1NjdfMTItMS0xLTEtNDI3OTI_b1600ddb-4a1a-4a86-90c2-53e7a0844fe1">11,839</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i926bcd92e3394962b4b7831cda0ea157_I20210331" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOjhhNjMyYmY5MWYyZDQwNTA4OTU4ZmM0YTliM2I0NTY3L3RhYmxlcmFuZ2U6OGE2MzJiZjkxZjJkNDA1MDg5NThmYzRhOWIzYjQ1NjdfMTItMy0xLTEtNDI3OTI_73f61d9b-dbf8-47d0-874f-98bb73daf310">12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i593139faed924dd193120eb4e1bcaeec_I20210331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOjhhNjMyYmY5MWYyZDQwNTA4OTU4ZmM0YTliM2I0NTY3L3RhYmxlcmFuZ2U6OGE2MzJiZjkxZjJkNDA1MDg5NThmYzRhOWIzYjQ1NjdfMTItNS0xLTEtNDI3OTI_663e531d-0cea-4254-9154-c60e3deea4ed">8,714</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4149861d44464055b0906f38bd8c72e2_I20210331" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOjhhNjMyYmY5MWYyZDQwNTA4OTU4ZmM0YTliM2I0NTY3L3RhYmxlcmFuZ2U6OGE2MzJiZjkxZjJkNDA1MDg5NThmYzRhOWIzYjQ1NjdfMTItNy0xLTEtNDI3OTI_828bbb44-65d4-4333-b23c-e87b839077d0">103</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53d4071f311c4bc6a78da6c7fb1ca3da_I20210331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOjhhNjMyYmY5MWYyZDQwNTA4OTU4ZmM0YTliM2I0NTY3L3RhYmxlcmFuZ2U6OGE2MzJiZjkxZjJkNDA1MDg5NThmYzRhOWIzYjQ1NjdfMTItOS0xLTEtNDI3OTI_30c79db2-5d1d-4695-af14-75e826d08599">178,562</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i432fec2efa784910b40e24a63bb087c5_I20210331" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOjhhNjMyYmY5MWYyZDQwNTA4OTU4ZmM0YTliM2I0NTY3L3RhYmxlcmFuZ2U6OGE2MzJiZjkxZjJkNDA1MDg5NThmYzRhOWIzYjQ1NjdfMTItMTEtMS0xLTQyNzky_8a93a26e-9495-49e3-9653-a00d50ed3674">12,500</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36a8ff01ce244ad6a7aaa930257b4d4f_I20210331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOjhhNjMyYmY5MWYyZDQwNTA4OTU4ZmM0YTliM2I0NTY3L3RhYmxlcmFuZ2U6OGE2MzJiZjkxZjJkNDA1MDg5NThmYzRhOWIzYjQ1NjdfMTItMTMtMS0xLTQyNzky_2cf3fc6a-8a52-451f-924d-3a37ca881d77">174,891</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Net income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia82656c7830f478dbef5fdc6935f568d_D20210401-20210630" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOjhhNjMyYmY5MWYyZDQwNTA4OTU4ZmM0YTliM2I0NTY3L3RhYmxlcmFuZ2U6OGE2MzJiZjkxZjJkNDA1MDg5NThmYzRhOWIzYjQ1NjdfMTMtOS0xLTEtNDI3OTI_4e34005e-7701-4cff-8036-c04036af32b0">46,963</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8148576927e64d0f8fda8e31eb6b529b_D20210401-20210630" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOjhhNjMyYmY5MWYyZDQwNTA4OTU4ZmM0YTliM2I0NTY3L3RhYmxlcmFuZ2U6OGE2MzJiZjkxZjJkNDA1MDg5NThmYzRhOWIzYjQ1NjdfMTMtMTMtMS0xLTQyNzky_57ce80a9-02e0-4451-a619-8b72d786cb56">46,963</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Share-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i02db23a8737b4985815005662095656a_D20210401-20210630" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOjhhNjMyYmY5MWYyZDQwNTA4OTU4ZmM0YTliM2I0NTY3L3RhYmxlcmFuZ2U6OGE2MzJiZjkxZjJkNDA1MDg5NThmYzRhOWIzYjQ1NjdfMTQtMS0xLTEtNDI3OTI_a75fae58-8f3a-4cbb-9db2-a75098fecf30">10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9224eb8da52e48a886d66dcac0ff9f06_D20210401-20210630" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOjhhNjMyYmY5MWYyZDQwNTA4OTU4ZmM0YTliM2I0NTY3L3RhYmxlcmFuZ2U6OGE2MzJiZjkxZjJkNDA1MDg5NThmYzRhOWIzYjQ1NjdfMTQtNS0xLTEtNDI3OTI_4756ea88-1de7-416a-977f-d390af5ab237">1,697</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia82656c7830f478dbef5fdc6935f568d_D20210401-20210630" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOjhhNjMyYmY5MWYyZDQwNTA4OTU4ZmM0YTliM2I0NTY3L3RhYmxlcmFuZ2U6OGE2MzJiZjkxZjJkNDA1MDg5NThmYzRhOWIzYjQ1NjdfMTQtOS0xLTEtNDI3OTI_59f340a7-d517-4df4-8a94-5d4c1d1dd276">142</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8148576927e64d0f8fda8e31eb6b529b_D20210401-20210630" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOjhhNjMyYmY5MWYyZDQwNTA4OTU4ZmM0YTliM2I0NTY3L3RhYmxlcmFuZ2U6OGE2MzJiZjkxZjJkNDA1MDg5NThmYzRhOWIzYjQ1NjdfMTQtMTMtMS0xLTQyNzky_180036ff-cb95-4b2b-b397-2403c3232357">1,839</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Options exercised by executives and directors</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i02db23a8737b4985815005662095656a_D20210401-20210630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOjhhNjMyYmY5MWYyZDQwNTA4OTU4ZmM0YTliM2I0NTY3L3RhYmxlcmFuZ2U6OGE2MzJiZjkxZjJkNDA1MDg5NThmYzRhOWIzYjQ1NjdfMTUtMS0xLTEtNDI3OTI_8456f6b6-c28a-4eaf-a9b8-5d52080b42a0">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9224eb8da52e48a886d66dcac0ff9f06_D20210401-20210630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOjhhNjMyYmY5MWYyZDQwNTA4OTU4ZmM0YTliM2I0NTY3L3RhYmxlcmFuZ2U6OGE2MzJiZjkxZjJkNDA1MDg5NThmYzRhOWIzYjQ1NjdfMTUtNS0xLTEtNDI3OTI_c8621a9d-5f79-4a1d-9a57-862c5e2f18f7">221</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8148576927e64d0f8fda8e31eb6b529b_D20210401-20210630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOjhhNjMyYmY5MWYyZDQwNTA4OTU4ZmM0YTliM2I0NTY3L3RhYmxlcmFuZ2U6OGE2MzJiZjkxZjJkNDA1MDg5NThmYzRhOWIzYjQ1NjdfMTUtMTMtMS0xLTQyNzky_85c7b0f7-83fc-4e16-875c-6275c2b1b603">221</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Net shares repurchased for taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9224eb8da52e48a886d66dcac0ff9f06_D20210401-20210630" decimals="-3" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOjhhNjMyYmY5MWYyZDQwNTA4OTU4ZmM0YTliM2I0NTY3L3RhYmxlcmFuZ2U6OGE2MzJiZjkxZjJkNDA1MDg5NThmYzRhOWIzYjQ1NjdfMTYtNS0xLTEtNDI3OTI_c54dca5d-4f53-4e5a-9b12-378346be85a9">26</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8148576927e64d0f8fda8e31eb6b529b_D20210401-20210630" decimals="-3" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOjhhNjMyYmY5MWYyZDQwNTA4OTU4ZmM0YTliM2I0NTY3L3RhYmxlcmFuZ2U6OGE2MzJiZjkxZjJkNDA1MDg5NThmYzRhOWIzYjQ1NjdfMTYtMTMtMS0xLTQyNzky_f69f2338-bf36-4323-9d85-910a653a5923">26</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7a3770d9964c4b419436e67fc0ef4044_D20210401-20210630" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOjhhNjMyYmY5MWYyZDQwNTA4OTU4ZmM0YTliM2I0NTY3L3RhYmxlcmFuZ2U6OGE2MzJiZjkxZjJkNDA1MDg5NThmYzRhOWIzYjQ1NjdfMTctNy0xLTEtNDI3OTI_86b28cb2-04b5-4f82-a809-8497ff9d8a26">28</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8148576927e64d0f8fda8e31eb6b529b_D20210401-20210630" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOjhhNjMyYmY5MWYyZDQwNTA4OTU4ZmM0YTliM2I0NTY3L3RhYmxlcmFuZ2U6OGE2MzJiZjkxZjJkNDA1MDg5NThmYzRhOWIzYjQ1NjdfMTctMTMtMS0xLTQyNzky_a6e4510b-64a5-4738-9895-a9dd9a936fa7">28</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Treasury stock from stock repurchases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i581ec4205b3c47a0a164d6c0e54036f6_D20210401-20210630" decimals="-3" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOjhhNjMyYmY5MWYyZDQwNTA4OTU4ZmM0YTliM2I0NTY3L3RhYmxlcmFuZ2U6OGE2MzJiZjkxZjJkNDA1MDg5NThmYzRhOWIzYjQ1NjdfMTgtMTEtMS0xLTQyNzky_ff4c3d39-be03-4db6-b858-4dc1de5c08b3">12,230</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8148576927e64d0f8fda8e31eb6b529b_D20210401-20210630" decimals="-3" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOjhhNjMyYmY5MWYyZDQwNTA4OTU4ZmM0YTliM2I0NTY3L3RhYmxlcmFuZ2U6OGE2MzJiZjkxZjJkNDA1MDg5NThmYzRhOWIzYjQ1NjdfMTgtMTMtMS0xLTQyNzky_15387783-eb9b-4f7a-8c95-69c7673fac8f">12,230</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Treasury stock retired from stock repurchases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i02db23a8737b4985815005662095656a_D20210401-20210630" decimals="-3" name="us-gaap:TreasuryStockSharesRetired" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOjhhNjMyYmY5MWYyZDQwNTA4OTU4ZmM0YTliM2I0NTY3L3RhYmxlcmFuZ2U6OGE2MzJiZjkxZjJkNDA1MDg5NThmYzRhOWIzYjQ1NjdfMTktMS0xLTEtNDI3OTI_889a1443-8f74-4447-b3e9-b0d7aa56b59c">114</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia82656c7830f478dbef5fdc6935f568d_D20210401-20210630" decimals="-3" name="us-gaap:TreasuryStockRetiredCostMethodAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOjhhNjMyYmY5MWYyZDQwNTA4OTU4ZmM0YTliM2I0NTY3L3RhYmxlcmFuZ2U6OGE2MzJiZjkxZjJkNDA1MDg5NThmYzRhOWIzYjQ1NjdfMTktOS0xLTEtNDI3OTI_96d794b8-c29c-4894-8175-7899baa92ae3">23,383</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i581ec4205b3c47a0a164d6c0e54036f6_D20210401-20210630" decimals="-3" sign="-" name="us-gaap:TreasuryStockRetiredCostMethodAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOjhhNjMyYmY5MWYyZDQwNTA4OTU4ZmM0YTliM2I0NTY3L3RhYmxlcmFuZ2U6OGE2MzJiZjkxZjJkNDA1MDg5NThmYzRhOWIzYjQ1NjdfMTktMTEtMS0xLTQyNzky_8744f85b-02fe-4054-9c19-e7fdf040cfb6">23,383</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8148576927e64d0f8fda8e31eb6b529b_D20210401-20210630" decimals="-3" name="us-gaap:TreasuryStockRetiredCostMethodAmount" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOjhhNjMyYmY5MWYyZDQwNTA4OTU4ZmM0YTliM2I0NTY3L3RhYmxlcmFuZ2U6OGE2MzJiZjkxZjJkNDA1MDg5NThmYzRhOWIzYjQ1NjdfMTktMTMtMS0xLTQyNzky_7b834c0f-1d20-44cc-a7be-e9a047ad2c92">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Cash dividends declared to stockholders</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia82656c7830f478dbef5fdc6935f568d_D20210401-20210630" decimals="-3" name="us-gaap:DividendsCommonStockCash" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOjhhNjMyYmY5MWYyZDQwNTA4OTU4ZmM0YTliM2I0NTY3L3RhYmxlcmFuZ2U6OGE2MzJiZjkxZjJkNDA1MDg5NThmYzRhOWIzYjQ1NjdfMjAtOS0xLTEtNDI3OTI_6f405db2-c33d-4c85-a6cb-b7c658bfd16c">16,941</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8148576927e64d0f8fda8e31eb6b529b_D20210401-20210630" decimals="-3" name="us-gaap:DividendsCommonStockCash" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOjhhNjMyYmY5MWYyZDQwNTA4OTU4ZmM0YTliM2I0NTY3L3RhYmxlcmFuZ2U6OGE2MzJiZjkxZjJkNDA1MDg5NThmYzRhOWIzYjQ1NjdfMjAtMTMtMS0xLTQyNzky_5488036d-6351-49e7-b851-c46d605da42e">16,941</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance, June 30, 2021</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9e9dcffbe0354e98962551a32828abc2_I20210630" decimals="-3" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOjhhNjMyYmY5MWYyZDQwNTA4OTU4ZmM0YTliM2I0NTY3L3RhYmxlcmFuZ2U6OGE2MzJiZjkxZjJkNDA1MDg5NThmYzRhOWIzYjQ1NjdfMjItMS0xLTEtNDI3OTI_9e9f49b4-2755-45bc-b05f-1297ca4d4405">11,738</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e9dcffbe0354e98962551a32828abc2_I20210630" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOjhhNjMyYmY5MWYyZDQwNTA4OTU4ZmM0YTliM2I0NTY3L3RhYmxlcmFuZ2U6OGE2MzJiZjkxZjJkNDA1MDg5NThmYzRhOWIzYjQ1NjdfMjItMy0xLTEtNDI3OTI_e8202447-42af-4e50-b299-502ad46b9a84">12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idfb0b0b879244ae7862113b2345aa1e6_I20210630" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOjhhNjMyYmY5MWYyZDQwNTA4OTU4ZmM0YTliM2I0NTY3L3RhYmxlcmFuZ2U6OGE2MzJiZjkxZjJkNDA1MDg5NThmYzRhOWIzYjQ1NjdfMjItNS0xLTEtNDI3OTI_9063bdc2-e034-4e01-80b8-c6d28eb900e6">10,606</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9cea7aaedf6e484b95020ab9ac02f011_I20210630" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOjhhNjMyYmY5MWYyZDQwNTA4OTU4ZmM0YTliM2I0NTY3L3RhYmxlcmFuZ2U6OGE2MzJiZjkxZjJkNDA1MDg5NThmYzRhOWIzYjQ1NjdfMjItNy0xLTEtNDI3OTI_b072803f-d2c6-40a1-ba03-eeb953cc4e96">75</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4a2d943c8664242a544b6294ec6c7c8_I20210630" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOjhhNjMyYmY5MWYyZDQwNTA4OTU4ZmM0YTliM2I0NTY3L3RhYmxlcmFuZ2U6OGE2MzJiZjkxZjJkNDA1MDg5NThmYzRhOWIzYjQ1NjdfMjItOS0xLTEtNDI3OTI_78d5fcbd-842f-4468-b0da-faad88c378d2">185,343</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib6dc7945bf0e400099cdcc1fed80fb2c_I20210630" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOjhhNjMyYmY5MWYyZDQwNTA4OTU4ZmM0YTliM2I0NTY3L3RhYmxlcmFuZ2U6OGE2MzJiZjkxZjJkNDA1MDg5NThmYzRhOWIzYjQ1NjdfMjItMTEtMS0xLTQyNzky_753574d2-557d-4cf3-983a-3283e003f329">1,347</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i059d81e5005e42788c673ccfaf1058e5_I20210630" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOjhhNjMyYmY5MWYyZDQwNTA4OTU4ZmM0YTliM2I0NTY3L3RhYmxlcmFuZ2U6OGE2MzJiZjkxZjJkNDA1MDg5NThmYzRhOWIzYjQ1NjdfMjItMTMtMS0xLTQyNzky_05148221-7bbc-4d3f-84c1-0afc8ca674c2">194,689</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73d2ec22c05b4c4fbe6a550f139a59ae_D20210701-20210930" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOjhhNjMyYmY5MWYyZDQwNTA4OTU4ZmM0YTliM2I0NTY3L3RhYmxlcmFuZ2U6OGE2MzJiZjkxZjJkNDA1MDg5NThmYzRhOWIzYjQ1NjdfMjMtOS0xLTEtNDM3NjE_be4bb976-0245-4b6d-8beb-d1c804b1ecff">41,982</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bb5592686d74afab4f7004818fd6f9b_D20210701-20210930" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOjhhNjMyYmY5MWYyZDQwNTA4OTU4ZmM0YTliM2I0NTY3L3RhYmxlcmFuZ2U6OGE2MzJiZjkxZjJkNDA1MDg5NThmYzRhOWIzYjQ1NjdfMjMtMTMtMS0xLTQzNzYx_14384877-d1af-45ee-b3fe-03a5ee8a07c3">41,982</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibd26354982214044ae591432e82c800d_D20210701-20210930" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOjhhNjMyYmY5MWYyZDQwNTA4OTU4ZmM0YTliM2I0NTY3L3RhYmxlcmFuZ2U6OGE2MzJiZjkxZjJkNDA1MDg5NThmYzRhOWIzYjQ1NjdfMjQtMS0xLTEtNDM3NjE_e61ba505-6c9e-4f81-a728-70cdbc18f27c">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1aab3bd0f0be43baa5e0bc44e70a5a28_D20210701-20210930" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOjhhNjMyYmY5MWYyZDQwNTA4OTU4ZmM0YTliM2I0NTY3L3RhYmxlcmFuZ2U6OGE2MzJiZjkxZjJkNDA1MDg5NThmYzRhOWIzYjQ1NjdfMjQtNS0xLTEtNDM3NjE_4fdf4926-dc6b-4468-9e66-7c8c44eb8535">2,269</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bb5592686d74afab4f7004818fd6f9b_D20210701-20210930" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOjhhNjMyYmY5MWYyZDQwNTA4OTU4ZmM0YTliM2I0NTY3L3RhYmxlcmFuZ2U6OGE2MzJiZjkxZjJkNDA1MDg5NThmYzRhOWIzYjQ1NjdfMjQtMTMtMS0xLTQzNzYx_ce96420a-f8d8-45c4-b0da-acbf30043ada">2,269</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Options exercised by executives and directors</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibd26354982214044ae591432e82c800d_D20210701-20210930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOjhhNjMyYmY5MWYyZDQwNTA4OTU4ZmM0YTliM2I0NTY3L3RhYmxlcmFuZ2U6OGE2MzJiZjkxZjJkNDA1MDg5NThmYzRhOWIzYjQ1NjdfMjUtMS0xLTEtNDM3NjE_0fa6fb94-53c0-47a9-aaad-53c4dd2e24ba">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1aab3bd0f0be43baa5e0bc44e70a5a28_D20210701-20210930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOjhhNjMyYmY5MWYyZDQwNTA4OTU4ZmM0YTliM2I0NTY3L3RhYmxlcmFuZ2U6OGE2MzJiZjkxZjJkNDA1MDg5NThmYzRhOWIzYjQ1NjdfMjUtNS0xLTEtNDM3NjE_581764d5-c17e-4f7c-9d22-14c1938554e5">109</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bb5592686d74afab4f7004818fd6f9b_D20210701-20210930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOjhhNjMyYmY5MWYyZDQwNTA4OTU4ZmM0YTliM2I0NTY3L3RhYmxlcmFuZ2U6OGE2MzJiZjkxZjJkNDA1MDg5NThmYzRhOWIzYjQ1NjdfMjUtMTMtMS0xLTQzNzYx_7e00b702-1746-45ff-9225-8cbef1f36bf2">109</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net shares repurchased for employee taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ibd26354982214044ae591432e82c800d_D20210701-20210930" decimals="-3" name="us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOjhhNjMyYmY5MWYyZDQwNTA4OTU4ZmM0YTliM2I0NTY3L3RhYmxlcmFuZ2U6OGE2MzJiZjkxZjJkNDA1MDg5NThmYzRhOWIzYjQ1NjdfMjYtMS0xLTEtNDM3NjE_1b75dc0f-f0aa-4bf0-97c0-38fb39542e7e">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1aab3bd0f0be43baa5e0bc44e70a5a28_D20210701-20210930" decimals="-3" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOjhhNjMyYmY5MWYyZDQwNTA4OTU4ZmM0YTliM2I0NTY3L3RhYmxlcmFuZ2U6OGE2MzJiZjkxZjJkNDA1MDg5NThmYzRhOWIzYjQ1NjdfMjYtNS0xLTEtNDM3NjE_ccb1a974-c9a4-48b9-bb43-6492886ca96a">34</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3bb5592686d74afab4f7004818fd6f9b_D20210701-20210930" decimals="-3" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOjhhNjMyYmY5MWYyZDQwNTA4OTU4ZmM0YTliM2I0NTY3L3RhYmxlcmFuZ2U6OGE2MzJiZjkxZjJkNDA1MDg5NThmYzRhOWIzYjQ1NjdfMjYtMTMtMS0xLTQzNzYx_d819ddfa-1e47-4956-a2ce-6c8be0e42e42">34</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive Income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4218dcf5ff3845e68993eb267c5fbe10_D20210701-20210930" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOjhhNjMyYmY5MWYyZDQwNTA4OTU4ZmM0YTliM2I0NTY3L3RhYmxlcmFuZ2U6OGE2MzJiZjkxZjJkNDA1MDg5NThmYzRhOWIzYjQ1NjdfMjctNy0xLTEtNDM3NjE_4f751b11-a794-4bb1-a78c-456f98ac7985">47</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bb5592686d74afab4f7004818fd6f9b_D20210701-20210930" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOjhhNjMyYmY5MWYyZDQwNTA4OTU4ZmM0YTliM2I0NTY3L3RhYmxlcmFuZ2U6OGE2MzJiZjkxZjJkNDA1MDg5NThmYzRhOWIzYjQ1NjdfMjctMTMtMS0xLTQzNzYx_a43d6d09-609b-4c91-8dc3-0b9953e64f1c">47</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Treasury stock from stock repurchases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i64699db86ad54ac8a14806cd578d3cf7_D20210701-20210930" decimals="-3" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOjhhNjMyYmY5MWYyZDQwNTA4OTU4ZmM0YTliM2I0NTY3L3RhYmxlcmFuZ2U6OGE2MzJiZjkxZjJkNDA1MDg5NThmYzRhOWIzYjQ1NjdfMjgtMTEtMS0xLTQzNzYx_5f71d076-785f-433f-9b01-b59c6d64d8e1">26,270</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3bb5592686d74afab4f7004818fd6f9b_D20210701-20210930" decimals="-3" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOjhhNjMyYmY5MWYyZDQwNTA4OTU4ZmM0YTliM2I0NTY3L3RhYmxlcmFuZ2U6OGE2MzJiZjkxZjJkNDA1MDg5NThmYzRhOWIzYjQ1NjdfMjgtMTMtMS0xLTQzNzYx_90078394-5b04-436d-b3ed-fd6d10ce52fb">26,270</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Treasury stock retired from stock repurchases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ibd26354982214044ae591432e82c800d_D20210701-20210930" decimals="-3" name="us-gaap:TreasuryStockSharesRetired" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOjhhNjMyYmY5MWYyZDQwNTA4OTU4ZmM0YTliM2I0NTY3L3RhYmxlcmFuZ2U6OGE2MzJiZjkxZjJkNDA1MDg5NThmYzRhOWIzYjQ1NjdfMjktMS0xLTEtNDM3NjE_85b6a957-98d5-4ca6-9c3e-7e0220c926d4">123</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i73d2ec22c05b4c4fbe6a550f139a59ae_D20210701-20210930" decimals="-3" name="us-gaap:TreasuryStockRetiredCostMethodAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOjhhNjMyYmY5MWYyZDQwNTA4OTU4ZmM0YTliM2I0NTY3L3RhYmxlcmFuZ2U6OGE2MzJiZjkxZjJkNDA1MDg5NThmYzRhOWIzYjQ1NjdfMjktOS0xLTEtNDM3NjE_f83e60a4-509e-4aa6-8f2d-fe48412a0de9">27,617</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64699db86ad54ac8a14806cd578d3cf7_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:TreasuryStockRetiredCostMethodAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOjhhNjMyYmY5MWYyZDQwNTA4OTU4ZmM0YTliM2I0NTY3L3RhYmxlcmFuZ2U6OGE2MzJiZjkxZjJkNDA1MDg5NThmYzRhOWIzYjQ1NjdfMjktMTEtMS0xLTQzNzYx_38fe1ee3-1bbe-4004-8f9a-1f672c027686">27,617</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash dividends declared to stockholders</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i73d2ec22c05b4c4fbe6a550f139a59ae_D20210701-20210930" decimals="-3" name="us-gaap:DividendsCommonStockCash" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOjhhNjMyYmY5MWYyZDQwNTA4OTU4ZmM0YTliM2I0NTY3L3RhYmxlcmFuZ2U6OGE2MzJiZjkxZjJkNDA1MDg5NThmYzRhOWIzYjQ1NjdfMzAtOS0xLTEtNDM3NjE_6c5824aa-0ad4-45e1-99b5-d359124a2d92">16,553</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3bb5592686d74afab4f7004818fd6f9b_D20210701-20210930" decimals="-3" name="us-gaap:DividendsCommonStockCash" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOjhhNjMyYmY5MWYyZDQwNTA4OTU4ZmM0YTliM2I0NTY3L3RhYmxlcmFuZ2U6OGE2MzJiZjkxZjJkNDA1MDg5NThmYzRhOWIzYjQ1NjdfMzAtMTMtMS0xLTQzNzYx_de518e62-38b9-4af2-b7ec-f67c0b40aff3">16,553</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance, September 30, 2021</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib9edd1f9ecfe40139a3c3fbfe3370644_I20210930" decimals="-3" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOjhhNjMyYmY5MWYyZDQwNTA4OTU4ZmM0YTliM2I0NTY3L3RhYmxlcmFuZ2U6OGE2MzJiZjkxZjJkNDA1MDg5NThmYzRhOWIzYjQ1NjdfMzItMS0xLTEtNDM3NjE_26133a95-0415-48f1-a3a3-5ae78d9bedf8">11,618</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9edd1f9ecfe40139a3c3fbfe3370644_I20210930" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOjhhNjMyYmY5MWYyZDQwNTA4OTU4ZmM0YTliM2I0NTY3L3RhYmxlcmFuZ2U6OGE2MzJiZjkxZjJkNDA1MDg5NThmYzRhOWIzYjQ1NjdfMzItMy0xLTEtNDM3NjE_c80ad748-de5c-4ef8-8cf3-f4fa9c9fd63f">12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i25169b23871e46eca074903e07db728c_I20210930" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOjhhNjMyYmY5MWYyZDQwNTA4OTU4ZmM0YTliM2I0NTY3L3RhYmxlcmFuZ2U6OGE2MzJiZjkxZjJkNDA1MDg5NThmYzRhOWIzYjQ1NjdfMzItNS0xLTEtNDM3NjE_d27cb3d6-424f-4af8-9c1d-fd9d940f24b3">12,950</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c3f2304fd3c47c18b9051b19c7301ea_I20210930" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOjhhNjMyYmY5MWYyZDQwNTA4OTU4ZmM0YTliM2I0NTY3L3RhYmxlcmFuZ2U6OGE2MzJiZjkxZjJkNDA1MDg5NThmYzRhOWIzYjQ1NjdfMzItNy0xLTEtNDM3NjE_5c610781-d0a5-47a3-aa6b-894f83de1fbd">122</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00844f75496c44e194d293f567033a2d_I20210930" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOjhhNjMyYmY5MWYyZDQwNTA4OTU4ZmM0YTliM2I0NTY3L3RhYmxlcmFuZ2U6OGE2MzJiZjkxZjJkNDA1MDg5NThmYzRhOWIzYjQ1NjdfMzItOS0xLTEtNDM3NjE_59bfbd9b-22d5-4da7-95d9-dfed30420a76">183,155</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e33dd9737fd44d6ab51db5290fd1254_I20210930" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOjhhNjMyYmY5MWYyZDQwNTA4OTU4ZmM0YTliM2I0NTY3L3RhYmxlcmFuZ2U6OGE2MzJiZjkxZjJkNDA1MDg5NThmYzRhOWIzYjQ1NjdfMzItMTEtMS0xLTQzNzYx_4a24ad3c-11ad-4c46-9e24-004bb8b5d8e8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb5de6f6a1b842d59a7c6674c3095ce8_I20210930" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOjhhNjMyYmY5MWYyZDQwNTA4OTU4ZmM0YTliM2I0NTY3L3RhYmxlcmFuZ2U6OGE2MzJiZjkxZjJkNDA1MDg5NThmYzRhOWIzYjQ1NjdfMzItMTMtMS0xLTQzNzYx_91b8af7a-bbf6-4311-b68b-5991968cde17">196,239</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these condensed consolidated financial statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">7</span></div></div></div><div id="ic8ae413b3ff34d56976502c585fa6ab3_31"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:21.6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#ic8ae413b3ff34d56976502c585fa6ab3_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">MEDIFAST, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)</span></div><div id="ic8ae413b3ff34d56976502c585fa6ab3_34"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1. <ix:nonNumeric contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930" name="us-gaap:SignificantAccountingPoliciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18zNC9mcmFnOjZhODRjZTVmYjIzMjQzYzc4ODU0YjM0OGZjZDc5ZDBmL3RleHRyZWdpb246NmE4NGNlNWZiMjMyNDNjNzg4NTRiMzQ4ZmNkNzlkMGZfMzUwNg_6ba77f91-2500-46fc-ad2a-73e18d0edbd2" continuedAt="i82182c6cc7c943549682659e8c72e341" escape="true">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</ix:nonNumeric></span></div><ix:continuation id="i82182c6cc7c943549682659e8c72e341" continuedAt="i482e84a613e942eaa965a20aa9f4e2e5"><ix:nonNumeric contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18zNC9mcmFnOjZhODRjZTVmYjIzMjQzYzc4ODU0YjM0OGZjZDc5ZDBmL3RleHRyZWdpb246NmE4NGNlNWZiMjMyNDNjNzg4NTRiMzQ4ZmNkNzlkMGZfMzUwNw_815bd213-7ed7-43d5-9393-bffdb596264c" escape="true"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basis of Presentation -</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The accompanying unaudited condensed consolidated financial statements of Medifast, Inc. and its wholly-owned subsidiaries (&#8220;Medifast,&#8221; the &#8220;Company,&#8221; &#8220;we,&#8221; &#8220;us,&#8221; or &#8220;our&#8221;) included herein have been prepared in accordance with generally accepted accounting principles in the United States of America (&#8220;GAAP&#8221;) for interim reporting and pursuant to the rules and regulations of the Securities and Exchange Commission (the &#8220;SEC&#8221;). Accordingly, certain information and notes that are normally required by GAAP have been condensed or omitted. However, in the opinion of management, all adjustments consisting of normal, recurring adjustments considered necessary for a fair presentation of the financial position and results of operations have been included and management believes the disclosures that are made are adequate to make the information presented not misleading. The condensed consolidated balance sheet at December&#160;31, 2021 has been derived from the audited consolidated financial statements at that date included in the Company&#8217;s Annual Report on Form 10-K for the fiscal year ended December&#160;31, 2021 (&#8220;2021 Form 10-K&#8221;).</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The results of operations for the three and nine months ended September 30, 2022 are not necessarily indicative of results that may be expected for the fiscal year ending December&#160;31, 2022. The accompanying unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto, which are included in the 2021 Form 10-K.</span></div></ix:nonNumeric><div style="margin-top:12pt;text-align:justify"><ix:nonNumeric contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930" name="us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18zNC9mcmFnOjZhODRjZTVmYjIzMjQzYzc4ODU0YjM0OGZjZDc5ZDBmL3RleHRyZWdpb246NmE4NGNlNWZiMjMyNDNjNzg4NTRiMzQ4ZmNkNzlkMGZfMzUwMg_7ce8e168-831d-4a3d-8876-9b5106f0074f" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Presentation of Financial Statements -</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The unaudited condensed consolidated financial statements included herein include the accounts of the Company. All significant intercompany accounts and transactions have been eliminated.</span></ix:nonNumeric></div><div style="margin-top:12pt;text-align:justify"><ix:nonNumeric contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930" name="us-gaap:PriorPeriodReclassificationAdjustmentDescription" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18zNC9mcmFnOjZhODRjZTVmYjIzMjQzYzc4ODU0YjM0OGZjZDc5ZDBmL3RleHRyZWdpb246NmE4NGNlNWZiMjMyNDNjNzg4NTRiMzQ4ZmNkNzlkMGZfMzUwMw_4c875417-4495-42db-98cb-a052f6017f7e" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Reclassification -</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Certain amounts reported for prior periods have been reclassified to be consistent with the current period presentation. No reclassification in the condensed consolidated financial statements had a material impact on the presentation.</span></ix:nonNumeric></div><div style="margin-top:12pt;text-align:justify"><ix:nonNumeric contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930" name="us-gaap:UseOfEstimates" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18zNC9mcmFnOjZhODRjZTVmYjIzMjQzYzc4ODU0YjM0OGZjZDc5ZDBmL3RleHRyZWdpb246NmE4NGNlNWZiMjMyNDNjNzg4NTRiMzQ4ZmNkNzlkMGZfMzUwNA_2c1d04ec-f2e6-4066-8eb9-89d2d588568c" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and reported amounts of revenue and expenses during the reporting period. Actual results could differ materially from those estimates.</span></ix:nonNumeric></div><div style="margin-top:12pt;text-align:justify"><ix:nonNumeric contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18zNC9mcmFnOjZhODRjZTVmYjIzMjQzYzc4ODU0YjM0OGZjZDc5ZDBmL3RleHRyZWdpb246NmE4NGNlNWZiMjMyNDNjNzg4NTRiMzQ4ZmNkNzlkMGZfMzUwNQ_b9fce907-3645-49fe-92d7-487ae3066112" continuedAt="i13f4616bb59c4adb9fab45b860e0b456" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accounting Pronouncements Adopted in 2022</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></ix:nonNumeric></div></ix:continuation><div style="margin-top:12pt;text-align:justify"><ix:continuation id="i482e84a613e942eaa965a20aa9f4e2e5" continuedAt="icde98fe283f640448f93f00483c385d9"><ix:continuation id="i13f4616bb59c4adb9fab45b860e0b456" continuedAt="i138eec47c777444180f3d7510161831a"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, the FASB issued Accounting Standards Update (&#8220;ASU&#8221;) 2020-04, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting</span></ix:continuation></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="icde98fe283f640448f93f00483c385d9"><ix:continuation id="i138eec47c777444180f3d7510161831a">, which provides optional guidance for a limited time to ease the potential burden in accounting for reference rate reform. The new guidance provides optional expedients and exceptions for applying accounting principles under GAAP to contracts, hedging relationships and other transactions affected by reference rate reform if certain criteria are met and to other derivative instruments if there is a change to the interest rates used for discounting, margining or contract price alignment. These amendments are effective immediately and may be applied prospectively to contract modifications made and hedging relationships entered into or evaluated on or before December 31, 2022. We adopted Topic 848 beginning in the first quarter of fiscal 2022 without any material impact on the Company's financial position and results of operations.</ix:continuation></ix:continuation>  </span></div><div id="ic8ae413b3ff34d56976502c585fa6ab3_37"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2. <ix:nonNumeric contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930" name="us-gaap:InventoryDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18zNy9mcmFnOjAwNzc4OWM5YjcxZjRlYjU5NzA5ZDZhMjhjMzdmZDZmL3RleHRyZWdpb246MDA3Nzg5YzliNzFmNGViNTk3MDlkNmEyOGMzN2ZkNmZfOTIw_9f0e58f5-e5f3-4e9d-8748-66d2d2cf24ea" continuedAt="i9dca024fc7b340dc8ec523ec0448dfbe" escape="true">INVENTORIES</ix:nonNumeric></span></div><ix:continuation id="i9dca024fc7b340dc8ec523ec0448dfbe" continuedAt="i1f9f3d0698be46a89c79c52ec4394c23"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories consist principally of raw materials, non-food finished goods and packaged meal replacements held in the Company&#8217;s warehouses and outsourced distribution centers. Inventories are stated at the lower of cost or net realizable value, utilizing the first-in, first-out method. The cost of finished goods includes the cost of raw materials, packaging supplies, direct and indirect labor and other indirect manufacturing costs. On a quarterly basis, management reviews inventories for unsalable or obsolete inventories.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company donated inventory with an aggregate cost of $<ix:nonFraction unitRef="usd" contextRef="i2f3a96a832ab4b0ca374599d1c3e9bce_D20220701-20220930" decimals="-5" name="us-gaap:NoncashContributionExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18zNy9mcmFnOjAwNzc4OWM5YjcxZjRlYjU5NzA5ZDZhMjhjMzdmZDZmL3RleHRyZWdpb246MDA3Nzg5YzliNzFmNGViNTk3MDlkNmEyOGMzN2ZkNmZfNjAz_ca2382c4-b472-4ef2-9b44-1e9f4ee16570">1.1</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930" decimals="-5" name="us-gaap:NoncashContributionExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18zNy9mcmFnOjAwNzc4OWM5YjcxZjRlYjU5NzA5ZDZhMjhjMzdmZDZmL3RleHRyZWdpb246MDA3Nzg5YzliNzFmNGViNTk3MDlkNmEyOGMzN2ZkNmZfNzY5NjU4MTM5NTY4Ng_167cbb33-8e7d-4b58-a646-0c57d8f8127c">10.5</ix:nonFraction>&#160;million to Ukrainian refugees and those in need in Ukraine, increasing selling, general and administrative (&#8220;SG&amp;A&#8221;) expenses during the three and nine months ended </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">8</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:21.6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#ic8ae413b3ff34d56976502c585fa6ab3_7">Table of Contents</a></span></div></div><ix:continuation id="i1f9f3d0698be46a89c79c52ec4394c23"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"><ix:nonNumeric contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18zNy9mcmFnOjAwNzc4OWM5YjcxZjRlYjU5NzA5ZDZhMjhjMzdmZDZmL3RleHRyZWdpb246MDA3Nzg5YzliNzFmNGViNTk3MDlkNmEyOGMzN2ZkNmZfOTg5NTYwNDY1MTMzMQ_75cfbe1e-17ec-4442-ae34-fd999dbe9ec2">September&#160;30, 2022</ix:nonNumeric>. The donations were made to two 501(c)(3) organizations that are coordinating the distribution throughout refugee camps in Europe and in Ukraine.</span></div><ix:nonNumeric contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930" name="us-gaap:ScheduleOfInventoryCurrentTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18zNy9mcmFnOjAwNzc4OWM5YjcxZjRlYjU5NzA5ZDZhMjhjMzdmZDZmL3RleHRyZWdpb246MDA3Nzg5YzliNzFmNGViNTk3MDlkNmEyOGMzN2ZkNmZfOTE5_70d50061-93c9-45ed-ab5f-a0b1e5f48c43" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories consisted of the following (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.549%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.929%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.638%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18zNy9mcmFnOjAwNzc4OWM5YjcxZjRlYjU5NzA5ZDZhMjhjMzdmZDZmL3RhYmxlOmQzNDEzZDg0OTk5YTRhY2M5MWZmZjBkZDJlODkwMGFhL3RhYmxlcmFuZ2U6ZDM0MTNkODQ5OTlhNGFjYzkxZmZmMGRkMmU4OTAwYWFfMC0xLTEtMS00Mjc5Mg_75cfbe1e-17ec-4442-ae34-fd999dbe9ec2">September 30, 2022</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">December 31, 2021</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Raw materials</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 1.37pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i5de311f5948148cda49342e2cea83715_I20220930" decimals="-3" name="us-gaap:InventoryRawMaterials" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18zNy9mcmFnOjAwNzc4OWM5YjcxZjRlYjU5NzA5ZDZhMjhjMzdmZDZmL3RhYmxlOmQzNDEzZDg0OTk5YTRhY2M5MWZmZjBkZDJlODkwMGFhL3RhYmxlcmFuZ2U6ZDM0MTNkODQ5OTlhNGFjYzkxZmZmMGRkMmU4OTAwYWFfMi0xLTEtMS00Mjc5Mg_dc7aa0ce-f386-42f2-a208-f3ec769f095c">11,989</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 1.37pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i47f09f18839440ffae0cf05a475aa7fe_I20211231" decimals="-3" name="us-gaap:InventoryRawMaterials" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18zNy9mcmFnOjAwNzc4OWM5YjcxZjRlYjU5NzA5ZDZhMjhjMzdmZDZmL3RhYmxlOmQzNDEzZDg0OTk5YTRhY2M5MWZmZjBkZDJlODkwMGFhL3RhYmxlcmFuZ2U6ZDM0MTNkODQ5OTlhNGFjYzkxZmZmMGRkMmU4OTAwYWFfMi0zLTEtMS00Mjc5Mg_55ee2620-e5c2-4ef6-9104-7e171fda8837">15,196</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Packaging</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i5de311f5948148cda49342e2cea83715_I20220930" decimals="-3" name="us-gaap:RetailRelatedInventoryPackagingAndOtherSupplies" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18zNy9mcmFnOjAwNzc4OWM5YjcxZjRlYjU5NzA5ZDZhMjhjMzdmZDZmL3RhYmxlOmQzNDEzZDg0OTk5YTRhY2M5MWZmZjBkZDJlODkwMGFhL3RhYmxlcmFuZ2U6ZDM0MTNkODQ5OTlhNGFjYzkxZmZmMGRkMmU4OTAwYWFfMy0xLTEtMS00Mjc5Mg_db3bc9fb-2fb2-407c-8ac6-dc66965c39e0">3,078</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i47f09f18839440ffae0cf05a475aa7fe_I20211231" decimals="-3" name="us-gaap:RetailRelatedInventoryPackagingAndOtherSupplies" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18zNy9mcmFnOjAwNzc4OWM5YjcxZjRlYjU5NzA5ZDZhMjhjMzdmZDZmL3RhYmxlOmQzNDEzZDg0OTk5YTRhY2M5MWZmZjBkZDJlODkwMGFhL3RhYmxlcmFuZ2U6ZDM0MTNkODQ5OTlhNGFjYzkxZmZmMGRkMmU4OTAwYWFfMy0zLTEtMS00Mjc5Mg_9f5f81a1-4e9d-4764-9817-07ca336d8633">3,641</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Non-food finished goods</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i5de311f5948148cda49342e2cea83715_I20220930" decimals="-3" name="med:InventoryNonFoodFinishedGoods" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18zNy9mcmFnOjAwNzc4OWM5YjcxZjRlYjU5NzA5ZDZhMjhjMzdmZDZmL3RhYmxlOmQzNDEzZDg0OTk5YTRhY2M5MWZmZjBkZDJlODkwMGFhL3RhYmxlcmFuZ2U6ZDM0MTNkODQ5OTlhNGFjYzkxZmZmMGRkMmU4OTAwYWFfNC0xLTEtMS00Mjc5Mg_6e38f0b1-c4b4-4b7b-a7f4-18a277b3776e">10,455</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i47f09f18839440ffae0cf05a475aa7fe_I20211231" decimals="-3" name="med:InventoryNonFoodFinishedGoods" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18zNy9mcmFnOjAwNzc4OWM5YjcxZjRlYjU5NzA5ZDZhMjhjMzdmZDZmL3RhYmxlOmQzNDEzZDg0OTk5YTRhY2M5MWZmZjBkZDJlODkwMGFhL3RhYmxlcmFuZ2U6ZDM0MTNkODQ5OTlhNGFjYzkxZmZmMGRkMmU4OTAwYWFfNC0zLTEtMS00Mjc5Mg_8ff2fd9d-5bc1-4c86-860f-ea8acd0b1177">15,991</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Finished goods</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i5de311f5948148cda49342e2cea83715_I20220930" decimals="-3" name="us-gaap:InventoryFinishedGoods" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18zNy9mcmFnOjAwNzc4OWM5YjcxZjRlYjU5NzA5ZDZhMjhjMzdmZDZmL3RhYmxlOmQzNDEzZDg0OTk5YTRhY2M5MWZmZjBkZDJlODkwMGFhL3RhYmxlcmFuZ2U6ZDM0MTNkODQ5OTlhNGFjYzkxZmZmMGRkMmU4OTAwYWFfNS0xLTEtMS00Mjc5Mg_2a60ecba-7dc8-4efe-864c-715fe7831841">122,227</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i47f09f18839440ffae0cf05a475aa7fe_I20211231" decimals="-3" name="us-gaap:InventoryFinishedGoods" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18zNy9mcmFnOjAwNzc4OWM5YjcxZjRlYjU5NzA5ZDZhMjhjMzdmZDZmL3RhYmxlOmQzNDEzZDg0OTk5YTRhY2M5MWZmZjBkZDJlODkwMGFhL3RhYmxlcmFuZ2U6ZDM0MTNkODQ5OTlhNGFjYzkxZmZmMGRkMmU4OTAwYWFfNS0zLTEtMS00Mjc5Mg_746733fd-aed3-442f-87de-27a96e7b95fe">152,687</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Reserve for obsolete inventory</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="i5de311f5948148cda49342e2cea83715_I20220930" decimals="-3" name="us-gaap:InventoryValuationReserves" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18zNy9mcmFnOjAwNzc4OWM5YjcxZjRlYjU5NzA5ZDZhMjhjMzdmZDZmL3RhYmxlOmQzNDEzZDg0OTk5YTRhY2M5MWZmZjBkZDJlODkwMGFhL3RhYmxlcmFuZ2U6ZDM0MTNkODQ5OTlhNGFjYzkxZmZmMGRkMmU4OTAwYWFfNi0xLTEtMS00Mjc5Mg_71842c3a-d91b-478c-af1e-efe3a156d97f">2,470</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="i47f09f18839440ffae0cf05a475aa7fe_I20211231" decimals="-3" name="us-gaap:InventoryValuationReserves" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18zNy9mcmFnOjAwNzc4OWM5YjcxZjRlYjU5NzA5ZDZhMjhjMzdmZDZmL3RhYmxlOmQzNDEzZDg0OTk5YTRhY2M5MWZmZjBkZDJlODkwMGFhL3RhYmxlcmFuZ2U6ZDM0MTNkODQ5OTlhNGFjYzkxZmZmMGRkMmU4OTAwYWFfNi0zLTEtMS00Mjc5Mg_d50d9962-341f-4b1f-9b90-3faaa3efd9e1">7,472</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1.37pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i5de311f5948148cda49342e2cea83715_I20220930" decimals="-3" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18zNy9mcmFnOjAwNzc4OWM5YjcxZjRlYjU5NzA5ZDZhMjhjMzdmZDZmL3RhYmxlOmQzNDEzZDg0OTk5YTRhY2M5MWZmZjBkZDJlODkwMGFhL3RhYmxlcmFuZ2U6ZDM0MTNkODQ5OTlhNGFjYzkxZmZmMGRkMmU4OTAwYWFfNy0xLTEtMS00Mjc5Mg_2ad80d04-1667-4efb-afa8-87ff8bd98aba">145,279</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1.37pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i47f09f18839440ffae0cf05a475aa7fe_I20211231" decimals="-3" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18zNy9mcmFnOjAwNzc4OWM5YjcxZjRlYjU5NzA5ZDZhMjhjMzdmZDZmL3RhYmxlOmQzNDEzZDg0OTk5YTRhY2M5MWZmZjBkZDJlODkwMGFhL3RhYmxlcmFuZ2U6ZDM0MTNkODQ5OTlhNGFjYzkxZmZmMGRkMmU4OTAwYWFfNy0zLTEtMS00Mjc5Mg_bc4d3b64-8bf5-47ef-8c89-9a8a182d3bc2">180,043</ix:nonFraction></span></td></tr></table></div></ix:nonNumeric></ix:continuation><div id="ic8ae413b3ff34d56976502c585fa6ab3_40"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3. <ix:nonNumeric contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930" name="us-gaap:EarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180MC9mcmFnOmU3ZDQ0NTc2ZmI2ZDQ5MWJiMmYwMmVlNDZhMDFkNDY5L3RleHRyZWdpb246ZTdkNDQ1NzZmYjZkNDkxYmIyZjAyZWU0NmEwMWQ0NjlfODg3_50e38cde-06d6-4db6-8fe6-dc5cec059fed" continuedAt="i52e791fa20f44e1388137b473c87dd06" escape="true">EARNINGS PER SHARE</ix:nonNumeric></span></div><ix:continuation id="i52e791fa20f44e1388137b473c87dd06"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic earnings per share (&#8220;EPS&#8221;) computations are calculated utilizing the weighted average number of shares of the Company&#8217;s common stock outstanding during the periods presented. Diluted EPS is calculated utilizing the weighted average number of shares of the Company&#8217;s common stock outstanding adjusted for the effect of dilutive common stock equivalents.</span></div><ix:nonNumeric contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180MC9mcmFnOmU3ZDQ0NTc2ZmI2ZDQ5MWJiMmYwMmVlNDZhMDFkNDY5L3RleHRyZWdpb246ZTdkNDQ1NzZmYjZkNDkxYmIyZjAyZWU0NmEwMWQ0NjlfODg4_6ad920e3-2b73-4113-8807-631587c18527" escape="true"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the computation of basic and diluted EPS (in thousands, except per share data):</span></div><div style="margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:49.329%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.361%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.373%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.361%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.373%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.364%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.373%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.366%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine months ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Numerator:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Net income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f3a96a832ab4b0ca374599d1c3e9bce_D20220701-20220930" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180MC9mcmFnOmU3ZDQ0NTc2ZmI2ZDQ5MWJiMmYwMmVlNDZhMDFkNDY5L3RhYmxlOjRkMzFjYzhhNTgxMTQwMThhMmQ3OTdlNDYyZGZjZTQyL3RhYmxlcmFuZ2U6NGQzMWNjOGE1ODExNDAxOGEyZDc5N2U0NjJkZmNlNDJfNC0xLTEtMS00Mjc5Mg_a8dda91d-2175-496c-9f08-a26d7da54d28">36,155</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bb5592686d74afab4f7004818fd6f9b_D20210701-20210930" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180MC9mcmFnOmU3ZDQ0NTc2ZmI2ZDQ5MWJiMmYwMmVlNDZhMDFkNDY5L3RhYmxlOjRkMzFjYzhhNTgxMTQwMThhMmQ3OTdlNDYyZGZjZTQyL3RhYmxlcmFuZ2U6NGQzMWNjOGE1ODExNDAxOGEyZDc5N2U0NjJkZmNlNDJfNC0zLTEtMS00Mjc5Mg_1debcfff-fbe8-498c-aa9f-09b9030d2bca">41,982</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180MC9mcmFnOmU3ZDQ0NTc2ZmI2ZDQ5MWJiMmYwMmVlNDZhMDFkNDY5L3RhYmxlOjRkMzFjYzhhNTgxMTQwMThhMmQ3OTdlNDYyZGZjZTQyL3RhYmxlcmFuZ2U6NGQzMWNjOGE1ODExNDAxOGEyZDc5N2U0NjJkZmNlNDJfNC01LTEtMS00Mjc5Mg_80832123-86c4-453b-95cf-1adedabcc4d8">117,050</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic431430d1ab24120b4507025a722d73a_D20210101-20210930" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180MC9mcmFnOmU3ZDQ0NTc2ZmI2ZDQ5MWJiMmYwMmVlNDZhMDFkNDY5L3RhYmxlOjRkMzFjYzhhNTgxMTQwMThhMmQ3OTdlNDYyZGZjZTQyL3RhYmxlcmFuZ2U6NGQzMWNjOGE1ODExNDAxOGEyZDc5N2U0NjJkZmNlNDJfNC03LTEtMS00Mjc5Mg_613b68c5-10ac-4dab-8b25-62d4a8bef4e3">130,008</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Denominator:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Weighted average shares of common stock outstanding</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2f3a96a832ab4b0ca374599d1c3e9bce_D20220701-20220930" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180MC9mcmFnOmU3ZDQ0NTc2ZmI2ZDQ5MWJiMmYwMmVlNDZhMDFkNDY5L3RhYmxlOjRkMzFjYzhhNTgxMTQwMThhMmQ3OTdlNDYyZGZjZTQyL3RhYmxlcmFuZ2U6NGQzMWNjOGE1ODExNDAxOGEyZDc5N2U0NjJkZmNlNDJfNy0xLTEtMS00Mjc5Mg_f898d3ca-f97f-4e85-983a-deb6e6fd412c">10,964</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3bb5592686d74afab4f7004818fd6f9b_D20210701-20210930" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180MC9mcmFnOmU3ZDQ0NTc2ZmI2ZDQ5MWJiMmYwMmVlNDZhMDFkNDY5L3RhYmxlOjRkMzFjYzhhNTgxMTQwMThhMmQ3OTdlNDYyZGZjZTQyL3RhYmxlcmFuZ2U6NGQzMWNjOGE1ODExNDAxOGEyZDc5N2U0NjJkZmNlNDJfNy0zLTEtMS00Mjc5Mg_4a9b94b8-a6e9-4989-b54c-3efaffe200c8">11,692</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180MC9mcmFnOmU3ZDQ0NTc2ZmI2ZDQ5MWJiMmYwMmVlNDZhMDFkNDY5L3RhYmxlOjRkMzFjYzhhNTgxMTQwMThhMmQ3OTdlNDYyZGZjZTQyL3RhYmxlcmFuZ2U6NGQzMWNjOGE1ODExNDAxOGEyZDc5N2U0NjJkZmNlNDJfNy01LTEtMS00Mjc5Mg_5b0062bc-29de-40ee-8380-519244f7cbfc">11,290</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic431430d1ab24120b4507025a722d73a_D20210101-20210930" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180MC9mcmFnOmU3ZDQ0NTc2ZmI2ZDQ5MWJiMmYwMmVlNDZhMDFkNDY5L3RhYmxlOjRkMzFjYzhhNTgxMTQwMThhMmQ3OTdlNDYyZGZjZTQyL3RhYmxlcmFuZ2U6NGQzMWNjOGE1ODExNDAxOGEyZDc5N2U0NjJkZmNlNDJfNy03LTEtMS00Mjc5Mg_53a9fe20-f7b4-440a-932c-59fe5edf5cf4">11,739</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Effect of dilutive common stock equivalents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2f3a96a832ab4b0ca374599d1c3e9bce_D20220701-20220930" decimals="-3" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180MC9mcmFnOmU3ZDQ0NTc2ZmI2ZDQ5MWJiMmYwMmVlNDZhMDFkNDY5L3RhYmxlOjRkMzFjYzhhNTgxMTQwMThhMmQ3OTdlNDYyZGZjZTQyL3RhYmxlcmFuZ2U6NGQzMWNjOGE1ODExNDAxOGEyZDc5N2U0NjJkZmNlNDJfOC0xLTEtMS00Mjc5Mg_6a0de0de-fab0-4cae-82ad-552f5a70b41d">78</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3bb5592686d74afab4f7004818fd6f9b_D20210701-20210930" decimals="-3" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180MC9mcmFnOmU3ZDQ0NTc2ZmI2ZDQ5MWJiMmYwMmVlNDZhMDFkNDY5L3RhYmxlOjRkMzFjYzhhNTgxMTQwMThhMmQ3OTdlNDYyZGZjZTQyL3RhYmxlcmFuZ2U6NGQzMWNjOGE1ODExNDAxOGEyZDc5N2U0NjJkZmNlNDJfOC0zLTEtMS00Mjc5Mg_df0307f9-622a-4ac8-ab10-5e30d5e46899">93</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930" decimals="-3" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180MC9mcmFnOmU3ZDQ0NTc2ZmI2ZDQ5MWJiMmYwMmVlNDZhMDFkNDY5L3RhYmxlOjRkMzFjYzhhNTgxMTQwMThhMmQ3OTdlNDYyZGZjZTQyL3RhYmxlcmFuZ2U6NGQzMWNjOGE1ODExNDAxOGEyZDc5N2U0NjJkZmNlNDJfOC01LTEtMS00Mjc5Mg_5b5e228f-5242-4640-9db4-207ba80f67f7">79</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic431430d1ab24120b4507025a722d73a_D20210101-20210930" decimals="-3" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180MC9mcmFnOmU3ZDQ0NTc2ZmI2ZDQ5MWJiMmYwMmVlNDZhMDFkNDY5L3RhYmxlOjRkMzFjYzhhNTgxMTQwMThhMmQ3OTdlNDYyZGZjZTQyL3RhYmxlcmFuZ2U6NGQzMWNjOGE1ODExNDAxOGEyZDc5N2U0NjJkZmNlNDJfOC03LTEtMS00Mjc5Mg_0351cfe9-84ff-4c38-9be2-dc18f8defeae">101</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Weighted average shares of common stock outstanding</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2f3a96a832ab4b0ca374599d1c3e9bce_D20220701-20220930" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180MC9mcmFnOmU3ZDQ0NTc2ZmI2ZDQ5MWJiMmYwMmVlNDZhMDFkNDY5L3RhYmxlOjRkMzFjYzhhNTgxMTQwMThhMmQ3OTdlNDYyZGZjZTQyL3RhYmxlcmFuZ2U6NGQzMWNjOGE1ODExNDAxOGEyZDc5N2U0NjJkZmNlNDJfOS0xLTEtMS00Mjc5Mg_84cb14e3-f772-485f-8732-41831c32018f">11,042</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3bb5592686d74afab4f7004818fd6f9b_D20210701-20210930" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180MC9mcmFnOmU3ZDQ0NTc2ZmI2ZDQ5MWJiMmYwMmVlNDZhMDFkNDY5L3RhYmxlOjRkMzFjYzhhNTgxMTQwMThhMmQ3OTdlNDYyZGZjZTQyL3RhYmxlcmFuZ2U6NGQzMWNjOGE1ODExNDAxOGEyZDc5N2U0NjJkZmNlNDJfOS0zLTEtMS00Mjc5Mg_2aff0e75-9228-4ea3-9954-217c28edb259">11,785</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180MC9mcmFnOmU3ZDQ0NTc2ZmI2ZDQ5MWJiMmYwMmVlNDZhMDFkNDY5L3RhYmxlOjRkMzFjYzhhNTgxMTQwMThhMmQ3OTdlNDYyZGZjZTQyL3RhYmxlcmFuZ2U6NGQzMWNjOGE1ODExNDAxOGEyZDc5N2U0NjJkZmNlNDJfOS01LTEtMS00Mjc5Mg_7427627c-dd54-4194-a276-a986871df6e4">11,369</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic431430d1ab24120b4507025a722d73a_D20210101-20210930" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180MC9mcmFnOmU3ZDQ0NTc2ZmI2ZDQ5MWJiMmYwMmVlNDZhMDFkNDY5L3RhYmxlOjRkMzFjYzhhNTgxMTQwMThhMmQ3OTdlNDYyZGZjZTQyL3RhYmxlcmFuZ2U6NGQzMWNjOGE1ODExNDAxOGEyZDc5N2U0NjJkZmNlNDJfOS03LTEtMS00Mjc5Mg_9b818bfe-be63-4fa5-9c90-f2a88eb256e3">11,840</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Earnings per share - basic</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i2f3a96a832ab4b0ca374599d1c3e9bce_D20220701-20220930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180MC9mcmFnOmU3ZDQ0NTc2ZmI2ZDQ5MWJiMmYwMmVlNDZhMDFkNDY5L3RhYmxlOjRkMzFjYzhhNTgxMTQwMThhMmQ3OTdlNDYyZGZjZTQyL3RhYmxlcmFuZ2U6NGQzMWNjOGE1ODExNDAxOGEyZDc5N2U0NjJkZmNlNDJfMTEtMS0xLTEtNDI3OTI_0e9d8a51-1252-4b35-aa02-03fc84b667a5">3.30</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i3bb5592686d74afab4f7004818fd6f9b_D20210701-20210930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180MC9mcmFnOmU3ZDQ0NTc2ZmI2ZDQ5MWJiMmYwMmVlNDZhMDFkNDY5L3RhYmxlOjRkMzFjYzhhNTgxMTQwMThhMmQ3OTdlNDYyZGZjZTQyL3RhYmxlcmFuZ2U6NGQzMWNjOGE1ODExNDAxOGEyZDc5N2U0NjJkZmNlNDJfMTEtMy0xLTEtNDI3OTI_1b2a2beb-1da2-487d-9b9c-63582e545254">3.59</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180MC9mcmFnOmU3ZDQ0NTc2ZmI2ZDQ5MWJiMmYwMmVlNDZhMDFkNDY5L3RhYmxlOjRkMzFjYzhhNTgxMTQwMThhMmQ3OTdlNDYyZGZjZTQyL3RhYmxlcmFuZ2U6NGQzMWNjOGE1ODExNDAxOGEyZDc5N2U0NjJkZmNlNDJfMTEtNS0xLTEtNDI3OTI_af82b6ad-081a-4e4a-8ad6-3849c0b87c39">10.37</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ic431430d1ab24120b4507025a722d73a_D20210101-20210930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180MC9mcmFnOmU3ZDQ0NTc2ZmI2ZDQ5MWJiMmYwMmVlNDZhMDFkNDY5L3RhYmxlOjRkMzFjYzhhNTgxMTQwMThhMmQ3OTdlNDYyZGZjZTQyL3RhYmxlcmFuZ2U6NGQzMWNjOGE1ODExNDAxOGEyZDc5N2U0NjJkZmNlNDJfMTEtNy0xLTEtNDI3OTI_64243f66-c29f-4d53-b182-a9cbd7e97946">11.07</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Earnings per share - diluted</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i2f3a96a832ab4b0ca374599d1c3e9bce_D20220701-20220930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180MC9mcmFnOmU3ZDQ0NTc2ZmI2ZDQ5MWJiMmYwMmVlNDZhMDFkNDY5L3RhYmxlOjRkMzFjYzhhNTgxMTQwMThhMmQ3OTdlNDYyZGZjZTQyL3RhYmxlcmFuZ2U6NGQzMWNjOGE1ODExNDAxOGEyZDc5N2U0NjJkZmNlNDJfMTMtMS0xLTEtNDI3OTI_d9d05442-ccfa-4851-8aaf-83277780d6c7">3.27</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i3bb5592686d74afab4f7004818fd6f9b_D20210701-20210930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180MC9mcmFnOmU3ZDQ0NTc2ZmI2ZDQ5MWJiMmYwMmVlNDZhMDFkNDY5L3RhYmxlOjRkMzFjYzhhNTgxMTQwMThhMmQ3OTdlNDYyZGZjZTQyL3RhYmxlcmFuZ2U6NGQzMWNjOGE1ODExNDAxOGEyZDc5N2U0NjJkZmNlNDJfMTMtMy0xLTEtNDI3OTI_22ec0c3e-593d-4696-841a-b59c2befff96">3.56</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180MC9mcmFnOmU3ZDQ0NTc2ZmI2ZDQ5MWJiMmYwMmVlNDZhMDFkNDY5L3RhYmxlOjRkMzFjYzhhNTgxMTQwMThhMmQ3OTdlNDYyZGZjZTQyL3RhYmxlcmFuZ2U6NGQzMWNjOGE1ODExNDAxOGEyZDc5N2U0NjJkZmNlNDJfMTMtNS0xLTEtNDI3OTI_7fd300b9-0cbf-4c57-944b-f8b3eeecba9f">10.30</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ic431430d1ab24120b4507025a722d73a_D20210101-20210930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180MC9mcmFnOmU3ZDQ0NTc2ZmI2ZDQ5MWJiMmYwMmVlNDZhMDFkNDY5L3RhYmxlOjRkMzFjYzhhNTgxMTQwMThhMmQ3OTdlNDYyZGZjZTQyL3RhYmxlcmFuZ2U6NGQzMWNjOGE1ODExNDAxOGEyZDc5N2U0NjJkZmNlNDJfMTMtNy0xLTEtNDI3OTI_acdf8146-9734-4b7b-b8de-afb060d105f5">10.98</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The calculation of diluted EPS excluded <ix:nonFraction unitRef="shares" contextRef="i8c40ccc203fe40598b003eaa16fd683f_D20220701-20220930" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180MC9mcmFnOmU3ZDQ0NTc2ZmI2ZDQ5MWJiMmYwMmVlNDZhMDFkNDY5L3RleHRyZWdpb246ZTdkNDQ1NzZmYjZkNDkxYmIyZjAyZWU0NmEwMWQ0NjlfNTM5_985a5274-4b6e-401e-881c-f055fbfca57f">10</ix:nonFraction> thousand and <ix:nonFraction unitRef="shares" contextRef="i44833e234c5b420caed39d2dbc002f2b_D20210701-20210930" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180MC9mcmFnOmU3ZDQ0NTc2ZmI2ZDQ5MWJiMmYwMmVlNDZhMDFkNDY5L3RleHRyZWdpb246ZTdkNDQ1NzZmYjZkNDkxYmIyZjAyZWU0NmEwMWQ0NjlfNTQ2_7df40e27-c439-4475-8978-05d80f8acb64">0</ix:nonFraction> thousand antidilutive restricted stock awards for the three months ended September 30, 2022 and 2021, respectively, and <ix:nonFraction unitRef="shares" contextRef="ide51255203a64d54b830864bda6b2f1f_D20220101-20220930" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180MC9mcmFnOmU3ZDQ0NTc2ZmI2ZDQ5MWJiMmYwMmVlNDZhMDFkNDY5L3RleHRyZWdpb246ZTdkNDQ1NzZmYjZkNDkxYmIyZjAyZWU0NmEwMWQ0NjlfNjIz_110290db-f0c9-4e6f-a82e-b1924c919b8a">3</ix:nonFraction> thousand and <ix:nonFraction unitRef="shares" contextRef="i873b1283e7f24f0c80ef84c8a9e20c76_D20210101-20210930" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180MC9mcmFnOmU3ZDQ0NTc2ZmI2ZDQ5MWJiMmYwMmVlNDZhMDFkNDY5L3RleHRyZWdpb246ZTdkNDQ1NzZmYjZkNDkxYmIyZjAyZWU0NmEwMWQ0NjlfNjMw_50aaed34-54ae-4e4b-8da7-c6405f9fbf55">0</ix:nonFraction> thousand antidilutive restricted stock awards for the nine months ended September 30, 2022 and 2021, respectively. EPS is computed independently for each of the periods presented above, and accordingly, the sum of the quarterly earnings per common share may not equal the year-to-date total computed.</span></div></ix:continuation><div id="ic8ae413b3ff34d56976502c585fa6ab3_43"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4. <ix:nonNumeric contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RleHRyZWdpb246ZTVhOGVlNTZmNGM1NDhmNzhjYjViOTk0YzJmYjU5OGRfNDczMQ_2556d421-d3a5-4193-a119-1218b92c632b" continuedAt="idace07ec838f4f8c8beeceb51f44633f" escape="true">SHARE-BASED COMPENSATION</ix:nonNumeric></span></div><ix:continuation id="idace07ec838f4f8c8beeceb51f44633f" continuedAt="if8a1193eec6b4108b82ad3450ef38d1c"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stock Options</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has issued non-qualified and incentive stock options to employees and non-employee directors. The fair value of these options are estimated on the date of grant using the Black-Scholes option pricing model, which requires estimates of the expected term of the option, the risk-free interest rate, the expected volatility of the price of the Company&#8217;s common stock, and dividend yield. Options outstanding as of <ix:nonNumeric contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RleHRyZWdpb246ZTVhOGVlNTZmNGM1NDhmNzhjYjViOTk0YzJmYjU5OGRfNDcw_75cfbe1e-17ec-4442-ae34-fd999dbe9ec2">September&#160;30, 2022</ix:nonNumeric> generally vest over a period of <ix:nonNumeric contextRef="if96bd90ed63041fc85fb7929f8aa69cf_D20220101-20220930" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RleHRyZWdpb246ZTVhOGVlNTZmNGM1NDhmNzhjYjViOTk0YzJmYjU5OGRfNTA1_94e305a9-6fe1-4337-9a4e-c9870f3b63d1">three years</ix:nonNumeric> and expire <ix:nonNumeric contextRef="if96bd90ed63041fc85fb7929f8aa69cf_D20220101-20220930" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RleHRyZWdpb246ZTVhOGVlNTZmNGM1NDhmNzhjYjViOTk0YzJmYjU5OGRfNTE5_163d5d78-f841-4a4d-bc4c-9860d302b5e1">ten years</ix:nonNumeric> from the date of grant. The exercise price of these options ranges from $<ix:nonFraction unitRef="usdPerShare" contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930" decimals="2" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RleHRyZWdpb246ZTVhOGVlNTZmNGM1NDhmNzhjYjViOTk0YzJmYjU5OGRfNTk0_a378676a-04bf-4ad9-a5d1-2f7bbdda230a">26.52</ix:nonFraction> to $<ix:nonFraction unitRef="usdPerShare" contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930" decimals="2" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RleHRyZWdpb246ZTVhOGVlNTZmNGM1NDhmNzhjYjViOTk0YzJmYjU5OGRfNjAw_b66c2f56-78e4-468f-969b-6db5fa498211">66.68</ix:nonFraction>. Due to the Company&#8217;s lack of option exercise history on the date of grant, the expected term is calculated using the simplified method defined as the midpoint </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:21.6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#ic8ae413b3ff34d56976502c585fa6ab3_7">Table of Contents</a></span></div></div><ix:continuation id="if8a1193eec6b4108b82ad3450ef38d1c" continuedAt="i510b0eaa8f674781897572e4d0477885"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">between the vesting period and the contractual term of each option. The risk free interest rate is based on the U.S. Treasury yield curve in effect on the date of grant that most closely corresponds to the expected term of the option. The expected volatility is based on the historical volatility of the Company&#8217;s common stock over the period of time equivalent to the expected term for each award. The dividend yield is computed as the annualized dividend rate at the grant date divided by the strike price of the stock option. For the nine months ended September 30, 2022 and 2021, the Company did <ix:nonFraction unitRef="shares" contextRef="ic431430d1ab24120b4507025a722d73a_D20210101-20210930" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RleHRyZWdpb246ZTVhOGVlNTZmNGM1NDhmNzhjYjViOTk0YzJmYjU5OGRfMTMyNw_1bf0f332-04cb-4043-812e-c95846601198"><ix:nonFraction unitRef="shares" contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RleHRyZWdpb246ZTVhOGVlNTZmNGM1NDhmNzhjYjViOTk0YzJmYjU5OGRfMTMyNw_f0d2c5a6-f684-4d50-9c42-4c5ccede2126">no</ix:nonFraction></ix:nonFraction>t grant stock options. </span></div><ix:nonNumeric contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RleHRyZWdpb246ZTVhOGVlNTZmNGM1NDhmNzhjYjViOTk0YzJmYjU5OGRfNDczNQ_61425146-3753-49b2-8bea-22201f854684" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of our stock option activity (in thousands, except per share data):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.525%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.929%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.056%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine months ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Awards</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted-Average Exercise Price</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Awards</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted-Average Exercise Price</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Outstanding at beginning of period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i47f09f18839440ffae0cf05a475aa7fe_I20211231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RhYmxlOjQ0Y2Q2NDFjNjQ4OTQyMzI4NmI1MDE0NTEwOGU5Mzk2L3RhYmxlcmFuZ2U6NDRjZDY0MWM2NDg5NDIzMjg2YjUwMTQ1MTA4ZTkzOTZfNC0xLTEtMS00Mjc5Mg_df4af431-4ca7-4e31-9a7c-f361c4e9bd55">33</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i47f09f18839440ffae0cf05a475aa7fe_I20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RhYmxlOjQ0Y2Q2NDFjNjQ4OTQyMzI4NmI1MDE0NTEwOGU5Mzk2L3RhYmxlcmFuZ2U6NDRjZDY0MWM2NDg5NDIzMjg2YjUwMTQ1MTA4ZTkzOTZfNC0zLTEtMS00Mjc5Mg_8e441d83-6d10-4420-a329-282c7e55b7ef">54.98</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i03d902ffc72e4d98b5eeb6fb903f405b_I20201231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RhYmxlOjQ0Y2Q2NDFjNjQ4OTQyMzI4NmI1MDE0NTEwOGU5Mzk2L3RhYmxlcmFuZ2U6NDRjZDY0MWM2NDg5NDIzMjg2YjUwMTQ1MTA4ZTkzOTZfNC01LTEtMS00Mjc5Mg_ae18ad6d-b5a2-4446-b7d7-9c290f70c09a">61</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i03d902ffc72e4d98b5eeb6fb903f405b_I20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RhYmxlOjQ0Y2Q2NDFjNjQ4OTQyMzI4NmI1MDE0NTEwOGU5Mzk2L3RhYmxlcmFuZ2U6NDRjZDY0MWM2NDg5NDIzMjg2YjUwMTQ1MTA4ZTkzOTZfNC03LTEtMS00Mjc5Mg_2433cf72-10a5-4b7c-b5f4-c8c92640147c">48.19</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Exercised</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RhYmxlOjQ0Y2Q2NDFjNjQ4OTQyMzI4NmI1MDE0NTEwOGU5Mzk2L3RhYmxlcmFuZ2U6NDRjZDY0MWM2NDg5NDIzMjg2YjUwMTQ1MTA4ZTkzOTZfNS0xLTEtMS00Mjc5Mg_a53879c3-74c7-47e7-a133-744f815be9d2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RhYmxlOjQ0Y2Q2NDFjNjQ4OTQyMzI4NmI1MDE0NTEwOGU5Mzk2L3RhYmxlcmFuZ2U6NDRjZDY0MWM2NDg5NDIzMjg2YjUwMTQ1MTA4ZTkzOTZfNS0zLTEtMS00Mjc5Mg_3674ed8c-1a3f-4a8b-983e-a1f9ce5bf21f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ic431430d1ab24120b4507025a722d73a_D20210101-20210930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RhYmxlOjQ0Y2Q2NDFjNjQ4OTQyMzI4NmI1MDE0NTEwOGU5Mzk2L3RhYmxlcmFuZ2U6NDRjZDY0MWM2NDg5NDIzMjg2YjUwMTQ1MTA4ZTkzOTZfNS01LTEtMS00Mjc5Mg_c9f06ad3-341a-47d2-8cc7-8a7c985eb9c4">16</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ic431430d1ab24120b4507025a722d73a_D20210101-20210930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RhYmxlOjQ0Y2Q2NDFjNjQ4OTQyMzI4NmI1MDE0NTEwOGU5Mzk2L3RhYmxlcmFuZ2U6NDRjZDY0MWM2NDg5NDIzMjg2YjUwMTQ1MTA4ZTkzOTZfNS03LTEtMS00Mjc5Mg_f64fc654-51f8-428f-ad8a-13662bc5f7eb">49.69</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Outstanding at end of the period</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5de311f5948148cda49342e2cea83715_I20220930" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RhYmxlOjQ0Y2Q2NDFjNjQ4OTQyMzI4NmI1MDE0NTEwOGU5Mzk2L3RhYmxlcmFuZ2U6NDRjZDY0MWM2NDg5NDIzMjg2YjUwMTQ1MTA4ZTkzOTZfNy0xLTEtMS00Mjc5Mg_a346decc-260c-4d51-ad19-d64cfb2ab36b">33</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5de311f5948148cda49342e2cea83715_I20220930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RhYmxlOjQ0Y2Q2NDFjNjQ4OTQyMzI4NmI1MDE0NTEwOGU5Mzk2L3RhYmxlcmFuZ2U6NDRjZDY0MWM2NDg5NDIzMjg2YjUwMTQ1MTA4ZTkzOTZfNy0zLTEtMS00Mjc5Mg_f46ba585-a128-44cf-954b-ec7f5f77b1b2">54.98</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ifb5de6f6a1b842d59a7c6674c3095ce8_I20210930" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RhYmxlOjQ0Y2Q2NDFjNjQ4OTQyMzI4NmI1MDE0NTEwOGU5Mzk2L3RhYmxlcmFuZ2U6NDRjZDY0MWM2NDg5NDIzMjg2YjUwMTQ1MTA4ZTkzOTZfNy01LTEtMS00Mjc5Mg_c88b15aa-4927-46bf-8cc1-89d63c1407a7">45</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ifb5de6f6a1b842d59a7c6674c3095ce8_I20210930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RhYmxlOjQ0Y2Q2NDFjNjQ4OTQyMzI4NmI1MDE0NTEwOGU5Mzk2L3RhYmxlcmFuZ2U6NDRjZDY0MWM2NDg5NDIzMjg2YjUwMTQ1MTA4ZTkzOTZfNy03LTEtMS00Mjc5Mg_c3e7c97c-b575-47ac-9b99-8cae8a67c927">47.66</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Exercisable at end of the period</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5de311f5948148cda49342e2cea83715_I20220930" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RhYmxlOjQ0Y2Q2NDFjNjQ4OTQyMzI4NmI1MDE0NTEwOGU5Mzk2L3RhYmxlcmFuZ2U6NDRjZDY0MWM2NDg5NDIzMjg2YjUwMTQ1MTA4ZTkzOTZfOC0xLTEtMS00Mjc5Mg_88222748-15db-4085-b792-b9d6bb2b84ee">28</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5de311f5948148cda49342e2cea83715_I20220930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RhYmxlOjQ0Y2Q2NDFjNjQ4OTQyMzI4NmI1MDE0NTEwOGU5Mzk2L3RhYmxlcmFuZ2U6NDRjZDY0MWM2NDg5NDIzMjg2YjUwMTQ1MTA4ZTkzOTZfOC0zLTEtMS00Mjc5Mg_db667807-e687-472c-951a-884bc8261d78">52.76</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ifb5de6f6a1b842d59a7c6674c3095ce8_I20210930" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RhYmxlOjQ0Y2Q2NDFjNjQ4OTQyMzI4NmI1MDE0NTEwOGU5Mzk2L3RhYmxlcmFuZ2U6NDRjZDY0MWM2NDg5NDIzMjg2YjUwMTQ1MTA4ZTkzOTZfOC01LTEtMS00Mjc5Mg_6350c4dc-f0f6-4015-beb3-4036c7e7f9df">35</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ifb5de6f6a1b842d59a7c6674c3095ce8_I20210930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RhYmxlOjQ0Y2Q2NDFjNjQ4OTQyMzI4NmI1MDE0NTEwOGU5Mzk2L3RhYmxlcmFuZ2U6NDRjZDY0MWM2NDg5NDIzMjg2YjUwMTQ1MTA4ZTkzOTZfOC03LTEtMS00Mjc5Mg_b7a7a3f5-67e7-44f6-a6f7-b17471a88a01">42.00</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of <ix:nonNumeric contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RleHRyZWdpb246ZTVhOGVlNTZmNGM1NDhmNzhjYjViOTk0YzJmYjU5OGRfMTQ2Mg_75cfbe1e-17ec-4442-ae34-fd999dbe9ec2">September&#160;30, 2022</ix:nonNumeric>, the weighted-average remaining contractual life for outstanding stock options was <ix:nonNumeric contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:durmonth" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RleHRyZWdpb246ZTVhOGVlNTZmNGM1NDhmNzhjYjViOTk0YzJmYjU5OGRfMTU0OA_b928dda8-7fe3-43e6-9b04-980b42d2d41c">55</ix:nonNumeric> months with an aggregate intrinsic value of $<ix:nonFraction unitRef="usd" contextRef="i5de311f5948148cda49342e2cea83715_I20220930" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RleHRyZWdpb246ZTVhOGVlNTZmNGM1NDhmNzhjYjViOTk0YzJmYjU5OGRfMTU4OA_34f4725b-6b9c-4ed9-b5ab-aa5f1321db5d">1.8</ix:nonFraction> million and the weighted-average remaining contractual life for exercisable stock options was <ix:nonNumeric contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" format="ixt-sec:durmonth" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RleHRyZWdpb246ZTVhOGVlNTZmNGM1NDhmNzhjYjViOTk0YzJmYjU5OGRfMTY3Nw_94386346-b3f3-450d-b4a9-9f2548c1f604">53</ix:nonNumeric> months with an aggregate intrinsic value of $<ix:nonFraction unitRef="usd" contextRef="i5de311f5948148cda49342e2cea83715_I20220930" decimals="-5" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RleHRyZWdpb246ZTVhOGVlNTZmNGM1NDhmNzhjYjViOTk0YzJmYjU5OGRfMTcxNw_412c3ad4-69d1-4a92-a982-d67465156632">1.5</ix:nonFraction> million. The unrecognized compensation expense calculated under the fair value method for stock options expected to vest as of <ix:nonNumeric contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RleHRyZWdpb246ZTVhOGVlNTZmNGM1NDhmNzhjYjViOTk0YzJmYjU5OGRfMTgzOQ_75cfbe1e-17ec-4442-ae34-fd999dbe9ec2">September&#160;30, 2022</ix:nonNumeric> was less than </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="ie17f9491af104b57837e5277e79f0dee_I20220930" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RleHRyZWdpb246ZTVhOGVlNTZmNGM1NDhmNzhjYjViOTk0YzJmYjU5OGRfMTg0Ng_3f729c7d-68ab-4df3-8f79-f9c2cffe6b8a">0.1</ix:nonFraction> million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and is expected to be recognized over a weighted-average period of </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="if96bd90ed63041fc85fb7929f8aa69cf_D20220101-20220930" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:durmonth" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RleHRyZWdpb246ZTVhOGVlNTZmNGM1NDhmNzhjYjViOTk0YzJmYjU5OGRfMTkxNg_885a0792-cbc5-4eb9-b166-a30428c230e6">4</ix:nonNumeric> months</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. For the nine months ended September 30, 2022, there was no exercise activity of stock options. For the nine months ended September 30, 2021, the Company received $<ix:nonFraction unitRef="usd" contextRef="ic431430d1ab24120b4507025a722d73a_D20210101-20210930" decimals="-5" name="us-gaap:ProceedsFromStockOptionsExercised" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RleHRyZWdpb246ZTVhOGVlNTZmNGM1NDhmNzhjYjViOTk0YzJmYjU5OGRfMjAxNA_e4a6443a-ddd2-4faf-a357-3c4559c33ed5">0.8</ix:nonFraction> million in cash proceeds from the exercise of stock options. The total intrinsic value for stock options exercised during the nine months ended September 30, 2021 was $<ix:nonFraction unitRef="usd" contextRef="ic431430d1ab24120b4507025a722d73a_D20210101-20210930" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RleHRyZWdpb246ZTVhOGVlNTZmNGM1NDhmNzhjYjViOTk0YzJmYjU5OGRfMjE0Mg_d4289b88-c736-4cfa-a938-8e90f8cc464b">3.3</ix:nonFraction> million.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Restricted Stock</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has issued restricted stock to employees and non-employee directors generally with vesting terms up to <ix:nonNumeric contextRef="id337c0920a144e0c91a6bed2853c1d7b_D20220101-20220930" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RleHRyZWdpb246ZTVhOGVlNTZmNGM1NDhmNzhjYjViOTk0YzJmYjU5OGRfMjI3OA_b3350ab7-ee49-48f0-ac6a-51317d2af41c">five years</ix:nonNumeric> after the date of grant. The fair value of the restricted stock is equal to the market price of the Company&#8217;s common stock on the date of grant. Expense for restricted stock is amortized ratably over the vesting period.</span></div><ix:nonNumeric contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930" name="us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RleHRyZWdpb246ZTVhOGVlNTZmNGM1NDhmNzhjYjViOTk0YzJmYjU5OGRfNDczNA_7c63ddf4-700c-4619-b596-93de537ab2fd" escape="true"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our restricted stock activity (in thousands, except per share data):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:33.549%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.344%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.617%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Nine months ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">2022</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Shares</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Weighted-Average Grant Date Fair Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Shares</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Weighted-Average Grant Date Fair Value</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Outstanding at beginning of period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia06f0db3dd8146e097bef1502f9f86af_I20211231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RhYmxlOjgxZTI1OTgxMWNmYzQwYTdiZGFlNmIyYjk4ZWIyZjk5L3RhYmxlcmFuZ2U6ODFlMjU5ODExY2ZjNDBhN2JkYWU2YjJiOThlYjJmOTlfNC0xLTEtMS00Mjc5Mg_d595c726-acf1-4e3e-b0c3-784dab6f3076">44</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ia06f0db3dd8146e097bef1502f9f86af_I20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RhYmxlOjgxZTI1OTgxMWNmYzQwYTdiZGFlNmIyYjk4ZWIyZjk5L3RhYmxlcmFuZ2U6ODFlMjU5ODExY2ZjNDBhN2JkYWU2YjJiOThlYjJmOTlfNC0zLTEtMS00Mjc5Mg_7f9edb34-af44-4abe-9433-50c7a9b3574f">183.51</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i64e1421ab00c4da49c0547bb9f5f234a_I20201231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RhYmxlOjgxZTI1OTgxMWNmYzQwYTdiZGFlNmIyYjk4ZWIyZjk5L3RhYmxlcmFuZ2U6ODFlMjU5ODExY2ZjNDBhN2JkYWU2YjJiOThlYjJmOTlfNC01LTEtMS00Mjc5Mg_3703c266-48e3-49f6-a682-175667ddb093">50</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i64e1421ab00c4da49c0547bb9f5f234a_I20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RhYmxlOjgxZTI1OTgxMWNmYzQwYTdiZGFlNmIyYjk4ZWIyZjk5L3RhYmxlcmFuZ2U6ODFlMjU5ODExY2ZjNDBhN2JkYWU2YjJiOThlYjJmOTlfNC03LTEtMS00Mjc5Mg_1306ea4a-471f-4431-aa6f-5699f98c26c6">116.06</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id337c0920a144e0c91a6bed2853c1d7b_D20220101-20220930" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RhYmxlOjgxZTI1OTgxMWNmYzQwYTdiZGFlNmIyYjk4ZWIyZjk5L3RhYmxlcmFuZ2U6ODFlMjU5ODExY2ZjNDBhN2JkYWU2YjJiOThlYjJmOTlfNS0xLTEtMS00Mjc5Mg_2f27d00f-0633-4e6f-b508-0fe01a1127be">38</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="id337c0920a144e0c91a6bed2853c1d7b_D20220101-20220930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RhYmxlOjgxZTI1OTgxMWNmYzQwYTdiZGFlNmIyYjk4ZWIyZjk5L3RhYmxlcmFuZ2U6ODFlMjU5ODExY2ZjNDBhN2JkYWU2YjJiOThlYjJmOTlfNS0zLTEtMS00Mjc5Mg_ceb745e2-9701-49ca-b621-38a011c84a8f">176.60</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if58da46cc9354a8eadc10f9e4f114ac2_D20210101-20210930" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RhYmxlOjgxZTI1OTgxMWNmYzQwYTdiZGFlNmIyYjk4ZWIyZjk5L3RhYmxlcmFuZ2U6ODFlMjU5ODExY2ZjNDBhN2JkYWU2YjJiOThlYjJmOTlfNS01LTEtMS00Mjc5Mg_b56152d0-6baa-42c3-ad09-d99d3d1829d4">21</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="if58da46cc9354a8eadc10f9e4f114ac2_D20210101-20210930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RhYmxlOjgxZTI1OTgxMWNmYzQwYTdiZGFlNmIyYjk4ZWIyZjk5L3RhYmxlcmFuZ2U6ODFlMjU5ODExY2ZjNDBhN2JkYWU2YjJiOThlYjJmOTlfNS03LTEtMS00Mjc5Mg_efc71e8c-b6bb-4dba-b346-67d4e718b5a4">266.99</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="id337c0920a144e0c91a6bed2853c1d7b_D20220101-20220930" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RhYmxlOjgxZTI1OTgxMWNmYzQwYTdiZGFlNmIyYjk4ZWIyZjk5L3RhYmxlcmFuZ2U6ODFlMjU5ODExY2ZjNDBhN2JkYWU2YjJiOThlYjJmOTlfNi0xLTEtMS00Mjc5Mg_a47644ff-c1a8-489b-a98d-08436969fd68">19</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="id337c0920a144e0c91a6bed2853c1d7b_D20220101-20220930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RhYmxlOjgxZTI1OTgxMWNmYzQwYTdiZGFlNmIyYjk4ZWIyZjk5L3RhYmxlcmFuZ2U6ODFlMjU5ODExY2ZjNDBhN2JkYWU2YjJiOThlYjJmOTlfNi0zLTEtMS00Mjc5Mg_6d0d70a2-b95b-4388-90ae-9ff46b1768dc">156.16</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="if58da46cc9354a8eadc10f9e4f114ac2_D20210101-20210930" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RhYmxlOjgxZTI1OTgxMWNmYzQwYTdiZGFlNmIyYjk4ZWIyZjk5L3RhYmxlcmFuZ2U6ODFlMjU5ODExY2ZjNDBhN2JkYWU2YjJiOThlYjJmOTlfNi01LTEtMS00Mjc5Mg_025d2a99-de2f-4241-be10-f7204ef2e777">26</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="if58da46cc9354a8eadc10f9e4f114ac2_D20210101-20210930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RhYmxlOjgxZTI1OTgxMWNmYzQwYTdiZGFlNmIyYjk4ZWIyZjk5L3RhYmxlcmFuZ2U6ODFlMjU5ODExY2ZjNDBhN2JkYWU2YjJiOThlYjJmOTlfNi03LTEtMS00Mjc5Mg_9c803b11-489d-4347-9a07-43935587484e">116.62</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="id337c0920a144e0c91a6bed2853c1d7b_D20220101-20220930" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RhYmxlOjgxZTI1OTgxMWNmYzQwYTdiZGFlNmIyYjk4ZWIyZjk5L3RhYmxlcmFuZ2U6ODFlMjU5ODExY2ZjNDBhN2JkYWU2YjJiOThlYjJmOTlfNy0xLTEtMS00Mjc5Mg_4d020f67-9111-4981-a919-599f267b386f">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="id337c0920a144e0c91a6bed2853c1d7b_D20220101-20220930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RhYmxlOjgxZTI1OTgxMWNmYzQwYTdiZGFlNmIyYjk4ZWIyZjk5L3RhYmxlcmFuZ2U6ODFlMjU5ODExY2ZjNDBhN2JkYWU2YjJiOThlYjJmOTlfNy0zLTEtMS00Mjc5Mg_fddf1473-fe2b-46bf-99d6-4d1a535a244e">186.53</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="if58da46cc9354a8eadc10f9e4f114ac2_D20210101-20210930" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RhYmxlOjgxZTI1OTgxMWNmYzQwYTdiZGFlNmIyYjk4ZWIyZjk5L3RhYmxlcmFuZ2U6ODFlMjU5ODExY2ZjNDBhN2JkYWU2YjJiOThlYjJmOTlfNy01LTEtMS00Mjc5Mg_9c67c21a-0b91-4b53-8242-896e05d8e46e">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="if58da46cc9354a8eadc10f9e4f114ac2_D20210101-20210930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RhYmxlOjgxZTI1OTgxMWNmYzQwYTdiZGFlNmIyYjk4ZWIyZjk5L3RhYmxlcmFuZ2U6ODFlMjU5ODExY2ZjNDBhN2JkYWU2YjJiOThlYjJmOTlfNy03LTEtMS00Mjc5Mg_ce916734-d773-4cad-b57f-7b7c645bfbf7">166.02</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Outstanding at end of the period</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iee1cf11574cc42609fde6f9c8aee4073_I20220930" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RhYmxlOjgxZTI1OTgxMWNmYzQwYTdiZGFlNmIyYjk4ZWIyZjk5L3RhYmxlcmFuZ2U6ODFlMjU5ODExY2ZjNDBhN2JkYWU2YjJiOThlYjJmOTlfOC0xLTEtMS00Mjc5Mg_77990c43-e02c-4238-b7d9-1b363f5bb263">62</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iee1cf11574cc42609fde6f9c8aee4073_I20220930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RhYmxlOjgxZTI1OTgxMWNmYzQwYTdiZGFlNmIyYjk4ZWIyZjk5L3RhYmxlcmFuZ2U6ODFlMjU5ODExY2ZjNDBhN2JkYWU2YjJiOThlYjJmOTlfOC0zLTEtMS00Mjc5Mg_893bb141-63eb-4230-9c5d-3c020e53e690">187.83</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic65b09ecdbb7426eb38e93fcf8817112_I20210930" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RhYmxlOjgxZTI1OTgxMWNmYzQwYTdiZGFlNmIyYjk4ZWIyZjk5L3RhYmxlcmFuZ2U6ODFlMjU5ODExY2ZjNDBhN2JkYWU2YjJiOThlYjJmOTlfOC01LTEtMS00Mjc5Mg_665346ba-3e5e-4d86-9e2d-24f8ffd87102">42</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ic65b09ecdbb7426eb38e93fcf8817112_I20210930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RhYmxlOjgxZTI1OTgxMWNmYzQwYTdiZGFlNmIyYjk4ZWIyZjk5L3RhYmxlcmFuZ2U6ODFlMjU5ODExY2ZjNDBhN2JkYWU2YjJiOThlYjJmOTlfOC03LTEtMS00Mjc5Mg_76352906-6156-4278-853b-aac4f6909d4d">183.04</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company withheld approximately <ix:nonFraction unitRef="shares" contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930" decimals="-3" name="us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RleHRyZWdpb246ZTVhOGVlNTZmNGM1NDhmNzhjYjViOTk0YzJmYjU5OGRfMjYzOA_1e851a60-984e-4f73-9b15-9dcc64bbd15a">8</ix:nonFraction> thousand and <ix:nonFraction unitRef="shares" contextRef="ic431430d1ab24120b4507025a722d73a_D20210101-20210930" decimals="-3" name="us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RleHRyZWdpb246ZTVhOGVlNTZmNGM1NDhmNzhjYjViOTk0YzJmYjU5OGRfMjY0NQ_3081a035-d016-4aca-9e5f-4b8719654382">7</ix:nonFraction> thousand shares of the Company&#8217;s common stock to cover minimum tax liability withholding obligations upon the vesting of shares of restricted stock for the nine months ended September 30, 2022 and 2021, respectively. The total fair value of restricted stock awards vested during the nine months ended September 30, 2022 and 2021 was $<ix:nonFraction unitRef="usd" contextRef="id337c0920a144e0c91a6bed2853c1d7b_D20220101-20220930" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RleHRyZWdpb246ZTVhOGVlNTZmNGM1NDhmNzhjYjViOTk0YzJmYjU5OGRfMjkwMA_a87bd3a8-22dc-4e7d-be5f-b7879db911dc">3</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="if58da46cc9354a8eadc10f9e4f114ac2_D20210101-20210930" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RleHRyZWdpb246ZTVhOGVlNTZmNGM1NDhmNzhjYjViOTk0YzJmYjU5OGRfMjkwNw_d7b71e7c-4868-451a-8df2-de1913e15bc6">7</ix:nonFraction>&#160;million, respectively.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Market and Performance-based Share Awards</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has issued market and performance-based share awards to certain key executives who were granted deferred shares and may earn between <ix:nonFraction unitRef="number" contextRef="if99f41a5e55c4b58ab6b630db3712adb_D20220101-20220930" decimals="INF" name="med:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesEarnedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RleHRyZWdpb246ZTVhOGVlNTZmNGM1NDhmNzhjYjViOTk0YzJmYjU5OGRfMzExMg_19df983e-de59-4d31-be18-dff0a67f7de5">0</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="i0ecdbda19ca5476b9e392faeaca89725_D20220101-20220930" decimals="INF" name="med:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesEarnedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RleHRyZWdpb246ZTVhOGVlNTZmNGM1NDhmNzhjYjViOTk0YzJmYjU5OGRfMzExOQ_f7e791f2-3292-4a9b-86bb-cbf7b40ec743">250</ix:nonFraction>% of the target number depending upon both the Company&#8217;s total stockholder return </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:21.6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#ic8ae413b3ff34d56976502c585fa6ab3_7">Table of Contents</a></span></div></div><ix:continuation id="i510b0eaa8f674781897572e4d0477885" continuedAt="i5018b831a2ea42fcb41d3ff7ac17b0d2"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(&#8220;TSR&#8221;) and the Company&#8217;s performance against predetermined performance goals over a <ix:nonNumeric contextRef="id883036fe81d4fbd9ce98760bd9584d6_D20220101-20220930" name="med:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesEarnedPerformancePeriod" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RleHRyZWdpb246ZTVhOGVlNTZmNGM1NDhmNzhjYjViOTk0YzJmYjU5OGRfNDczNg_91a2c218-38f2-4fa0-8d08-0e208feddf71">three-year</ix:nonNumeric> performance period after the date of grant. Market and performance-based share awards that are tied to the Company&#8217;s TSR are valued using the Monte Carlo method and are recognized ratably as expense over the award&#8217;s performance period. The fair value of the performance-based share awards is equal to the market price of the Company&#8217;s common stock on the date of grant adjusted by expected level of achievement over the performance period. Expense for performance-based share awards is amortized ratably over the performance period.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Share-based compensation expense is recorded in selling, general, and administrative expense in the accompanying Condensed Consolidated Statements of Income. <ix:nonNumeric contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930" name="us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RleHRyZWdpb246ZTVhOGVlNTZmNGM1NDhmNzhjYjViOTk0YzJmYjU5OGRfNDczMg_24f29885-14ed-4fe7-8917-d0007f1770fd" continuedAt="icb9d396c0f134265ab4e3f76b05c051d" escape="true">The total expenses during the three months ended September 30, 2022 and 2021 are as follows (in thousands):</ix:nonNumeric></span></div><div style="margin-top:12pt"><ix:continuation id="icb9d396c0f134265ab4e3f76b05c051d" continuedAt="i18798ac1534d4a39bf77c8378c986132"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.268%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.623%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Three months ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">2022</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Shares</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Share-Based Compensation Expense</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Shares</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Share-Based Compensation Expense</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Options and restricted stock</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibadc66af627d4a50adc5b6a3602689c5_D20220701-20220930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RhYmxlOmFhMDU2MTczZDc1ZTQwZjNhZjUzZWYwYzZhYzdlODAzL3RhYmxlcmFuZ2U6YWEwNTYxNzNkNzVlNDBmM2FmNTNlZjBjNmFjN2U4MDNfMy0xLTEtMS00Mjc5Mg_74d3f8dc-5579-411b-94d5-2b256cef64e9">90</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibadc66af627d4a50adc5b6a3602689c5_D20220701-20220930" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RhYmxlOmFhMDU2MTczZDc1ZTQwZjNhZjUzZWYwYzZhYzdlODAzL3RhYmxlcmFuZ2U6YWEwNTYxNzNkNzVlNDBmM2FmNTNlZjBjNmFjN2U4MDNfMy0zLTEtMS00Mjc5Mg_97e8f84e-253d-4046-9a38-ac390e9a7733">1,392</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i12f18bce76824fa181f9d54c1673be9d_D20210701-20210930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RhYmxlOmFhMDU2MTczZDc1ZTQwZjNhZjUzZWYwYzZhYzdlODAzL3RhYmxlcmFuZ2U6YWEwNTYxNzNkNzVlNDBmM2FmNTNlZjBjNmFjN2U4MDNfMy01LTEtMS00Mjc5Mg_5f5c26c5-df83-44d5-a947-c77e02441358">89</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12f18bce76824fa181f9d54c1673be9d_D20210701-20210930" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RhYmxlOmFhMDU2MTczZDc1ZTQwZjNhZjUzZWYwYzZhYzdlODAzL3RhYmxlcmFuZ2U6YWEwNTYxNzNkNzVlNDBmM2FmNTNlZjBjNmFjN2U4MDNfMy03LTEtMS00Mjc5Mg_380348b6-98f8-491a-86f7-1399e44da202">1,116</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Market and performance-based share awards granted in 2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i95d94f4202144399b49c964c8368ac37_D20220701-20220930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RhYmxlOmFhMDU2MTczZDc1ZTQwZjNhZjUzZWYwYzZhYzdlODAzL3RhYmxlcmFuZ2U6YWEwNTYxNzNkNzVlNDBmM2FmNTNlZjBjNmFjN2U4MDNfNC0xLTEtMS00Mjc5Mg_a0f6dc91-90ad-4a0d-9ef2-cde42a9f8544">25</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95d94f4202144399b49c964c8368ac37_D20220701-20220930" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RhYmxlOmFhMDU2MTczZDc1ZTQwZjNhZjUzZWYwYzZhYzdlODAzL3RhYmxlcmFuZ2U6YWEwNTYxNzNkNzVlNDBmM2FmNTNlZjBjNmFjN2U4MDNfNC0zLTEtMS00Mjc5Mg_5cee9fac-75c5-4cec-a15d-a528a103cd9a">438</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0901c79f16de41bea38c2f269bd6bd08_D20210701-20210930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RhYmxlOmFhMDU2MTczZDc1ZTQwZjNhZjUzZWYwYzZhYzdlODAzL3RhYmxlcmFuZ2U6YWEwNTYxNzNkNzVlNDBmM2FmNTNlZjBjNmFjN2U4MDNfNC01LTEtMS00Mjc5Mg_d3873803-d82e-4fc9-bf19-d1715f4cff2a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0901c79f16de41bea38c2f269bd6bd08_D20210701-20210930" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RhYmxlOmFhMDU2MTczZDc1ZTQwZjNhZjUzZWYwYzZhYzdlODAzL3RhYmxlcmFuZ2U6YWEwNTYxNzNkNzVlNDBmM2FmNTNlZjBjNmFjN2U4MDNfNC03LTEtMS00Mjc5Mg_bfda1a8e-08f8-4853-a5dc-de437b80fb07">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Performance-based share awards granted in 2021</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0a41616804a64fe39e2eb14b59e5df17_D20220701-20220930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RhYmxlOmFhMDU2MTczZDc1ZTQwZjNhZjUzZWYwYzZhYzdlODAzL3RhYmxlcmFuZ2U6YWEwNTYxNzNkNzVlNDBmM2FmNTNlZjBjNmFjN2U4MDNfNS0xLTEtMS00Mjc5Mg_3380fd8c-4e19-4276-a55c-8fed064a08c3">15</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a41616804a64fe39e2eb14b59e5df17_D20220701-20220930" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RhYmxlOmFhMDU2MTczZDc1ZTQwZjNhZjUzZWYwYzZhYzdlODAzL3RhYmxlcmFuZ2U6YWEwNTYxNzNkNzVlNDBmM2FmNTNlZjBjNmFjN2U4MDNfNS0zLTEtMS00Mjc5Mg_0eb3e3a6-1efe-451d-bb25-3bd18d1b720a">654</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie5d960394d1f4239b6b22f78b99ccbfd_D20210701-20210930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RhYmxlOmFhMDU2MTczZDc1ZTQwZjNhZjUzZWYwYzZhYzdlODAzL3RhYmxlcmFuZ2U6YWEwNTYxNzNkNzVlNDBmM2FmNTNlZjBjNmFjN2U4MDNfNS01LTEtMS00Mjc5Mg_14202fa6-3e4a-4bef-a3e9-d86163ddf547">14</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5d960394d1f4239b6b22f78b99ccbfd_D20210701-20210930" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RhYmxlOmFhMDU2MTczZDc1ZTQwZjNhZjUzZWYwYzZhYzdlODAzL3RhYmxlcmFuZ2U6YWEwNTYxNzNkNzVlNDBmM2FmNTNlZjBjNmFjN2U4MDNfNS03LTEtMS00Mjc5Mg_26649ef7-6e2c-4511-8ef6-56d1d39bdb3b">309</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Performance-based share awards granted in 2020</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia7b71491bfda423a9b849e5ba3c9591d_D20220701-20220930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RhYmxlOmFhMDU2MTczZDc1ZTQwZjNhZjUzZWYwYzZhYzdlODAzL3RhYmxlcmFuZ2U6YWEwNTYxNzNkNzVlNDBmM2FmNTNlZjBjNmFjN2U4MDNfNi0xLTEtMS00Mjc5Mg_fc8828a6-b45d-4f4a-a6e6-e8140a724959">26</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7b71491bfda423a9b849e5ba3c9591d_D20220701-20220930" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RhYmxlOmFhMDU2MTczZDc1ZTQwZjNhZjUzZWYwYzZhYzdlODAzL3RhYmxlcmFuZ2U6YWEwNTYxNzNkNzVlNDBmM2FmNTNlZjBjNmFjN2U4MDNfNi0zLTEtMS00Mjc5Mg_7c21ac31-b22d-4b0c-a052-179bdf645c58">479</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i840318db555b44f1929d580be8e92f97_D20210701-20210930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RhYmxlOmFhMDU2MTczZDc1ZTQwZjNhZjUzZWYwYzZhYzdlODAzL3RhYmxlcmFuZ2U6YWEwNTYxNzNkNzVlNDBmM2FmNTNlZjBjNmFjN2U4MDNfNi01LTEtMS00Mjc5Mg_130ab120-5903-4433-9779-48080564ab77">26</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i840318db555b44f1929d580be8e92f97_D20210701-20210930" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RhYmxlOmFhMDU2MTczZDc1ZTQwZjNhZjUzZWYwYzZhYzdlODAzL3RhYmxlcmFuZ2U6YWEwNTYxNzNkNzVlNDBmM2FmNTNlZjBjNmFjN2U4MDNfNi03LTEtMS00Mjc5Mg_a622c4f7-0ae6-4342-85f5-301a92fec8b0">479</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Performance-based share awards granted in 2019</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i86506a2c9bb242aab0a78a2c5c61556e_D20220701-20220930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RhYmxlOmFhMDU2MTczZDc1ZTQwZjNhZjUzZWYwYzZhYzdlODAzL3RhYmxlcmFuZ2U6YWEwNTYxNzNkNzVlNDBmM2FmNTNlZjBjNmFjN2U4MDNfNy0xLTEtMS00Mjc5Mg_2abb1fa7-1210-4571-a729-544dc7ac5646">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i86506a2c9bb242aab0a78a2c5c61556e_D20220701-20220930" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RhYmxlOmFhMDU2MTczZDc1ZTQwZjNhZjUzZWYwYzZhYzdlODAzL3RhYmxlcmFuZ2U6YWEwNTYxNzNkNzVlNDBmM2FmNTNlZjBjNmFjN2U4MDNfNy0zLTEtMS00Mjc5Mg_b7be531c-39bf-4e12-b982-8ab0d628f9b2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9f1fb4440c1a44f78177fa769579f56b_D20210701-20210930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RhYmxlOmFhMDU2MTczZDc1ZTQwZjNhZjUzZWYwYzZhYzdlODAzL3RhYmxlcmFuZ2U6YWEwNTYxNzNkNzVlNDBmM2FmNTNlZjBjNmFjN2U4MDNfNy01LTEtMS00Mjc5Mg_cc1d8700-fdfc-49e5-b771-65aa94ed97b6">16</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f1fb4440c1a44f78177fa769579f56b_D20210701-20210930" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RhYmxlOmFhMDU2MTczZDc1ZTQwZjNhZjUzZWYwYzZhYzdlODAzL3RhYmxlcmFuZ2U6YWEwNTYxNzNkNzVlNDBmM2FmNTNlZjBjNmFjN2U4MDNfNy03LTEtMS00Mjc5Mg_f734f226-d9c8-4610-86c1-cb4b71b93485">365</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total share-based compensation</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2f3a96a832ab4b0ca374599d1c3e9bce_D20220701-20220930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RhYmxlOmFhMDU2MTczZDc1ZTQwZjNhZjUzZWYwYzZhYzdlODAzL3RhYmxlcmFuZ2U6YWEwNTYxNzNkNzVlNDBmM2FmNTNlZjBjNmFjN2U4MDNfOC0xLTEtMS00Mjc5Mg_9611d214-eff9-4cc3-837b-a5c3cabf4226">156</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f3a96a832ab4b0ca374599d1c3e9bce_D20220701-20220930" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RhYmxlOmFhMDU2MTczZDc1ZTQwZjNhZjUzZWYwYzZhYzdlODAzL3RhYmxlcmFuZ2U6YWEwNTYxNzNkNzVlNDBmM2FmNTNlZjBjNmFjN2U4MDNfOC0zLTEtMS00Mjc5Mg_eafd2f69-954e-49d0-a76c-37bf08f6fa9d">2,963</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3bb5592686d74afab4f7004818fd6f9b_D20210701-20210930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RhYmxlOmFhMDU2MTczZDc1ZTQwZjNhZjUzZWYwYzZhYzdlODAzL3RhYmxlcmFuZ2U6YWEwNTYxNzNkNzVlNDBmM2FmNTNlZjBjNmFjN2U4MDNfOC01LTEtMS00Mjc5Mg_4edd1849-836d-4ae7-ad1e-d811cb2e6b5b">145</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bb5592686d74afab4f7004818fd6f9b_D20210701-20210930" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RhYmxlOmFhMDU2MTczZDc1ZTQwZjNhZjUzZWYwYzZhYzdlODAzL3RhYmxlcmFuZ2U6YWEwNTYxNzNkNzVlNDBmM2FmNTNlZjBjNmFjN2U4MDNfOC03LTEtMS00Mjc5Mg_e64431d2-7056-4317-9305-615e9de55ced">2,269</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div></ix:continuation><div style="margin-top:12pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:21.6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#ic8ae413b3ff34d56976502c585fa6ab3_7">Table of Contents</a></span></div></div><ix:continuation id="i5018b831a2ea42fcb41d3ff7ac17b0d2"><ix:continuation id="i18798ac1534d4a39bf77c8378c986132"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total expenses during the nine months ended September 30, 2022 and 2021 are as follows (in thousands):</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.268%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.623%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Nine months ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">2022</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Shares</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Share-Based Compensation Expense</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Shares</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Share-Based Compensation Expense</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Options and restricted stock</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic07f86d9e5da4afd87e67a65fb6f4791_D20220101-20220930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RhYmxlOjE4YjcxMDc0MDM5NzRhYWNiNzcxODY4YTFlOWJiMjE0L3RhYmxlcmFuZ2U6MThiNzEwNzQwMzk3NGFhY2I3NzE4NjhhMWU5YmIyMTRfMy0xLTEtMS00Mjc5Mg_05eafedb-7b5f-4137-bf14-35e24f98e956">90</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic07f86d9e5da4afd87e67a65fb6f4791_D20220101-20220930" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RhYmxlOjE4YjcxMDc0MDM5NzRhYWNiNzcxODY4YTFlOWJiMjE0L3RhYmxlcmFuZ2U6MThiNzEwNzQwMzk3NGFhY2I3NzE4NjhhMWU5YmIyMTRfMy0zLTEtMS00Mjc5Mg_0b9ba415-bf02-4521-bf51-6f0d3e0c5cf3">3,789</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie5f97af31c054e3788ba0bc81976a278_D20210101-20210930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RhYmxlOjE4YjcxMDc0MDM5NzRhYWNiNzcxODY4YTFlOWJiMjE0L3RhYmxlcmFuZ2U6MThiNzEwNzQwMzk3NGFhY2I3NzE4NjhhMWU5YmIyMTRfMy01LTEtMS00Mjc5Mg_e7467861-8212-45fe-bf60-5ba6f865e825">89</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5f97af31c054e3788ba0bc81976a278_D20210101-20210930" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RhYmxlOjE4YjcxMDc0MDM5NzRhYWNiNzcxODY4YTFlOWJiMjE0L3RhYmxlcmFuZ2U6MThiNzEwNzQwMzk3NGFhY2I3NzE4NjhhMWU5YmIyMTRfMy03LTEtMS00Mjc5Mg_86abb033-ff4a-415f-a320-e4146a1059f2">3,175</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Market and performance-based share awards granted in 2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="icf2b50e3ab554624b26461e34b8f1ca1_D20220101-20220930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RhYmxlOjE4YjcxMDc0MDM5NzRhYWNiNzcxODY4YTFlOWJiMjE0L3RhYmxlcmFuZ2U6MThiNzEwNzQwMzk3NGFhY2I3NzE4NjhhMWU5YmIyMTRfNC0xLTEtMS00Mjc5Mg_53ed1076-cfd9-44b5-adce-c3810b682b6d">25</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf2b50e3ab554624b26461e34b8f1ca1_D20220101-20220930" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RhYmxlOjE4YjcxMDc0MDM5NzRhYWNiNzcxODY4YTFlOWJiMjE0L3RhYmxlcmFuZ2U6MThiNzEwNzQwMzk3NGFhY2I3NzE4NjhhMWU5YmIyMTRfNC0zLTEtMS00Mjc5Mg_eefbe617-fa06-4d61-a6fe-8bbb64bb5942">950</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i69d71c00111f4c31a670e455a0400e4b_D20210101-20210930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RhYmxlOjE4YjcxMDc0MDM5NzRhYWNiNzcxODY4YTFlOWJiMjE0L3RhYmxlcmFuZ2U6MThiNzEwNzQwMzk3NGFhY2I3NzE4NjhhMWU5YmIyMTRfNC01LTEtMS00Mjc5Mg_39f341b3-0c69-4f28-83c9-2d0923740fa3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69d71c00111f4c31a670e455a0400e4b_D20210101-20210930" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RhYmxlOjE4YjcxMDc0MDM5NzRhYWNiNzcxODY4YTFlOWJiMjE0L3RhYmxlcmFuZ2U6MThiNzEwNzQwMzk3NGFhY2I3NzE4NjhhMWU5YmIyMTRfNC03LTEtMS00Mjc5Mg_d6c3fc8a-df55-4b63-ae9d-fc4bfef01d34">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Performance-based share awards granted in 2021</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8836599f5719436f91aef628c5b33be0_D20220101-20220930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RhYmxlOjE4YjcxMDc0MDM5NzRhYWNiNzcxODY4YTFlOWJiMjE0L3RhYmxlcmFuZ2U6MThiNzEwNzQwMzk3NGFhY2I3NzE4NjhhMWU5YmIyMTRfNS0xLTEtMS00Mjc5Mg_44b745e8-ae0a-4406-bb50-5e0d1ef063bd">15</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8836599f5719436f91aef628c5b33be0_D20220101-20220930" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RhYmxlOjE4YjcxMDc0MDM5NzRhYWNiNzcxODY4YTFlOWJiMjE0L3RhYmxlcmFuZ2U6MThiNzEwNzQwMzk3NGFhY2I3NzE4NjhhMWU5YmIyMTRfNS0zLTEtMS00Mjc5Mg_ced2c7b1-f208-4728-b6a9-82eeea7acba1">1,941</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if982f76b88b6470b88a0ed0c16c942e8_D20210101-20210930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RhYmxlOjE4YjcxMDc0MDM5NzRhYWNiNzcxODY4YTFlOWJiMjE0L3RhYmxlcmFuZ2U6MThiNzEwNzQwMzk3NGFhY2I3NzE4NjhhMWU5YmIyMTRfNS01LTEtMS00Mjc5Mg_d306dee7-5cf0-4aff-963b-48a5e757c7a3">14</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if982f76b88b6470b88a0ed0c16c942e8_D20210101-20210930" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RhYmxlOjE4YjcxMDc0MDM5NzRhYWNiNzcxODY4YTFlOWJiMjE0L3RhYmxlcmFuZ2U6MThiNzEwNzQwMzk3NGFhY2I3NzE4NjhhMWU5YmIyMTRfNS03LTEtMS00Mjc5Mg_f2e682f4-ecb9-4292-98ac-d483fd91a78f">666</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Performance-based share awards granted in 2020</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iaf70d20a80bb4d1aa9e3337f77338213_D20220101-20220930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RhYmxlOjE4YjcxMDc0MDM5NzRhYWNiNzcxODY4YTFlOWJiMjE0L3RhYmxlcmFuZ2U6MThiNzEwNzQwMzk3NGFhY2I3NzE4NjhhMWU5YmIyMTRfNi0xLTEtMS00Mjc5Mg_0eaaf040-9ee1-43c2-8239-c7d1fe405189">26</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf70d20a80bb4d1aa9e3337f77338213_D20220101-20220930" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RhYmxlOjE4YjcxMDc0MDM5NzRhYWNiNzcxODY4YTFlOWJiMjE0L3RhYmxlcmFuZ2U6MThiNzEwNzQwMzk3NGFhY2I3NzE4NjhhMWU5YmIyMTRfNi0zLTEtMS00Mjc5Mg_dfd7c578-2457-4489-b73b-95f1fddda9b0">1,423</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iec911248646e4fb08207555f658d9df7_D20210101-20210930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RhYmxlOjE4YjcxMDc0MDM5NzRhYWNiNzcxODY4YTFlOWJiMjE0L3RhYmxlcmFuZ2U6MThiNzEwNzQwMzk3NGFhY2I3NzE4NjhhMWU5YmIyMTRfNi01LTEtMS00Mjc5Mg_9eb5c25c-f2dd-452d-afe7-b60df9b48011">26</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec911248646e4fb08207555f658d9df7_D20210101-20210930" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RhYmxlOjE4YjcxMDc0MDM5NzRhYWNiNzcxODY4YTFlOWJiMjE0L3RhYmxlcmFuZ2U6MThiNzEwNzQwMzk3NGFhY2I3NzE4NjhhMWU5YmIyMTRfNi03LTEtMS00Mjc5Mg_7f57153f-7490-4b77-ad0c-cc5c4206be69">1,329</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Performance-based share awards granted in 2019</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2b5cd09c8d0d42ac95d3ad2f1003faf4_D20220101-20220930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RhYmxlOjE4YjcxMDc0MDM5NzRhYWNiNzcxODY4YTFlOWJiMjE0L3RhYmxlcmFuZ2U6MThiNzEwNzQwMzk3NGFhY2I3NzE4NjhhMWU5YmIyMTRfNy0xLTEtMS00Mjc5Mg_db694037-0e3f-4168-b558-74e7ac22db3e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b5cd09c8d0d42ac95d3ad2f1003faf4_D20220101-20220930" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RhYmxlOjE4YjcxMDc0MDM5NzRhYWNiNzcxODY4YTFlOWJiMjE0L3RhYmxlcmFuZ2U6MThiNzEwNzQwMzk3NGFhY2I3NzE4NjhhMWU5YmIyMTRfNy0zLTEtMS00Mjc5Mg_3616fdc3-4009-47d5-9c95-03a361818c4b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i22b57c2d55054a9da3152d65a3fac12e_D20210101-20210930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RhYmxlOjE4YjcxMDc0MDM5NzRhYWNiNzcxODY4YTFlOWJiMjE0L3RhYmxlcmFuZ2U6MThiNzEwNzQwMzk3NGFhY2I3NzE4NjhhMWU5YmIyMTRfNy01LTEtMS00Mjc5Mg_6e276cb5-4a38-4b40-8545-ace69c3b5a83">16</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22b57c2d55054a9da3152d65a3fac12e_D20210101-20210930" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RhYmxlOjE4YjcxMDc0MDM5NzRhYWNiNzcxODY4YTFlOWJiMjE0L3RhYmxlcmFuZ2U6MThiNzEwNzQwMzk3NGFhY2I3NzE4NjhhMWU5YmIyMTRfNy03LTEtMS00Mjc5Mg_86ff94f2-1a6a-4e01-bc96-15fe7f0701aa">1,443</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total share-based compensation</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RhYmxlOjE4YjcxMDc0MDM5NzRhYWNiNzcxODY4YTFlOWJiMjE0L3RhYmxlcmFuZ2U6MThiNzEwNzQwMzk3NGFhY2I3NzE4NjhhMWU5YmIyMTRfOC0xLTEtMS00Mjc5Mg_271fa0f8-3834-49dd-8a27-3fc41b1c1279">156</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RhYmxlOjE4YjcxMDc0MDM5NzRhYWNiNzcxODY4YTFlOWJiMjE0L3RhYmxlcmFuZ2U6MThiNzEwNzQwMzk3NGFhY2I3NzE4NjhhMWU5YmIyMTRfOC0zLTEtMS00Mjc5Mg_c829340d-8c45-4d1f-9b71-b06d5e63272e">8,103</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic431430d1ab24120b4507025a722d73a_D20210101-20210930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RhYmxlOjE4YjcxMDc0MDM5NzRhYWNiNzcxODY4YTFlOWJiMjE0L3RhYmxlcmFuZ2U6MThiNzEwNzQwMzk3NGFhY2I3NzE4NjhhMWU5YmIyMTRfOC01LTEtMS00Mjc5Mg_3c3184c0-70bd-4c68-bfcc-aaeaca2691bc">145</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic431430d1ab24120b4507025a722d73a_D20210101-20210930" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RhYmxlOjE4YjcxMDc0MDM5NzRhYWNiNzcxODY4YTFlOWJiMjE0L3RhYmxlcmFuZ2U6MThiNzEwNzQwMzk3NGFhY2I3NzE4NjhhMWU5YmIyMTRfOC03LTEtMS00Mjc5Mg_e7e529dd-a043-4f63-ae53-6c5955437aca">6,613</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total income tax benefit recognized in the accompanying Condensed Consolidated Statements of Income for restricted stock awards was </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="i0d192144959640fd8d222d1f8b709e6b_D20220701-20220930" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RleHRyZWdpb246ZTVhOGVlNTZmNGM1NDhmNzhjYjViOTk0YzJmYjU5OGRfNDI4MQ_7f2bc6f4-f92f-4d9b-8fef-30dc04cb3583">0.4</ix:nonFraction> million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and $<ix:nonFraction unitRef="usd" contextRef="i2fe34b3f982747e1929ba94579cd75e3_D20210701-20210930" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RleHRyZWdpb246ZTVhOGVlNTZmNGM1NDhmNzhjYjViOTk0YzJmYjU5OGRfNDI4OA_c1efa8b8-cd19-4e61-b758-6104aa873909">0.1</ix:nonFraction> million for the three months ended September 30, 2022 and 2021, respectively, and </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="id337c0920a144e0c91a6bed2853c1d7b_D20220101-20220930" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RleHRyZWdpb246ZTVhOGVlNTZmNGM1NDhmNzhjYjViOTk0YzJmYjU5OGRfNDMyOA_7c86e615-24e9-4ca5-adf7-06bf606f01a2">1.2</ix:nonFraction>&#160;million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and $<ix:nonFraction unitRef="usd" contextRef="if58da46cc9354a8eadc10f9e4f114ac2_D20210101-20210930" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RleHRyZWdpb246ZTVhOGVlNTZmNGM1NDhmNzhjYjViOTk0YzJmYjU5OGRfNDMzNQ_9c104a32-fb57-4972-999e-77b53b8a227d">2.3</ix:nonFraction>&#160;million for the nine months ended September 30, 2022 and 2021, respectively. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There was $<ix:nonFraction unitRef="usd" contextRef="iee1cf11574cc42609fde6f9c8aee4073_I20220930" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RleHRyZWdpb246ZTVhOGVlNTZmNGM1NDhmNzhjYjViOTk0YzJmYjU5OGRfNDM4Mg_05ec13d0-233b-4c43-bbf8-55c4093706dd">7.6</ix:nonFraction> million of total unrecognized compensation cost related to restricted stock awards as of <ix:nonNumeric contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RleHRyZWdpb246ZTVhOGVlNTZmNGM1NDhmNzhjYjViOTk0YzJmYjU5OGRfNDQ2Ng_75cfbe1e-17ec-4442-ae34-fd999dbe9ec2">September&#160;30, 2022</ix:nonNumeric>, which is expected to be recognized over a weighted-average period of <ix:nonNumeric contextRef="id337c0920a144e0c91a6bed2853c1d7b_D20220101-20220930" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:durmonth" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RleHRyZWdpb246ZTVhOGVlNTZmNGM1NDhmNzhjYjViOTk0YzJmYjU5OGRfNDUzOQ_ba454560-9be1-4ab3-8110-a966d950c4bc">23</ix:nonNumeric> months. There was $<ix:nonFraction unitRef="usd" contextRef="i6694abec73714bcba4d3d84d55594c48_I20220930" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RleHRyZWdpb246ZTVhOGVlNTZmNGM1NDhmNzhjYjViOTk0YzJmYjU5OGRfNDU1Mw_04b607cf-164f-40ac-a878-549300b59465">7.9</ix:nonFraction> million of unrecognized compensation costs related to the <ix:nonFraction unitRef="shares" contextRef="id883036fe81d4fbd9ce98760bd9584d6_D20220101-20220930" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RleHRyZWdpb246ZTVhOGVlNTZmNGM1NDhmNzhjYjViOTk0YzJmYjU5OGRfNDYwNg_6e3fca99-89bd-4dfd-b099-45b76fce9277">66</ix:nonFraction> thousand market and performance-based shares presented in the table above as of <ix:nonNumeric contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RleHRyZWdpb246ZTVhOGVlNTZmNGM1NDhmNzhjYjViOTk0YzJmYjU5OGRfNDY1Ng_75cfbe1e-17ec-4442-ae34-fd999dbe9ec2">September&#160;30, 2022</ix:nonNumeric>, which is expected to be recognized over a weighted-average period of <ix:nonNumeric contextRef="id883036fe81d4fbd9ce98760bd9584d6_D20220101-20220930" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:durmonth" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RleHRyZWdpb246ZTVhOGVlNTZmNGM1NDhmNzhjYjViOTk0YzJmYjU5OGRfNDcyOQ_5749dbf2-5c3f-4c2f-92f0-60ed344a2d64">23</ix:nonNumeric> months.</span></div></ix:continuation><div id="ic8ae413b3ff34d56976502c585fa6ab3_46"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5. <ix:nonNumeric contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930" name="us-gaap:LesseeOperatingLeasesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180Ni9mcmFnOjZjNzYyOWQ3ZTg4MTQ1MmVhNDBhY2E4OTgzMjc1ZWIxL3RleHRyZWdpb246NmM3NjI5ZDdlODgxNDUyZWE0MGFjYTg5ODMyNzVlYjFfMTM3OA_d300f593-e246-4781-b44c-bff7db94dfe7" continuedAt="i5c866b609ba24b228446e6c0699b7b2f" escape="true">LEASES</ix:nonNumeric></span></div><ix:continuation id="i5c866b609ba24b228446e6c0699b7b2f" continuedAt="i2c2d74ac02b149ecb827d13c1ac7445e"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Operating Leases</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has operating leases for office and warehouse space and certain equipment. In certain of the Company&#8217;s lease agreements, the rental payments are adjusted periodically based on defined terms within the lease. The Company did not have any finance leases as of <ix:nonNumeric contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180Ni9mcmFnOjZjNzYyOWQ3ZTg4MTQ1MmVhNDBhY2E4OTgzMjc1ZWIxL3RleHRyZWdpb246NmM3NjI5ZDdlODgxNDUyZWE0MGFjYTg5ODMyNzVlYjFfMzAy_75cfbe1e-17ec-4442-ae34-fd999dbe9ec2">September&#160;30, 2022</ix:nonNumeric> and 2021, respectively, or for the nine-month periods then ended, respectively.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our leases relating to office and warehouse space have lease terms of <ix:nonNumeric contextRef="ice458ff158834dc8b920eafada15a08c_I20220930" name="us-gaap:LesseeOperatingLeaseTermOfContract" format="ixt-sec:durmonth" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180Ni9mcmFnOjZjNzYyOWQ3ZTg4MTQ1MmVhNDBhY2E4OTgzMjc1ZWIxL3RleHRyZWdpb246NmM3NjI5ZDdlODgxNDUyZWE0MGFjYTg5ODMyNzVlYjFfNDQ1_931ba815-c75d-4474-8619-8d0002017107">18</ix:nonNumeric> months to <ix:nonNumeric contextRef="ic37ce3f978074bddbfb14a6e5f911b56_I20220930" name="us-gaap:LesseeOperatingLeaseTermOfContract" format="ixt-sec:durmonth" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180Ni9mcmFnOjZjNzYyOWQ3ZTg4MTQ1MmVhNDBhY2E4OTgzMjc1ZWIxL3RleHRyZWdpb246NmM3NjI5ZDdlODgxNDUyZWE0MGFjYTg5ODMyNzVlYjFfNDUx_86c8f90f-7672-4503-b4ab-0c0ac573e418">126</ix:nonNumeric> months. Our leases relating to equipment have lease terms of <ix:nonNumeric contextRef="i0399caeb91d24d5b95af603648d72cb4_I20220930" name="us-gaap:LesseeOperatingLeaseTermOfContract" format="ixt-sec:durmonth" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180Ni9mcmFnOjZjNzYyOWQ3ZTg4MTQ1MmVhNDBhY2E4OTgzMjc1ZWIxL3RleHRyZWdpb246NmM3NjI5ZDdlODgxNDUyZWE0MGFjYTg5ODMyNzVlYjFfNTA4_f23c619b-a95a-435d-9066-7e82f10241b8">24</ix:nonNumeric> months to <ix:nonNumeric contextRef="ie6bff7e9e26a4002b1c59b59832b37a2_I20220930" name="us-gaap:LesseeOperatingLeaseTermOfContract" format="ixt-sec:durmonth" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180Ni9mcmFnOjZjNzYyOWQ3ZTg4MTQ1MmVhNDBhY2E4OTgzMjc1ZWIxL3RleHRyZWdpb246NmM3NjI5ZDdlODgxNDUyZWE0MGFjYTg5ODMyNzVlYjFfNTE0_6adbd560-312d-4127-b1d0-207a0b8975fc">203</ix:nonNumeric> months, with certain of them having automatic renewal clauses.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s warehouse agreements also contain non-lease components, in the form of payments towards variable logistics services and labor charges, which the Company is obligated to pay based on the services consumed by it. Such amounts are not included in the measurement of the lease liability but are. recognized as expenses when they are incurred.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The operating lease expense was $<ix:nonFraction unitRef="usd" contextRef="i2f3a96a832ab4b0ca374599d1c3e9bce_D20220701-20220930" decimals="-5" name="us-gaap:OperatingLeaseExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180Ni9mcmFnOjZjNzYyOWQ3ZTg4MTQ1MmVhNDBhY2E4OTgzMjc1ZWIxL3RleHRyZWdpb246NmM3NjI5ZDdlODgxNDUyZWE0MGFjYTg5ODMyNzVlYjFfOTU3_6f60918e-68ab-4d6e-aef2-685b3ede1225">1.7</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i3bb5592686d74afab4f7004818fd6f9b_D20210701-20210930" decimals="-5" name="us-gaap:OperatingLeaseExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180Ni9mcmFnOjZjNzYyOWQ3ZTg4MTQ1MmVhNDBhY2E4OTgzMjc1ZWIxL3RleHRyZWdpb246NmM3NjI5ZDdlODgxNDUyZWE0MGFjYTg5ODMyNzVlYjFfOTY0_6c117fb5-7362-43d4-8b33-6af74d75c936">1.4</ix:nonFraction>&#160;million for the three months ended September 30, 2022 and 2021, respectively, and $<ix:nonFraction unitRef="usd" contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930" decimals="-5" name="us-gaap:OperatingLeaseExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180Ni9mcmFnOjZjNzYyOWQ3ZTg4MTQ1MmVhNDBhY2E4OTgzMjc1ZWIxL3RleHRyZWdpb246NmM3NjI5ZDdlODgxNDUyZWE0MGFjYTg5ODMyNzVlYjFfMTAwNA_026471a8-44f3-4b39-9aee-719d567cdbbf">5.2</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ic431430d1ab24120b4507025a722d73a_D20210101-20210930" decimals="-5" name="us-gaap:OperatingLeaseExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180Ni9mcmFnOjZjNzYyOWQ3ZTg4MTQ1MmVhNDBhY2E4OTgzMjc1ZWIxL3RleHRyZWdpb246NmM3NjI5ZDdlODgxNDUyZWE0MGFjYTg5ODMyNzVlYjFfMTAxMQ_b6cf2386-e622-427f-a464-87f2d4404f89">3.8</ix:nonFraction> million for the nine months ended September 30, 2022 and 2021, respectively.</span></div><ix:nonNumeric contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930" name="us-gaap:LeaseCostTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180Ni9mcmFnOjZjNzYyOWQ3ZTg4MTQ1MmVhNDBhY2E4OTgzMjc1ZWIxL3RleHRyZWdpb246NmM3NjI5ZDdlODgxNDUyZWE0MGFjYTg5ODMyNzVlYjFfMTM3Ng_fdeba23f-6724-4a55-8e5b-74f7e40761b0" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental cash flow information related to the Company&#8217;s operating leases was as follows (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.245%"><tr><td style="width:1.0%"></td><td style="width:63.780%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.905%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.395%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.420%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Nine months ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Cash paid for amounts included in the measurements of lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Operating cash flow used in operating leases</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930" decimals="-3" name="us-gaap:OperatingLeasePayments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180Ni9mcmFnOjZjNzYyOWQ3ZTg4MTQ1MmVhNDBhY2E4OTgzMjc1ZWIxL3RhYmxlOjRmMDc1MzA0YzljMjRlYjQ5NjI1ZGY4NzQwMDNlYjNjL3RhYmxlcmFuZ2U6NGYwNzUzMDRjOWMyNGViNDk2MjVkZjg3NDAwM2ViM2NfNC0xLTEtMS00Mjc5Mg_5bcb3fa4-989c-484d-b18d-eaf41724e9e5">5,413</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic431430d1ab24120b4507025a722d73a_D20210101-20210930" decimals="-3" name="us-gaap:OperatingLeasePayments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180Ni9mcmFnOjZjNzYyOWQ3ZTg4MTQ1MmVhNDBhY2E4OTgzMjc1ZWIxL3RhYmxlOjRmMDc1MzA0YzljMjRlYjQ5NjI1ZGY4NzQwMDNlYjNjL3RhYmxlcmFuZ2U6NGYwNzUzMDRjOWMyNGViNDk2MjVkZjg3NDAwM2ViM2NfNC0zLTEtMS00Mjc5Mg_b7cb3856-6b8b-4852-80e2-336977a9295d">3,175</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Right-of-use assets obtained in exchange for lease obligations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Operating leases</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930" decimals="-3" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180Ni9mcmFnOjZjNzYyOWQ3ZTg4MTQ1MmVhNDBhY2E4OTgzMjc1ZWIxL3RhYmxlOjRmMDc1MzA0YzljMjRlYjQ5NjI1ZGY4NzQwMDNlYjNjL3RhYmxlcmFuZ2U6NGYwNzUzMDRjOWMyNGViNDk2MjVkZjg3NDAwM2ViM2NfNy0xLTEtMS00Mjc5Mg_ec6a4ceb-ad03-4661-a647-02a63fb32e1c">103</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic431430d1ab24120b4507025a722d73a_D20210101-20210930" decimals="-3" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180Ni9mcmFnOjZjNzYyOWQ3ZTg4MTQ1MmVhNDBhY2E4OTgzMjc1ZWIxL3RhYmxlOjRmMDc1MzA0YzljMjRlYjQ5NjI1ZGY4NzQwMDNlYjNjL3RhYmxlcmFuZ2U6NGYwNzUzMDRjOWMyNGViNDk2MjVkZjg3NDAwM2ViM2NfNy0zLTEtMS00Mjc5Mg_e2db2261-a90a-4da4-8ced-a83e9ead9420">9,745</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of <ix:nonNumeric contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180Ni9mcmFnOjZjNzYyOWQ3ZTg4MTQ1MmVhNDBhY2E4OTgzMjc1ZWIxL3RleHRyZWdpb246NmM3NjI5ZDdlODgxNDUyZWE0MGFjYTg5ODMyNzVlYjFfMTE2Mw_75cfbe1e-17ec-4442-ae34-fd999dbe9ec2">September&#160;30, 2022</ix:nonNumeric>, the weighted average remaining lease term was <ix:nonNumeric contextRef="i5de311f5948148cda49342e2cea83715_I20220930" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:durmonth" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180Ni9mcmFnOjZjNzYyOWQ3ZTg4MTQ1MmVhNDBhY2E4OTgzMjc1ZWIxL3RleHRyZWdpb246NmM3NjI5ZDdlODgxNDUyZWE0MGFjYTg5ODMyNzVlYjFfMTIxMw_ab063b99-9764-44e1-a343-051c68d4d732">60</ix:nonNumeric> months and the weighted average discount rate was <ix:nonFraction unitRef="number" contextRef="i5de311f5948148cda49342e2cea83715_I20220930" decimals="3" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180Ni9mcmFnOjZjNzYyOWQ3ZTg4MTQ1MmVhNDBhY2E4OTgzMjc1ZWIxL3RleHRyZWdpb246NmM3NjI5ZDdlODgxNDUyZWE0MGFjYTg5ODMyNzVlYjFfMTI1OQ_c67727b8-87c4-4888-8e7b-48c6b758034b">2.1</ix:nonFraction>%.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:21.6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#ic8ae413b3ff34d56976502c585fa6ab3_7">Table of Contents</a></span></div></div><ix:continuation id="i2c2d74ac02b149ecb827d13c1ac7445e"><ix:nonNumeric contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180Ni9mcmFnOjZjNzYyOWQ3ZTg4MTQ1MmVhNDBhY2E4OTgzMjc1ZWIxL3RleHRyZWdpb246NmM3NjI5ZDdlODgxNDUyZWE0MGFjYTg5ODMyNzVlYjFfMTM3Nw_6c69329f-61ea-4de2-9569-fb421b80fd67" escape="true"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the maturity of the Company&#8217;s operating lease liabilities as of <ix:nonNumeric contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180Ni9mcmFnOjZjNzYyOWQ3ZTg4MTQ1MmVhNDBhY2E4OTgzMjc1ZWIxL3RleHRyZWdpb246NmM3NjI5ZDdlODgxNDUyZWE0MGFjYTg5ODMyNzVlYjFfMTM1Ng_75cfbe1e-17ec-4442-ae34-fd999dbe9ec2">September&#160;30, 2022</ix:nonNumeric> (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.660%"><tr><td style="width:1.0%"></td><td style="width:81.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.415%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">2022 (excluding the nine months ended <ix:nonNumeric contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180Ni9mcmFnOjZjNzYyOWQ3ZTg4MTQ1MmVhNDBhY2E4OTgzMjc1ZWIxL3RhYmxlOjgwNTVlOTdiYTU1ODQ3NDFhNjZlMGU2ODNmOTY5NjA3L3RhYmxlcmFuZ2U6ODA1NWU5N2JhNTU4NDc0MWE2NmUwZTY4M2Y5Njk2MDdfMC0wLTEtMS00Mjc5Mi90ZXh0cmVnaW9uOmRmOGZkODZlMDg3OTQ1NmQ5NTBkNDYxOGI2NGZhMzNiXzM5_75cfbe1e-17ec-4442-ae34-fd999dbe9ec2">September&#160;30, 2022</ix:nonNumeric>)</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5de311f5948148cda49342e2cea83715_I20220930" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180Ni9mcmFnOjZjNzYyOWQ3ZTg4MTQ1MmVhNDBhY2E4OTgzMjc1ZWIxL3RhYmxlOjgwNTVlOTdiYTU1ODQ3NDFhNjZlMGU2ODNmOTY5NjA3L3RhYmxlcmFuZ2U6ODA1NWU5N2JhNTU4NDc0MWE2NmUwZTY4M2Y5Njk2MDdfMC0xLTEtMS00Mjc5Mg_2a6fe753-6ad6-4de2-a39c-19af125669a8">1,787</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5de311f5948148cda49342e2cea83715_I20220930" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180Ni9mcmFnOjZjNzYyOWQ3ZTg4MTQ1MmVhNDBhY2E4OTgzMjc1ZWIxL3RhYmxlOjgwNTVlOTdiYTU1ODQ3NDFhNjZlMGU2ODNmOTY5NjA3L3RhYmxlcmFuZ2U6ODA1NWU5N2JhNTU4NDc0MWE2NmUwZTY4M2Y5Njk2MDdfMS0xLTEtMS00Mjc5Mg_c02ed2fc-a1e9-46af-85d8-c47727858094">6,241</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5de311f5948148cda49342e2cea83715_I20220930" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180Ni9mcmFnOjZjNzYyOWQ3ZTg4MTQ1MmVhNDBhY2E4OTgzMjc1ZWIxL3RhYmxlOjgwNTVlOTdiYTU1ODQ3NDFhNjZlMGU2ODNmOTY5NjA3L3RhYmxlcmFuZ2U6ODA1NWU5N2JhNTU4NDc0MWE2NmUwZTY4M2Y5Njk2MDdfMi0xLTEtMS00Mjc5Mg_15d49a83-3962-4cc0-bf4e-31075fe9235f">5,693</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5de311f5948148cda49342e2cea83715_I20220930" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180Ni9mcmFnOjZjNzYyOWQ3ZTg4MTQ1MmVhNDBhY2E4OTgzMjc1ZWIxL3RhYmxlOjgwNTVlOTdiYTU1ODQ3NDFhNjZlMGU2ODNmOTY5NjA3L3RhYmxlcmFuZ2U6ODA1NWU5N2JhNTU4NDc0MWE2NmUwZTY4M2Y5Njk2MDdfMy0xLTEtMS00Mjc5Mg_80fe46ce-c601-4e6a-93d0-fe61d33599a0">5,825</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5de311f5948148cda49342e2cea83715_I20220930" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180Ni9mcmFnOjZjNzYyOWQ3ZTg4MTQ1MmVhNDBhY2E4OTgzMjc1ZWIxL3RhYmxlOjgwNTVlOTdiYTU1ODQ3NDFhNjZlMGU2ODNmOTY5NjA3L3RhYmxlcmFuZ2U6ODA1NWU5N2JhNTU4NDc0MWE2NmUwZTY4M2Y5Njk2MDdfNC0xLTEtMS00Mjc5Mg_6bdc1fc0-7bd6-41cf-983e-2d621fb0888a">4,160</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5de311f5948148cda49342e2cea83715_I20220930" decimals="-3" name="med:LesseeOperatingLeaseLiabilityPaymentsDueYearFiveAndAfterYearFive" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180Ni9mcmFnOjZjNzYyOWQ3ZTg4MTQ1MmVhNDBhY2E4OTgzMjc1ZWIxL3RhYmxlOjgwNTVlOTdiYTU1ODQ3NDFhNjZlMGU2ODNmOTY5NjA3L3RhYmxlcmFuZ2U6ODA1NWU5N2JhNTU4NDc0MWE2NmUwZTY4M2Y5Njk2MDdfNS0xLTEtMS00Mjc5Mg_45bbe327-3469-4a4d-85b3-3d2a055803f8">5,412</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Total lease payments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5de311f5948148cda49342e2cea83715_I20220930" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180Ni9mcmFnOjZjNzYyOWQ3ZTg4MTQ1MmVhNDBhY2E4OTgzMjc1ZWIxL3RhYmxlOjgwNTVlOTdiYTU1ODQ3NDFhNjZlMGU2ODNmOTY5NjA3L3RhYmxlcmFuZ2U6ODA1NWU5N2JhNTU4NDc0MWE2NmUwZTY4M2Y5Njk2MDdfNi0xLTEtMS00Mjc5Mg_0bd10d80-cfd8-4945-a0fa-bdd198b5a630">29,118</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Less: imputed interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5de311f5948148cda49342e2cea83715_I20220930" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180Ni9mcmFnOjZjNzYyOWQ3ZTg4MTQ1MmVhNDBhY2E4OTgzMjc1ZWIxL3RhYmxlOjgwNTVlOTdiYTU1ODQ3NDFhNjZlMGU2ODNmOTY5NjA3L3RhYmxlcmFuZ2U6ODA1NWU5N2JhNTU4NDc0MWE2NmUwZTY4M2Y5Njk2MDdfNy0xLTEtMS00Mjc5Mg_44fd135a-1c48-4cb6-af9d-0b72c5f8d2be">1,418</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Total </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5de311f5948148cda49342e2cea83715_I20220930" decimals="-3" name="us-gaap:OperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180Ni9mcmFnOjZjNzYyOWQ3ZTg4MTQ1MmVhNDBhY2E4OTgzMjc1ZWIxL3RhYmxlOjgwNTVlOTdiYTU1ODQ3NDFhNjZlMGU2ODNmOTY5NjA3L3RhYmxlcmFuZ2U6ODA1NWU5N2JhNTU4NDc0MWE2NmUwZTY4M2Y5Njk2MDdfOC0xLTEtMS00Mjc5Mg_e924dfa4-f3e2-4742-9935-2b871ddff178">27,700</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div id="ic8ae413b3ff34d56976502c585fa6ab3_49"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6. <ix:nonNumeric contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930" name="us-gaap:ComprehensiveIncomeNoteTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180OS9mcmFnOjIwOGNhNTFjMWEzNTQyZjdiY2UzYWQ3NDNlY2FlZDQwL3RleHRyZWdpb246MjA4Y2E1MWMxYTM1NDJmN2JjZTNhZDc0M2VjYWVkNDBfMTgw_00dffdc8-348f-4f87-98b6-5620426cfffa" continuedAt="i66ee7436396645ab8fa58e8ac50ebdad" escape="true">ACCUMULATED OTHER COMPREHENSIVE INCOME</ix:nonNumeric></span></div><ix:continuation id="i66ee7436396645ab8fa58e8ac50ebdad"><ix:nonNumeric contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930" name="us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180OS9mcmFnOjIwOGNhNTFjMWEzNTQyZjdiY2UzYWQ3NDNlY2FlZDQwL3RleHRyZWdpb246MjA4Y2E1MWMxYTM1NDJmN2JjZTNhZDc0M2VjYWVkNDBfMTgx_6d87997c-5f1e-42ec-a010-223e889ffb55" escape="true"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the components of accumulated other comprehensive income, net of tax where applicable (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.345%"><tr><td style="width:1.0%"></td><td style="width:64.909%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.047%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.138%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180OS9mcmFnOjIwOGNhNTFjMWEzNTQyZjdiY2UzYWQ3NDNlY2FlZDQwL3RhYmxlOmZhZGMxM2Q5ZGZkNzQxMWVhYzY1YWUyYWY2ZmU5OTgwL3RhYmxlcmFuZ2U6ZmFkYzEzZDlkZmQ3NDExZWFjNjVhZTJhZjZmZTk5ODBfMC0xLTEtMS00Mjc5Mg_75cfbe1e-17ec-4442-ae34-fd999dbe9ec2">September 30,<br/>2022</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">December 31,<br/>2021</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Foreign currency translation</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9072f45fffaa474fb85e95c07d3eeec4_I20220930" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180OS9mcmFnOjIwOGNhNTFjMWEzNTQyZjdiY2UzYWQ3NDNlY2FlZDQwL3RhYmxlOmZhZGMxM2Q5ZGZkNzQxMWVhYzY1YWUyYWY2ZmU5OTgwL3RhYmxlcmFuZ2U6ZmFkYzEzZDlkZmQ3NDExZWFjNjVhZTJhZjZmZTk5ODBfMi0xLTEtMS00Mjc5Mg_ede97284-e5e5-4139-a4ef-b540f3a91984">391</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1f1d1f963874bf9a839c3e7d4c9af87_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180OS9mcmFnOjIwOGNhNTFjMWEzNTQyZjdiY2UzYWQ3NDNlY2FlZDQwL3RhYmxlOmZhZGMxM2Q5ZGZkNzQxMWVhYzY1YWUyYWY2ZmU5OTgwL3RhYmxlcmFuZ2U6ZmFkYzEzZDlkZmQ3NDExZWFjNjVhZTJhZjZmZTk5ODBfMi0zLTEtMS00Mjc5Mg_af67e46c-2083-49f3-bcb8-182eeed93fcd">90</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Unrealized gains on investment securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i097ff6133d214f6bb8b7dc45eed5eed7_I20220930" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180OS9mcmFnOjIwOGNhNTFjMWEzNTQyZjdiY2UzYWQ3NDNlY2FlZDQwL3RhYmxlOmZhZGMxM2Q5ZGZkNzQxMWVhYzY1YWUyYWY2ZmU5OTgwL3RhYmxlcmFuZ2U6ZmFkYzEzZDlkZmQ3NDExZWFjNjVhZTJhZjZmZTk5ODBfMy0xLTEtMS00Mjc5Mg_f5c7103e-4cb2-4d4e-b480-1316f5b61538">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8729459526e94e28ad22588635f7ca5e_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180OS9mcmFnOjIwOGNhNTFjMWEzNTQyZjdiY2UzYWQ3NDNlY2FlZDQwL3RhYmxlOmZhZGMxM2Q5ZGZkNzQxMWVhYzY1YWUyYWY2ZmU5OTgwL3RhYmxlcmFuZ2U6ZmFkYzEzZDlkZmQ3NDExZWFjNjVhZTJhZjZmZTk5ODBfMy0zLTEtMS00Mjc5Mg_184bf122-2a64-4df7-9669-868105e025b6">21</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Accumulated other comprehensive income</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4e37db708e64812ac81e983938b61df_I20220930" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180OS9mcmFnOjIwOGNhNTFjMWEzNTQyZjdiY2UzYWQ3NDNlY2FlZDQwL3RhYmxlOmZhZGMxM2Q5ZGZkNzQxMWVhYzY1YWUyYWY2ZmU5OTgwL3RhYmxlcmFuZ2U6ZmFkYzEzZDlkZmQ3NDExZWFjNjVhZTJhZjZmZTk5ODBfNC0xLTEtMS00Mjc5Mg_fcfee315-a02c-42c4-8496-fc18b6a2edcb">391</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id19243f3c67e4c9db2d2085c6f295c96_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180OS9mcmFnOjIwOGNhNTFjMWEzNTQyZjdiY2UzYWQ3NDNlY2FlZDQwL3RhYmxlOmZhZGMxM2Q5ZGZkNzQxMWVhYzY1YWUyYWY2ZmU5OTgwL3RhYmxlcmFuZ2U6ZmFkYzEzZDlkZmQ3NDExZWFjNjVhZTJhZjZmZTk5ODBfNC0zLTEtMS00Mjc5Mg_d4497dfb-d4f1-4373-a657-07e63b074de8">111</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div id="ic8ae413b3ff34d56976502c585fa6ab3_52"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">7. <ix:nonNumeric contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930" name="us-gaap:FinancialInstrumentsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM181Mi9mcmFnOmRiNzNlZjJjZDg0YzRhYzlhNDNiYTIzNmFkNTU3NDNiL3RleHRyZWdpb246ZGI3M2VmMmNkODRjNGFjOWE0M2JhMjM2YWQ1NTc0M2JfMTUxMA_44e3751a-24a0-4ee7-bea2-60c99280b9ef" continuedAt="i0a3919c1851c4ce78fb965b83762a12b" escape="true">FINANCIAL INSTRUMENTS</ix:nonNumeric></span></div><ix:continuation id="i0a3919c1851c4ce78fb965b83762a12b" continuedAt="i4dd1a449e8b340958efce7811823ff46"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain financial assets and liabilities are accounted for at fair value, which is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The following fair value hierarchy prioritizes the inputs used to measure fair value:</span></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 1 &#8211; Quoted prices are available in active markets for identical assets or liabilities as of the reporting date. Active markets are those in which transactions for the asset or liability occur in sufficient frequency and volume to provide pricing information on an ongoing basis.</span></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 2 &#8211; Pricing inputs are other than quoted prices in active markets included in Level 1, which are either directly or indirectly observable as of the reporting date. Level 2 includes those financial instruments that are valued using models or other valuation methodologies.</span></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 3 &#8211; Pricing inputs include significant inputs that are generally less observable from objective sources. These inputs may be used with internally developed methodologies that result in management&#8217;s best estimate of fair value from the perspective of a market participant.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:21.6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#ic8ae413b3ff34d56976502c585fa6ab3_7">Table of Contents</a></span></div></div><ix:continuation id="i4dd1a449e8b340958efce7811823ff46" continuedAt="i4510d749b9a34b6fa31662f964a45469"><ix:nonNumeric contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930" name="us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM181Mi9mcmFnOmRiNzNlZjJjZDg0YzRhYzlhNDNiYTIzNmFkNTU3NDNiL3RleHRyZWdpb246ZGI3M2VmMmNkODRjNGFjOWE0M2JhMjM2YWQ1NTc0M2JfMTUxMQ_24428ba5-d9ec-4c07-af93-045c570827c4" escape="true"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present the Company&#8217;s cash and financial assets that are measured at fair value on a recurring basis for each of the hierarchy levels (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:25.800%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.605%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM181Mi9mcmFnOmRiNzNlZjJjZDg0YzRhYzlhNDNiYTIzNmFkNTU3NDNiL3RhYmxlOjZlMmY0MTM2NDc5MTQyMGNhZjFjODNhN2E0Y2M0NjNjL3RhYmxlcmFuZ2U6NmUyZjQxMzY0NzkxNDIwY2FmMWM4M2E3YTRjYzQ2M2NfMC0xLTEtMS00Mjc5Mg_75cfbe1e-17ec-4442-ae34-fd999dbe9ec2">September 30, 2022</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Unrealized Gains</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Accrued Interest</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Estimated Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Cash &amp; Cash<br/>Equivalents</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Investment<br/>Securities</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Cash</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2441f967061c4361b6837702e3fee167_I20220930" decimals="-3" name="us-gaap:MarketableSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM181Mi9mcmFnOmRiNzNlZjJjZDg0YzRhYzlhNDNiYTIzNmFkNTU3NDNiL3RhYmxlOjZlMmY0MTM2NDc5MTQyMGNhZjFjODNhN2E0Y2M0NjNjL3RhYmxlcmFuZ2U6NmUyZjQxMzY0NzkxNDIwY2FmMWM4M2E3YTRjYzQ2M2NfMy0xLTEtMS00Mjc5Mg_90e400a4-988f-4755-9097-e079670cafa8">69,710</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2441f967061c4361b6837702e3fee167_I20220930" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM181Mi9mcmFnOmRiNzNlZjJjZDg0YzRhYzlhNDNiYTIzNmFkNTU3NDNiL3RhYmxlOjZlMmY0MTM2NDc5MTQyMGNhZjFjODNhN2E0Y2M0NjNjL3RhYmxlcmFuZ2U6NmUyZjQxMzY0NzkxNDIwY2FmMWM4M2E3YTRjYzQ2M2NfMy03LTEtMS00Mjc5Mg_ca5c02ea-b7dc-43fd-858b-b9592e72c4f6">69,710</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2441f967061c4361b6837702e3fee167_I20220930" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM181Mi9mcmFnOmRiNzNlZjJjZDg0YzRhYzlhNDNiYTIzNmFkNTU3NDNiL3RhYmxlOjZlMmY0MTM2NDc5MTQyMGNhZjFjODNhN2E0Y2M0NjNjL3RhYmxlcmFuZ2U6NmUyZjQxMzY0NzkxNDIwY2FmMWM4M2E3YTRjYzQ2M2NfMy05LTEtMS00Mjc5Mg_a4c5e897-7529-44fe-a9da-cf94da3300f3">69,710</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Level 1:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Money market accounts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea299389245a4a8b89c2066eaf7399d6_I20220930" decimals="-3" name="us-gaap:MarketableSecurities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM181Mi9mcmFnOmRiNzNlZjJjZDg0YzRhYzlhNDNiYTIzNmFkNTU3NDNiL3RhYmxlOjZlMmY0MTM2NDc5MTQyMGNhZjFjODNhN2E0Y2M0NjNjL3RhYmxlcmFuZ2U6NmUyZjQxMzY0NzkxNDIwY2FmMWM4M2E3YTRjYzQ2M2NfNi0xLTEtMS00Mjc5Mg_8da15f63-596c-49da-82da-cf643e196209">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea299389245a4a8b89c2066eaf7399d6_I20220930" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM181Mi9mcmFnOmRiNzNlZjJjZDg0YzRhYzlhNDNiYTIzNmFkNTU3NDNiL3RhYmxlOjZlMmY0MTM2NDc5MTQyMGNhZjFjODNhN2E0Y2M0NjNjL3RhYmxlcmFuZ2U6NmUyZjQxMzY0NzkxNDIwY2FmMWM4M2E3YTRjYzQ2M2NfNi03LTEtMS00Mjc5Mg_21e67820-0642-46a9-a110-89d4fe4890ab">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea299389245a4a8b89c2066eaf7399d6_I20220930" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM181Mi9mcmFnOmRiNzNlZjJjZDg0YzRhYzlhNDNiYTIzNmFkNTU3NDNiL3RhYmxlOjZlMmY0MTM2NDc5MTQyMGNhZjFjODNhN2E0Y2M0NjNjL3RhYmxlcmFuZ2U6NmUyZjQxMzY0NzkxNDIwY2FmMWM4M2E3YTRjYzQ2M2NfNi05LTEtMS00Mjc5Mg_92d5b9c1-d555-473b-90ff-a931091784c5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5de311f5948148cda49342e2cea83715_I20220930" decimals="-3" name="us-gaap:MarketableSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM181Mi9mcmFnOmRiNzNlZjJjZDg0YzRhYzlhNDNiYTIzNmFkNTU3NDNiL3RhYmxlOjZlMmY0MTM2NDc5MTQyMGNhZjFjODNhN2E0Y2M0NjNjL3RhYmxlcmFuZ2U6NmUyZjQxMzY0NzkxNDIwY2FmMWM4M2E3YTRjYzQ2M2NfMTMtMS0xLTEtNDI3OTI_0507db72-f148-4200-ba1c-71af0a8b35db">69,710</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930" decimals="-3" name="us-gaap:MarketableSecuritiesUnrealizedGainLoss" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM181Mi9mcmFnOmRiNzNlZjJjZDg0YzRhYzlhNDNiYTIzNmFkNTU3NDNiL3RhYmxlOjZlMmY0MTM2NDc5MTQyMGNhZjFjODNhN2E0Y2M0NjNjL3RhYmxlcmFuZ2U6NmUyZjQxMzY0NzkxNDIwY2FmMWM4M2E3YTRjYzQ2M2NfMTMtMy0xLTEtNDI3OTI_4efaf19f-83bf-4ecb-b082-fc2538b65672">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5de311f5948148cda49342e2cea83715_I20220930" decimals="-3" name="us-gaap:InterestReceivable" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM181Mi9mcmFnOmRiNzNlZjJjZDg0YzRhYzlhNDNiYTIzNmFkNTU3NDNiL3RhYmxlOjZlMmY0MTM2NDc5MTQyMGNhZjFjODNhN2E0Y2M0NjNjL3RhYmxlcmFuZ2U6NmUyZjQxMzY0NzkxNDIwY2FmMWM4M2E3YTRjYzQ2M2NfMTMtNS0xLTEtNDI3OTI_1e2b9dad-47ca-434d-9c87-7e42935703f9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5de311f5948148cda49342e2cea83715_I20220930" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM181Mi9mcmFnOmRiNzNlZjJjZDg0YzRhYzlhNDNiYTIzNmFkNTU3NDNiL3RhYmxlOjZlMmY0MTM2NDc5MTQyMGNhZjFjODNhN2E0Y2M0NjNjL3RhYmxlcmFuZ2U6NmUyZjQxMzY0NzkxNDIwY2FmMWM4M2E3YTRjYzQ2M2NfMTMtNy0xLTEtNDI3OTI_eac82e54-5a07-42dc-aaba-64e1cf44c727">69,710</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5de311f5948148cda49342e2cea83715_I20220930" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM181Mi9mcmFnOmRiNzNlZjJjZDg0YzRhYzlhNDNiYTIzNmFkNTU3NDNiL3RhYmxlOjZlMmY0MTM2NDc5MTQyMGNhZjFjODNhN2E0Y2M0NjNjL3RhYmxlcmFuZ2U6NmUyZjQxMzY0NzkxNDIwY2FmMWM4M2E3YTRjYzQ2M2NfMTMtOS0xLTEtNDI3OTI_fe8aaf5e-50f5-4b80-bfe6-2a6cd6d4303d">69,710</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5de311f5948148cda49342e2cea83715_I20220930" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM181Mi9mcmFnOmRiNzNlZjJjZDg0YzRhYzlhNDNiYTIzNmFkNTU3NDNiL3RhYmxlOjZlMmY0MTM2NDc5MTQyMGNhZjFjODNhN2E0Y2M0NjNjL3RhYmxlcmFuZ2U6NmUyZjQxMzY0NzkxNDIwY2FmMWM4M2E3YTRjYzQ2M2NfMTMtMTEtMS0xLTQyNzky_e7479859-ceaf-43b1-9523-ad1997e1bd76">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:25.800%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.605%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Unrealized Gains</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Accrued Interest</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Estimated Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Cash &amp; Cash<br/>Equivalents</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Investment<br/>Securities</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Cash</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ce2f0d8655c4a7da2f77d8aa8960f46_I20211231" decimals="-3" name="us-gaap:MarketableSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM181Mi9mcmFnOmRiNzNlZjJjZDg0YzRhYzlhNDNiYTIzNmFkNTU3NDNiL3RhYmxlOjU1YzA1N2VlYjgwNTQxN2ViYTgxYTBmMzRhZjM1N2NiL3RhYmxlcmFuZ2U6NTVjMDU3ZWViODA1NDE3ZWJhODFhMGYzNGFmMzU3Y2JfMy0xLTEtMS00Mjc5Mg_de71eada-1f44-49ff-9dfb-f8c7d58bb1fc">94,824</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ce2f0d8655c4a7da2f77d8aa8960f46_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM181Mi9mcmFnOmRiNzNlZjJjZDg0YzRhYzlhNDNiYTIzNmFkNTU3NDNiL3RhYmxlOjU1YzA1N2VlYjgwNTQxN2ViYTgxYTBmMzRhZjM1N2NiL3RhYmxlcmFuZ2U6NTVjMDU3ZWViODA1NDE3ZWJhODFhMGYzNGFmMzU3Y2JfMy03LTEtMS00Mjc5Mg_542807ab-e4ef-4834-974c-28e1ee576517">94,824</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ce2f0d8655c4a7da2f77d8aa8960f46_I20211231" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM181Mi9mcmFnOmRiNzNlZjJjZDg0YzRhYzlhNDNiYTIzNmFkNTU3NDNiL3RhYmxlOjU1YzA1N2VlYjgwNTQxN2ViYTgxYTBmMzRhZjM1N2NiL3RhYmxlcmFuZ2U6NTVjMDU3ZWViODA1NDE3ZWJhODFhMGYzNGFmMzU3Y2JfMy05LTEtMS00Mjc5Mg_1e848bd9-1f98-4c0c-b24c-e10537ceeac8">94,824</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Level 1:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Money market accounts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b9d5d43ca6d4d0a8b8eba73d75d9cd6_I20211231" decimals="-3" name="us-gaap:MarketableSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM181Mi9mcmFnOmRiNzNlZjJjZDg0YzRhYzlhNDNiYTIzNmFkNTU3NDNiL3RhYmxlOjU1YzA1N2VlYjgwNTQxN2ViYTgxYTBmMzRhZjM1N2NiL3RhYmxlcmFuZ2U6NTVjMDU3ZWViODA1NDE3ZWJhODFhMGYzNGFmMzU3Y2JfNi0xLTEtMS00Mjc5Mg_57cda507-3d91-43d1-ab7b-5b51179510b7">9,359</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b9d5d43ca6d4d0a8b8eba73d75d9cd6_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM181Mi9mcmFnOmRiNzNlZjJjZDg0YzRhYzlhNDNiYTIzNmFkNTU3NDNiL3RhYmxlOjU1YzA1N2VlYjgwNTQxN2ViYTgxYTBmMzRhZjM1N2NiL3RhYmxlcmFuZ2U6NTVjMDU3ZWViODA1NDE3ZWJhODFhMGYzNGFmMzU3Y2JfNi03LTEtMS00Mjc5Mg_e2f59884-cefa-4414-a660-4ab5871b61c7">9,359</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b9d5d43ca6d4d0a8b8eba73d75d9cd6_I20211231" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM181Mi9mcmFnOmRiNzNlZjJjZDg0YzRhYzlhNDNiYTIzNmFkNTU3NDNiL3RhYmxlOjU1YzA1N2VlYjgwNTQxN2ViYTgxYTBmMzRhZjM1N2NiL3RhYmxlcmFuZ2U6NTVjMDU3ZWViODA1NDE3ZWJhODFhMGYzNGFmMzU3Y2JfNi05LTEtMS00Mjc5Mg_45c2e1c6-e29b-41a0-9ed0-186004c67bd3">9,359</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Government &amp; agency securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8dd60027e0b14536ba3bfa6e34c9dfae_I20211231" decimals="-3" name="us-gaap:MarketableSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM181Mi9mcmFnOmRiNzNlZjJjZDg0YzRhYzlhNDNiYTIzNmFkNTU3NDNiL3RhYmxlOjU1YzA1N2VlYjgwNTQxN2ViYTgxYTBmMzRhZjM1N2NiL3RhYmxlcmFuZ2U6NTVjMDU3ZWViODA1NDE3ZWJhODFhMGYzNGFmMzU3Y2JfNy0xLTEtMS00Mjc5Mg_3ede47c1-d478-467d-bec2-24b39a1f1978">1,401</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23259e7a55774035a3ea3e0ab04e7338_D20210101-20211231" decimals="-3" name="us-gaap:MarketableSecuritiesUnrealizedGainLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM181Mi9mcmFnOmRiNzNlZjJjZDg0YzRhYzlhNDNiYTIzNmFkNTU3NDNiL3RhYmxlOjU1YzA1N2VlYjgwNTQxN2ViYTgxYTBmMzRhZjM1N2NiL3RhYmxlcmFuZ2U6NTVjMDU3ZWViODA1NDE3ZWJhODFhMGYzNGFmMzU3Y2JfNy0zLTEtMS00Mjc5Mg_50b0b8d8-3acc-454f-9e15-3f8c403743de">12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8dd60027e0b14536ba3bfa6e34c9dfae_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM181Mi9mcmFnOmRiNzNlZjJjZDg0YzRhYzlhNDNiYTIzNmFkNTU3NDNiL3RhYmxlOjU1YzA1N2VlYjgwNTQxN2ViYTgxYTBmMzRhZjM1N2NiL3RhYmxlcmFuZ2U6NTVjMDU3ZWViODA1NDE3ZWJhODFhMGYzNGFmMzU3Y2JfNy03LTEtMS00Mjc5Mg_c1a54c0a-b065-4946-b82b-04dbc36b469e">1,413</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8dd60027e0b14536ba3bfa6e34c9dfae_I20211231" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM181Mi9mcmFnOmRiNzNlZjJjZDg0YzRhYzlhNDNiYTIzNmFkNTU3NDNiL3RhYmxlOjU1YzA1N2VlYjgwNTQxN2ViYTgxYTBmMzRhZjM1N2NiL3RhYmxlcmFuZ2U6NTVjMDU3ZWViODA1NDE3ZWJhODFhMGYzNGFmMzU3Y2JfNy0xMS0xLTEtNDI3OTI_0c9d4b97-b789-40fc-8707-966c77b934b4">1,413</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if41dd7900bc54c728b2f679f78ab8cf8_I20211231" decimals="-3" name="us-gaap:MarketableSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM181Mi9mcmFnOmRiNzNlZjJjZDg0YzRhYzlhNDNiYTIzNmFkNTU3NDNiL3RhYmxlOjU1YzA1N2VlYjgwNTQxN2ViYTgxYTBmMzRhZjM1N2NiL3RhYmxlcmFuZ2U6NTVjMDU3ZWViODA1NDE3ZWJhODFhMGYzNGFmMzU3Y2JfOC0xLTEtMS00Mjc5Mg_7be77ad3-5acd-4708-8eb7-800db76352fc">10,760</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64b67de4322349efbcaab405308f4973_D20210101-20211231" decimals="-3" name="us-gaap:MarketableSecuritiesUnrealizedGainLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM181Mi9mcmFnOmRiNzNlZjJjZDg0YzRhYzlhNDNiYTIzNmFkNTU3NDNiL3RhYmxlOjU1YzA1N2VlYjgwNTQxN2ViYTgxYTBmMzRhZjM1N2NiL3RhYmxlcmFuZ2U6NTVjMDU3ZWViODA1NDE3ZWJhODFhMGYzNGFmMzU3Y2JfOC0zLTEtMS00Mjc5Mg_8987d768-931c-452f-8c41-3e3e06eb4f4b">12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if41dd7900bc54c728b2f679f78ab8cf8_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM181Mi9mcmFnOmRiNzNlZjJjZDg0YzRhYzlhNDNiYTIzNmFkNTU3NDNiL3RhYmxlOjU1YzA1N2VlYjgwNTQxN2ViYTgxYTBmMzRhZjM1N2NiL3RhYmxlcmFuZ2U6NTVjMDU3ZWViODA1NDE3ZWJhODFhMGYzNGFmMzU3Y2JfOC03LTEtMS00Mjc5Mg_f5e0d2a3-3124-4dbb-941e-6751dd9c3f9e">10,772</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if41dd7900bc54c728b2f679f78ab8cf8_I20211231" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM181Mi9mcmFnOmRiNzNlZjJjZDg0YzRhYzlhNDNiYTIzNmFkNTU3NDNiL3RhYmxlOjU1YzA1N2VlYjgwNTQxN2ViYTgxYTBmMzRhZjM1N2NiL3RhYmxlcmFuZ2U6NTVjMDU3ZWViODA1NDE3ZWJhODFhMGYzNGFmMzU3Y2JfOC05LTEtMS00Mjc5Mg_0e66d66d-cafb-4f1b-aaee-aa81c71584e2">9,359</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if41dd7900bc54c728b2f679f78ab8cf8_I20211231" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM181Mi9mcmFnOmRiNzNlZjJjZDg0YzRhYzlhNDNiYTIzNmFkNTU3NDNiL3RhYmxlOjU1YzA1N2VlYjgwNTQxN2ViYTgxYTBmMzRhZjM1N2NiL3RhYmxlcmFuZ2U6NTVjMDU3ZWViODA1NDE3ZWJhODFhMGYzNGFmMzU3Y2JfOC0xMS0xLTEtNDI3OTI_cfbcb98f-f458-4b03-a303-4e8c07c67091">1,413</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Level 2:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Municipal bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51ae42d5ac59407da626249ef44365c7_I20211231" decimals="-3" name="us-gaap:MarketableSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM181Mi9mcmFnOmRiNzNlZjJjZDg0YzRhYzlhNDNiYTIzNmFkNTU3NDNiL3RhYmxlOjU1YzA1N2VlYjgwNTQxN2ViYTgxYTBmMzRhZjM1N2NiL3RhYmxlcmFuZ2U6NTVjMDU3ZWViODA1NDE3ZWJhODFhMGYzNGFmMzU3Y2JfMTEtMS0xLTEtNDI3OTI_f2c4b5b2-cd52-417c-80b6-4ce6d296ac3a">3,880</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89429fed7a924252aaa74342106dea93_D20210101-20211231" decimals="-3" name="us-gaap:MarketableSecuritiesUnrealizedGainLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM181Mi9mcmFnOmRiNzNlZjJjZDg0YzRhYzlhNDNiYTIzNmFkNTU3NDNiL3RhYmxlOjU1YzA1N2VlYjgwNTQxN2ViYTgxYTBmMzRhZjM1N2NiL3RhYmxlcmFuZ2U6NTVjMDU3ZWViODA1NDE3ZWJhODFhMGYzNGFmMzU3Y2JfMTEtMy0xLTEtNDI3OTI_274ad5d2-eeac-4e63-a288-53103af5794e">9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51ae42d5ac59407da626249ef44365c7_I20211231" decimals="-3" name="us-gaap:InterestReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM181Mi9mcmFnOmRiNzNlZjJjZDg0YzRhYzlhNDNiYTIzNmFkNTU3NDNiL3RhYmxlOjU1YzA1N2VlYjgwNTQxN2ViYTgxYTBmMzRhZjM1N2NiL3RhYmxlcmFuZ2U6NTVjMDU3ZWViODA1NDE3ZWJhODFhMGYzNGFmMzU3Y2JfMTEtNS0xLTEtNDI3OTI_47f910b4-72f3-4caa-a139-e8b7e04c9f88">59</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51ae42d5ac59407da626249ef44365c7_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM181Mi9mcmFnOmRiNzNlZjJjZDg0YzRhYzlhNDNiYTIzNmFkNTU3NDNiL3RhYmxlOjU1YzA1N2VlYjgwNTQxN2ViYTgxYTBmMzRhZjM1N2NiL3RhYmxlcmFuZ2U6NTVjMDU3ZWViODA1NDE3ZWJhODFhMGYzNGFmMzU3Y2JfMTEtNy0xLTEtNDI3OTI_53056c29-04c7-4218-8780-d833a0d86afc">3,948</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51ae42d5ac59407da626249ef44365c7_I20211231" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM181Mi9mcmFnOmRiNzNlZjJjZDg0YzRhYzlhNDNiYTIzNmFkNTU3NDNiL3RhYmxlOjU1YzA1N2VlYjgwNTQxN2ViYTgxYTBmMzRhZjM1N2NiL3RhYmxlcmFuZ2U6NTVjMDU3ZWViODA1NDE3ZWJhODFhMGYzNGFmMzU3Y2JfMTEtMTEtMS0xLTQyNzky_313517a9-8a31-46c3-91eb-e79567b2e846">3,948</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Total</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47f09f18839440ffae0cf05a475aa7fe_I20211231" decimals="-3" name="us-gaap:MarketableSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM181Mi9mcmFnOmRiNzNlZjJjZDg0YzRhYzlhNDNiYTIzNmFkNTU3NDNiL3RhYmxlOjU1YzA1N2VlYjgwNTQxN2ViYTgxYTBmMzRhZjM1N2NiL3RhYmxlcmFuZ2U6NTVjMDU3ZWViODA1NDE3ZWJhODFhMGYzNGFmMzU3Y2JfMTMtMS0xLTEtNDI3OTI_94ccf7c7-1c45-4334-86c0-81c587e29245">109,464</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifaa46d08341a4f5db42a3cfd1e77e968_D20210101-20211231" decimals="-3" name="us-gaap:MarketableSecuritiesUnrealizedGainLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM181Mi9mcmFnOmRiNzNlZjJjZDg0YzRhYzlhNDNiYTIzNmFkNTU3NDNiL3RhYmxlOjU1YzA1N2VlYjgwNTQxN2ViYTgxYTBmMzRhZjM1N2NiL3RhYmxlcmFuZ2U6NTVjMDU3ZWViODA1NDE3ZWJhODFhMGYzNGFmMzU3Y2JfMTMtMy0xLTEtNDI3OTI_7b96912b-f804-40fe-8b5a-5c80a24d6b1d">21</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47f09f18839440ffae0cf05a475aa7fe_I20211231" decimals="-3" name="us-gaap:InterestReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM181Mi9mcmFnOmRiNzNlZjJjZDg0YzRhYzlhNDNiYTIzNmFkNTU3NDNiL3RhYmxlOjU1YzA1N2VlYjgwNTQxN2ViYTgxYTBmMzRhZjM1N2NiL3RhYmxlcmFuZ2U6NTVjMDU3ZWViODA1NDE3ZWJhODFhMGYzNGFmMzU3Y2JfMTMtNS0xLTEtNDI3OTI_7625e43b-55db-4922-a15d-5e395a1582dc">59</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47f09f18839440ffae0cf05a475aa7fe_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM181Mi9mcmFnOmRiNzNlZjJjZDg0YzRhYzlhNDNiYTIzNmFkNTU3NDNiL3RhYmxlOjU1YzA1N2VlYjgwNTQxN2ViYTgxYTBmMzRhZjM1N2NiL3RhYmxlcmFuZ2U6NTVjMDU3ZWViODA1NDE3ZWJhODFhMGYzNGFmMzU3Y2JfMTMtNy0xLTEtNDI3OTI_c48f4f76-1634-410d-a43b-c26fef844beb">109,544</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47f09f18839440ffae0cf05a475aa7fe_I20211231" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM181Mi9mcmFnOmRiNzNlZjJjZDg0YzRhYzlhNDNiYTIzNmFkNTU3NDNiL3RhYmxlOjU1YzA1N2VlYjgwNTQxN2ViYTgxYTBmMzRhZjM1N2NiL3RhYmxlcmFuZ2U6NTVjMDU3ZWViODA1NDE3ZWJhODFhMGYzNGFmMzU3Y2JfMTMtOS0xLTEtNDI3OTI_14304120-dea1-4d52-9d65-123a2e001074">104,183</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47f09f18839440ffae0cf05a475aa7fe_I20211231" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM181Mi9mcmFnOmRiNzNlZjJjZDg0YzRhYzlhNDNiYTIzNmFkNTU3NDNiL3RhYmxlOjU1YzA1N2VlYjgwNTQxN2ViYTgxYTBmMzRhZjM1N2NiL3RhYmxlcmFuZ2U6NTVjMDU3ZWViODA1NDE3ZWJhODFhMGYzNGFmMzU3Y2JfMTMtMTEtMS0xLTQyNzky_07897d3b-4feb-4f28-b536-df8058aad6c9">5,361</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"><ix:continuation id="i4510d749b9a34b6fa31662f964a45469">The Company had <ix:nonFraction unitRef="usd" contextRef="i2f3a96a832ab4b0ca374599d1c3e9bce_D20220701-20220930" decimals="-5" name="us-gaap:DebtAndEquitySecuritiesRealizedGainLoss" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM181Mi9mcmFnOmRiNzNlZjJjZDg0YzRhYzlhNDNiYTIzNmFkNTU3NDNiL3RleHRyZWdpb246ZGI3M2VmMmNkODRjNGFjOWE0M2JhMjM2YWQ1NTc0M2JfMzI5ODUzNDg4NTUwNQ_dcabff13-a4e1-4a66-b2dd-f4217c20d8a6">no</ix:nonFraction> realized gain or loss for the three months ended <ix:nonNumeric contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM181Mi9mcmFnOmRiNzNlZjJjZDg0YzRhYzlhNDNiYTIzNmFkNTU3NDNiL3RleHRyZWdpb246ZGI3M2VmMmNkODRjNGFjOWE0M2JhMjM2YWQ1NTc0M2JfMTQ0OQ_75cfbe1e-17ec-4442-ae34-fd999dbe9ec2">September&#160;30, 2022</ix:nonNumeric>. The company had a realized loss of $<ix:nonFraction unitRef="usd" contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930" decimals="-5" sign="-" name="us-gaap:DebtAndEquitySecuritiesRealizedGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM181Mi9mcmFnOmRiNzNlZjJjZDg0YzRhYzlhNDNiYTIzNmFkNTU3NDNiL3RleHRyZWdpb246ZGI3M2VmMmNkODRjNGFjOWE0M2JhMjM2YWQ1NTc0M2JfMzI5ODUzNDg4NTUwNw_c9eb2a5e-85b5-4915-bc59-5f8484c1b5d6">0.2</ix:nonFraction> million for the nine months ended September 30, 2022. There was <ix:nonFraction unitRef="usd" contextRef="i3bb5592686d74afab4f7004818fd6f9b_D20210701-20210930" decimals="INF" name="us-gaap:DebtAndEquitySecuritiesRealizedGainLoss" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM181Mi9mcmFnOmRiNzNlZjJjZDg0YzRhYzlhNDNiYTIzNmFkNTU3NDNiL3RleHRyZWdpb246ZGI3M2VmMmNkODRjNGFjOWE0M2JhMjM2YWQ1NTc0M2JfMTQ1Ng_0142c2a9-3775-4039-a0f6-ec597b132caa"><ix:nonFraction unitRef="usd" contextRef="ic431430d1ab24120b4507025a722d73a_D20210101-20210930" decimals="INF" name="us-gaap:DebtAndEquitySecuritiesRealizedGainLoss" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM181Mi9mcmFnOmRiNzNlZjJjZDg0YzRhYzlhNDNiYTIzNmFkNTU3NDNiL3RleHRyZWdpb246ZGI3M2VmMmNkODRjNGFjOWE0M2JhMjM2YWQ1NTc0M2JfMTQ1Ng_2f7c2163-8175-4d65-86bd-655c417c4561">no</ix:nonFraction></ix:nonFraction> realized gain or losses for the three and nine months ended September&#160;30, 2021.</ix:continuation> </span></div><div id="ic8ae413b3ff34d56976502c585fa6ab3_55"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">8. <ix:nonNumeric contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930" name="us-gaap:DebtDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM181NS9mcmFnOjFjMWU2MTk4MjE1NzRmNmJiNjU5YmU0YTI1ODljMjRkL3RleHRyZWdpb246MWMxZTYxOTgyMTU3NGY2YmI2NTliZTRhMjU4OWMyNGRfMzQ0MA_dc1f7c99-e347-49f6-8226-748f36a04323" continuedAt="ic89644e1ba9246a78c2babddced43c63" escape="true">DEBT</ix:nonNumeric></span></div><ix:continuation id="ic89644e1ba9246a78c2babddced43c63" continuedAt="i8e08aceebfd947eb9b1ea68dc0fa1b85"><div style="margin-top:12pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Credit Agreement</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On April&#160;13, 2021, the Company and certain of its subsidiaries (collectively, the &#8220;Guarantors&#8221;) entered into a credit agreement (the &#8220;Credit Agreement&#8221;) among the Company, the Guarantors, the lenders party thereto and Citibank, N.A., in its capacity as administrative agent. On May&#160;31, 2022, the Credit Agreement was amended to increase the borrowing capacity and convert the interest rate to be based on Secured Overnight Financing Rate (&#8220;SOFR&#8221;), from London Inter-Bank Offered Rate (LIBOR) (the &#8220;Amended Credit Agreement&#8221;).  The Amended Credit Agreement provides for a $<ix:nonFraction unitRef="usd" contextRef="ib975abad8363400482246009fad4070e_I20220531" decimals="-5" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM181NS9mcmFnOjFjMWU2MTk4MjE1NzRmNmJiNjU5YmU0YTI1ODljMjRkL3RleHRyZWdpb246MWMxZTYxOTgyMTU3NGY2YmI2NTliZTRhMjU4OWMyNGRfNTc3_96abdc8c-a3bb-4049-949e-31a99f5085e5">225.0</ix:nonFraction> million senior secured revolving credit facility with a $<ix:nonFraction unitRef="usd" contextRef="i9f7c21a6e6a1463a8de2e4295c68b795_I20220531" decimals="-5" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM181NS9mcmFnOjFjMWU2MTk4MjE1NzRmNmJiNjU5YmU0YTI1ODljMjRkL3RleHRyZWdpb246MWMxZTYxOTgyMTU3NGY2YmI2NTliZTRhMjU4OWMyNGRfNjI4_4a9ab666-e013-473a-9419-f67bdfcdf444">20.0</ix:nonFraction> million letter of credit sublimit. The Amended Credit Agreement also provides for an uncommitted incremental facility that permits the Company, subject to certain conditions, to increase the senior secured revolving credit facility by up to $<ix:nonFraction unitRef="usd" contextRef="i9f7c21a6e6a1463a8de2e4295c68b795_I20220531" decimals="-5" name="med:LineOfCreditFacilityAccordionFeatureIncreaseLimit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM181NS9mcmFnOjFjMWU2MTk4MjE1NzRmNmJiNjU5YmU0YTI1ODljMjRkL3RleHRyZWdpb246MWMxZTYxOTgyMTU3NGY2YmI2NTliZTRhMjU4OWMyNGRfODY0_6a7958c4-5708-4e65-b62c-5ffbead9bc1d">100.0</ix:nonFraction> million. The Amended Credit Agreement matures on April&#160;13, 2026.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s obligations under the Amended Credit Agreement are guaranteed by the Guarantors. The obligations of the Company and the Guarantors are secured by first-priority liens on substantially all of the assets of the Company and the Guarantors, subject to certain exceptions.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:21.6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#ic8ae413b3ff34d56976502c585fa6ab3_7">Table of Contents</a></span></div></div><ix:continuation id="i8e08aceebfd947eb9b1ea68dc0fa1b85"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the Amended Credit Agreement, the Company will pay to the administrative agent for the account of each revolving lender a commitment fee on a quarterly basis based on amounts committed but unused under the revolving facility from <ix:nonFraction unitRef="number" contextRef="ibea5baeea8b840488104a7e63ceeb4bc_D20220531-20220531" decimals="INF" name="us-gaap:LineOfCreditFacilityCommitmentFeePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM181NS9mcmFnOjFjMWU2MTk4MjE1NzRmNmJiNjU5YmU0YTI1ODljMjRkL3RleHRyZWdpb246MWMxZTYxOTgyMTU3NGY2YmI2NTliZTRhMjU4OWMyNGRfMTQzMA_6e560b9b-6f9d-4ff3-b239-3cb3a9a4a998">0.20</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="ie586fdb4b2b04c1f83bcdaff0af594c8_D20220531-20220531" decimals="INF" name="us-gaap:LineOfCreditFacilityCommitmentFeePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM181NS9mcmFnOjFjMWU2MTk4MjE1NzRmNmJiNjU5YmU0YTI1ODljMjRkL3RleHRyZWdpb246MWMxZTYxOTgyMTU3NGY2YmI2NTliZTRhMjU4OWMyNGRfMTQzNg_47a9f450-7e3f-4d14-9413-b92abec89790">0.40</ix:nonFraction>% per annum depending on the Company&#8217;s Total Net Leverage Ratio (as defined in the Amended Credit Agreement). The Company is also obligated to pay the administrative agent customary fees for credit facilities of this size and type.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revolving borrowings under the Amended Credit Agreement bear interest at a rate per annum equal to (i) the Term SOFR Rate for the interest period plus the Applicable Rate (as defined in the Amended Credit Agreement) based on the Company&#8217;s Total Net Leverage Ratio or (ii) the Alternate Base Rate (as defined in the Amended Credit Agreement) as in effect from time to time plus the Applicable Rate based on the Company&#8217;s Total Net Leverage Ratio. As of <ix:nonNumeric contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM181NS9mcmFnOjFjMWU2MTk4MjE1NzRmNmJiNjU5YmU0YTI1ODljMjRkL3RleHRyZWdpb246MWMxZTYxOTgyMTU3NGY2YmI2NTliZTRhMjU4OWMyNGRfMjEyMQ_75cfbe1e-17ec-4442-ae34-fd999dbe9ec2">September&#160;30, 2022</ix:nonNumeric>, the Applicable Rate for Term SOFR Loans is <ix:nonFraction unitRef="number" contextRef="i56c008dd01b046dda5a8ab4c98daf9d7_D20220101-20220930" decimals="4" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM181NS9mcmFnOjFjMWU2MTk4MjE1NzRmNmJiNjU5YmU0YTI1ODljMjRkL3RleHRyZWdpb246MWMxZTYxOTgyMTU3NGY2YmI2NTliZTRhMjU4OWMyNGRfMjE2OA_7ba55af0-07d4-4805-83d5-c0f2a3b7799f">1.25</ix:nonFraction>% per annum and the Applicable Rate for ABR Loans is <ix:nonFraction unitRef="number" contextRef="i761b85a615a044a28a135126fe49dca4_D20220101-20220930" decimals="4" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM181NS9mcmFnOjFjMWU2MTk4MjE1NzRmNmJiNjU5YmU0YTI1ODljMjRkL3RleHRyZWdpb246MWMxZTYxOTgyMTU3NGY2YmI2NTliZTRhMjU4OWMyNGRfMjIyMg_14a88f9a-26bc-463f-9cb3-189371a38f68">0.25</ix:nonFraction>% per annum. SOFR based loans also include a Credit Spread Adjustment based on the duration of the borrowing.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Amended Credit Agreement contains affirmative and negative covenants customarily applicable to senior secured credit facilities, including covenants that, among other things, limit or restrict the ability of the Company and its subsidiaries, subject to negotiated exceptions, to incur additional indebtedness and additional liens on their assets, engage in mergers or acquisitions or dispose of assets, pay dividends or make other distributions, voluntarily prepay other indebtedness, enter into transactions with affiliated persons, make investments and change the nature of their businesses. The Amended Credit Agreement also contains customary events of default, subject to thresholds and grace periods, including, among others, payment default, covenant default, cross default to other material indebtedness and judgment default. In addition, the Amended Credit Agreement requires the Company to maintain a Total Net Leverage Ratio of no more than <ix:nonFraction unitRef="number" contextRef="i1572f54925ef49918ea7d21b949a4e18_I20220531" decimals="2" name="med:MaximumTotalNetLeverageRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM181NS9mcmFnOjFjMWU2MTk4MjE1NzRmNmJiNjU5YmU0YTI1ODljMjRkL3RleHRyZWdpb246MWMxZTYxOTgyMTU3NGY2YmI2NTliZTRhMjU4OWMyNGRfMzI4OQ_91b7c93a-6e36-4377-9795-bc6baaa7b46b">2.75</ix:nonFraction> to 1.00 and an Interest Coverage Ratio of at least <ix:nonFraction unitRef="number" contextRef="i1572f54925ef49918ea7d21b949a4e18_I20220531" decimals="2" name="med:MinimumInterestCoverageRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM181NS9mcmFnOjFjMWU2MTk4MjE1NzRmNmJiNjU5YmU0YTI1ODljMjRkL3RleHRyZWdpb246MWMxZTYxOTgyMTU3NGY2YmI2NTliZTRhMjU4OWMyNGRfMzM0MQ_6c4d6410-814b-48a4-8b29-ea3d1d0af64e">3.50</ix:nonFraction> to 1.00.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has <ix:nonFraction unitRef="usd" contextRef="i116efaf8269843e38b3d65a462979897_I20220930" decimals="-5" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM181NS9mcmFnOjFjMWU2MTk4MjE1NzRmNmJiNjU5YmU0YTI1ODljMjRkL3RleHRyZWdpb246MWMxZTYxOTgyMTU3NGY2YmI2NTliZTRhMjU4OWMyNGRfMzI5ODUzNDg4Njc3Ng_e5afd223-f776-4519-8f78-8a4357d31ef9">no</ix:nonFraction> borrowings outstanding under the Amended Credit Agreement as of <ix:nonNumeric contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM181NS9mcmFnOjFjMWU2MTk4MjE1NzRmNmJiNjU5YmU0YTI1ODljMjRkL3RleHRyZWdpb246MWMxZTYxOTgyMTU3NGY2YmI2NTliZTRhMjU4OWMyNGRfMzQzNw_75cfbe1e-17ec-4442-ae34-fd999dbe9ec2">September&#160;30, 2022</ix:nonNumeric>.</span></div></ix:continuation><div><span><br/></span></div><div id="ic8ae413b3ff34d56976502c585fa6ab3_58"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">9. <ix:nonNumeric contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930" name="us-gaap:RepurchaseAgreementsResaleAgreementsSecuritiesBorrowedAndSecuritiesLoanedDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM181OC9mcmFnOjZjOWI1YzJiNDVmMjQ5ZmZhM2QzZjQ1NTRlZWM5NWU0L3RleHRyZWdpb246NmM5YjVjMmI0NWYyNDlmZmEzZDNmNDU1NGVlYzk1ZTRfMTA0OQ_39cb802d-3e10-4570-b7f8-7894bad1cd36" continuedAt="ieedc02013588455486a21ed590deec6e" escape="true">ACCELERATED SHARE REPURCHASE (&#8220;ASR&#8221;) PROGRAM</ix:nonNumeric></span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ieedc02013588455486a21ed590deec6e">In the second quarter of fiscal 2022, the Company entered into an ASR agreement with JPMorgan Chase, National Association ("JPMorgan Chase") to purchase shares of its common stock from JPMorgan Chase for an aggregate purchase price of $<ix:nonFraction unitRef="usd" contextRef="i9c92e926af9e4d908021e1a185782db8_I20220630" decimals="-5" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM181OC9mcmFnOjZjOWI1YzJiNDVmMjQ5ZmZhM2QzZjQ1NTRlZWM5NWU0L3RleHRyZWdpb246NmM5YjVjMmI0NWYyNDlmZmEzZDNmNDU1NGVlYzk1ZTRfMjg4_0a1dc973-1ebf-4670-a956-d2515ed00358">100.0</ix:nonFraction>&#160;million. Pursuant to the ASR program, the Company received an initial delivery of approximately <ix:nonFraction unitRef="shares" contextRef="i0b400b25989d44b2afb02aff99c3fc41_D20220531-20220531" decimals="-3" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM181OC9mcmFnOjZjOWI1YzJiNDVmMjQ5ZmZhM2QzZjQ1NTRlZWM5NWU0L3RleHRyZWdpb246NmM5YjVjMmI0NWYyNDlmZmEzZDNmNDU1NGVlYzk1ZTRfMzc5_105fe2f2-fb07-4021-a9c9-e5c3431e5ca3">480</ix:nonFraction>&#160;thousand shares of common stock based on the closing price of the common stock on May 31, 2022. Approximately <ix:nonFraction unitRef="shares" contextRef="i614062ec1b3741b0a8c6fc4b23ffa70c_D20220808-20220808" decimals="-3" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM181OC9mcmFnOjZjOWI1YzJiNDVmMjQ5ZmZhM2QzZjQ1NTRlZWM5NWU0L3RleHRyZWdpb246NmM5YjVjMmI0NWYyNDlmZmEzZDNmNDU1NGVlYzk1ZTRfNzY5NjU4MTM5NTk5OQ_57b8da93-a2c2-4df8-89f3-c77d1410e30e">91</ix:nonFraction>&#160;thousand additional shares of the Company's common stock were delivered upon termination of the agreement on August 8, 2022. The final number of shares delivered to the Company under the ASR agreement was based on the average of the daily volume-weighted average trading prices of the Company&#8217;s common stock during the term of the ASR program, less a discount.</ix:continuation></span></div><div><span><br/></span></div><div id="ic8ae413b3ff34d56976502c585fa6ab3_61"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2. MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</span></div><div id="ic8ae413b3ff34d56976502c585fa6ab3_64"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note Regarding Forward-Looking Statements</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain information in this report contains &#8220;forward-looking statements&#8221; within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the &#8220;Act&#8221;). These forward-looking statements generally can be identified by use of phrases or terminology such as &#8220;intend,&#8221; &#8220;anticipate,&#8221; &#8220;expect&#8221; or other similar words or the negative of such terminology. Similarly, descriptions of Medifast's objectives, strategies, plans, goals or targets contained herein are also considered forward-looking statements. These statements are based on the current expectations of our management and are subject to certain events, risks, uncertainties and other factors. These risks and uncertainties include, but are not limited to, those described in our 2021 Form 10-K and those described from time to time in our future reports filed with the SEC. Although Medifast believes that the expectations, statements and assumptions reflected in these forward-looking statements are reasonable, it cautions readers to always consider all of the risk factors and any other cautionary statements carefully in evaluating each forward-looking statement in this report. All of the forward-looking statements contained herein speak only as of the date of this report.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following discussion should be read in conjunction with the unaudited condensed consolidated financial statements and related notes appearing elsewhere herein.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">15</span></div></div></div><div id="ic8ae413b3ff34d56976502c585fa6ab3_67"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:21.6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#ic8ae413b3ff34d56976502c585fa6ab3_7">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medifast is the global company behind one of the fastest-growing health and wellness communities, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OPTA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">VIA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which offers Lifelong Transformation, One Healthy Habit at a Time</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Reflecting the success of our holistic approach to health and wellness, we have consistently grown annual revenue over the past five years. Of equal importance, we expect our differentiated model to continue to deliver growth in the foreseeable future.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OPTA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">VIA brand offers a highly competitive and effective lifestyle solution centered on developing new healthy habits through smaller, foundational changes called micro-habits. The program is built around four key components:</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Independent OPTA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">VIA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> Coaches: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Provide individualized support and guidance to customers on the path to optimal health and wellbeing.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">OPTA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">VIA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> Community</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A Community of like-hearted people providing each other with real-time connection and support.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">The Habits of Health</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> Transformational System:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> A proprietary system which offers easy steps to a sustainably healthy lifestyle. </span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Products &amp; Plans: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Clinically proven plans and scientifically developed products, called &#8220;Fuelings,&#8221; backed by dietitians, scientists and physicians.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We help customers achieve their health goals through a network of approximately 66,200 independent active earning </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OPTA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">VIA Coaches, about 90% of whom were customers first, and have impacted more than 2 million lives to date. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OPTA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">VIA Coaches introduce customers to a set of healthy habits, in most cases starting with the habit of healthy eating, and offer exclusive Fuelings, which are nutrient-dense, portion-controlled, nutritionally interchangeable and simple to use. They are formulated with high-quality ingredients and are fortified with probiotic cultures, vitamins and minerals, as well as other nutrients essential for good health. Our products support the process of integrating healthy habits into our customer&#8217;s day-to-day lives.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OPTA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">VIA coaching model is customer-centric and boasts an energized health and wellness community. It promotes holistic health and wellness and positions healthy weight as a catalyst to greater lifestyle changes. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OPTA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">VIA Coaches provide personalized support to customers and motivate them by sharing their passion for healthy living and lifestyle transformation. We believe this personal coaching is an essential factor in customer success based on findings from a clinical study published in Obesity Science and Practice in 2018, which validated the effectiveness of combining the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OPTA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">VIA meal plan with education and support consistent with that was provided by </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OPTA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">VIA Coaches.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The entrepreneurial spirit of our </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OPTA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">VIA Coaches is another key to our success, as they create a continuous cycle of growth, activating new customers, many of whom go on to become </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OPTA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">VIA Coaches. We offer economic incentives designed to support each </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OPTA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">VIA Coach&#8217;s long-term success, which we believe plays an important role in their financial wellness, providing the opportunity to improve their finances while changing the health trajectory of families, communities and generations.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">1</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OPTA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">VIA Coaches are independent contractors, not employees, who support customers and market our products and services primarily through word of mouth, email and social media channels such as Facebook, Instagram, Twitter and video conferencing platforms. As entrepreneurs, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OPTA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">VIA Coaches market our products to friends, family and other acquaintances.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> OPTA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">VIA products are shipped directly to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OPTA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">VIA customers who are working with an </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OPTA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">VIA Coach. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OPTA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">VIA Coaches do not handle or deliver merchandise to customers. This arrangement frees our </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OPTA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">VIA Coaches from having to manage inventory and allows them to maintain an arms-length transactional relationship while focusing their attention on support and encouragement.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are one of the fastest growing health and wellness companies in the United States, with a large and growing market opportunity. We believe our coach-based model is scalable and drives both customer success and growth. We expect our continued investment in fostering a robust community around our </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OPTA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">VIA brand and our </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OPTA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">VIA Coaching model will </span></div><div style="border-bottom:1pt solid black;margin-bottom:5pt;margin-top:10pt;width:150pt"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline">1</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">OPTA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">VIA makes no guarantee of financial success. Success with </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">OPTA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">VIA results from successful sales efforts, which require hard work, diligence, skill, persistence, competence, and leadership. Please see the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">OPTA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">VIA Income Disclosure Statement (http://bit.ly/ids</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">OPTA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">VIA) for statistics on actual earnings of Coaches.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:21.6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#ic8ae413b3ff34d56976502c585fa6ab3_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">continue to drive a sustainable, repeatable business rhythm focused on our mission of offering the world Lifelong Transformation, One Healthy Habit at a Time.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our operations are conducted through our wholly owned subsidiaries, Jason Pharmaceuticals, Inc., </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OPTA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">VIA, LLC, Jason Enterprises, Inc., Jason Properties, LLC, Seven Crondall Associates, LLC, Corporate Events, Inc., </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OPTA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">VIA (Hong Kong) Limited, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OPTA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">VIA (Singapore) PTE. LTD and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OPTA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">VIA Health Consultation (Shanghai) Co., Ltd.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As we previously disclosed, global expansion is an important component of our long-term growth strategy. In July 2019, we commenced our international operations, entering into the Asia Pacific markets of Hong Kong and Singapore. Our decision to enter these markets was based on industry market research that reflects a dynamic shift in how health care is being prioritized and consumed in those countries. We outsource a distribution center in Hong Kong to provide adequate product distribution capacity for the foreseeable future in these markets.</span></div><div id="ic8ae413b3ff34d56976502c585fa6ab3_70"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Macroeconomic Conditions </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Global economic challenges including the impact of rising inflation, adverse labor market conditions, the war in Ukraine and the continuing impact of the COVID-19 pandemic have caused macroeconomic uncertainty and volatility in markets where we, our suppliers and our </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OPTA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">VIA Coaches operate.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are exposed to market risks from changes in commodity or other raw material prices. Rising inflation could impact our cost structure and put pressure on consumer spending. Increases in commodity prices or food costs, including as a result of inflation, could affect the global and U.S. economies and could also adversely impact our business, financial condition or results of operations. Our variable cost structure can be utilized to adapt to changing market conditions with potential actions including adjustments to our manufacturing, distribution and customer support infrastructure. In addition, adverse labor market conditions could constrain our ability to manufacture and deliver products or increase the associated costs. We continue to take steps to attract, train, and develop personnel. As a response, we may periodically take incremental pricing actions to offset supply chain costs, inflationary pressures, and adverse labor market conditions.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, beginning in February 2022, the war in Ukraine and corresponding events have had, and could continue to have, adverse effects on regional and global markets. While our operations are not directly impacted by the war in Ukraine, the duration of hostilities and the vast array of sanctions and related events (including cyberattacks) cannot be predicted. As a result, those events present uncertainty and risk. To date, the war in Ukraine has had no material impact on our business.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Throughout the COVID-19 pandemic, we took and continue to take significant measures to protect our employees, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OPTA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">VIA Coaches and business, while remaining in compliance with local and national guidelines. Our manufacturing and distribution facilities remained fully operational during the pandemic, and we have not experienced any meaningful disruption to our worldwide supply chain due to the pandemic. It is possible the COVID-19 pandemic could negatively impact our operations and the operations of our suppliers and vendors. Should that occur, the extent to which the pandemic ultimately impacts the Company&#8217;s business, financial condition, results of operations, cash flows, and liquidity may differ from management&#8217;s current expectations. Factors that could cause actual results to differ from management&#8217;s expectations include inherent uncertainties regarding the duration and further spread of the outbreak, its severity, the emergence of variant strains, government actions taken to contain the virus or treat its impact, changes in consumer behavior resulting from the pandemic and how quickly and to what extent normal economic and operating conditions can resume. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The senior management team meets regularly to review and assess the status of the Company&#8217;s operations and the health and safety of its various constituencies, and will continue to communicate with our supply chain partners to identify and mitigate risk and to manage inventory levels. In response to changing macroeconomic conditions, the Company may take further actions that alter its business operations as may be required by governmental authorities, or that are determined to be in the best interests of employees, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OPTA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">VIA Coaches and customers.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">These macroeconomic uncertainties make it challenging for our management to estimate our future business performance. However, we intend to continue to actively monitor the impact of the pandemic and related developments on our business and will update our practices accordingly.</span></div><div id="ic8ae413b3ff34d56976502c585fa6ab3_73"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Critical Accounting Policies and Estimates</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our unaudited condensed consolidated financial statements are prepared in accordance with GAAP. Our significant accounting policies are described in Note 2 to the audited consolidated financial statements included in the 2021 Form 10-K. We consider </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:21.6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#ic8ae413b3ff34d56976502c585fa6ab3_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">all of our significant accounting policies and estimates to be critical. There were no significant changes in our critical accounting policies during the first nine months of 2022.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of our financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenue and expenses during the reporting period. Management develops, and changes periodically, these estimates and assumptions based on historical experience and on various other factors that are believed to be reasonable under the circumstances. Actual results may differ from these estimates under different assumptions or conditions. There were no significant changes in our critical estimates during the first nine months of 2022.</span></div><div id="ic8ae413b3ff34d56976502c585fa6ab3_76"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview of Results of Operations</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our product sales accounted for approximately 98.0% of our revenues for each of the three and nine months ended September&#160;30, 2022 and 2021.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables reflect our income statements (in thousands, except percentages):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:42.759%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.501%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Three months ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">$ Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">% Change</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Revenue</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">390,398&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">413,395&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(22,997)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Cost of sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">107,549&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">106,338&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,211&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Gross profit</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">282,849</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">307,057</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(24,208)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(7.9)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Selling, general, and administrative</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">234,693&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">251,886&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(17,193)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Income from operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">48,156</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">55,171</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(7,015)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(12.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Other income (expense)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Interest expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(261)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(94)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(167)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">177.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Other income (expense)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">115&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(132)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(114.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(278)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(299)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1423.8)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Income from operations before income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">47,878</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">55,192</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(7,314)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(13.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Provision for income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,723&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,210&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,487)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(11.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Net income</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">36,155</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">41,982</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(5,827)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(13.9)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%;text-decoration:underline">% of revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Gross profit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">72.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">74.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Selling, general, and administrative costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Income from operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:21.6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#ic8ae413b3ff34d56976502c585fa6ab3_7">Table of Contents</a></span></div></div><div style="margin-top:7pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:42.759%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.501%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Nine months ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">$ Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">% Change</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Revenue</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,261,332&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,148,253&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">113,079&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Cost of sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">354,515&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">298,942&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">55,573&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Gross profit</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">906,817</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">849,311</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">57,506</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">6.8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Selling, general, and administrative</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">754,610&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">679,907&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">74,703&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Income from operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">152,207</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">169,404</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(17,197)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(10.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Other income (expense)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Interest expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(519)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(138)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(381)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">276.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Other income (expense)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(37)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">112&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(149)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(133.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(556)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(26)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(530)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2038.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Income from operations before income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">151,651</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">169,378</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(17,727)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(10.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Provision for income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">34,601&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">39,370&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,769)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(12.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Net income</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">117,050</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">130,008</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(12,958)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(10.0)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%;text-decoration:underline">% of revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Gross profit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">71.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">74.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Selling, general, and administrative costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">59.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">59.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Income from operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Revenue:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Revenue decreased $23.0 million, or 5.6%, to $390.4 million for the three months ended September 30, 2022 from $413.4 million for the three months ended September 30, 2021. The average revenue per active earning </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OPTA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">VIA Coach was $5,897 for the three months ended September 30, 2022 compared to $6,773 for the three months ended September 30, 2021. The decline in revenue for the three months ended September 30, 2022 was primarily driven by the decline in the productivity per active earning </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OPTA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">VIA Coach partially offset by the increase in the number of active earning </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OPTA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">VIA Coaches to 66,200 as of September 30, 2022 from 61,000 as of September 30, 2021. The decrease in productivity per active earning </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OPTA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">VIA Coach for the quarter was driven by a decrease in the number of customers supported by each Coach. Revenue increased $113.1 million, or 9.8%, to $1,261.3 million for the nine months ended September 30, 2022 from $1,148.3 million for the nine months ended September 30, 2021. The average revenue per active earning </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OPTA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">VIA Coach was $6,367 for the nine months ended September 30, 2022 compared to $6,630 for the nine months ended September 30, 2021. The decrease in the productivity per active earning </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OPTA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">VIA Coach for the nine months ended September 30, 2022 was driven by an decrease in the number of customers supported by each Coach. The year-over-year growth in revenue was primarily driven by the increase in the number of active earning </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OPTA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">VIA Coaches partially offset by the decrease in productivity per active earning </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OPTA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">VIA Coach.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cost of sales:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Cost of sales increased $1.2 million, or 1.1%, to $107.5 million from $106.3 million for the three months ended September 30, 2022 from the corresponding period in 2021. The increase in cost of sales for the three months ended September 30, 2022 was primarily driven by higher product costs resulting from increases in raw ingredient costs, shipping costs, and labor costs. Cost of sales increased $55.6 million, or 18.6%, to $354.5 million from $298.9 million for the nine months ended September 30, 2022 from the corresponding period in 2021. The increase in cost of sales for the nine months ended September 30, 2022 was primarily driven by an increase in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OPTA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">VIA product sales and higher product costs resulting from increases in raw ingredient costs, shipping costs, and labor costs. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Gross profit:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> For the three months ended September 30, 2022, gross profit decreased $24.2 million, or 7.9%, to $282.8 million from $307.1 million for the three months ended September 30, 2021.  The decrease in gross profit for the three months ended September 30, 2022 was due to both a decrease in the number of customers supported by each Coach and higher products costs </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:21.6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#ic8ae413b3ff34d56976502c585fa6ab3_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">resulting from increases in raw ingredient costs, shipping costs, and labor costs. As a percentage of revenue, gross profit decreased 183 basis points to 72.5% for the three months ended September 30, 2022 from 74.3% for the corresponding period in 2021. The decrease in gross profit as a percentage of revenue for the three months ended September 30, 2022 is due to higher products costs resulting from increases in raw ingredient costs, shipping costs, and labor costs. For the nine months ended September 30, 2022, gross profit increased $57.5 million, or 6.8%, to $906.8 million from $849.3 million for the nine months ended September 30, 2021. The increase in gross profit for the nine-month period was primarily attributable to higher revenue partially offset by increased cost of sales. As a percentage of revenue, gross profit decreased 207 basis points to 71.9% for the nine months ended September 30, 2022 from 74.0% for the corresponding period in 2021. The decrease in gross margin percentage for the nine months ended September 30, 2022 was primarily due to a customer acquisition program, which ran from late March to early May in 2022, and higher product costs resulting from increases in raw ingredient costs, shipping costs, and labor costs. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Selling, general, and administrative:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> SG&amp;A expenses were $234.7 million for the three months ended September 30, 2022, a decrease of $17.2 million, or 6.8%, as compared to $251.9 million from the corresponding period in 2021. As a percentage of revenue, SG&amp;A expenses were 60.1% for the three months ended September 30, 2022 as compared to 60.9% for the corresponding period in 2021. SG&amp;A expenses included research and development costs of $1.1 million and $1.2 million for the three months ended September 30, 2022 and 2021, respectively, in connection with the development of new products and programs and clinical research activities. The decrease in SG&amp;A expenses for the three months ended September 30, 2022 was primarily due to lower </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OPTA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">VIA Coach compensation expense. SG&amp;A expenses were $754.6 million for the nine months ended September 30, 2022, an increase of $74.7 million, or 11.0%, as compared to $679.9 million from the corresponding period in 2021. As a percentage of revenue, SG&amp;A expenses were 59.8% for the nine months ended September 30, 2022 as compared to 59.2% for the corresponding period in 2021. SG&amp;A expenses included research and development costs of $3.3 million and $3.3 million for the nine months ended September 30, 2022 and 2021, respectively, in connection with the development of new products and programs and clinical research activities. The increase in SG&amp;A expenses for the nine months ended September 30, 2022 was primarily due to higher </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OPTA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">VIA Coach compensation expense, donations made to support the Ukraine relief effort, incremental costs related to continued investment in information technology and distribution infrastructure, as well as the increased credit card fees resulting from higher sales. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Non-GAAP adjusted SG&amp;A expenses were $233.6&#160;million for the three months ended September 30, 2022, a decrease of $18.3&#160;million, or 7.3%, as compared to $251.9&#160;million from the corresponding period in 2021. Non-GAAP adjusted SG&amp;A expenses were $744.1&#160;million for the nine months ended September 30, 2022, an increase of $64.2&#160;million, or 9.4%, as compared to 679.9 million from the corresponding period in 2021. Non-GAAP adjusted SG&amp;A excludes expenses in connection with donations made to support the Ukrainian relief effort of $1.1&#160;million and $10.5&#160;million for the three and nine months ended September&#160;30, 2022, respectively. Refer to the section titled &#8220;Non-GAAP Financial Measures&#8221; below for a reconciliation of each of Non-GAAP financial measures to its most comparable GAAP financial measure.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OPTA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">VIA Coach compensation expense, which is a variable expense, decreased $17.2 million, or 9.5%, to $164.8 million for the three months ended September 30, 2022 from $182.1 million for the corresponding period in 2021. The decrease was primarily the result of decreased </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OPTA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">VIA product sales. For the nine months ended September 30, 2022, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OPTA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">VIA compensation expense increased $47.7 million, or 9.5%, to $548.4 million from $500.7 million for the corresponding period in 2021. The increase was primarily the result of increased </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OPTA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">VIA product sales in the first half of the year. The total number of active earning </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OPTA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">VIA Coaches as of September 30, 2022 increased to 66,200 from 61,000 for the corresponding date in 2021, an increase of 8.5%.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Income from operations:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> For the three months ended September 30, 2022, income from operations decreased $7.0 million to $48.2 million from $55.2 million for the corresponding period in 2021 primarily as a result of decreased gross profit partially offset by decreased SG&amp;A expenses. Income from operations as a percentage of revenue decreased to 12.3% for the three months ended September 30, 2022 from 13.3% for the corresponding period in 2021 due to the factors described above impacting revenue and SG&amp;A expenses. For the nine months ended September 30, 2022, income from operations decreased $17.2 million to $152.2 million from $169.4 million for the corresponding period in 2021 primarily as a result of increased SG&amp;A expenses partially offset by increased gross profit. Income from operations as a percentage of revenue decreased to 12.1% for the nine months ended September 30, 2022 from 14.8% for the corresponding period in 2021 due to the factors described above impacting revenue, cost of sales and SG&amp;A expenses. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Non-GAAP adjusted income from operations was $49.2&#160;million for the three months ended September 30, 2022, a decrease of $5.9&#160;million, or 10.7%, as compared to $55.2&#160;million from the corresponding period in 2021. Non-GAAP adjusted income from operations was $162.7&#160;million for the nine months ended September 30, 2022, a decrease of $6.7&#160;million, or 3.9%, as compared </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:21.6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#ic8ae413b3ff34d56976502c585fa6ab3_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to $169.4&#160;million from the corresponding period in 2021. Refer to the section titled &#8220;Non-GAAP Financial Measures&#8221; below for a reconciliation of each of Non-GAAP financial measures to its most comparable GAAP financial measure.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Provision for income taxes:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> For the three months ended September 30, 2022, the Company recorded $11.7 million in income tax expense, an effective tax rate of 24.5%, as compared to $13.2 million in income tax expense, an effective tax rate of 23.9%, for the three months ended September 30, 2021. The increase in the effective tax rate for the three months ended September 30, 2022 was primarily driven by an increase in state income taxes partially offset by increased tax benefits for inventory donations and research and development tax credits. For the nine months ended September 30, 2022, the Company recorded $34.6 million in income tax expense, an effective tax rate of 22.8%, as compared to $39.4 million in income tax expense, an effective tax rate of 23.2%, for the nine months ended September 30, 2021. The decrease in the effective tax rate for the nine months ended September 30, 2022 was primarily driven by the tax benefits for inventory donations and research and development tax credits partially offset by an increase in state income taxes and a decrease in the tax benefit of stock compensation. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Non-GAAP adjusted income tax provision was $12.2&#160;million for the three months ended September 30, 2022, an effective tax rate of 24.9% as compared to 23.9% for the corresponding period in 2021. Non-GAAP adjusted income tax provision was $39.4&#160;million for the nine months ended September 30, 2022, an effective tax rate of 24.3%, as compared to 23.2% for the corresponding period in 2021. Refer to the section titled &#8220;Non-GAAP Financial Measures&#8221; below for a reconciliation of each of Non-GAAP financial measures to its most comparable GAAP financial measure.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Net income: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Net income was $36.2 million and $117.1 million, or $3.27 and $10.30 per diluted share, for the three and nine months ended September&#160;30, 2022 as compared to $42.0 million and $130.0 million, or $3.56 and $10.98 per diluted share, for the three and nine months ended September&#160;30, 2021. The period-over-period changes were driven by the factors described above in the section titled &#8220;Income from operations.&#8221;</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Non-GAAP adjusted net income was $36.8&#160;million or $3.32 per diluted share for the three months ended September 30, 2022 as compared to $3.56 per diluted share for the corresponding period in 2021. Non-GAAP adjusted net income was $122.8&#160;million or $10.81 per diluted share for the nine months ended September 30, 2022 as compared to $10.98 per diluted share for the corresponding period in 2021.  Refer to the section titled &#8220;Non-GAAP Financial Measures&#8221; below for a reconciliation of each of Non-GAAP financial measures to its most comparable GAAP financial measure.</span></div><div id="ic8ae413b3ff34d56976502c585fa6ab3_79"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Non-GAAP Financial Measures</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In an effort to provide investors with additional information regarding our results as determined by GAAP, we disclose various non-GAAP financial measures in this quarterly report, our quarterly earnings press release and other public disclosures. The following GAAP financial measures have been presented on an as-adjusted basis: SG&amp;A expenses, income from operations, provision for income taxes, net income and diluted earnings per share. Each of these as-adjusted financial measures excludes the impact of certain amounts related to our donations to support the Ukrainian relief effort as further identified below and have not been calculated in accordance with GAAP. A reconciliation of each of these non-GAAP financial measures to its most comparable GAAP financial measure is included below. These non-GAAP financial measures are not intended to replace GAAP financial measures.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We use these non-GAAP financial measures internally to evaluate and manage the Company&#8217;s operations because we believe they provide useful supplemental information regarding the Company&#8217;s on-going economic performance. We have chosen to provide this information to investors to enable them to perform more meaningful comparisons of operating results and as a means to emphasize the results of on-going operations.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The following tables reconcile the non-GAAP financial measures included in this report (in thousands, except per share amounts):</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:21.6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#ic8ae413b3ff34d56976502c585fa6ab3_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:25.800%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.605%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended September 30, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">GAAP</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Donation<br/>Adjustments</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Non-GAAP</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">GAAP</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Donations Adjustments</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Non-GAAP</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Selling, general, and administrative</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">234,693&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,087)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">233,606&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">251,886&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">251,886&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income from operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">48,156&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,087&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49,243&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">55,171&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">55,171&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Provision for income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,723&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">491&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,214&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,210&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,210&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">36,155&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">596&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">36,751&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">41,982&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">41,982&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Diluted earnings per share </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.27&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.05&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.32&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.56&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.56&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:25.800%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.605%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended September 30, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">GAAP</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Donation<br/>Adjustments</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Non-GAAP</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">GAAP</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Donations Adjustments</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Non-GAAP</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Selling, general, and administrative</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">754,610&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(10,513)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">744,097&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">679,907&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">679,907&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income from operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">152,207&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,513&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">162,720&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">169,404&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">169,404&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Provision for income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">34,601&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,752&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">39,353&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">39,370&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">39,370&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">117,050&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,761&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">122,811&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">130,008&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">130,008&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Diluted earnings per share </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.30&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.51&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.81&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.98&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.98&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1) The weighted-average diluted shares outstanding used in the calculation of these non-GAAP financial measures are the same as the weighted-average shares outstanding used in the calculation of the reported per share amounts.</span></div><div id="ic8ae413b3ff34d56976502c585fa6ab3_82"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liquidity and Capital Resources</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company had stockholders&#8217; equity of $150.5&#160;million and working capital of $75.3&#160;million at September&#160;30, 2022 as compared with $202.5&#160;million and $137.0&#160;million at December&#160;31, 2021, respectively. The $52.0&#160;million net decrease in stockholders&#8217; equity reflects $117.1&#160;million in net income for the nine months ended September 30, 2022 offset by $120.0 million used for repurchases of the Company&#8217;s common stock and $55.8&#160;million for declared dividends paid to holders of the Company&#8217;s common stock as well as the other equity transactions described in the &#8220;Condensed Consolidated Statements of Changes in Stockholders&#8217; Equity&#8221; included in this report. On September 8, 2022, the Company declared a quarterly dividend of $1.64 per share payable on November 8, 2022, to stockholders of record as of September 20, 2022. While we intend to continue the dividend program and believe we will have sufficient liquidity to do so, we can provide no assurance that we will be able to continue to declare and pay dividends. The Company&#8217;s cash, cash equivalents and investment securities decreased from $109.5 million at December&#160;31, 2021 to $69.7 million at September&#160;30, 2022. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Net cash provided by operating activities increased by $40.8&#160;million to $142.8&#160;million for the nine months ended September 30, 2022 from $102.0&#160;million for the nine months ended September 30, 2021 primarily driven by a $111.0 million increase related to changes in  inventory balances, a $7.0&#160;million increase in prepaid expenses and other current assets partially offset by a reduction in net income, as well as decreases related to changes in certain balance sheet accounts, including  $5.2&#160;million in other assets and $65.0&#160;million in accounts payable and accrued expenses. We continued to expand our cloud computing technology capabilities to support our planned growth during the nine months ended September 30, 2022.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Net cash used in investing activities was $2.4&#160;million for the nine months ended September 30, 2022 as compared to $17.4&#160;million for the nine months ended September 30, 2021. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Net cash used in financing activities increased by $81.3&#160;million to $175.3&#160;million for the nine months ended September 30, 2022 from $93.9&#160;million for the nine months ended September 30, 2021. This increase was primarily due to $74&#160;million used for repurchases of the Company's common stock under the accelerated share repurchase (&#8220;ASR&#8221;) program and $6.9&#160;million in cash dividends paid to stockholders. Under the terms of the ASR agreement, approximately 480 thousand shares were delivered in the second quarter of 2022. A final delivery of approximately 91 thousand shares was received on August 8, 2022 to complete the ASR agreement. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In pursuing its business strategy, the Company may require additional cash for operating and investing activities. The Company expects future cash requirements, if any, to be funded from operating cash flow and financing activities.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:21.6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#ic8ae413b3ff34d56976502c585fa6ab3_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">From time to time the Company evaluates potential acquisitions that complement our business. If consummated, any such transactions may use a portion of our working capital or require the issuance of equity or debt. We have no present understandings, commitments or agreements with respect to any material acquisitions.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On April&#160;13, 2021, the Company and certain of its subsidiaries (collectively, the &#8220;Guarantors&#8221;) entered into a credit agreement among the Company, the Guarantors, the lenders party thereto and Citibank, N.A., in its capacity as administrative agent. On May&#160;31, 2022, the Credit Agreement was amended to increase the borrowing capacity and convert the interest rate to be based on SOFR, from LIBOR (the &#8220;Amended Credit Agreement&#8221;). The Amended Credit Agreement provides for a $225.0&#160;million senior secured revolving credit facility with a $20.0&#160;million letter of credit sublimit. The Amended Credit Agreement also provides for an uncommitted incremental facility that permits the Company, subject to certain conditions, to increase the senior secured revolving credit facility by up to $100.0&#160;million. The Amended Credit Agreement contains affirmative and negative covenants customarily applicable to credit facilities. As of September&#160;30, 2022, the Company had no borrowings under the credit facility and was in compliance with all of its debt covenants.</span></div><div id="ic8ae413b3ff34d56976502c585fa6ab3_85"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 3. Quantitative and Qualitative Disclosures about Market Risk</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Market risk is the potential loss arising from adverse changes in market rates and prices, such as interest rates and a decline in the stock market. The Company does not enter into derivatives, foreign exchange transactions or other financial instruments for trading or speculative purposes.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company is exposed to market risk related to changes in interest rates and market pricing impacting our credit facility.  If market interest rates were to increase and market pricing were to decrease immediately and uniformly by 10% from levels at September&#160;30, 2022, the Company estimates that the fair value of its borrowings under its credit facility would decline by an immaterial amount and therefore it would not expect its operating results or cash flows to be affected to any significant degree by the effect of a change in market conditions on our investments.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">There have been no material changes to our market risk exposure since December&#160;31, 2021.</span></div><div id="ic8ae413b3ff34d56976502c585fa6ab3_88"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 4. Controls and Procedures</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Management, including our Chief Executive Officer and Chief Financial Officer, conducted an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures, as defined in Rules 13a-15(e) and 15d-15(e) under the Act, as amended, as of September&#160;30, 2022. Our disclosure controls and procedures are designed to ensure that information required to be disclosed by us in the reports that we file or submit under the Act is recorded, processed, summarized and reported accurately and on a timely basis. Based on this evaluation performed in accordance with the criteria established in the 2013 Internal Control &#8211; Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission, our management concluded that the Company&#8217;s disclosure controls and procedures are effective at the reasonable assurance level as of the end of the period covered by this report.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Changes in Internal Control over Financial Reporting</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">There have been no material changes in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Act) during the fiscal quarter ended September&#160;30, 2022 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">23</span></div></div></div><div id="ic8ae413b3ff34d56976502c585fa6ab3_91"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:21.6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#ic8ae413b3ff34d56976502c585fa6ab3_7">Table of Contents</a></span></div></div><div style="margin-bottom:12pt;margin-top:21.6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Part II Other Information</span></div><div id="ic8ae413b3ff34d56976502c585fa6ab3_94"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1. Legal Proceedings</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company is, from time to time, subject to a variety of litigation and similar proceedings that arise out of the ordinary course of its business. Based upon the Company&#8217;s experience, current information and applicable law, it does not believe that these proceedings and claims will have a material adverse effect on its results of operations, financial position or liquidity. However, the results of legal actions cannot be predicted with certainty. Therefore, it is possible that the Company&#8217;s results of operations, financial condition or cash flows could be materially adversely affected in any particular period by the unfavorable resolution of one or more legal actions.</span></div><div id="ic8ae413b3ff34d56976502c585fa6ab3_97"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1A. Risk Factors</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">There have been no material changes to the risk factors set forth in Part I, Item 1A of the 2021 Form 10-K.</span></div><div id="ic8ae413b3ff34d56976502c585fa6ab3_100"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2. Unregistered Sales of Equity Securities and Use of Proceeds</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Issuer Purchases of Equity Securities</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.807%"><tr><td style="width:1.0%"></td><td style="width:19.826%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.397%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.790%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.397%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.744%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.397%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.264%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.397%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.488%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:115%">Total Number of Shares Purchased </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:115%;position:relative;top:-3.15pt;vertical-align:baseline">(1)(3)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Average Price Paid per Share</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Total Number of Shares Purchased<br/>as Part of a Publicly Announced<br/>Plan or Program</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:115%">Maximum Number of Shares that May</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:115%">Yet Be Purchased Under the Plans or Programs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:115%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">July 1 - July 31</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">120&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">174.16&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,499,197</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">August 1 - August 31</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">91,292&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">178.66&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">91,292&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,407,905</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">September 1 - September 30</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">115.09&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,407,905</span></td></tr></table></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Also included are shares of common stock surrendered by employees and directors to the Company to cover minimum tax liability withholding obligations upon the exercise of stock options or the vesting of shares of restricted stock previously granted to such employees and directors.</span></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">At the outset of the quarter ended September&#160;30, 2022, there were 1,499,197 shares of the Company&#8217;s common stock eligible for repurchase under the stock repurchase authorization dated September 16, 2014 (the "Stock Repurchase Plan").</span></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">In the second quarter of fiscal 2022, the Company paid $100 million under an Accelerated Share Repurchase (&#8220;ASR&#8221;) agreement and received an initial delivery of approximately 480 thousand shares. A final delivery of approximately 91 thousand shares was received on August 8, 2022 to complete the ASR agreement. See Note 9 to the Consolidated Financial Statements included in this report for further description of the ASR.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">As of September&#160;30, 2022, there were 1,407,905 shares of the Company&#8217;s common stock eligible for repurchase under the Stock Repurchase Plan. There can be no assurances as to the amount, timing or prices of repurchases, which may vary based on market conditions and other factors. The Stock Repurchase Plan does not have an expiration date and can be modified or terminated by the Board of Directors at any time.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">24</span></div></div></div><div id="ic8ae413b3ff34d56976502c585fa6ab3_103"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="-sec-extract:summary;margin-top:21.6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#ic8ae413b3ff34d56976502c585fa6ab3_7">Table of Contents</a></span></div></div><div style="-sec-extract:summary;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 6. Exhibits </span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.099%"><tr><td style="width:1.0%"></td><td style="width:8.438%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.396%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:88.766%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Exhibit Number</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Description of Exhibit</span></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3.1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/910329/000114420415012727/v402962_ex3-1.htm">Restated and Amended Certificate of Incorporation of Medifast, Inc. (incorporated by reference to Exhibit 3.1 of the Company&#8217;s Current Report on Form 8-K (File No. 001-31573) filed February 27, 2015).</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3.2</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/910329/000110465919069652/tm1923867d1_ex3-1.htm">Amended and Restated Bylaws of Medifast, Inc. (incorporated by reference to Exhibit 3.1 to the Company&#8217;s Amendment No. 1 Current Report on Form 8-K (File No. 001-31573) filed on December 4, 2019).</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">31.1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="med-20220930xexx311.htm">Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (filed herewith).</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">31.2</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="med-20220930xexx312.htm">Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (filed herewith).</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">32.1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="med-20220930xexx321.htm">Certification of Chief Executive Officer and Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="med-20220930xexx321.htm">.</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">101</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">The following financial statements from Medifast, Inc.&#8217;s Quarterly Report on Form 10-Q for the quarter ended September&#160;30, 2022 filed November&#160;3, 2022, formatted in Inline XBRL (eXtensible Business Reporting Language): (i) Condensed Consolidated Statements of Income, (ii) Condensed Consolidated Statements of Comprehensive Income, (iii) Condensed Consolidated Balance Sheets, (iv) Condensed Consolidated Statements of Cash Flows, (v) Condensed Consolidated Statements of Changes in Stockholders&#8217; Equity, and (vi) Notes to the Condensed Consolidated Financial Statements (filed herewith).</span></div></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">104</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Cover Page Interactive Data File - The cover page interactive data file does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.</span></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with SEC Release No. 33-8238, Exhibit 32.1 is being furnished and not filed.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">25</span></div></div></div><div id="ic8ae413b3ff34d56976502c585fa6ab3_106"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:21.6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#ic8ae413b3ff34d56976502c585fa6ab3_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Medifast, Inc.</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:5.771%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:42.028%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.901%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">/s/ DANIEL R. CHARD</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Daniel R. Chard</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Chief Executive Officer</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(Principal Executive Officer)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Dated:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">November 3, 2022</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">/s/ JAMES P. MALONEY</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">James P. Maloney</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Chief Financial Officer</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(Principal Financial Officer)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Dated:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 3, 2022</span></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">26</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>2
<FILENAME>med-20220930xexx311.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i508c9bfb759c4e06be0c2585f4a34b95_1"></div><div style="min-height:45pt;width:100%"><div><font><br></font></div></div><div style="margin-top:12pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit&#160;31.1</font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RULE 13a-14(a) CERTIFICATION</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Daniel R. Chard, certify that&#58;</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">I have reviewed this report on Form 10-Q of Medifast, Inc.&#59;</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer and I have disclosed, based on my most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:4.747%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.052%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.901%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 3, 2022</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47;&#160;&#160;&#160;&#160;Daniel R. Chard</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Daniel R. Chard</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer</font></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>3
<FILENAME>med-20220930xexx312.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i5f55a9b05a2e47648c56da81b5bfcc6e_1"></div><div style="min-height:45pt;width:100%"><div><font><br></font></div></div><div style="margin-top:12pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit&#160;31.2</font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RULE 13a-14(a) CERTIFICATION</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, James P. Maloney, certify that&#58;</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">I have reviewed this report on Form 10-Q of Medifast, Inc.&#59;</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">I have disclosed, based on my most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:4.747%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.052%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.901%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 3, 2022</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47;&#160;&#160;&#160;&#160;James P. Maloney</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">James P. Maloney</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</font></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>4
<FILENAME>med-20220930xexx321.htm
<DESCRIPTION>EX-32.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i8bc16caa675840c2826fcf6ce95ffc32_1"></div><div style="min-height:45pt;width:100%"><div><font><br></font></div></div><div style="margin-top:12pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit&#160;32.1</font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">MEDIFAST, INC.</font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">18 U.S.C. SECTION 1350,</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Quarterly Report on Form 10-Q (the &#8220;Report&#8221;) for the quarter ended September 30, 2022 of Medifast, Inc. (the &#8220;Company&#8221;), as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;), I, Daniel R. Chard, Chief Executive Officer and I, James P. Maloney, Chief Financial Officer, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, to the best of my knowledge, that&#58;</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended&#59; and</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">The information contained in the Report fairly presents, in all material respects, the financial condition and results of the operations of the Company.</font></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.847%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:44.075%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:49.778%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; DANIEL R. CHARD</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt 2px 8.2pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Daniel R. Chard</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 8.2pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 8.2pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 3, 2022</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; JAMES P. MALONEY</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt 2px 8.2pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">James P. Maloney</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 8.2pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 8.2pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 3, 2022</font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>5
<FILENAME>med-20220930.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:1ae599f9-ff00-4d75-90b9-110349ab0236,g:6d08fa26-e8d0-4031-9c9e-a858e7464a0f-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:med="http://www.medifast1.com/20220930" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.medifast1.com/20220930">
  <xs:import namespace="http://fasb.org/srt/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2021q4" schemaLocation="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="med-20220930_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="med-20220930_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="med-20220930_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="med-20220930_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="Cover" roleURI="http://www.medifast1.com/role/Cover">
        <link:definition>0000001 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEUNAUDITED" roleURI="http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEUNAUDITED">
        <link:definition>0000002 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF INCOME (UNAUDITED)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUNAUDITED" roleURI="http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUNAUDITED">
        <link:definition>0000003 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (UNAUDITED)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED" roleURI="http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED">
        <link:definition>0000004 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical" roleURI="http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical">
        <link:definition>0000005 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" roleURI="http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED">
        <link:definition>0000006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYUNAUDITED" roleURI="http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYUNAUDITED">
        <link:definition>0000007 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (UNAUDITED)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES" roleURI="http://www.medifast1.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES">
        <link:definition>0000008 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INVENTORIES" roleURI="http://www.medifast1.com/role/INVENTORIES">
        <link:definition>0000009 - Disclosure - INVENTORIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EARNINGSPERSHARE" roleURI="http://www.medifast1.com/role/EARNINGSPERSHARE">
        <link:definition>0000010 - Disclosure - EARNINGS PER SHARE</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SHAREBASEDCOMPENSATION" roleURI="http://www.medifast1.com/role/SHAREBASEDCOMPENSATION">
        <link:definition>0000011 - Disclosure - SHARE-BASED COMPENSATION</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEASES" roleURI="http://www.medifast1.com/role/LEASES">
        <link:definition>0000012 - Disclosure - LEASES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACCUMULATEDOTHERCOMPREHENSIVEINCOME" roleURI="http://www.medifast1.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOME">
        <link:definition>0000013 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE INCOME</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FINANCIALINSTRUMENTS" roleURI="http://www.medifast1.com/role/FINANCIALINSTRUMENTS">
        <link:definition>0000014 - Disclosure - FINANCIAL INSTRUMENTS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DEBT" roleURI="http://www.medifast1.com/role/DEBT">
        <link:definition>0000015 - Disclosure - DEBT</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACCELERATEDSHAREREPURCHASEASRPROGRAM" roleURI="http://www.medifast1.com/role/ACCELERATEDSHAREREPURCHASEASRPROGRAM">
        <link:definition>0000016 - Disclosure - ACCELERATED SHARE REPURCHASE ("ASR") PROGRAM</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" roleURI="http://www.medifast1.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies">
        <link:definition>0000017 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INVENTORIESTables" roleURI="http://www.medifast1.com/role/INVENTORIESTables">
        <link:definition>0000018 - Disclosure - INVENTORIES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EARNINGSPERSHARETables" roleURI="http://www.medifast1.com/role/EARNINGSPERSHARETables">
        <link:definition>0000019 - Disclosure - EARNINGS PER SHARE (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SHAREBASEDCOMPENSATIONTables" roleURI="http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONTables">
        <link:definition>0000020 - Disclosure - SHARE-BASED COMPENSATION (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEASESTables" roleURI="http://www.medifast1.com/role/LEASESTables">
        <link:definition>0000021 - Disclosure - LEASES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACCUMULATEDOTHERCOMPREHENSIVEINCOMETables" roleURI="http://www.medifast1.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMETables">
        <link:definition>0000022 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE INCOME (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FINANCIALINSTRUMENTSTables" roleURI="http://www.medifast1.com/role/FINANCIALINSTRUMENTSTables">
        <link:definition>0000023 - Disclosure - FINANCIAL INSTRUMENTS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INVENTORIESDetails" roleURI="http://www.medifast1.com/role/INVENTORIESDetails">
        <link:definition>0000024 - Disclosure - INVENTORIES (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EARNINGSPERSHAREComputationofBasicandDilutedEPSDetails" roleURI="http://www.medifast1.com/role/EARNINGSPERSHAREComputationofBasicandDilutedEPSDetails">
        <link:definition>0000025 - Disclosure - EARNINGS PER SHARE - Computation of Basic and Diluted EPS (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EARNINGSPERSHARENarrativeDetails" roleURI="http://www.medifast1.com/role/EARNINGSPERSHARENarrativeDetails">
        <link:definition>0000026 - Disclosure - EARNINGS PER SHARE - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SHAREBASEDCOMPENSATIONNarrativeDetails" roleURI="http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails">
        <link:definition>0000027 - Disclosure - SHARE-BASED COMPENSATION - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SHAREBASEDCOMPENSATIONStockOptionsActivityDetails" roleURI="http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONStockOptionsActivityDetails">
        <link:definition>0000028 - Disclosure - SHARE-BASED COMPENSATION - Stock Options Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SHAREBASEDCOMPENSATIONRestrictedStockActivityDetails" roleURI="http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONRestrictedStockActivityDetails">
        <link:definition>0000029 - Disclosure - SHARE-BASED COMPENSATION - Restricted Stock Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SHAREBASEDCOMPENSATIONSummaryofPerformancebasedShareAwardsDetails" roleURI="http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONSummaryofPerformancebasedShareAwardsDetails">
        <link:definition>0000030 - Disclosure - SHARE-BASED COMPENSATION - Summary of Performance-based Share Awards (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEASESNarrativeDetails" roleURI="http://www.medifast1.com/role/LEASESNarrativeDetails">
        <link:definition>0000031 - Disclosure - LEASES - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEASESSupplementalCashFlowInformationDetails" roleURI="http://www.medifast1.com/role/LEASESSupplementalCashFlowInformationDetails">
        <link:definition>0000032 - Disclosure - LEASES - Supplemental Cash Flow Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEASESFutureMinimumLeaseCommitmentsDetails" roleURI="http://www.medifast1.com/role/LEASESFutureMinimumLeaseCommitmentsDetails">
        <link:definition>0000033 - Disclosure - LEASES - Future Minimum Lease Commitments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEASESFutureMinimumLeaseCommitmentsDetails_1" roleURI="http://www.medifast1.com/role/LEASESFutureMinimumLeaseCommitmentsDetails_1">
        <link:definition>0000033 - Disclosure - LEASES - Future Minimum Lease Commitments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACCUMULATEDOTHERCOMPREHENSIVEINCOMEAccumulatedOtherComprehensiveIncomeDetails" roleURI="http://www.medifast1.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMEAccumulatedOtherComprehensiveIncomeDetails">
        <link:definition>0000034 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE INCOME - Accumulated Other Comprehensive Income (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FINANCIALINSTRUMENTSCashandFinancialAssetsThatareMeasuredatFairValueonaRecurringBasisforEachoftheHierarchyLevelsDetails" roleURI="http://www.medifast1.com/role/FINANCIALINSTRUMENTSCashandFinancialAssetsThatareMeasuredatFairValueonaRecurringBasisforEachoftheHierarchyLevelsDetails">
        <link:definition>0000035 - Disclosure - FINANCIAL INSTRUMENTS - Cash and Financial Assets That are Measured at Fair Value on a Recurring Basis for Each of the Hierarchy Levels (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FINANCIALINSTRUMENTSNarrativeDetails" roleURI="http://www.medifast1.com/role/FINANCIALINSTRUMENTSNarrativeDetails">
        <link:definition>0000036 - Disclosure - FINANCIAL INSTRUMENTS - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DEBTNarrativeDetails" roleURI="http://www.medifast1.com/role/DEBTNarrativeDetails">
        <link:definition>0000037 - Disclosure - DEBT - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACCELERATEDSHAREREPURCHASEASRPROGRAMDetails" roleURI="http://www.medifast1.com/role/ACCELERATEDSHAREREPURCHASEASRPROGRAMDetails">
        <link:definition>0000038 - Disclosure - ACCELERATED SHARE REPURCHASE ("ASR") PROGRAM (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="med_OptionsAndRestrictedStockMember" abstract="true" name="OptionsAndRestrictedStockMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="med_LineOfCreditFacilityAccordionFeatureIncreaseLimit" abstract="false" name="LineOfCreditFacilityAccordionFeatureIncreaseLimit" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="med_GrantedIn2020Member" abstract="true" name="GrantedIn2020Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="med_OperatingLeaseExpenseNonCash" abstract="false" name="OperatingLeaseExpenseNonCash" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="med_MinimumInterestCoverageRatio" abstract="false" name="MinimumInterestCoverageRatio" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="med_LesseeOperatingLeaseLiabilityPaymentsDueYearFiveAndAfterYearFive" abstract="false" name="LesseeOperatingLeaseLiabilityPaymentsDueYearFiveAndAfterYearFive" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="med_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesEarnedPerformancePeriod" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesEarnedPerformancePeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="med_GrantedIn2022Member" abstract="true" name="GrantedIn2022Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="med_InventoryNonFoodFinishedGoods" abstract="false" name="InventoryNonFoodFinishedGoods" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="med_NumeratorAbstract" abstract="true" name="NumeratorAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="med_CreditAgreementMember" abstract="true" name="CreditAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="med_CashAndCashEquivalentsAndMarketableSecuritiesLineItems" abstract="true" name="CashAndCashEquivalentsAndMarketableSecuritiesLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="med_OperatingLeaseArrangementForEquipmentMember" abstract="true" name="OperatingLeaseArrangementForEquipmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="med_GovernmentAgencySecuritiesMember" abstract="true" name="GovernmentAgencySecuritiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="med_OperatingLeaseArrangementForRealEstateMember" abstract="true" name="OperatingLeaseArrangementForRealEstateMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="med_MaximumTotalNetLeverageRatio" abstract="false" name="MaximumTotalNetLeverageRatio" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="med_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesEarnedPercentage" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesEarnedPercentage" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="med_MarketAndPerformanceSharesMember" abstract="true" name="MarketAndPerformanceSharesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="med_CashAndCashEquivalentsAndMarketableSecuritiesTable" abstract="true" name="CashAndCashEquivalentsAndMarketableSecuritiesTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="med_DenominatorAbstract" abstract="true" name="DenominatorAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="med_AmortizationOfPremiumOnInvestmentSecurities" abstract="false" name="AmortizationOfPremiumOnInvestmentSecurities" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="med_AdjustmentsToPaidInCapitalShareRepurchasesNotYetSettled" abstract="false" name="AdjustmentsToPaidInCapitalShareRepurchasesNotYetSettled" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="med_GrantedIn2019Member" abstract="true" name="GrantedIn2019Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="med_GrantedIn2021Member" abstract="true" name="GrantedIn2021Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>6
<FILENAME>med-20220930_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:1ae599f9-ff00-4d75-90b9-110349ab0236,g:6d08fa26-e8d0-4031-9c9e-a858e7464a0f-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEUNAUDITED" xlink:type="simple" xlink:href="med-20220930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEUNAUDITED"/>
  <link:calculationLink xlink:role="http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEUNAUDITED" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_98bc9125-eb0a-4202-8362-eb74dc4051ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_bd54b8a2-8fce-4890-bd20-2dd22cf503f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_98bc9125-eb0a-4202-8362-eb74dc4051ff" xlink:to="loc_us-gaap_GrossProfit_bd54b8a2-8fce-4890-bd20-2dd22cf503f5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_9bbed8e0-06dd-4ecc-b506-0e0a520d91be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_98bc9125-eb0a-4202-8362-eb74dc4051ff" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_9bbed8e0-06dd-4ecc-b506-0e0a520d91be" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_40e42bbe-2a74-4a80-8608-284fe8a44ff0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_0e2dcc74-90a3-4ee8-bd8f-f63f26dcbb18" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_40e42bbe-2a74-4a80-8608-284fe8a44ff0" xlink:to="loc_us-gaap_Revenues_0e2dcc74-90a3-4ee8-bd8f-f63f26dcbb18" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue_819348de-be45-44bb-961d-c9d8826918d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfRevenue"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_40e42bbe-2a74-4a80-8608-284fe8a44ff0" xlink:to="loc_us-gaap_CostOfRevenue_819348de-be45-44bb-961d-c9d8826918d6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_b8f6d6e9-74a7-44f2-a954-bc8941e1c4ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_c4c6bd96-79f5-4632-93c0-71085eb610a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestIncomeExpenseNonoperatingNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_b8f6d6e9-74a7-44f2-a954-bc8941e1c4ec" xlink:to="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_c4c6bd96-79f5-4632-93c0-71085eb610a8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_082d1439-98c4-4f2a-8996-f8dd2d8d8081" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_b8f6d6e9-74a7-44f2-a954-bc8941e1c4ec" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_082d1439-98c4-4f2a-8996-f8dd2d8d8081" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_beedcb0e-761b-4128-a0a9-59082ad921a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_00b20fd5-1e26-4907-a544-7a5d814eba4d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_beedcb0e-761b-4128-a0a9-59082ad921a8" xlink:to="loc_us-gaap_OperatingIncomeLoss_00b20fd5-1e26-4907-a544-7a5d814eba4d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_3d196858-7be0-40b1-8d79-883d00964921" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_beedcb0e-761b-4128-a0a9-59082ad921a8" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_3d196858-7be0-40b1-8d79-883d00964921" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_aee9b548-90d1-4bf7-859c-4891a0d5e65a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_fb8c9b63-63a7-438d-aa46-052b02175eb2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_aee9b548-90d1-4bf7-859c-4891a0d5e65a" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_fb8c9b63-63a7-438d-aa46-052b02175eb2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_279fda0d-8335-4fa7-a111-b22dfc73a6f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_aee9b548-90d1-4bf7-859c-4891a0d5e65a" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_279fda0d-8335-4fa7-a111-b22dfc73a6f4" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUNAUDITED" xlink:type="simple" xlink:href="med-20220930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUNAUDITED"/>
  <link:calculationLink xlink:role="http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUNAUDITED" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_fd531838-9670-4f72-bd05-4ab99037165a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_970b47c1-c3a5-4923-a074-ecf5285f0a95" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_fd531838-9670-4f72-bd05-4ab99037165a" xlink:to="loc_us-gaap_NetIncomeLoss_970b47c1-c3a5-4923-a074-ecf5285f0a95" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_18e9aee3-6553-4ac8-9a38-02afad39f5dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_fd531838-9670-4f72-bd05-4ab99037165a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_18e9aee3-6553-4ac8-9a38-02afad39f5dc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_891d9e3d-afed-4d08-87fc-b59ab05bb8bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_cd0e3c68-82c8-4dda-815e-823aee9d7fd9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_891d9e3d-afed-4d08-87fc-b59ab05bb8bc" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_cd0e3c68-82c8-4dda-815e-823aee9d7fd9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_a58e66ce-690e-4522-9d89-2117c2829619" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_891d9e3d-afed-4d08-87fc-b59ab05bb8bc" xlink:to="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_a58e66ce-690e-4522-9d89-2117c2829619" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED" xlink:type="simple" xlink:href="med-20220930.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"/>
  <link:calculationLink xlink:role="http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_ee5c2359-48b9-4d70-8651-be7618ca996a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_66f97c2b-ad2d-48d3-83e0-906c4295f886" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_ee5c2359-48b9-4d70-8651-be7618ca996a" xlink:to="loc_us-gaap_AdditionalPaidInCapital_66f97c2b-ad2d-48d3-83e0-906c4295f886" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_05129f99-131c-4368-9b9f-28e93fcb58f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_ee5c2359-48b9-4d70-8651-be7618ca996a" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_05129f99-131c-4368-9b9f-28e93fcb58f6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_090951f2-08e0-4e69-ba36-184145af3837" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_ee5c2359-48b9-4d70-8651-be7618ca996a" xlink:to="loc_us-gaap_CommonStockValue_090951f2-08e0-4e69-ba36-184145af3837" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_3db204b2-8bf3-4e14-930b-0e88f38ecb57" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_ee5c2359-48b9-4d70-8651-be7618ca996a" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_3db204b2-8bf3-4e14-930b-0e88f38ecb57" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_94acf971-5e70-4c86-8ffd-8b420ca64fc6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_3faa2391-4757-4968-8812-85d2ffca2f32" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_94acf971-5e70-4c86-8ffd-8b420ca64fc6" xlink:to="loc_us-gaap_AssetsCurrent_3faa2391-4757-4968-8812-85d2ffca2f32" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_e0ba27ad-4810-48c9-bd7e-4456433004c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_94acf971-5e70-4c86-8ffd-8b420ca64fc6" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_e0ba27ad-4810-48c9-bd7e-4456433004c7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_e8679c06-9b50-42e6-96c6-d32f1ba7af36" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_94acf971-5e70-4c86-8ffd-8b420ca64fc6" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_e8679c06-9b50-42e6-96c6-d32f1ba7af36" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_4e69d76e-84a7-463d-937d-de0b1e0d51db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_94acf971-5e70-4c86-8ffd-8b420ca64fc6" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_4e69d76e-84a7-463d-937d-de0b1e0d51db" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_fb655c0f-8bfa-4d9a-8366-718ee5ffea60" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_94acf971-5e70-4c86-8ffd-8b420ca64fc6" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_fb655c0f-8bfa-4d9a-8366-718ee5ffea60" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_791dfc02-ed5b-4db0-a1e1-218458eb3baa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments_58f5de0b-f826-4a55-9d2c-7287e7e68671" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermInvestments"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_791dfc02-ed5b-4db0-a1e1-218458eb3baa" xlink:to="loc_us-gaap_ShortTermInvestments_58f5de0b-f826-4a55-9d2c-7287e7e68671" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_c4ea6be6-32fd-40fe-bec0-e1aac1005ac3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_791dfc02-ed5b-4db0-a1e1-218458eb3baa" xlink:to="loc_us-gaap_InventoryNet_c4ea6be6-32fd-40fe-bec0-e1aac1005ac3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidTaxes_bdae8a16-b09d-4534-9206-3f03b24c82e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidTaxes"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_791dfc02-ed5b-4db0-a1e1-218458eb3baa" xlink:to="loc_us-gaap_PrepaidTaxes_bdae8a16-b09d-4534-9206-3f03b24c82e7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_a84600a0-5f77-42ca-bc0b-1ae1313510f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_791dfc02-ed5b-4db0-a1e1-218458eb3baa" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_a84600a0-5f77-42ca-bc0b-1ae1313510f4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_c3f1aadf-ef35-4e2f-bc24-32cfeab47812" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_791dfc02-ed5b-4db0-a1e1-218458eb3baa" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_c3f1aadf-ef35-4e2f-bc24-32cfeab47812" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_c0e3b85f-e333-44f7-8d53-b5a24ba6227d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_f305d33c-5a8d-40d1-946f-f850c3abdb8b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_c0e3b85f-e333-44f7-8d53-b5a24ba6227d" xlink:to="loc_us-gaap_Liabilities_f305d33c-5a8d-40d1-946f-f850c3abdb8b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_639494c6-4dcf-4b4f-8af1-49a67993ecd9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_c0e3b85f-e333-44f7-8d53-b5a24ba6227d" xlink:to="loc_us-gaap_StockholdersEquity_639494c6-4dcf-4b4f-8af1-49a67993ecd9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_5148fa80-60d7-4ca6-9edf-ad252660eb55" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_d94fd7eb-35c1-443a-9d89-2d0bf92298c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_5148fa80-60d7-4ca6-9edf-ad252660eb55" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_d94fd7eb-35c1-443a-9d89-2d0bf92298c6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LinesOfCreditCurrent_864b7d45-759c-4b07-935f-eda82ee81843" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LinesOfCreditCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_5148fa80-60d7-4ca6-9edf-ad252660eb55" xlink:to="loc_us-gaap_LinesOfCreditCurrent_864b7d45-759c-4b07-935f-eda82ee81843" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_8f524c9a-26f3-4e5a-b68f-07d7397f3228" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_5148fa80-60d7-4ca6-9edf-ad252660eb55" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_8f524c9a-26f3-4e5a-b68f-07d7397f3228" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_36199173-e861-44e2-ad7c-5682b91e7ede" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_612d977d-1b17-4b42-b676-38ec0e84105e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_36199173-e861-44e2-ad7c-5682b91e7ede" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_612d977d-1b17-4b42-b676-38ec0e84105e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_9ab0d794-0c37-4f40-9686-2932debd7bdf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_36199173-e861-44e2-ad7c-5682b91e7ede" xlink:to="loc_us-gaap_LiabilitiesCurrent_9ab0d794-0c37-4f40-9686-2932debd7bdf" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" xlink:type="simple" xlink:href="med-20220930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"/>
  <link:calculationLink xlink:role="http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_1834fab6-9291-4954-a671-672d05c18e42" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfShortTermInvestments_1079be9d-4724-496f-a9e6-0a2a54f9e5c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfShortTermInvestments"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_1834fab6-9291-4954-a671-672d05c18e42" xlink:to="loc_us-gaap_ProceedsFromSaleOfShortTermInvestments_1079be9d-4724-496f-a9e6-0a2a54f9e5c9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_699527a3-b297-4877-99c4-ee2ba505ce97" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_1834fab6-9291-4954-a671-672d05c18e42" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_699527a3-b297-4877-99c4-ee2ba505ce97" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_12420b0a-0fe5-486c-86df-7419e270dc99" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_283bb76c-6020-437b-8224-2364963f64ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_12420b0a-0fe5-486c-86df-7419e270dc99" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_283bb76c-6020-437b-8224-2364963f64ae" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5a67e605-a402-4d9b-a810-30e963daa1de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_12420b0a-0fe5-486c-86df-7419e270dc99" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5a67e605-a402-4d9b-a810-30e963daa1de" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_8225b91d-d616-473d-a0a9-3b1024f717ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_12420b0a-0fe5-486c-86df-7419e270dc99" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_8225b91d-d616-473d-a0a9-3b1024f717ba" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_eacd294d-6cfe-46ca-b61c-deb3513b3363" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_12420b0a-0fe5-486c-86df-7419e270dc99" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_eacd294d-6cfe-46ca-b61c-deb3513b3363" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2f009398-b8ac-4633-95d0-6540797a7f66" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_76314941-3182-4b77-b6f6-235fda2e6e08" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2f009398-b8ac-4633-95d0-6540797a7f66" xlink:to="loc_us-gaap_NetIncomeLoss_76314941-3182-4b77-b6f6-235fda2e6e08" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_d8db07af-08ce-4345-9164-88089a9a6be6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2f009398-b8ac-4633-95d0-6540797a7f66" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_d8db07af-08ce-4345-9164-88089a9a6be6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_med_OperatingLeaseExpenseNonCash_dfd3e68a-20b7-4d91-82d9-359747a4ab23" xlink:href="med-20220930.xsd#med_OperatingLeaseExpenseNonCash"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2f009398-b8ac-4633-95d0-6540797a7f66" xlink:to="loc_med_OperatingLeaseExpenseNonCash_dfd3e68a-20b7-4d91-82d9-359747a4ab23" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_65edf2fe-b745-4a57-aeff-aca0099dc2d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2f009398-b8ac-4633-95d0-6540797a7f66" xlink:to="loc_us-gaap_ShareBasedCompensation_65edf2fe-b745-4a57-aeff-aca0099dc2d7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_med_AmortizationOfPremiumOnInvestmentSecurities_348a915e-2b56-414d-9355-64b47c86d77d" xlink:href="med-20220930.xsd#med_AmortizationOfPremiumOnInvestmentSecurities"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2f009398-b8ac-4633-95d0-6540797a7f66" xlink:to="loc_med_AmortizationOfPremiumOnInvestmentSecurities_348a915e-2b56-414d-9355-64b47c86d77d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_3fe03e2a-079a-42a4-b5c9-2a40dedca2af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2f009398-b8ac-4633-95d0-6540797a7f66" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_3fe03e2a-079a-42a4-b5c9-2a40dedca2af" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidTaxes_381a3287-9f2f-4313-8b6c-d2e460a4bbf3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidTaxes"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2f009398-b8ac-4633-95d0-6540797a7f66" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidTaxes_381a3287-9f2f-4313-8b6c-d2e460a4bbf3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_e1df90c1-16d2-48b0-a0ae-440a8b609ed1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2f009398-b8ac-4633-95d0-6540797a7f66" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_e1df90c1-16d2-48b0-a0ae-440a8b609ed1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_06ce5d8c-d4a5-43d7-b187-f951b5f44fd7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2f009398-b8ac-4633-95d0-6540797a7f66" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_06ce5d8c-d4a5-43d7-b187-f951b5f44fd7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_ac3cfd64-3e6c-435d-9671-ad7b2c9fbc32" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2f009398-b8ac-4633-95d0-6540797a7f66" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_ac3cfd64-3e6c-435d-9671-ad7b2c9fbc32" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_0c3ef6a0-125d-4005-9647-822092938a55" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2f009398-b8ac-4633-95d0-6540797a7f66" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_0c3ef6a0-125d-4005-9647-822092938a55" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_aa4d523a-72a0-4f8c-97e1-261706348c61" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfOtherEquity_e505bee9-2cf9-41c9-95f5-79f6c10ad3d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRepurchaseOfOtherEquity"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_aa4d523a-72a0-4f8c-97e1-261706348c61" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfOtherEquity_e505bee9-2cf9-41c9-95f5-79f6c10ad3d9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_45e1379f-caa7-4a8c-b3dd-7134479a96f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_aa4d523a-72a0-4f8c-97e1-261706348c61" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_45e1379f-caa7-4a8c-b3dd-7134479a96f3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_c4f5f061-0415-491b-b147-162d58333d20" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_aa4d523a-72a0-4f8c-97e1-261706348c61" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_c4f5f061-0415-491b-b147-162d58333d20" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividends_f11752f8-28ea-4d7e-9071-18986c4f52c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDividends"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_aa4d523a-72a0-4f8c-97e1-261706348c61" xlink:to="loc_us-gaap_PaymentsOfDividends_f11752f8-28ea-4d7e-9071-18986c4f52c6" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.medifast1.com/role/INVENTORIESDetails" xlink:type="simple" xlink:href="med-20220930.xsd#INVENTORIESDetails"/>
  <link:calculationLink xlink:role="http://www.medifast1.com/role/INVENTORIESDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_aee1da26-2f74-4d02-9c3f-dca0d8abf459" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterials_9653ff09-b11a-4008-a1c8-d8b6107f1786" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryRawMaterials"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_aee1da26-2f74-4d02-9c3f-dca0d8abf459" xlink:to="loc_us-gaap_InventoryRawMaterials_9653ff09-b11a-4008-a1c8-d8b6107f1786" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetailRelatedInventoryPackagingAndOtherSupplies_d8237071-b18d-4198-93dd-fb1f5cd6b567" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetailRelatedInventoryPackagingAndOtherSupplies"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_aee1da26-2f74-4d02-9c3f-dca0d8abf459" xlink:to="loc_us-gaap_RetailRelatedInventoryPackagingAndOtherSupplies_d8237071-b18d-4198-93dd-fb1f5cd6b567" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_med_InventoryNonFoodFinishedGoods_14744e0e-d55f-4ad4-9ade-9ea0bec2005f" xlink:href="med-20220930.xsd#med_InventoryNonFoodFinishedGoods"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_aee1da26-2f74-4d02-9c3f-dca0d8abf459" xlink:to="loc_med_InventoryNonFoodFinishedGoods_14744e0e-d55f-4ad4-9ade-9ea0bec2005f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoods_43d68f31-1f53-498e-a0c4-6c18882a7a16" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryFinishedGoods"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_aee1da26-2f74-4d02-9c3f-dca0d8abf459" xlink:to="loc_us-gaap_InventoryFinishedGoods_43d68f31-1f53-498e-a0c4-6c18882a7a16" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryValuationReserves_ee25f957-041b-43b8-b466-9b82ada310bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryValuationReserves"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_aee1da26-2f74-4d02-9c3f-dca0d8abf459" xlink:to="loc_us-gaap_InventoryValuationReserves_ee25f957-041b-43b8-b466-9b82ada310bf" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.medifast1.com/role/EARNINGSPERSHAREComputationofBasicandDilutedEPSDetails" xlink:type="simple" xlink:href="med-20220930.xsd#EARNINGSPERSHAREComputationofBasicandDilutedEPSDetails"/>
  <link:calculationLink xlink:role="http://www.medifast1.com/role/EARNINGSPERSHAREComputationofBasicandDilutedEPSDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_f4498d88-7e3f-4960-a15b-d47df111a9b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_b57db3ba-5efe-422e-bec9-89cab9f8919b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_f4498d88-7e3f-4960-a15b-d47df111a9b5" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_b57db3ba-5efe-422e-bec9-89cab9f8919b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_f10ae389-cc54-449c-abd8-c4f660c1043b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_f4498d88-7e3f-4960-a15b-d47df111a9b5" xlink:to="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_f10ae389-cc54-449c-abd8-c4f660c1043b" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.medifast1.com/role/LEASESFutureMinimumLeaseCommitmentsDetails" xlink:type="simple" xlink:href="med-20220930.xsd#LEASESFutureMinimumLeaseCommitmentsDetails"/>
  <link:calculationLink xlink:role="http://www.medifast1.com/role/LEASESFutureMinimumLeaseCommitmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_60842d76-fb83-44e4-bfad-e4a690bd38d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_eeec93ff-ec5f-4d5a-90b8-b88e03d3a1ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_60842d76-fb83-44e4-bfad-e4a690bd38d7" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_eeec93ff-ec5f-4d5a-90b8-b88e03d3a1ae" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_375d0973-0569-49bc-9ae7-683015fc677d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_60842d76-fb83-44e4-bfad-e4a690bd38d7" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_375d0973-0569-49bc-9ae7-683015fc677d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_355f11a0-5fc9-4a7e-aaa3-ab4cd90a06b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_60842d76-fb83-44e4-bfad-e4a690bd38d7" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_355f11a0-5fc9-4a7e-aaa3-ab4cd90a06b9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_13dcc5b1-9dd9-4772-bde3-98b5e8e3c5f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_60842d76-fb83-44e4-bfad-e4a690bd38d7" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_13dcc5b1-9dd9-4772-bde3-98b5e8e3c5f5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_7324adc9-405e-40f4-94d2-92953624c62d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_60842d76-fb83-44e4-bfad-e4a690bd38d7" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_7324adc9-405e-40f4-94d2-92953624c62d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_med_LesseeOperatingLeaseLiabilityPaymentsDueYearFiveAndAfterYearFive_10584ae6-79f5-4f58-bb4f-3fd26c963b7e" xlink:href="med-20220930.xsd#med_LesseeOperatingLeaseLiabilityPaymentsDueYearFiveAndAfterYearFive"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_60842d76-fb83-44e4-bfad-e4a690bd38d7" xlink:to="loc_med_LesseeOperatingLeaseLiabilityPaymentsDueYearFiveAndAfterYearFive_10584ae6-79f5-4f58-bb4f-3fd26c963b7e" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.medifast1.com/role/LEASESFutureMinimumLeaseCommitmentsDetails_1" xlink:type="simple" xlink:href="med-20220930.xsd#LEASESFutureMinimumLeaseCommitmentsDetails_1"/>
  <link:calculationLink xlink:role="http://www.medifast1.com/role/LEASESFutureMinimumLeaseCommitmentsDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_d9d68f55-31c4-418c-a2de-f2547f4f71f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_83df2a5e-cc8e-4e2f-be56-769aab478194" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_d9d68f55-31c4-418c-a2de-f2547f4f71f7" xlink:to="loc_us-gaap_OperatingLeaseLiability_83df2a5e-cc8e-4e2f-be56-769aab478194" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0d3f4ff0-f63d-4bd9-8c46-eabc01be7ba0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_d9d68f55-31c4-418c-a2de-f2547f4f71f7" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0d3f4ff0-f63d-4bd9-8c46-eabc01be7ba0" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>7
<FILENAME>med-20220930_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:1ae599f9-ff00-4d75-90b9-110349ab0236,g:6d08fa26-e8d0-4031-9c9e-a858e7464a0f-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYUNAUDITED" xlink:type="simple" xlink:href="med-20220930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYUNAUDITED"/>
  <link:definitionLink xlink:role="http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYUNAUDITED" xlink:type="extended" id="i3e9ef29b99c94ea984fadd87682dd094_CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYUNAUDITED">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_ef1bcf94-5607-4a12-9bb2-693e92551716" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b1c3ec23-26ff-4327-9b88-a8a431832129" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_ef1bcf94-5607-4a12-9bb2-693e92551716" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b1c3ec23-26ff-4327-9b88-a8a431832129" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_743342ae-fe92-4644-b55f-bc19e2c00e9e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b1c3ec23-26ff-4327-9b88-a8a431832129" xlink:to="loc_us-gaap_CommonStockSharesIssued_743342ae-fe92-4644-b55f-bc19e2c00e9e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_cd3f3789-01ee-4ba1-980f-cfc2093c7751" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b1c3ec23-26ff-4327-9b88-a8a431832129" xlink:to="loc_us-gaap_StockholdersEquity_cd3f3789-01ee-4ba1-980f-cfc2093c7751" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_c4d792f2-9bff-4f27-b0ea-3fbce42e507e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b1c3ec23-26ff-4327-9b88-a8a431832129" xlink:to="loc_us-gaap_NetIncomeLoss_c4d792f2-9bff-4f27-b0ea-3fbce42e507e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_cc86e065-9ea2-4cf1-8a55-6bb0d22c5137" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b1c3ec23-26ff-4327-9b88-a8a431832129" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_cc86e065-9ea2-4cf1-8a55-6bb0d22c5137" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions_c1c6b055-2a0c-403b-a3a4-430810f41df5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b1c3ec23-26ff-4327-9b88-a8a431832129" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions_c1c6b055-2a0c-403b-a3a4-430810f41df5" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_24e7654d-15ae-4b05-8a27-e0f8f62db557" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b1c3ec23-26ff-4327-9b88-a8a431832129" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_24e7654d-15ae-4b05-8a27-e0f8f62db557" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_ff80789f-788d-4b1c-917d-0a686da9fb78" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b1c3ec23-26ff-4327-9b88-a8a431832129" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_ff80789f-788d-4b1c-917d-0a686da9fb78" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_4e53a392-e5a4-4e38-b8ba-63d3e4263dac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b1c3ec23-26ff-4327-9b88-a8a431832129" xlink:to="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_4e53a392-e5a4-4e38-b8ba-63d3e4263dac" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_5d7feaaa-7145-49f8-a309-86f0f014ae93" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b1c3ec23-26ff-4327-9b88-a8a431832129" xlink:to="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_5d7feaaa-7145-49f8-a309-86f0f014ae93" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_3debd9d6-6b7e-44b9-8ffc-092c270e52d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b1c3ec23-26ff-4327-9b88-a8a431832129" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_3debd9d6-6b7e-44b9-8ffc-092c270e52d1" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesRetired_e5c3aeb2-a0cd-46bf-9c1b-f4fb40f05300" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockSharesRetired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b1c3ec23-26ff-4327-9b88-a8a431832129" xlink:to="loc_us-gaap_TreasuryStockSharesRetired_e5c3aeb2-a0cd-46bf-9c1b-f4fb40f05300" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockRetiredCostMethodAmount_757350d8-8987-4d0f-aa05-8c3d0c67826c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockRetiredCostMethodAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b1c3ec23-26ff-4327-9b88-a8a431832129" xlink:to="loc_us-gaap_TreasuryStockRetiredCostMethodAmount_757350d8-8987-4d0f-aa05-8c3d0c67826c" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_med_AdjustmentsToPaidInCapitalShareRepurchasesNotYetSettled_5ae06770-d9d8-4aa4-be2b-73c1ed1353eb" xlink:href="med-20220930.xsd#med_AdjustmentsToPaidInCapitalShareRepurchasesNotYetSettled"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b1c3ec23-26ff-4327-9b88-a8a431832129" xlink:to="loc_med_AdjustmentsToPaidInCapitalShareRepurchasesNotYetSettled_5ae06770-d9d8-4aa4-be2b-73c1ed1353eb" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchaseProgramAdjustment_227898df-1199-484a-8e9f-6e3be1c19349" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcceleratedShareRepurchaseProgramAdjustment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b1c3ec23-26ff-4327-9b88-a8a431832129" xlink:to="loc_us-gaap_AcceleratedShareRepurchaseProgramAdjustment_227898df-1199-484a-8e9f-6e3be1c19349" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_f185b45f-b6d0-4b55-82cb-4d089ae0af3e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b1c3ec23-26ff-4327-9b88-a8a431832129" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_f185b45f-b6d0-4b55-82cb-4d089ae0af3e" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash_04f9ef3d-83d1-4efb-ae8e-c83713ea0cb4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b1c3ec23-26ff-4327-9b88-a8a431832129" xlink:to="loc_us-gaap_DividendsCommonStockCash_04f9ef3d-83d1-4efb-ae8e-c83713ea0cb4" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_4c4fd010-4be7-4a24-bda2-deb99b7c269a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_00019b0b-4e91-49b9-940a-90ed1b46675c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_cc2e2bc7-1fc9-4f06-9e8c-842829561748" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_ef1bcf94-5607-4a12-9bb2-693e92551716" xlink:to="loc_us-gaap_StatementTable_cc2e2bc7-1fc9-4f06-9e8c-842829561748" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_2ee8d58b-c072-494e-82ac-94d7a48728c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_cc2e2bc7-1fc9-4f06-9e8c-842829561748" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_2ee8d58b-c072-494e-82ac-94d7a48728c3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_2ee8d58b-c072-494e-82ac-94d7a48728c3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_2ee8d58b-c072-494e-82ac-94d7a48728c3" xlink:to="loc_us-gaap_EquityComponentDomain_2ee8d58b-c072-494e-82ac-94d7a48728c3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_bbe90df0-21fa-4cd9-a6e1-83724a94d4a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_2ee8d58b-c072-494e-82ac-94d7a48728c3" xlink:to="loc_us-gaap_EquityComponentDomain_bbe90df0-21fa-4cd9-a6e1-83724a94d4a5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_2931acc5-9521-4eb1-883d-b06be80865fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_bbe90df0-21fa-4cd9-a6e1-83724a94d4a5" xlink:to="loc_us-gaap_CommonStockMember_2931acc5-9521-4eb1-883d-b06be80865fa" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_521f9a16-2223-47e3-ae94-03271ab8868a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_bbe90df0-21fa-4cd9-a6e1-83724a94d4a5" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_521f9a16-2223-47e3-ae94-03271ab8868a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_b8863288-2d35-4010-a52a-1c2a58c7b4fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_bbe90df0-21fa-4cd9-a6e1-83724a94d4a5" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_b8863288-2d35-4010-a52a-1c2a58c7b4fe" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_9a523ca0-460c-4145-806d-bc5453bd9719" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_bbe90df0-21fa-4cd9-a6e1-83724a94d4a5" xlink:to="loc_us-gaap_RetainedEarningsMember_9a523ca0-460c-4145-806d-bc5453bd9719" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonMember_472e82f1-728e-46b3-8fde-b6a9f405948b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockCommonMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_bbe90df0-21fa-4cd9-a6e1-83724a94d4a5" xlink:to="loc_us-gaap_TreasuryStockCommonMember_472e82f1-728e-46b3-8fde-b6a9f405948b" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.medifast1.com/role/EARNINGSPERSHARENarrativeDetails" xlink:type="simple" xlink:href="med-20220930.xsd#EARNINGSPERSHARENarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.medifast1.com/role/EARNINGSPERSHARENarrativeDetails" xlink:type="extended" id="i9382a1a8aca74d7da1cb7f7b17257fc6_EARNINGSPERSHARENarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_1fb4cd38-ff04-4b18-8ca0-8f089d21b3a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_68fcae99-001f-43ce-bc8b-bcd6fc46633e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1fb4cd38-ff04-4b18-8ca0-8f089d21b3a0" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_68fcae99-001f-43ce-bc8b-bcd6fc46633e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_734c6744-9473-4c3e-8b29-a1346011f2da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_1fb4cd38-ff04-4b18-8ca0-8f089d21b3a0" xlink:to="loc_us-gaap_StatementTable_734c6744-9473-4c3e-8b29-a1346011f2da" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_29f5df8a-2b78-4b5d-b0fa-aa37a2cf4661" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_734c6744-9473-4c3e-8b29-a1346011f2da" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_29f5df8a-2b78-4b5d-b0fa-aa37a2cf4661" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_29f5df8a-2b78-4b5d-b0fa-aa37a2cf4661_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_29f5df8a-2b78-4b5d-b0fa-aa37a2cf4661" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_29f5df8a-2b78-4b5d-b0fa-aa37a2cf4661_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_6adcb098-dc2f-4a53-8f0f-0861bfcf659d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_29f5df8a-2b78-4b5d-b0fa-aa37a2cf4661" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_6adcb098-dc2f-4a53-8f0f-0861bfcf659d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_187fe810-a525-4f52-8c20-26bf0fe37afb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_6adcb098-dc2f-4a53-8f0f-0861bfcf659d" xlink:to="loc_us-gaap_RestrictedStockMember_187fe810-a525-4f52-8c20-26bf0fe37afb" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails" xlink:type="simple" xlink:href="med-20220930.xsd#SHAREBASEDCOMPENSATIONNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails" xlink:type="extended" id="i064d28e2e07c4e3caf3194bb3c2920e7_SHAREBASEDCOMPENSATIONNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a859e31a-768c-40ff-9295-46c70eb828d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_18d7df5f-a532-4d62-8d6f-651f86a7c45e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a859e31a-768c-40ff-9295-46c70eb828d0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_18d7df5f-a532-4d62-8d6f-651f86a7c45e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_f3791204-ee87-47a1-b54a-a5bd73addaf5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a859e31a-768c-40ff-9295-46c70eb828d0" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_f3791204-ee87-47a1-b54a-a5bd73addaf5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_431433f6-5126-4070-b8f0-d9b4d5a56421" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a859e31a-768c-40ff-9295-46c70eb828d0" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_431433f6-5126-4070-b8f0-d9b4d5a56421" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_314b0954-bb88-40e5-b43b-6c12fb2ba7a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a859e31a-768c-40ff-9295-46c70eb828d0" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_314b0954-bb88-40e5-b43b-6c12fb2ba7a7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_15bd26c3-402e-4624-809c-f8a272573833" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a859e31a-768c-40ff-9295-46c70eb828d0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_15bd26c3-402e-4624-809c-f8a272573833" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_3cafed22-4b7d-421f-be73-cf7fb74b6e08" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a859e31a-768c-40ff-9295-46c70eb828d0" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_3cafed22-4b7d-421f-be73-cf7fb74b6e08" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_2b618cb7-aa5b-433d-8ede-7ab504226a0c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a859e31a-768c-40ff-9295-46c70eb828d0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_2b618cb7-aa5b-433d-8ede-7ab504226a0c" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_4173137c-a311-48df-828b-d93eb8f8f9a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a859e31a-768c-40ff-9295-46c70eb828d0" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_4173137c-a311-48df-828b-d93eb8f8f9a2" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_07be1230-0619-4d69-85d0-7f5eb1ac1c24" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a859e31a-768c-40ff-9295-46c70eb828d0" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_07be1230-0619-4d69-85d0-7f5eb1ac1c24" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_c4cf26fc-88fd-4a26-96d2-18515c9c7f64" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a859e31a-768c-40ff-9295-46c70eb828d0" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_c4cf26fc-88fd-4a26-96d2-18515c9c7f64" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_b2624baa-9470-4de7-9bdb-fe48253877ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a859e31a-768c-40ff-9295-46c70eb828d0" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_b2624baa-9470-4de7-9bdb-fe48253877ac" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_0d1ac0bc-b425-4ace-a08f-98aedb55ce0c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a859e31a-768c-40ff-9295-46c70eb828d0" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_0d1ac0bc-b425-4ace-a08f-98aedb55ce0c" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_f84f7485-acc7-47b6-a0dc-b9f88d2bcdde" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a859e31a-768c-40ff-9295-46c70eb828d0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_f84f7485-acc7-47b6-a0dc-b9f88d2bcdde" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_753eca97-a699-424a-850c-7133dab2d96c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a859e31a-768c-40ff-9295-46c70eb828d0" xlink:to="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_753eca97-a699-424a-850c-7133dab2d96c" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_e12e85dd-4b3f-4365-9440-d07d53487301" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a859e31a-768c-40ff-9295-46c70eb828d0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_e12e85dd-4b3f-4365-9440-d07d53487301" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_med_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesEarnedPercentage_eb1cc02d-4f37-4024-971c-43d6efa60f56" xlink:href="med-20220930.xsd#med_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesEarnedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a859e31a-768c-40ff-9295-46c70eb828d0" xlink:to="loc_med_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesEarnedPercentage_eb1cc02d-4f37-4024-971c-43d6efa60f56" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_med_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesEarnedPerformancePeriod_7aad7c4e-e9f0-4534-afc9-be5c8bcc17d7" xlink:href="med-20220930.xsd#med_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesEarnedPerformancePeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a859e31a-768c-40ff-9295-46c70eb828d0" xlink:to="loc_med_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesEarnedPerformancePeriod_7aad7c4e-e9f0-4534-afc9-be5c8bcc17d7" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_f74eb03c-9245-4d3d-99d5-97b75b8ec2f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a859e31a-768c-40ff-9295-46c70eb828d0" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_f74eb03c-9245-4d3d-99d5-97b75b8ec2f6" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_9e70f8ff-fc53-495b-b9e9-4fd46b1a362e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a859e31a-768c-40ff-9295-46c70eb828d0" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_9e70f8ff-fc53-495b-b9e9-4fd46b1a362e" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_861e086f-2278-4ca0-b1e7-c2911bb97508" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a859e31a-768c-40ff-9295-46c70eb828d0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_861e086f-2278-4ca0-b1e7-c2911bb97508" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_e512f51d-bd57-431f-bede-d8516d4b0088" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a859e31a-768c-40ff-9295-46c70eb828d0" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_e512f51d-bd57-431f-bede-d8516d4b0088" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_9227d7a0-4cd1-4a02-80d9-179e9e45d5fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_e512f51d-bd57-431f-bede-d8516d4b0088" xlink:to="loc_us-gaap_AwardTypeAxis_9227d7a0-4cd1-4a02-80d9-179e9e45d5fd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9227d7a0-4cd1-4a02-80d9-179e9e45d5fd_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_9227d7a0-4cd1-4a02-80d9-179e9e45d5fd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9227d7a0-4cd1-4a02-80d9-179e9e45d5fd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_78c18b21-87b5-42e2-817f-eab49b4a1716" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_9227d7a0-4cd1-4a02-80d9-179e9e45d5fd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_78c18b21-87b5-42e2-817f-eab49b4a1716" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_34a35bd3-d7b4-4bed-a72c-0f10616d7390" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_78c18b21-87b5-42e2-817f-eab49b4a1716" xlink:to="loc_us-gaap_EmployeeStockOptionMember_34a35bd3-d7b4-4bed-a72c-0f10616d7390" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_9940262e-b058-4587-8221-a6c2d8f98d41" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_78c18b21-87b5-42e2-817f-eab49b4a1716" xlink:to="loc_us-gaap_RestrictedStockMember_9940262e-b058-4587-8221-a6c2d8f98d41" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_69547e95-6c33-49f3-93f2-d8cad5ba3cd1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PerformanceSharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_78c18b21-87b5-42e2-817f-eab49b4a1716" xlink:to="loc_us-gaap_PerformanceSharesMember_69547e95-6c33-49f3-93f2-d8cad5ba3cd1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_434a7827-d1a1-4d05-b0da-3b61a3b2bfca" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_e512f51d-bd57-431f-bede-d8516d4b0088" xlink:to="loc_srt_RangeAxis_434a7827-d1a1-4d05-b0da-3b61a3b2bfca" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_434a7827-d1a1-4d05-b0da-3b61a3b2bfca_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_434a7827-d1a1-4d05-b0da-3b61a3b2bfca" xlink:to="loc_srt_RangeMember_434a7827-d1a1-4d05-b0da-3b61a3b2bfca_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_9d93998c-c62d-4421-9908-548393944415" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_434a7827-d1a1-4d05-b0da-3b61a3b2bfca" xlink:to="loc_srt_RangeMember_9d93998c-c62d-4421-9908-548393944415" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_0c1bee4f-5b11-49b2-ae2b-55cc9f8bc00a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_9d93998c-c62d-4421-9908-548393944415" xlink:to="loc_srt_MinimumMember_0c1bee4f-5b11-49b2-ae2b-55cc9f8bc00a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_5502ab48-2798-46c9-8f39-9dc15a07476c" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_9d93998c-c62d-4421-9908-548393944415" xlink:to="loc_srt_MaximumMember_5502ab48-2798-46c9-8f39-9dc15a07476c" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONRestrictedStockActivityDetails" xlink:type="simple" xlink:href="med-20220930.xsd#SHAREBASEDCOMPENSATIONRestrictedStockActivityDetails"/>
  <link:definitionLink xlink:role="http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONRestrictedStockActivityDetails" xlink:type="extended" id="i050d13120de141b9aaedbb8574ff6cf6_SHAREBASEDCOMPENSATIONRestrictedStockActivityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_d88f3c57-5f84-4fcc-88b4-656a976d24c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_4bef2596-d15e-4853-a3f7-d4039a043fa6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_d88f3c57-5f84-4fcc-88b4-656a976d24c7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_4bef2596-d15e-4853-a3f7-d4039a043fa6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_457f41ff-1e7c-462c-be24-7ff84bbf8f28" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_4bef2596-d15e-4853-a3f7-d4039a043fa6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_457f41ff-1e7c-462c-be24-7ff84bbf8f28" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_1a87ab17-1f49-4161-8224-e0d626e6c12c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_4bef2596-d15e-4853-a3f7-d4039a043fa6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_1a87ab17-1f49-4161-8224-e0d626e6c12c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_d5cc0eec-6121-435f-a90c-4b91e2d40565" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_4bef2596-d15e-4853-a3f7-d4039a043fa6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_d5cc0eec-6121-435f-a90c-4b91e2d40565" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_ba58c422-d8a2-4379-ad94-3cc294369321" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_4bef2596-d15e-4853-a3f7-d4039a043fa6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_ba58c422-d8a2-4379-ad94-3cc294369321" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_0b25d288-714d-45fc-ab15-d8e8d25d6541" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_37d523f9-ab3b-49d4-972a-7cf384bc8c33" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_d88f3c57-5f84-4fcc-88b4-656a976d24c7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_37d523f9-ab3b-49d4-972a-7cf384bc8c33" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_b6025cae-4ebb-48ad-87ed-aa1d7e1d9bc5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_37d523f9-ab3b-49d4-972a-7cf384bc8c33" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_b6025cae-4ebb-48ad-87ed-aa1d7e1d9bc5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_8261ddc3-aeb3-4a99-bbbd-8401e507d664" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_37d523f9-ab3b-49d4-972a-7cf384bc8c33" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_8261ddc3-aeb3-4a99-bbbd-8401e507d664" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_cab9f988-466d-4073-9d25-cce944a8c059" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_37d523f9-ab3b-49d4-972a-7cf384bc8c33" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_cab9f988-466d-4073-9d25-cce944a8c059" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_4a7b627f-bf01-4a65-b117-fffd2c8faced" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_37d523f9-ab3b-49d4-972a-7cf384bc8c33" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_4a7b627f-bf01-4a65-b117-fffd2c8faced" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_e5817817-7ad6-443d-b4a9-775e9eaa6b4f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_98f083be-d321-4131-82c7-d5b6bcb2df12" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_d88f3c57-5f84-4fcc-88b4-656a976d24c7" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_98f083be-d321-4131-82c7-d5b6bcb2df12" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_030e319c-9db4-4fdb-86ce-997ca5014b95" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_98f083be-d321-4131-82c7-d5b6bcb2df12" xlink:to="loc_us-gaap_AwardTypeAxis_030e319c-9db4-4fdb-86ce-997ca5014b95" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_030e319c-9db4-4fdb-86ce-997ca5014b95_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_030e319c-9db4-4fdb-86ce-997ca5014b95" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_030e319c-9db4-4fdb-86ce-997ca5014b95_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6a65bcb1-32b2-4617-9555-64774f37f87d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_030e319c-9db4-4fdb-86ce-997ca5014b95" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6a65bcb1-32b2-4617-9555-64774f37f87d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_a2fb4b4d-9008-4e25-b189-bac681115a95" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6a65bcb1-32b2-4617-9555-64774f37f87d" xlink:to="loc_us-gaap_RestrictedStockMember_a2fb4b4d-9008-4e25-b189-bac681115a95" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONSummaryofPerformancebasedShareAwardsDetails" xlink:type="simple" xlink:href="med-20220930.xsd#SHAREBASEDCOMPENSATIONSummaryofPerformancebasedShareAwardsDetails"/>
  <link:definitionLink xlink:role="http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONSummaryofPerformancebasedShareAwardsDetails" xlink:type="extended" id="ide4d0163184744aaacb3effcdc3764e3_SHAREBASEDCOMPENSATIONSummaryofPerformancebasedShareAwardsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a2b4f832-fa54-460e-ad50-3e0ea47ab0c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_38cc16a6-b2a2-40fc-845f-fee918ea8280" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a2b4f832-fa54-460e-ad50-3e0ea47ab0c7" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_38cc16a6-b2a2-40fc-845f-fee918ea8280" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_00aab1fa-42ac-429d-bc4f-8b04de7ddb68" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a2b4f832-fa54-460e-ad50-3e0ea47ab0c7" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_00aab1fa-42ac-429d-bc4f-8b04de7ddb68" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3cb9229a-7092-48d1-81be-4160f7ae691f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a2b4f832-fa54-460e-ad50-3e0ea47ab0c7" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3cb9229a-7092-48d1-81be-4160f7ae691f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_691b1cbe-c961-4649-a5c5-0c5ca3cac073" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3cb9229a-7092-48d1-81be-4160f7ae691f" xlink:to="loc_us-gaap_AwardTypeAxis_691b1cbe-c961-4649-a5c5-0c5ca3cac073" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_691b1cbe-c961-4649-a5c5-0c5ca3cac073_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_691b1cbe-c961-4649-a5c5-0c5ca3cac073" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_691b1cbe-c961-4649-a5c5-0c5ca3cac073_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_61fa37e2-45aa-4486-b47f-75f42d22313f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_691b1cbe-c961-4649-a5c5-0c5ca3cac073" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_61fa37e2-45aa-4486-b47f-75f42d22313f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_med_OptionsAndRestrictedStockMember_82e8d0aa-3214-47b7-af2d-23d90ee0edfa" xlink:href="med-20220930.xsd#med_OptionsAndRestrictedStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_61fa37e2-45aa-4486-b47f-75f42d22313f" xlink:to="loc_med_OptionsAndRestrictedStockMember_82e8d0aa-3214-47b7-af2d-23d90ee0edfa" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_med_MarketAndPerformanceSharesMember_d0445e3b-3287-4add-b987-3d902eabc616" xlink:href="med-20220930.xsd#med_MarketAndPerformanceSharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_61fa37e2-45aa-4486-b47f-75f42d22313f" xlink:to="loc_med_MarketAndPerformanceSharesMember_d0445e3b-3287-4add-b987-3d902eabc616" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_615f68d1-2927-46dc-bc42-6f4e09d15cca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PerformanceSharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_61fa37e2-45aa-4486-b47f-75f42d22313f" xlink:to="loc_us-gaap_PerformanceSharesMember_615f68d1-2927-46dc-bc42-6f4e09d15cca" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardDateAxis_3a8ac5b1-786f-4c05-af33-b0a782720115" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardDateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3cb9229a-7092-48d1-81be-4160f7ae691f" xlink:to="loc_us-gaap_AwardDateAxis_3a8ac5b1-786f-4c05-af33-b0a782720115" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardDateDomain_3a8ac5b1-786f-4c05-af33-b0a782720115_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardDateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardDateAxis_3a8ac5b1-786f-4c05-af33-b0a782720115" xlink:to="loc_us-gaap_AwardDateDomain_3a8ac5b1-786f-4c05-af33-b0a782720115_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardDateDomain_f0710092-d33b-4aa9-94ad-b25c600f81f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardDateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardDateAxis_3a8ac5b1-786f-4c05-af33-b0a782720115" xlink:to="loc_us-gaap_AwardDateDomain_f0710092-d33b-4aa9-94ad-b25c600f81f4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_med_GrantedIn2022Member_70d995a3-488b-4606-b46c-9f67b7d0c847" xlink:href="med-20220930.xsd#med_GrantedIn2022Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AwardDateDomain_f0710092-d33b-4aa9-94ad-b25c600f81f4" xlink:to="loc_med_GrantedIn2022Member_70d995a3-488b-4606-b46c-9f67b7d0c847" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_med_GrantedIn2021Member_03ebd95e-0d5a-48d5-b273-95b1f51c6f09" xlink:href="med-20220930.xsd#med_GrantedIn2021Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AwardDateDomain_f0710092-d33b-4aa9-94ad-b25c600f81f4" xlink:to="loc_med_GrantedIn2021Member_03ebd95e-0d5a-48d5-b273-95b1f51c6f09" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_med_GrantedIn2020Member_135599fe-8ff1-4a19-8e51-66d87813b434" xlink:href="med-20220930.xsd#med_GrantedIn2020Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AwardDateDomain_f0710092-d33b-4aa9-94ad-b25c600f81f4" xlink:to="loc_med_GrantedIn2020Member_135599fe-8ff1-4a19-8e51-66d87813b434" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_med_GrantedIn2019Member_225ff279-7871-41d6-8ff3-7e704bee4f8c" xlink:href="med-20220930.xsd#med_GrantedIn2019Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AwardDateDomain_f0710092-d33b-4aa9-94ad-b25c600f81f4" xlink:to="loc_med_GrantedIn2019Member_225ff279-7871-41d6-8ff3-7e704bee4f8c" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.medifast1.com/role/LEASESNarrativeDetails" xlink:type="simple" xlink:href="med-20220930.xsd#LEASESNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.medifast1.com/role/LEASESNarrativeDetails" xlink:type="extended" id="i2c3208c7578b4c75a6f22c910322c078_LEASESNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_f281a03b-d7cc-498f-817e-a5f1178e2a88" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract_d4f99609-e577-4d48-a0cc-d9fdc1ffa8c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_f281a03b-d7cc-498f-817e-a5f1178e2a88" xlink:to="loc_us-gaap_LesseeOperatingLeaseTermOfContract_d4f99609-e577-4d48-a0cc-d9fdc1ffa8c6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseExpense_d4bbebef-ad73-493f-9218-4736c921b383" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_f281a03b-d7cc-498f-817e-a5f1178e2a88" xlink:to="loc_us-gaap_OperatingLeaseExpense_d4bbebef-ad73-493f-9218-4736c921b383" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_a2a36be5-921c-4f6e-9593-482cbd8d5ce3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_f281a03b-d7cc-498f-817e-a5f1178e2a88" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_a2a36be5-921c-4f6e-9593-482cbd8d5ce3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_ceab0b8f-7c76-4424-8b55-96c11a184733" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_a2a36be5-921c-4f6e-9593-482cbd8d5ce3" xlink:to="loc_srt_RangeAxis_ceab0b8f-7c76-4424-8b55-96c11a184733" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_ceab0b8f-7c76-4424-8b55-96c11a184733_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_ceab0b8f-7c76-4424-8b55-96c11a184733" xlink:to="loc_srt_RangeMember_ceab0b8f-7c76-4424-8b55-96c11a184733_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_05f000c3-caa5-4ec5-a30a-db482c9d1509" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_ceab0b8f-7c76-4424-8b55-96c11a184733" xlink:to="loc_srt_RangeMember_05f000c3-caa5-4ec5-a30a-db482c9d1509" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_1985a2e7-5817-42b5-8c90-ea5f2cae5c71" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_05f000c3-caa5-4ec5-a30a-db482c9d1509" xlink:to="loc_srt_MinimumMember_1985a2e7-5817-42b5-8c90-ea5f2cae5c71" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_af3fa3e0-ef5b-4ee2-8257-3f9827379b25" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_05f000c3-caa5-4ec5-a30a-db482c9d1509" xlink:to="loc_srt_MaximumMember_af3fa3e0-ef5b-4ee2-8257-3f9827379b25" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_06efee69-f1fd-43e5-a620-2d7a28e4ccb1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_a2a36be5-921c-4f6e-9593-482cbd8d5ce3" xlink:to="loc_us-gaap_TypeOfArrangementAxis_06efee69-f1fd-43e5-a620-2d7a28e4ccb1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_06efee69-f1fd-43e5-a620-2d7a28e4ccb1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TypeOfArrangementAxis_06efee69-f1fd-43e5-a620-2d7a28e4ccb1" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_06efee69-f1fd-43e5-a620-2d7a28e4ccb1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_d2cf44f0-de7b-4c72-bce7-11cc0c75d8c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TypeOfArrangementAxis_06efee69-f1fd-43e5-a620-2d7a28e4ccb1" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_d2cf44f0-de7b-4c72-bce7-11cc0c75d8c8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_med_OperatingLeaseArrangementForRealEstateMember_d37313c5-4809-4bc7-adce-877787f4e259" xlink:href="med-20220930.xsd#med_OperatingLeaseArrangementForRealEstateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_d2cf44f0-de7b-4c72-bce7-11cc0c75d8c8" xlink:to="loc_med_OperatingLeaseArrangementForRealEstateMember_d37313c5-4809-4bc7-adce-877787f4e259" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_med_OperatingLeaseArrangementForEquipmentMember_0dcd464d-ea9d-4bf6-a905-157d14c46500" xlink:href="med-20220930.xsd#med_OperatingLeaseArrangementForEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_d2cf44f0-de7b-4c72-bce7-11cc0c75d8c8" xlink:to="loc_med_OperatingLeaseArrangementForEquipmentMember_0dcd464d-ea9d-4bf6-a905-157d14c46500" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.medifast1.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMEAccumulatedOtherComprehensiveIncomeDetails" xlink:type="simple" xlink:href="med-20220930.xsd#ACCUMULATEDOTHERCOMPREHENSIVEINCOMEAccumulatedOtherComprehensiveIncomeDetails"/>
  <link:definitionLink xlink:role="http://www.medifast1.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMEAccumulatedOtherComprehensiveIncomeDetails" xlink:type="extended" id="i917708d4047d4d5499feb7a7854dbdbc_ACCUMULATEDOTHERCOMPREHENSIVEINCOMEAccumulatedOtherComprehensiveIncomeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_fb07f6b3-61da-47d2-8e4c-c61a6d396b99" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_d95bbc9b-d05a-416a-8f26-5722195f01dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_fb07f6b3-61da-47d2-8e4c-c61a6d396b99" xlink:to="loc_us-gaap_StockholdersEquity_d95bbc9b-d05a-416a-8f26-5722195f01dd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_74b955b7-f0a3-4795-badd-9b267c45b05f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_fb07f6b3-61da-47d2-8e4c-c61a6d396b99" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_74b955b7-f0a3-4795-badd-9b267c45b05f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_32268cc3-2feb-43f6-8f7f-a17f77886644" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_74b955b7-f0a3-4795-badd-9b267c45b05f" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_32268cc3-2feb-43f6-8f7f-a17f77886644" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_32268cc3-2feb-43f6-8f7f-a17f77886644_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_32268cc3-2feb-43f6-8f7f-a17f77886644" xlink:to="loc_us-gaap_EquityComponentDomain_32268cc3-2feb-43f6-8f7f-a17f77886644_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_fb616758-f139-4449-8177-d85e17bda034" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_32268cc3-2feb-43f6-8f7f-a17f77886644" xlink:to="loc_us-gaap_EquityComponentDomain_fb616758-f139-4449-8177-d85e17bda034" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_ad5d6c7d-3383-4ce7-a3d0-66a71e9c4fa6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_fb616758-f139-4449-8177-d85e17bda034" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_ad5d6c7d-3383-4ce7-a3d0-66a71e9c4fa6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_b7ba1e98-8e8b-4e0c-ab3a-6f4bda0e8dc3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_fb616758-f139-4449-8177-d85e17bda034" xlink:to="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_b7ba1e98-8e8b-4e0c-ab3a-6f4bda0e8dc3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_3beed3d5-ed0e-45fe-95da-af4a87a58634" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_fb616758-f139-4449-8177-d85e17bda034" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_3beed3d5-ed0e-45fe-95da-af4a87a58634" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.medifast1.com/role/FINANCIALINSTRUMENTSCashandFinancialAssetsThatareMeasuredatFairValueonaRecurringBasisforEachoftheHierarchyLevelsDetails" xlink:type="simple" xlink:href="med-20220930.xsd#FINANCIALINSTRUMENTSCashandFinancialAssetsThatareMeasuredatFairValueonaRecurringBasisforEachoftheHierarchyLevelsDetails"/>
  <link:definitionLink xlink:role="http://www.medifast1.com/role/FINANCIALINSTRUMENTSCashandFinancialAssetsThatareMeasuredatFairValueonaRecurringBasisforEachoftheHierarchyLevelsDetails" xlink:type="extended" id="i32d27d156b0b4ef4918fe91fa8a5b8fa_FINANCIALINSTRUMENTSCashandFinancialAssetsThatareMeasuredatFairValueonaRecurringBasisforEachoftheHierarchyLevelsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_med_CashAndCashEquivalentsAndMarketableSecuritiesLineItems_1ccd2367-5759-4dec-a896-6cfbbb4d1f4d" xlink:href="med-20220930.xsd#med_CashAndCashEquivalentsAndMarketableSecuritiesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecurities_2ead12ab-bb2d-4b83-8d01-fb85647b9843" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketableSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_med_CashAndCashEquivalentsAndMarketableSecuritiesLineItems_1ccd2367-5759-4dec-a896-6cfbbb4d1f4d" xlink:to="loc_us-gaap_MarketableSecurities_2ead12ab-bb2d-4b83-8d01-fb85647b9843" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesUnrealizedGainLoss_2fec9145-112d-428c-9b45-3ee67ea597f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketableSecuritiesUnrealizedGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_med_CashAndCashEquivalentsAndMarketableSecuritiesLineItems_1ccd2367-5759-4dec-a896-6cfbbb4d1f4d" xlink:to="loc_us-gaap_MarketableSecuritiesUnrealizedGainLoss_2fec9145-112d-428c-9b45-3ee67ea597f0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestReceivable_c2b5e3d0-af3e-4258-ad3a-c8ef8daf9d36" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_med_CashAndCashEquivalentsAndMarketableSecuritiesLineItems_1ccd2367-5759-4dec-a896-6cfbbb4d1f4d" xlink:to="loc_us-gaap_InterestReceivable_c2b5e3d0-af3e-4258-ad3a-c8ef8daf9d36" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_5d0a9090-a3cf-4691-a79e-c3a60a0a6088" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_med_CashAndCashEquivalentsAndMarketableSecuritiesLineItems_1ccd2367-5759-4dec-a896-6cfbbb4d1f4d" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_5d0a9090-a3cf-4691-a79e-c3a60a0a6088" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_0bd050d9-3bd2-47c8-ada4-3e4d0ddd8fd4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_med_CashAndCashEquivalentsAndMarketableSecuritiesLineItems_1ccd2367-5759-4dec-a896-6cfbbb4d1f4d" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_0bd050d9-3bd2-47c8-ada4-3e4d0ddd8fd4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentOwnedAtFairValue_f6f7e6ae-3e53-4523-a3c4-6aa87855591c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentOwnedAtFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_med_CashAndCashEquivalentsAndMarketableSecuritiesLineItems_1ccd2367-5759-4dec-a896-6cfbbb4d1f4d" xlink:to="loc_us-gaap_InvestmentOwnedAtFairValue_f6f7e6ae-3e53-4523-a3c4-6aa87855591c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_med_CashAndCashEquivalentsAndMarketableSecuritiesTable_a3e13023-dd38-4c02-967c-4fe26390fb63" xlink:href="med-20220930.xsd#med_CashAndCashEquivalentsAndMarketableSecuritiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_med_CashAndCashEquivalentsAndMarketableSecuritiesLineItems_1ccd2367-5759-4dec-a896-6cfbbb4d1f4d" xlink:to="loc_med_CashAndCashEquivalentsAndMarketableSecuritiesTable_a3e13023-dd38-4c02-967c-4fe26390fb63" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_673a1f6c-ee0c-46c4-bd81-18c33f4ae2a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_med_CashAndCashEquivalentsAndMarketableSecuritiesTable_a3e13023-dd38-4c02-967c-4fe26390fb63" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_673a1f6c-ee0c-46c4-bd81-18c33f4ae2a7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_673a1f6c-ee0c-46c4-bd81-18c33f4ae2a7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_673a1f6c-ee0c-46c4-bd81-18c33f4ae2a7" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_673a1f6c-ee0c-46c4-bd81-18c33f4ae2a7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6279e367-b452-459b-9e4d-90e43659dce2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_673a1f6c-ee0c-46c4-bd81-18c33f4ae2a7" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6279e367-b452-459b-9e4d-90e43659dce2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_e6dccd6f-19d9-4f86-a865-f6a38b5c33b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6279e367-b452-459b-9e4d-90e43659dce2" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_e6dccd6f-19d9-4f86-a865-f6a38b5c33b2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_eae59ed8-7cc8-4190-910f-b8d4f2ef7be7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6279e367-b452-459b-9e4d-90e43659dce2" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_eae59ed8-7cc8-4190-910f-b8d4f2ef7be7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_0f2b2587-7aa0-4f64-b0d8-a5321abf2184" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_med_CashAndCashEquivalentsAndMarketableSecuritiesTable_a3e13023-dd38-4c02-967c-4fe26390fb63" xlink:to="loc_us-gaap_FinancialInstrumentAxis_0f2b2587-7aa0-4f64-b0d8-a5321abf2184" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_0f2b2587-7aa0-4f64-b0d8-a5321abf2184_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_0f2b2587-7aa0-4f64-b0d8-a5321abf2184" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_0f2b2587-7aa0-4f64-b0d8-a5321abf2184_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_3bf1d329-37ea-4ae4-8e9e-4e2ad58b7277" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_0f2b2587-7aa0-4f64-b0d8-a5321abf2184" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_3bf1d329-37ea-4ae4-8e9e-4e2ad58b7277" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashMember_d4a6b328-2351-4d9f-b903-3b66249bc5d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_3bf1d329-37ea-4ae4-8e9e-4e2ad58b7277" xlink:to="loc_us-gaap_CashMember_d4a6b328-2351-4d9f-b903-3b66249bc5d4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember_92f04c7b-f09f-484a-a676-938d57cfbcd1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_3bf1d329-37ea-4ae4-8e9e-4e2ad58b7277" xlink:to="loc_us-gaap_MoneyMarketFundsMember_92f04c7b-f09f-484a-a676-938d57cfbcd1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_med_GovernmentAgencySecuritiesMember_bb827bed-c014-4c3e-80b2-948579ed0282" xlink:href="med-20220930.xsd#med_GovernmentAgencySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_3bf1d329-37ea-4ae4-8e9e-4e2ad58b7277" xlink:to="loc_med_GovernmentAgencySecuritiesMember_bb827bed-c014-4c3e-80b2-948579ed0282" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MunicipalBondsMember_353c0e34-bcec-4f4b-a3b9-e88840b7eba5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MunicipalBondsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_3bf1d329-37ea-4ae4-8e9e-4e2ad58b7277" xlink:to="loc_us-gaap_MunicipalBondsMember_353c0e34-bcec-4f4b-a3b9-e88840b7eba5" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.medifast1.com/role/DEBTNarrativeDetails" xlink:type="simple" xlink:href="med-20220930.xsd#DEBTNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.medifast1.com/role/DEBTNarrativeDetails" xlink:type="extended" id="i7429d91a14ae45e9864406f148ae25bc_DEBTNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_a0eb3c74-d767-474e-925d-642ff66efbc5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_9327221f-fdfb-4906-8957-dae98ed20c37" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a0eb3c74-d767-474e-925d-642ff66efbc5" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_9327221f-fdfb-4906-8957-dae98ed20c37" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_med_LineOfCreditFacilityAccordionFeatureIncreaseLimit_0a84c30e-01a5-4786-933d-de47a7d09a88" xlink:href="med-20220930.xsd#med_LineOfCreditFacilityAccordionFeatureIncreaseLimit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a0eb3c74-d767-474e-925d-642ff66efbc5" xlink:to="loc_med_LineOfCreditFacilityAccordionFeatureIncreaseLimit_0a84c30e-01a5-4786-933d-de47a7d09a88" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_6a86e507-d7c6-416e-a5f7-518b5c518291" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityCommitmentFeePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a0eb3c74-d767-474e-925d-642ff66efbc5" xlink:to="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_6a86e507-d7c6-416e-a5f7-518b5c518291" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_a30ecd40-dfa3-4d16-b9b5-fdc4914927ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a0eb3c74-d767-474e-925d-642ff66efbc5" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_a30ecd40-dfa3-4d16-b9b5-fdc4914927ce" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_med_MaximumTotalNetLeverageRatio_a1190cf0-6820-4db5-81f9-b8909b971d41" xlink:href="med-20220930.xsd#med_MaximumTotalNetLeverageRatio"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a0eb3c74-d767-474e-925d-642ff66efbc5" xlink:to="loc_med_MaximumTotalNetLeverageRatio_a1190cf0-6820-4db5-81f9-b8909b971d41" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_med_MinimumInterestCoverageRatio_2de422a4-aeff-4537-90aa-3073d6e1f760" xlink:href="med-20220930.xsd#med_MinimumInterestCoverageRatio"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a0eb3c74-d767-474e-925d-642ff66efbc5" xlink:to="loc_med_MinimumInterestCoverageRatio_2de422a4-aeff-4537-90aa-3073d6e1f760" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_b9ffa807-b70a-4253-bcdc-e6a633762d18" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a0eb3c74-d767-474e-925d-642ff66efbc5" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_b9ffa807-b70a-4253-bcdc-e6a633762d18" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_0f9359cb-76e4-443a-a8d0-dde02c81f464" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a0eb3c74-d767-474e-925d-642ff66efbc5" xlink:to="loc_us-gaap_DebtInstrumentTable_0f9359cb-76e4-443a-a8d0-dde02c81f464" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_3d3a3a9c-a0f3-4a71-ac43-bf1d01c98547" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_0f9359cb-76e4-443a-a8d0-dde02c81f464" xlink:to="loc_us-gaap_DebtInstrumentAxis_3d3a3a9c-a0f3-4a71-ac43-bf1d01c98547" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_3d3a3a9c-a0f3-4a71-ac43-bf1d01c98547_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_3d3a3a9c-a0f3-4a71-ac43-bf1d01c98547" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_3d3a3a9c-a0f3-4a71-ac43-bf1d01c98547_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_d58942d8-a33e-4150-b5bb-936515ad277f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_3d3a3a9c-a0f3-4a71-ac43-bf1d01c98547" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_d58942d8-a33e-4150-b5bb-936515ad277f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_med_CreditAgreementMember_ff2a434e-b4a2-477c-82b8-3b7935522b54" xlink:href="med-20220930.xsd#med_CreditAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_d58942d8-a33e-4150-b5bb-936515ad277f" xlink:to="loc_med_CreditAgreementMember_ff2a434e-b4a2-477c-82b8-3b7935522b54" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_e6024451-eaf5-4498-b674-d47e47d0e499" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_0f9359cb-76e4-443a-a8d0-dde02c81f464" xlink:to="loc_us-gaap_CreditFacilityAxis_e6024451-eaf5-4498-b674-d47e47d0e499" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_e6024451-eaf5-4498-b674-d47e47d0e499_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_e6024451-eaf5-4498-b674-d47e47d0e499" xlink:to="loc_us-gaap_CreditFacilityDomain_e6024451-eaf5-4498-b674-d47e47d0e499_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_4b2085b8-0021-490a-97e4-74e118d08660" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_e6024451-eaf5-4498-b674-d47e47d0e499" xlink:to="loc_us-gaap_CreditFacilityDomain_4b2085b8-0021-490a-97e4-74e118d08660" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_f117ef77-fc2a-4ce3-a59e-f93a07ace0ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_4b2085b8-0021-490a-97e4-74e118d08660" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_f117ef77-fc2a-4ce3-a59e-f93a07ace0ad" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember_71755f66-e0ae-4bdd-ae8c-7e41d06614ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LetterOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevolvingCreditFacilityMember_f117ef77-fc2a-4ce3-a59e-f93a07ace0ad" xlink:to="loc_us-gaap_LetterOfCreditMember_71755f66-e0ae-4bdd-ae8c-7e41d06614ae" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_58c4c904-1768-4e17-b078-a16e1dc51d99" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_0f9359cb-76e4-443a-a8d0-dde02c81f464" xlink:to="loc_srt_RangeAxis_58c4c904-1768-4e17-b078-a16e1dc51d99" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_58c4c904-1768-4e17-b078-a16e1dc51d99_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_58c4c904-1768-4e17-b078-a16e1dc51d99" xlink:to="loc_srt_RangeMember_58c4c904-1768-4e17-b078-a16e1dc51d99_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_73b4c742-144f-41a8-a06e-31bc3fc5e55a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_58c4c904-1768-4e17-b078-a16e1dc51d99" xlink:to="loc_srt_RangeMember_73b4c742-144f-41a8-a06e-31bc3fc5e55a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_02b8f8da-d6e9-4fa5-b287-929eefa45246" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_73b4c742-144f-41a8-a06e-31bc3fc5e55a" xlink:to="loc_srt_MinimumMember_02b8f8da-d6e9-4fa5-b287-929eefa45246" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_c6757186-7799-44c7-a8bc-4c00b5c1aa0f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_73b4c742-144f-41a8-a06e-31bc3fc5e55a" xlink:to="loc_srt_MaximumMember_c6757186-7799-44c7-a8bc-4c00b5c1aa0f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_672fac94-c9f4-4e4a-8c4e-84fc49ce1b26" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_0f9359cb-76e4-443a-a8d0-dde02c81f464" xlink:to="loc_us-gaap_VariableRateAxis_672fac94-c9f4-4e4a-8c4e-84fc49ce1b26" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_672fac94-c9f4-4e4a-8c4e-84fc49ce1b26_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_672fac94-c9f4-4e4a-8c4e-84fc49ce1b26" xlink:to="loc_us-gaap_VariableRateDomain_672fac94-c9f4-4e4a-8c4e-84fc49ce1b26_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_166c9d39-f4c0-461a-9200-3144cc6cab1e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_672fac94-c9f4-4e4a-8c4e-84fc49ce1b26" xlink:to="loc_us-gaap_VariableRateDomain_166c9d39-f4c0-461a-9200-3144cc6cab1e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EurodollarMember_b49ad755-dbd7-4089-bb69-1a36db45329f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EurodollarMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_166c9d39-f4c0-461a-9200-3144cc6cab1e" xlink:to="loc_us-gaap_EurodollarMember_b49ad755-dbd7-4089-bb69-1a36db45329f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BaseRateMember_301c69dc-f3fe-4e3a-b2d7-623a94995ec2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BaseRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_166c9d39-f4c0-461a-9200-3144cc6cab1e" xlink:to="loc_us-gaap_BaseRateMember_301c69dc-f3fe-4e3a-b2d7-623a94995ec2" xlink:type="arc" order="1"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>8
<FILENAME>med-20220930_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:1ae599f9-ff00-4d75-90b9-110349ab0236,g:6d08fa26-e8d0-4031-9c9e-a858e7464a0f-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_c3f69fab-bb88-4f75-874a-a11b27111dd6_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase amount</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Authorized Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNoteTextBlock_46454548-f851-497c-a677-347dc31306d5_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ACCUMULATED OTHER COMPREHENSIVE INCOME</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNoteTextBlock_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss) Note [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNoteTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:to="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_0df08d38-f76a-405d-bf3e-d3fb8b1003f7_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental disclosure of cash flow information:</link:label>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_label_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_65a10bd8-cffb-4646-8017-c0c0125aea9c_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease obligations, net of current lease obligations</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_cd70e63c-55a9-47b2-9067-2c56292a955e_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized gains on investment securities</link:label>
    <link:label id="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-sale, Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:to="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LetterOfCreditMember_6f441792-fee5-4689-873e-6d4216c413b9_terseLabel_en-US" xlink:label="lab_us-gaap_LetterOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letter of Credit</link:label>
    <link:label id="lab_us-gaap_LetterOfCreditMember_label_en-US" xlink:label="lab_us-gaap_LetterOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letter of Credit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LetterOfCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LetterOfCreditMember" xlink:to="lab_us-gaap_LetterOfCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_0a27e97a-139a-407e-9c27-68f6bf911a61_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_65e6907b-f601-4920-9de0-2740942e65c8_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_6a020215-7b22-4af8-9846-9416e5687bcc_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_2ac027bb-db84-4c59-bbdb-1c60c4b0f8e9_verboseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_f341c961-de8a-4f3c-9196-a94d63468317_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_1f7ed102-59c5-4684-9590-e980ad846182_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-use assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_med_MaximumTotalNetLeverageRatio_5084e3f7-8b2d-4fcd-acba-fd22fd49a5aa_terseLabel_en-US" xlink:label="lab_med_MaximumTotalNetLeverageRatio" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum Total Net Leverage Ratio</link:label>
    <link:label id="lab_med_MaximumTotalNetLeverageRatio_label_en-US" xlink:label="lab_med_MaximumTotalNetLeverageRatio" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum Total Net Leverage Ratio</link:label>
    <link:label id="lab_med_MaximumTotalNetLeverageRatio_documentation_en-US" xlink:label="lab_med_MaximumTotalNetLeverageRatio" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum ratio as of any date, of (a) Total Net Funded Indebtedness on such date to (b) Consolidated EBITDA for the Reference Period ended on such date under credit facility.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_med_MaximumTotalNetLeverageRatio" xlink:href="med-20220930.xsd#med_MaximumTotalNetLeverageRatio"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_med_MaximumTotalNetLeverageRatio" xlink:to="lab_med_MaximumTotalNetLeverageRatio" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_a2bc1273-6be9-4575-8615-0cd8598edd40_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated Fair Value</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_340c9448-a957-42a1-bb4a-998ecf26345c_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total income tax benefit recognized related to restricted stock awards</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expense, Tax Benefit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_fb6d23c0-a6aa-4081-8531-81fa8448eea5_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Range [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_32779b23-eb8e-4460-bac9-67b3b2a52c4e_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseTermOfContract_2582ccbc-c7fd-4b8c-8e0f-9cdb63d3f68a_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease term</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseTermOfContract_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Term of Contract</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:to="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_903e2a82-d432-4f70-aeb4-7b39c4352969_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award expiration period</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_0d8b1de2-b037-42cb-b4f3-a7b9101dfb07_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_533e65ef-52da-41c2-884c-be4c838fe6ff_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsCommonStockCash_3764dc0b-e220-44a2-b6cf-648ad2ee7f60_negatedLabel_en-US" xlink:label="lab_us-gaap_DividendsCommonStockCash" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash dividends declared to stockholders</link:label>
    <link:label id="lab_us-gaap_DividendsCommonStockCash_label_en-US" xlink:label="lab_us-gaap_DividendsCommonStockCash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends, Common Stock, Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsCommonStockCash" xlink:to="lab_us-gaap_DividendsCommonStockCash" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_d28fdc35-52a6-41e1-9f6f-1718916c7d1f_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_ad6d9bd7-29b3-4f03-a3c9-faf777584139_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_med_OperatingLeaseArrangementForEquipmentMember_aa80ab4c-9947-4983-9060-e5ff39ecd755_terseLabel_en-US" xlink:label="lab_med_OperatingLeaseArrangementForEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease Arrangement for Equipment</link:label>
    <link:label id="lab_med_OperatingLeaseArrangementForEquipmentMember_label_en-US" xlink:label="lab_med_OperatingLeaseArrangementForEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease Arrangement For Equipment [Member]</link:label>
    <link:label id="lab_med_OperatingLeaseArrangementForEquipmentMember_documentation_en-US" xlink:label="lab_med_OperatingLeaseArrangementForEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the operating lease arrangement for equipment.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_med_OperatingLeaseArrangementForEquipmentMember" xlink:href="med-20220930.xsd#med_OperatingLeaseArrangementForEquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_med_OperatingLeaseArrangementForEquipmentMember" xlink:to="lab_med_OperatingLeaseArrangementForEquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_427bd775-2739-4f35-a613-0501b645e084_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_26b77aa1-e23d-4b07-ada3-0db2aee0e2e1_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_d7d5a342-4189-4c37-becf-70bf22070191_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_73bc1567-853e-4b73-af3d-ffbfbf6faaaf_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average remaining lease term</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryDisclosureAbstract_3dc28828-656c-434b-b91b-57a921bb9ec2_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_InventoryDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_InventoryDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryDisclosureAbstract" xlink:to="lab_us-gaap_InventoryDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_med_LineOfCreditFacilityAccordionFeatureIncreaseLimit_d36b3de0-52f7-48de-bbe1-d171c824bcd4_terseLabel_en-US" xlink:label="lab_med_LineOfCreditFacilityAccordionFeatureIncreaseLimit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accordion feature, increase limit</link:label>
    <link:label id="lab_med_LineOfCreditFacilityAccordionFeatureIncreaseLimit_label_en-US" xlink:label="lab_med_LineOfCreditFacilityAccordionFeatureIncreaseLimit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Accordion Feature, Increase Limit</link:label>
    <link:label id="lab_med_LineOfCreditFacilityAccordionFeatureIncreaseLimit_documentation_en-US" xlink:label="lab_med_LineOfCreditFacilityAccordionFeatureIncreaseLimit" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of credit facility, accordion feature, increase limit, subject to certain conditions by obtaining additional commitments from existing and/or new lenders.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_med_LineOfCreditFacilityAccordionFeatureIncreaseLimit" xlink:href="med-20220930.xsd#med_LineOfCreditFacilityAccordionFeatureIncreaseLimit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_med_LineOfCreditFacilityAccordionFeatureIncreaseLimit" xlink:to="lab_med_LineOfCreditFacilityAccordionFeatureIncreaseLimit" xlink:type="arc" order="1"/>
    <link:label id="lab_med_OptionsAndRestrictedStockMember_d1a51975-0f7f-43c1-ac81-ec662e995e96_terseLabel_en-US" xlink:label="lab_med_OptionsAndRestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options And Restricted Stock</link:label>
    <link:label id="lab_med_OptionsAndRestrictedStockMember_label_en-US" xlink:label="lab_med_OptionsAndRestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options And Restricted Stock [Member]</link:label>
    <link:label id="lab_med_OptionsAndRestrictedStockMember_documentation_en-US" xlink:label="lab_med_OptionsAndRestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options And Restricted Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_med_OptionsAndRestrictedStockMember" xlink:href="med-20220930.xsd#med_OptionsAndRestrictedStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_med_OptionsAndRestrictedStockMember" xlink:to="lab_med_OptionsAndRestrictedStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_med_AdjustmentsToPaidInCapitalShareRepurchasesNotYetSettled_b19200c8-b5ab-4c30-8213-179836857333_negatedTerseLabel_en-US" xlink:label="lab_med_AdjustmentsToPaidInCapitalShareRepurchasesNotYetSettled" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock repurchases, not yet settled</link:label>
    <link:label id="lab_med_AdjustmentsToPaidInCapitalShareRepurchasesNotYetSettled_label_en-US" xlink:label="lab_med_AdjustmentsToPaidInCapitalShareRepurchasesNotYetSettled" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments To Paid In Capital, Share Repurchases Not Yet Settled</link:label>
    <link:label id="lab_med_AdjustmentsToPaidInCapitalShareRepurchasesNotYetSettled_documentation_en-US" xlink:label="lab_med_AdjustmentsToPaidInCapitalShareRepurchasesNotYetSettled" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments To Paid In Capital, Share Repurchases Not Yet Settled</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_med_AdjustmentsToPaidInCapitalShareRepurchasesNotYetSettled" xlink:href="med-20220930.xsd#med_AdjustmentsToPaidInCapitalShareRepurchasesNotYetSettled"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_med_AdjustmentsToPaidInCapitalShareRepurchasesNotYetSettled" xlink:to="lab_med_AdjustmentsToPaidInCapitalShareRepurchasesNotYetSettled" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfOtherEquity_54b5851c-abb5-477c-bc23-de4d37076a17_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfOtherEquity" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net shares repurchased for taxes</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfOtherEquity_label_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfOtherEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Repurchase of Other Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfOtherEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRepurchaseOfOtherEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRepurchaseOfOtherEquity" xlink:to="lab_us-gaap_PaymentsForRepurchaseOfOtherEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_77535448-8ecc-422e-a1c8-2250936f85e9_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_dbbbc060-b80b-40c9-a72a-5b73e281a7d5_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_60984274-9628-4e7e-88be-30aa0354341f_verboseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options exercised by executives and directors</link:label>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_97f0f1e0-75d8-4295-85ae-82f6c539571d_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from stock options exercised</link:label>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:to="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermInvestments_cc59ad75-58e5-458c-9c5b-7256e3a1b1cb_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment securities</link:label>
    <link:label id="lab_us-gaap_ShortTermInvestments_label_en-US" xlink:label="lab_us-gaap_ShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermInvestments" xlink:to="lab_us-gaap_ShortTermInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_05acf6c7-b1b9-41df-bcce-0cd5df6d4a4b_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decrease in cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_3d986cf3-f973-44ee-a6b0-64d8f3dc3a91_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_81903cd2-a5cc-4fbb-9f6c-0dddaa81bea3_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_c9a39724-eff2-4e35-8aeb-3f0236c47308_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_038b7af5-3613-47fa-aaaa-d94271910a17_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intrinsic value of options exercised</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_55b7421d-2e76-4069-845b-43ecf6fade5a_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_d21ee825-109a-4338-b30a-f59475585b24_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_ee92af75-3762-42fc-b94f-7e16d8721b71_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_med_AmortizationOfPremiumOnInvestmentSecurities_824210e3-602f-4809-8c31-0a6a9c325e96_terseLabel_en-US" xlink:label="lab_med_AmortizationOfPremiumOnInvestmentSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of premium on investment securities</link:label>
    <link:label id="lab_med_AmortizationOfPremiumOnInvestmentSecurities_label_en-US" xlink:label="lab_med_AmortizationOfPremiumOnInvestmentSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Premium on Investment Securities</link:label>
    <link:label id="lab_med_AmortizationOfPremiumOnInvestmentSecurities_documentation_en-US" xlink:label="lab_med_AmortizationOfPremiumOnInvestmentSecurities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The expense charged against amortization of premium on investment securities.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_med_AmortizationOfPremiumOnInvestmentSecurities" xlink:href="med-20220930.xsd#med_AmortizationOfPremiumOnInvestmentSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_med_AmortizationOfPremiumOnInvestmentSecurities" xlink:to="lab_med_AmortizationOfPremiumOnInvestmentSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_c19cc8d6-67e3-455f-b44c-0c49f9bf4696_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_c00a673b-3161-42d8-ad4e-5bf4e466137f_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_med_GrantedIn2020Member_ef132032-69c2-4440-ae4d-da0653c349e8_terseLabel_en-US" xlink:label="lab_med_GrantedIn2020Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted In 2020</link:label>
    <link:label id="lab_med_GrantedIn2020Member_label_en-US" xlink:label="lab_med_GrantedIn2020Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted In 2020 [Member]</link:label>
    <link:label id="lab_med_GrantedIn2020Member_documentation_en-US" xlink:label="lab_med_GrantedIn2020Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted In 2020</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_med_GrantedIn2020Member" xlink:href="med-20220930.xsd#med_GrantedIn2020Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_med_GrantedIn2020Member" xlink:to="lab_med_GrantedIn2020Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_39f589a0-c9ec-4cd5-b4ba-17abb1149262_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_8a4d7485-7f6d-4a34-9a01-a39ed2801d56_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_dc2e41e0-2fd2-45a5-850f-07a56c4635f7_totalLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total lease payments</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_6a4ede8c-79d5-4806-8492-d68e8244e108_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation, shares authorized under stock option plans, exercise price range, lower range limit (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option, Exercise Price Range, Lower Range Limit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:to="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_ba088e7a-7a6f-4bce-a7d7-3ac578c8173e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNet_9435f207-ad4f-4c42-8098-c85ed7916b0d_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryNet_1bac8b88-aa22-4883-82fe-291cabade35f_totalLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_InventoryNet_label_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet" xlink:to="lab_us-gaap_InventoryNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_3eda9d91-b984-4bd9-99aa-91f8a0367d16_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_36a4be3f-3ac2-4929-9e4b-7c0854593308_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_a9099f4e-6e5b-45d3-ad86-e1acd9ed9d3a_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average discount rate</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_ea41c8a7-53c7-4783-97f2-b097942c61ad_verboseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Anti-dilutive awards</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_000f2f1e-332b-43ac-ae5d-2bb9dcfacb2d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Inventories</link:label>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Inventory, Current [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidTaxes_a73186c1-8b7d-42b7-90f1-4d5f63da1420_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidTaxes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes, prepaid</link:label>
    <link:label id="lab_us-gaap_PrepaidTaxes_label_en-US" xlink:label="lab_us-gaap_PrepaidTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Taxes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidTaxes" xlink:to="lab_us-gaap_PrepaidTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_85bd4783-a728-46cb-80ef-73907f2a1803_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized compensation costs</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_8fdb5cb3-9dec-40e5-9553-6bff2dde7a33_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitment fee percentage</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Commitment Fee Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityCommitmentFeePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:to="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_7041958e-edd5-4e54-9237-30a0bc37a371_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_0dc1943e-1b2e-4632-9f84-d2a5eaa02687_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation arrangement, fair value of awards vested</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_b686f7dc-8bf7-4513-961f-6384c686eec2_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_med_CreditAgreementMember_1b34b20b-3127-474e-afc5-575e1768e916_terseLabel_en-US" xlink:label="lab_med_CreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Agreement</link:label>
    <link:label id="lab_med_CreditAgreementMember_label_en-US" xlink:label="lab_med_CreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Agreement [Member]</link:label>
    <link:label id="lab_med_CreditAgreementMember_documentation_en-US" xlink:label="lab_med_CreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Agreement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_med_CreditAgreementMember" xlink:href="med-20220930.xsd#med_CreditAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_med_CreditAgreementMember" xlink:to="lab_med_CreditAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MunicipalBondsMember_db7392fc-c6c8-43aa-aef3-fa8d7d057943_terseLabel_en-US" xlink:label="lab_us-gaap_MunicipalBondsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Municipal bonds</link:label>
    <link:label id="lab_us-gaap_MunicipalBondsMember_label_en-US" xlink:label="lab_us-gaap_MunicipalBondsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Municipal Bonds [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MunicipalBondsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MunicipalBondsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MunicipalBondsMember" xlink:to="lab_us-gaap_MunicipalBondsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepurchaseAgreementsResaleAgreementsSecuritiesBorrowedAndSecuritiesLoanedDisclosureTextBlock_1c855ea1-48cc-44e4-b6af-90aa6d026597_terseLabel_en-US" xlink:label="lab_us-gaap_RepurchaseAgreementsResaleAgreementsSecuritiesBorrowedAndSecuritiesLoanedDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ACCELERATED SHARE REPURCHASE ("ASR") PROGRAM</link:label>
    <link:label id="lab_us-gaap_RepurchaseAgreementsResaleAgreementsSecuritiesBorrowedAndSecuritiesLoanedDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_RepurchaseAgreementsResaleAgreementsSecuritiesBorrowedAndSecuritiesLoanedDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase Agreements, Resale Agreements, Securities Borrowed, and Securities Loaned Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepurchaseAgreementsResaleAgreementsSecuritiesBorrowedAndSecuritiesLoanedDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepurchaseAgreementsResaleAgreementsSecuritiesBorrowedAndSecuritiesLoanedDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepurchaseAgreementsResaleAgreementsSecuritiesBorrowedAndSecuritiesLoanedDisclosureTextBlock" xlink:to="lab_us-gaap_RepurchaseAgreementsResaleAgreementsSecuritiesBorrowedAndSecuritiesLoanedDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_med_CashAndCashEquivalentsAndMarketableSecuritiesLineItems_d276fdff-2715-4d1a-bb74-aef532aa6251_terseLabel_en-US" xlink:label="lab_med_CashAndCashEquivalentsAndMarketableSecuritiesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash And Cash Equivalents And Marketable securities [Line Items]</link:label>
    <link:label id="lab_med_CashAndCashEquivalentsAndMarketableSecuritiesLineItems_label_en-US" xlink:label="lab_med_CashAndCashEquivalentsAndMarketableSecuritiesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash And Cash Equivalents And Marketable securities [Line Items]</link:label>
    <link:label id="lab_med_CashAndCashEquivalentsAndMarketableSecuritiesLineItems_documentation_en-US" xlink:label="lab_med_CashAndCashEquivalentsAndMarketableSecuritiesLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">N/A</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_med_CashAndCashEquivalentsAndMarketableSecuritiesLineItems" xlink:href="med-20220930.xsd#med_CashAndCashEquivalentsAndMarketableSecuritiesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_med_CashAndCashEquivalentsAndMarketableSecuritiesLineItems" xlink:to="lab_med_CashAndCashEquivalentsAndMarketableSecuritiesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_d5be63ad-0b77-4375-88cb-1cbf74fec5fb_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_f35ac86a-1cb4-4041-9e50-8d2bc4130476_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2e7cd5b6-2bca-4a52-90d4-8c185267ad44_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Award [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_d5f69054-fafd-47f6-834e-c054c3a1a84f_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_7c3355af-31af-4e5a-abe5-d4cfb203fff9_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityDomain_98304cb5-71c4-4061-b756-a5aaedb96a4a_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityDomain_label_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityDomain" xlink:to="lab_us-gaap_CreditFacilityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_ef5c284a-bb29-46ed-b903-61199e7205e6_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASSETS</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock_67547dab-093c-465a-be80-6470c172865a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Cash and Financial Assets that are Measured at Fair Value on a Recurring Basis for each of the Hierarchy Levels</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Available-for-sale Securities Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_265dec0b-595b-4ba6-8474-360e1890549d_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares, Exercisable at end of the period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_ed3cbaab-fd3a-4b09-b6c5-feaafd588c4e_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_a5d0b07a-b2e2-4073-aad7-8038a02665e6_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares granted in period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_b8c5611f-83a5-4009-b7e2-e8c46bdeecd6_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_4ad165d6-f318-437d-984f-da3e12430e9e_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-Average Exercise Price</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsCash_35194baa-0ae6-4614-9f9b-066b775c173b_verboseLabel_en-US" xlink:label="lab_us-gaap_DividendsCash" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends declared included in accounts payable</link:label>
    <link:label id="lab_us-gaap_DividendsCash_label_en-US" xlink:label="lab_us-gaap_DividendsCash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends, Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCash" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsCash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsCash" xlink:to="lab_us-gaap_DividendsCash" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_4b1bd92f-1ae1-4c07-a695-688b06bc0c43_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares, Outstanding at beginning of period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_28b73501-f2f9-4c9f-8c3d-20574fbf7b2f_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares, Outstanding at end of the period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_7bd4c154-8b46-48f5-9474-20956807b905_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_cb59bd5b-deaa-4e1f-8973-d8c393d3eee3_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_5aefb587-97fe-460c-a412-b2475f1d40cb_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Prepaid Expense and Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockRetiredCostMethodAmount_5d8607aa-78f2-4b74-b8e5-835bc1d5aa6e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockRetiredCostMethodAmount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock retired from stock repurchases</link:label>
    <link:label id="lab_us-gaap_TreasuryStockRetiredCostMethodAmount_label_en-US" xlink:label="lab_us-gaap_TreasuryStockRetiredCostMethodAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Retired, Cost Method, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockRetiredCostMethodAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockRetiredCostMethodAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockRetiredCostMethodAmount" xlink:to="lab_us-gaap_TreasuryStockRetiredCostMethodAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_35a4e7c0-95ce-45f3-ab69-9d3de4aa9ae8_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_454db26d-5cc4-4f53-91c4-18d914a90a38_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_cc1cbabb-4faa-439c-89fc-7ce61da35790_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of Share-based Compensation Arrangements by Share-based Payment Award</link:label>
    <link:label id="lab_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_label_en-US" xlink:label="lab_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of Share-based Compensation Arrangements by Share-based Payment Award [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:to="lab_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_d0dbfcc7-deba-4b89-929e-6aa81e26e515_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income from operations before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_0ddd4ec2-f04a-4fc4-a834-341ea03d45f3_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 2:</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncashContributionExpense_9e83b2c0-c3a9-47e5-afda-8e5836cb151a_terseLabel_en-US" xlink:label="lab_us-gaap_NoncashContributionExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Donated inventory</link:label>
    <link:label id="lab_us-gaap_NoncashContributionExpense_label_en-US" xlink:label="lab_us-gaap_NoncashContributionExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncash Contribution Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashContributionExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncashContributionExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncashContributionExpense" xlink:to="lab_us-gaap_NoncashContributionExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsAllOtherInvestmentsAbstract_b3ce4041-7785-4fee-ac90-f9e35b5d3496_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsAllOtherInvestmentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments, All Other Investments [Abstract]</link:label>
    <link:label id="lab_us-gaap_InvestmentsAllOtherInvestmentsAbstract_label_en-US" xlink:label="lab_us-gaap_InvestmentsAllOtherInvestmentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments, All Other Investments [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAllOtherInvestmentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsAllOtherInvestmentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsAllOtherInvestmentsAbstract" xlink:to="lab_us-gaap_InvestmentsAllOtherInvestmentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LinesOfCreditCurrent_d5fa7342-f606-4ba2-8551-81b1dce53e6d_terseLabel_en-US" xlink:label="lab_us-gaap_LinesOfCreditCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving credit facility</link:label>
    <link:label id="lab_us-gaap_LinesOfCreditCurrent_label_en-US" xlink:label="lab_us-gaap_LinesOfCreditCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LinesOfCreditCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LinesOfCreditCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LinesOfCreditCurrent" xlink:to="lab_us-gaap_LinesOfCreditCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_aff288be-2ae2-465f-8c56-6c388b49ee1b_verboseLabel_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-use assets obtained in exchange for lease obligations - Operating leases</link:label>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Operating Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:to="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UseOfEstimates_ecc34467-335b-496d-89c4-87eaf464d3dc_verboseLabel_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates</link:label>
    <link:label id="lab_us-gaap_UseOfEstimates_label_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UseOfEstimates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates" xlink:to="lab_us-gaap_UseOfEstimates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_d73b2840-54c9-428e-a44c-302abf9fac40_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation arrangement by share-based payment award, options, grants in period, gross</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_160adf45-bdb2-45de-ab71-0a83c25b700c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of the Computation of Basic and Diluted EPS</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_7a4df825-8e08-4b43-b2fb-f5b45cc1fe4e_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss), net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_4ca40072-4392-42e4-8881-7563bc7bf69a_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive Income (loss)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_93bbeb67-34ec-47cd-a06b-c1122627bcaa_negatedLabel_en-US" xlink:label="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net shares repurchased for taxes (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_20e2e3bd-c253-495b-993b-38b15f61de8c_terseLabel_en-US" xlink:label="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares withheld for employee taxes</link:label>
    <link:label id="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Shares Withheld for Tax Withholding Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_e0701b1f-ecf1-42d2-bf18-8e47df3606d9_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_med_GrantedIn2019Member_84772520-45cd-42de-a623-31b38ff8254e_terseLabel_en-US" xlink:label="lab_med_GrantedIn2019Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted In 2019</link:label>
    <link:label id="lab_med_GrantedIn2019Member_label_en-US" xlink:label="lab_med_GrantedIn2019Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted In 2019 [Member]</link:label>
    <link:label id="lab_med_GrantedIn2019Member_documentation_en-US" xlink:label="lab_med_GrantedIn2019Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted In 2019</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_med_GrantedIn2019Member" xlink:href="med-20220930.xsd#med_GrantedIn2019Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_med_GrantedIn2019Member" xlink:to="lab_med_GrantedIn2019Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_6aca80cd-835e-4ea1-bd0e-edd69c320c6d_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">TOTAL ASSETS</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_988d0805-56d6-4f3d-88bf-1312f7033e80_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_med_NumeratorAbstract_32bbea0d-3eae-454c-8bff-6152a70a945e_verboseLabel_en-US" xlink:label="lab_med_NumeratorAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Numerator:</link:label>
    <link:label id="lab_med_NumeratorAbstract_label_en-US" xlink:label="lab_med_NumeratorAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Numerator [Abstract]</link:label>
    <link:label id="lab_med_NumeratorAbstract_documentation_en-US" xlink:label="lab_med_NumeratorAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Numerator [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_med_NumeratorAbstract" xlink:href="med-20220930.xsd#med_NumeratorAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_med_NumeratorAbstract" xlink:to="lab_med_NumeratorAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_75bcae33-0ce4-4761-b1ca-adc37821a1e2_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings per share - basic (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_med_OperatingLeaseExpenseNonCash_1b97751f-c0ad-4e24-9f74-085696a5fca6_terseLabel_en-US" xlink:label="lab_med_OperatingLeaseExpenseNonCash" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cash lease expense</link:label>
    <link:label id="lab_med_OperatingLeaseExpenseNonCash_label_en-US" xlink:label="lab_med_OperatingLeaseExpenseNonCash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Expense, Non-Cash</link:label>
    <link:label id="lab_med_OperatingLeaseExpenseNonCash_documentation_en-US" xlink:label="lab_med_OperatingLeaseExpenseNonCash" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Expense, Non-Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_med_OperatingLeaseExpenseNonCash" xlink:href="med-20220930.xsd#med_OperatingLeaseExpenseNonCash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_med_OperatingLeaseExpenseNonCash" xlink:to="lab_med_OperatingLeaseExpenseNonCash" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseExpense_273848ac-af3f-47b6-938f-72775de9231f_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease expense</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseExpense_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseExpense" xlink:to="lab_us-gaap_OperatingLeaseExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_f1c5b9b5-871b-43cf-9839-32e322386f7c_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_e7096171-004b-4f11-b0b3-3c30925d6f19_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_238885c6-e473-446c-a8dc-dc81abe6a4a0_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Restricted Stock Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Nonvested Restricted Stock Units Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_2924d78e-b920-44c5-a6c0-ed1d91b97da4_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding at beginning of period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_d26edc32-87dc-4516-89b0-65567cb4475e_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding at end of period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryRawMaterials_fd9bda0e-051e-4b65-98cb-a8b665a3540f_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryRawMaterials" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Raw materials</link:label>
    <link:label id="lab_us-gaap_InventoryRawMaterials_label_en-US" xlink:label="lab_us-gaap_InventoryRawMaterials" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Raw Materials, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterials" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryRawMaterials"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryRawMaterials" xlink:to="lab_us-gaap_InventoryRawMaterials" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_d25de3b6-af60-42dc-87da-ee8ef7040e63_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_240e11d4-4066-4b23-bfc3-6bfd5b006d82_terseLabel_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Secured Revolving Credit Facility</link:label>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_label_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevolvingCreditFacilityMember" xlink:to="lab_us-gaap_RevolvingCreditFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_b4495795-8658-41bb-826e-db64e5263bbf_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashMember_376b169b-7140-44db-ac3c-373d74d16fc1_terseLabel_en-US" xlink:label="lab_us-gaap_CashMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash</link:label>
    <link:label id="lab_us-gaap_CashMember_label_en-US" xlink:label="lab_us-gaap_CashMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashMember" xlink:to="lab_us-gaap_CashMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_8220f83c-9c2b-4307-94bb-533e8c7cca76_verboseLabel_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</link:label>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDilutedAbstract_abf1c77f-2603-4af0-9b60-11c03bb92c58_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted earnings per share</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDilutedAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDilutedAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract" xlink:to="lab_us-gaap_EarningsPerShareDilutedAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_7222a9e5-8998-4057-95d7-88c393e40323_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash flow provided by operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_med_OperatingLeaseArrangementForRealEstateMember_f54a6baf-62a8-4c69-aa56-3ce6cb111029_terseLabel_en-US" xlink:label="lab_med_OperatingLeaseArrangementForRealEstateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease Arrangement for Real Estate</link:label>
    <link:label id="lab_med_OperatingLeaseArrangementForRealEstateMember_label_en-US" xlink:label="lab_med_OperatingLeaseArrangementForRealEstateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease Arrangement For Real Estate [Member]</link:label>
    <link:label id="lab_med_OperatingLeaseArrangementForRealEstateMember_documentation_en-US" xlink:label="lab_med_OperatingLeaseArrangementForRealEstateMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the operating lease arrangement for real estate.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_med_OperatingLeaseArrangementForRealEstateMember" xlink:href="med-20220930.xsd#med_OperatingLeaseArrangementForRealEstateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_med_OperatingLeaseArrangementForRealEstateMember" xlink:to="lab_med_OperatingLeaseArrangementForRealEstateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_921320f2-8551-4884-9d32-d7972b4f13f8_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_ed1717b4-d79e-4689-ab02-bf3bd5145e8b_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Supplemental Cash Flow Information</link:label>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCostTableTextBlock" xlink:to="lab_us-gaap_LeaseCostTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_418b5dbe-bb86-4562-aaa6-663e1d691f80_negatedLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net shares repurchased for taxes</link:label>
    <link:label id="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Decrease for Tax Withholding Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasePayments_f2946fe1-028f-4915-ba90-73922931e831_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid for amounts included in the measurements of lease liabilities - Operating cash flow used in operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeasePayments_label_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasePayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasePayments" xlink:to="lab_us-gaap_OperatingLeasePayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAbstract_bfe048b2-82d9-4ef0-99a0-62745bc1cfbd_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic earnings per share</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract" xlink:to="lab_us-gaap_EarningsPerShareBasicAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_bebba24a-5b71-4e05-b2b3-14452acbbc66_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_4b279adb-9501-47f8-b20b-e3ecfba1867f_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average shares of common stock outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_a6bfb118-e45d-4b8c-aa08-20214f270dcc_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings per share - diluted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_30fba7ee-0e9b-4780-8a5c-c1902b0bda8b_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of dilutive common stock equivalents (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number Diluted Shares Outstanding Adjustment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:to="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesPaidNet_3ed84624-2922-43c2-abc4-0d1dad304f7d_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes paid</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesPaidNet_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Paid, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesPaidNet" xlink:to="lab_us-gaap_IncomeTaxesPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_69197003-6f6e-4f36-b327-049b3909975e_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Borrowings</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:to="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_med_MinimumInterestCoverageRatio_2d178221-489b-43b9-a0e1-64780e7df4d0_terseLabel_en-US" xlink:label="lab_med_MinimumInterestCoverageRatio" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum Interest Coverage Ratio</link:label>
    <link:label id="lab_med_MinimumInterestCoverageRatio_label_en-US" xlink:label="lab_med_MinimumInterestCoverageRatio" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum Interest Coverage Ratio</link:label>
    <link:label id="lab_med_MinimumInterestCoverageRatio_documentation_en-US" xlink:label="lab_med_MinimumInterestCoverageRatio" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum Interest Coverage Ratio</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_med_MinimumInterestCoverageRatio" xlink:href="med-20220930.xsd#med_MinimumInterestCoverageRatio"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_med_MinimumInterestCoverageRatio" xlink:to="lab_med_MinimumInterestCoverageRatio" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_f77c7c3f-976d-4124-bc78-36f28f1edf5b_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfRevenue_dfe31af0-2fb7-4218-b46c-04fa9d01b750_verboseLabel_en-US" xlink:label="lab_us-gaap_CostOfRevenue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of sales</link:label>
    <link:label id="lab_us-gaap_CostOfRevenue_label_en-US" xlink:label="lab_us-gaap_CostOfRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfRevenue" xlink:to="lab_us-gaap_CostOfRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_med_GovernmentAgencySecuritiesMember_861a3a12-6b7e-4e1e-ac78-9ad9085add5b_terseLabel_en-US" xlink:label="lab_med_GovernmentAgencySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Government &amp; agency securities</link:label>
    <link:label id="lab_med_GovernmentAgencySecuritiesMember_label_en-US" xlink:label="lab_med_GovernmentAgencySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Government Agency Securities [Member]</link:label>
    <link:label id="lab_med_GovernmentAgencySecuritiesMember_documentation_en-US" xlink:label="lab_med_GovernmentAgencySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Government Agency Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_med_GovernmentAgencySecuritiesMember" xlink:href="med-20220930.xsd#med_GovernmentAgencySecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_med_GovernmentAgencySecuritiesMember" xlink:to="lab_med_GovernmentAgencySecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_5d2f2fbb-91c6-4933-be88-d7b954a3e252_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 1:</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_dd2056b5-6b0e-421f-8fbe-77e181d5a1e3_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investing Activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_dc679660-07a0-408f-a2ec-eb824d169fe3_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash flow used in financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_32c7b1c7-2acc-403c-a6a5-8fefaf1ee503_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss), net of tax:</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_b84f4199-c836-4c8c-b89a-ff79229d44ef_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average shares outstanding -</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_13905131-42c2-48b1-b9cb-041f338b1627_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_a3c8d4cd-3ced-47f8-b4d2-569231c0823b_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Payment, Due [Abstract]</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Payment, Due [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_2c6288ea-6d92-4578-ae1f-a65b6039005c_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award vesting period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BaseRateMember_0de406f3-88f5-40b5-9cb2-dfea07fcf8b2_terseLabel_en-US" xlink:label="lab_us-gaap_BaseRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Base Rate</link:label>
    <link:label id="lab_us-gaap_BaseRateMember_label_en-US" xlink:label="lab_us-gaap_BaseRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Base Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BaseRateMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BaseRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BaseRateMember" xlink:to="lab_us-gaap_BaseRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_med_MarketAndPerformanceSharesMember_72b7da31-411c-4e03-bf57-1469f35177bd_terseLabel_en-US" xlink:label="lab_med_MarketAndPerformanceSharesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Market and Performance-Based Shares</link:label>
    <link:label id="lab_med_MarketAndPerformanceSharesMember_label_en-US" xlink:label="lab_med_MarketAndPerformanceSharesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Market And Performance Shares [Member]</link:label>
    <link:label id="lab_med_MarketAndPerformanceSharesMember_documentation_en-US" xlink:label="lab_med_MarketAndPerformanceSharesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Market And Performance Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_med_MarketAndPerformanceSharesMember" xlink:href="med-20220930.xsd#med_MarketAndPerformanceSharesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_med_MarketAndPerformanceSharesMember" xlink:to="lab_med_MarketAndPerformanceSharesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_d18c2257-bc77-4fa1-99ea-dbb19d7e7be6_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcceleratedShareRepurchaseProgramAdjustment_f78b8e81-ad6a-4883-b598-f0173811a454_terseLabel_en-US" xlink:label="lab_us-gaap_AcceleratedShareRepurchaseProgramAdjustment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settlement of accelerated share repurchase agreement</link:label>
    <link:label id="lab_us-gaap_AcceleratedShareRepurchaseProgramAdjustment_label_en-US" xlink:label="lab_us-gaap_AcceleratedShareRepurchaseProgramAdjustment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchase Program, Adjustment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchaseProgramAdjustment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcceleratedShareRepurchaseProgramAdjustment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcceleratedShareRepurchaseProgramAdjustment" xlink:to="lab_us-gaap_AcceleratedShareRepurchaseProgramAdjustment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_1ad6fe3f-27d0-42fa-8f86-a7890624c862_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-Average Exercise Price, Exercised (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_310bb34c-3347-43b9-a149-76bc5c2f5f23_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_7cd781e3-6901-42e0-a43e-bd4e9cc6c9f2_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapital" xlink:to="lab_us-gaap_AdditionalPaidInCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_8dbce8fe-8f9d-46fb-ab11-378d8d84d7db_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:to="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_a3c1c7d3-1ae9-4d3e-b855-5f8152905651_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIABILITIES AND STOCKHOLDERS' EQUITY</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_fcaae0b1-6605-4a50-8d38-c4490d85fcc7_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_b5a45861-b4ea-40cf-a101-e0c034c5485c_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInventories" xlink:to="lab_us-gaap_IncreaseDecreaseInInventories" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_478c52c3-1073-4176-9fa3-d0b23206785f_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable and accrued expenses</link:label>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable and Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetailRelatedInventoryPackagingAndOtherSupplies_9d899fff-37cc-4908-b770-8cd60e750cb7_terseLabel_en-US" xlink:label="lab_us-gaap_RetailRelatedInventoryPackagingAndOtherSupplies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Packaging</link:label>
    <link:label id="lab_us-gaap_RetailRelatedInventoryPackagingAndOtherSupplies_label_en-US" xlink:label="lab_us-gaap_RetailRelatedInventoryPackagingAndOtherSupplies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retail Related Inventory, Packaging and Other Supplies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetailRelatedInventoryPackagingAndOtherSupplies" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetailRelatedInventoryPackagingAndOtherSupplies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetailRelatedInventoryPackagingAndOtherSupplies" xlink:to="lab_us-gaap_RetailRelatedInventoryPackagingAndOtherSupplies" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_df70299a-67ac-4f5c-8536-961c4559e0e6_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ea7bb74f-0a8e-4b06-bca7-43301de30c8c_terseLabel_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_label_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_8f143efa-59e6-47a6-bcd4-32646af7f73b_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EARNINGS PER SHARE</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_7578b290-6e50-4aae-a02c-200668930ed7_negatedLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock from stock repurchases</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value, Acquired, Cost Method</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:to="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockSharesRetired_9e962c78-6b95-44ee-aea2-1f734cbc1e4d_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesRetired" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock retired from stock repurchases (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockSharesRetired_label_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesRetired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares, Retired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesRetired" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockSharesRetired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockSharesRetired" xlink:to="lab_us-gaap_TreasuryStockSharesRetired" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_ea5833c2-1edb-4191-8c52-9ba1f5bd3320_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_fa1018fc-426a-40cb-bed7-8e7bff425c22_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options exercised by executives and directors</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_1766d85a-39f6-4732-b94a-3d1ceb9f1f59_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_f365c346-3dfc-4492-81e1-0792c8680251_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_a7ffaed6-94be-42b4-9d24-7a49fbb116eb_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GrossProfit_414dfce1-490b-4fbd-b89e-5eccfe610749_totalLabel_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross profit</link:label>
    <link:label id="lab_us-gaap_GrossProfit_label_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Profit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GrossProfit" xlink:to="lab_us-gaap_GrossProfit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_bb988133-a760-4de7-9a44-d4c205b44eaf_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0665d533-7ec6-42b4-8ab2-c6f7388ce624_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency impact</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_a2029679-5175-4ba2-9138-39de487191af_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Awards</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_37167c0b-bb6e-4831-b385-d7eaac65a038_verboseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, general, and administrative</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardDateDomain_7c52e86b-8ff5-49d6-ae7a-d6d93dca45ee_terseLabel_en-US" xlink:label="lab_us-gaap_AwardDateDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Date [Domain]</link:label>
    <link:label id="lab_us-gaap_AwardDateDomain_label_en-US" xlink:label="lab_us-gaap_AwardDateDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Date [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardDateDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardDateDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardDateDomain" xlink:to="lab_us-gaap_AwardDateDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription_36c9d668-2ba1-4d6f-bf0a-2b3067a0e18e_verboseLabel_en-US" xlink:label="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification</link:label>
    <link:label id="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription_label_en-US" xlink:label="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification, Comparability Adjustment [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PriorPeriodReclassificationAdjustmentDescription"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:to="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_dc8be4f4-5f9f-40e7-a349-b7a3c43a3d38_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation, shares authorized under stock option plans, exercise price range, upper range limit (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option, Exercise Price Range, Upper Range Limit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:to="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_8216b567-38c9-435e-951a-d2db07e073a4_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_2726727e-4c91-41b7-aaab-d73f3e7190f2_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestReceivable_28459008-2d55-4d33-9af7-2cea4f373222_terseLabel_en-US" xlink:label="lab_us-gaap_InterestReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Interest</link:label>
    <link:label id="lab_us-gaap_InterestReceivable_label_en-US" xlink:label="lab_us-gaap_InterestReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestReceivable" xlink:to="lab_us-gaap_InterestReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_b1128389-cf3c-43e4-a69e-9e5c107b0aaa_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment - net of accumulated depreciation</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_b85d05d0-fb97-4cfa-8480-0b15e2538aa9_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax assets</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:to="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_5ea8314b-1998-4592-a7f7-c053b9f55dfa_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_9a14a7ea-ca27-41d2-85dd-63610cc7229a_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Initial amount received (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_label_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares, Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockSharesAcquired" xlink:to="lab_us-gaap_TreasuryStockSharesAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_c62edff2-1a17-4a48-9ac0-999c45784cad_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MarketableSecurities_6640f9c2-55d2-4f67-a141-9bf54b5909fa_terseLabel_en-US" xlink:label="lab_us-gaap_MarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost</link:label>
    <link:label id="lab_us-gaap_MarketableSecurities_label_en-US" xlink:label="lab_us-gaap_MarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketableSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketableSecurities" xlink:to="lab_us-gaap_MarketableSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedTranslationAdjustmentMember_470eb73d-165d-4fca-93c6-ecac7d0eee1d_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation</link:label>
    <link:label id="lab_us-gaap_AccumulatedTranslationAdjustmentMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Foreign Currency Adjustment Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:to="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_70c68eaa-7bcd-474d-8ecc-2c7d573fcd94_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DEBT</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureTextBlock" xlink:to="lab_us-gaap_DebtDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_d6904052-33b0-4dbb-9419-e2185376b67b_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_4d9fc47f-fda5-4f14-a425-71b3f5b3f064_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_e364711d-bc7a-41b7-b518-31e1f344495c_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-Average Exercise Price, Exercisable at end of the period (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_10eb59fe-d1d9-441f-83bc-c7c954380e60_verboseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SHARE-BASED COMPENSATION</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_med_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesEarnedPercentage_c998d442-45a2-417f-b687-21bb46265a33_terseLabel_en-US" xlink:label="lab_med_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesEarnedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional performance-based shares, percentage</link:label>
    <link:label id="lab_med_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesEarnedPercentage_label_en-US" xlink:label="lab_med_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesEarnedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Number Of Additional Shares Earned, Percentage</link:label>
    <link:label id="lab_med_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesEarnedPercentage_documentation_en-US" xlink:label="lab_med_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesEarnedPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Number Of Additional Shares Earned, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_med_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesEarnedPercentage" xlink:href="med-20220930.xsd#med_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesEarnedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_med_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesEarnedPercentage" xlink:to="lab_med_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesEarnedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryDisclosureTextBlock_f4fabc79-6c1b-4f20-a396-dd7c6f18d292_verboseLabel_en-US" xlink:label="lab_us-gaap_InventoryDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">INVENTORIES</link:label>
    <link:label id="lab_us-gaap_InventoryDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_InventoryDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryDisclosureTextBlock" xlink:to="lab_us-gaap_InventoryDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_e2800a0f-dc8a-4cf3-841c-4763af2605af_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_81563a48-c4d1-453c-a544-8df9e52bebde_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets_b1ee78e5-0607-4896-bbff-d0d4f8113261_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Operating Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Revenues_024dfb7f-fbe0-42a9-9bea-80936453e021_verboseLabel_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue</link:label>
    <link:label id="lab_us-gaap_Revenues_label_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Revenues" xlink:to="lab_us-gaap_Revenues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_18499fe4-196f-436a-b32e-312f9d1a3682_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average remaining contractual life of options outstanding</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryFinishedGoods_a7f47326-6768-41de-9840-ad7317214dd7_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoods" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finished goods</link:label>
    <link:label id="lab_us-gaap_InventoryFinishedGoods_label_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoods" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Finished Goods, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoods" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryFinishedGoods"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryFinishedGoods" xlink:to="lab_us-gaap_InventoryFinishedGoods" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_d4034620-4a27-4e06-abf6-bdab30659c15_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiability" xlink:to="lab_us-gaap_OperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_00aa71cc-dddc-4d17-ab26-386d79b8d679_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_e7e03ef5-71be-4585-b233-a1dc876eb19f_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-Average Exercise Price, Outstanding at beginning of period (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_01a57cc9-b698-427b-9f94-50e1717d9807_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-Average Exercise Price, Outstanding at end of the period (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_ed632d56-2167-4e21-94bd-1ca6d7c17400_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value $0.001 per share: 20,000 shares authorized; 10,929 and 11,594 issued and 10,928 and 11,593 outstanding at September&#160;30, 2022 and December&#160;31, 2021, respectively</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_fb3cb8ea-a97f-4ab2-8239-86e06edb85a6_totalLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total other (expense) income</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpense" xlink:to="lab_us-gaap_NonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_d836241f-05b8-415d-a021-ff29b41e65f0_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation cost recognition weighted average period</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockCommonMember_52ffe352-9330-4670-854d-a64119212e43_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonMember_label_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Common [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockCommonMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockCommonMember" xlink:to="lab_us-gaap_TreasuryStockCommonMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_51881892-e2ec-4f63-bfb8-dbf1bc0ef7ac_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding at beginning of period (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_919889ba-b868-4afe-a62f-8dfdddab0016_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding at end of period (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_16890fea-5b36-40e8-a86b-723ba4378ddc_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation</link:label>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PerformanceSharesMember_c82d857e-04e4-4b14-90d9-e08ea8aed71d_terseLabel_en-US" xlink:label="lab_us-gaap_PerformanceSharesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance-Based Shares</link:label>
    <link:label id="lab_us-gaap_PerformanceSharesMember_label_en-US" xlink:label="lab_us-gaap_PerformanceSharesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Shares [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PerformanceSharesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PerformanceSharesMember" xlink:to="lab_us-gaap_PerformanceSharesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_f5f08950-07cb-4354-be19-524c69ba3cce_terseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Expense</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_label_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_dcd8e97a-388a-441f-b2f8-530dc2fb9962_verboseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LEASES</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_640e1c6d-418f-433f-af60-1a0da2327a81_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive income</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_b0dc0640-dc5e-40a5-8562-af84ba52b16d_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_651b5875-2d0d-4d33-bc99-b3d39451b87b_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average remaining contractual life of options exercisable</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_6cf18863-642a-4b6e-81fe-41370badae55_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentOwnedAtFairValue_4481a5a6-1d5f-4334-9fe8-f939154a4369_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentOwnedAtFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Securities</link:label>
    <link:label id="lab_us-gaap_InvestmentOwnedAtFairValue_label_en-US" xlink:label="lab_us-gaap_InvestmentOwnedAtFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Owned, at Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentOwnedAtFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentOwnedAtFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentOwnedAtFairValue" xlink:to="lab_us-gaap_InvestmentOwnedAtFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_90b082b4-59cc-45d8-91a0-83bac813e713_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022 (excluding the nine months ended September&#160;30, 2022)</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_13aa2812-2db7-48fb-9f1e-7104bfbe1064_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-Average Grant Date Fair Value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockMember_74a6ae5b-4750-4f74-beb5-e75adeee9951_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock</link:label>
    <link:label id="lab_us-gaap_RestrictedStockMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockMember" xlink:to="lab_us-gaap_RestrictedStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_med_InventoryNonFoodFinishedGoods_82a5a9c1-b5ed-4559-9a4d-9716af37fed8_verboseLabel_en-US" xlink:label="lab_med_InventoryNonFoodFinishedGoods" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-food finished goods</link:label>
    <link:label id="lab_med_InventoryNonFoodFinishedGoods_label_en-US" xlink:label="lab_med_InventoryNonFoodFinishedGoods" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Non Food Finished Goods</link:label>
    <link:label id="lab_med_InventoryNonFoodFinishedGoods_documentation_en-US" xlink:label="lab_med_InventoryNonFoodFinishedGoods" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount before last-in first-out (LIFO) and valuation reserves of (Non-food) merchandise or goods held by the entity that are readily available for sale.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_med_InventoryNonFoodFinishedGoods" xlink:href="med-20220930.xsd#med_InventoryNonFoodFinishedGoods"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_med_InventoryNonFoodFinishedGoods" xlink:to="lab_med_InventoryNonFoodFinishedGoods" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidTaxes_a2252fee-878d-4ba8-a158-a22c065b260b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidTaxes" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes, prepaid</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidTaxes_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Prepaid Taxes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInPrepaidTaxes" xlink:to="lab_us-gaap_IncreaseDecreaseInPrepaidTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_med_GrantedIn2022Member_68f32e9f-92e0-441d-b6bb-2610ddc60e51_terseLabel_en-US" xlink:label="lab_med_GrantedIn2022Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted In 2022</link:label>
    <link:label id="lab_med_GrantedIn2022Member_label_en-US" xlink:label="lab_med_GrantedIn2022Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted In 2022 [Member]</link:label>
    <link:label id="lab_med_GrantedIn2022Member_documentation_en-US" xlink:label="lab_med_GrantedIn2022Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted In 2022</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_med_GrantedIn2022Member" xlink:href="med-20220930.xsd#med_GrantedIn2022Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_med_GrantedIn2022Member" xlink:to="lab_med_GrantedIn2022Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_b0f5c99d-ee5a-4b06-9056-202bf317e254_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryValuationReserves_a1269005-b0e5-48ba-9609-3f5b85e5c790_negatedLabel_en-US" xlink:label="lab_us-gaap_InventoryValuationReserves" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reserve for obsolete inventory</link:label>
    <link:label id="lab_us-gaap_InventoryValuationReserves_label_en-US" xlink:label="lab_us-gaap_InventoryValuationReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Valuation Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryValuationReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryValuationReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryValuationReserves" xlink:to="lab_us-gaap_InventoryValuationReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_da1bc67a-080e-4f3f-b154-9639c8522f14_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2bc362de-dc8d-4b76-a76a-41cb38235b69_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents - beginning of the period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_cbc45f4c-e8cf-4d88-9e54-4784839e1a91_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents - end of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_f03f88b9-7c0f-4ee4-be2d-edc28676a26c_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfArrangementAxis_c524c635-c376-4150-8ae0-f89d35ac50c5_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfArrangementAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Axis]</link:label>
    <link:label id="lab_us-gaap_TypeOfArrangementAxis_label_en-US" xlink:label="lab_us-gaap_TypeOfArrangementAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfArrangementAxis" xlink:to="lab_us-gaap_TypeOfArrangementAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_07fa252a-21f7-4d72-b331-343c18cc51b8_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_d2380088-48c8-4452-8254-d74dd40f3ba3_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_54d41c4c-4574-4a73-978f-ec1501c2cfaa_negatedLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: imputed interest</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestIncomeExpenseNonoperatingNet_5371c849-89de-4e73-a611-4f86ccf5d029_verboseLabel_en-US" xlink:label="lab_us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestIncomeExpenseNonoperatingNet_label_en-US" xlink:label="lab_us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Income (Expense), Nonoperating, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestIncomeExpenseNonoperatingNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:to="lab_us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardDateAxis_1b3cd29c-701b-4bec-ae9d-630736ccd5d5_terseLabel_en-US" xlink:label="lab_us-gaap_AwardDateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Date [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardDateAxis_label_en-US" xlink:label="lab_us-gaap_AwardDateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Date [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardDateAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardDateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardDateAxis" xlink:to="lab_us-gaap_AwardDateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeasesAbstract_431d49ea-704b-437b-8b06-1cdcf685a830_terseLabel_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:label id="lab_us-gaap_LeasesAbstract_label_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeasesAbstract" xlink:to="lab_us-gaap_LeasesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_8fb1427c-c9ae-40b7-86ae-6582fb97d1ba_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_f8f1e8cc-a5b9-462a-9369-f7cbbcbb8d4a_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_3e7d7e88-6d12-452d-9764-795a21f338f6_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options exercised by executives and directors (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_a48c3953-04a3-4a64-9d2d-4c38b6b79b33_negatedLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares, Exercised (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_24a44910-50ab-49aa-8f13-699efeb6bfdf_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense and Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_926cba45-6e92-4794-a5a6-15db0277787e_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_1dcd39e7-d134-414b-b882-01c9f77632ed_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average shares of common stock outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_f1f04a90-1946-4c78-b1ed-5536c7586145_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialInstrumentAxis" xlink:to="lab_us-gaap_FinancialInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareDeclared_ca789c6e-cc41-4c5a-b10b-c0e0e85db50e_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash dividends declared per share (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareDeclared_label_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Dividends, Per Share, Declared</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockDividendsPerShareDeclared" xlink:to="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtAndEquitySecuritiesRealizedGainLoss_ad7e68c1-74b5-4e7d-847c-22d3a5285d55_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DebtAndEquitySecuritiesRealizedGainLoss" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Realized loss or gains</link:label>
    <link:label id="lab_us-gaap_DebtAndEquitySecuritiesRealizedGainLoss_label_en-US" xlink:label="lab_us-gaap_DebtAndEquitySecuritiesRealizedGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt and Equity Securities, Realized Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtAndEquitySecuritiesRealizedGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtAndEquitySecuritiesRealizedGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtAndEquitySecuritiesRealizedGainLoss" xlink:to="lab_us-gaap_DebtAndEquitySecuritiesRealizedGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_med_DenominatorAbstract_596fd84f-62a5-4801-a881-bca9f804af04_verboseLabel_en-US" xlink:label="lab_med_DenominatorAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Denominator:</link:label>
    <link:label id="lab_med_DenominatorAbstract_label_en-US" xlink:label="lab_med_DenominatorAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Denominator [Abstract]</link:label>
    <link:label id="lab_med_DenominatorAbstract_documentation_en-US" xlink:label="lab_med_DenominatorAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Denominator [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_med_DenominatorAbstract" xlink:href="med-20220930.xsd#med_DenominatorAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_med_DenominatorAbstract" xlink:to="lab_med_DenominatorAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_d72c4ffe-190d-44bc-8379-f80456caf19f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Stock Option Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDividends_03755fbb-723c-44fd-b4fc-cd0b7b558f62_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDividends" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash dividends paid to stockholders</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDividends_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDividends" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Dividends</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividends" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDividends"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDividends" xlink:to="lab_us-gaap_PaymentsOfDividends" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_75014369-3d2a-4008-96d0-7ddf7afb8cc4_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Applicable Rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Basis Spread on Variable Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:to="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_33f58f8a-d106-4fa7-8dfa-e67ce2cc8334_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Options</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember" xlink:to="lab_us-gaap_EmployeeStockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_med_GrantedIn2021Member_f447cc01-efe8-4761-84fd-1e3b2f21c1ec_terseLabel_en-US" xlink:label="lab_med_GrantedIn2021Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted In 2021</link:label>
    <link:label id="lab_med_GrantedIn2021Member_label_en-US" xlink:label="lab_med_GrantedIn2021Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted In 2021 [Member]</link:label>
    <link:label id="lab_med_GrantedIn2021Member_documentation_en-US" xlink:label="lab_med_GrantedIn2021Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted In 2021</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_med_GrantedIn2021Member" xlink:href="med-20220930.xsd#med_GrantedIn2021Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_med_GrantedIn2021Member" xlink:to="lab_med_GrantedIn2021Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_6440a726-4df1-4257-910e-c7d787d35a76_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityAbstract_label_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityAbstract" xlink:to="lab_us-gaap_EquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentQuarterlyReport_f89bc149-6182-4d83-8085-30a45dd98673_terseLabel_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:label id="lab_dei_DocumentQuarterlyReport_label_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentQuarterlyReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentQuarterlyReport" xlink:to="lab_dei_DocumentQuarterlyReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_31fc7a03-0f03-4c30-a101-edf36f03ad62_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpenseAbstract_df4a1ee7-5b71-434c-ae92-694f9ccec688_terseLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income (expense)</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpenseAbstract_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonoperating Income (Expense) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpenseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_med_CashAndCashEquivalentsAndMarketableSecuritiesTable_a50964c2-8842-4f02-a90c-800cae895313_terseLabel_en-US" xlink:label="lab_med_CashAndCashEquivalentsAndMarketableSecuritiesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash And Cash Equivalents And Marketable securities [Table]</link:label>
    <link:label id="lab_med_CashAndCashEquivalentsAndMarketableSecuritiesTable_label_en-US" xlink:label="lab_med_CashAndCashEquivalentsAndMarketableSecuritiesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash And Cash Equivalents And Marketable securities [Table]</link:label>
    <link:label id="lab_med_CashAndCashEquivalentsAndMarketableSecuritiesTable_documentation_en-US" xlink:label="lab_med_CashAndCashEquivalentsAndMarketableSecuritiesTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">N/A</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_med_CashAndCashEquivalentsAndMarketableSecuritiesTable" xlink:href="med-20220930.xsd#med_CashAndCashEquivalentsAndMarketableSecuritiesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_med_CashAndCashEquivalentsAndMarketableSecuritiesTable" xlink:to="lab_med_CashAndCashEquivalentsAndMarketableSecuritiesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfShortTermInvestments_0c5e0ddb-bd73-4119-9df4-775ae9937337_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale and maturities of investment securities</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfShortTermInvestments_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale of Short-term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfShortTermInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfShortTermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleOfShortTermInvestments" xlink:to="lab_us-gaap_ProceedsFromSaleOfShortTermInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityAxis_0773dcd1-3e05-4c9b-bb34-a0bef31724fb_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityAxis" xlink:to="lab_us-gaap_CreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_20818e50-2810-4764-8a47-aeb0c539c60c_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_5fc0bda5-e4d8-4b25-a019-9ce7c9668c97_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateAxis_809c1569-90db-4583-9667-788f45ac39e1_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:label id="lab_us-gaap_VariableRateAxis_label_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateAxis" xlink:to="lab_us-gaap_VariableRateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_2b0a9767-6876-45d8-80b2-c99f62fefc4f_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash flow used in investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_394d66a1-7f88-4697-a330-744e54b8d222_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in operating assets and liabilities:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_ff6ed2e4-c4d2-46a8-af54-1a561c216861_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income from operations</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_ea086e88-6798-4c2f-8e15-feac10ec5e98_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized losses on investment securities</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, Net of Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_91a699d5-2eb6-4a1f-bc7b-90231d9bb51b_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_8189a648-b7fb-4a3a-8263-b50a7999a3c5_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_b57d5843-b64f-4f48-8b30-74a0c8a262f5_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_25d5c1a8-a719-43c2-af23-87b4cbbaf646_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current lease obligations</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock_9513e7ed-12ec-48df-a0ca-ab41b8bead5f_verboseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Presentation of Financial Statements</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation, Basis of Presentation, Business Description and Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_cbd01ea6-654a-4a80-acb2-f40d66ed08a2_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_91760c72-e816-4cba-8dbb-6558eea6ae16_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_19340dc0-c0f8-4557-beac-855417275785_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions_cbe560e1-f534-4f3c-bfce-8a35977b92a2_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-based Payment Arrangement, Recognition and Exercise</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_7dc21682-d57f-41f9-8db3-8ea0132fba2e_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateDomain_1a30958c-4a95-4e4c-9aa9-597f98674a25_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:label id="lab_us-gaap_VariableRateDomain_label_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateDomain" xlink:to="lab_us-gaap_VariableRateDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_e29cac6c-1e00-46f1-ac43-b5b596b2fc34_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-In Capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_faa5c2cd-dc8b-4cf7-aac8-f1b43f635027_verboseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_5d78ab20-67dc-44ea-aa3c-a52b651e049a_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash &amp; Cash Equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_dc13454b-565a-4628-bdea-04b82463f6d9_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit facility maximum borrowing capacity</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MoneyMarketFundsMember_0de50ebf-b268-42cc-b85b-6bcb2d78f078_terseLabel_en-US" xlink:label="lab_us-gaap_MoneyMarketFundsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Money market accounts</link:label>
    <link:label id="lab_us-gaap_MoneyMarketFundsMember_label_en-US" xlink:label="lab_us-gaap_MoneyMarketFundsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Money Market Funds [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MoneyMarketFundsMember" xlink:to="lab_us-gaap_MoneyMarketFundsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_48160c50-3a18-4c7d-8bc8-3c51e830fa15_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialInstrumentsDisclosureTextBlock_d414e5a0-3b7d-4dec-bdeb-2be4e5dc4470_verboseLabel_en-US" xlink:label="lab_us-gaap_FinancialInstrumentsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">FINANCIAL INSTRUMENTS</link:label>
    <link:label id="lab_us-gaap_FinancialInstrumentsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_FinancialInstrumentsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialInstrumentsDisclosureTextBlock" xlink:to="lab_us-gaap_FinancialInstrumentsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember_fbebdbb9-b9e7-4490-861c-bc2595ca4ca6_terseLabel_en-US" xlink:label="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Domain]</link:label>
    <link:label id="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember_label_en-US" xlink:label="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_caa463be-dd06-4b7f-a0a3-f4fe404cc513_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_0cf077ae-183a-43de-a8ae-95dbe3309408_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income (expense)</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_aca20457-3640-41a5-8d0d-fd86efea3e8e_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MarketableSecuritiesUnrealizedGainLoss_7da136dd-4f16-4508-9238-742260288c37_terseLabel_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesUnrealizedGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Gains</link:label>
    <link:label id="lab_us-gaap_MarketableSecuritiesUnrealizedGainLoss_label_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesUnrealizedGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities, Unrealized Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesUnrealizedGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketableSecuritiesUnrealizedGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketableSecuritiesUnrealizedGainLoss" xlink:to="lab_us-gaap_MarketableSecuritiesUnrealizedGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_b95fd293-1147-4517-80e2-9eddef98389e_verboseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Pronouncements Adopted in 2022</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_0767135b-5dee-4d12-8a3e-2e600ba9d34a_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of property and equipment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_8fda75f3-ce0d-45e5-a47c-e4c397a98e6f_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee service share based compensation nonvested awards total compensation cost not yet recognized (less than)</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_ef1d0fd6-6def-4dde-99df-5111a6f5d443_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_c7ac00ef-fbd3-4104-9399-9ad12effcc5f_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_15053b93-d797-4221-a6af-1c29c7886b1a_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_med_LesseeOperatingLeaseLiabilityPaymentsDueYearFiveAndAfterYearFive_aaafc8b2-12f0-400a-9ca5-be691811678d_terseLabel_en-US" xlink:label="lab_med_LesseeOperatingLeaseLiabilityPaymentsDueYearFiveAndAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_med_LesseeOperatingLeaseLiabilityPaymentsDueYearFiveAndAfterYearFive_label_en-US" xlink:label="lab_med_LesseeOperatingLeaseLiabilityPaymentsDueYearFiveAndAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee Operating Lease Liability Payments Due Year Five And After Year Five</link:label>
    <link:label id="lab_med_LesseeOperatingLeaseLiabilityPaymentsDueYearFiveAndAfterYearFive_documentation_en-US" xlink:label="lab_med_LesseeOperatingLeaseLiabilityPaymentsDueYearFiveAndAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee Operating Lease Liability Payments Due Year Five And After Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_med_LesseeOperatingLeaseLiabilityPaymentsDueYearFiveAndAfterYearFive" xlink:href="med-20220930.xsd#med_LesseeOperatingLeaseLiabilityPaymentsDueYearFiveAndAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_med_LesseeOperatingLeaseLiabilityPaymentsDueYearFiveAndAfterYearFive" xlink:to="lab_med_LesseeOperatingLeaseLiabilityPaymentsDueYearFiveAndAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_c9eafd40-8723-43c0-87ea-979f70317ae8_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_2bfd4b12-d1fb-4091-bdc6-65fcd5da3bcd_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_85b055a9-4d9b-4d81-b14e-ab2ae9114229_verboseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_3c091372-17ef-4926-9ba7-04b27580e707_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate intrinsic value of options outstanding</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_ff29c9d6-60c7-49f2-aca7-3a7c0d45d195_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Maturity of the Company's Operating Lease Liabilities</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_e00e7813-8961-43bb-b99b-ac6659a93a17_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total stockholders' equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_c9f627aa-4752-4143-980f-7d1e0995fa62_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_ed540fe5-244d-4d8a-a9d3-b2c01f45be66_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_dc491302-e108-4a94-a85d-11f410667abd_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive income</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_cfcb6103-9bad-4633-84d6-b3267d3d44b5_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_4467fc15-5ea9-47fa-9954-e484af572197_periodStartLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_6822452c-4c58-4823-923b-305737efa2c6_periodEndLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_0c934d15-6f1a-4ee3-9a83-b0b663e17cdb_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_med_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesEarnedPerformancePeriod_d7744f72-7d54-4d60-8134-122c12a39e4b_terseLabel_en-US" xlink:label="lab_med_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesEarnedPerformancePeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance period</link:label>
    <link:label id="lab_med_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesEarnedPerformancePeriod_label_en-US" xlink:label="lab_med_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesEarnedPerformancePeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Number Of Additional Shares Earned, Performance Period</link:label>
    <link:label id="lab_med_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesEarnedPerformancePeriod_documentation_en-US" xlink:label="lab_med_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesEarnedPerformancePeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Number Of Additional Shares Earned, Performance Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_med_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesEarnedPerformancePeriod" xlink:href="med-20220930.xsd#med_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesEarnedPerformancePeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_med_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesEarnedPerformancePeriod" xlink:to="lab_med_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesEarnedPerformancePeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_7a8c7fdb-cf13-4e4f-b9df-2b07eb07c747_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable and accrued expenses</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable and Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_737d8757-1ccb-43d6-abc7-ed373f7b4146_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate intrinsic value of options exercisable</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_876a420f-db8a-4f1f-b5d8-84c325cb64b6_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile net income to cash provided by operating activities</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_f8b96c91-c2d2-4f31-bf6d-62740095137c_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_f3a30d6a-4043-460b-9be3-d3c9484d2158_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock repurchases</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Repurchase of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:to="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EurodollarMember_a8a49987-1ef7-4240-9a2d-7dff2590931e_terseLabel_en-US" xlink:label="lab_us-gaap_EurodollarMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Eurodollar</link:label>
    <link:label id="lab_us-gaap_EurodollarMember_label_en-US" xlink:label="lab_us-gaap_EurodollarMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Eurodollar [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EurodollarMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EurodollarMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EurodollarMember" xlink:to="lab_us-gaap_EurodollarMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_944da272-677e-4ccb-8396-ebe5fccc8eaf_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_268af854-cfae-4d48-8aed-20d396e2e426_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_9c63607d-4a14-4f78-a99a-9837a8d62d55_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>9
<FILENAME>med-20220930_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:1ae599f9-ff00-4d75-90b9-110349ab0236,g:6d08fa26-e8d0-4031-9c9e-a858e7464a0f-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.medifast1.com/role/Cover" xlink:type="simple" xlink:href="med-20220930.xsd#Cover"/>
  <link:presentationLink xlink:role="http://www.medifast1.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_e698ad94-d7a9-460d-b9c7-96a39e9ee51a" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_4968d09c-31d7-4c5a-904d-4a66ca36459c" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e698ad94-d7a9-460d-b9c7-96a39e9ee51a" xlink:to="loc_dei_DocumentType_4968d09c-31d7-4c5a-904d-4a66ca36459c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_5ea9b1f4-23e0-4a88-a9d3-a6da45651916" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentQuarterlyReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e698ad94-d7a9-460d-b9c7-96a39e9ee51a" xlink:to="loc_dei_DocumentQuarterlyReport_5ea9b1f4-23e0-4a88-a9d3-a6da45651916" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_c1e67856-b011-4833-8825-c99372436a9f" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e698ad94-d7a9-460d-b9c7-96a39e9ee51a" xlink:to="loc_dei_DocumentPeriodEndDate_c1e67856-b011-4833-8825-c99372436a9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_a4e05c63-ce1e-4b75-b4c8-8a7c7162b696" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e698ad94-d7a9-460d-b9c7-96a39e9ee51a" xlink:to="loc_dei_DocumentTransitionReport_a4e05c63-ce1e-4b75-b4c8-8a7c7162b696" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_21d07605-41e3-45be-8e67-bca3e36552b6" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e698ad94-d7a9-460d-b9c7-96a39e9ee51a" xlink:to="loc_dei_EntityFileNumber_21d07605-41e3-45be-8e67-bca3e36552b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_7786dc97-1add-4419-a5ed-780223e19f03" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e698ad94-d7a9-460d-b9c7-96a39e9ee51a" xlink:to="loc_dei_EntityRegistrantName_7786dc97-1add-4419-a5ed-780223e19f03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_8baa6202-646a-4d42-993a-b6e21d00d6f1" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e698ad94-d7a9-460d-b9c7-96a39e9ee51a" xlink:to="loc_dei_EntityIncorporationStateCountryCode_8baa6202-646a-4d42-993a-b6e21d00d6f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_2f3965c9-12f4-4789-a75b-1ca6e66f3001" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e698ad94-d7a9-460d-b9c7-96a39e9ee51a" xlink:to="loc_dei_EntityTaxIdentificationNumber_2f3965c9-12f4-4789-a75b-1ca6e66f3001" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_8eb4a70c-1497-43fb-8078-fc54c1be6db5" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e698ad94-d7a9-460d-b9c7-96a39e9ee51a" xlink:to="loc_dei_EntityAddressAddressLine1_8eb4a70c-1497-43fb-8078-fc54c1be6db5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_56a75548-0bc9-4d70-a66f-730fb7681f31" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e698ad94-d7a9-460d-b9c7-96a39e9ee51a" xlink:to="loc_dei_EntityAddressCityOrTown_56a75548-0bc9-4d70-a66f-730fb7681f31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_e30faa7e-912e-4a11-a5ce-c1082ee4b18a" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e698ad94-d7a9-460d-b9c7-96a39e9ee51a" xlink:to="loc_dei_EntityAddressStateOrProvince_e30faa7e-912e-4a11-a5ce-c1082ee4b18a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_069a970d-f191-466b-acd5-d9beb5ba30f5" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e698ad94-d7a9-460d-b9c7-96a39e9ee51a" xlink:to="loc_dei_EntityAddressPostalZipCode_069a970d-f191-466b-acd5-d9beb5ba30f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_da2c33f5-7336-4568-b0a2-6d6773d7148a" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e698ad94-d7a9-460d-b9c7-96a39e9ee51a" xlink:to="loc_dei_CityAreaCode_da2c33f5-7336-4568-b0a2-6d6773d7148a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_d3788efc-2a0f-40df-bd27-8ea2d0bf0f0f" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e698ad94-d7a9-460d-b9c7-96a39e9ee51a" xlink:to="loc_dei_LocalPhoneNumber_d3788efc-2a0f-40df-bd27-8ea2d0bf0f0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_4767c5b0-8485-4488-87f5-a2697f2d2c87" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e698ad94-d7a9-460d-b9c7-96a39e9ee51a" xlink:to="loc_dei_Security12bTitle_4767c5b0-8485-4488-87f5-a2697f2d2c87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_eab3a442-4ea3-4437-9b5f-ce69996d60e9" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e698ad94-d7a9-460d-b9c7-96a39e9ee51a" xlink:to="loc_dei_TradingSymbol_eab3a442-4ea3-4437-9b5f-ce69996d60e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_2cd1e9f6-1de7-456f-ac36-aa71951d188b" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e698ad94-d7a9-460d-b9c7-96a39e9ee51a" xlink:to="loc_dei_SecurityExchangeName_2cd1e9f6-1de7-456f-ac36-aa71951d188b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_fdd78376-5194-4c07-8ceb-bd4c0c693b72" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e698ad94-d7a9-460d-b9c7-96a39e9ee51a" xlink:to="loc_dei_EntityCurrentReportingStatus_fdd78376-5194-4c07-8ceb-bd4c0c693b72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_081f7839-8f5c-4ed6-bc84-bc853a1559e7" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e698ad94-d7a9-460d-b9c7-96a39e9ee51a" xlink:to="loc_dei_EntityInteractiveDataCurrent_081f7839-8f5c-4ed6-bc84-bc853a1559e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_196adbee-cb33-458b-b814-889709dcc0bd" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e698ad94-d7a9-460d-b9c7-96a39e9ee51a" xlink:to="loc_dei_EntityFilerCategory_196adbee-cb33-458b-b814-889709dcc0bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_44f75030-8240-48ed-9540-f26e2ea1e355" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e698ad94-d7a9-460d-b9c7-96a39e9ee51a" xlink:to="loc_dei_EntitySmallBusiness_44f75030-8240-48ed-9540-f26e2ea1e355" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_4d027ff2-bc2c-42ff-959d-f4c923cddd3f" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e698ad94-d7a9-460d-b9c7-96a39e9ee51a" xlink:to="loc_dei_EntityEmergingGrowthCompany_4d027ff2-bc2c-42ff-959d-f4c923cddd3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_f5c5369c-f4db-4ccd-afff-f91f0d88fb70" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e698ad94-d7a9-460d-b9c7-96a39e9ee51a" xlink:to="loc_dei_EntityShellCompany_f5c5369c-f4db-4ccd-afff-f91f0d88fb70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_057fbd75-5ab5-4b24-ab25-9dcd7ccf1457" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e698ad94-d7a9-460d-b9c7-96a39e9ee51a" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_057fbd75-5ab5-4b24-ab25-9dcd7ccf1457" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_2f97e2a8-11ec-4352-b87c-b6dbccea2790" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e698ad94-d7a9-460d-b9c7-96a39e9ee51a" xlink:to="loc_dei_EntityCentralIndexKey_2f97e2a8-11ec-4352-b87c-b6dbccea2790" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_40e4059a-ab50-41f1-9959-bf3af6c5fe60" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e698ad94-d7a9-460d-b9c7-96a39e9ee51a" xlink:to="loc_dei_CurrentFiscalYearEndDate_40e4059a-ab50-41f1-9959-bf3af6c5fe60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_4ea16232-a1bb-48cc-b52c-d80b1d5b10e9" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e698ad94-d7a9-460d-b9c7-96a39e9ee51a" xlink:to="loc_dei_DocumentFiscalYearFocus_4ea16232-a1bb-48cc-b52c-d80b1d5b10e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_4bf13c8f-62ef-450b-8dd1-669f6b42d3da" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e698ad94-d7a9-460d-b9c7-96a39e9ee51a" xlink:to="loc_dei_DocumentFiscalPeriodFocus_4bf13c8f-62ef-450b-8dd1-669f6b42d3da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_81cf0280-7ab3-4861-92f2-6ffc9e0284e3" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e698ad94-d7a9-460d-b9c7-96a39e9ee51a" xlink:to="loc_dei_AmendmentFlag_81cf0280-7ab3-4861-92f2-6ffc9e0284e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEUNAUDITED" xlink:type="simple" xlink:href="med-20220930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEUNAUDITED"/>
  <link:presentationLink xlink:role="http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEUNAUDITED" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_c5708aac-6cba-472a-9916-d9b5f4b6c4d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_b07e7fb1-5da6-40fb-9de9-d989219d19dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_c5708aac-6cba-472a-9916-d9b5f4b6c4d3" xlink:to="loc_us-gaap_Revenues_b07e7fb1-5da6-40fb-9de9-d989219d19dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue_8485e0de-1e7e-4ea5-8ace-d555e4493ae5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfRevenue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_c5708aac-6cba-472a-9916-d9b5f4b6c4d3" xlink:to="loc_us-gaap_CostOfRevenue_8485e0de-1e7e-4ea5-8ace-d555e4493ae5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_418f0968-2529-4b5d-81b6-5cb09827ee14" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_c5708aac-6cba-472a-9916-d9b5f4b6c4d3" xlink:to="loc_us-gaap_GrossProfit_418f0968-2529-4b5d-81b6-5cb09827ee14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_f9ae18a6-3afe-409e-90fa-976dfb75dcc5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_c5708aac-6cba-472a-9916-d9b5f4b6c4d3" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_f9ae18a6-3afe-409e-90fa-976dfb75dcc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_df7e0015-d257-4103-a9ec-25a0673febc7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_c5708aac-6cba-472a-9916-d9b5f4b6c4d3" xlink:to="loc_us-gaap_OperatingIncomeLoss_df7e0015-d257-4103-a9ec-25a0673febc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract_3053640f-feaa-4b17-8c8c-80cbf296360d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpenseAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_c5708aac-6cba-472a-9916-d9b5f4b6c4d3" xlink:to="loc_us-gaap_NonoperatingIncomeExpenseAbstract_3053640f-feaa-4b17-8c8c-80cbf296360d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_7f7fce9c-bf6a-4751-8757-ca04a7350baf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestIncomeExpenseNonoperatingNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_3053640f-feaa-4b17-8c8c-80cbf296360d" xlink:to="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_7f7fce9c-bf6a-4751-8757-ca04a7350baf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_8b257aab-8c4b-4a39-8813-fff515a16f0c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_3053640f-feaa-4b17-8c8c-80cbf296360d" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_8b257aab-8c4b-4a39-8813-fff515a16f0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_74c0fe16-7c7f-41cb-ae30-e1ff173f05c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_3053640f-feaa-4b17-8c8c-80cbf296360d" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_74c0fe16-7c7f-41cb-ae30-e1ff173f05c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_d5be4651-7853-464c-8415-76f0d6cf6bf1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_3053640f-feaa-4b17-8c8c-80cbf296360d" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_d5be4651-7853-464c-8415-76f0d6cf6bf1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_69b9912d-7d52-49bd-be1e-ddde41105591" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_3053640f-feaa-4b17-8c8c-80cbf296360d" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_69b9912d-7d52-49bd-be1e-ddde41105591" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_e1e72c22-e90f-4038-9767-9629defaccdb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_3053640f-feaa-4b17-8c8c-80cbf296360d" xlink:to="loc_us-gaap_NetIncomeLoss_e1e72c22-e90f-4038-9767-9629defaccdb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAbstract_4b2dc543-43a5-4786-a17c-0247f179efd4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_3053640f-feaa-4b17-8c8c-80cbf296360d" xlink:to="loc_us-gaap_EarningsPerShareBasicAbstract_4b2dc543-43a5-4786-a17c-0247f179efd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_0e634567-9037-44ca-9b0a-db63ef23ff34" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_4b2dc543-43a5-4786-a17c-0247f179efd4" xlink:to="loc_us-gaap_EarningsPerShareBasic_0e634567-9037-44ca-9b0a-db63ef23ff34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedAbstract_1dde12b1-8453-418d-9844-4fec1f0dfeb1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDilutedAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_3053640f-feaa-4b17-8c8c-80cbf296360d" xlink:to="loc_us-gaap_EarningsPerShareDilutedAbstract_1dde12b1-8453-418d-9844-4fec1f0dfeb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_787f7361-1365-4c26-9a46-0a07d5c5a4e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_1dde12b1-8453-418d-9844-4fec1f0dfeb1" xlink:to="loc_us-gaap_EarningsPerShareDiluted_787f7361-1365-4c26-9a46-0a07d5c5a4e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_f3334e64-5723-4657-b5ad-d9307366147a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_c5708aac-6cba-472a-9916-d9b5f4b6c4d3" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_f3334e64-5723-4657-b5ad-d9307366147a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_88b38ab8-288c-477e-849e-9fcbf822d308" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_f3334e64-5723-4657-b5ad-d9307366147a" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_88b38ab8-288c-477e-849e-9fcbf822d308" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_de5fa321-c069-4585-8b05-3f29f2ad6eb2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_f3334e64-5723-4657-b5ad-d9307366147a" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_de5fa321-c069-4585-8b05-3f29f2ad6eb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_a71f07ef-1704-4e60-bf0d-1f458d83764e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_c5708aac-6cba-472a-9916-d9b5f4b6c4d3" xlink:to="loc_us-gaap_CommonStockDividendsPerShareDeclared_a71f07ef-1704-4e60-bf0d-1f458d83764e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUNAUDITED" xlink:type="simple" xlink:href="med-20220930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUNAUDITED"/>
  <link:presentationLink xlink:role="http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUNAUDITED" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_be45de4f-83b9-4372-b027-149e69a98003" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_9ba634bc-05bd-42c2-aa19-985b1295c63e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_be45de4f-83b9-4372-b027-149e69a98003" xlink:to="loc_us-gaap_NetIncomeLoss_9ba634bc-05bd-42c2-aa19-985b1295c63e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_41e65624-6a09-41cc-b742-4fe1cbd4205d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_be45de4f-83b9-4372-b027-149e69a98003" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_41e65624-6a09-41cc-b742-4fe1cbd4205d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_b93e6002-0922-444b-8685-a3fc6c14d974" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_41e65624-6a09-41cc-b742-4fe1cbd4205d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_b93e6002-0922-444b-8685-a3fc6c14d974" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_b4937494-79b3-4de0-a36c-12bde681b7c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_41e65624-6a09-41cc-b742-4fe1cbd4205d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_b4937494-79b3-4de0-a36c-12bde681b7c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_0082cfcd-f08d-458e-a88d-fbba8c83ec79" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_41e65624-6a09-41cc-b742-4fe1cbd4205d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_0082cfcd-f08d-458e-a88d-fbba8c83ec79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_b080536d-922d-4b48-a250-89ae78ba82f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_41e65624-6a09-41cc-b742-4fe1cbd4205d" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_b080536d-922d-4b48-a250-89ae78ba82f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED" xlink:type="simple" xlink:href="med-20220930.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"/>
  <link:presentationLink xlink:role="http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_d6b9726f-3e06-4924-a146-ad04a4585e7f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_6e95c8b5-b0b5-4b66-84f8-18818b5a09de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_d6b9726f-3e06-4924-a146-ad04a4585e7f" xlink:to="loc_us-gaap_AssetsAbstract_6e95c8b5-b0b5-4b66-84f8-18818b5a09de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_f4796734-14da-427c-b619-d2c175e097d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_6e95c8b5-b0b5-4b66-84f8-18818b5a09de" xlink:to="loc_us-gaap_AssetsCurrentAbstract_f4796734-14da-427c-b619-d2c175e097d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_c98bc3de-a4fe-4cf6-a5aa-1a0f03aefaf4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_f4796734-14da-427c-b619-d2c175e097d9" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_c98bc3de-a4fe-4cf6-a5aa-1a0f03aefaf4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_735fab69-dbb4-4fb3-bd50-9e381765795d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_f4796734-14da-427c-b619-d2c175e097d9" xlink:to="loc_us-gaap_InventoryNet_735fab69-dbb4-4fb3-bd50-9e381765795d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments_345a4c19-87ca-4e36-be8d-072cdd6814d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermInvestments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_f4796734-14da-427c-b619-d2c175e097d9" xlink:to="loc_us-gaap_ShortTermInvestments_345a4c19-87ca-4e36-be8d-072cdd6814d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidTaxes_a5fb243f-de62-4ba8-a6d4-4dd056055674" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidTaxes"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_f4796734-14da-427c-b619-d2c175e097d9" xlink:to="loc_us-gaap_PrepaidTaxes_a5fb243f-de62-4ba8-a6d4-4dd056055674" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_451308b8-73bf-45b9-8e6a-866740dacf0d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_f4796734-14da-427c-b619-d2c175e097d9" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_451308b8-73bf-45b9-8e6a-866740dacf0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_a0e77c65-5915-41fc-8f80-c5be7d7c471d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_6e95c8b5-b0b5-4b66-84f8-18818b5a09de" xlink:to="loc_us-gaap_AssetsCurrent_a0e77c65-5915-41fc-8f80-c5be7d7c471d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_b4ac178b-5eb1-4a08-8dff-62aea3970797" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_6e95c8b5-b0b5-4b66-84f8-18818b5a09de" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_b4ac178b-5eb1-4a08-8dff-62aea3970797" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_b76b799d-0974-4641-9cbf-3840d938cf9b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_6e95c8b5-b0b5-4b66-84f8-18818b5a09de" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_b76b799d-0974-4641-9cbf-3840d938cf9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_5c3b9c9d-760c-48a5-a71e-82fa96359645" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_6e95c8b5-b0b5-4b66-84f8-18818b5a09de" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_5c3b9c9d-760c-48a5-a71e-82fa96359645" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_8953e456-9339-49be-9779-ebfcdf22f1ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_6e95c8b5-b0b5-4b66-84f8-18818b5a09de" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_8953e456-9339-49be-9779-ebfcdf22f1ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_70f3975b-ae32-4ed4-8e3b-85b7a91f4cef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_6e95c8b5-b0b5-4b66-84f8-18818b5a09de" xlink:to="loc_us-gaap_Assets_70f3975b-ae32-4ed4-8e3b-85b7a91f4cef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_8a1e4af0-a122-4421-b7a4-e38de8f0cc53" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_d6b9726f-3e06-4924-a146-ad04a4585e7f" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_8a1e4af0-a122-4421-b7a4-e38de8f0cc53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_5648f46d-086a-4936-9ade-5ff366b49765" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_8a1e4af0-a122-4421-b7a4-e38de8f0cc53" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_5648f46d-086a-4936-9ade-5ff366b49765" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_3f2be505-a92f-435f-bd65-2b1887756553" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_5648f46d-086a-4936-9ade-5ff366b49765" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_3f2be505-a92f-435f-bd65-2b1887756553" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LinesOfCreditCurrent_47fb9527-fa42-4d5a-8316-1b409d0c9e04" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LinesOfCreditCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_5648f46d-086a-4936-9ade-5ff366b49765" xlink:to="loc_us-gaap_LinesOfCreditCurrent_47fb9527-fa42-4d5a-8316-1b409d0c9e04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_c38dcab6-29c8-4a19-aac5-ac673e84be8b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_5648f46d-086a-4936-9ade-5ff366b49765" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_c38dcab6-29c8-4a19-aac5-ac673e84be8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_1d8479dc-d7f5-4662-87d0-3541d2013dd1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_5648f46d-086a-4936-9ade-5ff366b49765" xlink:to="loc_us-gaap_LiabilitiesCurrent_1d8479dc-d7f5-4662-87d0-3541d2013dd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_f803de57-fea5-4313-9680-fe55abdc32db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_8a1e4af0-a122-4421-b7a4-e38de8f0cc53" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_f803de57-fea5-4313-9680-fe55abdc32db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_0df4a199-f3ee-440e-b020-7e270a37242a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_8a1e4af0-a122-4421-b7a4-e38de8f0cc53" xlink:to="loc_us-gaap_Liabilities_0df4a199-f3ee-440e-b020-7e270a37242a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_1e1418d3-4a24-4d74-b887-89733a3ad1ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_8a1e4af0-a122-4421-b7a4-e38de8f0cc53" xlink:to="loc_us-gaap_StockholdersEquityAbstract_1e1418d3-4a24-4d74-b887-89733a3ad1ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_3eee72ee-e289-47b2-9324-1bcf2f7efdf0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_1e1418d3-4a24-4d74-b887-89733a3ad1ca" xlink:to="loc_us-gaap_CommonStockValue_3eee72ee-e289-47b2-9324-1bcf2f7efdf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_3bd27b05-313b-4791-a63e-bc4753d1c8e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_1e1418d3-4a24-4d74-b887-89733a3ad1ca" xlink:to="loc_us-gaap_AdditionalPaidInCapital_3bd27b05-313b-4791-a63e-bc4753d1c8e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_16464adf-66e0-4ff9-ac21-6d0a3bf76b5e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_1e1418d3-4a24-4d74-b887-89733a3ad1ca" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_16464adf-66e0-4ff9-ac21-6d0a3bf76b5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_483b8d40-08bf-4581-8350-5de23e6307fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_1e1418d3-4a24-4d74-b887-89733a3ad1ca" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_483b8d40-08bf-4581-8350-5de23e6307fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_c2e8a603-5aa8-4a3d-bae3-ba3c599852d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_1e1418d3-4a24-4d74-b887-89733a3ad1ca" xlink:to="loc_us-gaap_StockholdersEquity_c2e8a603-5aa8-4a3d-bae3-ba3c599852d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_b20ee543-f960-435b-bbcd-40f81715d299" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_8a1e4af0-a122-4421-b7a4-e38de8f0cc53" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_b20ee543-f960-435b-bbcd-40f81715d299" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="simple" xlink:href="med-20220930.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"/>
  <link:presentationLink xlink:role="http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_4cf44f30-b870-4442-8a04-e70854622ccf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_407cd2e6-c692-4c67-9382-d22b043172ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_4cf44f30-b870-4442-8a04-e70854622ccf" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_407cd2e6-c692-4c67-9382-d22b043172ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_67843bf4-8263-48a4-8f44-64d0960c8166" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_4cf44f30-b870-4442-8a04-e70854622ccf" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_67843bf4-8263-48a4-8f44-64d0960c8166" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_324443e0-9adf-486d-a14e-e7e5f128d212" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_4cf44f30-b870-4442-8a04-e70854622ccf" xlink:to="loc_us-gaap_CommonStockSharesIssued_324443e0-9adf-486d-a14e-e7e5f128d212" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_813e8aa2-7b66-40ef-a13b-a7a7fc5d4be8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_4cf44f30-b870-4442-8a04-e70854622ccf" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_813e8aa2-7b66-40ef-a13b-a7a7fc5d4be8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" xlink:type="simple" xlink:href="med-20220930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"/>
  <link:presentationLink xlink:role="http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_76fc54ec-0c73-4af2-8d8a-583bd4e97da2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_b779a174-9d54-4ae2-b03b-b7e745d72e2e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_76fc54ec-0c73-4af2-8d8a-583bd4e97da2" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_b779a174-9d54-4ae2-b03b-b7e745d72e2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_51afe9a0-ae20-44a0-acfe-42ca47982667" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_b779a174-9d54-4ae2-b03b-b7e745d72e2e" xlink:to="loc_us-gaap_NetIncomeLoss_51afe9a0-ae20-44a0-acfe-42ca47982667" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_5cee0060-849a-4828-886c-2608f6c4ce92" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_b779a174-9d54-4ae2-b03b-b7e745d72e2e" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_5cee0060-849a-4828-886c-2608f6c4ce92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_5014c0cc-0f4d-4b53-9eb9-bc8844d414d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_5cee0060-849a-4828-886c-2608f6c4ce92" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_5014c0cc-0f4d-4b53-9eb9-bc8844d414d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_med_OperatingLeaseExpenseNonCash_0f1c21ab-8aaf-4c66-b86b-74b3d4d7fdb8" xlink:href="med-20220930.xsd#med_OperatingLeaseExpenseNonCash"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_5cee0060-849a-4828-886c-2608f6c4ce92" xlink:to="loc_med_OperatingLeaseExpenseNonCash_0f1c21ab-8aaf-4c66-b86b-74b3d4d7fdb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_41dddb02-2eae-4539-934f-331b99bc6061" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_5cee0060-849a-4828-886c-2608f6c4ce92" xlink:to="loc_us-gaap_ShareBasedCompensation_41dddb02-2eae-4539-934f-331b99bc6061" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_med_AmortizationOfPremiumOnInvestmentSecurities_d8b7fd7d-1bf3-44a0-8120-419ca5f6a9a3" xlink:href="med-20220930.xsd#med_AmortizationOfPremiumOnInvestmentSecurities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_5cee0060-849a-4828-886c-2608f6c4ce92" xlink:to="loc_med_AmortizationOfPremiumOnInvestmentSecurities_d8b7fd7d-1bf3-44a0-8120-419ca5f6a9a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_0feac739-eb56-4ddf-af5e-55ec00d64c6d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_5cee0060-849a-4828-886c-2608f6c4ce92" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_0feac739-eb56-4ddf-af5e-55ec00d64c6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_d3dc1bc6-df76-4ee8-aaea-b95d7888ef9b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_5cee0060-849a-4828-886c-2608f6c4ce92" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_d3dc1bc6-df76-4ee8-aaea-b95d7888ef9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_8df85748-82cf-4031-ae36-dc316640be64" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_d3dc1bc6-df76-4ee8-aaea-b95d7888ef9b" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_8df85748-82cf-4031-ae36-dc316640be64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidTaxes_2ef66bac-0889-48b9-8a44-46765da66d49" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidTaxes"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_d3dc1bc6-df76-4ee8-aaea-b95d7888ef9b" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidTaxes_2ef66bac-0889-48b9-8a44-46765da66d49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_b753f2b5-b5bf-4f5f-8b1d-0b297b401523" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_d3dc1bc6-df76-4ee8-aaea-b95d7888ef9b" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_b753f2b5-b5bf-4f5f-8b1d-0b297b401523" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_e3c8106e-414c-4fcf-8812-e69859d76bd5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_d3dc1bc6-df76-4ee8-aaea-b95d7888ef9b" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_e3c8106e-414c-4fcf-8812-e69859d76bd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_c5bc6b1c-640b-42e7-ad51-3b6c1f29a8b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_d3dc1bc6-df76-4ee8-aaea-b95d7888ef9b" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_c5bc6b1c-640b-42e7-ad51-3b6c1f29a8b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_7c815928-ca22-428c-9a92-96229662c023" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_d3dc1bc6-df76-4ee8-aaea-b95d7888ef9b" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_7c815928-ca22-428c-9a92-96229662c023" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_fecff541-9fe3-443e-b064-da985a1485f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_76fc54ec-0c73-4af2-8d8a-583bd4e97da2" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_fecff541-9fe3-443e-b064-da985a1485f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfShortTermInvestments_5079affe-caa3-4259-a34e-81440b5218bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfShortTermInvestments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_fecff541-9fe3-443e-b064-da985a1485f0" xlink:to="loc_us-gaap_ProceedsFromSaleOfShortTermInvestments_5079affe-caa3-4259-a34e-81440b5218bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_226a4a0c-f45f-4f39-893b-2e8d39cc3a1f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_fecff541-9fe3-443e-b064-da985a1485f0" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_226a4a0c-f45f-4f39-893b-2e8d39cc3a1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_f0e2b20a-7384-4a94-8d5d-6f115f8aeb0d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_fecff541-9fe3-443e-b064-da985a1485f0" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_f0e2b20a-7384-4a94-8d5d-6f115f8aeb0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_9b043f58-e5d6-4b9a-8773-3b38cffe0f00" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_76fc54ec-0c73-4af2-8d8a-583bd4e97da2" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_9b043f58-e5d6-4b9a-8773-3b38cffe0f00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_246ff57c-1085-4215-95dd-30cf3b4e8776" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_9b043f58-e5d6-4b9a-8773-3b38cffe0f00" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_246ff57c-1085-4215-95dd-30cf3b4e8776" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfOtherEquity_b7950d12-3b0c-47bb-8025-e7984082b305" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRepurchaseOfOtherEquity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_9b043f58-e5d6-4b9a-8773-3b38cffe0f00" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfOtherEquity_b7950d12-3b0c-47bb-8025-e7984082b305" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividends_cc80ba22-888e-45cc-b72c-28ceeda7fbab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDividends"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_9b043f58-e5d6-4b9a-8773-3b38cffe0f00" xlink:to="loc_us-gaap_PaymentsOfDividends_cc80ba22-888e-45cc-b72c-28ceeda7fbab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_93c77944-5f67-40ef-b56a-8ec84a90dbbf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_9b043f58-e5d6-4b9a-8773-3b38cffe0f00" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_93c77944-5f67-40ef-b56a-8ec84a90dbbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_145134b8-d5f8-44cd-868a-8111facbe6cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_9b043f58-e5d6-4b9a-8773-3b38cffe0f00" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_145134b8-d5f8-44cd-868a-8111facbe6cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_a4926100-2822-4103-b233-245ffa35c172" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_76fc54ec-0c73-4af2-8d8a-583bd4e97da2" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_a4926100-2822-4103-b233-245ffa35c172" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_7384b750-807d-4013-9b03-8a38f47370d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_76fc54ec-0c73-4af2-8d8a-583bd4e97da2" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_7384b750-807d-4013-9b03-8a38f47370d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_852d5a09-6ef7-4834-affa-2d9567ab2239" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_76fc54ec-0c73-4af2-8d8a-583bd4e97da2" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_852d5a09-6ef7-4834-affa-2d9567ab2239" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_32ae64f2-4293-45d1-aeba-2ac743e8a432" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_76fc54ec-0c73-4af2-8d8a-583bd4e97da2" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_32ae64f2-4293-45d1-aeba-2ac743e8a432" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_9d84c31d-a101-4ece-8a92-a1e77247d69a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_76fc54ec-0c73-4af2-8d8a-583bd4e97da2" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_9d84c31d-a101-4ece-8a92-a1e77247d69a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet_1f3d42cb-eb4b-4fc1-8242-53da297c4500" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_9d84c31d-a101-4ece-8a92-a1e77247d69a" xlink:to="loc_us-gaap_IncomeTaxesPaidNet_1f3d42cb-eb4b-4fc1-8242-53da297c4500" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCash_5c76c4b8-7847-4568-b997-b5b315988bc8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsCash"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_9d84c31d-a101-4ece-8a92-a1e77247d69a" xlink:to="loc_us-gaap_DividendsCash_5c76c4b8-7847-4568-b997-b5b315988bc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYUNAUDITED" xlink:type="simple" xlink:href="med-20220930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYUNAUDITED"/>
  <link:presentationLink xlink:role="http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYUNAUDITED" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_9c22f3d4-8d33-488d-a8ce-9aa6df0e546c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_cc2e2bc7-1fc9-4f06-9e8c-842829561748" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_9c22f3d4-8d33-488d-a8ce-9aa6df0e546c" xlink:to="loc_us-gaap_StatementTable_cc2e2bc7-1fc9-4f06-9e8c-842829561748" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_2ee8d58b-c072-494e-82ac-94d7a48728c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_cc2e2bc7-1fc9-4f06-9e8c-842829561748" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_2ee8d58b-c072-494e-82ac-94d7a48728c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_bbe90df0-21fa-4cd9-a6e1-83724a94d4a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_2ee8d58b-c072-494e-82ac-94d7a48728c3" xlink:to="loc_us-gaap_EquityComponentDomain_bbe90df0-21fa-4cd9-a6e1-83724a94d4a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_2931acc5-9521-4eb1-883d-b06be80865fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_bbe90df0-21fa-4cd9-a6e1-83724a94d4a5" xlink:to="loc_us-gaap_CommonStockMember_2931acc5-9521-4eb1-883d-b06be80865fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_521f9a16-2223-47e3-ae94-03271ab8868a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_bbe90df0-21fa-4cd9-a6e1-83724a94d4a5" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_521f9a16-2223-47e3-ae94-03271ab8868a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_b8863288-2d35-4010-a52a-1c2a58c7b4fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_bbe90df0-21fa-4cd9-a6e1-83724a94d4a5" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_b8863288-2d35-4010-a52a-1c2a58c7b4fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_9a523ca0-460c-4145-806d-bc5453bd9719" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_bbe90df0-21fa-4cd9-a6e1-83724a94d4a5" xlink:to="loc_us-gaap_RetainedEarningsMember_9a523ca0-460c-4145-806d-bc5453bd9719" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonMember_472e82f1-728e-46b3-8fde-b6a9f405948b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockCommonMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_bbe90df0-21fa-4cd9-a6e1-83724a94d4a5" xlink:to="loc_us-gaap_TreasuryStockCommonMember_472e82f1-728e-46b3-8fde-b6a9f405948b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_ef1bcf94-5607-4a12-9bb2-693e92551716" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_cc2e2bc7-1fc9-4f06-9e8c-842829561748" xlink:to="loc_us-gaap_StatementLineItems_ef1bcf94-5607-4a12-9bb2-693e92551716" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b1c3ec23-26ff-4327-9b88-a8a431832129" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ef1bcf94-5607-4a12-9bb2-693e92551716" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b1c3ec23-26ff-4327-9b88-a8a431832129" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_743342ae-fe92-4644-b55f-bc19e2c00e9e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b1c3ec23-26ff-4327-9b88-a8a431832129" xlink:to="loc_us-gaap_CommonStockSharesIssued_743342ae-fe92-4644-b55f-bc19e2c00e9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_cd3f3789-01ee-4ba1-980f-cfc2093c7751" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b1c3ec23-26ff-4327-9b88-a8a431832129" xlink:to="loc_us-gaap_StockholdersEquity_cd3f3789-01ee-4ba1-980f-cfc2093c7751" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_c4d792f2-9bff-4f27-b0ea-3fbce42e507e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b1c3ec23-26ff-4327-9b88-a8a431832129" xlink:to="loc_us-gaap_NetIncomeLoss_c4d792f2-9bff-4f27-b0ea-3fbce42e507e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_cc86e065-9ea2-4cf1-8a55-6bb0d22c5137" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b1c3ec23-26ff-4327-9b88-a8a431832129" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_cc86e065-9ea2-4cf1-8a55-6bb0d22c5137" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions_c1c6b055-2a0c-403b-a3a4-430810f41df5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b1c3ec23-26ff-4327-9b88-a8a431832129" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions_c1c6b055-2a0c-403b-a3a4-430810f41df5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_24e7654d-15ae-4b05-8a27-e0f8f62db557" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b1c3ec23-26ff-4327-9b88-a8a431832129" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_24e7654d-15ae-4b05-8a27-e0f8f62db557" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_ff80789f-788d-4b1c-917d-0a686da9fb78" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b1c3ec23-26ff-4327-9b88-a8a431832129" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_ff80789f-788d-4b1c-917d-0a686da9fb78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_4e53a392-e5a4-4e38-b8ba-63d3e4263dac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b1c3ec23-26ff-4327-9b88-a8a431832129" xlink:to="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_4e53a392-e5a4-4e38-b8ba-63d3e4263dac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_5d7feaaa-7145-49f8-a309-86f0f014ae93" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b1c3ec23-26ff-4327-9b88-a8a431832129" xlink:to="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_5d7feaaa-7145-49f8-a309-86f0f014ae93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_3debd9d6-6b7e-44b9-8ffc-092c270e52d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b1c3ec23-26ff-4327-9b88-a8a431832129" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_3debd9d6-6b7e-44b9-8ffc-092c270e52d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesRetired_e5c3aeb2-a0cd-46bf-9c1b-f4fb40f05300" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockSharesRetired"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b1c3ec23-26ff-4327-9b88-a8a431832129" xlink:to="loc_us-gaap_TreasuryStockSharesRetired_e5c3aeb2-a0cd-46bf-9c1b-f4fb40f05300" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockRetiredCostMethodAmount_757350d8-8987-4d0f-aa05-8c3d0c67826c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockRetiredCostMethodAmount"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b1c3ec23-26ff-4327-9b88-a8a431832129" xlink:to="loc_us-gaap_TreasuryStockRetiredCostMethodAmount_757350d8-8987-4d0f-aa05-8c3d0c67826c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_med_AdjustmentsToPaidInCapitalShareRepurchasesNotYetSettled_5ae06770-d9d8-4aa4-be2b-73c1ed1353eb" xlink:href="med-20220930.xsd#med_AdjustmentsToPaidInCapitalShareRepurchasesNotYetSettled"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b1c3ec23-26ff-4327-9b88-a8a431832129" xlink:to="loc_med_AdjustmentsToPaidInCapitalShareRepurchasesNotYetSettled_5ae06770-d9d8-4aa4-be2b-73c1ed1353eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchaseProgramAdjustment_227898df-1199-484a-8e9f-6e3be1c19349" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcceleratedShareRepurchaseProgramAdjustment"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b1c3ec23-26ff-4327-9b88-a8a431832129" xlink:to="loc_us-gaap_AcceleratedShareRepurchaseProgramAdjustment_227898df-1199-484a-8e9f-6e3be1c19349" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_f185b45f-b6d0-4b55-82cb-4d089ae0af3e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b1c3ec23-26ff-4327-9b88-a8a431832129" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_f185b45f-b6d0-4b55-82cb-4d089ae0af3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash_04f9ef3d-83d1-4efb-ae8e-c83713ea0cb4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b1c3ec23-26ff-4327-9b88-a8a431832129" xlink:to="loc_us-gaap_DividendsCommonStockCash_04f9ef3d-83d1-4efb-ae8e-c83713ea0cb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_4c4fd010-4be7-4a24-bda2-deb99b7c269a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b1c3ec23-26ff-4327-9b88-a8a431832129" xlink:to="loc_us-gaap_CommonStockSharesIssued_4c4fd010-4be7-4a24-bda2-deb99b7c269a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_00019b0b-4e91-49b9-940a-90ed1b46675c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b1c3ec23-26ff-4327-9b88-a8a431832129" xlink:to="loc_us-gaap_StockholdersEquity_00019b0b-4e91-49b9-940a-90ed1b46675c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medifast1.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES" xlink:type="simple" xlink:href="med-20220930.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES"/>
  <link:presentationLink xlink:role="http://www.medifast1.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_3f71a3fa-76ff-4700-b3c4-605fc193515b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock_f5a1ed50-0caf-415c-966f-026a8861d355" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_3f71a3fa-76ff-4700-b3c4-605fc193515b" xlink:to="loc_us-gaap_SignificantAccountingPoliciesTextBlock_f5a1ed50-0caf-415c-966f-026a8861d355" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medifast1.com/role/INVENTORIES" xlink:type="simple" xlink:href="med-20220930.xsd#INVENTORIES"/>
  <link:presentationLink xlink:role="http://www.medifast1.com/role/INVENTORIES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_2ed72819-0763-426c-9e17-6938a4e71466" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureTextBlock_4169bd3c-87ac-4bab-ac55-8f93bbd187b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_2ed72819-0763-426c-9e17-6938a4e71466" xlink:to="loc_us-gaap_InventoryDisclosureTextBlock_4169bd3c-87ac-4bab-ac55-8f93bbd187b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medifast1.com/role/EARNINGSPERSHARE" xlink:type="simple" xlink:href="med-20220930.xsd#EARNINGSPERSHARE"/>
  <link:presentationLink xlink:role="http://www.medifast1.com/role/EARNINGSPERSHARE" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_2267541e-b544-41ec-9c90-3e998ddfa34b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_d8eca499-0a89-47ce-902e-2c8ed30e2052" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_2267541e-b544-41ec-9c90-3e998ddfa34b" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_d8eca499-0a89-47ce-902e-2c8ed30e2052" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medifast1.com/role/SHAREBASEDCOMPENSATION" xlink:type="simple" xlink:href="med-20220930.xsd#SHAREBASEDCOMPENSATION"/>
  <link:presentationLink xlink:role="http://www.medifast1.com/role/SHAREBASEDCOMPENSATION" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_4887eda7-59a6-4fe1-9d99-f330e28bc36c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_0b06a90b-496b-4d5d-803e-1bed3cef1847" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_4887eda7-59a6-4fe1-9d99-f330e28bc36c" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_0b06a90b-496b-4d5d-803e-1bed3cef1847" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medifast1.com/role/LEASES" xlink:type="simple" xlink:href="med-20220930.xsd#LEASES"/>
  <link:presentationLink xlink:role="http://www.medifast1.com/role/LEASES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_bd60c360-ab37-4309-9c41-7774631b937a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock_86e43350-8d65-4ad6-a632-496fa8f48206" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_bd60c360-ab37-4309-9c41-7774631b937a" xlink:to="loc_us-gaap_LesseeOperatingLeasesTextBlock_86e43350-8d65-4ad6-a632-496fa8f48206" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medifast1.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOME" xlink:type="simple" xlink:href="med-20220930.xsd#ACCUMULATEDOTHERCOMPREHENSIVEINCOME"/>
  <link:presentationLink xlink:role="http://www.medifast1.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOME" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_139b8011-ed9e-4b3d-b7d6-529b0f5176ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNoteTextBlock_8e8ce42b-36c2-4872-826a-a1da096c31d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNoteTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_139b8011-ed9e-4b3d-b7d6-529b0f5176ad" xlink:to="loc_us-gaap_ComprehensiveIncomeNoteTextBlock_8e8ce42b-36c2-4872-826a-a1da096c31d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medifast1.com/role/FINANCIALINSTRUMENTS" xlink:type="simple" xlink:href="med-20220930.xsd#FINANCIALINSTRUMENTS"/>
  <link:presentationLink xlink:role="http://www.medifast1.com/role/FINANCIALINSTRUMENTS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAllOtherInvestmentsAbstract_29cfb5d3-3932-4a25-9a51-e2f6aefe4450" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsAllOtherInvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentsDisclosureTextBlock_cdba2384-adaf-4ca2-9e44-b872eb534224" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAllOtherInvestmentsAbstract_29cfb5d3-3932-4a25-9a51-e2f6aefe4450" xlink:to="loc_us-gaap_FinancialInstrumentsDisclosureTextBlock_cdba2384-adaf-4ca2-9e44-b872eb534224" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medifast1.com/role/DEBT" xlink:type="simple" xlink:href="med-20220930.xsd#DEBT"/>
  <link:presentationLink xlink:role="http://www.medifast1.com/role/DEBT" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_2c70c6d4-050e-4288-9a0d-9badec94af4f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_d3ede8f2-02fc-4ea3-84df-e5e4ad5e3ac8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_2c70c6d4-050e-4288-9a0d-9badec94af4f" xlink:to="loc_us-gaap_DebtDisclosureTextBlock_d3ede8f2-02fc-4ea3-84df-e5e4ad5e3ac8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medifast1.com/role/ACCELERATEDSHAREREPURCHASEASRPROGRAM" xlink:type="simple" xlink:href="med-20220930.xsd#ACCELERATEDSHAREREPURCHASEASRPROGRAM"/>
  <link:presentationLink xlink:role="http://www.medifast1.com/role/ACCELERATEDSHAREREPURCHASEASRPROGRAM" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_4b2e1a53-f1af-437b-a53d-27296775fedc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepurchaseAgreementsResaleAgreementsSecuritiesBorrowedAndSecuritiesLoanedDisclosureTextBlock_eeda2bd7-05b4-48b3-bee2-574568979334" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepurchaseAgreementsResaleAgreementsSecuritiesBorrowedAndSecuritiesLoanedDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_4b2e1a53-f1af-437b-a53d-27296775fedc" xlink:to="loc_us-gaap_RepurchaseAgreementsResaleAgreementsSecuritiesBorrowedAndSecuritiesLoanedDisclosureTextBlock_eeda2bd7-05b4-48b3-bee2-574568979334" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medifast1.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" xlink:type="simple" xlink:href="med-20220930.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"/>
  <link:presentationLink xlink:role="http://www.medifast1.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_3fcd6be2-4b75-4b1a-b5b0-875761a995dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_40c1c5ef-f704-4c19-b453-7d7b44c2b32b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_3fcd6be2-4b75-4b1a-b5b0-875761a995dc" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_40c1c5ef-f704-4c19-b453-7d7b44c2b32b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock_c718ef10-6e7c-4039-af65-5a64603d9344" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_3fcd6be2-4b75-4b1a-b5b0-875761a995dc" xlink:to="loc_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock_c718ef10-6e7c-4039-af65-5a64603d9344" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription_bd49dc15-6f74-4b50-b7b2-ded9b4463042" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PriorPeriodReclassificationAdjustmentDescription"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_3fcd6be2-4b75-4b1a-b5b0-875761a995dc" xlink:to="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription_bd49dc15-6f74-4b50-b7b2-ded9b4463042" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_42552a8f-31ce-4e39-9a05-f0bee9614058" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_3fcd6be2-4b75-4b1a-b5b0-875761a995dc" xlink:to="loc_us-gaap_UseOfEstimates_42552a8f-31ce-4e39-9a05-f0bee9614058" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_51a4dcc7-f491-42e9-8ff0-c7c8cd1efab1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_3fcd6be2-4b75-4b1a-b5b0-875761a995dc" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_51a4dcc7-f491-42e9-8ff0-c7c8cd1efab1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medifast1.com/role/INVENTORIESTables" xlink:type="simple" xlink:href="med-20220930.xsd#INVENTORIESTables"/>
  <link:presentationLink xlink:role="http://www.medifast1.com/role/INVENTORIESTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_6f1aaa99-21e2-4ad1-91f2-7a50815854e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_7a4f5b0d-2d40-4e84-b86c-04c1bf2eaf75" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_6f1aaa99-21e2-4ad1-91f2-7a50815854e9" xlink:to="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_7a4f5b0d-2d40-4e84-b86c-04c1bf2eaf75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medifast1.com/role/EARNINGSPERSHARETables" xlink:type="simple" xlink:href="med-20220930.xsd#EARNINGSPERSHARETables"/>
  <link:presentationLink xlink:role="http://www.medifast1.com/role/EARNINGSPERSHARETables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_34b70855-a9bd-475c-b351-347567eb2ba4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_792efea9-5eb2-4732-a354-4ed322ef0644" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_34b70855-a9bd-475c-b351-347567eb2ba4" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_792efea9-5eb2-4732-a354-4ed322ef0644" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONTables" xlink:type="simple" xlink:href="med-20220930.xsd#SHAREBASEDCOMPENSATIONTables"/>
  <link:presentationLink xlink:role="http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_628b5c53-7aaf-4dae-a565-782e27c4fb63" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_98522f5a-6400-4931-82d4-597b5bac859c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_628b5c53-7aaf-4dae-a565-782e27c4fb63" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_98522f5a-6400-4931-82d4-597b5bac859c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_93900672-e39f-40d5-9064-a8b1872e062b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_628b5c53-7aaf-4dae-a565-782e27c4fb63" xlink:to="loc_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_93900672-e39f-40d5-9064-a8b1872e062b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_2e795156-a029-4d6f-abec-4a1a51c43c6b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_628b5c53-7aaf-4dae-a565-782e27c4fb63" xlink:to="loc_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_2e795156-a029-4d6f-abec-4a1a51c43c6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medifast1.com/role/LEASESTables" xlink:type="simple" xlink:href="med-20220930.xsd#LEASESTables"/>
  <link:presentationLink xlink:role="http://www.medifast1.com/role/LEASESTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_cb328c00-d6e0-42d9-86be-1d7a675ded02" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock_7e26fc33-e341-46c4-8e7f-181227abb5b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_cb328c00-d6e0-42d9-86be-1d7a675ded02" xlink:to="loc_us-gaap_LeaseCostTableTextBlock_7e26fc33-e341-46c4-8e7f-181227abb5b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_96875c25-58a6-4ace-96a3-952a1cd75ec6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_cb328c00-d6e0-42d9-86be-1d7a675ded02" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_96875c25-58a6-4ace-96a3-952a1cd75ec6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medifast1.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMETables" xlink:type="simple" xlink:href="med-20220930.xsd#ACCUMULATEDOTHERCOMPREHENSIVEINCOMETables"/>
  <link:presentationLink xlink:role="http://www.medifast1.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMETables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_bead872a-5e4d-497b-a8d2-32d065080579" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_67b40ce2-a8ed-46d7-8e92-ac13ad87f3fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_bead872a-5e4d-497b-a8d2-32d065080579" xlink:to="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_67b40ce2-a8ed-46d7-8e92-ac13ad87f3fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medifast1.com/role/FINANCIALINSTRUMENTSTables" xlink:type="simple" xlink:href="med-20220930.xsd#FINANCIALINSTRUMENTSTables"/>
  <link:presentationLink xlink:role="http://www.medifast1.com/role/FINANCIALINSTRUMENTSTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAllOtherInvestmentsAbstract_adfe9c95-ad14-4aae-a230-29a40cddfd56" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsAllOtherInvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock_31b8338a-9114-4229-aa57-0da2b2d9a23e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAllOtherInvestmentsAbstract_adfe9c95-ad14-4aae-a230-29a40cddfd56" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock_31b8338a-9114-4229-aa57-0da2b2d9a23e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medifast1.com/role/INVENTORIESDetails" xlink:type="simple" xlink:href="med-20220930.xsd#INVENTORIESDetails"/>
  <link:presentationLink xlink:role="http://www.medifast1.com/role/INVENTORIESDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_dcc0db4c-bd3d-4280-bb60-a54f0850ad41" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashContributionExpense_218e5b03-3878-49cc-93fc-8eba1648c124" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncashContributionExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_dcc0db4c-bd3d-4280-bb60-a54f0850ad41" xlink:to="loc_us-gaap_NoncashContributionExpense_218e5b03-3878-49cc-93fc-8eba1648c124" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterials_fe8eaa25-92a5-4013-bdba-c2025c8182a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryRawMaterials"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_dcc0db4c-bd3d-4280-bb60-a54f0850ad41" xlink:to="loc_us-gaap_InventoryRawMaterials_fe8eaa25-92a5-4013-bdba-c2025c8182a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetailRelatedInventoryPackagingAndOtherSupplies_4cdb612a-2b6c-43aa-a08b-521811796cbb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetailRelatedInventoryPackagingAndOtherSupplies"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_dcc0db4c-bd3d-4280-bb60-a54f0850ad41" xlink:to="loc_us-gaap_RetailRelatedInventoryPackagingAndOtherSupplies_4cdb612a-2b6c-43aa-a08b-521811796cbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_med_InventoryNonFoodFinishedGoods_daa63899-3850-4cd8-9ed2-1a58da65e912" xlink:href="med-20220930.xsd#med_InventoryNonFoodFinishedGoods"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_dcc0db4c-bd3d-4280-bb60-a54f0850ad41" xlink:to="loc_med_InventoryNonFoodFinishedGoods_daa63899-3850-4cd8-9ed2-1a58da65e912" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoods_88d398dc-6000-41d3-a62c-e6a403620b56" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryFinishedGoods"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_dcc0db4c-bd3d-4280-bb60-a54f0850ad41" xlink:to="loc_us-gaap_InventoryFinishedGoods_88d398dc-6000-41d3-a62c-e6a403620b56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryValuationReserves_c75eb405-2c0d-476e-b068-b0e2023067f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryValuationReserves"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_dcc0db4c-bd3d-4280-bb60-a54f0850ad41" xlink:to="loc_us-gaap_InventoryValuationReserves_c75eb405-2c0d-476e-b068-b0e2023067f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_f9ff32e1-a05d-45a4-94ab-cf1e76b00bff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_dcc0db4c-bd3d-4280-bb60-a54f0850ad41" xlink:to="loc_us-gaap_InventoryNet_f9ff32e1-a05d-45a4-94ab-cf1e76b00bff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medifast1.com/role/EARNINGSPERSHAREComputationofBasicandDilutedEPSDetails" xlink:type="simple" xlink:href="med-20220930.xsd#EARNINGSPERSHAREComputationofBasicandDilutedEPSDetails"/>
  <link:presentationLink xlink:role="http://www.medifast1.com/role/EARNINGSPERSHAREComputationofBasicandDilutedEPSDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_8ed84d70-d3d0-495c-bf29-b921f330ba3b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_med_NumeratorAbstract_88592aeb-1015-4dd0-a8ca-879074c07c36" xlink:href="med-20220930.xsd#med_NumeratorAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_8ed84d70-d3d0-495c-bf29-b921f330ba3b" xlink:to="loc_med_NumeratorAbstract_88592aeb-1015-4dd0-a8ca-879074c07c36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_3ef4cd4c-2769-40a8-95b6-680faab601fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_med_NumeratorAbstract_88592aeb-1015-4dd0-a8ca-879074c07c36" xlink:to="loc_us-gaap_NetIncomeLoss_3ef4cd4c-2769-40a8-95b6-680faab601fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_med_DenominatorAbstract_3c38517e-158e-408b-b270-38d2c2590958" xlink:href="med-20220930.xsd#med_DenominatorAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_8ed84d70-d3d0-495c-bf29-b921f330ba3b" xlink:to="loc_med_DenominatorAbstract_3c38517e-158e-408b-b270-38d2c2590958" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_1a711314-6be2-4402-90f9-1064d3e2075a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_med_DenominatorAbstract_3c38517e-158e-408b-b270-38d2c2590958" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_1a711314-6be2-4402-90f9-1064d3e2075a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_c5833984-4d6c-4706-8a31-c8d2d5c6687e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_med_DenominatorAbstract_3c38517e-158e-408b-b270-38d2c2590958" xlink:to="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_c5833984-4d6c-4706-8a31-c8d2d5c6687e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_3cc502b0-f46e-4f0f-85e9-1a24ee3611c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_med_DenominatorAbstract_3c38517e-158e-408b-b270-38d2c2590958" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_3cc502b0-f46e-4f0f-85e9-1a24ee3611c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAbstract_ad1a0a6b-1d8f-4588-8f42-31cd0ad8b413" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_med_DenominatorAbstract_3c38517e-158e-408b-b270-38d2c2590958" xlink:to="loc_us-gaap_EarningsPerShareBasicAbstract_ad1a0a6b-1d8f-4588-8f42-31cd0ad8b413" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_85ba7bf7-e13e-47ba-b4b9-370d2f450815" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_ad1a0a6b-1d8f-4588-8f42-31cd0ad8b413" xlink:to="loc_us-gaap_EarningsPerShareBasic_85ba7bf7-e13e-47ba-b4b9-370d2f450815" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedAbstract_746a26c8-5639-4752-a887-c521680ae7b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDilutedAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_med_DenominatorAbstract_3c38517e-158e-408b-b270-38d2c2590958" xlink:to="loc_us-gaap_EarningsPerShareDilutedAbstract_746a26c8-5639-4752-a887-c521680ae7b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_3b980b0a-1a6b-4d96-bbd5-4f786122984b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_746a26c8-5639-4752-a887-c521680ae7b3" xlink:to="loc_us-gaap_EarningsPerShareDiluted_3b980b0a-1a6b-4d96-bbd5-4f786122984b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medifast1.com/role/EARNINGSPERSHARENarrativeDetails" xlink:type="simple" xlink:href="med-20220930.xsd#EARNINGSPERSHARENarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.medifast1.com/role/EARNINGSPERSHARENarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_db94bf52-ca0f-4da4-bda1-acc2f1743b33" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_734c6744-9473-4c3e-8b29-a1346011f2da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_db94bf52-ca0f-4da4-bda1-acc2f1743b33" xlink:to="loc_us-gaap_StatementTable_734c6744-9473-4c3e-8b29-a1346011f2da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_29f5df8a-2b78-4b5d-b0fa-aa37a2cf4661" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_734c6744-9473-4c3e-8b29-a1346011f2da" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_29f5df8a-2b78-4b5d-b0fa-aa37a2cf4661" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_6adcb098-dc2f-4a53-8f0f-0861bfcf659d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_29f5df8a-2b78-4b5d-b0fa-aa37a2cf4661" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_6adcb098-dc2f-4a53-8f0f-0861bfcf659d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_187fe810-a525-4f52-8c20-26bf0fe37afb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_6adcb098-dc2f-4a53-8f0f-0861bfcf659d" xlink:to="loc_us-gaap_RestrictedStockMember_187fe810-a525-4f52-8c20-26bf0fe37afb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_1fb4cd38-ff04-4b18-8ca0-8f089d21b3a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_734c6744-9473-4c3e-8b29-a1346011f2da" xlink:to="loc_us-gaap_StatementLineItems_1fb4cd38-ff04-4b18-8ca0-8f089d21b3a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_68fcae99-001f-43ce-bc8b-bcd6fc46633e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1fb4cd38-ff04-4b18-8ca0-8f089d21b3a0" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_68fcae99-001f-43ce-bc8b-bcd6fc46633e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails" xlink:type="simple" xlink:href="med-20220930.xsd#SHAREBASEDCOMPENSATIONNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0c2719ad-f13d-41d9-b0f1-c2c7212f5fdc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_e512f51d-bd57-431f-bede-d8516d4b0088" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0c2719ad-f13d-41d9-b0f1-c2c7212f5fdc" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_e512f51d-bd57-431f-bede-d8516d4b0088" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_9227d7a0-4cd1-4a02-80d9-179e9e45d5fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_e512f51d-bd57-431f-bede-d8516d4b0088" xlink:to="loc_us-gaap_AwardTypeAxis_9227d7a0-4cd1-4a02-80d9-179e9e45d5fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_78c18b21-87b5-42e2-817f-eab49b4a1716" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_9227d7a0-4cd1-4a02-80d9-179e9e45d5fd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_78c18b21-87b5-42e2-817f-eab49b4a1716" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_34a35bd3-d7b4-4bed-a72c-0f10616d7390" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_78c18b21-87b5-42e2-817f-eab49b4a1716" xlink:to="loc_us-gaap_EmployeeStockOptionMember_34a35bd3-d7b4-4bed-a72c-0f10616d7390" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_9940262e-b058-4587-8221-a6c2d8f98d41" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_78c18b21-87b5-42e2-817f-eab49b4a1716" xlink:to="loc_us-gaap_RestrictedStockMember_9940262e-b058-4587-8221-a6c2d8f98d41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_69547e95-6c33-49f3-93f2-d8cad5ba3cd1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PerformanceSharesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_78c18b21-87b5-42e2-817f-eab49b4a1716" xlink:to="loc_us-gaap_PerformanceSharesMember_69547e95-6c33-49f3-93f2-d8cad5ba3cd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_434a7827-d1a1-4d05-b0da-3b61a3b2bfca" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_e512f51d-bd57-431f-bede-d8516d4b0088" xlink:to="loc_srt_RangeAxis_434a7827-d1a1-4d05-b0da-3b61a3b2bfca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_9d93998c-c62d-4421-9908-548393944415" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_434a7827-d1a1-4d05-b0da-3b61a3b2bfca" xlink:to="loc_srt_RangeMember_9d93998c-c62d-4421-9908-548393944415" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_0c1bee4f-5b11-49b2-ae2b-55cc9f8bc00a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_9d93998c-c62d-4421-9908-548393944415" xlink:to="loc_srt_MinimumMember_0c1bee4f-5b11-49b2-ae2b-55cc9f8bc00a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_5502ab48-2798-46c9-8f39-9dc15a07476c" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_9d93998c-c62d-4421-9908-548393944415" xlink:to="loc_srt_MaximumMember_5502ab48-2798-46c9-8f39-9dc15a07476c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a859e31a-768c-40ff-9295-46c70eb828d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_e512f51d-bd57-431f-bede-d8516d4b0088" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a859e31a-768c-40ff-9295-46c70eb828d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_18d7df5f-a532-4d62-8d6f-651f86a7c45e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a859e31a-768c-40ff-9295-46c70eb828d0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_18d7df5f-a532-4d62-8d6f-651f86a7c45e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_f3791204-ee87-47a1-b54a-a5bd73addaf5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a859e31a-768c-40ff-9295-46c70eb828d0" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_f3791204-ee87-47a1-b54a-a5bd73addaf5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_431433f6-5126-4070-b8f0-d9b4d5a56421" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a859e31a-768c-40ff-9295-46c70eb828d0" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_431433f6-5126-4070-b8f0-d9b4d5a56421" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_314b0954-bb88-40e5-b43b-6c12fb2ba7a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a859e31a-768c-40ff-9295-46c70eb828d0" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_314b0954-bb88-40e5-b43b-6c12fb2ba7a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_15bd26c3-402e-4624-809c-f8a272573833" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a859e31a-768c-40ff-9295-46c70eb828d0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_15bd26c3-402e-4624-809c-f8a272573833" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_3cafed22-4b7d-421f-be73-cf7fb74b6e08" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a859e31a-768c-40ff-9295-46c70eb828d0" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_3cafed22-4b7d-421f-be73-cf7fb74b6e08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_2b618cb7-aa5b-433d-8ede-7ab504226a0c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a859e31a-768c-40ff-9295-46c70eb828d0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_2b618cb7-aa5b-433d-8ede-7ab504226a0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_4173137c-a311-48df-828b-d93eb8f8f9a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a859e31a-768c-40ff-9295-46c70eb828d0" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_4173137c-a311-48df-828b-d93eb8f8f9a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_07be1230-0619-4d69-85d0-7f5eb1ac1c24" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a859e31a-768c-40ff-9295-46c70eb828d0" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_07be1230-0619-4d69-85d0-7f5eb1ac1c24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_c4cf26fc-88fd-4a26-96d2-18515c9c7f64" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a859e31a-768c-40ff-9295-46c70eb828d0" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_c4cf26fc-88fd-4a26-96d2-18515c9c7f64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_b2624baa-9470-4de7-9bdb-fe48253877ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a859e31a-768c-40ff-9295-46c70eb828d0" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_b2624baa-9470-4de7-9bdb-fe48253877ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_0d1ac0bc-b425-4ace-a08f-98aedb55ce0c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a859e31a-768c-40ff-9295-46c70eb828d0" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_0d1ac0bc-b425-4ace-a08f-98aedb55ce0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_f84f7485-acc7-47b6-a0dc-b9f88d2bcdde" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a859e31a-768c-40ff-9295-46c70eb828d0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_f84f7485-acc7-47b6-a0dc-b9f88d2bcdde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_753eca97-a699-424a-850c-7133dab2d96c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a859e31a-768c-40ff-9295-46c70eb828d0" xlink:to="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_753eca97-a699-424a-850c-7133dab2d96c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_e12e85dd-4b3f-4365-9440-d07d53487301" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a859e31a-768c-40ff-9295-46c70eb828d0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_e12e85dd-4b3f-4365-9440-d07d53487301" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_med_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesEarnedPercentage_eb1cc02d-4f37-4024-971c-43d6efa60f56" xlink:href="med-20220930.xsd#med_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesEarnedPercentage"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a859e31a-768c-40ff-9295-46c70eb828d0" xlink:to="loc_med_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesEarnedPercentage_eb1cc02d-4f37-4024-971c-43d6efa60f56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_med_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesEarnedPerformancePeriod_7aad7c4e-e9f0-4534-afc9-be5c8bcc17d7" xlink:href="med-20220930.xsd#med_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesEarnedPerformancePeriod"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a859e31a-768c-40ff-9295-46c70eb828d0" xlink:to="loc_med_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesEarnedPerformancePeriod_7aad7c4e-e9f0-4534-afc9-be5c8bcc17d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_f74eb03c-9245-4d3d-99d5-97b75b8ec2f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a859e31a-768c-40ff-9295-46c70eb828d0" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_f74eb03c-9245-4d3d-99d5-97b75b8ec2f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_9e70f8ff-fc53-495b-b9e9-4fd46b1a362e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a859e31a-768c-40ff-9295-46c70eb828d0" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_9e70f8ff-fc53-495b-b9e9-4fd46b1a362e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_861e086f-2278-4ca0-b1e7-c2911bb97508" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a859e31a-768c-40ff-9295-46c70eb828d0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_861e086f-2278-4ca0-b1e7-c2911bb97508" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONStockOptionsActivityDetails" xlink:type="simple" xlink:href="med-20220930.xsd#SHAREBASEDCOMPENSATIONStockOptionsActivityDetails"/>
  <link:presentationLink xlink:role="http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONStockOptionsActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0f2c9238-31a6-4afa-aefe-9438294b7edc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_1cedb9e4-346f-4e54-81d6-77d90b0e8821" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0f2c9238-31a6-4afa-aefe-9438294b7edc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_1cedb9e4-346f-4e54-81d6-77d90b0e8821" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0c470209-780e-4d2a-bef0-e85869ca6c88" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_1cedb9e4-346f-4e54-81d6-77d90b0e8821" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0c470209-780e-4d2a-bef0-e85869ca6c88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_bddacafa-46d8-4598-890e-e16e04b1d861" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_1cedb9e4-346f-4e54-81d6-77d90b0e8821" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_bddacafa-46d8-4598-890e-e16e04b1d861" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_26c4249f-027c-4825-9e87-c81ce5fab43a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_1cedb9e4-346f-4e54-81d6-77d90b0e8821" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_26c4249f-027c-4825-9e87-c81ce5fab43a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_6178abc1-8b19-45a6-acf2-9046c6639707" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_1cedb9e4-346f-4e54-81d6-77d90b0e8821" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_6178abc1-8b19-45a6-acf2-9046c6639707" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_a4d264b2-ffe0-4b5d-9152-7f0433a76001" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0f2c9238-31a6-4afa-aefe-9438294b7edc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_a4d264b2-ffe0-4b5d-9152-7f0433a76001" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_9acee4ee-441e-453d-842b-373ea8d9d831" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_a4d264b2-ffe0-4b5d-9152-7f0433a76001" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_9acee4ee-441e-453d-842b-373ea8d9d831" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_f0c9c1ed-8422-4454-9265-4ed9c4551776" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_a4d264b2-ffe0-4b5d-9152-7f0433a76001" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_f0c9c1ed-8422-4454-9265-4ed9c4551776" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0eb4b9ba-fc36-4ed9-aa3a-58aa77ba5455" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_a4d264b2-ffe0-4b5d-9152-7f0433a76001" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0eb4b9ba-fc36-4ed9-aa3a-58aa77ba5455" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_cfefaedf-7ba3-4ef8-90c7-efff22eaf0f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_a4d264b2-ffe0-4b5d-9152-7f0433a76001" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_cfefaedf-7ba3-4ef8-90c7-efff22eaf0f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONRestrictedStockActivityDetails" xlink:type="simple" xlink:href="med-20220930.xsd#SHAREBASEDCOMPENSATIONRestrictedStockActivityDetails"/>
  <link:presentationLink xlink:role="http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONRestrictedStockActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_90ef1f81-ce7f-4c50-9ad4-4c20001d86dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_98f083be-d321-4131-82c7-d5b6bcb2df12" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_90ef1f81-ce7f-4c50-9ad4-4c20001d86dd" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_98f083be-d321-4131-82c7-d5b6bcb2df12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_030e319c-9db4-4fdb-86ce-997ca5014b95" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_98f083be-d321-4131-82c7-d5b6bcb2df12" xlink:to="loc_us-gaap_AwardTypeAxis_030e319c-9db4-4fdb-86ce-997ca5014b95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6a65bcb1-32b2-4617-9555-64774f37f87d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_030e319c-9db4-4fdb-86ce-997ca5014b95" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6a65bcb1-32b2-4617-9555-64774f37f87d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_a2fb4b4d-9008-4e25-b189-bac681115a95" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6a65bcb1-32b2-4617-9555-64774f37f87d" xlink:to="loc_us-gaap_RestrictedStockMember_a2fb4b4d-9008-4e25-b189-bac681115a95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_d88f3c57-5f84-4fcc-88b4-656a976d24c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_98f083be-d321-4131-82c7-d5b6bcb2df12" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_d88f3c57-5f84-4fcc-88b4-656a976d24c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_4bef2596-d15e-4853-a3f7-d4039a043fa6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_d88f3c57-5f84-4fcc-88b4-656a976d24c7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_4bef2596-d15e-4853-a3f7-d4039a043fa6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_457f41ff-1e7c-462c-be24-7ff84bbf8f28" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_4bef2596-d15e-4853-a3f7-d4039a043fa6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_457f41ff-1e7c-462c-be24-7ff84bbf8f28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_1a87ab17-1f49-4161-8224-e0d626e6c12c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_4bef2596-d15e-4853-a3f7-d4039a043fa6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_1a87ab17-1f49-4161-8224-e0d626e6c12c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_d5cc0eec-6121-435f-a90c-4b91e2d40565" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_4bef2596-d15e-4853-a3f7-d4039a043fa6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_d5cc0eec-6121-435f-a90c-4b91e2d40565" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_ba58c422-d8a2-4379-ad94-3cc294369321" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_4bef2596-d15e-4853-a3f7-d4039a043fa6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_ba58c422-d8a2-4379-ad94-3cc294369321" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_0b25d288-714d-45fc-ab15-d8e8d25d6541" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_4bef2596-d15e-4853-a3f7-d4039a043fa6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_0b25d288-714d-45fc-ab15-d8e8d25d6541" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_37d523f9-ab3b-49d4-972a-7cf384bc8c33" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_d88f3c57-5f84-4fcc-88b4-656a976d24c7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_37d523f9-ab3b-49d4-972a-7cf384bc8c33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_b6025cae-4ebb-48ad-87ed-aa1d7e1d9bc5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_37d523f9-ab3b-49d4-972a-7cf384bc8c33" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_b6025cae-4ebb-48ad-87ed-aa1d7e1d9bc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_8261ddc3-aeb3-4a99-bbbd-8401e507d664" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_37d523f9-ab3b-49d4-972a-7cf384bc8c33" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_8261ddc3-aeb3-4a99-bbbd-8401e507d664" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_cab9f988-466d-4073-9d25-cce944a8c059" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_37d523f9-ab3b-49d4-972a-7cf384bc8c33" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_cab9f988-466d-4073-9d25-cce944a8c059" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_4a7b627f-bf01-4a65-b117-fffd2c8faced" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_37d523f9-ab3b-49d4-972a-7cf384bc8c33" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_4a7b627f-bf01-4a65-b117-fffd2c8faced" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_e5817817-7ad6-443d-b4a9-775e9eaa6b4f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_37d523f9-ab3b-49d4-972a-7cf384bc8c33" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_e5817817-7ad6-443d-b4a9-775e9eaa6b4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONSummaryofPerformancebasedShareAwardsDetails" xlink:type="simple" xlink:href="med-20220930.xsd#SHAREBASEDCOMPENSATIONSummaryofPerformancebasedShareAwardsDetails"/>
  <link:presentationLink xlink:role="http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONSummaryofPerformancebasedShareAwardsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_313a0970-c344-4747-a4a3-c77aeb6767c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3cb9229a-7092-48d1-81be-4160f7ae691f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_313a0970-c344-4747-a4a3-c77aeb6767c3" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3cb9229a-7092-48d1-81be-4160f7ae691f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_691b1cbe-c961-4649-a5c5-0c5ca3cac073" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3cb9229a-7092-48d1-81be-4160f7ae691f" xlink:to="loc_us-gaap_AwardTypeAxis_691b1cbe-c961-4649-a5c5-0c5ca3cac073" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_61fa37e2-45aa-4486-b47f-75f42d22313f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_691b1cbe-c961-4649-a5c5-0c5ca3cac073" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_61fa37e2-45aa-4486-b47f-75f42d22313f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_med_OptionsAndRestrictedStockMember_82e8d0aa-3214-47b7-af2d-23d90ee0edfa" xlink:href="med-20220930.xsd#med_OptionsAndRestrictedStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_61fa37e2-45aa-4486-b47f-75f42d22313f" xlink:to="loc_med_OptionsAndRestrictedStockMember_82e8d0aa-3214-47b7-af2d-23d90ee0edfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_med_MarketAndPerformanceSharesMember_d0445e3b-3287-4add-b987-3d902eabc616" xlink:href="med-20220930.xsd#med_MarketAndPerformanceSharesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_61fa37e2-45aa-4486-b47f-75f42d22313f" xlink:to="loc_med_MarketAndPerformanceSharesMember_d0445e3b-3287-4add-b987-3d902eabc616" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_615f68d1-2927-46dc-bc42-6f4e09d15cca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PerformanceSharesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_61fa37e2-45aa-4486-b47f-75f42d22313f" xlink:to="loc_us-gaap_PerformanceSharesMember_615f68d1-2927-46dc-bc42-6f4e09d15cca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardDateAxis_3a8ac5b1-786f-4c05-af33-b0a782720115" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardDateAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3cb9229a-7092-48d1-81be-4160f7ae691f" xlink:to="loc_us-gaap_AwardDateAxis_3a8ac5b1-786f-4c05-af33-b0a782720115" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardDateDomain_f0710092-d33b-4aa9-94ad-b25c600f81f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardDateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardDateAxis_3a8ac5b1-786f-4c05-af33-b0a782720115" xlink:to="loc_us-gaap_AwardDateDomain_f0710092-d33b-4aa9-94ad-b25c600f81f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_med_GrantedIn2022Member_70d995a3-488b-4606-b46c-9f67b7d0c847" xlink:href="med-20220930.xsd#med_GrantedIn2022Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardDateDomain_f0710092-d33b-4aa9-94ad-b25c600f81f4" xlink:to="loc_med_GrantedIn2022Member_70d995a3-488b-4606-b46c-9f67b7d0c847" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_med_GrantedIn2021Member_03ebd95e-0d5a-48d5-b273-95b1f51c6f09" xlink:href="med-20220930.xsd#med_GrantedIn2021Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardDateDomain_f0710092-d33b-4aa9-94ad-b25c600f81f4" xlink:to="loc_med_GrantedIn2021Member_03ebd95e-0d5a-48d5-b273-95b1f51c6f09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_med_GrantedIn2020Member_135599fe-8ff1-4a19-8e51-66d87813b434" xlink:href="med-20220930.xsd#med_GrantedIn2020Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardDateDomain_f0710092-d33b-4aa9-94ad-b25c600f81f4" xlink:to="loc_med_GrantedIn2020Member_135599fe-8ff1-4a19-8e51-66d87813b434" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_med_GrantedIn2019Member_225ff279-7871-41d6-8ff3-7e704bee4f8c" xlink:href="med-20220930.xsd#med_GrantedIn2019Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardDateDomain_f0710092-d33b-4aa9-94ad-b25c600f81f4" xlink:to="loc_med_GrantedIn2019Member_225ff279-7871-41d6-8ff3-7e704bee4f8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a2b4f832-fa54-460e-ad50-3e0ea47ab0c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3cb9229a-7092-48d1-81be-4160f7ae691f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a2b4f832-fa54-460e-ad50-3e0ea47ab0c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_38cc16a6-b2a2-40fc-845f-fee918ea8280" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a2b4f832-fa54-460e-ad50-3e0ea47ab0c7" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_38cc16a6-b2a2-40fc-845f-fee918ea8280" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_00aab1fa-42ac-429d-bc4f-8b04de7ddb68" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a2b4f832-fa54-460e-ad50-3e0ea47ab0c7" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_00aab1fa-42ac-429d-bc4f-8b04de7ddb68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medifast1.com/role/LEASESNarrativeDetails" xlink:type="simple" xlink:href="med-20220930.xsd#LEASESNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.medifast1.com/role/LEASESNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_d7418a61-537d-43f5-b446-c6bb0228651e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_a2a36be5-921c-4f6e-9593-482cbd8d5ce3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_d7418a61-537d-43f5-b446-c6bb0228651e" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_a2a36be5-921c-4f6e-9593-482cbd8d5ce3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_ceab0b8f-7c76-4424-8b55-96c11a184733" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_a2a36be5-921c-4f6e-9593-482cbd8d5ce3" xlink:to="loc_srt_RangeAxis_ceab0b8f-7c76-4424-8b55-96c11a184733" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_05f000c3-caa5-4ec5-a30a-db482c9d1509" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_ceab0b8f-7c76-4424-8b55-96c11a184733" xlink:to="loc_srt_RangeMember_05f000c3-caa5-4ec5-a30a-db482c9d1509" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_1985a2e7-5817-42b5-8c90-ea5f2cae5c71" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_05f000c3-caa5-4ec5-a30a-db482c9d1509" xlink:to="loc_srt_MinimumMember_1985a2e7-5817-42b5-8c90-ea5f2cae5c71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_af3fa3e0-ef5b-4ee2-8257-3f9827379b25" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_05f000c3-caa5-4ec5-a30a-db482c9d1509" xlink:to="loc_srt_MaximumMember_af3fa3e0-ef5b-4ee2-8257-3f9827379b25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_06efee69-f1fd-43e5-a620-2d7a28e4ccb1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_a2a36be5-921c-4f6e-9593-482cbd8d5ce3" xlink:to="loc_us-gaap_TypeOfArrangementAxis_06efee69-f1fd-43e5-a620-2d7a28e4ccb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_d2cf44f0-de7b-4c72-bce7-11cc0c75d8c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfArrangementAxis_06efee69-f1fd-43e5-a620-2d7a28e4ccb1" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_d2cf44f0-de7b-4c72-bce7-11cc0c75d8c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_med_OperatingLeaseArrangementForRealEstateMember_d37313c5-4809-4bc7-adce-877787f4e259" xlink:href="med-20220930.xsd#med_OperatingLeaseArrangementForRealEstateMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_d2cf44f0-de7b-4c72-bce7-11cc0c75d8c8" xlink:to="loc_med_OperatingLeaseArrangementForRealEstateMember_d37313c5-4809-4bc7-adce-877787f4e259" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_med_OperatingLeaseArrangementForEquipmentMember_0dcd464d-ea9d-4bf6-a905-157d14c46500" xlink:href="med-20220930.xsd#med_OperatingLeaseArrangementForEquipmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_d2cf44f0-de7b-4c72-bce7-11cc0c75d8c8" xlink:to="loc_med_OperatingLeaseArrangementForEquipmentMember_0dcd464d-ea9d-4bf6-a905-157d14c46500" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_f281a03b-d7cc-498f-817e-a5f1178e2a88" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_a2a36be5-921c-4f6e-9593-482cbd8d5ce3" xlink:to="loc_us-gaap_LesseeLeaseDescriptionLineItems_f281a03b-d7cc-498f-817e-a5f1178e2a88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract_d4f99609-e577-4d48-a0cc-d9fdc1ffa8c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_f281a03b-d7cc-498f-817e-a5f1178e2a88" xlink:to="loc_us-gaap_LesseeOperatingLeaseTermOfContract_d4f99609-e577-4d48-a0cc-d9fdc1ffa8c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseExpense_d4bbebef-ad73-493f-9218-4736c921b383" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_f281a03b-d7cc-498f-817e-a5f1178e2a88" xlink:to="loc_us-gaap_OperatingLeaseExpense_d4bbebef-ad73-493f-9218-4736c921b383" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medifast1.com/role/LEASESSupplementalCashFlowInformationDetails" xlink:type="simple" xlink:href="med-20220930.xsd#LEASESSupplementalCashFlowInformationDetails"/>
  <link:presentationLink xlink:role="http://www.medifast1.com/role/LEASESSupplementalCashFlowInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_d9333a66-d618-4730-ac8b-1cf59382029f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments_610ada86-b221-40ed-bb38-6bb90defd1f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasePayments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_d9333a66-d618-4730-ac8b-1cf59382029f" xlink:to="loc_us-gaap_OperatingLeasePayments_610ada86-b221-40ed-bb38-6bb90defd1f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_af0b4116-dcc3-4786-84ee-4d1b123b4024" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_d9333a66-d618-4730-ac8b-1cf59382029f" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_af0b4116-dcc3-4786-84ee-4d1b123b4024" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_fa23c01a-8615-4036-955e-0d21acd12f0b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_d9333a66-d618-4730-ac8b-1cf59382029f" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_fa23c01a-8615-4036-955e-0d21acd12f0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_ec5809e1-74e7-41f4-9a62-cd97cf5dbc5a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_d9333a66-d618-4730-ac8b-1cf59382029f" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_ec5809e1-74e7-41f4-9a62-cd97cf5dbc5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medifast1.com/role/LEASESFutureMinimumLeaseCommitmentsDetails" xlink:type="simple" xlink:href="med-20220930.xsd#LEASESFutureMinimumLeaseCommitmentsDetails"/>
  <link:presentationLink xlink:role="http://www.medifast1.com/role/LEASESFutureMinimumLeaseCommitmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_cbff3ce5-47f7-4ba9-a5a8-144bd72a2989" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_994250bb-ee51-44ba-bc79-2d7b367280ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_cbff3ce5-47f7-4ba9-a5a8-144bd72a2989" xlink:to="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_994250bb-ee51-44ba-bc79-2d7b367280ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_1cfdd4f5-ac36-4da3-ab34-1c436bf73255" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_994250bb-ee51-44ba-bc79-2d7b367280ec" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_1cfdd4f5-ac36-4da3-ab34-1c436bf73255" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_f125dc4c-9654-4b81-a47a-97214e1103b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_994250bb-ee51-44ba-bc79-2d7b367280ec" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_f125dc4c-9654-4b81-a47a-97214e1103b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_b29f5e82-4f29-4e3c-b1a1-89e0491e1569" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_994250bb-ee51-44ba-bc79-2d7b367280ec" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_b29f5e82-4f29-4e3c-b1a1-89e0491e1569" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_601e7b0e-f803-4dcc-bb44-420ce821b0fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_994250bb-ee51-44ba-bc79-2d7b367280ec" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_601e7b0e-f803-4dcc-bb44-420ce821b0fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_c69fe859-2fb4-4e0b-a273-1d45fd90ab11" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_994250bb-ee51-44ba-bc79-2d7b367280ec" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_c69fe859-2fb4-4e0b-a273-1d45fd90ab11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_med_LesseeOperatingLeaseLiabilityPaymentsDueYearFiveAndAfterYearFive_7666abaa-bbe6-4409-a97f-ff696625035e" xlink:href="med-20220930.xsd#med_LesseeOperatingLeaseLiabilityPaymentsDueYearFiveAndAfterYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_994250bb-ee51-44ba-bc79-2d7b367280ec" xlink:to="loc_med_LesseeOperatingLeaseLiabilityPaymentsDueYearFiveAndAfterYearFive_7666abaa-bbe6-4409-a97f-ff696625035e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_ebe2f886-6b4d-49c5-878a-4e6decc45504" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_994250bb-ee51-44ba-bc79-2d7b367280ec" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_ebe2f886-6b4d-49c5-878a-4e6decc45504" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_5caf85b4-7759-4aff-ae20-c195a88c94e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_994250bb-ee51-44ba-bc79-2d7b367280ec" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_5caf85b4-7759-4aff-ae20-c195a88c94e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_c1096d80-dc09-4eb5-bee4-15805d4ca38f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_994250bb-ee51-44ba-bc79-2d7b367280ec" xlink:to="loc_us-gaap_OperatingLeaseLiability_c1096d80-dc09-4eb5-bee4-15805d4ca38f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medifast1.com/role/LEASESFutureMinimumLeaseCommitmentsDetails_1" xlink:type="simple" xlink:href="med-20220930.xsd#LEASESFutureMinimumLeaseCommitmentsDetails_1"/>
  <link:presentationLink xlink:role="http://www.medifast1.com/role/LEASESFutureMinimumLeaseCommitmentsDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.medifast1.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMEAccumulatedOtherComprehensiveIncomeDetails" xlink:type="simple" xlink:href="med-20220930.xsd#ACCUMULATEDOTHERCOMPREHENSIVEINCOMEAccumulatedOtherComprehensiveIncomeDetails"/>
  <link:presentationLink xlink:role="http://www.medifast1.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMEAccumulatedOtherComprehensiveIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_b9368e78-21d1-41cd-a81c-96b68ebd7fe9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_74b955b7-f0a3-4795-badd-9b267c45b05f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_b9368e78-21d1-41cd-a81c-96b68ebd7fe9" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_74b955b7-f0a3-4795-badd-9b267c45b05f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_32268cc3-2feb-43f6-8f7f-a17f77886644" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_74b955b7-f0a3-4795-badd-9b267c45b05f" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_32268cc3-2feb-43f6-8f7f-a17f77886644" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_fb616758-f139-4449-8177-d85e17bda034" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_32268cc3-2feb-43f6-8f7f-a17f77886644" xlink:to="loc_us-gaap_EquityComponentDomain_fb616758-f139-4449-8177-d85e17bda034" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_ad5d6c7d-3383-4ce7-a3d0-66a71e9c4fa6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_fb616758-f139-4449-8177-d85e17bda034" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_ad5d6c7d-3383-4ce7-a3d0-66a71e9c4fa6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_b7ba1e98-8e8b-4e0c-ab3a-6f4bda0e8dc3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_fb616758-f139-4449-8177-d85e17bda034" xlink:to="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_b7ba1e98-8e8b-4e0c-ab3a-6f4bda0e8dc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_3beed3d5-ed0e-45fe-95da-af4a87a58634" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_fb616758-f139-4449-8177-d85e17bda034" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_3beed3d5-ed0e-45fe-95da-af4a87a58634" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_fb07f6b3-61da-47d2-8e4c-c61a6d396b99" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_74b955b7-f0a3-4795-badd-9b267c45b05f" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_fb07f6b3-61da-47d2-8e4c-c61a6d396b99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_d95bbc9b-d05a-416a-8f26-5722195f01dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_fb07f6b3-61da-47d2-8e4c-c61a6d396b99" xlink:to="loc_us-gaap_StockholdersEquity_d95bbc9b-d05a-416a-8f26-5722195f01dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medifast1.com/role/FINANCIALINSTRUMENTSCashandFinancialAssetsThatareMeasuredatFairValueonaRecurringBasisforEachoftheHierarchyLevelsDetails" xlink:type="simple" xlink:href="med-20220930.xsd#FINANCIALINSTRUMENTSCashandFinancialAssetsThatareMeasuredatFairValueonaRecurringBasisforEachoftheHierarchyLevelsDetails"/>
  <link:presentationLink xlink:role="http://www.medifast1.com/role/FINANCIALINSTRUMENTSCashandFinancialAssetsThatareMeasuredatFairValueonaRecurringBasisforEachoftheHierarchyLevelsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAllOtherInvestmentsAbstract_b568c1de-173a-4d48-84e5-e537357cbcad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsAllOtherInvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_med_CashAndCashEquivalentsAndMarketableSecuritiesTable_a3e13023-dd38-4c02-967c-4fe26390fb63" xlink:href="med-20220930.xsd#med_CashAndCashEquivalentsAndMarketableSecuritiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAllOtherInvestmentsAbstract_b568c1de-173a-4d48-84e5-e537357cbcad" xlink:to="loc_med_CashAndCashEquivalentsAndMarketableSecuritiesTable_a3e13023-dd38-4c02-967c-4fe26390fb63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_673a1f6c-ee0c-46c4-bd81-18c33f4ae2a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_med_CashAndCashEquivalentsAndMarketableSecuritiesTable_a3e13023-dd38-4c02-967c-4fe26390fb63" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_673a1f6c-ee0c-46c4-bd81-18c33f4ae2a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6279e367-b452-459b-9e4d-90e43659dce2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_673a1f6c-ee0c-46c4-bd81-18c33f4ae2a7" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6279e367-b452-459b-9e4d-90e43659dce2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_e6dccd6f-19d9-4f86-a865-f6a38b5c33b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6279e367-b452-459b-9e4d-90e43659dce2" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_e6dccd6f-19d9-4f86-a865-f6a38b5c33b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_eae59ed8-7cc8-4190-910f-b8d4f2ef7be7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6279e367-b452-459b-9e4d-90e43659dce2" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_eae59ed8-7cc8-4190-910f-b8d4f2ef7be7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_0f2b2587-7aa0-4f64-b0d8-a5321abf2184" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_med_CashAndCashEquivalentsAndMarketableSecuritiesTable_a3e13023-dd38-4c02-967c-4fe26390fb63" xlink:to="loc_us-gaap_FinancialInstrumentAxis_0f2b2587-7aa0-4f64-b0d8-a5321abf2184" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_3bf1d329-37ea-4ae4-8e9e-4e2ad58b7277" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_0f2b2587-7aa0-4f64-b0d8-a5321abf2184" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_3bf1d329-37ea-4ae4-8e9e-4e2ad58b7277" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashMember_d4a6b328-2351-4d9f-b903-3b66249bc5d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_3bf1d329-37ea-4ae4-8e9e-4e2ad58b7277" xlink:to="loc_us-gaap_CashMember_d4a6b328-2351-4d9f-b903-3b66249bc5d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember_92f04c7b-f09f-484a-a676-938d57cfbcd1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_3bf1d329-37ea-4ae4-8e9e-4e2ad58b7277" xlink:to="loc_us-gaap_MoneyMarketFundsMember_92f04c7b-f09f-484a-a676-938d57cfbcd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_med_GovernmentAgencySecuritiesMember_bb827bed-c014-4c3e-80b2-948579ed0282" xlink:href="med-20220930.xsd#med_GovernmentAgencySecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_3bf1d329-37ea-4ae4-8e9e-4e2ad58b7277" xlink:to="loc_med_GovernmentAgencySecuritiesMember_bb827bed-c014-4c3e-80b2-948579ed0282" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MunicipalBondsMember_353c0e34-bcec-4f4b-a3b9-e88840b7eba5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MunicipalBondsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_3bf1d329-37ea-4ae4-8e9e-4e2ad58b7277" xlink:to="loc_us-gaap_MunicipalBondsMember_353c0e34-bcec-4f4b-a3b9-e88840b7eba5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_med_CashAndCashEquivalentsAndMarketableSecuritiesLineItems_1ccd2367-5759-4dec-a896-6cfbbb4d1f4d" xlink:href="med-20220930.xsd#med_CashAndCashEquivalentsAndMarketableSecuritiesLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_med_CashAndCashEquivalentsAndMarketableSecuritiesTable_a3e13023-dd38-4c02-967c-4fe26390fb63" xlink:to="loc_med_CashAndCashEquivalentsAndMarketableSecuritiesLineItems_1ccd2367-5759-4dec-a896-6cfbbb4d1f4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecurities_2ead12ab-bb2d-4b83-8d01-fb85647b9843" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketableSecurities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_med_CashAndCashEquivalentsAndMarketableSecuritiesLineItems_1ccd2367-5759-4dec-a896-6cfbbb4d1f4d" xlink:to="loc_us-gaap_MarketableSecurities_2ead12ab-bb2d-4b83-8d01-fb85647b9843" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesUnrealizedGainLoss_2fec9145-112d-428c-9b45-3ee67ea597f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketableSecuritiesUnrealizedGainLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_med_CashAndCashEquivalentsAndMarketableSecuritiesLineItems_1ccd2367-5759-4dec-a896-6cfbbb4d1f4d" xlink:to="loc_us-gaap_MarketableSecuritiesUnrealizedGainLoss_2fec9145-112d-428c-9b45-3ee67ea597f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestReceivable_c2b5e3d0-af3e-4258-ad3a-c8ef8daf9d36" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestReceivable"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_med_CashAndCashEquivalentsAndMarketableSecuritiesLineItems_1ccd2367-5759-4dec-a896-6cfbbb4d1f4d" xlink:to="loc_us-gaap_InterestReceivable_c2b5e3d0-af3e-4258-ad3a-c8ef8daf9d36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_5d0a9090-a3cf-4691-a79e-c3a60a0a6088" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_med_CashAndCashEquivalentsAndMarketableSecuritiesLineItems_1ccd2367-5759-4dec-a896-6cfbbb4d1f4d" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_5d0a9090-a3cf-4691-a79e-c3a60a0a6088" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_0bd050d9-3bd2-47c8-ada4-3e4d0ddd8fd4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_med_CashAndCashEquivalentsAndMarketableSecuritiesLineItems_1ccd2367-5759-4dec-a896-6cfbbb4d1f4d" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_0bd050d9-3bd2-47c8-ada4-3e4d0ddd8fd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentOwnedAtFairValue_f6f7e6ae-3e53-4523-a3c4-6aa87855591c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentOwnedAtFairValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_med_CashAndCashEquivalentsAndMarketableSecuritiesLineItems_1ccd2367-5759-4dec-a896-6cfbbb4d1f4d" xlink:to="loc_us-gaap_InvestmentOwnedAtFairValue_f6f7e6ae-3e53-4523-a3c4-6aa87855591c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medifast1.com/role/FINANCIALINSTRUMENTSNarrativeDetails" xlink:type="simple" xlink:href="med-20220930.xsd#FINANCIALINSTRUMENTSNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.medifast1.com/role/FINANCIALINSTRUMENTSNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAllOtherInvestmentsAbstract_b7b96745-2e88-4684-aed8-d0178d83ccf8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsAllOtherInvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtAndEquitySecuritiesRealizedGainLoss_34c41d50-6eba-4821-899f-be492aa48d27" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtAndEquitySecuritiesRealizedGainLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAllOtherInvestmentsAbstract_b7b96745-2e88-4684-aed8-d0178d83ccf8" xlink:to="loc_us-gaap_DebtAndEquitySecuritiesRealizedGainLoss_34c41d50-6eba-4821-899f-be492aa48d27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medifast1.com/role/DEBTNarrativeDetails" xlink:type="simple" xlink:href="med-20220930.xsd#DEBTNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.medifast1.com/role/DEBTNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_2ffcea13-3a92-479d-a7e9-233d0eabd334" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_0f9359cb-76e4-443a-a8d0-dde02c81f464" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_2ffcea13-3a92-479d-a7e9-233d0eabd334" xlink:to="loc_us-gaap_DebtInstrumentTable_0f9359cb-76e4-443a-a8d0-dde02c81f464" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_3d3a3a9c-a0f3-4a71-ac43-bf1d01c98547" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_0f9359cb-76e4-443a-a8d0-dde02c81f464" xlink:to="loc_us-gaap_DebtInstrumentAxis_3d3a3a9c-a0f3-4a71-ac43-bf1d01c98547" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_d58942d8-a33e-4150-b5bb-936515ad277f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_3d3a3a9c-a0f3-4a71-ac43-bf1d01c98547" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_d58942d8-a33e-4150-b5bb-936515ad277f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_med_CreditAgreementMember_ff2a434e-b4a2-477c-82b8-3b7935522b54" xlink:href="med-20220930.xsd#med_CreditAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_d58942d8-a33e-4150-b5bb-936515ad277f" xlink:to="loc_med_CreditAgreementMember_ff2a434e-b4a2-477c-82b8-3b7935522b54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_e6024451-eaf5-4498-b674-d47e47d0e499" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_0f9359cb-76e4-443a-a8d0-dde02c81f464" xlink:to="loc_us-gaap_CreditFacilityAxis_e6024451-eaf5-4498-b674-d47e47d0e499" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_4b2085b8-0021-490a-97e4-74e118d08660" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_e6024451-eaf5-4498-b674-d47e47d0e499" xlink:to="loc_us-gaap_CreditFacilityDomain_4b2085b8-0021-490a-97e4-74e118d08660" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_f117ef77-fc2a-4ce3-a59e-f93a07ace0ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_4b2085b8-0021-490a-97e4-74e118d08660" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_f117ef77-fc2a-4ce3-a59e-f93a07ace0ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember_71755f66-e0ae-4bdd-ae8c-7e41d06614ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LetterOfCreditMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevolvingCreditFacilityMember_f117ef77-fc2a-4ce3-a59e-f93a07ace0ad" xlink:to="loc_us-gaap_LetterOfCreditMember_71755f66-e0ae-4bdd-ae8c-7e41d06614ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_58c4c904-1768-4e17-b078-a16e1dc51d99" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_0f9359cb-76e4-443a-a8d0-dde02c81f464" xlink:to="loc_srt_RangeAxis_58c4c904-1768-4e17-b078-a16e1dc51d99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_73b4c742-144f-41a8-a06e-31bc3fc5e55a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_58c4c904-1768-4e17-b078-a16e1dc51d99" xlink:to="loc_srt_RangeMember_73b4c742-144f-41a8-a06e-31bc3fc5e55a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_02b8f8da-d6e9-4fa5-b287-929eefa45246" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_73b4c742-144f-41a8-a06e-31bc3fc5e55a" xlink:to="loc_srt_MinimumMember_02b8f8da-d6e9-4fa5-b287-929eefa45246" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_c6757186-7799-44c7-a8bc-4c00b5c1aa0f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_73b4c742-144f-41a8-a06e-31bc3fc5e55a" xlink:to="loc_srt_MaximumMember_c6757186-7799-44c7-a8bc-4c00b5c1aa0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_672fac94-c9f4-4e4a-8c4e-84fc49ce1b26" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_0f9359cb-76e4-443a-a8d0-dde02c81f464" xlink:to="loc_us-gaap_VariableRateAxis_672fac94-c9f4-4e4a-8c4e-84fc49ce1b26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_166c9d39-f4c0-461a-9200-3144cc6cab1e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_672fac94-c9f4-4e4a-8c4e-84fc49ce1b26" xlink:to="loc_us-gaap_VariableRateDomain_166c9d39-f4c0-461a-9200-3144cc6cab1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EurodollarMember_b49ad755-dbd7-4089-bb69-1a36db45329f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EurodollarMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_166c9d39-f4c0-461a-9200-3144cc6cab1e" xlink:to="loc_us-gaap_EurodollarMember_b49ad755-dbd7-4089-bb69-1a36db45329f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BaseRateMember_301c69dc-f3fe-4e3a-b2d7-623a94995ec2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BaseRateMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_166c9d39-f4c0-461a-9200-3144cc6cab1e" xlink:to="loc_us-gaap_BaseRateMember_301c69dc-f3fe-4e3a-b2d7-623a94995ec2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_a0eb3c74-d767-474e-925d-642ff66efbc5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_0f9359cb-76e4-443a-a8d0-dde02c81f464" xlink:to="loc_us-gaap_DebtInstrumentLineItems_a0eb3c74-d767-474e-925d-642ff66efbc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_9327221f-fdfb-4906-8957-dae98ed20c37" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a0eb3c74-d767-474e-925d-642ff66efbc5" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_9327221f-fdfb-4906-8957-dae98ed20c37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_med_LineOfCreditFacilityAccordionFeatureIncreaseLimit_0a84c30e-01a5-4786-933d-de47a7d09a88" xlink:href="med-20220930.xsd#med_LineOfCreditFacilityAccordionFeatureIncreaseLimit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a0eb3c74-d767-474e-925d-642ff66efbc5" xlink:to="loc_med_LineOfCreditFacilityAccordionFeatureIncreaseLimit_0a84c30e-01a5-4786-933d-de47a7d09a88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_6a86e507-d7c6-416e-a5f7-518b5c518291" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityCommitmentFeePercentage"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a0eb3c74-d767-474e-925d-642ff66efbc5" xlink:to="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_6a86e507-d7c6-416e-a5f7-518b5c518291" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_a30ecd40-dfa3-4d16-b9b5-fdc4914927ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a0eb3c74-d767-474e-925d-642ff66efbc5" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_a30ecd40-dfa3-4d16-b9b5-fdc4914927ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_med_MaximumTotalNetLeverageRatio_a1190cf0-6820-4db5-81f9-b8909b971d41" xlink:href="med-20220930.xsd#med_MaximumTotalNetLeverageRatio"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a0eb3c74-d767-474e-925d-642ff66efbc5" xlink:to="loc_med_MaximumTotalNetLeverageRatio_a1190cf0-6820-4db5-81f9-b8909b971d41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_med_MinimumInterestCoverageRatio_2de422a4-aeff-4537-90aa-3073d6e1f760" xlink:href="med-20220930.xsd#med_MinimumInterestCoverageRatio"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a0eb3c74-d767-474e-925d-642ff66efbc5" xlink:to="loc_med_MinimumInterestCoverageRatio_2de422a4-aeff-4537-90aa-3073d6e1f760" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_b9ffa807-b70a-4253-bcdc-e6a633762d18" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a0eb3c74-d767-474e-925d-642ff66efbc5" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_b9ffa807-b70a-4253-bcdc-e6a633762d18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medifast1.com/role/ACCELERATEDSHAREREPURCHASEASRPROGRAMDetails" xlink:type="simple" xlink:href="med-20220930.xsd#ACCELERATEDSHAREREPURCHASEASRPROGRAMDetails"/>
  <link:presentationLink xlink:role="http://www.medifast1.com/role/ACCELERATEDSHAREREPURCHASEASRPROGRAMDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_076c62bd-6ff7-4ca7-bf27-b5c23c773d84" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_9d30af43-c2d1-4cc5-91d9-2f35a29ac783" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_076c62bd-6ff7-4ca7-bf27-b5c23c773d84" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_9d30af43-c2d1-4cc5-91d9-2f35a29ac783" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_e813b11d-03c0-4e9f-8656-445f88e05032" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_076c62bd-6ff7-4ca7-bf27-b5c23c773d84" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_e813b11d-03c0-4e9f-8656-445f88e05032" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140363521507584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover - shares<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Oct. 26, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Sep. 30,  2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-31573<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Medifast, Inc.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">13-3714405<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">100 International Drive<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Baltimore<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">MD<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">21202<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">410<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">581-8042<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.001 per share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MED<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,926,989<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000910329<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140363520902992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF INCOME (UNAUDITED) - USD ($)<br> shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenue</a></td>
<td class="nump">$ 390,398<span></span>
</td>
<td class="nump">$ 413,395<span></span>
</td>
<td class="nump">$ 1,261,332<span></span>
</td>
<td class="nump">$ 1,148,253<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfRevenue', window );">Cost of sales</a></td>
<td class="nump">107,549<span></span>
</td>
<td class="nump">106,338<span></span>
</td>
<td class="nump">354,515<span></span>
</td>
<td class="nump">298,942<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">282,849<span></span>
</td>
<td class="nump">307,057<span></span>
</td>
<td class="nump">906,817<span></span>
</td>
<td class="nump">849,311<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general, and administrative</a></td>
<td class="nump">234,693<span></span>
</td>
<td class="nump">251,886<span></span>
</td>
<td class="nump">754,610<span></span>
</td>
<td class="nump">679,907<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Income from operations</a></td>
<td class="nump">48,156<span></span>
</td>
<td class="nump">55,171<span></span>
</td>
<td class="nump">152,207<span></span>
</td>
<td class="nump">169,404<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpenseAbstract', window );"><strong>Other income (expense)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestIncomeExpenseNonoperatingNet', window );">Interest expense</a></td>
<td class="num">(261)<span></span>
</td>
<td class="num">(94)<span></span>
</td>
<td class="num">(519)<span></span>
</td>
<td class="num">(138)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income (expense)</a></td>
<td class="num">(17)<span></span>
</td>
<td class="nump">115<span></span>
</td>
<td class="num">(37)<span></span>
</td>
<td class="nump">112<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Total other (expense) income</a></td>
<td class="num">(278)<span></span>
</td>
<td class="nump">21<span></span>
</td>
<td class="num">(556)<span></span>
</td>
<td class="num">(26)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income from operations before income taxes</a></td>
<td class="nump">47,878<span></span>
</td>
<td class="nump">55,192<span></span>
</td>
<td class="nump">151,651<span></span>
</td>
<td class="nump">169,378<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for income taxes</a></td>
<td class="nump">11,723<span></span>
</td>
<td class="nump">13,210<span></span>
</td>
<td class="nump">34,601<span></span>
</td>
<td class="nump">39,370<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 36,155<span></span>
</td>
<td class="nump">$ 41,982<span></span>
</td>
<td class="nump">$ 117,050<span></span>
</td>
<td class="nump">$ 130,008<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAbstract', window );"><strong>Basic earnings per share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Earnings per share - basic (in dollars per share)</a></td>
<td class="nump">$ 3.30<span></span>
</td>
<td class="nump">$ 3.59<span></span>
</td>
<td class="nump">$ 10.37<span></span>
</td>
<td class="nump">$ 11.07<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDilutedAbstract', window );"><strong>Diluted earnings per share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Earnings per share - diluted (in dollars per share)</a></td>
<td class="nump">$ 3.27<span></span>
</td>
<td class="nump">$ 3.56<span></span>
</td>
<td class="nump">$ 10.30<span></span>
</td>
<td class="nump">$ 10.98<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>Weighted average shares outstanding -</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic (in shares)</a></td>
<td class="nump">10,964<span></span>
</td>
<td class="nump">11,692<span></span>
</td>
<td class="nump">11,290<span></span>
</td>
<td class="nump">11,739<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted (in shares)</a></td>
<td class="nump">11,042<span></span>
</td>
<td class="nump">11,785<span></span>
</td>
<td class="nump">11,369<span></span>
</td>
<td class="nump">11,840<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareDeclared', window );">Cash dividends declared per share (in dollars per share)</a></td>
<td class="nump">$ 1.64<span></span>
</td>
<td class="nump">$ 1.42<span></span>
</td>
<td class="nump">$ 4.92<span></span>
</td>
<td class="nump">$ 4.26<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockDividendsPerShareDeclared">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends declared during the period for each share of common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockDividendsPerShareDeclared</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate cost of goods produced and sold and services rendered during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 18: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123384075&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeExpenseNonoperatingNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net amount of nonoperating interest income (expense).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeExpenseNonoperatingNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140363521415904">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (UNAUDITED) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 36,155<span></span>
</td>
<td class="nump">$ 41,982<span></span>
</td>
<td class="nump">$ 117,050<span></span>
</td>
<td class="nump">$ 130,008<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Other comprehensive income (loss), net of tax:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent', window );">Foreign currency translation</a></td>
<td class="nump">123<span></span>
</td>
<td class="nump">63<span></span>
</td>
<td class="nump">300<span></span>
</td>
<td class="nump">130<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent', window );">Unrealized losses on investment securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(16)<span></span>
</td>
<td class="num">(21)<span></span>
</td>
<td class="num">(49)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income (loss), net of tax</a></td>
<td class="nump">123<span></span>
</td>
<td class="nump">47<span></span>
</td>
<td class="nump">279<span></span>
</td>
<td class="nump">81<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive income</a></td>
<td class="nump">$ 36,278<span></span>
</td>
<td class="nump">$ 42,029<span></span>
</td>
<td class="nump">$ 117,329<span></span>
</td>
<td class="nump">$ 130,089<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments, of appreciation (loss) in value of unsold available-for-sale securities, attributable to parent entity. Excludes amounts related to other than temporary impairment (OTTI) loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569643-111683<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569643-111683<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569643-111683<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140363520855440">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 69,710<span></span>
</td>
<td class="nump">$ 104,183<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories</a></td>
<td class="nump">145,279<span></span>
</td>
<td class="nump">180,043<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermInvestments', window );">Investment securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">5,361<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidTaxes', window );">Income taxes, prepaid</a></td>
<td class="nump">150<span></span>
</td>
<td class="nump">945<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">14,445<span></span>
</td>
<td class="nump">16,334<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">229,584<span></span>
</td>
<td class="nump">306,866<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment - net of accumulated depreciation</a></td>
<td class="nump">58,107<span></span>
</td>
<td class="nump">56,131<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Right-of-use assets</a></td>
<td class="nump">19,819<span></span>
</td>
<td class="nump">24,457<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets</a></td>
<td class="nump">12,691<span></span>
</td>
<td class="nump">6,468<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxAssetsNet', window );">Deferred tax assets</a></td>
<td class="nump">6,150<span></span>
</td>
<td class="nump">4,404<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">TOTAL ASSETS</a></td>
<td class="nump">326,351<span></span>
</td>
<td class="nump">398,326<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent', window );">Accounts payable and accrued expenses</a></td>
<td class="nump">148,129<span></span>
</td>
<td class="nump">163,309<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LinesOfCreditCurrent', window );">Revolving credit facility</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Current lease obligations</a></td>
<td class="nump">6,126<span></span>
</td>
<td class="nump">6,523<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">154,255<span></span>
</td>
<td class="nump">169,832<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Lease obligations, net of current lease obligations</a></td>
<td class="nump">21,574<span></span>
</td>
<td class="nump">26,020<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">175,829<span></span>
</td>
<td class="nump">195,852<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders' Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, par value $0.001 per share: 20,000 shares authorized; 10,929 and 11,594 issued and 10,928 and 11,593 outstanding at September&#160;30, 2022 and December&#160;31, 2021, respectively</a></td>
<td class="nump">11<span></span>
</td>
<td class="nump">12<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="nump">18,617<span></span>
</td>
<td class="nump">12,018<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive income</a></td>
<td class="nump">391<span></span>
</td>
<td class="nump">111<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="nump">131,503<span></span>
</td>
<td class="nump">190,333<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders' equity</a></td>
<td class="nump">150,522<span></span>
</td>
<td class="nump">202,474<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY</a></td>
<td class="nump">$ 326,351<span></span>
</td>
<td class="nump">$ 398,326<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6801-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LinesOfCreditCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the current portion of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LinesOfCreditCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for income and other taxes that provide economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6787-107765<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6387103&amp;loc=d3e6435-108320<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 05<br> -Paragraph 5<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123349782&amp;loc=d3e5879-108316<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1)(g))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140363521705072">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares<br> shares in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in shares)</a></td>
<td class="nump">20,000<span></span>
</td>
<td class="nump">20,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, issued (in shares)</a></td>
<td class="nump">10,929<span></span>
</td>
<td class="nump">11,594<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, outstanding (in shares)</a></td>
<td class="nump">10,928<span></span>
</td>
<td class="nump">11,593<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140363521659808">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Operating Activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 117,050<span></span>
</td>
<td class="nump">$ 130,008<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net income to cash provided by operating activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">8,026<span></span>
</td>
<td class="nump">3,767<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_med_OperatingLeaseExpenseNonCash', window );">Non-cash lease expense</a></td>
<td class="nump">4,740<span></span>
</td>
<td class="nump">3,508<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-based compensation</a></td>
<td class="nump">8,103<span></span>
</td>
<td class="nump">6,613<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_med_AmortizationOfPremiumOnInvestmentSecurities', window );">Amortization of premium on investment securities</a></td>
<td class="nump">14<span></span>
</td>
<td class="nump">70<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred income taxes</a></td>
<td class="num">(1,746)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Change in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventories</a></td>
<td class="nump">34,764<span></span>
</td>
<td class="num">(76,222)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidTaxes', window );">Income taxes, prepaid</a></td>
<td class="nump">795<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">1,889<span></span>
</td>
<td class="num">(5,094)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets', window );">Other assets</a></td>
<td class="num">(8,545)<span></span>
</td>
<td class="num">(3,393)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities', window );">Accounts payable and accrued expenses</a></td>
<td class="num">(22,259)<span></span>
</td>
<td class="nump">42,747<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash flow provided by operating activities</a></td>
<td class="nump">142,831<span></span>
</td>
<td class="nump">102,004<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Investing Activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfShortTermInvestments', window );">Sale and maturities of investment securities</a></td>
<td class="nump">5,267<span></span>
</td>
<td class="nump">5,145<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchase of property and equipment</a></td>
<td class="num">(7,617)<span></span>
</td>
<td class="num">(22,585)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash flow used in investing activities</a></td>
<td class="num">(2,350)<span></span>
</td>
<td class="num">(17,440)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Financing Activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Options exercised by executives and directors</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">811<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfOtherEquity', window );">Net shares repurchased for taxes</a></td>
<td class="num">(1,504)<span></span>
</td>
<td class="num">(1,867)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfDividends', window );">Cash dividends paid to stockholders</a></td>
<td class="num">(53,698)<span></span>
</td>
<td class="num">(46,845)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Stock repurchases</a></td>
<td class="num">(120,048)<span></span>
</td>
<td class="num">(46,000)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash flow used in financing activities</a></td>
<td class="num">(175,250)<span></span>
</td>
<td class="num">(93,901)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Foreign currency impact</a></td>
<td class="nump">296<span></span>
</td>
<td class="nump">130<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Decrease in cash and cash equivalents</a></td>
<td class="num">(34,473)<span></span>
</td>
<td class="num">(9,207)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents - beginning of the period</a></td>
<td class="nump">104,183<span></span>
</td>
<td class="nump">163,723<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents - end of period</a></td>
<td class="nump">69,710<span></span>
</td>
<td class="nump">154,516<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental disclosure of cash flow information:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaidNet', window );">Income taxes paid</a></td>
<td class="nump">33,906<span></span>
</td>
<td class="nump">41,302<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsCash', window );">Dividends declared included in accounts payable</a></td>
<td class="nump">$ 19,395<span></span>
</td>
<td class="nump">$ 17,351<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_med_AmortizationOfPremiumOnInvestmentSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The expense charged against amortization of premium on investment securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">med_AmortizationOfPremiumOnInvestmentSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>med_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_med_OperatingLeaseExpenseNonCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Operating Lease, Expense, Non-Cash</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">med_OperatingLeaseExpenseNonCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>med_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid cash dividends declared for classes of stock, for example, but not limited to, common and preferred.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 405<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6957935&amp;loc=d3e64057-112817<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4297-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) of consideration paid in advance for income and other taxes that provide economic benefits in future periods.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfOtherEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to reacquire equity classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfOtherEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDividends">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash outflow in the form of capital distributions and dividends to common shareholders, preferred shareholders and noncontrolling interests.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDividends</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from sales of all investments, including securities and other assets, having ready marketability and intended by management to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140363514364240">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (UNAUDITED) - USD ($)<br> shares in Thousands, $ in Thousands</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Common Stock</div></th>
<th class="th"><div>Additional Paid-In Capital</div></th>
<th class="th"><div>Accumulated Other Comprehensive Income</div></th>
<th class="th"><div>Retained Earnings</div></th>
<th class="th"><div>Treasury Stock</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Balance (in shares) at Dec. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,822<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2020</a></td>
<td class="nump">$ 157,246<span></span>
</td>
<td class="nump">$ 12<span></span>
</td>
<td class="nump">$ 7,842<span></span>
</td>
<td class="nump">$ 41<span></span>
</td>
<td class="nump">$ 154,351<span></span>
</td>
<td class="num">$ (5,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">41,063<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">41,063<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod', window );">Share-based compensation (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions', window );">Share-based compensation</a></td>
<td class="nump">2,198<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,198<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Options exercised by executives and directors (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Options exercised by executives and directors</a></td>
<td class="nump">481<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">481<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation', window );">Net shares repurchased for taxes (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(7)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Net shares repurchased for taxes</a></td>
<td class="num">(1,807)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,807)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Treasury stock from stock repurchases</a></td>
<td class="num">(7,500)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(7,500)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive Income (loss)</a></td>
<td class="nump">62<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">62<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsCommonStockCash', window );">Cash dividends declared to stockholders</a></td>
<td class="num">(16,852)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(16,852)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Balance (in shares) at Mar. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,839<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Mar. 31, 2021</a></td>
<td class="nump">174,891<span></span>
</td>
<td class="nump">$ 12<span></span>
</td>
<td class="nump">8,714<span></span>
</td>
<td class="nump">103<span></span>
</td>
<td class="nump">178,562<span></span>
</td>
<td class="num">(12,500)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Balance (in shares) at Dec. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,822<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2020</a></td>
<td class="nump">157,246<span></span>
</td>
<td class="nump">$ 12<span></span>
</td>
<td class="nump">7,842<span></span>
</td>
<td class="nump">41<span></span>
</td>
<td class="nump">154,351<span></span>
</td>
<td class="num">(5,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 130,008<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Options exercised by executives and directors (in shares)</a></td>
<td class="nump">16<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation', window );">Net shares repurchased for taxes (in shares)</a></td>
<td class="num">(7)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive Income (loss)</a></td>
<td class="nump">$ 81<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Balance (in shares) at Sep. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,618<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Sep. 30, 2021</a></td>
<td class="nump">196,239<span></span>
</td>
<td class="nump">$ 12<span></span>
</td>
<td class="nump">12,950<span></span>
</td>
<td class="nump">122<span></span>
</td>
<td class="nump">183,155<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Balance (in shares) at Mar. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,839<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Mar. 31, 2021</a></td>
<td class="nump">174,891<span></span>
</td>
<td class="nump">$ 12<span></span>
</td>
<td class="nump">8,714<span></span>
</td>
<td class="nump">103<span></span>
</td>
<td class="nump">178,562<span></span>
</td>
<td class="num">(12,500)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">46,963<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">46,963<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod', window );">Share-based compensation (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions', window );">Share-based compensation</a></td>
<td class="nump">1,839<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,697<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">142<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Options exercised by executives and directors (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Options exercised by executives and directors</a></td>
<td class="nump">221<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">221<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Net shares repurchased for taxes</a></td>
<td class="num">(26)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(26)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Treasury stock from stock repurchases</a></td>
<td class="num">(12,230)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(12,230)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesRetired', window );">Treasury stock retired from stock repurchases (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(114)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockRetiredCostMethodAmount', window );">Treasury stock retired from stock repurchases</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(23,383)<span></span>
</td>
<td class="nump">23,383<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive Income (loss)</a></td>
<td class="num">(28)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(28)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsCommonStockCash', window );">Cash dividends declared to stockholders</a></td>
<td class="num">(16,941)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(16,941)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Balance (in shares) at Jun. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,738<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Jun. 30, 2021</a></td>
<td class="nump">194,689<span></span>
</td>
<td class="nump">$ 12<span></span>
</td>
<td class="nump">10,606<span></span>
</td>
<td class="nump">75<span></span>
</td>
<td class="nump">185,343<span></span>
</td>
<td class="num">(1,347)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">41,982<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">41,982<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod', window );">Share-based compensation (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions', window );">Share-based compensation</a></td>
<td class="nump">2,269<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,269<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Options exercised by executives and directors (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Options exercised by executives and directors</a></td>
<td class="nump">109<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">109<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation', window );">Net shares repurchased for taxes (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Net shares repurchased for taxes</a></td>
<td class="num">(34)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(34)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Treasury stock from stock repurchases</a></td>
<td class="num">(26,270)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(26,270)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesRetired', window );">Treasury stock retired from stock repurchases (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(123)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockRetiredCostMethodAmount', window );">Treasury stock retired from stock repurchases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(27,617)<span></span>
</td>
<td class="nump">27,617<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive Income (loss)</a></td>
<td class="nump">47<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">47<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsCommonStockCash', window );">Cash dividends declared to stockholders</a></td>
<td class="num">(16,553)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(16,553)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Balance (in shares) at Sep. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,618<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Sep. 30, 2021</a></td>
<td class="nump">$ 196,239<span></span>
</td>
<td class="nump">$ 12<span></span>
</td>
<td class="nump">12,950<span></span>
</td>
<td class="nump">122<span></span>
</td>
<td class="nump">183,155<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Balance (in shares) at Dec. 31, 2021</a></td>
<td class="nump">11,594<span></span>
</td>
<td class="nump">11,594<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2021</a></td>
<td class="nump">$ 202,474<span></span>
</td>
<td class="nump">$ 12<span></span>
</td>
<td class="nump">12,018<span></span>
</td>
<td class="nump">111<span></span>
</td>
<td class="nump">190,333<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">41,781<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">41,781<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod', window );">Share-based compensation (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions', window );">Share-based compensation</a></td>
<td class="nump">2,275<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,275<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation', window );">Net shares repurchased for taxes (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(8)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Net shares repurchased for taxes</a></td>
<td class="num">(1,459)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,459)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Treasury stock from stock repurchases</a></td>
<td class="num">(10,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(10,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesRetired', window );">Treasury stock retired from stock repurchases (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(51)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockRetiredCostMethodAmount', window );">Treasury stock retired from stock repurchases</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(10,000)<span></span>
</td>
<td class="nump">10,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive Income (loss)</a></td>
<td class="nump">16<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsCommonStockCash', window );">Cash dividends declared to stockholders</a></td>
<td class="num">(19,063)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(19,063)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Balance (in shares) at Mar. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,553<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Mar. 31, 2022</a></td>
<td class="nump">$ 216,024<span></span>
</td>
<td class="nump">$ 12<span></span>
</td>
<td class="nump">12,834<span></span>
</td>
<td class="nump">127<span></span>
</td>
<td class="nump">203,051<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Balance (in shares) at Dec. 31, 2021</a></td>
<td class="nump">11,594<span></span>
</td>
<td class="nump">11,594<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2021</a></td>
<td class="nump">$ 202,474<span></span>
</td>
<td class="nump">$ 12<span></span>
</td>
<td class="nump">12,018<span></span>
</td>
<td class="nump">111<span></span>
</td>
<td class="nump">190,333<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 117,050<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Options exercised by executives and directors (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation', window );">Net shares repurchased for taxes (in shares)</a></td>
<td class="num">(8)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive Income (loss)</a></td>
<td class="nump">$ 279<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Balance (in shares) at Sep. 30, 2022</a></td>
<td class="nump">10,929<span></span>
</td>
<td class="nump">10,929<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Sep. 30, 2022</a></td>
<td class="nump">$ 150,522<span></span>
</td>
<td class="nump">$ 11<span></span>
</td>
<td class="nump">18,617<span></span>
</td>
<td class="nump">391<span></span>
</td>
<td class="nump">131,503<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Balance (in shares) at Mar. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,553<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Mar. 31, 2022</a></td>
<td class="nump">216,024<span></span>
</td>
<td class="nump">$ 12<span></span>
</td>
<td class="nump">12,834<span></span>
</td>
<td class="nump">127<span></span>
</td>
<td class="nump">203,051<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">39,113<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">39,113<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod', window );">Share-based compensation (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions', window );">Share-based compensation</a></td>
<td class="nump">2,865<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,865<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Net shares repurchased for taxes</a></td>
<td class="num">(20)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(20)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Treasury stock from stock repurchases</a></td>
<td class="num">(90,038)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(90,038)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesRetired', window );">Treasury stock retired from stock repurchases (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(535)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockRetiredCostMethodAmount', window );">Treasury stock retired from stock repurchases</a></td>
<td class="num">(1)<span></span>
</td>
<td class="num">$ (1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(90,038)<span></span>
</td>
<td class="nump">90,038<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_med_AdjustmentsToPaidInCapitalShareRepurchasesNotYetSettled', window );">Stock repurchases, not yet settled</a></td>
<td class="num">(20,010)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(15,679)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4,331)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive Income (loss)</a></td>
<td class="nump">141<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">141<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsCommonStockCash', window );">Cash dividends declared to stockholders</a></td>
<td class="num">(18,598)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(18,598)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Balance (in shares) at Jun. 30, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,019<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Jun. 30, 2022</a></td>
<td class="nump">129,476<span></span>
</td>
<td class="nump">$ 11<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">268<span></span>
</td>
<td class="nump">129,197<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">36,155<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">36,155<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod', window );">Share-based compensation (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions', window );">Share-based compensation</a></td>
<td class="nump">2,963<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,963<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Net shares repurchased for taxes</a></td>
<td class="num">(25)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(25)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Treasury stock from stock repurchases</a></td>
<td class="num">(20,010)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(20,010)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesRetired', window );">Treasury stock retired from stock repurchases (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(91)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockRetiredCostMethodAmount', window );">Treasury stock retired from stock repurchases</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(20,010)<span></span>
</td>
<td class="nump">20,010<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcceleratedShareRepurchaseProgramAdjustment', window );">Settlement of accelerated share repurchase agreement</a></td>
<td class="nump">20,010<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,679<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,331<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive Income (loss)</a></td>
<td class="nump">123<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">123<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsCommonStockCash', window );">Cash dividends declared to stockholders</a></td>
<td class="num">$ (18,170)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(18,170)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Balance (in shares) at Sep. 30, 2022</a></td>
<td class="nump">10,929<span></span>
</td>
<td class="nump">10,929<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Sep. 30, 2022</a></td>
<td class="nump">$ 150,522<span></span>
</td>
<td class="nump">$ 11<span></span>
</td>
<td class="nump">$ 18,617<span></span>
</td>
<td class="nump">$ 391<span></span>
</td>
<td class="nump">$ 131,503<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_med_AdjustmentsToPaidInCapitalShareRepurchasesNotYetSettled">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments To Paid In Capital, Share Repurchases Not Yet Settled</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">med_AdjustmentsToPaidInCapitalShareRepurchasesNotYetSettled</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>med_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcceleratedShareRepurchaseProgramAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount needed to adjust previously recorded stockholders' equity balances to the actual aggregate amounts paid, whether in cash or other consideration, to acquire all of the shares purchased under an Accelerated Share Repurchase arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcceleratedShareRepurchaseProgramAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease to equity for grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) to additional paid-in capital (APIC) for recognition and exercise of award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsCommonStockCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid common stock dividends declared with the form of settlement in cash.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsCommonStockCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569643-111683<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares used to settle grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockRetiredCostMethodAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease of par value, additional paid in capital (APIC) and retained earnings of common and preferred stock retired from treasury when treasury stock is accounted for under the cost method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockRetiredCostMethodAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockSharesRetired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common and preferred stock retired from treasury during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockSharesRetired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValueAcquiredCostMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValueAcquiredCostMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140363521507120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</a></td>
<td class="text">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES<div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basis of Presentation -</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The accompanying unaudited condensed consolidated financial statements of Medifast, Inc. and its wholly-owned subsidiaries (&#8220;Medifast,&#8221; the &#8220;Company,&#8221; &#8220;we,&#8221; &#8220;us,&#8221; or &#8220;our&#8221;) included herein have been prepared in accordance with generally accepted accounting principles in the United States of America (&#8220;GAAP&#8221;) for interim reporting and pursuant to the rules and regulations of the Securities and Exchange Commission (the &#8220;SEC&#8221;). Accordingly, certain information and notes that are normally required by GAAP have been condensed or omitted. However, in the opinion of management, all adjustments consisting of normal, recurring adjustments considered necessary for a fair presentation of the financial position and results of operations have been included and management believes the disclosures that are made are adequate to make the information presented not misleading. The condensed consolidated balance sheet at December&#160;31, 2021 has been derived from the audited consolidated financial statements at that date included in the Company&#8217;s Annual Report on Form 10-K for the fiscal year ended December&#160;31, 2021 (&#8220;2021 Form 10-K&#8221;).</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The results of operations for the three and nine months ended September 30, 2022 are not necessarily indicative of results that may be expected for the fiscal year ending December&#160;31, 2022. The accompanying unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto, which are included in the 2021 Form 10-K.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Presentation of Financial Statements -</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The unaudited condensed consolidated financial statements included herein include the accounts of the Company. All significant intercompany accounts and transactions have been eliminated.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Reclassification -</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Certain amounts reported for prior periods have been reclassified to be consistent with the current period presentation. No reclassification in the condensed consolidated financial statements had a material impact on the presentation.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and reported amounts of revenue and expenses during the reporting period. Actual results could differ materially from those estimates.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accounting Pronouncements Adopted in 2022</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, the FASB issued Accounting Standards Update (&#8220;ASU&#8221;) 2020-04, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting</span>, which provides optional guidance for a limited time to ease the potential burden in accounting for reference rate reform. The new guidance provides optional expedients and exceptions for applying accounting principles under GAAP to contracts, hedging relationships and other transactions affected by reference rate reform if certain criteria are met and to other derivative instruments if there is a change to the interest rates used for discounting, margining or contract price alignment. These amendments are effective immediately and may be applied prospectively to contract modifications made and hedging relationships entered into or evaluated on or before December 31, 2022. We adopted Topic 848 beginning in the first quarter of fiscal 2022 without any material impact on the Company's financial position and results of operations.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18726-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140363521503024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INVENTORIES<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureTextBlock', window );">INVENTORIES</a></td>
<td class="text">INVENTORIES<div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories consist principally of raw materials, non-food finished goods and packaged meal replacements held in the Company&#8217;s warehouses and outsourced distribution centers. Inventories are stated at the lower of cost or net realizable value, utilizing the first-in, first-out method. The cost of finished goods includes the cost of raw materials, packaging supplies, direct and indirect labor and other indirect manufacturing costs. On a quarterly basis, management reviews inventories for unsalable or obsolete inventories.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company donated inventory with an aggregate cost of $1.1&#160;million and $10.5&#160;million to Ukrainian refugees and those in need in Ukraine, increasing selling, general and administrative (&#8220;SG&amp;A&#8221;) expenses during the three and nine months ended </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">September&#160;30, 2022. The donations were made to two 501(c)(3) organizations that are coordinating the distribution throughout refugee camps in Europe and in Ukraine.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories consisted of the following (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.549%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.929%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.638%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">December 31, 2021</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Raw materials</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 1.37pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">11,989</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 1.37pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">15,196</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Packaging</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">3,078</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">3,641</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Non-food finished goods</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">10,455</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">15,991</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Finished goods</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">122,227</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">152,687</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Reserve for obsolete inventory</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(2,470)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(7,472)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1.37pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">145,279</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1.37pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">180,043</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -URI http://asc.fasb.org/topic&amp;trid=2126998<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140363521504400">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EARNINGS PER SHARE<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">EARNINGS PER SHARE</a></td>
<td class="text">EARNINGS PER SHARE<div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic earnings per share (&#8220;EPS&#8221;) computations are calculated utilizing the weighted average number of shares of the Company&#8217;s common stock outstanding during the periods presented. Diluted EPS is calculated utilizing the weighted average number of shares of the Company&#8217;s common stock outstanding adjusted for the effect of dilutive common stock equivalents.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the computation of basic and diluted EPS (in thousands, except per share data):</span></div><div style="margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:49.329%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.361%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.373%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.361%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.373%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.364%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.373%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.366%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine months ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Numerator:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Net income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">36,155&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">41,982&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">117,050&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">130,008&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Denominator:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Weighted average shares of common stock outstanding</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,964&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,692&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,290&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,739&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Effect of dilutive common stock equivalents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">78&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">93&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">101&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Weighted average shares of common stock outstanding</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,042&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,785&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,369&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,840&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Earnings per share - basic</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.30&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.59&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.37&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11.07&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Earnings per share - diluted</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.27&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.56&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.30&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.98&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The calculation of diluted EPS excluded 10 thousand and 0 thousand antidilutive restricted stock awards for the three months ended September 30, 2022 and 2021, respectively, and 3 thousand and 0 thousand antidilutive restricted stock awards for the nine months ended September 30, 2022 and 2021, respectively. EPS is computed independently for each of the periods presented above, and accordingly, the sum of the quarterly earnings per common share may not equal the year-to-date total computed.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI http://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140363523147280">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SHARE-BASED COMPENSATION<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">SHARE-BASED COMPENSATION</a></td>
<td class="text">SHARE-BASED COMPENSATION<div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stock Options</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has issued non-qualified and incentive stock options to employees and non-employee directors. The fair value of these options are estimated on the date of grant using the Black-Scholes option pricing model, which requires estimates of the expected term of the option, the risk-free interest rate, the expected volatility of the price of the Company&#8217;s common stock, and dividend yield. Options outstanding as of September&#160;30, 2022 generally vest over a period of three years and expire ten years from the date of grant. The exercise price of these options ranges from $26.52 to $66.68. Due to the Company&#8217;s lack of option exercise history on the date of grant, the expected term is calculated using the simplified method defined as the midpoint </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">between the vesting period and the contractual term of each option. The risk free interest rate is based on the U.S. Treasury yield curve in effect on the date of grant that most closely corresponds to the expected term of the option. The expected volatility is based on the historical volatility of the Company&#8217;s common stock over the period of time equivalent to the expected term for each award. The dividend yield is computed as the annualized dividend rate at the grant date divided by the strike price of the stock option. For the nine months ended September 30, 2022 and 2021, the Company did not grant stock options. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of our stock option activity (in thousands, except per share data):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:32.525%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.929%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.056%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine months ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Awards</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted-Average Exercise Price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Awards</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted-Average Exercise Price</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Outstanding at beginning of period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">54.98&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">61&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">48.19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Exercised</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49.69&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Outstanding at end of the period</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">54.98&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">47.66&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Exercisable at end of the period</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">52.76&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">42.00&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2022, the weighted-average remaining contractual life for outstanding stock options was 55 months with an aggregate intrinsic value of $1.8 million and the weighted-average remaining contractual life for exercisable stock options was 53 months with an aggregate intrinsic value of $1.5 million. The unrecognized compensation expense calculated under the fair value method for stock options expected to vest as of September&#160;30, 2022 was less than </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$0.1 million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and is expected to be recognized over a weighted-average period of </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4 months</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. For the nine months ended September 30, 2022, there was no exercise activity of stock options. For the nine months ended September 30, 2021, the Company received $0.8 million in cash proceeds from the exercise of stock options. The total intrinsic value for stock options exercised during the nine months ended September 30, 2021 was $3.3 million.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Restricted Stock</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has issued restricted stock to employees and non-employee directors generally with vesting terms up to five years after the date of grant. The fair value of the restricted stock is equal to the market price of the Company&#8217;s common stock on the date of grant. Expense for restricted stock is amortized ratably over the vesting period.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our restricted stock activity (in thousands, except per share data):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:33.549%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.344%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.617%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-bottom:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Nine months ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">2022</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Shares</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Weighted-Average Grant Date Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Shares</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Weighted-Average Grant Date Fair Value</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Outstanding at beginning of period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">183.51&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">116.06&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">176.60&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">266.99&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">156.16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(26)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">116.62&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">186.53&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">166.02&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Outstanding at end of the period</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">187.83&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">183.04&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company withheld approximately 8 thousand and 7 thousand shares of the Company&#8217;s common stock to cover minimum tax liability withholding obligations upon the vesting of shares of restricted stock for the nine months ended September 30, 2022 and 2021, respectively. The total fair value of restricted stock awards vested during the nine months ended September 30, 2022 and 2021 was $3&#160;million and $7&#160;million, respectively.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Market and Performance-based Share Awards</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has issued market and performance-based share awards to certain key executives who were granted deferred shares and may earn between 0% and 250% of the target number depending upon both the Company&#8217;s total stockholder return </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(&#8220;TSR&#8221;) and the Company&#8217;s performance against predetermined performance goals over a three-year performance period after the date of grant. Market and performance-based share awards that are tied to the Company&#8217;s TSR are valued using the Monte Carlo method and are recognized ratably as expense over the award&#8217;s performance period. The fair value of the performance-based share awards is equal to the market price of the Company&#8217;s common stock on the date of grant adjusted by expected level of achievement over the performance period. Expense for performance-based share awards is amortized ratably over the performance period.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Share-based compensation expense is recorded in selling, general, and administrative expense in the accompanying Condensed Consolidated Statements of Income. The total expenses during the three months ended September 30, 2022 and 2021 are as follows (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.268%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.623%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-bottom:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Three months ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">2022</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Shares</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Share-Based Compensation Expense</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Shares</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Share-Based Compensation Expense</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Options and restricted stock</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">90&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,392&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">89&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,116&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Market and performance-based share awards granted in 2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">438&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Performance-based share awards granted in 2021</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">654&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">309&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Performance-based share awards granted in 2020</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">479&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">479&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Performance-based share awards granted in 2019</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">365&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total share-based compensation</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">156&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,963&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">145&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,269&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total expenses during the nine months ended September 30, 2022 and 2021 are as follows (in thousands):</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.268%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.623%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-bottom:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Nine months ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">2022</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Shares</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Share-Based Compensation Expense</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Shares</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Share-Based Compensation Expense</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Options and restricted stock</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">90&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,789&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">89&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,175&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Market and performance-based share awards granted in 2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">950&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Performance-based share awards granted in 2021</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,941&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">666&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Performance-based share awards granted in 2020</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,423&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,329&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Performance-based share awards granted in 2019</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,443&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total share-based compensation</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">156&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,103&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">145&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,613&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total income tax benefit recognized in the accompanying Condensed Consolidated Statements of Income for restricted stock awards was </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$0.4 million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and $0.1 million for the three months ended September 30, 2022 and 2021, respectively, and </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$1.2&#160;million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and $2.3&#160;million for the nine months ended September 30, 2022 and 2021, respectively. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There was $7.6 million of total unrecognized compensation cost related to restricted stock awards as of September&#160;30, 2022, which is expected to be recognized over a weighted-average period of 23 months. There was $7.9 million of unrecognized compensation costs related to the 66 thousand market and performance-based shares presented in the table above as of September&#160;30, 2022, which is expected to be recognized over a weighted-average period of 23 months.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI http://asc.fasb.org/topic&amp;trid=2228938<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140363524328992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LEASES<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">LEASES</a></td>
<td class="text">LEASES<div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Operating Leases</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has operating leases for office and warehouse space and certain equipment. In certain of the Company&#8217;s lease agreements, the rental payments are adjusted periodically based on defined terms within the lease. The Company did not have any finance leases as of September&#160;30, 2022 and 2021, respectively, or for the nine-month periods then ended, respectively.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our leases relating to office and warehouse space have lease terms of 18 months to 126 months. Our leases relating to equipment have lease terms of 24 months to 203 months, with certain of them having automatic renewal clauses.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s warehouse agreements also contain non-lease components, in the form of payments towards variable logistics services and labor charges, which the Company is obligated to pay based on the services consumed by it. Such amounts are not included in the measurement of the lease liability but are. recognized as expenses when they are incurred.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The operating lease expense was $1.7&#160;million and $1.4&#160;million for the three months ended September 30, 2022 and 2021, respectively, and $5.2 million and $3.8 million for the nine months ended September 30, 2022 and 2021, respectively.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental cash flow information related to the Company&#8217;s operating leases was as follows (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.245%"><tr><td style="width:1.0%"/><td style="width:63.780%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.905%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.420%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Nine months ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Cash paid for amounts included in the measurements of lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Operating cash flow used in operating leases</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,413&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,175&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Right-of-use assets obtained in exchange for lease obligations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Operating leases</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">103&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,745&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2022, the weighted average remaining lease term was 60 months and the weighted average discount rate was 2.1%.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the maturity of the Company&#8217;s operating lease liabilities as of September&#160;30, 2022 (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.660%"><tr><td style="width:1.0%"/><td style="width:81.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.415%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">2022 (excluding the nine months ended September&#160;30, 2022)</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,787&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,241&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,693&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,825&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,160&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,412&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Total lease payments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29,118&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Less: imputed interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,418)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Total </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27,700&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -URI http://asc.fasb.org/subtopic&amp;trid=77888251<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140363612272048">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACCUMULATED OTHER COMPREHENSIVE INCOME<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract', window );"><strong>Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNoteTextBlock', window );">ACCUMULATED OTHER COMPREHENSIVE INCOME</a></td>
<td class="text">ACCUMULATED OTHER COMPREHENSIVE INCOME<div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the components of accumulated other comprehensive income, net of tax where applicable (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.345%"><tr><td style="width:1.0%"/><td style="width:64.909%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.047%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.138%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">September 30,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">December 31,<br/>2021</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Foreign currency translation</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">391&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">90&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Unrealized gains on investment securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Accumulated other comprehensive income</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">391&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">111&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNoteTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -URI http://asc.fasb.org/topic&amp;trid=2134417<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNoteTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140363525373216">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FINANCIAL INSTRUMENTS<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsAllOtherInvestmentsAbstract', window );"><strong>Investments, All Other Investments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsDisclosureTextBlock', window );">FINANCIAL INSTRUMENTS</a></td>
<td class="text">FINANCIAL INSTRUMENTS<div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain financial assets and liabilities are accounted for at fair value, which is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The following fair value hierarchy prioritizes the inputs used to measure fair value:</span></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 1 &#8211; Quoted prices are available in active markets for identical assets or liabilities as of the reporting date. Active markets are those in which transactions for the asset or liability occur in sufficient frequency and volume to provide pricing information on an ongoing basis.</span></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 2 &#8211; Pricing inputs are other than quoted prices in active markets included in Level 1, which are either directly or indirectly observable as of the reporting date. Level 2 includes those financial instruments that are valued using models or other valuation methodologies.</span></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 3 &#8211; Pricing inputs include significant inputs that are generally less observable from objective sources. These inputs may be used with internally developed methodologies that result in management&#8217;s best estimate of fair value from the perspective of a market participant.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present the Company&#8217;s cash and financial assets that are measured at fair value on a recurring basis for each of the hierarchy levels (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:25.800%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.605%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">September 30, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Unrealized Gains</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Accrued Interest</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Estimated Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Cash &amp; Cash<br/>Equivalents</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Investment<br/>Securities</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Cash</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">69,710&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">69,710&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">69,710&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Level 1:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Money market accounts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">69,710&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">69,710&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">69,710&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:25.800%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.605%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Unrealized Gains</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Accrued Interest</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Estimated Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Cash &amp; Cash<br/>Equivalents</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Investment<br/>Securities</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Cash</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">94,824&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">94,824&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">94,824&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Level 1:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Money market accounts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,359&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,359&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,359&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Government &amp; agency securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,401&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,413&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,413&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,760&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,772&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,359&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,413&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Level 2:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Municipal bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,880&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,948&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,948&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Total</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">109,464&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">109,544&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">104,183&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,361&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr></table></div>The Company had no realized gain or loss for the three months ended September&#160;30, 2022. The company had a realized loss of $0.2 million for the nine months ended September 30, 2022. There was no realized gain or losses for the three and nine months ended September&#160;30, 2021.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for financial instruments. This disclosure includes, but is not limited to, fair value measurements of short and long term marketable securities, international currencies forward contracts, and auction rate securities. Financial instruments may include hedging and non-hedging currency exchange instruments, derivatives, securitizations and securities available for sale at fair value. Also included are investment results, realized and unrealized gains and losses as well as impairments and risk management disclosures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsAllOtherInvestmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsAllOtherInvestmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140363521383744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DEBT<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">DEBT</a></td>
<td class="text">DEBT<div style="margin-top:12pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Credit Agreement</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On April&#160;13, 2021, the Company and certain of its subsidiaries (collectively, the &#8220;Guarantors&#8221;) entered into a credit agreement (the &#8220;Credit Agreement&#8221;) among the Company, the Guarantors, the lenders party thereto and Citibank, N.A., in its capacity as administrative agent. On May&#160;31, 2022, the Credit Agreement was amended to increase the borrowing capacity and convert the interest rate to be based on Secured Overnight Financing Rate (&#8220;SOFR&#8221;), from London Inter-Bank Offered Rate (LIBOR) (the &#8220;Amended Credit Agreement&#8221;).  The Amended Credit Agreement provides for a $225.0 million senior secured revolving credit facility with a $20.0 million letter of credit sublimit. The Amended Credit Agreement also provides for an uncommitted incremental facility that permits the Company, subject to certain conditions, to increase the senior secured revolving credit facility by up to $100.0 million. The Amended Credit Agreement matures on April&#160;13, 2026.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s obligations under the Amended Credit Agreement are guaranteed by the Guarantors. The obligations of the Company and the Guarantors are secured by first-priority liens on substantially all of the assets of the Company and the Guarantors, subject to certain exceptions.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the Amended Credit Agreement, the Company will pay to the administrative agent for the account of each revolving lender a commitment fee on a quarterly basis based on amounts committed but unused under the revolving facility from 0.20% to 0.40% per annum depending on the Company&#8217;s Total Net Leverage Ratio (as defined in the Amended Credit Agreement). The Company is also obligated to pay the administrative agent customary fees for credit facilities of this size and type.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revolving borrowings under the Amended Credit Agreement bear interest at a rate per annum equal to (i) the Term SOFR Rate for the interest period plus the Applicable Rate (as defined in the Amended Credit Agreement) based on the Company&#8217;s Total Net Leverage Ratio or (ii) the Alternate Base Rate (as defined in the Amended Credit Agreement) as in effect from time to time plus the Applicable Rate based on the Company&#8217;s Total Net Leverage Ratio. As of September&#160;30, 2022, the Applicable Rate for Term SOFR Loans is 1.25% per annum and the Applicable Rate for ABR Loans is 0.25% per annum. SOFR based loans also include a Credit Spread Adjustment based on the duration of the borrowing.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Amended Credit Agreement contains affirmative and negative covenants customarily applicable to senior secured credit facilities, including covenants that, among other things, limit or restrict the ability of the Company and its subsidiaries, subject to negotiated exceptions, to incur additional indebtedness and additional liens on their assets, engage in mergers or acquisitions or dispose of assets, pay dividends or make other distributions, voluntarily prepay other indebtedness, enter into transactions with affiliated persons, make investments and change the nature of their businesses. The Amended Credit Agreement also contains customary events of default, subject to thresholds and grace periods, including, among others, payment default, covenant default, cross default to other material indebtedness and judgment default. In addition, the Amended Credit Agreement requires the Company to maintain a Total Net Leverage Ratio of no more than 2.75 to 1.00 and an Interest Coverage Ratio of at least 3.50 to 1.00.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has no borrowings outstanding under the Amended Credit Agreement as of September&#160;30, 2022.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI http://asc.fasb.org/topic&amp;trid=2208564<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140363525373216">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACCELERATED SHARE REPURCHASE ("ASR") PROGRAM<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepurchaseAgreementsResaleAgreementsSecuritiesBorrowedAndSecuritiesLoanedDisclosureTextBlock', window );">ACCELERATED SHARE REPURCHASE ("ASR") PROGRAM</a></td>
<td class="text">ACCELERATED SHARE REPURCHASE (&#8220;ASR&#8221;) PROGRAMIn the second quarter of fiscal 2022, the Company entered into an ASR agreement with JPMorgan Chase, National Association ("JPMorgan Chase") to purchase shares of its common stock from JPMorgan Chase for an aggregate purchase price of $100.0&#160;million. Pursuant to the ASR program, the Company received an initial delivery of approximately 480&#160;thousand shares of common stock based on the closing price of the common stock on May 31, 2022. Approximately 91&#160;thousand additional shares of the Company's common stock were delivered upon termination of the agreement on August 8, 2022. The final number of shares delivered to the Company under the ASR agreement was based on the average of the daily volume-weighted average trading prices of the Company&#8217;s common stock during the term of the ASR program, less a discount.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepurchaseAgreementsResaleAgreementsSecuritiesBorrowedAndSecuritiesLoanedDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for repurchase agreements (also known as repos), resale agreements (also known as reverse repurchase agreements or reverse repos), securities borrowed transactions, and securities loaned transactions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -URI http://asc.fasb.org/topic&amp;trid=2197590<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepurchaseAgreementsResaleAgreementsSecuritiesBorrowedAndSecuritiesLoanedDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140363524360464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basis of Presentation -</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The accompanying unaudited condensed consolidated financial statements of Medifast, Inc. and its wholly-owned subsidiaries (&#8220;Medifast,&#8221; the &#8220;Company,&#8221; &#8220;we,&#8221; &#8220;us,&#8221; or &#8220;our&#8221;) included herein have been prepared in accordance with generally accepted accounting principles in the United States of America (&#8220;GAAP&#8221;) for interim reporting and pursuant to the rules and regulations of the Securities and Exchange Commission (the &#8220;SEC&#8221;). Accordingly, certain information and notes that are normally required by GAAP have been condensed or omitted. However, in the opinion of management, all adjustments consisting of normal, recurring adjustments considered necessary for a fair presentation of the financial position and results of operations have been included and management believes the disclosures that are made are adequate to make the information presented not misleading. The condensed consolidated balance sheet at December&#160;31, 2021 has been derived from the audited consolidated financial statements at that date included in the Company&#8217;s Annual Report on Form 10-K for the fiscal year ended December&#160;31, 2021 (&#8220;2021 Form 10-K&#8221;).</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The results of operations for the three and nine months ended September 30, 2022 are not necessarily indicative of results that may be expected for the fiscal year ending December&#160;31, 2022. The accompanying unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto, which are included in the 2021 Form 10-K.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock', window );">Presentation of Financial Statements</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Presentation of Financial Statements -</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The unaudited condensed consolidated financial statements included herein include the accounts of the Company. All significant intercompany accounts and transactions have been eliminated.</span><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PriorPeriodReclassificationAdjustmentDescription', window );">Reclassification</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Reclassification -</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Certain amounts reported for prior periods have been reclassified to be consistent with the current period presentation. No reclassification in the condensed consolidated financial statements had a material impact on the presentation.</span><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and reported amounts of revenue and expenses during the reporting period. Actual results could differ materially from those estimates.</span><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Accounting Pronouncements Adopted in 2022</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accounting Pronouncements Adopted in 2022</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, the FASB issued Accounting Standards Update (&#8220;ASU&#8221;) 2020-04, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting</span>, which provides optional guidance for a limited time to ease the potential burden in accounting for reference rate reform. The new guidance provides optional expedients and exceptions for applying accounting principles under GAAP to contracts, hedging relationships and other transactions affected by reference rate reform if certain criteria are met and to other derivative instruments if there is a change to the interest rates used for discounting, margining or contract price alignment. These amendments are effective immediately and may be applied prospectively to contract modifications made and hedging relationships entered into or evaluated on or before December 31, 2022. We adopted Topic 848 beginning in the first quarter of fiscal 2022 without any material impact on the Company's financial position and results of operations.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the general note to the financial statements for the reporting entity which may include, descriptions of the basis of presentation, business description, significant accounting policies, consolidations, reclassifications, new pronouncements not yet adopted and changes in accounting principles.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI http://asc.fasb.org/topic&amp;trid=2197479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI http://asc.fasb.org/topic&amp;trid=2134479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -URI http://asc.fasb.org/topic&amp;trid=2122394<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PriorPeriodReclassificationAdjustmentDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429488&amp;loc=d3e326-107755<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PriorPeriodReclassificationAdjustmentDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140363523089728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INVENTORIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock', window );">Schedule of Inventories</a></td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories consisted of the following (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.549%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.929%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.638%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">December 31, 2021</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Raw materials</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 1.37pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">11,989</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 1.37pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">15,196</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Packaging</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">3,078</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">3,641</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Non-food finished goods</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">10,455</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">15,991</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Finished goods</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">122,227</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">152,687</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Reserve for obsolete inventory</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(2,470)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(7,472)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1.37pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">145,279</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1.37pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">180,043</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInventoryCurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140363523616096">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EARNINGS PER SHARE (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of the Computation of Basic and Diluted EPS</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the computation of basic and diluted EPS (in thousands, except per share data):</span></div><div style="margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:49.329%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.361%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.373%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.361%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.373%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.364%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.373%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.366%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine months ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Numerator:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Net income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">36,155&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">41,982&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">117,050&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">130,008&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Denominator:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Weighted average shares of common stock outstanding</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,964&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,692&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,290&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,739&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Effect of dilutive common stock equivalents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">78&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">93&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">101&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Weighted average shares of common stock outstanding</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,042&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,785&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,369&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,840&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Earnings per share - basic</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.30&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.59&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.37&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11.07&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Earnings per share - diluted</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.27&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.56&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.30&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.98&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140363523605984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SHARE-BASED COMPENSATION (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Summary of Stock Option Activity</a></td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of our stock option activity (in thousands, except per share data):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:32.525%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.929%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.056%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine months ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Awards</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted-Average Exercise Price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Awards</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted-Average Exercise Price</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Outstanding at beginning of period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">54.98&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">61&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">48.19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Exercised</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49.69&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Outstanding at end of the period</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">54.98&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">47.66&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Exercisable at end of the period</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">52.76&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">42.00&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock', window );">Summary of Restricted Stock Activity</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our restricted stock activity (in thousands, except per share data):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:33.549%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.344%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.617%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-bottom:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Nine months ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">2022</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Shares</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Weighted-Average Grant Date Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Shares</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Weighted-Average Grant Date Fair Value</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Outstanding at beginning of period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">183.51&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">116.06&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">176.60&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">266.99&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">156.16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(26)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">116.62&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">186.53&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">166.02&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Outstanding at end of the period</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">187.83&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">183.04&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock', window );">Disclosure of Share-based Compensation Arrangements by Share-based Payment Award</a></td>
<td class="text">The total expenses during the three months ended September 30, 2022 and 2021 are as follows (in thousands):<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.268%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.623%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-bottom:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Three months ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">2022</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Shares</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Share-Based Compensation Expense</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Shares</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Share-Based Compensation Expense</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Options and restricted stock</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">90&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,392&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">89&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,116&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Market and performance-based share awards granted in 2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">438&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Performance-based share awards granted in 2021</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">654&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">309&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Performance-based share awards granted in 2020</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">479&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">479&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Performance-based share awards granted in 2019</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">365&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total share-based compensation</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">156&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,963&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">145&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,269&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total expenses during the nine months ended September 30, 2022 and 2021 are as follows (in thousands):</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.268%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.623%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-bottom:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Nine months ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">2022</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Shares</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Share-Based Compensation Expense</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Shares</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Share-Based Compensation Expense</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Options and restricted stock</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">90&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,789&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">89&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,175&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Market and performance-based share awards granted in 2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">950&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Performance-based share awards granted in 2021</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,941&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">666&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Performance-based share awards granted in 2020</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,423&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,329&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Performance-based share awards granted in 2019</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,443&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total share-based compensation</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">156&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,103&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">145&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,613&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the changes in outstanding nonvested restricted stock units.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140363514241152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LEASES (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCostTableTextBlock', window );">Summary of Supplemental Cash Flow Information</a></td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental cash flow information related to the Company&#8217;s operating leases was as follows (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.245%"><tr><td style="width:1.0%"/><td style="width:63.780%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.905%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.420%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Nine months ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Cash paid for amounts included in the measurements of lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Operating cash flow used in operating leases</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,413&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,175&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Right-of-use assets obtained in exchange for lease obligations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Operating leases</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">103&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,745&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Summary of Maturity of the Company's Operating Lease Liabilities</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the maturity of the Company&#8217;s operating lease liabilities as of September&#160;30, 2022 (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.660%"><tr><td style="width:1.0%"/><td style="width:81.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.415%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">2022 (excluding the nine months ended September&#160;30, 2022)</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,787&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,241&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,693&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,825&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,160&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,412&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Total lease payments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29,118&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Less: imputed interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,418)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Total </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27,700&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140363525150160">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACCUMULATED OTHER COMPREHENSIVE INCOME (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract', window );"><strong>Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Schedule of Accumulated Other Comprehensive Income</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the components of accumulated other comprehensive income, net of tax where applicable (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.345%"><tr><td style="width:1.0%"/><td style="width:64.909%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.047%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.138%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">September 30,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">December 31,<br/>2021</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Foreign currency translation</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">391&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">90&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Unrealized gains on investment securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Accumulated other comprehensive income</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">391&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">111&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140363523674624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FINANCIAL INSTRUMENTS (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsAllOtherInvestmentsAbstract', window );"><strong>Investments, All Other Investments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock', window );">Schedule of Cash and Financial Assets that are Measured at Fair Value on a Recurring Basis for each of the Hierarchy Levels</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present the Company&#8217;s cash and financial assets that are measured at fair value on a recurring basis for each of the hierarchy levels (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:25.800%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.605%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">September 30, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Unrealized Gains</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Accrued Interest</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Estimated Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Cash &amp; Cash<br/>Equivalents</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Investment<br/>Securities</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Cash</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">69,710&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">69,710&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">69,710&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Level 1:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Money market accounts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">69,710&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">69,710&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">69,710&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:25.800%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.605%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Unrealized Gains</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Accrued Interest</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Estimated Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Cash &amp; Cash<br/>Equivalents</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Investment<br/>Securities</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Cash</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">94,824&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">94,824&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">94,824&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Level 1:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Money market accounts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,359&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,359&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,359&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Government &amp; agency securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,401&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,413&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,413&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,760&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,772&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,359&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,413&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Level 2:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Municipal bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,880&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,948&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,948&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Total</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">109,464&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">109,544&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">104,183&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,361&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsAllOtherInvestmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsAllOtherInvestmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation of available-for-sale securities from cost basis to fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140363521634224">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INVENTORIES (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncashContributionExpense', window );">Donated inventory</a></td>
<td class="nump">$ 1,100<span></span>
</td>
<td class="nump">$ 10,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryRawMaterials', window );">Raw materials</a></td>
<td class="nump">11,989<span></span>
</td>
<td class="nump">11,989<span></span>
</td>
<td class="nump">$ 15,196<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetailRelatedInventoryPackagingAndOtherSupplies', window );">Packaging</a></td>
<td class="nump">3,078<span></span>
</td>
<td class="nump">3,078<span></span>
</td>
<td class="nump">3,641<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_med_InventoryNonFoodFinishedGoods', window );">Non-food finished goods</a></td>
<td class="nump">10,455<span></span>
</td>
<td class="nump">10,455<span></span>
</td>
<td class="nump">15,991<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoods', window );">Finished goods</a></td>
<td class="nump">122,227<span></span>
</td>
<td class="nump">122,227<span></span>
</td>
<td class="nump">152,687<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryValuationReserves', window );">Reserve for obsolete inventory</a></td>
<td class="num">(2,470)<span></span>
</td>
<td class="num">(2,470)<span></span>
</td>
<td class="num">(7,472)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Total</a></td>
<td class="nump">$ 145,279<span></span>
</td>
<td class="nump">$ 145,279<span></span>
</td>
<td class="nump">$ 180,043<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_med_InventoryNonFoodFinishedGoods">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before last-in first-out (LIFO) and valuation reserves of (Non-food) merchandise or goods held by the entity that are readily available for sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">med_InventoryNonFoodFinishedGoods</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>med_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoods">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoods</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryRawMaterials">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation and LIFO reserves of raw materials expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryRawMaterials</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryValuationReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of valuation reserve for inventory.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryValuationReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncashContributionExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Noncash charitable contributions made by the entity during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncashContributionExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetailRelatedInventoryPackagingAndOtherSupplies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of items used in storage, presentation or transportation of physical goods that are targeted for sale to end users.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetailRelatedInventoryPackagingAndOtherSupplies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140363516622848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EARNINGS PER SHARE - Computation of Basic and Diluted EPS (Details) - USD ($)<br> $ / shares in Units, shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="6">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_med_NumeratorAbstract', window );"><strong>Numerator:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 36,155<span></span>
</td>
<td class="nump">$ 39,113<span></span>
</td>
<td class="nump">$ 41,781<span></span>
</td>
<td class="nump">$ 41,982<span></span>
</td>
<td class="nump">$ 46,963<span></span>
</td>
<td class="nump">$ 41,063<span></span>
</td>
<td class="nump">$ 117,050<span></span>
</td>
<td class="nump">$ 130,008<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_med_DenominatorAbstract', window );"><strong>Denominator:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average shares of common stock outstanding (in shares)</a></td>
<td class="nump">10,964<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,692<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,290<span></span>
</td>
<td class="nump">11,739<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment', window );">Effect of dilutive common stock equivalents (in shares)</a></td>
<td class="nump">78<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">93<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">79<span></span>
</td>
<td class="nump">101<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average shares of common stock outstanding (in shares)</a></td>
<td class="nump">11,042<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,785<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,369<span></span>
</td>
<td class="nump">11,840<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAbstract', window );"><strong>Basic earnings per share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Earnings per share - basic (in dollars per share)</a></td>
<td class="nump">$ 3.30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.59<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.37<span></span>
</td>
<td class="nump">$ 11.07<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDilutedAbstract', window );"><strong>Diluted earnings per share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Earnings per share - diluted (in dollars per share)</a></td>
<td class="nump">$ 3.27<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.56<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.30<span></span>
</td>
<td class="nump">$ 10.98<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_med_DenominatorAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Denominator [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">med_DenominatorAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>med_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_med_NumeratorAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Numerator [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">med_NumeratorAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>med_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140363523654608">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EARNINGS PER SHARE - Narrative (Details) - shares<br> shares in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockMember', window );">Restricted Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Anti-dilutive awards</a></td>
<td class="nump">10<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140363519307728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SHARE-BASED COMPENSATION - Narrative (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit', window );">Share-based compensation, shares authorized under stock option plans, exercise price range, lower range limit (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 26.52<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit', window );">Share-based compensation, shares authorized under stock option plans, exercise price range, upper range limit (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 66.68<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Share-based compensation arrangement by share-based payment award, options, grants in period, gross</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Weighted-average remaining contractual life of options outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">55 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Aggregate intrinsic value of options outstanding</a></td>
<td class="nump">$ 1,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1', window );">Weighted-average remaining contractual life of options exercisable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">53 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Aggregate intrinsic value of options exercisable</a></td>
<td class="nump">1,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Proceeds from stock options exercised</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 811<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue', window );">Intrinsic value of options exercised</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,300<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation', window );">Shares withheld for employee taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,000<span></span>
</td>
<td class="nump">7,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Award vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Award expiration period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Employee service share based compensation nonvested awards total compensation cost not yet recognized (less than)</a></td>
<td class="nump">100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Compensation cost recognition weighted average period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">Restricted Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Award vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Compensation cost recognition weighted average period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">23 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue', window );">Share-based compensation arrangement, fair value of awards vested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,000<span></span>
</td>
<td class="nump">$ 7,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense', window );">Total income tax benefit recognized related to restricted stock awards</a></td>
<td class="nump">400<span></span>
</td>
<td class="nump">$ 100<span></span>
</td>
<td class="nump">1,200<span></span>
</td>
<td class="nump">$ 2,300<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions', window );">Unrecognized compensation costs</a></td>
<td class="nump">7,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Shares granted in period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">38,000<span></span>
</td>
<td class="nump">21,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">Performance-Based Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Compensation cost recognition weighted average period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">23 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_med_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesEarnedPerformancePeriod', window );">Performance period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions', window );">Unrecognized compensation costs</a></td>
<td class="nump">$ 7,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Shares granted in period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">66,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">Performance-Based Shares | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_med_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesEarnedPercentage', window );">Additional performance-based shares, percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">Performance-Based Shares | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_med_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesEarnedPercentage', window );">Additional performance-based shares, percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">250.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_med_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesEarnedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement By Share-Based Payment Award, Number Of Additional Shares Earned, Percentage</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">med_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesEarnedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>med_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_med_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesEarnedPerformancePeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement By Share-Based Payment Award, Number Of Additional Shares Earned, Performance Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">med_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesEarnedPerformancePeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>med_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost not yet recognized for nonvested award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost to be recognized for nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of tax benefit for recognition of expense of award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The floor of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The ceiling of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares used to settle grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140363521547888">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SHARE-BASED COMPENSATION - Stock Options Activity (Details)<br> shares in Thousands</strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Awards</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Shares, Outstanding at beginning of period (in shares) | shares</a></td>
<td class="nump">33<span></span>
</td>
<td class="nump">61<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Shares, Exercised (in shares) | shares</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(16)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Shares, Outstanding at end of the period (in shares) | shares</a></td>
<td class="nump">33<span></span>
</td>
<td class="nump">45<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Shares, Exercisable at end of the period (in shares) | shares</a></td>
<td class="nump">28<span></span>
</td>
<td class="nump">35<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Weighted-Average Exercise Price</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted-Average Exercise Price, Outstanding at beginning of period (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 54.98<span></span>
</td>
<td class="nump">$ 48.19<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Weighted-Average Exercise Price, Exercised (in dollars per share) | $ / shares</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">49.69<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted-Average Exercise Price, Outstanding at end of the period (in dollars per share) | $ / shares</a></td>
<td class="nump">54.98<span></span>
</td>
<td class="nump">47.66<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Weighted-Average Exercise Price, Exercisable at end of the period (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 52.76<span></span>
</td>
<td class="nump">$ 42.00<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140363520135808">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SHARE-BASED COMPENSATION - Restricted Stock Activity (Details) - Restricted Stock - $ / shares<br> shares in Thousands</strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Outstanding at beginning of period (in shares)</a></td>
<td class="nump">44<span></span>
</td>
<td class="nump">50<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares)</a></td>
<td class="nump">38<span></span>
</td>
<td class="nump">21<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested (in shares)</a></td>
<td class="num">(19)<span></span>
</td>
<td class="num">(26)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Forfeited (in shares)</a></td>
<td class="num">(1)<span></span>
</td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Outstanding at end of period (in shares)</a></td>
<td class="nump">62<span></span>
</td>
<td class="nump">42<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted-Average Grant Date Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Outstanding at beginning of period (in dollars per share)</a></td>
<td class="nump">$ 183.51<span></span>
</td>
<td class="nump">$ 116.06<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted (in dollars per share)</a></td>
<td class="nump">176.60<span></span>
</td>
<td class="nump">266.99<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Vested (in dollars per share)</a></td>
<td class="nump">156.16<span></span>
</td>
<td class="nump">116.62<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Forfeited (in dollars per share)</a></td>
<td class="nump">186.53<span></span>
</td>
<td class="nump">166.02<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Outstanding at end of period (in dollars per share)</a></td>
<td class="nump">$ 187.83<span></span>
</td>
<td class="nump">$ 183.04<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140363516692080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SHARE-BASED COMPENSATION - Summary of Performance-based Share Awards (Details) - USD ($)<br> shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Shares</a></td>
<td class="nump">156<span></span>
</td>
<td class="nump">145<span></span>
</td>
<td class="nump">156<span></span>
</td>
<td class="nump">145<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-Based Compensation Expense</a></td>
<td class="nump">$ 2,963<span></span>
</td>
<td class="nump">$ 2,269<span></span>
</td>
<td class="nump">$ 8,103<span></span>
</td>
<td class="nump">$ 6,613<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=med_OptionsAndRestrictedStockMember', window );">Options And Restricted Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Shares</a></td>
<td class="nump">90<span></span>
</td>
<td class="nump">89<span></span>
</td>
<td class="nump">90<span></span>
</td>
<td class="nump">89<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-Based Compensation Expense</a></td>
<td class="nump">$ 1,392<span></span>
</td>
<td class="nump">$ 1,116<span></span>
</td>
<td class="nump">$ 3,789<span></span>
</td>
<td class="nump">$ 3,175<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=med_MarketAndPerformanceSharesMember', window );">Market and Performance-Based Shares | Granted In 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Shares</a></td>
<td class="nump">25<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">25<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-Based Compensation Expense</a></td>
<td class="nump">$ 438<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 950<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">Performance-Based Shares | Granted In 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Shares</a></td>
<td class="nump">15<span></span>
</td>
<td class="nump">14<span></span>
</td>
<td class="nump">15<span></span>
</td>
<td class="nump">14<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-Based Compensation Expense</a></td>
<td class="nump">$ 654<span></span>
</td>
<td class="nump">$ 309<span></span>
</td>
<td class="nump">$ 1,941<span></span>
</td>
<td class="nump">$ 666<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">Performance-Based Shares | Granted In 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Shares</a></td>
<td class="nump">26<span></span>
</td>
<td class="nump">26<span></span>
</td>
<td class="nump">26<span></span>
</td>
<td class="nump">26<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-Based Compensation Expense</a></td>
<td class="nump">$ 479<span></span>
</td>
<td class="nump">$ 479<span></span>
</td>
<td class="nump">$ 1,423<span></span>
</td>
<td class="nump">$ 1,329<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">Performance-Based Shares | Granted In 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Shares</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">16<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">16<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-Based Compensation Expense</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 365<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 1,443<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=med_OptionsAndRestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=med_OptionsAndRestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=med_MarketAndPerformanceSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=med_MarketAndPerformanceSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardDateAxis=med_GrantedIn2022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardDateAxis=med_GrantedIn2022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardDateAxis=med_GrantedIn2021Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardDateAxis=med_GrantedIn2021Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardDateAxis=med_GrantedIn2020Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardDateAxis=med_GrantedIn2020Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardDateAxis=med_GrantedIn2019Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardDateAxis=med_GrantedIn2019Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140363516724928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LEASES - Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseExpense', window );">Operating lease expense</a></td>
<td class="nump">$ 1.7<span></span>
</td>
<td class="nump">$ 1.4<span></span>
</td>
<td class="nump">$ 5.2<span></span>
</td>
<td class="nump">$ 3.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Operating Lease Arrangement for Real Estate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Lease term</a></td>
<td class="text">18 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">18 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Operating Lease Arrangement for Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Lease term</a></td>
<td class="text">24 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">24 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Operating Lease Arrangement for Real Estate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Lease term</a></td>
<td class="text">126 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">126 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Operating Lease Arrangement for Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Lease term</a></td>
<td class="text">203 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">203 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeaseDescriptionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeaseDescriptionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseTermOfContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseTermOfContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of operating lease expense. Excludes sublease income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918638-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=med_OperatingLeaseArrangementForRealEstateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=med_OperatingLeaseArrangementForRealEstateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=med_OperatingLeaseArrangementForEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=med_OperatingLeaseArrangementForEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140363523402256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LEASES - Supplemental Cash Flow Information (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Cash paid for amounts included in the measurements of lease liabilities - Operating cash flow used in operating leases</a></td>
<td class="nump">$ 5,413<span></span>
</td>
<td class="nump">$ 3,175<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability', window );">Right-of-use assets obtained in exchange for lease obligations - Operating leases</a></td>
<td class="nump">$ 103<span></span>
</td>
<td class="nump">$ 9,745<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Weighted average remaining lease term</a></td>
<td class="text">60 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Weighted average discount rate</a></td>
<td class="nump">2.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140363516690192">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>LEASES - Future Minimum Lease Commitments (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract', window );"><strong>Lessee, Operating Lease, Liability, Payment, Due [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear', window );">2022 (excluding the nine months ended September&#160;30, 2022)</a></td>
<td class="nump">$ 1,787<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2023</a></td>
<td class="nump">6,241<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2024</a></td>
<td class="nump">5,693<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2025</a></td>
<td class="nump">5,825<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">2026</a></td>
<td class="nump">4,160<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_med_LesseeOperatingLeaseLiabilityPaymentsDueYearFiveAndAfterYearFive', window );">Thereafter</a></td>
<td class="nump">5,412<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total lease payments</a></td>
<td class="nump">29,118<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Less: imputed interest</a></td>
<td class="num">(1,418)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total</a></td>
<td class="nump">$ 27,700<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_med_LesseeOperatingLeaseLiabilityPaymentsDueYearFiveAndAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lessee Operating Lease Liability Payments Due Year Five And After Year Five</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">med_LesseeOperatingLeaseLiabilityPaymentsDueYearFiveAndAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>med_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140363516682176">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>ACCUMULATED OTHER COMPREHENSIVE INCOME - Accumulated Other Comprehensive Income (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Accumulated other comprehensive income</a></td>
<td class="nump">$ 150,522<span></span>
</td>
<td class="nump">$ 129,476<span></span>
</td>
<td class="nump">$ 216,024<span></span>
</td>
<td class="nump">$ 202,474<span></span>
</td>
<td class="nump">$ 196,239<span></span>
</td>
<td class="nump">$ 194,689<span></span>
</td>
<td class="nump">$ 174,891<span></span>
</td>
<td class="nump">$ 157,246<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember', window );">Foreign currency translation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Accumulated other comprehensive income</a></td>
<td class="nump">391<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">90<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember', window );">Unrealized gains on investment securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Accumulated other comprehensive income</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember', window );">Accumulated Other Comprehensive Income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Accumulated other comprehensive income</a></td>
<td class="nump">$ 391<span></span>
</td>
<td class="nump">$ 268<span></span>
</td>
<td class="nump">$ 127<span></span>
</td>
<td class="nump">$ 111<span></span>
</td>
<td class="nump">$ 122<span></span>
</td>
<td class="nump">$ 75<span></span>
</td>
<td class="nump">$ 103<span></span>
</td>
<td class="nump">$ 41<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140363521057536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FINANCIAL INSTRUMENTS - Cash and Financial Assets That are Measured at Fair Value on a Recurring Basis for Each of the Hierarchy Levels (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_med_CashAndCashEquivalentsAndMarketableSecuritiesLineItems', window );"><strong>Cash And Cash Equivalents And Marketable securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecurities', window );">Cost</a></td>
<td class="nump">$ 69,710<span></span>
</td>
<td class="nump">$ 109,464<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesUnrealizedGainLoss', window );">Unrealized Gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">21<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestReceivable', window );">Accrued Interest</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">59<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Estimated Fair Value</a></td>
<td class="nump">69,710<span></span>
</td>
<td class="nump">109,544<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash &amp; Cash Equivalents</a></td>
<td class="nump">69,710<span></span>
</td>
<td class="nump">104,183<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Investment Securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">5,361<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CashMember', window );">Cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_med_CashAndCashEquivalentsAndMarketableSecuritiesLineItems', window );"><strong>Cash And Cash Equivalents And Marketable securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecurities', window );">Cost</a></td>
<td class="nump">69,710<span></span>
</td>
<td class="nump">94,824<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Estimated Fair Value</a></td>
<td class="nump">69,710<span></span>
</td>
<td class="nump">94,824<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash &amp; Cash Equivalents</a></td>
<td class="nump">69,710<span></span>
</td>
<td class="nump">94,824<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1:</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_med_CashAndCashEquivalentsAndMarketableSecuritiesLineItems', window );"><strong>Cash And Cash Equivalents And Marketable securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecurities', window );">Cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,760<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesUnrealizedGainLoss', window );">Unrealized Gains</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Estimated Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,772<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash &amp; Cash Equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,359<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Investment Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,413<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1: | Money market accounts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_med_CashAndCashEquivalentsAndMarketableSecuritiesLineItems', window );"><strong>Cash And Cash Equivalents And Marketable securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecurities', window );">Cost</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">9,359<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Estimated Fair Value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">9,359<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash &amp; Cash Equivalents</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">9,359<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1: | Government &amp; agency securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_med_CashAndCashEquivalentsAndMarketableSecuritiesLineItems', window );"><strong>Cash And Cash Equivalents And Marketable securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecurities', window );">Cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,401<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesUnrealizedGainLoss', window );">Unrealized Gains</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Estimated Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,413<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Investment Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,413<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2: | Municipal bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_med_CashAndCashEquivalentsAndMarketableSecuritiesLineItems', window );"><strong>Cash And Cash Equivalents And Marketable securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecurities', window );">Cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,880<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesUnrealizedGainLoss', window );">Unrealized Gains</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestReceivable', window );">Accrued Interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">59<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Estimated Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,948<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Investment Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,948<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_med_CashAndCashEquivalentsAndMarketableSecuritiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>N/A</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">med_CashAndCashEquivalentsAndMarketableSecuritiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>med_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26626-111562<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of interest earned but not received. Also called accrued interest or accrued interest receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentOwnedAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of the investment at close of period. For schedules of investments that are categorized, the value would be aggregated by category. For investment in and advances to affiliates, if operations of any controlled companies are different in character from those of the company, group such affiliates within divisions and by type of activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=99383244&amp;loc=d3e12121-115841<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 320<br> -Section S99<br> -Paragraph 5D<br> -Subparagraph (SX 210.12-13D(Column C))<br> -URI http://asc.fasb.org/extlink&amp;oid=122147990&amp;loc=SL120429264-123010<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 320<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column C))<br> -URI http://asc.fasb.org/extlink&amp;oid=122147990&amp;loc=d3e611197-123010<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentOwnedAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in marketable security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesUnrealizedGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized gain (loss) on investment in marketable security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(7)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesUnrealizedGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CashMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CashMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_MoneyMarketFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_MoneyMarketFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=med_GovernmentAgencySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=med_GovernmentAgencySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_MunicipalBondsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_MunicipalBondsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140363520157456">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FINANCIAL INSTRUMENTS - Narrative (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsAllOtherInvestmentsAbstract', window );"><strong>Investments, All Other Investments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtAndEquitySecuritiesRealizedGainLoss', window );">Realized loss or gains</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 200,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtAndEquitySecuritiesRealizedGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of realized gain (loss) on investment in debt and equity securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtAndEquitySecuritiesRealizedGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsAllOtherInvestmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsAllOtherInvestmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140363514256432">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DEBT - Narrative (Details) - Credit Agreement<br> $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>May 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_med_MaximumTotalNetLeverageRatio', window );">Maximum Total Net Leverage Ratio</a></td>
<td class="nump">2.75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_med_MinimumInterestCoverageRatio', window );">Minimum Interest Coverage Ratio</a></td>
<td class="nump">3.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Borrowings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=med_CreditAgreementMember', window );">Eurodollar</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Applicable Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.25%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=med_CreditAgreementMember', window );">Base Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Applicable Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.25%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=med_CreditAgreementMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage', window );">Commitment fee percentage</a></td>
<td class="nump">0.20%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=med_CreditAgreementMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage', window );">Commitment fee percentage</a></td>
<td class="nump">0.40%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=med_CreditAgreementMember', window );">Senior Secured Revolving Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Credit facility maximum borrowing capacity</a></td>
<td class="nump">$ 225.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=med_CreditAgreementMember', window );">Letter of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Credit facility maximum borrowing capacity</a></td>
<td class="nump">20.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_med_LineOfCreditFacilityAccordionFeatureIncreaseLimit', window );">Accordion feature, increase limit</a></td>
<td class="nump">$ 100.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_med_LineOfCreditFacilityAccordionFeatureIncreaseLimit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line of credit facility, accordion feature, increase limit, subject to certain conditions by obtaining additional commitments from existing and/or new lenders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">med_LineOfCreditFacilityAccordionFeatureIncreaseLimit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>med_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_med_MaximumTotalNetLeverageRatio">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum ratio as of any date, of (a) Total Net Funded Indebtedness on such date to (b) Consolidated EBITDA for the Reference Period ended on such date under credit facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">med_MaximumTotalNetLeverageRatio</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>med_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_med_MinimumInterestCoverageRatio">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Minimum Interest Coverage Ratio</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">med_MinimumInterestCoverageRatio</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>med_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fee, expressed as a percentage of the line of credit facility, for the line of credit facility regardless of whether the facility has been used.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityCommitmentFeePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=med_CreditAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=med_CreditAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_EurodollarMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_EurodollarMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_BaseRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_BaseRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140363612295168">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>ACCELERATED SHARE REPURCHASE ("ASR") PROGRAM (Details) - USD ($)<br> shares in Thousands, $ in Millions</strong></div></th>
<th class="th"><div>Aug. 08, 2022</div></th>
<th class="th"><div>May 31, 2022</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1', window );">Repurchase amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Initial amount received (in shares)</a></td>
<td class="nump">91<span></span>
</td>
<td class="nump">480<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramAuthorizedAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockSharesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and are being held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockSharesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>med-20220930_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2021q4"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:med="http://www.medifast1.com/20220930"
  xmlns:srt="http://fasb.org/srt/2021-01-31"
  xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="med-20220930.xsd" xlink:type="simple"/>
    <context id="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i7165f9e7627148d7b4334bd7c0b51707_I20221026">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
        </entity>
        <period>
            <instant>2022-10-26</instant>
        </period>
    </context>
    <context id="i2f3a96a832ab4b0ca374599d1c3e9bce_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i3bb5592686d74afab4f7004818fd6f9b_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ic431430d1ab24120b4507025a722d73a_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i5de311f5948148cda49342e2cea83715_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i47f09f18839440ffae0cf05a475aa7fe_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i03d902ffc72e4d98b5eeb6fb903f405b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ifb5de6f6a1b842d59a7c6674c3095ce8_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i77931d79ec4a440094a82f9812ccc722_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i4daa9b081467438bab4674c0946e08cd_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id19243f3c67e4c9db2d2085c6f295c96_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic425e1f1f3a24303b14c8132e098ec51_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i87d2a4b91677497c84867fb9eb0d1fe3_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i4c296c25c3154c589996445b02c8b46f_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i35ec1b88d067414ebdd617a1caddf764_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i9d58012ea00c40debc6e3821ba8c53e8_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ifef10a2343ba477a98a2732ea2e3188d_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ifcda0fa259164bf4a392c5cadde798d0_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="iedb06a9ecbbd425b9ff4de89c5ec443c_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i1aa514aadcf045659a010e7c7dff59d4_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i9b72febc917d4ba4a54ef5179a1ddbbf_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="id441c59bc18c4d6faf4dc590c7376782_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i6b8a276003b3422d87146a73aca9877e_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i5d8f60be441544f9a5706ed808193db4_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ife6dd959a81f4995b5e17747ce77289e_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i825be310f0914f779c3296901da45216_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i6a350b34ff224fcfb66d3b6986b8d85d_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i31e2c05019204ecc9f2b00f8685ed1de_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i7c04a52245ee4a18af7538a5b3926bd8_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i3fe461be5d8a4b1d8f4f96a4471aae50_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i4b731dc434c94dbca7470032b562d581_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i44dccac463fc4d3d841cabd5924e0d7b_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i1a26a14e2dc041cc84ce9b142e145c9e_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i74ad881c792442baa75df8b807911f09_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i7bf72d1c8e9744c19c58f817cb47d391_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i913ea3b7a1e249509ae836a1357f94f2_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i9c92e926af9e4d908021e1a185782db8_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i46cc59e8b81644bfa9c00742166adce3_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i5a90f297c41946ada6274ba46fe40700_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i543db287df984eccb3551d94073d122d_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i2a8af11f752e4e7cb2dba522b9ad74d2_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i5c1aea55f14840448c42fb7a08b519b6_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i86b6fd23b7b042e2ba7777c1c5d29391_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i0c74a76f5cb04d3896ad8481dd40c875_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ib4e37db708e64812ac81e983938b61df_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i45eff40e381645728b84813044e661c6_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i82d77786c5f844c8a6ad979988ec850e_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i1163d3352fc648fabd60e9dbcf073a70_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if34e8b84444d41ce8edf53d30fe4aa32_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i19f7e6a88c8d41818d290843acae9d96_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i2b15d638707f47c0b49ae2a29db046e6_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i52670ec43ed94ac3b4d465333938624b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id4f9149bb4104ee2963222e63eef1ac9_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i68572f7de11f487eb008f9ea31479d93_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i470e4e9ecca64945928eff798199788e_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ia13ecf3f80ad40c2a77b77116d4ed43c_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i38351930dc7542bba71c26ab68521fec_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i7ffa4de1d96a472385d9f446aded3673_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i926bcd92e3394962b4b7831cda0ea157_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i593139faed924dd193120eb4e1bcaeec_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i4149861d44464055b0906f38bd8c72e2_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i53d4071f311c4bc6a78da6c7fb1ca3da_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i432fec2efa784910b40e24a63bb087c5_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i36a8ff01ce244ad6a7aaa930257b4d4f_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ia82656c7830f478dbef5fdc6935f568d_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i8148576927e64d0f8fda8e31eb6b529b_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i02db23a8737b4985815005662095656a_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i9224eb8da52e48a886d66dcac0ff9f06_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i7a3770d9964c4b419436e67fc0ef4044_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i581ec4205b3c47a0a164d6c0e54036f6_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i9e9dcffbe0354e98962551a32828abc2_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="idfb0b0b879244ae7862113b2345aa1e6_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i9cea7aaedf6e484b95020ab9ac02f011_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ic4a2d943c8664242a544b6294ec6c7c8_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ib6dc7945bf0e400099cdcc1fed80fb2c_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i059d81e5005e42788c673ccfaf1058e5_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i73d2ec22c05b4c4fbe6a550f139a59ae_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ibd26354982214044ae591432e82c800d_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i1aab3bd0f0be43baa5e0bc44e70a5a28_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i4218dcf5ff3845e68993eb267c5fbe10_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i64699db86ad54ac8a14806cd578d3cf7_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ib9edd1f9ecfe40139a3c3fbfe3370644_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i25169b23871e46eca074903e07db728c_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i9c3f2304fd3c47c18b9051b19c7301ea_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i00844f75496c44e194d293f567033a2d_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i0e33dd9737fd44d6ab51db5290fd1254_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i8c40ccc203fe40598b003eaa16fd683f_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i44833e234c5b420caed39d2dbc002f2b_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ide51255203a64d54b830864bda6b2f1f_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i873b1283e7f24f0c80ef84c8a9e20c76_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="if96bd90ed63041fc85fb7929f8aa69cf_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ie17f9491af104b57837e5277e79f0dee_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="id337c0920a144e0c91a6bed2853c1d7b_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ia06f0db3dd8146e097bef1502f9f86af_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i64e1421ab00c4da49c0547bb9f5f234a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if58da46cc9354a8eadc10f9e4f114ac2_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="iee1cf11574cc42609fde6f9c8aee4073_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ic65b09ecdbb7426eb38e93fcf8817112_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="if99f41a5e55c4b58ab6b630db3712adb_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i0ecdbda19ca5476b9e392faeaca89725_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="id883036fe81d4fbd9ce98760bd9584d6_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ibadc66af627d4a50adc5b6a3602689c5_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">med:OptionsAndRestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i12f18bce76824fa181f9d54c1673be9d_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">med:OptionsAndRestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i95d94f4202144399b49c964c8368ac37_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">med:GrantedIn2022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">med:MarketAndPerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i0901c79f16de41bea38c2f269bd6bd08_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">med:GrantedIn2022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">med:MarketAndPerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i0a41616804a64fe39e2eb14b59e5df17_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">med:GrantedIn2021Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ie5d960394d1f4239b6b22f78b99ccbfd_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">med:GrantedIn2021Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ia7b71491bfda423a9b849e5ba3c9591d_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">med:GrantedIn2020Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i840318db555b44f1929d580be8e92f97_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">med:GrantedIn2020Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i86506a2c9bb242aab0a78a2c5c61556e_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">med:GrantedIn2019Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i9f1fb4440c1a44f78177fa769579f56b_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">med:GrantedIn2019Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ic07f86d9e5da4afd87e67a65fb6f4791_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">med:OptionsAndRestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ie5f97af31c054e3788ba0bc81976a278_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">med:OptionsAndRestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="icf2b50e3ab554624b26461e34b8f1ca1_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">med:GrantedIn2022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">med:MarketAndPerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i69d71c00111f4c31a670e455a0400e4b_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">med:GrantedIn2022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">med:MarketAndPerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i8836599f5719436f91aef628c5b33be0_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">med:GrantedIn2021Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="if982f76b88b6470b88a0ed0c16c942e8_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">med:GrantedIn2021Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="iaf70d20a80bb4d1aa9e3337f77338213_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">med:GrantedIn2020Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="iec911248646e4fb08207555f658d9df7_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">med:GrantedIn2020Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i2b5cd09c8d0d42ac95d3ad2f1003faf4_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">med:GrantedIn2019Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i22b57c2d55054a9da3152d65a3fac12e_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">med:GrantedIn2019Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i0d192144959640fd8d222d1f8b709e6b_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i2fe34b3f982747e1929ba94579cd75e3_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i6694abec73714bcba4d3d84d55594c48_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ice458ff158834dc8b920eafada15a08c_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">med:OperatingLeaseArrangementForRealEstateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ic37ce3f978074bddbfb14a6e5f911b56_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">med:OperatingLeaseArrangementForRealEstateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i0399caeb91d24d5b95af603648d72cb4_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">med:OperatingLeaseArrangementForEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ie6bff7e9e26a4002b1c59b59832b37a2_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">med:OperatingLeaseArrangementForEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i9072f45fffaa474fb85e95c07d3eeec4_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="if1f1d1f963874bf9a839c3e7d4c9af87_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i097ff6133d214f6bb8b7dc45eed5eed7_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i8729459526e94e28ad22588635f7ca5e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i2441f967061c4361b6837702e3fee167_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CashMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="iea299389245a4a8b89c2066eaf7399d6_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i1ce2f0d8655c4a7da2f77d8aa8960f46_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CashMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1b9d5d43ca6d4d0a8b8eba73d75d9cd6_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i8dd60027e0b14536ba3bfa6e34c9dfae_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">med:GovernmentAgencySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i23259e7a55774035a3ea3e0ab04e7338_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">med:GovernmentAgencySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="if41dd7900bc54c728b2f679f78ab8cf8_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i64b67de4322349efbcaab405308f4973_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i51ae42d5ac59407da626249ef44365c7_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i89429fed7a924252aaa74342106dea93_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ifaa46d08341a4f5db42a3cfd1e77e968_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ib975abad8363400482246009fad4070e_I20220531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">med:CreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-05-31</instant>
        </period>
    </context>
    <context id="i9f7c21a6e6a1463a8de2e4295c68b795_I20220531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">med:CreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-05-31</instant>
        </period>
    </context>
    <context id="ibea5baeea8b840488104a7e63ceeb4bc_D20220531-20220531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">med:CreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-31</startDate>
            <endDate>2022-05-31</endDate>
        </period>
    </context>
    <context id="ie586fdb4b2b04c1f83bcdaff0af594c8_D20220531-20220531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">med:CreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-31</startDate>
            <endDate>2022-05-31</endDate>
        </period>
    </context>
    <context id="i56c008dd01b046dda5a8ab4c98daf9d7_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">med:CreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:EurodollarMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i761b85a615a044a28a135126fe49dca4_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">med:CreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i1572f54925ef49918ea7d21b949a4e18_I20220531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">med:CreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-05-31</instant>
        </period>
    </context>
    <context id="i116efaf8269843e38b3d65a462979897_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">med:CreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i0b400b25989d44b2afb02aff99c3fc41_D20220531-20220531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
        </entity>
        <period>
            <startDate>2022-05-31</startDate>
            <endDate>2022-05-31</endDate>
        </period>
    </context>
    <context id="i614062ec1b3741b0a8c6fc4b23ffa70c_D20220808-20220808">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
        </entity>
        <period>
            <startDate>2022-08-08</startDate>
            <endDate>2022-08-08</endDate>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <dei:EntityCentralIndexKey
      contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180L2ZyYWc6OGJhOGUzMWM0NGMxNGE4Mjk1OWJhMjYyMjYxN2QxZWQvdGFibGU6OGJhNjQ3MGEwZDU0NDVlY2JiNmQyYWRlM2E5Nzc4NjIvdGFibGVyYW5nZTo4YmE2NDcwYTBkNTQ0NWVjYmI2ZDJhZGUzYTk3Nzg2Ml8yNi0xLTEtMS00Mjc5Mg_f2e92489-7f46-4f21-b9d6-55376ff33fb1">0000910329</dei:EntityCentralIndexKey>
    <dei:CurrentFiscalYearEndDate
      contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180L2ZyYWc6OGJhOGUzMWM0NGMxNGE4Mjk1OWJhMjYyMjYxN2QxZWQvdGFibGU6OGJhNjQ3MGEwZDU0NDVlY2JiNmQyYWRlM2E5Nzc4NjIvdGFibGVyYW5nZTo4YmE2NDcwYTBkNTQ0NWVjYmI2ZDJhZGUzYTk3Nzg2Ml8yNy0xLTEtMS00Mjc5Mg_c66bc7d7-36da-4a8c-9930-9ab7e338ba66">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalYearFocus
      contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180L2ZyYWc6OGJhOGUzMWM0NGMxNGE4Mjk1OWJhMjYyMjYxN2QxZWQvdGFibGU6OGJhNjQ3MGEwZDU0NDVlY2JiNmQyYWRlM2E5Nzc4NjIvdGFibGVyYW5nZTo4YmE2NDcwYTBkNTQ0NWVjYmI2ZDJhZGUzYTk3Nzg2Ml8yOC0xLTEtMS00Mjc5Mg_81a20340-410e-45db-a0cc-b4da1574b98f">2022</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180L2ZyYWc6OGJhOGUzMWM0NGMxNGE4Mjk1OWJhMjYyMjYxN2QxZWQvdGFibGU6OGJhNjQ3MGEwZDU0NDVlY2JiNmQyYWRlM2E5Nzc4NjIvdGFibGVyYW5nZTo4YmE2NDcwYTBkNTQ0NWVjYmI2ZDJhZGUzYTk3Nzg2Ml8yOS0xLTEtMS00Mjc5Mg_ef0d0d7b-138d-4ded-aba6-23053c5a155b">Q3</dei:DocumentFiscalPeriodFocus>
    <dei:AmendmentFlag
      contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180L2ZyYWc6OGJhOGUzMWM0NGMxNGE4Mjk1OWJhMjYyMjYxN2QxZWQvdGFibGU6OGJhNjQ3MGEwZDU0NDVlY2JiNmQyYWRlM2E5Nzc4NjIvdGFibGVyYW5nZTo4YmE2NDcwYTBkNTQ0NWVjYmI2ZDJhZGUzYTk3Nzg2Ml8zMC0xLTEtMS00Mjc5Mg_86122db8-41f7-44f5-a43c-3657c780e950">false</dei:AmendmentFlag>
    <dei:DocumentType
      contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xL2ZyYWc6MjNlYzlhNDY1OTg4NDgyMWFkOWE4ODRmNWJiMGI2NWUvdGV4dHJlZ2lvbjoyM2VjOWE0NjU5ODg0ODIxYWQ5YTg4NGY1YmIwYjY1ZV8yMzI0_a78b224a-e2b5-46e7-9800-389ee435e21d">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport
      contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xL2ZyYWc6MjNlYzlhNDY1OTg4NDgyMWFkOWE4ODRmNWJiMGI2NWUvdGV4dHJlZ2lvbjoyM2VjOWE0NjU5ODg0ODIxYWQ5YTg4NGY1YmIwYjY1ZV8yMzIx_84f861ee-ffd0-44f8-b2f9-dba16572fc2b">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate
      contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xL2ZyYWc6MjNlYzlhNDY1OTg4NDgyMWFkOWE4ODRmNWJiMGI2NWUvdGV4dHJlZ2lvbjoyM2VjOWE0NjU5ODg0ODIxYWQ5YTg4NGY1YmIwYjY1ZV81NDk3NTU4MTYyNzU_ef8a5a93-31a4-4825-bb56-d81214346466">2022-09-30</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport
      contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xL2ZyYWc6MjNlYzlhNDY1OTg4NDgyMWFkOWE4ODRmNWJiMGI2NWUvdGV4dHJlZ2lvbjoyM2VjOWE0NjU5ODg0ODIxYWQ5YTg4NGY1YmIwYjY1ZV8yMzE0_6b799bb2-837f-4113-a908-1cacd9a7b8aa">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xL2ZyYWc6MjNlYzlhNDY1OTg4NDgyMWFkOWE4ODRmNWJiMGI2NWUvdGV4dHJlZ2lvbjoyM2VjOWE0NjU5ODg0ODIxYWQ5YTg4NGY1YmIwYjY1ZV8yMzI4_819f0b41-dd64-40df-ac0b-a93f0ff4d1ed">001-31573</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xL2ZyYWc6MjNlYzlhNDY1OTg4NDgyMWFkOWE4ODRmNWJiMGI2NWUvdGV4dHJlZ2lvbjoyM2VjOWE0NjU5ODg0ODIxYWQ5YTg4NGY1YmIwYjY1ZV8yMzE1_5407a282-c640-4b7f-a548-ec1ce12915ca">Medifast, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xL2ZyYWc6MjNlYzlhNDY1OTg4NDgyMWFkOWE4ODRmNWJiMGI2NWUvdGFibGU6NzYwZWY3MTUwODIxNDU3MmJhYzgwYWI4M2JiYjY2NzMvdGFibGVyYW5nZTo3NjBlZjcxNTA4MjE0NTcyYmFjODBhYjgzYmJiNjY3M18wLTAtMS0xLTQyNzky_6a5b0262-b9da-4d16-a25f-880b9ddecbc3">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xL2ZyYWc6MjNlYzlhNDY1OTg4NDgyMWFkOWE4ODRmNWJiMGI2NWUvdGFibGU6NzYwZWY3MTUwODIxNDU3MmJhYzgwYWI4M2JiYjY2NzMvdGFibGVyYW5nZTo3NjBlZjcxNTA4MjE0NTcyYmFjODBhYjgzYmJiNjY3M18wLTItMS0xLTQyNzky_ee5fd4cf-b482-4c93-8ccf-66b141c99a92">13-3714405</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xL2ZyYWc6MjNlYzlhNDY1OTg4NDgyMWFkOWE4ODRmNWJiMGI2NWUvdGV4dHJlZ2lvbjoyM2VjOWE0NjU5ODg0ODIxYWQ5YTg4NGY1YmIwYjY1ZV8yMzIy_64b87af1-a627-49d8-9b48-b0f6654466fa">100 International Drive</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xL2ZyYWc6MjNlYzlhNDY1OTg4NDgyMWFkOWE4ODRmNWJiMGI2NWUvdGV4dHJlZ2lvbjoyM2VjOWE0NjU5ODg0ODIxYWQ5YTg4NGY1YmIwYjY1ZV8yMzI3_49f85d6c-2e51-490c-bea9-c85f5ba88d1b">Baltimore</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xL2ZyYWc6MjNlYzlhNDY1OTg4NDgyMWFkOWE4ODRmNWJiMGI2NWUvdGV4dHJlZ2lvbjoyM2VjOWE0NjU5ODg0ODIxYWQ5YTg4NGY1YmIwYjY1ZV8yMzIz_69e58803-f738-4828-82f9-ba0183d54fe5">MD</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xL2ZyYWc6MjNlYzlhNDY1OTg4NDgyMWFkOWE4ODRmNWJiMGI2NWUvdGV4dHJlZ2lvbjoyM2VjOWE0NjU5ODg0ODIxYWQ5YTg4NGY1YmIwYjY1ZV8yMzI1_3d70c88c-09f2-4faf-a489-bee2d0f818df">21202</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xL2ZyYWc6MjNlYzlhNDY1OTg4NDgyMWFkOWE4ODRmNWJiMGI2NWUvdGV4dHJlZ2lvbjoyM2VjOWE0NjU5ODg0ODIxYWQ5YTg4NGY1YmIwYjY1ZV8yMzI2_1c743ce2-590e-4407-af26-048328a63f5b">410</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xL2ZyYWc6MjNlYzlhNDY1OTg4NDgyMWFkOWE4ODRmNWJiMGI2NWUvdGV4dHJlZ2lvbjoyM2VjOWE0NjU5ODg0ODIxYWQ5YTg4NGY1YmIwYjY1ZV8yMzE2_d1d5af12-8c2b-4ea2-a91f-6f8df2202ea9">581-8042</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xL2ZyYWc6MjNlYzlhNDY1OTg4NDgyMWFkOWE4ODRmNWJiMGI2NWUvdGFibGU6NGVlMGNkYmU5NjIwNGU5NjkxNGIzZWE5OWNkNWZiYjYvdGFibGVyYW5nZTo0ZWUwY2RiZTk2MjA0ZTk2OTE0YjNlYTk5Y2Q1ZmJiNl8xLTAtMS0xLTQyNzky_41b67bdf-c8f6-4663-b226-871d214b67b0">Common Stock, par value $0.001 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xL2ZyYWc6MjNlYzlhNDY1OTg4NDgyMWFkOWE4ODRmNWJiMGI2NWUvdGFibGU6NGVlMGNkYmU5NjIwNGU5NjkxNGIzZWE5OWNkNWZiYjYvdGFibGVyYW5nZTo0ZWUwY2RiZTk2MjA0ZTk2OTE0YjNlYTk5Y2Q1ZmJiNl8xLTItMS0xLTQyNzky_1b980732-663b-44fa-acc6-57e7ff050976">MED</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xL2ZyYWc6MjNlYzlhNDY1OTg4NDgyMWFkOWE4ODRmNWJiMGI2NWUvdGFibGU6NGVlMGNkYmU5NjIwNGU5NjkxNGIzZWE5OWNkNWZiYjYvdGFibGVyYW5nZTo0ZWUwY2RiZTk2MjA0ZTk2OTE0YjNlYTk5Y2Q1ZmJiNl8xLTQtMS0xLTQyNzky_080d864f-6b6c-44ec-8071-1ce2e731d494">NYSE</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus
      contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xL2ZyYWc6MjNlYzlhNDY1OTg4NDgyMWFkOWE4ODRmNWJiMGI2NWUvdGV4dHJlZ2lvbjoyM2VjOWE0NjU5ODg0ODIxYWQ5YTg4NGY1YmIwYjY1ZV8yMzE3_b05f279c-f328-4daa-9060-196cd22a3f20">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xL2ZyYWc6MjNlYzlhNDY1OTg4NDgyMWFkOWE4ODRmNWJiMGI2NWUvdGV4dHJlZ2lvbjoyM2VjOWE0NjU5ODg0ODIxYWQ5YTg4NGY1YmIwYjY1ZV8yMzE4_b2d89e4b-1a86-4e95-9f7d-118e5129d090">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xL2ZyYWc6MjNlYzlhNDY1OTg4NDgyMWFkOWE4ODRmNWJiMGI2NWUvdGFibGU6Mjk5OWY0Y2U4NDg3NDA4Yzg0NjdkNGQyYzEyYWM0NGIvdGFibGVyYW5nZToyOTk5ZjRjZTg0ODc0MDhjODQ2N2Q0ZDJjMTJhYzQ0Yl8wLTAtMS0xLTQyNzky_e3a02346-a7ea-4b5f-a285-1937e1bc669b">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xL2ZyYWc6MjNlYzlhNDY1OTg4NDgyMWFkOWE4ODRmNWJiMGI2NWUvdGFibGU6Mjk5OWY0Y2U4NDg3NDA4Yzg0NjdkNGQyYzEyYWM0NGIvdGFibGVyYW5nZToyOTk5ZjRjZTg0ODc0MDhjODQ2N2Q0ZDJjMTJhYzQ0Yl8xLTMtMS0xLTQyNzky_82a60286-5c69-4216-8105-1733f56e2c36">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xL2ZyYWc6MjNlYzlhNDY1OTg4NDgyMWFkOWE4ODRmNWJiMGI2NWUvdGFibGU6Mjk5OWY0Y2U4NDg3NDA4Yzg0NjdkNGQyYzEyYWM0NGIvdGFibGVyYW5nZToyOTk5ZjRjZTg0ODc0MDhjODQ2N2Q0ZDJjMTJhYzQ0Yl8yLTEtMS0xLTQyNzky_3b6dfb82-6d5d-4d85-b400-e01d1f1aa05d">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany
      contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xL2ZyYWc6MjNlYzlhNDY1OTg4NDgyMWFkOWE4ODRmNWJiMGI2NWUvdGV4dHJlZ2lvbjoyM2VjOWE0NjU5ODg0ODIxYWQ5YTg4NGY1YmIwYjY1ZV8yMzIw_333b23ea-009f-423a-b889-5aa7eeb55c8d">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="i7165f9e7627148d7b4334bd7c0b51707_I20221026"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xL2ZyYWc6MjNlYzlhNDY1OTg4NDgyMWFkOWE4ODRmNWJiMGI2NWUvdGV4dHJlZ2lvbjoyM2VjOWE0NjU5ODg0ODIxYWQ5YTg4NGY1YmIwYjY1ZV8yMzEw_d17a4045-8cd3-4408-ae70-26565293af3b"
      unitRef="shares">10926989</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:Revenues
      contextRef="i2f3a96a832ab4b0ca374599d1c3e9bce_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xNi9mcmFnOjZjYzAzOTMyMGFhZjRjYmQ5M2QwZTYxZTBlY2Q5NTViL3RhYmxlOjM5NWNhYWJhZDg1MzQ3NGQ5ZGI5Y2M1NTI5NzU2YTJlL3RhYmxlcmFuZ2U6Mzk1Y2FhYmFkODUzNDc0ZDlkYjljYzU1Mjk3NTZhMmVfMy0xLTEtMS00Mjc5Mg_38d99f09-9919-42b3-94f7-9f2d41f5ff49"
      unitRef="usd">390398000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i3bb5592686d74afab4f7004818fd6f9b_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xNi9mcmFnOjZjYzAzOTMyMGFhZjRjYmQ5M2QwZTYxZTBlY2Q5NTViL3RhYmxlOjM5NWNhYWJhZDg1MzQ3NGQ5ZGI5Y2M1NTI5NzU2YTJlL3RhYmxlcmFuZ2U6Mzk1Y2FhYmFkODUzNDc0ZDlkYjljYzU1Mjk3NTZhMmVfMy0zLTEtMS00Mjc5Mg_ebfb0475-f09d-4a88-bcc0-10fc818ec083"
      unitRef="usd">413395000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xNi9mcmFnOjZjYzAzOTMyMGFhZjRjYmQ5M2QwZTYxZTBlY2Q5NTViL3RhYmxlOjM5NWNhYWJhZDg1MzQ3NGQ5ZGI5Y2M1NTI5NzU2YTJlL3RhYmxlcmFuZ2U6Mzk1Y2FhYmFkODUzNDc0ZDlkYjljYzU1Mjk3NTZhMmVfMy01LTEtMS00Mjc5Mg_3b510e77-74b9-4101-b14f-5d9b0ee1a977"
      unitRef="usd">1261332000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ic431430d1ab24120b4507025a722d73a_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xNi9mcmFnOjZjYzAzOTMyMGFhZjRjYmQ5M2QwZTYxZTBlY2Q5NTViL3RhYmxlOjM5NWNhYWJhZDg1MzQ3NGQ5ZGI5Y2M1NTI5NzU2YTJlL3RhYmxlcmFuZ2U6Mzk1Y2FhYmFkODUzNDc0ZDlkYjljYzU1Mjk3NTZhMmVfMy03LTEtMS00Mjc5Mg_e8dac241-fabf-4b35-878a-2651de3655d9"
      unitRef="usd">1148253000</us-gaap:Revenues>
    <us-gaap:CostOfRevenue
      contextRef="i2f3a96a832ab4b0ca374599d1c3e9bce_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xNi9mcmFnOjZjYzAzOTMyMGFhZjRjYmQ5M2QwZTYxZTBlY2Q5NTViL3RhYmxlOjM5NWNhYWJhZDg1MzQ3NGQ5ZGI5Y2M1NTI5NzU2YTJlL3RhYmxlcmFuZ2U6Mzk1Y2FhYmFkODUzNDc0ZDlkYjljYzU1Mjk3NTZhMmVfNC0xLTEtMS00Mjc5Mg_bc7aba9d-edce-4eb0-bdf3-0f042ad62b09"
      unitRef="usd">107549000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="i3bb5592686d74afab4f7004818fd6f9b_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xNi9mcmFnOjZjYzAzOTMyMGFhZjRjYmQ5M2QwZTYxZTBlY2Q5NTViL3RhYmxlOjM5NWNhYWJhZDg1MzQ3NGQ5ZGI5Y2M1NTI5NzU2YTJlL3RhYmxlcmFuZ2U6Mzk1Y2FhYmFkODUzNDc0ZDlkYjljYzU1Mjk3NTZhMmVfNC0zLTEtMS00Mjc5Mg_c8f76e06-cd93-416b-a5de-9bcca24a98ee"
      unitRef="usd">106338000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xNi9mcmFnOjZjYzAzOTMyMGFhZjRjYmQ5M2QwZTYxZTBlY2Q5NTViL3RhYmxlOjM5NWNhYWJhZDg1MzQ3NGQ5ZGI5Y2M1NTI5NzU2YTJlL3RhYmxlcmFuZ2U6Mzk1Y2FhYmFkODUzNDc0ZDlkYjljYzU1Mjk3NTZhMmVfNC01LTEtMS00Mjc5Mg_5f398335-4177-483d-9c12-c7d77c69b52d"
      unitRef="usd">354515000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="ic431430d1ab24120b4507025a722d73a_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xNi9mcmFnOjZjYzAzOTMyMGFhZjRjYmQ5M2QwZTYxZTBlY2Q5NTViL3RhYmxlOjM5NWNhYWJhZDg1MzQ3NGQ5ZGI5Y2M1NTI5NzU2YTJlL3RhYmxlcmFuZ2U6Mzk1Y2FhYmFkODUzNDc0ZDlkYjljYzU1Mjk3NTZhMmVfNC03LTEtMS00Mjc5Mg_cb152896-80ad-49a0-8380-cb41658221d7"
      unitRef="usd">298942000</us-gaap:CostOfRevenue>
    <us-gaap:GrossProfit
      contextRef="i2f3a96a832ab4b0ca374599d1c3e9bce_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xNi9mcmFnOjZjYzAzOTMyMGFhZjRjYmQ5M2QwZTYxZTBlY2Q5NTViL3RhYmxlOjM5NWNhYWJhZDg1MzQ3NGQ5ZGI5Y2M1NTI5NzU2YTJlL3RhYmxlcmFuZ2U6Mzk1Y2FhYmFkODUzNDc0ZDlkYjljYzU1Mjk3NTZhMmVfNS0xLTEtMS00Mjc5Mg_547362ab-fe50-4c8d-b9ec-61d6d6d0be11"
      unitRef="usd">282849000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i3bb5592686d74afab4f7004818fd6f9b_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xNi9mcmFnOjZjYzAzOTMyMGFhZjRjYmQ5M2QwZTYxZTBlY2Q5NTViL3RhYmxlOjM5NWNhYWJhZDg1MzQ3NGQ5ZGI5Y2M1NTI5NzU2YTJlL3RhYmxlcmFuZ2U6Mzk1Y2FhYmFkODUzNDc0ZDlkYjljYzU1Mjk3NTZhMmVfNS0zLTEtMS00Mjc5Mg_40d1f606-5ea9-40c7-be5b-76bf91d68529"
      unitRef="usd">307057000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xNi9mcmFnOjZjYzAzOTMyMGFhZjRjYmQ5M2QwZTYxZTBlY2Q5NTViL3RhYmxlOjM5NWNhYWJhZDg1MzQ3NGQ5ZGI5Y2M1NTI5NzU2YTJlL3RhYmxlcmFuZ2U6Mzk1Y2FhYmFkODUzNDc0ZDlkYjljYzU1Mjk3NTZhMmVfNS01LTEtMS00Mjc5Mg_70895429-6ba7-4b1f-b5ad-01664e7b4373"
      unitRef="usd">906817000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="ic431430d1ab24120b4507025a722d73a_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xNi9mcmFnOjZjYzAzOTMyMGFhZjRjYmQ5M2QwZTYxZTBlY2Q5NTViL3RhYmxlOjM5NWNhYWJhZDg1MzQ3NGQ5ZGI5Y2M1NTI5NzU2YTJlL3RhYmxlcmFuZ2U6Mzk1Y2FhYmFkODUzNDc0ZDlkYjljYzU1Mjk3NTZhMmVfNS03LTEtMS00Mjc5Mg_1eb56662-c1eb-4d0c-a720-c70412db3fb2"
      unitRef="usd">849311000</us-gaap:GrossProfit>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i2f3a96a832ab4b0ca374599d1c3e9bce_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xNi9mcmFnOjZjYzAzOTMyMGFhZjRjYmQ5M2QwZTYxZTBlY2Q5NTViL3RhYmxlOjM5NWNhYWJhZDg1MzQ3NGQ5ZGI5Y2M1NTI5NzU2YTJlL3RhYmxlcmFuZ2U6Mzk1Y2FhYmFkODUzNDc0ZDlkYjljYzU1Mjk3NTZhMmVfNy0xLTEtMS00Mjc5Mg_9ae7a2d0-7896-408f-b623-04bd21e6515d"
      unitRef="usd">234693000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i3bb5592686d74afab4f7004818fd6f9b_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xNi9mcmFnOjZjYzAzOTMyMGFhZjRjYmQ5M2QwZTYxZTBlY2Q5NTViL3RhYmxlOjM5NWNhYWJhZDg1MzQ3NGQ5ZGI5Y2M1NTI5NzU2YTJlL3RhYmxlcmFuZ2U6Mzk1Y2FhYmFkODUzNDc0ZDlkYjljYzU1Mjk3NTZhMmVfNy0zLTEtMS00Mjc5Mg_55fa7b2a-81fd-4386-91f6-9c2374bec3de"
      unitRef="usd">251886000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xNi9mcmFnOjZjYzAzOTMyMGFhZjRjYmQ5M2QwZTYxZTBlY2Q5NTViL3RhYmxlOjM5NWNhYWJhZDg1MzQ3NGQ5ZGI5Y2M1NTI5NzU2YTJlL3RhYmxlcmFuZ2U6Mzk1Y2FhYmFkODUzNDc0ZDlkYjljYzU1Mjk3NTZhMmVfNy01LTEtMS00Mjc5Mg_dd1503ef-1e50-4d0b-9123-fadcdef0236b"
      unitRef="usd">754610000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="ic431430d1ab24120b4507025a722d73a_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xNi9mcmFnOjZjYzAzOTMyMGFhZjRjYmQ5M2QwZTYxZTBlY2Q5NTViL3RhYmxlOjM5NWNhYWJhZDg1MzQ3NGQ5ZGI5Y2M1NTI5NzU2YTJlL3RhYmxlcmFuZ2U6Mzk1Y2FhYmFkODUzNDc0ZDlkYjljYzU1Mjk3NTZhMmVfNy03LTEtMS00Mjc5Mg_a5a27ef7-f500-481d-ac45-d10860eb4981"
      unitRef="usd">679907000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:OperatingIncomeLoss
      contextRef="i2f3a96a832ab4b0ca374599d1c3e9bce_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xNi9mcmFnOjZjYzAzOTMyMGFhZjRjYmQ5M2QwZTYxZTBlY2Q5NTViL3RhYmxlOjM5NWNhYWJhZDg1MzQ3NGQ5ZGI5Y2M1NTI5NzU2YTJlL3RhYmxlcmFuZ2U6Mzk1Y2FhYmFkODUzNDc0ZDlkYjljYzU1Mjk3NTZhMmVfOS0xLTEtMS00Mjc5Mg_41174499-04fe-482c-bb13-de35c598ad61"
      unitRef="usd">48156000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i3bb5592686d74afab4f7004818fd6f9b_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xNi9mcmFnOjZjYzAzOTMyMGFhZjRjYmQ5M2QwZTYxZTBlY2Q5NTViL3RhYmxlOjM5NWNhYWJhZDg1MzQ3NGQ5ZGI5Y2M1NTI5NzU2YTJlL3RhYmxlcmFuZ2U6Mzk1Y2FhYmFkODUzNDc0ZDlkYjljYzU1Mjk3NTZhMmVfOS0zLTEtMS00Mjc5Mg_4a189f56-c8fa-40d8-acf0-29455ba112bc"
      unitRef="usd">55171000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xNi9mcmFnOjZjYzAzOTMyMGFhZjRjYmQ5M2QwZTYxZTBlY2Q5NTViL3RhYmxlOjM5NWNhYWJhZDg1MzQ3NGQ5ZGI5Y2M1NTI5NzU2YTJlL3RhYmxlcmFuZ2U6Mzk1Y2FhYmFkODUzNDc0ZDlkYjljYzU1Mjk3NTZhMmVfOS01LTEtMS00Mjc5Mg_f72758a3-7e23-4c9b-b0cf-5e09161db4da"
      unitRef="usd">152207000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ic431430d1ab24120b4507025a722d73a_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xNi9mcmFnOjZjYzAzOTMyMGFhZjRjYmQ5M2QwZTYxZTBlY2Q5NTViL3RhYmxlOjM5NWNhYWJhZDg1MzQ3NGQ5ZGI5Y2M1NTI5NzU2YTJlL3RhYmxlcmFuZ2U6Mzk1Y2FhYmFkODUzNDc0ZDlkYjljYzU1Mjk3NTZhMmVfOS03LTEtMS00Mjc5Mg_140669f1-2f84-410e-88b7-71adbc08ae97"
      unitRef="usd">169404000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestIncomeExpenseNonoperatingNet
      contextRef="i2f3a96a832ab4b0ca374599d1c3e9bce_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xNi9mcmFnOjZjYzAzOTMyMGFhZjRjYmQ5M2QwZTYxZTBlY2Q5NTViL3RhYmxlOjM5NWNhYWJhZDg1MzQ3NGQ5ZGI5Y2M1NTI5NzU2YTJlL3RhYmxlcmFuZ2U6Mzk1Y2FhYmFkODUzNDc0ZDlkYjljYzU1Mjk3NTZhMmVfMTItMS0xLTEtNDI3OTI_88fdb537-99fb-4ead-9950-f8c98b13d954"
      unitRef="usd">-261000</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:InterestIncomeExpenseNonoperatingNet
      contextRef="i3bb5592686d74afab4f7004818fd6f9b_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xNi9mcmFnOjZjYzAzOTMyMGFhZjRjYmQ5M2QwZTYxZTBlY2Q5NTViL3RhYmxlOjM5NWNhYWJhZDg1MzQ3NGQ5ZGI5Y2M1NTI5NzU2YTJlL3RhYmxlcmFuZ2U6Mzk1Y2FhYmFkODUzNDc0ZDlkYjljYzU1Mjk3NTZhMmVfMTItMy0xLTEtNDI3OTI_df3f366f-fcb6-4268-8b33-0bd0cb97ca9e"
      unitRef="usd">-94000</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:InterestIncomeExpenseNonoperatingNet
      contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xNi9mcmFnOjZjYzAzOTMyMGFhZjRjYmQ5M2QwZTYxZTBlY2Q5NTViL3RhYmxlOjM5NWNhYWJhZDg1MzQ3NGQ5ZGI5Y2M1NTI5NzU2YTJlL3RhYmxlcmFuZ2U6Mzk1Y2FhYmFkODUzNDc0ZDlkYjljYzU1Mjk3NTZhMmVfMTItNS0xLTEtNDI3OTI_7c514816-ae6d-4594-ba8c-bd82b0a295c9"
      unitRef="usd">-519000</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:InterestIncomeExpenseNonoperatingNet
      contextRef="ic431430d1ab24120b4507025a722d73a_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xNi9mcmFnOjZjYzAzOTMyMGFhZjRjYmQ5M2QwZTYxZTBlY2Q5NTViL3RhYmxlOjM5NWNhYWJhZDg1MzQ3NGQ5ZGI5Y2M1NTI5NzU2YTJlL3RhYmxlcmFuZ2U6Mzk1Y2FhYmFkODUzNDc0ZDlkYjljYzU1Mjk3NTZhMmVfMTItNy0xLTEtNDI3OTI_f3583b37-de98-4f34-aa78-3d6c4ff77bd1"
      unitRef="usd">-138000</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i2f3a96a832ab4b0ca374599d1c3e9bce_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xNi9mcmFnOjZjYzAzOTMyMGFhZjRjYmQ5M2QwZTYxZTBlY2Q5NTViL3RhYmxlOjM5NWNhYWJhZDg1MzQ3NGQ5ZGI5Y2M1NTI5NzU2YTJlL3RhYmxlcmFuZ2U6Mzk1Y2FhYmFkODUzNDc0ZDlkYjljYzU1Mjk3NTZhMmVfMTMtMS0xLTEtNDI3OTI_de7fc987-c7d5-465f-86b6-d1b246c7d425"
      unitRef="usd">-17000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i3bb5592686d74afab4f7004818fd6f9b_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xNi9mcmFnOjZjYzAzOTMyMGFhZjRjYmQ5M2QwZTYxZTBlY2Q5NTViL3RhYmxlOjM5NWNhYWJhZDg1MzQ3NGQ5ZGI5Y2M1NTI5NzU2YTJlL3RhYmxlcmFuZ2U6Mzk1Y2FhYmFkODUzNDc0ZDlkYjljYzU1Mjk3NTZhMmVfMTMtMy0xLTEtNDI3OTI_4fbf4db5-3b8d-4e83-aefc-e7c39eefa2e5"
      unitRef="usd">115000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xNi9mcmFnOjZjYzAzOTMyMGFhZjRjYmQ5M2QwZTYxZTBlY2Q5NTViL3RhYmxlOjM5NWNhYWJhZDg1MzQ3NGQ5ZGI5Y2M1NTI5NzU2YTJlL3RhYmxlcmFuZ2U6Mzk1Y2FhYmFkODUzNDc0ZDlkYjljYzU1Mjk3NTZhMmVfMTMtNS0xLTEtNDI3OTI_ac952459-53ce-4250-8612-3bcba4a72c7c"
      unitRef="usd">-37000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="ic431430d1ab24120b4507025a722d73a_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xNi9mcmFnOjZjYzAzOTMyMGFhZjRjYmQ5M2QwZTYxZTBlY2Q5NTViL3RhYmxlOjM5NWNhYWJhZDg1MzQ3NGQ5ZGI5Y2M1NTI5NzU2YTJlL3RhYmxlcmFuZ2U6Mzk1Y2FhYmFkODUzNDc0ZDlkYjljYzU1Mjk3NTZhMmVfMTMtNy0xLTEtNDI3OTI_cc597800-677b-436e-8643-90ea5f106b95"
      unitRef="usd">112000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i2f3a96a832ab4b0ca374599d1c3e9bce_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xNi9mcmFnOjZjYzAzOTMyMGFhZjRjYmQ5M2QwZTYxZTBlY2Q5NTViL3RhYmxlOjM5NWNhYWJhZDg1MzQ3NGQ5ZGI5Y2M1NTI5NzU2YTJlL3RhYmxlcmFuZ2U6Mzk1Y2FhYmFkODUzNDc0ZDlkYjljYzU1Mjk3NTZhMmVfMTQtMS0xLTEtNDI3OTI_81b1d080-8ef5-451c-84a8-484d69d055c1"
      unitRef="usd">-278000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i3bb5592686d74afab4f7004818fd6f9b_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xNi9mcmFnOjZjYzAzOTMyMGFhZjRjYmQ5M2QwZTYxZTBlY2Q5NTViL3RhYmxlOjM5NWNhYWJhZDg1MzQ3NGQ5ZGI5Y2M1NTI5NzU2YTJlL3RhYmxlcmFuZ2U6Mzk1Y2FhYmFkODUzNDc0ZDlkYjljYzU1Mjk3NTZhMmVfMTQtMy0xLTEtNDI3OTI_0f64cb07-6a09-45f7-8ff4-53965f5c4618"
      unitRef="usd">21000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xNi9mcmFnOjZjYzAzOTMyMGFhZjRjYmQ5M2QwZTYxZTBlY2Q5NTViL3RhYmxlOjM5NWNhYWJhZDg1MzQ3NGQ5ZGI5Y2M1NTI5NzU2YTJlL3RhYmxlcmFuZ2U6Mzk1Y2FhYmFkODUzNDc0ZDlkYjljYzU1Mjk3NTZhMmVfMTQtNS0xLTEtNDI3OTI_0f3fa899-ba1b-494f-a6be-4deee977da63"
      unitRef="usd">-556000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="ic431430d1ab24120b4507025a722d73a_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xNi9mcmFnOjZjYzAzOTMyMGFhZjRjYmQ5M2QwZTYxZTBlY2Q5NTViL3RhYmxlOjM5NWNhYWJhZDg1MzQ3NGQ5ZGI5Y2M1NTI5NzU2YTJlL3RhYmxlcmFuZ2U6Mzk1Y2FhYmFkODUzNDc0ZDlkYjljYzU1Mjk3NTZhMmVfMTQtNy0xLTEtNDI3OTI_7e7ff5e7-03d9-4504-b377-97656f632ef8"
      unitRef="usd">-26000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i2f3a96a832ab4b0ca374599d1c3e9bce_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xNi9mcmFnOjZjYzAzOTMyMGFhZjRjYmQ5M2QwZTYxZTBlY2Q5NTViL3RhYmxlOjM5NWNhYWJhZDg1MzQ3NGQ5ZGI5Y2M1NTI5NzU2YTJlL3RhYmxlcmFuZ2U6Mzk1Y2FhYmFkODUzNDc0ZDlkYjljYzU1Mjk3NTZhMmVfMTYtMS0xLTEtNDI3OTI_238b6f9e-9726-4039-ae6d-0399d8082f9f"
      unitRef="usd">47878000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i3bb5592686d74afab4f7004818fd6f9b_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xNi9mcmFnOjZjYzAzOTMyMGFhZjRjYmQ5M2QwZTYxZTBlY2Q5NTViL3RhYmxlOjM5NWNhYWJhZDg1MzQ3NGQ5ZGI5Y2M1NTI5NzU2YTJlL3RhYmxlcmFuZ2U6Mzk1Y2FhYmFkODUzNDc0ZDlkYjljYzU1Mjk3NTZhMmVfMTYtMy0xLTEtNDI3OTI_5c750045-2afc-4278-9c58-8d2eec871d3b"
      unitRef="usd">55192000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xNi9mcmFnOjZjYzAzOTMyMGFhZjRjYmQ5M2QwZTYxZTBlY2Q5NTViL3RhYmxlOjM5NWNhYWJhZDg1MzQ3NGQ5ZGI5Y2M1NTI5NzU2YTJlL3RhYmxlcmFuZ2U6Mzk1Y2FhYmFkODUzNDc0ZDlkYjljYzU1Mjk3NTZhMmVfMTYtNS0xLTEtNDI3OTI_0cca4fd9-54e7-4c8d-91ff-5fc428281faf"
      unitRef="usd">151651000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ic431430d1ab24120b4507025a722d73a_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xNi9mcmFnOjZjYzAzOTMyMGFhZjRjYmQ5M2QwZTYxZTBlY2Q5NTViL3RhYmxlOjM5NWNhYWJhZDg1MzQ3NGQ5ZGI5Y2M1NTI5NzU2YTJlL3RhYmxlcmFuZ2U6Mzk1Y2FhYmFkODUzNDc0ZDlkYjljYzU1Mjk3NTZhMmVfMTYtNy0xLTEtNDI3OTI_0353e287-e4f0-4db2-91fe-8533f1642ba0"
      unitRef="usd">169378000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i2f3a96a832ab4b0ca374599d1c3e9bce_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xNi9mcmFnOjZjYzAzOTMyMGFhZjRjYmQ5M2QwZTYxZTBlY2Q5NTViL3RhYmxlOjM5NWNhYWJhZDg1MzQ3NGQ5ZGI5Y2M1NTI5NzU2YTJlL3RhYmxlcmFuZ2U6Mzk1Y2FhYmFkODUzNDc0ZDlkYjljYzU1Mjk3NTZhMmVfMTgtMS0xLTEtNDI3OTI_37333495-cab2-4095-b2fb-99e8afb13582"
      unitRef="usd">11723000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i3bb5592686d74afab4f7004818fd6f9b_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xNi9mcmFnOjZjYzAzOTMyMGFhZjRjYmQ5M2QwZTYxZTBlY2Q5NTViL3RhYmxlOjM5NWNhYWJhZDg1MzQ3NGQ5ZGI5Y2M1NTI5NzU2YTJlL3RhYmxlcmFuZ2U6Mzk1Y2FhYmFkODUzNDc0ZDlkYjljYzU1Mjk3NTZhMmVfMTgtMy0xLTEtNDI3OTI_b3551f54-2735-470a-bf94-38b0e31efbe4"
      unitRef="usd">13210000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xNi9mcmFnOjZjYzAzOTMyMGFhZjRjYmQ5M2QwZTYxZTBlY2Q5NTViL3RhYmxlOjM5NWNhYWJhZDg1MzQ3NGQ5ZGI5Y2M1NTI5NzU2YTJlL3RhYmxlcmFuZ2U6Mzk1Y2FhYmFkODUzNDc0ZDlkYjljYzU1Mjk3NTZhMmVfMTgtNS0xLTEtNDI3OTI_e3c0507a-be8a-4091-a798-e54568896850"
      unitRef="usd">34601000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ic431430d1ab24120b4507025a722d73a_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xNi9mcmFnOjZjYzAzOTMyMGFhZjRjYmQ5M2QwZTYxZTBlY2Q5NTViL3RhYmxlOjM5NWNhYWJhZDg1MzQ3NGQ5ZGI5Y2M1NTI5NzU2YTJlL3RhYmxlcmFuZ2U6Mzk1Y2FhYmFkODUzNDc0ZDlkYjljYzU1Mjk3NTZhMmVfMTgtNy0xLTEtNDI3OTI_e8972e8c-46ec-4446-897a-6b2490812549"
      unitRef="usd">39370000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss
      contextRef="i2f3a96a832ab4b0ca374599d1c3e9bce_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xNi9mcmFnOjZjYzAzOTMyMGFhZjRjYmQ5M2QwZTYxZTBlY2Q5NTViL3RhYmxlOjM5NWNhYWJhZDg1MzQ3NGQ5ZGI5Y2M1NTI5NzU2YTJlL3RhYmxlcmFuZ2U6Mzk1Y2FhYmFkODUzNDc0ZDlkYjljYzU1Mjk3NTZhMmVfMjAtMS0xLTEtNDI3OTI_a8dda91d-2175-496c-9f08-a26d7da54d28"
      unitRef="usd">36155000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i3bb5592686d74afab4f7004818fd6f9b_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xNi9mcmFnOjZjYzAzOTMyMGFhZjRjYmQ5M2QwZTYxZTBlY2Q5NTViL3RhYmxlOjM5NWNhYWJhZDg1MzQ3NGQ5ZGI5Y2M1NTI5NzU2YTJlL3RhYmxlcmFuZ2U6Mzk1Y2FhYmFkODUzNDc0ZDlkYjljYzU1Mjk3NTZhMmVfMjAtMy0xLTEtNDI3OTI_1debcfff-fbe8-498c-aa9f-09b9030d2bca"
      unitRef="usd">41982000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xNi9mcmFnOjZjYzAzOTMyMGFhZjRjYmQ5M2QwZTYxZTBlY2Q5NTViL3RhYmxlOjM5NWNhYWJhZDg1MzQ3NGQ5ZGI5Y2M1NTI5NzU2YTJlL3RhYmxlcmFuZ2U6Mzk1Y2FhYmFkODUzNDc0ZDlkYjljYzU1Mjk3NTZhMmVfMjAtNS0xLTEtNDI3OTI_80832123-86c4-453b-95cf-1adedabcc4d8"
      unitRef="usd">117050000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ic431430d1ab24120b4507025a722d73a_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xNi9mcmFnOjZjYzAzOTMyMGFhZjRjYmQ5M2QwZTYxZTBlY2Q5NTViL3RhYmxlOjM5NWNhYWJhZDg1MzQ3NGQ5ZGI5Y2M1NTI5NzU2YTJlL3RhYmxlcmFuZ2U6Mzk1Y2FhYmFkODUzNDc0ZDlkYjljYzU1Mjk3NTZhMmVfMjAtNy0xLTEtNDI3OTI_613b68c5-10ac-4dab-8b25-62d4a8bef4e3"
      unitRef="usd">130008000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="i2f3a96a832ab4b0ca374599d1c3e9bce_D20220701-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xNi9mcmFnOjZjYzAzOTMyMGFhZjRjYmQ5M2QwZTYxZTBlY2Q5NTViL3RhYmxlOjM5NWNhYWJhZDg1MzQ3NGQ5ZGI5Y2M1NTI5NzU2YTJlL3RhYmxlcmFuZ2U6Mzk1Y2FhYmFkODUzNDc0ZDlkYjljYzU1Mjk3NTZhMmVfMjItMS0xLTEtNDI3OTI_f779a94b-ce2b-4784-a0d9-d8551bea32dc"
      unitRef="usdPerShare">3.30</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i3bb5592686d74afab4f7004818fd6f9b_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xNi9mcmFnOjZjYzAzOTMyMGFhZjRjYmQ5M2QwZTYxZTBlY2Q5NTViL3RhYmxlOjM5NWNhYWJhZDg1MzQ3NGQ5ZGI5Y2M1NTI5NzU2YTJlL3RhYmxlcmFuZ2U6Mzk1Y2FhYmFkODUzNDc0ZDlkYjljYzU1Mjk3NTZhMmVfMjItMy0xLTEtNDI3OTI_a680f3d5-ff6b-4e4d-ad85-e6aaa347b2f8"
      unitRef="usdPerShare">3.59</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xNi9mcmFnOjZjYzAzOTMyMGFhZjRjYmQ5M2QwZTYxZTBlY2Q5NTViL3RhYmxlOjM5NWNhYWJhZDg1MzQ3NGQ5ZGI5Y2M1NTI5NzU2YTJlL3RhYmxlcmFuZ2U6Mzk1Y2FhYmFkODUzNDc0ZDlkYjljYzU1Mjk3NTZhMmVfMjItNS0xLTEtNDI3OTI_0beb3564-2177-493c-8520-7781c4d83775"
      unitRef="usdPerShare">10.37</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="ic431430d1ab24120b4507025a722d73a_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xNi9mcmFnOjZjYzAzOTMyMGFhZjRjYmQ5M2QwZTYxZTBlY2Q5NTViL3RhYmxlOjM5NWNhYWJhZDg1MzQ3NGQ5ZGI5Y2M1NTI5NzU2YTJlL3RhYmxlcmFuZ2U6Mzk1Y2FhYmFkODUzNDc0ZDlkYjljYzU1Mjk3NTZhMmVfMjItNy0xLTEtNDI3OTI_e7ffab24-513c-49a0-a6e3-3c22d450c7fb"
      unitRef="usdPerShare">11.07</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i2f3a96a832ab4b0ca374599d1c3e9bce_D20220701-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xNi9mcmFnOjZjYzAzOTMyMGFhZjRjYmQ5M2QwZTYxZTBlY2Q5NTViL3RhYmxlOjM5NWNhYWJhZDg1MzQ3NGQ5ZGI5Y2M1NTI5NzU2YTJlL3RhYmxlcmFuZ2U6Mzk1Y2FhYmFkODUzNDc0ZDlkYjljYzU1Mjk3NTZhMmVfMjQtMS0xLTEtNDI3OTI_284aa335-cd1c-4a90-abba-cb4db81aece0"
      unitRef="usdPerShare">3.27</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i3bb5592686d74afab4f7004818fd6f9b_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xNi9mcmFnOjZjYzAzOTMyMGFhZjRjYmQ5M2QwZTYxZTBlY2Q5NTViL3RhYmxlOjM5NWNhYWJhZDg1MzQ3NGQ5ZGI5Y2M1NTI5NzU2YTJlL3RhYmxlcmFuZ2U6Mzk1Y2FhYmFkODUzNDc0ZDlkYjljYzU1Mjk3NTZhMmVfMjQtMy0xLTEtNDI3OTI_7630d1ab-db8c-48a4-a4d8-71d495566801"
      unitRef="usdPerShare">3.56</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xNi9mcmFnOjZjYzAzOTMyMGFhZjRjYmQ5M2QwZTYxZTBlY2Q5NTViL3RhYmxlOjM5NWNhYWJhZDg1MzQ3NGQ5ZGI5Y2M1NTI5NzU2YTJlL3RhYmxlcmFuZ2U6Mzk1Y2FhYmFkODUzNDc0ZDlkYjljYzU1Mjk3NTZhMmVfMjQtNS0xLTEtNDI3OTI_6fdcb574-4b2b-41bd-8740-30541ba9e5ad"
      unitRef="usdPerShare">10.30</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ic431430d1ab24120b4507025a722d73a_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xNi9mcmFnOjZjYzAzOTMyMGFhZjRjYmQ5M2QwZTYxZTBlY2Q5NTViL3RhYmxlOjM5NWNhYWJhZDg1MzQ3NGQ5ZGI5Y2M1NTI5NzU2YTJlL3RhYmxlcmFuZ2U6Mzk1Y2FhYmFkODUzNDc0ZDlkYjljYzU1Mjk3NTZhMmVfMjQtNy0xLTEtNDI3OTI_83e55467-43c8-4ea0-b605-65fbbc041180"
      unitRef="usdPerShare">10.98</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i2f3a96a832ab4b0ca374599d1c3e9bce_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xNi9mcmFnOjZjYzAzOTMyMGFhZjRjYmQ5M2QwZTYxZTBlY2Q5NTViL3RhYmxlOjM5NWNhYWJhZDg1MzQ3NGQ5ZGI5Y2M1NTI5NzU2YTJlL3RhYmxlcmFuZ2U6Mzk1Y2FhYmFkODUzNDc0ZDlkYjljYzU1Mjk3NTZhMmVfMjctMS0xLTEtNDI3OTI_f898d3ca-f97f-4e85-983a-deb6e6fd412c"
      unitRef="shares">10964000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i3bb5592686d74afab4f7004818fd6f9b_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xNi9mcmFnOjZjYzAzOTMyMGFhZjRjYmQ5M2QwZTYxZTBlY2Q5NTViL3RhYmxlOjM5NWNhYWJhZDg1MzQ3NGQ5ZGI5Y2M1NTI5NzU2YTJlL3RhYmxlcmFuZ2U6Mzk1Y2FhYmFkODUzNDc0ZDlkYjljYzU1Mjk3NTZhMmVfMjctMy0xLTEtNDI3OTI_4a9b94b8-a6e9-4989-b54c-3efaffe200c8"
      unitRef="shares">11692000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xNi9mcmFnOjZjYzAzOTMyMGFhZjRjYmQ5M2QwZTYxZTBlY2Q5NTViL3RhYmxlOjM5NWNhYWJhZDg1MzQ3NGQ5ZGI5Y2M1NTI5NzU2YTJlL3RhYmxlcmFuZ2U6Mzk1Y2FhYmFkODUzNDc0ZDlkYjljYzU1Mjk3NTZhMmVfMjctNS0xLTEtNDI3OTI_5b0062bc-29de-40ee-8380-519244f7cbfc"
      unitRef="shares">11290000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ic431430d1ab24120b4507025a722d73a_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xNi9mcmFnOjZjYzAzOTMyMGFhZjRjYmQ5M2QwZTYxZTBlY2Q5NTViL3RhYmxlOjM5NWNhYWJhZDg1MzQ3NGQ5ZGI5Y2M1NTI5NzU2YTJlL3RhYmxlcmFuZ2U6Mzk1Y2FhYmFkODUzNDc0ZDlkYjljYzU1Mjk3NTZhMmVfMjctNy0xLTEtNDI3OTI_53a9fe20-f7b4-440a-932c-59fe5edf5cf4"
      unitRef="shares">11739000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i2f3a96a832ab4b0ca374599d1c3e9bce_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xNi9mcmFnOjZjYzAzOTMyMGFhZjRjYmQ5M2QwZTYxZTBlY2Q5NTViL3RhYmxlOjM5NWNhYWJhZDg1MzQ3NGQ5ZGI5Y2M1NTI5NzU2YTJlL3RhYmxlcmFuZ2U6Mzk1Y2FhYmFkODUzNDc0ZDlkYjljYzU1Mjk3NTZhMmVfMjgtMS0xLTEtNDI3OTI_84cb14e3-f772-485f-8732-41831c32018f"
      unitRef="shares">11042000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i3bb5592686d74afab4f7004818fd6f9b_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xNi9mcmFnOjZjYzAzOTMyMGFhZjRjYmQ5M2QwZTYxZTBlY2Q5NTViL3RhYmxlOjM5NWNhYWJhZDg1MzQ3NGQ5ZGI5Y2M1NTI5NzU2YTJlL3RhYmxlcmFuZ2U6Mzk1Y2FhYmFkODUzNDc0ZDlkYjljYzU1Mjk3NTZhMmVfMjgtMy0xLTEtNDI3OTI_2aff0e75-9228-4ea3-9954-217c28edb259"
      unitRef="shares">11785000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xNi9mcmFnOjZjYzAzOTMyMGFhZjRjYmQ5M2QwZTYxZTBlY2Q5NTViL3RhYmxlOjM5NWNhYWJhZDg1MzQ3NGQ5ZGI5Y2M1NTI5NzU2YTJlL3RhYmxlcmFuZ2U6Mzk1Y2FhYmFkODUzNDc0ZDlkYjljYzU1Mjk3NTZhMmVfMjgtNS0xLTEtNDI3OTI_29f83474-b0d0-4714-87bc-f322e657534f"
      unitRef="shares">11369000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ic431430d1ab24120b4507025a722d73a_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xNi9mcmFnOjZjYzAzOTMyMGFhZjRjYmQ5M2QwZTYxZTBlY2Q5NTViL3RhYmxlOjM5NWNhYWJhZDg1MzQ3NGQ5ZGI5Y2M1NTI5NzU2YTJlL3RhYmxlcmFuZ2U6Mzk1Y2FhYmFkODUzNDc0ZDlkYjljYzU1Mjk3NTZhMmVfMjgtNy0xLTEtNDI3OTI_86928965-7a7c-43de-8636-bee6945313b6"
      unitRef="shares">11840000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i2f3a96a832ab4b0ca374599d1c3e9bce_D20220701-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xNi9mcmFnOjZjYzAzOTMyMGFhZjRjYmQ5M2QwZTYxZTBlY2Q5NTViL3RhYmxlOjM5NWNhYWJhZDg1MzQ3NGQ5ZGI5Y2M1NTI5NzU2YTJlL3RhYmxlcmFuZ2U6Mzk1Y2FhYmFkODUzNDc0ZDlkYjljYzU1Mjk3NTZhMmVfMzAtMS0xLTEtNDI3OTI_0f6f5ae2-516b-44ae-8a62-74073969d4c9"
      unitRef="usdPerShare">1.64</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i3bb5592686d74afab4f7004818fd6f9b_D20210701-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xNi9mcmFnOjZjYzAzOTMyMGFhZjRjYmQ5M2QwZTYxZTBlY2Q5NTViL3RhYmxlOjM5NWNhYWJhZDg1MzQ3NGQ5ZGI5Y2M1NTI5NzU2YTJlL3RhYmxlcmFuZ2U6Mzk1Y2FhYmFkODUzNDc0ZDlkYjljYzU1Mjk3NTZhMmVfMzAtMy0xLTEtNDI3OTI_04efb8ad-6d52-478e-87e8-cf3cd9030819"
      unitRef="usdPerShare">1.42</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xNi9mcmFnOjZjYzAzOTMyMGFhZjRjYmQ5M2QwZTYxZTBlY2Q5NTViL3RhYmxlOjM5NWNhYWJhZDg1MzQ3NGQ5ZGI5Y2M1NTI5NzU2YTJlL3RhYmxlcmFuZ2U6Mzk1Y2FhYmFkODUzNDc0ZDlkYjljYzU1Mjk3NTZhMmVfMzAtNS0xLTEtNDI3OTI_2c70e941-3712-4174-9737-b54556c0cca2"
      unitRef="usdPerShare">4.92</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="ic431430d1ab24120b4507025a722d73a_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xNi9mcmFnOjZjYzAzOTMyMGFhZjRjYmQ5M2QwZTYxZTBlY2Q5NTViL3RhYmxlOjM5NWNhYWJhZDg1MzQ3NGQ5ZGI5Y2M1NTI5NzU2YTJlL3RhYmxlcmFuZ2U6Mzk1Y2FhYmFkODUzNDc0ZDlkYjljYzU1Mjk3NTZhMmVfMzAtNy0xLTEtNDI3OTI_66d402ed-c5a7-4621-a509-ebecb27e1b85"
      unitRef="usdPerShare">4.26</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:NetIncomeLoss
      contextRef="i2f3a96a832ab4b0ca374599d1c3e9bce_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xOS9mcmFnOjBhMzgwODEwMmVmMjQxNjFhNjQxNDgwMjQ5MGRjZjNlL3RhYmxlOjI4M2VkZmNkZjU3MjQxNjU5ODA3MGMxNWQ3NmVkMmYxL3RhYmxlcmFuZ2U6MjgzZWRmY2RmNTcyNDE2NTk4MDcwYzE1ZDc2ZWQyZjFfMy0xLTEtMS00Mjc5Mg_3951fec1-2c4e-4289-882e-e623ae4bde4d"
      unitRef="usd">36155000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i3bb5592686d74afab4f7004818fd6f9b_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xOS9mcmFnOjBhMzgwODEwMmVmMjQxNjFhNjQxNDgwMjQ5MGRjZjNlL3RhYmxlOjI4M2VkZmNkZjU3MjQxNjU5ODA3MGMxNWQ3NmVkMmYxL3RhYmxlcmFuZ2U6MjgzZWRmY2RmNTcyNDE2NTk4MDcwYzE1ZDc2ZWQyZjFfMy0zLTEtMS00Mjc5Mg_5c8c19ea-df2f-4e1b-8744-b891f6d1fa4b"
      unitRef="usd">41982000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xOS9mcmFnOjBhMzgwODEwMmVmMjQxNjFhNjQxNDgwMjQ5MGRjZjNlL3RhYmxlOjI4M2VkZmNkZjU3MjQxNjU5ODA3MGMxNWQ3NmVkMmYxL3RhYmxlcmFuZ2U6MjgzZWRmY2RmNTcyNDE2NTk4MDcwYzE1ZDc2ZWQyZjFfMy01LTEtMS00Mjc5Mg_5f2d8789-0c10-4075-aaaa-ee3bc16ad713"
      unitRef="usd">117050000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ic431430d1ab24120b4507025a722d73a_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xOS9mcmFnOjBhMzgwODEwMmVmMjQxNjFhNjQxNDgwMjQ5MGRjZjNlL3RhYmxlOjI4M2VkZmNkZjU3MjQxNjU5ODA3MGMxNWQ3NmVkMmYxL3RhYmxlcmFuZ2U6MjgzZWRmY2RmNTcyNDE2NTk4MDcwYzE1ZDc2ZWQyZjFfMy03LTEtMS00Mjc5Mg_98041895-14f6-4055-8e4f-47c4b383463b"
      unitRef="usd">130008000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i2f3a96a832ab4b0ca374599d1c3e9bce_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xOS9mcmFnOjBhMzgwODEwMmVmMjQxNjFhNjQxNDgwMjQ5MGRjZjNlL3RhYmxlOjI4M2VkZmNkZjU3MjQxNjU5ODA3MGMxNWQ3NmVkMmYxL3RhYmxlcmFuZ2U6MjgzZWRmY2RmNTcyNDE2NTk4MDcwYzE1ZDc2ZWQyZjFfNi0xLTEtMS00Mjc5Mg_5d036f59-ec23-4879-845c-44d898833a14"
      unitRef="usd">123000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i3bb5592686d74afab4f7004818fd6f9b_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xOS9mcmFnOjBhMzgwODEwMmVmMjQxNjFhNjQxNDgwMjQ5MGRjZjNlL3RhYmxlOjI4M2VkZmNkZjU3MjQxNjU5ODA3MGMxNWQ3NmVkMmYxL3RhYmxlcmFuZ2U6MjgzZWRmY2RmNTcyNDE2NTk4MDcwYzE1ZDc2ZWQyZjFfNi0zLTEtMS00Mjc5Mg_0a6dcb24-c766-4b67-92d2-7ee1d6712bf3"
      unitRef="usd">63000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xOS9mcmFnOjBhMzgwODEwMmVmMjQxNjFhNjQxNDgwMjQ5MGRjZjNlL3RhYmxlOjI4M2VkZmNkZjU3MjQxNjU5ODA3MGMxNWQ3NmVkMmYxL3RhYmxlcmFuZ2U6MjgzZWRmY2RmNTcyNDE2NTk4MDcwYzE1ZDc2ZWQyZjFfNi01LTEtMS00Mjc5Mg_191eae13-0cb9-4d34-8995-2278cf0e9684"
      unitRef="usd">300000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="ic431430d1ab24120b4507025a722d73a_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xOS9mcmFnOjBhMzgwODEwMmVmMjQxNjFhNjQxNDgwMjQ5MGRjZjNlL3RhYmxlOjI4M2VkZmNkZjU3MjQxNjU5ODA3MGMxNWQ3NmVkMmYxL3RhYmxlcmFuZ2U6MjgzZWRmY2RmNTcyNDE2NTk4MDcwYzE1ZDc2ZWQyZjFfNi03LTEtMS00Mjc5Mg_8f9a1971-ab4c-413a-8ae2-8dd2628f3e2b"
      unitRef="usd">130000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i2f3a96a832ab4b0ca374599d1c3e9bce_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xOS9mcmFnOjBhMzgwODEwMmVmMjQxNjFhNjQxNDgwMjQ5MGRjZjNlL3RhYmxlOjI4M2VkZmNkZjU3MjQxNjU5ODA3MGMxNWQ3NmVkMmYxL3RhYmxlcmFuZ2U6MjgzZWRmY2RmNTcyNDE2NTk4MDcwYzE1ZDc2ZWQyZjFfNy0xLTEtMS00Mjc5Mg_9c99dbcc-d625-4489-bcff-8a0956ab483b"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i3bb5592686d74afab4f7004818fd6f9b_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xOS9mcmFnOjBhMzgwODEwMmVmMjQxNjFhNjQxNDgwMjQ5MGRjZjNlL3RhYmxlOjI4M2VkZmNkZjU3MjQxNjU5ODA3MGMxNWQ3NmVkMmYxL3RhYmxlcmFuZ2U6MjgzZWRmY2RmNTcyNDE2NTk4MDcwYzE1ZDc2ZWQyZjFfNy0zLTEtMS00Mjc5Mg_7e4a5d2e-6264-46ee-b8a0-5cfb41e918da"
      unitRef="usd">-16000</us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xOS9mcmFnOjBhMzgwODEwMmVmMjQxNjFhNjQxNDgwMjQ5MGRjZjNlL3RhYmxlOjI4M2VkZmNkZjU3MjQxNjU5ODA3MGMxNWQ3NmVkMmYxL3RhYmxlcmFuZ2U6MjgzZWRmY2RmNTcyNDE2NTk4MDcwYzE1ZDc2ZWQyZjFfNy01LTEtMS00Mjc5Mg_1f65e53a-f135-490f-98c7-99b79b8e6bed"
      unitRef="usd">-21000</us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="ic431430d1ab24120b4507025a722d73a_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xOS9mcmFnOjBhMzgwODEwMmVmMjQxNjFhNjQxNDgwMjQ5MGRjZjNlL3RhYmxlOjI4M2VkZmNkZjU3MjQxNjU5ODA3MGMxNWQ3NmVkMmYxL3RhYmxlcmFuZ2U6MjgzZWRmY2RmNTcyNDE2NTk4MDcwYzE1ZDc2ZWQyZjFfNy03LTEtMS00Mjc5Mg_23aa749d-59ed-452d-a9ab-18972a552db7"
      unitRef="usd">-49000</us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i2f3a96a832ab4b0ca374599d1c3e9bce_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xOS9mcmFnOjBhMzgwODEwMmVmMjQxNjFhNjQxNDgwMjQ5MGRjZjNlL3RhYmxlOjI4M2VkZmNkZjU3MjQxNjU5ODA3MGMxNWQ3NmVkMmYxL3RhYmxlcmFuZ2U6MjgzZWRmY2RmNTcyNDE2NTk4MDcwYzE1ZDc2ZWQyZjFfOC0xLTEtMS00Mjc5Mg_ee7e9b48-c671-4224-a66d-da3958391922"
      unitRef="usd">123000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i3bb5592686d74afab4f7004818fd6f9b_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xOS9mcmFnOjBhMzgwODEwMmVmMjQxNjFhNjQxNDgwMjQ5MGRjZjNlL3RhYmxlOjI4M2VkZmNkZjU3MjQxNjU5ODA3MGMxNWQ3NmVkMmYxL3RhYmxlcmFuZ2U6MjgzZWRmY2RmNTcyNDE2NTk4MDcwYzE1ZDc2ZWQyZjFfOC0zLTEtMS00Mjc5Mg_41e4df67-2aa7-45e1-89e2-94b66acdda56"
      unitRef="usd">47000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xOS9mcmFnOjBhMzgwODEwMmVmMjQxNjFhNjQxNDgwMjQ5MGRjZjNlL3RhYmxlOjI4M2VkZmNkZjU3MjQxNjU5ODA3MGMxNWQ3NmVkMmYxL3RhYmxlcmFuZ2U6MjgzZWRmY2RmNTcyNDE2NTk4MDcwYzE1ZDc2ZWQyZjFfOC01LTEtMS00Mjc5Mg_90e056db-ed12-4193-8758-61648cf1ab9c"
      unitRef="usd">279000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="ic431430d1ab24120b4507025a722d73a_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xOS9mcmFnOjBhMzgwODEwMmVmMjQxNjFhNjQxNDgwMjQ5MGRjZjNlL3RhYmxlOjI4M2VkZmNkZjU3MjQxNjU5ODA3MGMxNWQ3NmVkMmYxL3RhYmxlcmFuZ2U6MjgzZWRmY2RmNTcyNDE2NTk4MDcwYzE1ZDc2ZWQyZjFfOC03LTEtMS00Mjc5Mg_7b16a58b-aa5b-429f-b468-2d0c0c612aa8"
      unitRef="usd">81000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i2f3a96a832ab4b0ca374599d1c3e9bce_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xOS9mcmFnOjBhMzgwODEwMmVmMjQxNjFhNjQxNDgwMjQ5MGRjZjNlL3RhYmxlOjI4M2VkZmNkZjU3MjQxNjU5ODA3MGMxNWQ3NmVkMmYxL3RhYmxlcmFuZ2U6MjgzZWRmY2RmNTcyNDE2NTk4MDcwYzE1ZDc2ZWQyZjFfMTAtMS0xLTEtNDI3OTI_df535255-b848-4680-994e-0a3a946e14f6"
      unitRef="usd">36278000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i3bb5592686d74afab4f7004818fd6f9b_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xOS9mcmFnOjBhMzgwODEwMmVmMjQxNjFhNjQxNDgwMjQ5MGRjZjNlL3RhYmxlOjI4M2VkZmNkZjU3MjQxNjU5ODA3MGMxNWQ3NmVkMmYxL3RhYmxlcmFuZ2U6MjgzZWRmY2RmNTcyNDE2NTk4MDcwYzE1ZDc2ZWQyZjFfMTAtMy0xLTEtNDI3OTI_34ac9587-cd6a-4f49-b762-64f0b5561290"
      unitRef="usd">42029000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xOS9mcmFnOjBhMzgwODEwMmVmMjQxNjFhNjQxNDgwMjQ5MGRjZjNlL3RhYmxlOjI4M2VkZmNkZjU3MjQxNjU5ODA3MGMxNWQ3NmVkMmYxL3RhYmxlcmFuZ2U6MjgzZWRmY2RmNTcyNDE2NTk4MDcwYzE1ZDc2ZWQyZjFfMTAtNS0xLTEtNDI3OTI_e303f13f-cd97-4a4c-9710-d98aa820f8d3"
      unitRef="usd">117329000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="ic431430d1ab24120b4507025a722d73a_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18xOS9mcmFnOjBhMzgwODEwMmVmMjQxNjFhNjQxNDgwMjQ5MGRjZjNlL3RhYmxlOjI4M2VkZmNkZjU3MjQxNjU5ODA3MGMxNWQ3NmVkMmYxL3RhYmxlcmFuZ2U6MjgzZWRmY2RmNTcyNDE2NTk4MDcwYzE1ZDc2ZWQyZjFfMTAtNy0xLTEtNDI3OTI_b720d72d-75b4-4efa-be08-a1ba1564fb01"
      unitRef="usd">130089000</us-gaap:ComprehensiveIncomeNetOfTax>
    <dei:DocumentPeriodEndDate
      contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yMi9mcmFnOjYwNmIyYmE0ZmEyOTQxNDBhNGQ5Njk4ODFlNmFlZjA0L3RhYmxlOjMwOWU2MjUwZDA1NzRiNTk5ZTBjZjRjMWIyOTc3ZjE0L3RhYmxlcmFuZ2U6MzA5ZTYyNTBkMDU3NGI1OTllMGNmNGMxYjI5NzdmMTRfMC0xLTEtMS00Mjc5Mg_75cfbe1e-17ec-4442-ae34-fd999dbe9ec2">2022-09-30</dei:DocumentPeriodEndDate>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i5de311f5948148cda49342e2cea83715_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yMi9mcmFnOjYwNmIyYmE0ZmEyOTQxNDBhNGQ5Njk4ODFlNmFlZjA0L3RhYmxlOjMwOWU2MjUwZDA1NzRiNTk5ZTBjZjRjMWIyOTc3ZjE0L3RhYmxlcmFuZ2U6MzA5ZTYyNTBkMDU3NGI1OTllMGNmNGMxYjI5NzdmMTRfNC0xLTEtMS00Mjc5Mg_fce2aa72-9790-4ccb-aff5-f6375007c9b7"
      unitRef="usd">69710000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i47f09f18839440ffae0cf05a475aa7fe_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yMi9mcmFnOjYwNmIyYmE0ZmEyOTQxNDBhNGQ5Njk4ODFlNmFlZjA0L3RhYmxlOjMwOWU2MjUwZDA1NzRiNTk5ZTBjZjRjMWIyOTc3ZjE0L3RhYmxlcmFuZ2U6MzA5ZTYyNTBkMDU3NGI1OTllMGNmNGMxYjI5NzdmMTRfNC0zLTEtMS00Mjc5Mg_1564c355-c962-4b5a-a949-00cc4e38c3ce"
      unitRef="usd">104183000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:InventoryNet
      contextRef="i5de311f5948148cda49342e2cea83715_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yMi9mcmFnOjYwNmIyYmE0ZmEyOTQxNDBhNGQ5Njk4ODFlNmFlZjA0L3RhYmxlOjMwOWU2MjUwZDA1NzRiNTk5ZTBjZjRjMWIyOTc3ZjE0L3RhYmxlcmFuZ2U6MzA5ZTYyNTBkMDU3NGI1OTllMGNmNGMxYjI5NzdmMTRfNS0xLTEtMS00Mjc5Mg_a405ee8c-a8c2-4412-858d-f84da4793fe1"
      unitRef="usd">145279000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="i47f09f18839440ffae0cf05a475aa7fe_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yMi9mcmFnOjYwNmIyYmE0ZmEyOTQxNDBhNGQ5Njk4ODFlNmFlZjA0L3RhYmxlOjMwOWU2MjUwZDA1NzRiNTk5ZTBjZjRjMWIyOTc3ZjE0L3RhYmxlcmFuZ2U6MzA5ZTYyNTBkMDU3NGI1OTllMGNmNGMxYjI5NzdmMTRfNS0zLTEtMS00Mjc5Mg_8cc134d5-597b-40ed-ab0b-16deef41d0e8"
      unitRef="usd">180043000</us-gaap:InventoryNet>
    <us-gaap:ShortTermInvestments
      contextRef="i5de311f5948148cda49342e2cea83715_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yMi9mcmFnOjYwNmIyYmE0ZmEyOTQxNDBhNGQ5Njk4ODFlNmFlZjA0L3RhYmxlOjMwOWU2MjUwZDA1NzRiNTk5ZTBjZjRjMWIyOTc3ZjE0L3RhYmxlcmFuZ2U6MzA5ZTYyNTBkMDU3NGI1OTllMGNmNGMxYjI5NzdmMTRfNi0xLTEtMS00Mjc5Mg_0f3abab3-f26b-4fa5-9874-1d9f24d5fd52"
      unitRef="usd">0</us-gaap:ShortTermInvestments>
    <us-gaap:ShortTermInvestments
      contextRef="i47f09f18839440ffae0cf05a475aa7fe_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yMi9mcmFnOjYwNmIyYmE0ZmEyOTQxNDBhNGQ5Njk4ODFlNmFlZjA0L3RhYmxlOjMwOWU2MjUwZDA1NzRiNTk5ZTBjZjRjMWIyOTc3ZjE0L3RhYmxlcmFuZ2U6MzA5ZTYyNTBkMDU3NGI1OTllMGNmNGMxYjI5NzdmMTRfNi0zLTEtMS00Mjc5Mg_af182fff-048e-49d4-a559-b83a7d53802a"
      unitRef="usd">5361000</us-gaap:ShortTermInvestments>
    <us-gaap:PrepaidTaxes
      contextRef="i5de311f5948148cda49342e2cea83715_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yMi9mcmFnOjYwNmIyYmE0ZmEyOTQxNDBhNGQ5Njk4ODFlNmFlZjA0L3RhYmxlOjMwOWU2MjUwZDA1NzRiNTk5ZTBjZjRjMWIyOTc3ZjE0L3RhYmxlcmFuZ2U6MzA5ZTYyNTBkMDU3NGI1OTllMGNmNGMxYjI5NzdmMTRfNy0xLTEtMS00Mjc5Mg_687757cd-9fe3-48a1-9f9b-c7477802589b"
      unitRef="usd">150000</us-gaap:PrepaidTaxes>
    <us-gaap:PrepaidTaxes
      contextRef="i47f09f18839440ffae0cf05a475aa7fe_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yMi9mcmFnOjYwNmIyYmE0ZmEyOTQxNDBhNGQ5Njk4ODFlNmFlZjA0L3RhYmxlOjMwOWU2MjUwZDA1NzRiNTk5ZTBjZjRjMWIyOTc3ZjE0L3RhYmxlcmFuZ2U6MzA5ZTYyNTBkMDU3NGI1OTllMGNmNGMxYjI5NzdmMTRfNy0zLTEtMS00Mjc5Mg_498100ee-cc4f-403b-a0b8-004a93a21bc6"
      unitRef="usd">945000</us-gaap:PrepaidTaxes>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i5de311f5948148cda49342e2cea83715_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yMi9mcmFnOjYwNmIyYmE0ZmEyOTQxNDBhNGQ5Njk4ODFlNmFlZjA0L3RhYmxlOjMwOWU2MjUwZDA1NzRiNTk5ZTBjZjRjMWIyOTc3ZjE0L3RhYmxlcmFuZ2U6MzA5ZTYyNTBkMDU3NGI1OTllMGNmNGMxYjI5NzdmMTRfOC0xLTEtMS00Mjc5Mg_23a44577-a43e-4615-8d9a-2f95489b4b2b"
      unitRef="usd">14445000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i47f09f18839440ffae0cf05a475aa7fe_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yMi9mcmFnOjYwNmIyYmE0ZmEyOTQxNDBhNGQ5Njk4ODFlNmFlZjA0L3RhYmxlOjMwOWU2MjUwZDA1NzRiNTk5ZTBjZjRjMWIyOTc3ZjE0L3RhYmxlcmFuZ2U6MzA5ZTYyNTBkMDU3NGI1OTllMGNmNGMxYjI5NzdmMTRfOC0zLTEtMS00Mjc5Mg_93d47478-045d-414d-9680-178b6b3575e2"
      unitRef="usd">16334000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i5de311f5948148cda49342e2cea83715_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yMi9mcmFnOjYwNmIyYmE0ZmEyOTQxNDBhNGQ5Njk4ODFlNmFlZjA0L3RhYmxlOjMwOWU2MjUwZDA1NzRiNTk5ZTBjZjRjMWIyOTc3ZjE0L3RhYmxlcmFuZ2U6MzA5ZTYyNTBkMDU3NGI1OTllMGNmNGMxYjI5NzdmMTRfOS0xLTEtMS00Mjc5Mg_51ca2728-eee5-4a99-815f-f1efae33b32b"
      unitRef="usd">229584000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i47f09f18839440ffae0cf05a475aa7fe_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yMi9mcmFnOjYwNmIyYmE0ZmEyOTQxNDBhNGQ5Njk4ODFlNmFlZjA0L3RhYmxlOjMwOWU2MjUwZDA1NzRiNTk5ZTBjZjRjMWIyOTc3ZjE0L3RhYmxlcmFuZ2U6MzA5ZTYyNTBkMDU3NGI1OTllMGNmNGMxYjI5NzdmMTRfOS0zLTEtMS00Mjc5Mg_75eb677c-8e4e-48d7-9a82-8b36732e4b47"
      unitRef="usd">306866000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i5de311f5948148cda49342e2cea83715_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yMi9mcmFnOjYwNmIyYmE0ZmEyOTQxNDBhNGQ5Njk4ODFlNmFlZjA0L3RhYmxlOjMwOWU2MjUwZDA1NzRiNTk5ZTBjZjRjMWIyOTc3ZjE0L3RhYmxlcmFuZ2U6MzA5ZTYyNTBkMDU3NGI1OTllMGNmNGMxYjI5NzdmMTRfMTEtMS0xLTEtNDI3OTI_e47a9e72-a2b4-4510-855d-8da0566602c8"
      unitRef="usd">58107000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i47f09f18839440ffae0cf05a475aa7fe_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yMi9mcmFnOjYwNmIyYmE0ZmEyOTQxNDBhNGQ5Njk4ODFlNmFlZjA0L3RhYmxlOjMwOWU2MjUwZDA1NzRiNTk5ZTBjZjRjMWIyOTc3ZjE0L3RhYmxlcmFuZ2U6MzA5ZTYyNTBkMDU3NGI1OTllMGNmNGMxYjI5NzdmMTRfMTEtMy0xLTEtNDI3OTI_33626c32-c15e-42b4-b12d-4078803a7a4e"
      unitRef="usd">56131000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i5de311f5948148cda49342e2cea83715_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yMi9mcmFnOjYwNmIyYmE0ZmEyOTQxNDBhNGQ5Njk4ODFlNmFlZjA0L3RhYmxlOjMwOWU2MjUwZDA1NzRiNTk5ZTBjZjRjMWIyOTc3ZjE0L3RhYmxlcmFuZ2U6MzA5ZTYyNTBkMDU3NGI1OTllMGNmNGMxYjI5NzdmMTRfMTItMS0xLTEtNDI3OTI_c27b15d2-dde4-4408-bc54-57d404a36312"
      unitRef="usd">19819000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i47f09f18839440ffae0cf05a475aa7fe_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yMi9mcmFnOjYwNmIyYmE0ZmEyOTQxNDBhNGQ5Njk4ODFlNmFlZjA0L3RhYmxlOjMwOWU2MjUwZDA1NzRiNTk5ZTBjZjRjMWIyOTc3ZjE0L3RhYmxlcmFuZ2U6MzA5ZTYyNTBkMDU3NGI1OTllMGNmNGMxYjI5NzdmMTRfMTItMy0xLTEtNDI3OTI_eb4d522c-734d-42ea-b5d1-2069d88c1ccc"
      unitRef="usd">24457000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i5de311f5948148cda49342e2cea83715_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yMi9mcmFnOjYwNmIyYmE0ZmEyOTQxNDBhNGQ5Njk4ODFlNmFlZjA0L3RhYmxlOjMwOWU2MjUwZDA1NzRiNTk5ZTBjZjRjMWIyOTc3ZjE0L3RhYmxlcmFuZ2U6MzA5ZTYyNTBkMDU3NGI1OTllMGNmNGMxYjI5NzdmMTRfMTMtMS0xLTEtNDI3OTI_32cb0416-931d-4c85-b3bf-6eb75a967555"
      unitRef="usd">12691000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i47f09f18839440ffae0cf05a475aa7fe_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yMi9mcmFnOjYwNmIyYmE0ZmEyOTQxNDBhNGQ5Njk4ODFlNmFlZjA0L3RhYmxlOjMwOWU2MjUwZDA1NzRiNTk5ZTBjZjRjMWIyOTc3ZjE0L3RhYmxlcmFuZ2U6MzA5ZTYyNTBkMDU3NGI1OTllMGNmNGMxYjI5NzdmMTRfMTMtMy0xLTEtNDI3OTI_6f85ffcb-0f9e-41f6-b5d4-93e43f778387"
      unitRef="usd">6468000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="i5de311f5948148cda49342e2cea83715_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yMi9mcmFnOjYwNmIyYmE0ZmEyOTQxNDBhNGQ5Njk4ODFlNmFlZjA0L3RhYmxlOjMwOWU2MjUwZDA1NzRiNTk5ZTBjZjRjMWIyOTc3ZjE0L3RhYmxlcmFuZ2U6MzA5ZTYyNTBkMDU3NGI1OTllMGNmNGMxYjI5NzdmMTRfMTQtMS0xLTEtNDI3OTI_406c3785-49fc-4a30-b963-cef891032a96"
      unitRef="usd">6150000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="i47f09f18839440ffae0cf05a475aa7fe_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yMi9mcmFnOjYwNmIyYmE0ZmEyOTQxNDBhNGQ5Njk4ODFlNmFlZjA0L3RhYmxlOjMwOWU2MjUwZDA1NzRiNTk5ZTBjZjRjMWIyOTc3ZjE0L3RhYmxlcmFuZ2U6MzA5ZTYyNTBkMDU3NGI1OTllMGNmNGMxYjI5NzdmMTRfMTQtMy0xLTEtNDI3OTI_82a2b6c2-285e-4407-8ead-26ff88dd80f6"
      unitRef="usd">4404000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:Assets
      contextRef="i5de311f5948148cda49342e2cea83715_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yMi9mcmFnOjYwNmIyYmE0ZmEyOTQxNDBhNGQ5Njk4ODFlNmFlZjA0L3RhYmxlOjMwOWU2MjUwZDA1NzRiNTk5ZTBjZjRjMWIyOTc3ZjE0L3RhYmxlcmFuZ2U6MzA5ZTYyNTBkMDU3NGI1OTllMGNmNGMxYjI5NzdmMTRfMTctMS0xLTEtNDI3OTI_960e6299-cb45-4860-a023-0c432ee91191"
      unitRef="usd">326351000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i47f09f18839440ffae0cf05a475aa7fe_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yMi9mcmFnOjYwNmIyYmE0ZmEyOTQxNDBhNGQ5Njk4ODFlNmFlZjA0L3RhYmxlOjMwOWU2MjUwZDA1NzRiNTk5ZTBjZjRjMWIyOTc3ZjE0L3RhYmxlcmFuZ2U6MzA5ZTYyNTBkMDU3NGI1OTllMGNmNGMxYjI5NzdmMTRfMTctMy0xLTEtNDI3OTI_fcf779a5-7ccc-4dcd-967c-6c039e5ce84f"
      unitRef="usd">398326000</us-gaap:Assets>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent
      contextRef="i5de311f5948148cda49342e2cea83715_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yMi9mcmFnOjYwNmIyYmE0ZmEyOTQxNDBhNGQ5Njk4ODFlNmFlZjA0L3RhYmxlOjMwOWU2MjUwZDA1NzRiNTk5ZTBjZjRjMWIyOTc3ZjE0L3RhYmxlcmFuZ2U6MzA5ZTYyNTBkMDU3NGI1OTllMGNmNGMxYjI5NzdmMTRfMjEtMS0xLTEtNDI3OTI_dae2dd66-326c-4ff0-bbcd-7a8576ef8045"
      unitRef="usd">148129000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent
      contextRef="i47f09f18839440ffae0cf05a475aa7fe_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yMi9mcmFnOjYwNmIyYmE0ZmEyOTQxNDBhNGQ5Njk4ODFlNmFlZjA0L3RhYmxlOjMwOWU2MjUwZDA1NzRiNTk5ZTBjZjRjMWIyOTc3ZjE0L3RhYmxlcmFuZ2U6MzA5ZTYyNTBkMDU3NGI1OTllMGNmNGMxYjI5NzdmMTRfMjEtMy0xLTEtNDI3OTI_4a8b2be3-bace-4b25-b539-6d13fa3fc69a"
      unitRef="usd">163309000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:LinesOfCreditCurrent
      contextRef="i5de311f5948148cda49342e2cea83715_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yMi9mcmFnOjYwNmIyYmE0ZmEyOTQxNDBhNGQ5Njk4ODFlNmFlZjA0L3RhYmxlOjMwOWU2MjUwZDA1NzRiNTk5ZTBjZjRjMWIyOTc3ZjE0L3RhYmxlcmFuZ2U6MzA5ZTYyNTBkMDU3NGI1OTllMGNmNGMxYjI5NzdmMTRfMjItMS0xLTEtNDI3OTI_faa8c2da-b981-4db1-ac11-0fc99ec0e6e1"
      unitRef="usd">0</us-gaap:LinesOfCreditCurrent>
    <us-gaap:LinesOfCreditCurrent
      contextRef="i47f09f18839440ffae0cf05a475aa7fe_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yMi9mcmFnOjYwNmIyYmE0ZmEyOTQxNDBhNGQ5Njk4ODFlNmFlZjA0L3RhYmxlOjMwOWU2MjUwZDA1NzRiNTk5ZTBjZjRjMWIyOTc3ZjE0L3RhYmxlcmFuZ2U6MzA5ZTYyNTBkMDU3NGI1OTllMGNmNGMxYjI5NzdmMTRfMjItMy0xLTEtNDI3OTI_952e2b62-67be-41d7-bd25-d53226fefa82"
      unitRef="usd">0</us-gaap:LinesOfCreditCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i5de311f5948148cda49342e2cea83715_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yMi9mcmFnOjYwNmIyYmE0ZmEyOTQxNDBhNGQ5Njk4ODFlNmFlZjA0L3RhYmxlOjMwOWU2MjUwZDA1NzRiNTk5ZTBjZjRjMWIyOTc3ZjE0L3RhYmxlcmFuZ2U6MzA5ZTYyNTBkMDU3NGI1OTllMGNmNGMxYjI5NzdmMTRfMjMtMS0xLTEtNDI3OTI_28b2bf50-6b7f-4dc5-b638-7cd06db645cc"
      unitRef="usd">6126000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i47f09f18839440ffae0cf05a475aa7fe_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yMi9mcmFnOjYwNmIyYmE0ZmEyOTQxNDBhNGQ5Njk4ODFlNmFlZjA0L3RhYmxlOjMwOWU2MjUwZDA1NzRiNTk5ZTBjZjRjMWIyOTc3ZjE0L3RhYmxlcmFuZ2U6MzA5ZTYyNTBkMDU3NGI1OTllMGNmNGMxYjI5NzdmMTRfMjMtMy0xLTEtNDI3OTI_ebc6bab9-c691-4a01-a17d-abac6c654cd3"
      unitRef="usd">6523000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i5de311f5948148cda49342e2cea83715_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yMi9mcmFnOjYwNmIyYmE0ZmEyOTQxNDBhNGQ5Njk4ODFlNmFlZjA0L3RhYmxlOjMwOWU2MjUwZDA1NzRiNTk5ZTBjZjRjMWIyOTc3ZjE0L3RhYmxlcmFuZ2U6MzA5ZTYyNTBkMDU3NGI1OTllMGNmNGMxYjI5NzdmMTRfMjQtMS0xLTEtNDI3OTI_b00b7b33-ff00-4a4a-83fd-7a9f1fdb0d4a"
      unitRef="usd">154255000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i47f09f18839440ffae0cf05a475aa7fe_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yMi9mcmFnOjYwNmIyYmE0ZmEyOTQxNDBhNGQ5Njk4ODFlNmFlZjA0L3RhYmxlOjMwOWU2MjUwZDA1NzRiNTk5ZTBjZjRjMWIyOTc3ZjE0L3RhYmxlcmFuZ2U6MzA5ZTYyNTBkMDU3NGI1OTllMGNmNGMxYjI5NzdmMTRfMjQtMy0xLTEtNDI3OTI_86838a45-c509-462a-8453-5ddcac5dc7cc"
      unitRef="usd">169832000</us-gaap:LiabilitiesCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i5de311f5948148cda49342e2cea83715_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yMi9mcmFnOjYwNmIyYmE0ZmEyOTQxNDBhNGQ5Njk4ODFlNmFlZjA0L3RhYmxlOjMwOWU2MjUwZDA1NzRiNTk5ZTBjZjRjMWIyOTc3ZjE0L3RhYmxlcmFuZ2U6MzA5ZTYyNTBkMDU3NGI1OTllMGNmNGMxYjI5NzdmMTRfMjYtMS0xLTEtNDI3OTI_fc0615d9-1509-488a-bfa7-b40a6cbe57b0"
      unitRef="usd">21574000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i47f09f18839440ffae0cf05a475aa7fe_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yMi9mcmFnOjYwNmIyYmE0ZmEyOTQxNDBhNGQ5Njk4ODFlNmFlZjA0L3RhYmxlOjMwOWU2MjUwZDA1NzRiNTk5ZTBjZjRjMWIyOTc3ZjE0L3RhYmxlcmFuZ2U6MzA5ZTYyNTBkMDU3NGI1OTllMGNmNGMxYjI5NzdmMTRfMjYtMy0xLTEtNDI3OTI_4e58bd40-2fab-4192-bbba-9acd0208748e"
      unitRef="usd">26020000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:Liabilities
      contextRef="i5de311f5948148cda49342e2cea83715_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yMi9mcmFnOjYwNmIyYmE0ZmEyOTQxNDBhNGQ5Njk4ODFlNmFlZjA0L3RhYmxlOjMwOWU2MjUwZDA1NzRiNTk5ZTBjZjRjMWIyOTc3ZjE0L3RhYmxlcmFuZ2U6MzA5ZTYyNTBkMDU3NGI1OTllMGNmNGMxYjI5NzdmMTRfMjktMS0xLTEtNDI3OTI_7bcd01f1-3c15-42df-a8b4-859f286d4b4f"
      unitRef="usd">175829000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="i47f09f18839440ffae0cf05a475aa7fe_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yMi9mcmFnOjYwNmIyYmE0ZmEyOTQxNDBhNGQ5Njk4ODFlNmFlZjA0L3RhYmxlOjMwOWU2MjUwZDA1NzRiNTk5ZTBjZjRjMWIyOTc3ZjE0L3RhYmxlcmFuZ2U6MzA5ZTYyNTBkMDU3NGI1OTllMGNmNGMxYjI5NzdmMTRfMjktMy0xLTEtNDI3OTI_b4125600-ddba-44d1-a772-f2306c9a06b0"
      unitRef="usd">195852000</us-gaap:Liabilities>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i47f09f18839440ffae0cf05a475aa7fe_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yMi9mcmFnOjYwNmIyYmE0ZmEyOTQxNDBhNGQ5Njk4ODFlNmFlZjA0L3RhYmxlOjMwOWU2MjUwZDA1NzRiNTk5ZTBjZjRjMWIyOTc3ZjE0L3RhYmxlcmFuZ2U6MzA5ZTYyNTBkMDU3NGI1OTllMGNmNGMxYjI5NzdmMTRfMzItMC0xLTEtNDI3OTIvdGV4dHJlZ2lvbjoxNGFkYjg0Y2Y3NzY0ODczODM2ZjUwN2VjODQ4MGM1OV8yOA_5029a283-ae4e-43d7-8a6e-f10c565c8577"
      unitRef="usdPerShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i5de311f5948148cda49342e2cea83715_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yMi9mcmFnOjYwNmIyYmE0ZmEyOTQxNDBhNGQ5Njk4ODFlNmFlZjA0L3RhYmxlOjMwOWU2MjUwZDA1NzRiNTk5ZTBjZjRjMWIyOTc3ZjE0L3RhYmxlcmFuZ2U6MzA5ZTYyNTBkMDU3NGI1OTllMGNmNGMxYjI5NzdmMTRfMzItMC0xLTEtNDI3OTIvdGV4dHJlZ2lvbjoxNGFkYjg0Y2Y3NzY0ODczODM2ZjUwN2VjODQ4MGM1OV8yOA_d1ef4535-b396-4cf7-a660-442971bf45ce"
      unitRef="usdPerShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i5de311f5948148cda49342e2cea83715_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yMi9mcmFnOjYwNmIyYmE0ZmEyOTQxNDBhNGQ5Njk4ODFlNmFlZjA0L3RhYmxlOjMwOWU2MjUwZDA1NzRiNTk5ZTBjZjRjMWIyOTc3ZjE0L3RhYmxlcmFuZ2U6MzA5ZTYyNTBkMDU3NGI1OTllMGNmNGMxYjI5NzdmMTRfMzItMC0xLTEtNDI3OTIvdGV4dHJlZ2lvbjoxNGFkYjg0Y2Y3NzY0ODczODM2ZjUwN2VjODQ4MGM1OV80Mg_762678db-cdcf-4745-9af9-e0297dc5397e"
      unitRef="shares">20000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i47f09f18839440ffae0cf05a475aa7fe_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yMi9mcmFnOjYwNmIyYmE0ZmEyOTQxNDBhNGQ5Njk4ODFlNmFlZjA0L3RhYmxlOjMwOWU2MjUwZDA1NzRiNTk5ZTBjZjRjMWIyOTc3ZjE0L3RhYmxlcmFuZ2U6MzA5ZTYyNTBkMDU3NGI1OTllMGNmNGMxYjI5NzdmMTRfMzItMC0xLTEtNDI3OTIvdGV4dHJlZ2lvbjoxNGFkYjg0Y2Y3NzY0ODczODM2ZjUwN2VjODQ4MGM1OV80Mg_bba9a21b-93a0-4bd8-9f42-f2b9f5e7b604"
      unitRef="shares">20000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="i5de311f5948148cda49342e2cea83715_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yMi9mcmFnOjYwNmIyYmE0ZmEyOTQxNDBhNGQ5Njk4ODFlNmFlZjA0L3RhYmxlOjMwOWU2MjUwZDA1NzRiNTk5ZTBjZjRjMWIyOTc3ZjE0L3RhYmxlcmFuZ2U6MzA5ZTYyNTBkMDU3NGI1OTllMGNmNGMxYjI5NzdmMTRfMzMtMC0xLTEtNDI3OTIvdGV4dHJlZ2lvbjo1NWQ3OWI0MWVjMjM0MDU3YTJmZDI4NDc5YjE1ZThhMF80_1bdfe5db-ebad-4de3-8dae-5152506d950d"
      unitRef="shares">10929000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="i47f09f18839440ffae0cf05a475aa7fe_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yMi9mcmFnOjYwNmIyYmE0ZmEyOTQxNDBhNGQ5Njk4ODFlNmFlZjA0L3RhYmxlOjMwOWU2MjUwZDA1NzRiNTk5ZTBjZjRjMWIyOTc3ZjE0L3RhYmxlcmFuZ2U6MzA5ZTYyNTBkMDU3NGI1OTllMGNmNGMxYjI5NzdmMTRfMzMtMC0xLTEtNDI3OTIvdGV4dHJlZ2lvbjo1NWQ3OWI0MWVjMjM0MDU3YTJmZDI4NDc5YjE1ZThhMF8xMQ_c50d2001-b820-4926-891f-14395dfabda1"
      unitRef="shares">11594000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i5de311f5948148cda49342e2cea83715_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yMi9mcmFnOjYwNmIyYmE0ZmEyOTQxNDBhNGQ5Njk4ODFlNmFlZjA0L3RhYmxlOjMwOWU2MjUwZDA1NzRiNTk5ZTBjZjRjMWIyOTc3ZjE0L3RhYmxlcmFuZ2U6MzA5ZTYyNTBkMDU3NGI1OTllMGNmNGMxYjI5NzdmMTRfMzMtMC0xLTEtNDI3OTIvdGV4dHJlZ2lvbjo1NWQ3OWI0MWVjMjM0MDU3YTJmZDI4NDc5YjE1ZThhMF8yNQ_3ed1cb26-063d-4281-99d5-97dd3d450f9d"
      unitRef="shares">10928000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i47f09f18839440ffae0cf05a475aa7fe_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yMi9mcmFnOjYwNmIyYmE0ZmEyOTQxNDBhNGQ5Njk4ODFlNmFlZjA0L3RhYmxlOjMwOWU2MjUwZDA1NzRiNTk5ZTBjZjRjMWIyOTc3ZjE0L3RhYmxlcmFuZ2U6MzA5ZTYyNTBkMDU3NGI1OTllMGNmNGMxYjI5NzdmMTRfMzMtMC0xLTEtNDI3OTIvdGV4dHJlZ2lvbjo1NWQ3OWI0MWVjMjM0MDU3YTJmZDI4NDc5YjE1ZThhMF8zMg_0b86542c-b56a-4887-9e5d-1183f971d88d"
      unitRef="shares">11593000</us-gaap:CommonStockSharesOutstanding>
    <dei:DocumentPeriodEndDate
      contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yMi9mcmFnOjYwNmIyYmE0ZmEyOTQxNDBhNGQ5Njk4ODFlNmFlZjA0L3RhYmxlOjMwOWU2MjUwZDA1NzRiNTk5ZTBjZjRjMWIyOTc3ZjE0L3RhYmxlcmFuZ2U6MzA5ZTYyNTBkMDU3NGI1OTllMGNmNGMxYjI5NzdmMTRfMzQtMC0xLTEtNDI3OTIvdGV4dHJlZ2lvbjphZWVjYzQyODE5NzQ0NjNlYTViNmQ0OTI0NTA0MjZiN183_75cfbe1e-17ec-4442-ae34-fd999dbe9ec2">2022-09-30</dei:DocumentPeriodEndDate>
    <us-gaap:CommonStockValue
      contextRef="i5de311f5948148cda49342e2cea83715_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yMi9mcmFnOjYwNmIyYmE0ZmEyOTQxNDBhNGQ5Njk4ODFlNmFlZjA0L3RhYmxlOjMwOWU2MjUwZDA1NzRiNTk5ZTBjZjRjMWIyOTc3ZjE0L3RhYmxlcmFuZ2U6MzA5ZTYyNTBkMDU3NGI1OTllMGNmNGMxYjI5NzdmMTRfMzQtMS0xLTEtNDI3OTI_431d86ae-0acf-456b-bc4c-005ab7536ba4"
      unitRef="usd">11000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="i47f09f18839440ffae0cf05a475aa7fe_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yMi9mcmFnOjYwNmIyYmE0ZmEyOTQxNDBhNGQ5Njk4ODFlNmFlZjA0L3RhYmxlOjMwOWU2MjUwZDA1NzRiNTk5ZTBjZjRjMWIyOTc3ZjE0L3RhYmxlcmFuZ2U6MzA5ZTYyNTBkMDU3NGI1OTllMGNmNGMxYjI5NzdmMTRfMzQtMy0xLTEtNDI3OTI_ae584758-0f15-4848-b21f-faf4eea813e0"
      unitRef="usd">12000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital
      contextRef="i5de311f5948148cda49342e2cea83715_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yMi9mcmFnOjYwNmIyYmE0ZmEyOTQxNDBhNGQ5Njk4ODFlNmFlZjA0L3RhYmxlOjMwOWU2MjUwZDA1NzRiNTk5ZTBjZjRjMWIyOTc3ZjE0L3RhYmxlcmFuZ2U6MzA5ZTYyNTBkMDU3NGI1OTllMGNmNGMxYjI5NzdmMTRfMzUtMS0xLTEtNDI3OTI_5b7a9dcf-61c6-4a06-9cbf-ce6fc1085324"
      unitRef="usd">18617000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital
      contextRef="i47f09f18839440ffae0cf05a475aa7fe_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yMi9mcmFnOjYwNmIyYmE0ZmEyOTQxNDBhNGQ5Njk4ODFlNmFlZjA0L3RhYmxlOjMwOWU2MjUwZDA1NzRiNTk5ZTBjZjRjMWIyOTc3ZjE0L3RhYmxlcmFuZ2U6MzA5ZTYyNTBkMDU3NGI1OTllMGNmNGMxYjI5NzdmMTRfMzUtMy0xLTEtNDI3OTI_193c25b3-8cc2-4e3d-9963-82fa22897066"
      unitRef="usd">12018000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i5de311f5948148cda49342e2cea83715_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yMi9mcmFnOjYwNmIyYmE0ZmEyOTQxNDBhNGQ5Njk4ODFlNmFlZjA0L3RhYmxlOjMwOWU2MjUwZDA1NzRiNTk5ZTBjZjRjMWIyOTc3ZjE0L3RhYmxlcmFuZ2U6MzA5ZTYyNTBkMDU3NGI1OTllMGNmNGMxYjI5NzdmMTRfMzYtMS0xLTEtNDI3OTI_c8981ce3-f53d-4f8f-ba23-de049969fa14"
      unitRef="usd">391000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i47f09f18839440ffae0cf05a475aa7fe_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yMi9mcmFnOjYwNmIyYmE0ZmEyOTQxNDBhNGQ5Njk4ODFlNmFlZjA0L3RhYmxlOjMwOWU2MjUwZDA1NzRiNTk5ZTBjZjRjMWIyOTc3ZjE0L3RhYmxlcmFuZ2U6MzA5ZTYyNTBkMDU3NGI1OTllMGNmNGMxYjI5NzdmMTRfMzYtMy0xLTEtNDI3OTI_b0717347-d8bf-4259-8c0f-b6600499e628"
      unitRef="usd">111000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i5de311f5948148cda49342e2cea83715_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yMi9mcmFnOjYwNmIyYmE0ZmEyOTQxNDBhNGQ5Njk4ODFlNmFlZjA0L3RhYmxlOjMwOWU2MjUwZDA1NzRiNTk5ZTBjZjRjMWIyOTc3ZjE0L3RhYmxlcmFuZ2U6MzA5ZTYyNTBkMDU3NGI1OTllMGNmNGMxYjI5NzdmMTRfMzctMS0xLTEtNDI3OTI_3580446e-4a3b-4d27-add3-51a2cd9ff4d0"
      unitRef="usd">131503000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i47f09f18839440ffae0cf05a475aa7fe_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yMi9mcmFnOjYwNmIyYmE0ZmEyOTQxNDBhNGQ5Njk4ODFlNmFlZjA0L3RhYmxlOjMwOWU2MjUwZDA1NzRiNTk5ZTBjZjRjMWIyOTc3ZjE0L3RhYmxlcmFuZ2U6MzA5ZTYyNTBkMDU3NGI1OTllMGNmNGMxYjI5NzdmMTRfMzctMy0xLTEtNDI3OTI_d4119757-fbb5-4c94-a2ac-5cb01d45cfb1"
      unitRef="usd">190333000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity
      contextRef="i5de311f5948148cda49342e2cea83715_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yMi9mcmFnOjYwNmIyYmE0ZmEyOTQxNDBhNGQ5Njk4ODFlNmFlZjA0L3RhYmxlOjMwOWU2MjUwZDA1NzRiNTk5ZTBjZjRjMWIyOTc3ZjE0L3RhYmxlcmFuZ2U6MzA5ZTYyNTBkMDU3NGI1OTllMGNmNGMxYjI5NzdmMTRfMzktMS0xLTEtNDI3OTI_9a3dba30-0dbe-43a3-a946-dc669cf73246"
      unitRef="usd">150522000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i47f09f18839440ffae0cf05a475aa7fe_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yMi9mcmFnOjYwNmIyYmE0ZmEyOTQxNDBhNGQ5Njk4ODFlNmFlZjA0L3RhYmxlOjMwOWU2MjUwZDA1NzRiNTk5ZTBjZjRjMWIyOTc3ZjE0L3RhYmxlcmFuZ2U6MzA5ZTYyNTBkMDU3NGI1OTllMGNmNGMxYjI5NzdmMTRfMzktMy0xLTEtNDI3OTI_ae0dec76-72b0-43fe-978f-00478b28c208"
      unitRef="usd">202474000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i5de311f5948148cda49342e2cea83715_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yMi9mcmFnOjYwNmIyYmE0ZmEyOTQxNDBhNGQ5Njk4ODFlNmFlZjA0L3RhYmxlOjMwOWU2MjUwZDA1NzRiNTk5ZTBjZjRjMWIyOTc3ZjE0L3RhYmxlcmFuZ2U6MzA5ZTYyNTBkMDU3NGI1OTllMGNmNGMxYjI5NzdmMTRfNDEtMS0xLTEtNDI3OTI_eea47f96-36fe-49d6-98a4-3eeed1642e17"
      unitRef="usd">326351000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i47f09f18839440ffae0cf05a475aa7fe_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yMi9mcmFnOjYwNmIyYmE0ZmEyOTQxNDBhNGQ5Njk4ODFlNmFlZjA0L3RhYmxlOjMwOWU2MjUwZDA1NzRiNTk5ZTBjZjRjMWIyOTc3ZjE0L3RhYmxlcmFuZ2U6MzA5ZTYyNTBkMDU3NGI1OTllMGNmNGMxYjI5NzdmMTRfNDEtMy0xLTEtNDI3OTI_149cbb0d-3547-4135-bb7f-5bda61bb1b2c"
      unitRef="usd">398326000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yNS9mcmFnOmE1MmJkOGZiZTY1ZjQ3ZWI4ZmVhNTIzNjZjZjJiM2NmL3RhYmxlOjEwZjViZTk1NjExOTQ5NzlhODdhYjVjZTdmZTgyYTIxL3RhYmxlcmFuZ2U6MTBmNWJlOTU2MTE5NDk3OWE4N2FiNWNlN2ZlODJhMjFfNC0xLTEtMS00Mjc5Mg_51affeed-2e8e-4c9b-a2f8-7f244fd8e430"
      unitRef="usd">117050000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ic431430d1ab24120b4507025a722d73a_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yNS9mcmFnOmE1MmJkOGZiZTY1ZjQ3ZWI4ZmVhNTIzNjZjZjJiM2NmL3RhYmxlOjEwZjViZTk1NjExOTQ5NzlhODdhYjVjZTdmZTgyYTIxL3RhYmxlcmFuZ2U6MTBmNWJlOTU2MTE5NDk3OWE4N2FiNWNlN2ZlODJhMjFfNC0zLTEtMS00Mjc5Mg_95a1e57d-8e63-418d-93ed-a2a5e878a312"
      unitRef="usd">130008000</us-gaap:NetIncomeLoss>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yNS9mcmFnOmE1MmJkOGZiZTY1ZjQ3ZWI4ZmVhNTIzNjZjZjJiM2NmL3RhYmxlOjEwZjViZTk1NjExOTQ5NzlhODdhYjVjZTdmZTgyYTIxL3RhYmxlcmFuZ2U6MTBmNWJlOTU2MTE5NDk3OWE4N2FiNWNlN2ZlODJhMjFfNi0xLTEtMS00Mjc5Mg_de32e084-78a9-4f07-b457-f57823afbd57"
      unitRef="usd">8026000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="ic431430d1ab24120b4507025a722d73a_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yNS9mcmFnOmE1MmJkOGZiZTY1ZjQ3ZWI4ZmVhNTIzNjZjZjJiM2NmL3RhYmxlOjEwZjViZTk1NjExOTQ5NzlhODdhYjVjZTdmZTgyYTIxL3RhYmxlcmFuZ2U6MTBmNWJlOTU2MTE5NDk3OWE4N2FiNWNlN2ZlODJhMjFfNi0zLTEtMS00Mjc5Mg_07711508-a324-4862-b58e-28af884f9b93"
      unitRef="usd">3767000</us-gaap:DepreciationDepletionAndAmortization>
    <med:OperatingLeaseExpenseNonCash
      contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yNS9mcmFnOmE1MmJkOGZiZTY1ZjQ3ZWI4ZmVhNTIzNjZjZjJiM2NmL3RhYmxlOjEwZjViZTk1NjExOTQ5NzlhODdhYjVjZTdmZTgyYTIxL3RhYmxlcmFuZ2U6MTBmNWJlOTU2MTE5NDk3OWE4N2FiNWNlN2ZlODJhMjFfNy0xLTEtMS00Mjc5Mg_affa4d46-3e12-4186-a2b8-bdf10a0c3fe6"
      unitRef="usd">4740000</med:OperatingLeaseExpenseNonCash>
    <med:OperatingLeaseExpenseNonCash
      contextRef="ic431430d1ab24120b4507025a722d73a_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yNS9mcmFnOmE1MmJkOGZiZTY1ZjQ3ZWI4ZmVhNTIzNjZjZjJiM2NmL3RhYmxlOjEwZjViZTk1NjExOTQ5NzlhODdhYjVjZTdmZTgyYTIxL3RhYmxlcmFuZ2U6MTBmNWJlOTU2MTE5NDk3OWE4N2FiNWNlN2ZlODJhMjFfNy0zLTEtMS00Mjc5Mg_c6c813de-7093-4cf1-8011-780a0493209c"
      unitRef="usd">3508000</med:OperatingLeaseExpenseNonCash>
    <us-gaap:ShareBasedCompensation
      contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yNS9mcmFnOmE1MmJkOGZiZTY1ZjQ3ZWI4ZmVhNTIzNjZjZjJiM2NmL3RhYmxlOjEwZjViZTk1NjExOTQ5NzlhODdhYjVjZTdmZTgyYTIxL3RhYmxlcmFuZ2U6MTBmNWJlOTU2MTE5NDk3OWE4N2FiNWNlN2ZlODJhMjFfOC0xLTEtMS00Mjc5Mg_f06fb114-7b90-4c7f-ad68-ace1a63f12ed"
      unitRef="usd">8103000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="ic431430d1ab24120b4507025a722d73a_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yNS9mcmFnOmE1MmJkOGZiZTY1ZjQ3ZWI4ZmVhNTIzNjZjZjJiM2NmL3RhYmxlOjEwZjViZTk1NjExOTQ5NzlhODdhYjVjZTdmZTgyYTIxL3RhYmxlcmFuZ2U6MTBmNWJlOTU2MTE5NDk3OWE4N2FiNWNlN2ZlODJhMjFfOC0zLTEtMS00Mjc5Mg_9ebbd387-5510-4d96-8f79-46f3c7fc0107"
      unitRef="usd">6613000</us-gaap:ShareBasedCompensation>
    <med:AmortizationOfPremiumOnInvestmentSecurities
      contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yNS9mcmFnOmE1MmJkOGZiZTY1ZjQ3ZWI4ZmVhNTIzNjZjZjJiM2NmL3RhYmxlOjEwZjViZTk1NjExOTQ5NzlhODdhYjVjZTdmZTgyYTIxL3RhYmxlcmFuZ2U6MTBmNWJlOTU2MTE5NDk3OWE4N2FiNWNlN2ZlODJhMjFfMTAtMS0xLTEtNDI3OTI_39a88ea6-9601-4d54-8764-a728b3255b7b"
      unitRef="usd">14000</med:AmortizationOfPremiumOnInvestmentSecurities>
    <med:AmortizationOfPremiumOnInvestmentSecurities
      contextRef="ic431430d1ab24120b4507025a722d73a_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yNS9mcmFnOmE1MmJkOGZiZTY1ZjQ3ZWI4ZmVhNTIzNjZjZjJiM2NmL3RhYmxlOjEwZjViZTk1NjExOTQ5NzlhODdhYjVjZTdmZTgyYTIxL3RhYmxlcmFuZ2U6MTBmNWJlOTU2MTE5NDk3OWE4N2FiNWNlN2ZlODJhMjFfMTAtMy0xLTEtNDI3OTI_1845a214-57f9-4da6-8fba-490748ccced3"
      unitRef="usd">70000</med:AmortizationOfPremiumOnInvestmentSecurities>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yNS9mcmFnOmE1MmJkOGZiZTY1ZjQ3ZWI4ZmVhNTIzNjZjZjJiM2NmL3RhYmxlOjEwZjViZTk1NjExOTQ5NzlhODdhYjVjZTdmZTgyYTIxL3RhYmxlcmFuZ2U6MTBmNWJlOTU2MTE5NDk3OWE4N2FiNWNlN2ZlODJhMjFfMTEtMS0xLTEtNDI3OTI_e60ceaaa-f28f-44a3-87e2-140263af3017"
      unitRef="usd">-1746000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="ic431430d1ab24120b4507025a722d73a_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yNS9mcmFnOmE1MmJkOGZiZTY1ZjQ3ZWI4ZmVhNTIzNjZjZjJiM2NmL3RhYmxlOjEwZjViZTk1NjExOTQ5NzlhODdhYjVjZTdmZTgyYTIxL3RhYmxlcmFuZ2U6MTBmNWJlOTU2MTE5NDk3OWE4N2FiNWNlN2ZlODJhMjFfMTEtMy0xLTEtNDI3OTI_92a94342-a034-407f-be1d-44427af07d63"
      unitRef="usd">0</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yNS9mcmFnOmE1MmJkOGZiZTY1ZjQ3ZWI4ZmVhNTIzNjZjZjJiM2NmL3RhYmxlOjEwZjViZTk1NjExOTQ5NzlhODdhYjVjZTdmZTgyYTIxL3RhYmxlcmFuZ2U6MTBmNWJlOTU2MTE5NDk3OWE4N2FiNWNlN2ZlODJhMjFfMTQtMS0xLTEtNDI3OTI_d680cc76-7326-4837-bfc3-a4d86ce3e7e1"
      unitRef="usd">-34764000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="ic431430d1ab24120b4507025a722d73a_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yNS9mcmFnOmE1MmJkOGZiZTY1ZjQ3ZWI4ZmVhNTIzNjZjZjJiM2NmL3RhYmxlOjEwZjViZTk1NjExOTQ5NzlhODdhYjVjZTdmZTgyYTIxL3RhYmxlcmFuZ2U6MTBmNWJlOTU2MTE5NDk3OWE4N2FiNWNlN2ZlODJhMjFfMTQtMy0xLTEtNDI3OTI_dee37617-4e97-4aa5-b452-fc0357ae93e4"
      unitRef="usd">76222000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInPrepaidTaxes
      contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yNS9mcmFnOmE1MmJkOGZiZTY1ZjQ3ZWI4ZmVhNTIzNjZjZjJiM2NmL3RhYmxlOjEwZjViZTk1NjExOTQ5NzlhODdhYjVjZTdmZTgyYTIxL3RhYmxlcmFuZ2U6MTBmNWJlOTU2MTE5NDk3OWE4N2FiNWNlN2ZlODJhMjFfMTUtMS0xLTEtNDI3OTI_252704f3-0b50-4d34-9358-c7a269931e57"
      unitRef="usd">-795000</us-gaap:IncreaseDecreaseInPrepaidTaxes>
    <us-gaap:IncreaseDecreaseInPrepaidTaxes
      contextRef="ic431430d1ab24120b4507025a722d73a_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yNS9mcmFnOmE1MmJkOGZiZTY1ZjQ3ZWI4ZmVhNTIzNjZjZjJiM2NmL3RhYmxlOjEwZjViZTk1NjExOTQ5NzlhODdhYjVjZTdmZTgyYTIxL3RhYmxlcmFuZ2U6MTBmNWJlOTU2MTE5NDk3OWE4N2FiNWNlN2ZlODJhMjFfMTUtMy0xLTEtNDI3OTI_f2aad2e5-d38d-4550-88eb-2b01cd49283b"
      unitRef="usd">0</us-gaap:IncreaseDecreaseInPrepaidTaxes>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yNS9mcmFnOmE1MmJkOGZiZTY1ZjQ3ZWI4ZmVhNTIzNjZjZjJiM2NmL3RhYmxlOjEwZjViZTk1NjExOTQ5NzlhODdhYjVjZTdmZTgyYTIxL3RhYmxlcmFuZ2U6MTBmNWJlOTU2MTE5NDk3OWE4N2FiNWNlN2ZlODJhMjFfMTYtMS0xLTEtNDI3OTI_72e6553b-8444-4f6a-8b6d-c8e784cdaaac"
      unitRef="usd">-1889000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="ic431430d1ab24120b4507025a722d73a_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yNS9mcmFnOmE1MmJkOGZiZTY1ZjQ3ZWI4ZmVhNTIzNjZjZjJiM2NmL3RhYmxlOjEwZjViZTk1NjExOTQ5NzlhODdhYjVjZTdmZTgyYTIxL3RhYmxlcmFuZ2U6MTBmNWJlOTU2MTE5NDk3OWE4N2FiNWNlN2ZlODJhMjFfMTYtMy0xLTEtNDI3OTI_369cd9cd-d6f8-4f2b-a259-a3b303936710"
      unitRef="usd">5094000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets
      contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yNS9mcmFnOmE1MmJkOGZiZTY1ZjQ3ZWI4ZmVhNTIzNjZjZjJiM2NmL3RhYmxlOjEwZjViZTk1NjExOTQ5NzlhODdhYjVjZTdmZTgyYTIxL3RhYmxlcmFuZ2U6MTBmNWJlOTU2MTE5NDk3OWE4N2FiNWNlN2ZlODJhMjFfMTctMS0xLTEtNDI3OTI_fdc8725a-d2dd-4ce1-a0a1-a986f9ab7583"
      unitRef="usd">8545000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets
      contextRef="ic431430d1ab24120b4507025a722d73a_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yNS9mcmFnOmE1MmJkOGZiZTY1ZjQ3ZWI4ZmVhNTIzNjZjZjJiM2NmL3RhYmxlOjEwZjViZTk1NjExOTQ5NzlhODdhYjVjZTdmZTgyYTIxL3RhYmxlcmFuZ2U6MTBmNWJlOTU2MTE5NDk3OWE4N2FiNWNlN2ZlODJhMjFfMTctMy0xLTEtNDI3OTI_21f6e395-fb4f-4394-9523-cda2525787af"
      unitRef="usd">3393000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yNS9mcmFnOmE1MmJkOGZiZTY1ZjQ3ZWI4ZmVhNTIzNjZjZjJiM2NmL3RhYmxlOjEwZjViZTk1NjExOTQ5NzlhODdhYjVjZTdmZTgyYTIxL3RhYmxlcmFuZ2U6MTBmNWJlOTU2MTE5NDk3OWE4N2FiNWNlN2ZlODJhMjFfMTgtMS0xLTEtNDI3OTI_2656f10c-7f37-417f-b899-5999036f66b2"
      unitRef="usd">-22259000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="ic431430d1ab24120b4507025a722d73a_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yNS9mcmFnOmE1MmJkOGZiZTY1ZjQ3ZWI4ZmVhNTIzNjZjZjJiM2NmL3RhYmxlOjEwZjViZTk1NjExOTQ5NzlhODdhYjVjZTdmZTgyYTIxL3RhYmxlcmFuZ2U6MTBmNWJlOTU2MTE5NDk3OWE4N2FiNWNlN2ZlODJhMjFfMTgtMy0xLTEtNDI3OTI_b1abe8ed-ee93-49c0-9b51-2915b5f098ab"
      unitRef="usd">42747000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yNS9mcmFnOmE1MmJkOGZiZTY1ZjQ3ZWI4ZmVhNTIzNjZjZjJiM2NmL3RhYmxlOjEwZjViZTk1NjExOTQ5NzlhODdhYjVjZTdmZTgyYTIxL3RhYmxlcmFuZ2U6MTBmNWJlOTU2MTE5NDk3OWE4N2FiNWNlN2ZlODJhMjFfMTktMS0xLTEtNDI3OTI_618b955d-daa1-4725-b1c2-44460833526a"
      unitRef="usd">142831000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="ic431430d1ab24120b4507025a722d73a_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yNS9mcmFnOmE1MmJkOGZiZTY1ZjQ3ZWI4ZmVhNTIzNjZjZjJiM2NmL3RhYmxlOjEwZjViZTk1NjExOTQ5NzlhODdhYjVjZTdmZTgyYTIxL3RhYmxlcmFuZ2U6MTBmNWJlOTU2MTE5NDk3OWE4N2FiNWNlN2ZlODJhMjFfMTktMy0xLTEtNDI3OTI_06c974aa-c992-45e5-81a6-c37abc5e1c80"
      unitRef="usd">102004000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:ProceedsFromSaleOfShortTermInvestments
      contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yNS9mcmFnOmE1MmJkOGZiZTY1ZjQ3ZWI4ZmVhNTIzNjZjZjJiM2NmL3RhYmxlOjEwZjViZTk1NjExOTQ5NzlhODdhYjVjZTdmZTgyYTIxL3RhYmxlcmFuZ2U6MTBmNWJlOTU2MTE5NDk3OWE4N2FiNWNlN2ZlODJhMjFfMjItMS0xLTEtNDI3OTI_5a16e06a-02be-4501-a6e9-13d8b53685dc"
      unitRef="usd">5267000</us-gaap:ProceedsFromSaleOfShortTermInvestments>
    <us-gaap:ProceedsFromSaleOfShortTermInvestments
      contextRef="ic431430d1ab24120b4507025a722d73a_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yNS9mcmFnOmE1MmJkOGZiZTY1ZjQ3ZWI4ZmVhNTIzNjZjZjJiM2NmL3RhYmxlOjEwZjViZTk1NjExOTQ5NzlhODdhYjVjZTdmZTgyYTIxL3RhYmxlcmFuZ2U6MTBmNWJlOTU2MTE5NDk3OWE4N2FiNWNlN2ZlODJhMjFfMjItMy0xLTEtNDI3OTI_e465f417-d180-4cd1-9185-30810886cf9c"
      unitRef="usd">5145000</us-gaap:ProceedsFromSaleOfShortTermInvestments>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yNS9mcmFnOmE1MmJkOGZiZTY1ZjQ3ZWI4ZmVhNTIzNjZjZjJiM2NmL3RhYmxlOjEwZjViZTk1NjExOTQ5NzlhODdhYjVjZTdmZTgyYTIxL3RhYmxlcmFuZ2U6MTBmNWJlOTU2MTE5NDk3OWE4N2FiNWNlN2ZlODJhMjFfMjMtMS0xLTEtNDI3OTI_0520a961-789f-439a-a40f-bcec527eedfc"
      unitRef="usd">7617000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="ic431430d1ab24120b4507025a722d73a_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yNS9mcmFnOmE1MmJkOGZiZTY1ZjQ3ZWI4ZmVhNTIzNjZjZjJiM2NmL3RhYmxlOjEwZjViZTk1NjExOTQ5NzlhODdhYjVjZTdmZTgyYTIxL3RhYmxlcmFuZ2U6MTBmNWJlOTU2MTE5NDk3OWE4N2FiNWNlN2ZlODJhMjFfMjMtMy0xLTEtNDI3OTI_2c822ac3-d1cb-4422-84be-ad1080c95f47"
      unitRef="usd">22585000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yNS9mcmFnOmE1MmJkOGZiZTY1ZjQ3ZWI4ZmVhNTIzNjZjZjJiM2NmL3RhYmxlOjEwZjViZTk1NjExOTQ5NzlhODdhYjVjZTdmZTgyYTIxL3RhYmxlcmFuZ2U6MTBmNWJlOTU2MTE5NDk3OWE4N2FiNWNlN2ZlODJhMjFfMjQtMS0xLTEtNDI3OTI_ffef3d0c-3411-4110-86fc-d1ec3cec85cb"
      unitRef="usd">-2350000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="ic431430d1ab24120b4507025a722d73a_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yNS9mcmFnOmE1MmJkOGZiZTY1ZjQ3ZWI4ZmVhNTIzNjZjZjJiM2NmL3RhYmxlOjEwZjViZTk1NjExOTQ5NzlhODdhYjVjZTdmZTgyYTIxL3RhYmxlcmFuZ2U6MTBmNWJlOTU2MTE5NDk3OWE4N2FiNWNlN2ZlODJhMjFfMjQtMy0xLTEtNDI3OTI_b6f7d4a6-c95c-4201-9608-ebcf336b228b"
      unitRef="usd">-17440000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yNS9mcmFnOmE1MmJkOGZiZTY1ZjQ3ZWI4ZmVhNTIzNjZjZjJiM2NmL3RhYmxlOjEwZjViZTk1NjExOTQ5NzlhODdhYjVjZTdmZTgyYTIxL3RhYmxlcmFuZ2U6MTBmNWJlOTU2MTE5NDk3OWE4N2FiNWNlN2ZlODJhMjFfMjgtMS0xLTEtNDI3OTI_057e3ca4-42f0-4ea3-a041-788e273656f8"
      unitRef="usd">0</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="ic431430d1ab24120b4507025a722d73a_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yNS9mcmFnOmE1MmJkOGZiZTY1ZjQ3ZWI4ZmVhNTIzNjZjZjJiM2NmL3RhYmxlOjEwZjViZTk1NjExOTQ5NzlhODdhYjVjZTdmZTgyYTIxL3RhYmxlcmFuZ2U6MTBmNWJlOTU2MTE5NDk3OWE4N2FiNWNlN2ZlODJhMjFfMjgtMy0xLTEtNDI3OTI_601ba0b5-537b-4e94-b548-97d54c73b63e"
      unitRef="usd">811000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:PaymentsForRepurchaseOfOtherEquity
      contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yNS9mcmFnOmE1MmJkOGZiZTY1ZjQ3ZWI4ZmVhNTIzNjZjZjJiM2NmL3RhYmxlOjEwZjViZTk1NjExOTQ5NzlhODdhYjVjZTdmZTgyYTIxL3RhYmxlcmFuZ2U6MTBmNWJlOTU2MTE5NDk3OWE4N2FiNWNlN2ZlODJhMjFfMjktMS0xLTEtNDI3OTI_3f40b894-672c-4d1d-b5bf-0317983a405f"
      unitRef="usd">1504000</us-gaap:PaymentsForRepurchaseOfOtherEquity>
    <us-gaap:PaymentsForRepurchaseOfOtherEquity
      contextRef="ic431430d1ab24120b4507025a722d73a_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yNS9mcmFnOmE1MmJkOGZiZTY1ZjQ3ZWI4ZmVhNTIzNjZjZjJiM2NmL3RhYmxlOjEwZjViZTk1NjExOTQ5NzlhODdhYjVjZTdmZTgyYTIxL3RhYmxlcmFuZ2U6MTBmNWJlOTU2MTE5NDk3OWE4N2FiNWNlN2ZlODJhMjFfMjktMy0xLTEtNDI3OTI_e0961cb3-5979-42b6-8f7d-267c45b673d9"
      unitRef="usd">1867000</us-gaap:PaymentsForRepurchaseOfOtherEquity>
    <us-gaap:PaymentsOfDividends
      contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yNS9mcmFnOmE1MmJkOGZiZTY1ZjQ3ZWI4ZmVhNTIzNjZjZjJiM2NmL3RhYmxlOjEwZjViZTk1NjExOTQ5NzlhODdhYjVjZTdmZTgyYTIxL3RhYmxlcmFuZ2U6MTBmNWJlOTU2MTE5NDk3OWE4N2FiNWNlN2ZlODJhMjFfMzAtMS0xLTEtNDI3OTI_de811a30-3009-4609-b172-e02a9e3ceb56"
      unitRef="usd">53698000</us-gaap:PaymentsOfDividends>
    <us-gaap:PaymentsOfDividends
      contextRef="ic431430d1ab24120b4507025a722d73a_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yNS9mcmFnOmE1MmJkOGZiZTY1ZjQ3ZWI4ZmVhNTIzNjZjZjJiM2NmL3RhYmxlOjEwZjViZTk1NjExOTQ5NzlhODdhYjVjZTdmZTgyYTIxL3RhYmxlcmFuZ2U6MTBmNWJlOTU2MTE5NDk3OWE4N2FiNWNlN2ZlODJhMjFfMzAtMy0xLTEtNDI3OTI_237eaf91-24dd-4387-8a2d-5d609e6f2256"
      unitRef="usd">46845000</us-gaap:PaymentsOfDividends>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yNS9mcmFnOmE1MmJkOGZiZTY1ZjQ3ZWI4ZmVhNTIzNjZjZjJiM2NmL3RhYmxlOjEwZjViZTk1NjExOTQ5NzlhODdhYjVjZTdmZTgyYTIxL3RhYmxlcmFuZ2U6MTBmNWJlOTU2MTE5NDk3OWE4N2FiNWNlN2ZlODJhMjFfMzEtMS0xLTEtNDI3OTI_7ad717b9-3666-4cb0-874d-621566f41543"
      unitRef="usd">120048000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="ic431430d1ab24120b4507025a722d73a_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yNS9mcmFnOmE1MmJkOGZiZTY1ZjQ3ZWI4ZmVhNTIzNjZjZjJiM2NmL3RhYmxlOjEwZjViZTk1NjExOTQ5NzlhODdhYjVjZTdmZTgyYTIxL3RhYmxlcmFuZ2U6MTBmNWJlOTU2MTE5NDk3OWE4N2FiNWNlN2ZlODJhMjFfMzEtMy0xLTEtNDI3OTI_0a35d764-411a-4906-810c-74fbbe99a9f8"
      unitRef="usd">46000000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yNS9mcmFnOmE1MmJkOGZiZTY1ZjQ3ZWI4ZmVhNTIzNjZjZjJiM2NmL3RhYmxlOjEwZjViZTk1NjExOTQ5NzlhODdhYjVjZTdmZTgyYTIxL3RhYmxlcmFuZ2U6MTBmNWJlOTU2MTE5NDk3OWE4N2FiNWNlN2ZlODJhMjFfMzMtMS0xLTEtNDI3OTI_f929402f-d405-4b71-8a55-fc50c2c74dc1"
      unitRef="usd">-175250000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="ic431430d1ab24120b4507025a722d73a_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yNS9mcmFnOmE1MmJkOGZiZTY1ZjQ3ZWI4ZmVhNTIzNjZjZjJiM2NmL3RhYmxlOjEwZjViZTk1NjExOTQ5NzlhODdhYjVjZTdmZTgyYTIxL3RhYmxlcmFuZ2U6MTBmNWJlOTU2MTE5NDk3OWE4N2FiNWNlN2ZlODJhMjFfMzMtMy0xLTEtNDI3OTI_924b235d-a564-477f-944e-bce8abda89f2"
      unitRef="usd">-93901000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yNS9mcmFnOmE1MmJkOGZiZTY1ZjQ3ZWI4ZmVhNTIzNjZjZjJiM2NmL3RhYmxlOjEwZjViZTk1NjExOTQ5NzlhODdhYjVjZTdmZTgyYTIxL3RhYmxlcmFuZ2U6MTBmNWJlOTU2MTE5NDk3OWE4N2FiNWNlN2ZlODJhMjFfMzUtMS0xLTEtNDI3OTI_6eea6b9e-3d75-4aee-b8b6-90f2294501a1"
      unitRef="usd">296000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ic431430d1ab24120b4507025a722d73a_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yNS9mcmFnOmE1MmJkOGZiZTY1ZjQ3ZWI4ZmVhNTIzNjZjZjJiM2NmL3RhYmxlOjEwZjViZTk1NjExOTQ5NzlhODdhYjVjZTdmZTgyYTIxL3RhYmxlcmFuZ2U6MTBmNWJlOTU2MTE5NDk3OWE4N2FiNWNlN2ZlODJhMjFfMzUtMy0xLTEtNDI3OTI_8ea56dcb-1d40-400a-9f8d-9ecfd6efdcf4"
      unitRef="usd">130000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yNS9mcmFnOmE1MmJkOGZiZTY1ZjQ3ZWI4ZmVhNTIzNjZjZjJiM2NmL3RhYmxlOjEwZjViZTk1NjExOTQ5NzlhODdhYjVjZTdmZTgyYTIxL3RhYmxlcmFuZ2U6MTBmNWJlOTU2MTE5NDk3OWE4N2FiNWNlN2ZlODJhMjFfMzctMS0xLTEtNDI3OTI_9f833e61-f2a8-4398-ad42-e3bdc310eebe"
      unitRef="usd">-34473000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="ic431430d1ab24120b4507025a722d73a_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yNS9mcmFnOmE1MmJkOGZiZTY1ZjQ3ZWI4ZmVhNTIzNjZjZjJiM2NmL3RhYmxlOjEwZjViZTk1NjExOTQ5NzlhODdhYjVjZTdmZTgyYTIxL3RhYmxlcmFuZ2U6MTBmNWJlOTU2MTE5NDk3OWE4N2FiNWNlN2ZlODJhMjFfMzctMy0xLTEtNDI3OTI_0ee3a712-6291-4b18-994c-d2bb238ac0b8"
      unitRef="usd">-9207000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i47f09f18839440ffae0cf05a475aa7fe_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yNS9mcmFnOmE1MmJkOGZiZTY1ZjQ3ZWI4ZmVhNTIzNjZjZjJiM2NmL3RhYmxlOjEwZjViZTk1NjExOTQ5NzlhODdhYjVjZTdmZTgyYTIxL3RhYmxlcmFuZ2U6MTBmNWJlOTU2MTE5NDk3OWE4N2FiNWNlN2ZlODJhMjFfMzgtMS0xLTEtNDI3OTI_bbe1d34d-8656-4674-a5e2-a4f2f4c416f4"
      unitRef="usd">104183000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i03d902ffc72e4d98b5eeb6fb903f405b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yNS9mcmFnOmE1MmJkOGZiZTY1ZjQ3ZWI4ZmVhNTIzNjZjZjJiM2NmL3RhYmxlOjEwZjViZTk1NjExOTQ5NzlhODdhYjVjZTdmZTgyYTIxL3RhYmxlcmFuZ2U6MTBmNWJlOTU2MTE5NDk3OWE4N2FiNWNlN2ZlODJhMjFfMzgtMy0xLTEtNDI3OTI_ec7efb2a-ed20-455e-a52a-d9dbcbc87006"
      unitRef="usd">163723000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i5de311f5948148cda49342e2cea83715_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yNS9mcmFnOmE1MmJkOGZiZTY1ZjQ3ZWI4ZmVhNTIzNjZjZjJiM2NmL3RhYmxlOjEwZjViZTk1NjExOTQ5NzlhODdhYjVjZTdmZTgyYTIxL3RhYmxlcmFuZ2U6MTBmNWJlOTU2MTE5NDk3OWE4N2FiNWNlN2ZlODJhMjFfMzktMS0xLTEtNDI3OTI_9a56f374-df4a-4987-8980-c32ea0f928b9"
      unitRef="usd">69710000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ifb5de6f6a1b842d59a7c6674c3095ce8_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yNS9mcmFnOmE1MmJkOGZiZTY1ZjQ3ZWI4ZmVhNTIzNjZjZjJiM2NmL3RhYmxlOjEwZjViZTk1NjExOTQ5NzlhODdhYjVjZTdmZTgyYTIxL3RhYmxlcmFuZ2U6MTBmNWJlOTU2MTE5NDk3OWE4N2FiNWNlN2ZlODJhMjFfMzktMy0xLTEtNDI3OTI_211efb01-8c22-43d2-947a-2f9486b668ee"
      unitRef="usd">154516000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yNS9mcmFnOmE1MmJkOGZiZTY1ZjQ3ZWI4ZmVhNTIzNjZjZjJiM2NmL3RhYmxlOjEwZjViZTk1NjExOTQ5NzlhODdhYjVjZTdmZTgyYTIxL3RhYmxlcmFuZ2U6MTBmNWJlOTU2MTE5NDk3OWE4N2FiNWNlN2ZlODJhMjFfNDItMS0xLTEtNDI3OTI_28e41871-7ba6-42a0-8130-8a3240254ccb"
      unitRef="usd">33906000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="ic431430d1ab24120b4507025a722d73a_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yNS9mcmFnOmE1MmJkOGZiZTY1ZjQ3ZWI4ZmVhNTIzNjZjZjJiM2NmL3RhYmxlOjEwZjViZTk1NjExOTQ5NzlhODdhYjVjZTdmZTgyYTIxL3RhYmxlcmFuZ2U6MTBmNWJlOTU2MTE5NDk3OWE4N2FiNWNlN2ZlODJhMjFfNDItMy0xLTEtNDI3OTI_33569e70-b3ea-4d11-9b34-d0e270d89d2c"
      unitRef="usd">41302000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:DividendsCash
      contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yNS9mcmFnOmE1MmJkOGZiZTY1ZjQ3ZWI4ZmVhNTIzNjZjZjJiM2NmL3RhYmxlOjEwZjViZTk1NjExOTQ5NzlhODdhYjVjZTdmZTgyYTIxL3RhYmxlcmFuZ2U6MTBmNWJlOTU2MTE5NDk3OWE4N2FiNWNlN2ZlODJhMjFfNDMtMS0xLTEtNDI3OTI_97098aae-503c-4a0a-9799-a2fafd7fe6bf"
      unitRef="usd">19395000</us-gaap:DividendsCash>
    <us-gaap:DividendsCash
      contextRef="ic431430d1ab24120b4507025a722d73a_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yNS9mcmFnOmE1MmJkOGZiZTY1ZjQ3ZWI4ZmVhNTIzNjZjZjJiM2NmL3RhYmxlOjEwZjViZTk1NjExOTQ5NzlhODdhYjVjZTdmZTgyYTIxL3RhYmxlcmFuZ2U6MTBmNWJlOTU2MTE5NDk3OWE4N2FiNWNlN2ZlODJhMjFfNDMtMy0xLTEtNDI3OTI_f99cf643-225a-40cc-8f1a-ad8875768514"
      unitRef="usd">17351000</us-gaap:DividendsCash>
    <us-gaap:CommonStockSharesIssued
      contextRef="i77931d79ec4a440094a82f9812ccc722_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOmYwOWZlYWUyNmU5OTQ5Mzk4MDk5NmU5MjgzMzdkZDZiL3RhYmxlcmFuZ2U6ZjA5ZmVhZTI2ZTk5NDkzOTgwOTk2ZTkyODMzN2RkNmJfMy0xLTEtMS00Mjc5Mg_86976645-d4e7-48b2-b036-ebaf4c9aedd9"
      unitRef="shares">11594000</us-gaap:CommonStockSharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="i77931d79ec4a440094a82f9812ccc722_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOmYwOWZlYWUyNmU5OTQ5Mzk4MDk5NmU5MjgzMzdkZDZiL3RhYmxlcmFuZ2U6ZjA5ZmVhZTI2ZTk5NDkzOTgwOTk2ZTkyODMzN2RkNmJfMy0zLTEtMS00Mjc5Mg_285b6b2d-1ee3-4dfa-9d20-c353695d9ab6"
      unitRef="usd">12000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i4daa9b081467438bab4674c0946e08cd_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOmYwOWZlYWUyNmU5OTQ5Mzk4MDk5NmU5MjgzMzdkZDZiL3RhYmxlcmFuZ2U6ZjA5ZmVhZTI2ZTk5NDkzOTgwOTk2ZTkyODMzN2RkNmJfMy01LTEtMS00Mjc5Mg_bcd54ed4-280b-438b-a7f4-9d51796b4cd5"
      unitRef="usd">12018000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="id19243f3c67e4c9db2d2085c6f295c96_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOmYwOWZlYWUyNmU5OTQ5Mzk4MDk5NmU5MjgzMzdkZDZiL3RhYmxlcmFuZ2U6ZjA5ZmVhZTI2ZTk5NDkzOTgwOTk2ZTkyODMzN2RkNmJfMy03LTEtMS00Mjc5Mg_2b3c046b-42af-4fc1-9403-cd395350a58d"
      unitRef="usd">111000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ic425e1f1f3a24303b14c8132e098ec51_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOmYwOWZlYWUyNmU5OTQ5Mzk4MDk5NmU5MjgzMzdkZDZiL3RhYmxlcmFuZ2U6ZjA5ZmVhZTI2ZTk5NDkzOTgwOTk2ZTkyODMzN2RkNmJfMy05LTEtMS00Mjc5Mg_a06ebfd8-d47b-4860-b99e-60803a29c44d"
      unitRef="usd">190333000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i87d2a4b91677497c84867fb9eb0d1fe3_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOmYwOWZlYWUyNmU5OTQ5Mzk4MDk5NmU5MjgzMzdkZDZiL3RhYmxlcmFuZ2U6ZjA5ZmVhZTI2ZTk5NDkzOTgwOTk2ZTkyODMzN2RkNmJfMy0xMS0xLTEtNDI3OTI_bc0478aa-bc29-4f5e-8e96-241b369a0761"
      unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i47f09f18839440ffae0cf05a475aa7fe_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOmYwOWZlYWUyNmU5OTQ5Mzk4MDk5NmU5MjgzMzdkZDZiL3RhYmxlcmFuZ2U6ZjA5ZmVhZTI2ZTk5NDkzOTgwOTk2ZTkyODMzN2RkNmJfMy0xMy0xLTEtNDI3OTI_d46079a6-4935-494c-b542-1861b8279402"
      unitRef="usd">202474000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="i4c296c25c3154c589996445b02c8b46f_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOmYwOWZlYWUyNmU5OTQ5Mzk4MDk5NmU5MjgzMzdkZDZiL3RhYmxlcmFuZ2U6ZjA5ZmVhZTI2ZTk5NDkzOTgwOTk2ZTkyODMzN2RkNmJfNC05LTEtMS00Mjc5Mg_5fd9cee4-2253-48c0-a892-95535b0bcdb9"
      unitRef="usd">41781000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i35ec1b88d067414ebdd617a1caddf764_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOmYwOWZlYWUyNmU5OTQ5Mzk4MDk5NmU5MjgzMzdkZDZiL3RhYmxlcmFuZ2U6ZjA5ZmVhZTI2ZTk5NDkzOTgwOTk2ZTkyODMzN2RkNmJfNC0xMy0xLTEtNDI3OTI_44ce9256-173c-4dc2-88b2-b397bdbef6d8"
      unitRef="usd">41781000</us-gaap:NetIncomeLoss>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod
      contextRef="i9d58012ea00c40debc6e3821ba8c53e8_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOmYwOWZlYWUyNmU5OTQ5Mzk4MDk5NmU5MjgzMzdkZDZiL3RhYmxlcmFuZ2U6ZjA5ZmVhZTI2ZTk5NDkzOTgwOTk2ZTkyODMzN2RkNmJfNS0xLTEtMS00Mjc5Mg_d4af9c93-c6f9-499e-bdcf-17b5ec49fb8b"
      unitRef="shares">18000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
      contextRef="ifef10a2343ba477a98a2732ea2e3188d_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOmYwOWZlYWUyNmU5OTQ5Mzk4MDk5NmU5MjgzMzdkZDZiL3RhYmxlcmFuZ2U6ZjA5ZmVhZTI2ZTk5NDkzOTgwOTk2ZTkyODMzN2RkNmJfNS01LTEtMS00Mjc5Mg_9dfd3af8-bbe7-4622-abac-e8c7370eb64e"
      unitRef="usd">2275000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
      contextRef="i35ec1b88d067414ebdd617a1caddf764_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOmYwOWZlYWUyNmU5OTQ5Mzk4MDk5NmU5MjgzMzdkZDZiL3RhYmxlcmFuZ2U6ZjA5ZmVhZTI2ZTk5NDkzOTgwOTk2ZTkyODMzN2RkNmJfNS0xMy0xLTEtNDI3OTI_994adb5f-d7dc-405a-aaa5-9e6d65c64752"
      unitRef="usd">2275000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions>
    <us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation
      contextRef="i9d58012ea00c40debc6e3821ba8c53e8_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOmYwOWZlYWUyNmU5OTQ5Mzk4MDk5NmU5MjgzMzdkZDZiL3RhYmxlcmFuZ2U6ZjA5ZmVhZTI2ZTk5NDkzOTgwOTk2ZTkyODMzN2RkNmJfNi0xLTEtMS00Mjc5Mg_e9ddcbe9-bbb5-4bc0-af96-27a02fb013e7"
      unitRef="shares">8000</us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="ifef10a2343ba477a98a2732ea2e3188d_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOmYwOWZlYWUyNmU5OTQ5Mzk4MDk5NmU5MjgzMzdkZDZiL3RhYmxlcmFuZ2U6ZjA5ZmVhZTI2ZTk5NDkzOTgwOTk2ZTkyODMzN2RkNmJfNi01LTEtMS00Mjc5Mg_fc2e5ab2-ab3f-4c2a-a483-ec6b78e50f2f"
      unitRef="usd">1459000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i35ec1b88d067414ebdd617a1caddf764_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOmYwOWZlYWUyNmU5OTQ5Mzk4MDk5NmU5MjgzMzdkZDZiL3RhYmxlcmFuZ2U6ZjA5ZmVhZTI2ZTk5NDkzOTgwOTk2ZTkyODMzN2RkNmJfNi0xMy0xLTEtNDI3OTI_b047598d-8a8d-4458-851f-5d119e3d907f"
      unitRef="usd">1459000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="ifcda0fa259164bf4a392c5cadde798d0_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOmYwOWZlYWUyNmU5OTQ5Mzk4MDk5NmU5MjgzMzdkZDZiL3RhYmxlcmFuZ2U6ZjA5ZmVhZTI2ZTk5NDkzOTgwOTk2ZTkyODMzN2RkNmJfNy0xMS0xLTEtNDI3OTI_30d09897-82e5-44ba-bf66-c51592848663"
      unitRef="usd">10000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i35ec1b88d067414ebdd617a1caddf764_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOmYwOWZlYWUyNmU5OTQ5Mzk4MDk5NmU5MjgzMzdkZDZiL3RhYmxlcmFuZ2U6ZjA5ZmVhZTI2ZTk5NDkzOTgwOTk2ZTkyODMzN2RkNmJfNy0xMy0xLTEtNDI3OTI_81a7b37b-975a-477e-861f-4421c3cc03b8"
      unitRef="usd">10000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockSharesRetired
      contextRef="i9d58012ea00c40debc6e3821ba8c53e8_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOmYwOWZlYWUyNmU5OTQ5Mzk4MDk5NmU5MjgzMzdkZDZiL3RhYmxlcmFuZ2U6ZjA5ZmVhZTI2ZTk5NDkzOTgwOTk2ZTkyODMzN2RkNmJfOC0xLTEtMS00Mjc5Mg_c2bd1c78-60b1-480d-9c18-4a7492c10460"
      unitRef="shares">51000</us-gaap:TreasuryStockSharesRetired>
    <us-gaap:TreasuryStockRetiredCostMethodAmount
      contextRef="i4c296c25c3154c589996445b02c8b46f_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOmYwOWZlYWUyNmU5OTQ5Mzk4MDk5NmU5MjgzMzdkZDZiL3RhYmxlcmFuZ2U6ZjA5ZmVhZTI2ZTk5NDkzOTgwOTk2ZTkyODMzN2RkNmJfOC05LTEtMS00Mjc5Mg_d8b97f36-2627-4175-a7ae-c5f577a29b21"
      unitRef="usd">10000000</us-gaap:TreasuryStockRetiredCostMethodAmount>
    <us-gaap:TreasuryStockRetiredCostMethodAmount
      contextRef="ifcda0fa259164bf4a392c5cadde798d0_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOmYwOWZlYWUyNmU5OTQ5Mzk4MDk5NmU5MjgzMzdkZDZiL3RhYmxlcmFuZ2U6ZjA5ZmVhZTI2ZTk5NDkzOTgwOTk2ZTkyODMzN2RkNmJfOC0xMS0xLTEtNDI3OTI_99c0cad7-449c-4386-aa36-b0e76f04a652"
      unitRef="usd">-10000000</us-gaap:TreasuryStockRetiredCostMethodAmount>
    <us-gaap:TreasuryStockRetiredCostMethodAmount
      contextRef="i35ec1b88d067414ebdd617a1caddf764_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOmYwOWZlYWUyNmU5OTQ5Mzk4MDk5NmU5MjgzMzdkZDZiL3RhYmxlcmFuZ2U6ZjA5ZmVhZTI2ZTk5NDkzOTgwOTk2ZTkyODMzN2RkNmJfOC0xMy0xLTEtNDI3OTI_ebbb8c5c-a2e0-4ce5-a899-9d7cc4dfed2d"
      unitRef="usd">0</us-gaap:TreasuryStockRetiredCostMethodAmount>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="iedb06a9ecbbd425b9ff4de89c5ec443c_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOmYwOWZlYWUyNmU5OTQ5Mzk4MDk5NmU5MjgzMzdkZDZiL3RhYmxlcmFuZ2U6ZjA5ZmVhZTI2ZTk5NDkzOTgwOTk2ZTkyODMzN2RkNmJfOS03LTEtMS00Mjc5Mg_b16c1351-3d64-44be-aecb-9774f6e6082f"
      unitRef="usd">16000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i35ec1b88d067414ebdd617a1caddf764_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOmYwOWZlYWUyNmU5OTQ5Mzk4MDk5NmU5MjgzMzdkZDZiL3RhYmxlcmFuZ2U6ZjA5ZmVhZTI2ZTk5NDkzOTgwOTk2ZTkyODMzN2RkNmJfOS0xMy0xLTEtNDI3OTI_9ed6eee9-418f-4d7f-a5ca-83091bb5914d"
      unitRef="usd">16000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:DividendsCommonStockCash
      contextRef="i4c296c25c3154c589996445b02c8b46f_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOmYwOWZlYWUyNmU5OTQ5Mzk4MDk5NmU5MjgzMzdkZDZiL3RhYmxlcmFuZ2U6ZjA5ZmVhZTI2ZTk5NDkzOTgwOTk2ZTkyODMzN2RkNmJfMTAtOS0xLTEtNDI3OTI_ab160f31-d67e-4127-8b85-ee1085ca1370"
      unitRef="usd">19063000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="i35ec1b88d067414ebdd617a1caddf764_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOmYwOWZlYWUyNmU5OTQ5Mzk4MDk5NmU5MjgzMzdkZDZiL3RhYmxlcmFuZ2U6ZjA5ZmVhZTI2ZTk5NDkzOTgwOTk2ZTkyODMzN2RkNmJfMTAtMTMtMS0xLTQyNzky_bf1bd379-ec8b-4c39-94b4-2d30fc80213f"
      unitRef="usd">19063000</us-gaap:DividendsCommonStockCash>
    <us-gaap:CommonStockSharesIssued
      contextRef="i1aa514aadcf045659a010e7c7dff59d4_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOmYwOWZlYWUyNmU5OTQ5Mzk4MDk5NmU5MjgzMzdkZDZiL3RhYmxlcmFuZ2U6ZjA5ZmVhZTI2ZTk5NDkzOTgwOTk2ZTkyODMzN2RkNmJfMTItMS0xLTEtNDI3OTI_9cf606a6-f4d3-4a4b-aa68-cd61be7367ac"
      unitRef="shares">11553000</us-gaap:CommonStockSharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="i1aa514aadcf045659a010e7c7dff59d4_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOmYwOWZlYWUyNmU5OTQ5Mzk4MDk5NmU5MjgzMzdkZDZiL3RhYmxlcmFuZ2U6ZjA5ZmVhZTI2ZTk5NDkzOTgwOTk2ZTkyODMzN2RkNmJfMTItMy0xLTEtNDI3OTI_352a75f0-83d5-40c4-981e-57d8db0367a6"
      unitRef="usd">12000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i9b72febc917d4ba4a54ef5179a1ddbbf_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOmYwOWZlYWUyNmU5OTQ5Mzk4MDk5NmU5MjgzMzdkZDZiL3RhYmxlcmFuZ2U6ZjA5ZmVhZTI2ZTk5NDkzOTgwOTk2ZTkyODMzN2RkNmJfMTItNS0xLTEtNDI3OTI_dd70086b-bfa8-4b08-b6ec-707aadf2fb7d"
      unitRef="usd">12834000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="id441c59bc18c4d6faf4dc590c7376782_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOmYwOWZlYWUyNmU5OTQ5Mzk4MDk5NmU5MjgzMzdkZDZiL3RhYmxlcmFuZ2U6ZjA5ZmVhZTI2ZTk5NDkzOTgwOTk2ZTkyODMzN2RkNmJfMTItNy0xLTEtNDI3OTI_11ba3119-736d-4531-80fa-23b28efe8d05"
      unitRef="usd">127000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i6b8a276003b3422d87146a73aca9877e_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOmYwOWZlYWUyNmU5OTQ5Mzk4MDk5NmU5MjgzMzdkZDZiL3RhYmxlcmFuZ2U6ZjA5ZmVhZTI2ZTk5NDkzOTgwOTk2ZTkyODMzN2RkNmJfMTItOS0xLTEtNDI3OTI_9ea22545-114d-4725-aebd-eb61dffa1f84"
      unitRef="usd">203051000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i5d8f60be441544f9a5706ed808193db4_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOmYwOWZlYWUyNmU5OTQ5Mzk4MDk5NmU5MjgzMzdkZDZiL3RhYmxlcmFuZ2U6ZjA5ZmVhZTI2ZTk5NDkzOTgwOTk2ZTkyODMzN2RkNmJfMTItMTEtMS0xLTQyNzky_c0402550-7d80-495b-a711-d2dafc0a3500"
      unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ife6dd959a81f4995b5e17747ce77289e_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOmYwOWZlYWUyNmU5OTQ5Mzk4MDk5NmU5MjgzMzdkZDZiL3RhYmxlcmFuZ2U6ZjA5ZmVhZTI2ZTk5NDkzOTgwOTk2ZTkyODMzN2RkNmJfMTItMTMtMS0xLTQyNzky_f1bbe1b7-60c3-4a4c-b92b-08b00ee76693"
      unitRef="usd">216024000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="i825be310f0914f779c3296901da45216_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOmYwOWZlYWUyNmU5OTQ5Mzk4MDk5NmU5MjgzMzdkZDZiL3RhYmxlcmFuZ2U6ZjA5ZmVhZTI2ZTk5NDkzOTgwOTk2ZTkyODMzN2RkNmJfMTMtOS0xLTEtNDI3OTI_134c5d6f-339f-46c1-aec8-8c4dbd2e8afd"
      unitRef="usd">39113000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i6a350b34ff224fcfb66d3b6986b8d85d_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOmYwOWZlYWUyNmU5OTQ5Mzk4MDk5NmU5MjgzMzdkZDZiL3RhYmxlcmFuZ2U6ZjA5ZmVhZTI2ZTk5NDkzOTgwOTk2ZTkyODMzN2RkNmJfMTMtMTMtMS0xLTQyNzky_efee6062-6a9e-40c5-8d3b-430fdd09d64e"
      unitRef="usd">39113000</us-gaap:NetIncomeLoss>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod
      contextRef="i31e2c05019204ecc9f2b00f8685ed1de_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOmYwOWZlYWUyNmU5OTQ5Mzk4MDk5NmU5MjgzMzdkZDZiL3RhYmxlcmFuZ2U6ZjA5ZmVhZTI2ZTk5NDkzOTgwOTk2ZTkyODMzN2RkNmJfMTQtMS0xLTEtNDI3OTI_92112386-0da4-4783-b9ce-09f47af45778"
      unitRef="shares">1000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
      contextRef="i7c04a52245ee4a18af7538a5b3926bd8_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOmYwOWZlYWUyNmU5OTQ5Mzk4MDk5NmU5MjgzMzdkZDZiL3RhYmxlcmFuZ2U6ZjA5ZmVhZTI2ZTk5NDkzOTgwOTk2ZTkyODMzN2RkNmJfMTQtNS0xLTEtNDI3OTI_8d36cfd6-1c21-47a6-bafe-d70378f3f2e2"
      unitRef="usd">2865000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
      contextRef="i6a350b34ff224fcfb66d3b6986b8d85d_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOmYwOWZlYWUyNmU5OTQ5Mzk4MDk5NmU5MjgzMzdkZDZiL3RhYmxlcmFuZ2U6ZjA5ZmVhZTI2ZTk5NDkzOTgwOTk2ZTkyODMzN2RkNmJfMTQtMTMtMS0xLTQyNzky_2fecf6ad-fcfa-41d5-98a7-b93244a9392f"
      unitRef="usd">2865000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i7c04a52245ee4a18af7538a5b3926bd8_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOmYwOWZlYWUyNmU5OTQ5Mzk4MDk5NmU5MjgzMzdkZDZiL3RhYmxlcmFuZ2U6ZjA5ZmVhZTI2ZTk5NDkzOTgwOTk2ZTkyODMzN2RkNmJfMTUtNS0xLTEtNDI3OTI_b6e0c757-eb7f-4eb2-ad55-29b52934a967"
      unitRef="usd">20000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i6a350b34ff224fcfb66d3b6986b8d85d_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOmYwOWZlYWUyNmU5OTQ5Mzk4MDk5NmU5MjgzMzdkZDZiL3RhYmxlcmFuZ2U6ZjA5ZmVhZTI2ZTk5NDkzOTgwOTk2ZTkyODMzN2RkNmJfMTUtMTMtMS0xLTQyNzky_6e27534e-9af5-4c5b-9437-6999bb1bbdc2"
      unitRef="usd">20000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i3fe461be5d8a4b1d8f4f96a4471aae50_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOmYwOWZlYWUyNmU5OTQ5Mzk4MDk5NmU5MjgzMzdkZDZiL3RhYmxlcmFuZ2U6ZjA5ZmVhZTI2ZTk5NDkzOTgwOTk2ZTkyODMzN2RkNmJfMTYtMTEtMS0xLTQyNzky_88defd38-7015-4b0c-97ec-de5f6d1aef77"
      unitRef="usd">90038000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i6a350b34ff224fcfb66d3b6986b8d85d_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOmYwOWZlYWUyNmU5OTQ5Mzk4MDk5NmU5MjgzMzdkZDZiL3RhYmxlcmFuZ2U6ZjA5ZmVhZTI2ZTk5NDkzOTgwOTk2ZTkyODMzN2RkNmJfMTYtMTMtMS0xLTQyNzky_711672e3-7e11-4732-8b45-c592f2f4763b"
      unitRef="usd">90038000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockSharesRetired
      contextRef="i31e2c05019204ecc9f2b00f8685ed1de_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOmYwOWZlYWUyNmU5OTQ5Mzk4MDk5NmU5MjgzMzdkZDZiL3RhYmxlcmFuZ2U6ZjA5ZmVhZTI2ZTk5NDkzOTgwOTk2ZTkyODMzN2RkNmJfMTctMS0xLTEtNDI3OTI_f266dec4-29e2-4d76-97f0-08aca6a5ca6f"
      unitRef="shares">535000</us-gaap:TreasuryStockSharesRetired>
    <us-gaap:TreasuryStockRetiredCostMethodAmount
      contextRef="i31e2c05019204ecc9f2b00f8685ed1de_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOmYwOWZlYWUyNmU5OTQ5Mzk4MDk5NmU5MjgzMzdkZDZiL3RhYmxlcmFuZ2U6ZjA5ZmVhZTI2ZTk5NDkzOTgwOTk2ZTkyODMzN2RkNmJfMTctMy0xLTEtNDI3OTI_d022abf6-bca2-4c6d-a249-9a2955a7d0d7"
      unitRef="usd">1000</us-gaap:TreasuryStockRetiredCostMethodAmount>
    <us-gaap:TreasuryStockRetiredCostMethodAmount
      contextRef="i825be310f0914f779c3296901da45216_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOmYwOWZlYWUyNmU5OTQ5Mzk4MDk5NmU5MjgzMzdkZDZiL3RhYmxlcmFuZ2U6ZjA5ZmVhZTI2ZTk5NDkzOTgwOTk2ZTkyODMzN2RkNmJfMTctOS0xLTEtNDI3OTI_9d09d5ba-ba4d-47d3-b18d-6604160363ef"
      unitRef="usd">90038000</us-gaap:TreasuryStockRetiredCostMethodAmount>
    <us-gaap:TreasuryStockRetiredCostMethodAmount
      contextRef="i3fe461be5d8a4b1d8f4f96a4471aae50_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOmYwOWZlYWUyNmU5OTQ5Mzk4MDk5NmU5MjgzMzdkZDZiL3RhYmxlcmFuZ2U6ZjA5ZmVhZTI2ZTk5NDkzOTgwOTk2ZTkyODMzN2RkNmJfMTctMTEtMS0xLTQyNzky_371cc47f-ae0d-41bc-9359-ad151253b0cc"
      unitRef="usd">-90038000</us-gaap:TreasuryStockRetiredCostMethodAmount>
    <us-gaap:TreasuryStockRetiredCostMethodAmount
      contextRef="i6a350b34ff224fcfb66d3b6986b8d85d_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOmYwOWZlYWUyNmU5OTQ5Mzk4MDk5NmU5MjgzMzdkZDZiL3RhYmxlcmFuZ2U6ZjA5ZmVhZTI2ZTk5NDkzOTgwOTk2ZTkyODMzN2RkNmJfMTctMTMtMS0xLTQyNzky_4757ded8-a717-4ade-8916-fd4a67c7181e"
      unitRef="usd">1000</us-gaap:TreasuryStockRetiredCostMethodAmount>
    <med:AdjustmentsToPaidInCapitalShareRepurchasesNotYetSettled
      contextRef="i7c04a52245ee4a18af7538a5b3926bd8_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOmYwOWZlYWUyNmU5OTQ5Mzk4MDk5NmU5MjgzMzdkZDZiL3RhYmxlcmFuZ2U6ZjA5ZmVhZTI2ZTk5NDkzOTgwOTk2ZTkyODMzN2RkNmJfMTgtNS0xLTEtNDI3OTI_e622db32-1dc5-4111-814f-c8162a1e8793"
      unitRef="usd">15679000</med:AdjustmentsToPaidInCapitalShareRepurchasesNotYetSettled>
    <med:AdjustmentsToPaidInCapitalShareRepurchasesNotYetSettled
      contextRef="i825be310f0914f779c3296901da45216_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOmYwOWZlYWUyNmU5OTQ5Mzk4MDk5NmU5MjgzMzdkZDZiL3RhYmxlcmFuZ2U6ZjA5ZmVhZTI2ZTk5NDkzOTgwOTk2ZTkyODMzN2RkNmJfMTgtOS0xLTEtNDI3OTI_ae9de390-9706-443c-b847-0c3dc26a6ab1"
      unitRef="usd">4331000</med:AdjustmentsToPaidInCapitalShareRepurchasesNotYetSettled>
    <med:AdjustmentsToPaidInCapitalShareRepurchasesNotYetSettled
      contextRef="i6a350b34ff224fcfb66d3b6986b8d85d_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOmYwOWZlYWUyNmU5OTQ5Mzk4MDk5NmU5MjgzMzdkZDZiL3RhYmxlcmFuZ2U6ZjA5ZmVhZTI2ZTk5NDkzOTgwOTk2ZTkyODMzN2RkNmJfMTgtMTMtMS0xLTQyNzky_cec1efb8-8488-4a0e-b807-1ccaf5d2c6b6"
      unitRef="usd">20010000</med:AdjustmentsToPaidInCapitalShareRepurchasesNotYetSettled>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i4b731dc434c94dbca7470032b562d581_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOmYwOWZlYWUyNmU5OTQ5Mzk4MDk5NmU5MjgzMzdkZDZiL3RhYmxlcmFuZ2U6ZjA5ZmVhZTI2ZTk5NDkzOTgwOTk2ZTkyODMzN2RkNmJfMTktNy0xLTEtNDI3OTI_e1aa1062-9227-4e5c-b9bc-bfedfdf92757"
      unitRef="usd">141000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i6a350b34ff224fcfb66d3b6986b8d85d_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOmYwOWZlYWUyNmU5OTQ5Mzk4MDk5NmU5MjgzMzdkZDZiL3RhYmxlcmFuZ2U6ZjA5ZmVhZTI2ZTk5NDkzOTgwOTk2ZTkyODMzN2RkNmJfMTktMTMtMS0xLTQyNzky_0c75dc2e-84a6-438d-909b-9792e04213a2"
      unitRef="usd">141000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:DividendsCommonStockCash
      contextRef="i825be310f0914f779c3296901da45216_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOmYwOWZlYWUyNmU5OTQ5Mzk4MDk5NmU5MjgzMzdkZDZiL3RhYmxlcmFuZ2U6ZjA5ZmVhZTI2ZTk5NDkzOTgwOTk2ZTkyODMzN2RkNmJfMjAtOS0xLTEtNDI3OTI_d92a381f-4b3e-49a5-8161-aeea2fdee961"
      unitRef="usd">18598000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="i6a350b34ff224fcfb66d3b6986b8d85d_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOmYwOWZlYWUyNmU5OTQ5Mzk4MDk5NmU5MjgzMzdkZDZiL3RhYmxlcmFuZ2U6ZjA5ZmVhZTI2ZTk5NDkzOTgwOTk2ZTkyODMzN2RkNmJfMjAtMTMtMS0xLTQyNzky_963bc6ac-5606-416b-81d5-31b9b9d19bb9"
      unitRef="usd">18598000</us-gaap:DividendsCommonStockCash>
    <us-gaap:CommonStockSharesIssued
      contextRef="i44dccac463fc4d3d841cabd5924e0d7b_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOmYwOWZlYWUyNmU5OTQ5Mzk4MDk5NmU5MjgzMzdkZDZiL3RhYmxlcmFuZ2U6ZjA5ZmVhZTI2ZTk5NDkzOTgwOTk2ZTkyODMzN2RkNmJfMjItMS0xLTEtNDI3OTI_5871e0ba-765b-4f34-ba8e-28bfe193d8ad"
      unitRef="shares">11019000</us-gaap:CommonStockSharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="i44dccac463fc4d3d841cabd5924e0d7b_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOmYwOWZlYWUyNmU5OTQ5Mzk4MDk5NmU5MjgzMzdkZDZiL3RhYmxlcmFuZ2U6ZjA5ZmVhZTI2ZTk5NDkzOTgwOTk2ZTkyODMzN2RkNmJfMjItMy0xLTEtNDI3OTI_3444bf3a-d474-481c-ab93-6741f6a04ff8"
      unitRef="usd">11000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i1a26a14e2dc041cc84ce9b142e145c9e_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOmYwOWZlYWUyNmU5OTQ5Mzk4MDk5NmU5MjgzMzdkZDZiL3RhYmxlcmFuZ2U6ZjA5ZmVhZTI2ZTk5NDkzOTgwOTk2ZTkyODMzN2RkNmJfMjItNS0xLTEtNDI3OTI_824242a7-80f9-4e00-aa32-9ece44f0b3d2"
      unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i74ad881c792442baa75df8b807911f09_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOmYwOWZlYWUyNmU5OTQ5Mzk4MDk5NmU5MjgzMzdkZDZiL3RhYmxlcmFuZ2U6ZjA5ZmVhZTI2ZTk5NDkzOTgwOTk2ZTkyODMzN2RkNmJfMjItNy0xLTEtNDI3OTI_05b62759-7778-4318-86f0-89fc2ffad6ba"
      unitRef="usd">268000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i7bf72d1c8e9744c19c58f817cb47d391_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOmYwOWZlYWUyNmU5OTQ5Mzk4MDk5NmU5MjgzMzdkZDZiL3RhYmxlcmFuZ2U6ZjA5ZmVhZTI2ZTk5NDkzOTgwOTk2ZTkyODMzN2RkNmJfMjItOS0xLTEtNDI3OTI_a7103553-c92f-4672-9519-5832bbfd6df6"
      unitRef="usd">129197000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i913ea3b7a1e249509ae836a1357f94f2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOmYwOWZlYWUyNmU5OTQ5Mzk4MDk5NmU5MjgzMzdkZDZiL3RhYmxlcmFuZ2U6ZjA5ZmVhZTI2ZTk5NDkzOTgwOTk2ZTkyODMzN2RkNmJfMjItMTEtMS0xLTQyNzky_e1c55e6c-c547-4349-a8bb-f520046d6656"
      unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i9c92e926af9e4d908021e1a185782db8_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOmYwOWZlYWUyNmU5OTQ5Mzk4MDk5NmU5MjgzMzdkZDZiL3RhYmxlcmFuZ2U6ZjA5ZmVhZTI2ZTk5NDkzOTgwOTk2ZTkyODMzN2RkNmJfMjItMTMtMS0xLTQyNzky_0002422d-2b17-4662-b666-b4bbee7ad859"
      unitRef="usd">129476000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="i46cc59e8b81644bfa9c00742166adce3_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOmYwOWZlYWUyNmU5OTQ5Mzk4MDk5NmU5MjgzMzdkZDZiL3RhYmxlcmFuZ2U6ZjA5ZmVhZTI2ZTk5NDkzOTgwOTk2ZTkyODMzN2RkNmJfMjMtOS0xLTEtNDM3Mzg_cdeb2bd1-34b6-4039-8aa2-76e06809cc80"
      unitRef="usd">36155000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i2f3a96a832ab4b0ca374599d1c3e9bce_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOmYwOWZlYWUyNmU5OTQ5Mzk4MDk5NmU5MjgzMzdkZDZiL3RhYmxlcmFuZ2U6ZjA5ZmVhZTI2ZTk5NDkzOTgwOTk2ZTkyODMzN2RkNmJfMjMtMTMtMS0xLTQzNzM4_7ab0f95c-2934-41cb-8a94-ad1ef1d884ef"
      unitRef="usd">36155000</us-gaap:NetIncomeLoss>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod
      contextRef="i5a90f297c41946ada6274ba46fe40700_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOmYwOWZlYWUyNmU5OTQ5Mzk4MDk5NmU5MjgzMzdkZDZiL3RhYmxlcmFuZ2U6ZjA5ZmVhZTI2ZTk5NDkzOTgwOTk2ZTkyODMzN2RkNmJfMjQtMS0xLTEtNDM3Mzg_5d9c1420-953f-4826-86b3-cdf676586f2e"
      unitRef="shares">1000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
      contextRef="i543db287df984eccb3551d94073d122d_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOmYwOWZlYWUyNmU5OTQ5Mzk4MDk5NmU5MjgzMzdkZDZiL3RhYmxlcmFuZ2U6ZjA5ZmVhZTI2ZTk5NDkzOTgwOTk2ZTkyODMzN2RkNmJfMjQtNS0xLTEtNDM3Mzg_21804b6d-04dd-467b-8c56-531f3c2b7abf"
      unitRef="usd">2963000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
      contextRef="i2f3a96a832ab4b0ca374599d1c3e9bce_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOmYwOWZlYWUyNmU5OTQ5Mzk4MDk5NmU5MjgzMzdkZDZiL3RhYmxlcmFuZ2U6ZjA5ZmVhZTI2ZTk5NDkzOTgwOTk2ZTkyODMzN2RkNmJfMjQtMTMtMS0xLTQzNzM4_805cbf03-3e19-4967-b535-fdbe061914e0"
      unitRef="usd">2963000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i543db287df984eccb3551d94073d122d_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOmYwOWZlYWUyNmU5OTQ5Mzk4MDk5NmU5MjgzMzdkZDZiL3RhYmxlcmFuZ2U6ZjA5ZmVhZTI2ZTk5NDkzOTgwOTk2ZTkyODMzN2RkNmJfMjUtNS0xLTEtNDM3Mzg_6e115ea1-8e8e-4548-8368-4f38f9fa2afe"
      unitRef="usd">25000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i2f3a96a832ab4b0ca374599d1c3e9bce_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOmYwOWZlYWUyNmU5OTQ5Mzk4MDk5NmU5MjgzMzdkZDZiL3RhYmxlcmFuZ2U6ZjA5ZmVhZTI2ZTk5NDkzOTgwOTk2ZTkyODMzN2RkNmJfMjUtMTMtMS0xLTQzNzM4_63199886-3a2e-44cb-bea5-d59b5003b96a"
      unitRef="usd">25000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i2a8af11f752e4e7cb2dba522b9ad74d2_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOmYwOWZlYWUyNmU5OTQ5Mzk4MDk5NmU5MjgzMzdkZDZiL3RhYmxlcmFuZ2U6ZjA5ZmVhZTI2ZTk5NDkzOTgwOTk2ZTkyODMzN2RkNmJfMjYtMTEtMS0xLTQzNzM4_418119b8-e05b-47ee-866f-92f6d0fb710c"
      unitRef="usd">20010000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i2f3a96a832ab4b0ca374599d1c3e9bce_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOmYwOWZlYWUyNmU5OTQ5Mzk4MDk5NmU5MjgzMzdkZDZiL3RhYmxlcmFuZ2U6ZjA5ZmVhZTI2ZTk5NDkzOTgwOTk2ZTkyODMzN2RkNmJfMjYtMTMtMS0xLTQzNzM4_0d517971-d40e-49d3-aef9-c0b5f90569b4"
      unitRef="usd">20010000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockSharesRetired
      contextRef="i5a90f297c41946ada6274ba46fe40700_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOmYwOWZlYWUyNmU5OTQ5Mzk4MDk5NmU5MjgzMzdkZDZiL3RhYmxlcmFuZ2U6ZjA5ZmVhZTI2ZTk5NDkzOTgwOTk2ZTkyODMzN2RkNmJfMjctMS0xLTEtNDM3Mzg_fb01778c-6b14-4699-896e-08524535f041"
      unitRef="shares">91000</us-gaap:TreasuryStockSharesRetired>
    <us-gaap:TreasuryStockRetiredCostMethodAmount
      contextRef="i46cc59e8b81644bfa9c00742166adce3_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOmYwOWZlYWUyNmU5OTQ5Mzk4MDk5NmU5MjgzMzdkZDZiL3RhYmxlcmFuZ2U6ZjA5ZmVhZTI2ZTk5NDkzOTgwOTk2ZTkyODMzN2RkNmJfMjctOS0xLTEtNDM3Mzg_d717af47-9686-419b-a7c3-666e1a4c73a3"
      unitRef="usd">20010000</us-gaap:TreasuryStockRetiredCostMethodAmount>
    <us-gaap:TreasuryStockRetiredCostMethodAmount
      contextRef="i2a8af11f752e4e7cb2dba522b9ad74d2_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOmYwOWZlYWUyNmU5OTQ5Mzk4MDk5NmU5MjgzMzdkZDZiL3RhYmxlcmFuZ2U6ZjA5ZmVhZTI2ZTk5NDkzOTgwOTk2ZTkyODMzN2RkNmJfMjctMTEtMS0xLTQzNzM4_ca893898-4b18-4067-b146-2e7cb9453667"
      unitRef="usd">-20010000</us-gaap:TreasuryStockRetiredCostMethodAmount>
    <us-gaap:TreasuryStockRetiredCostMethodAmount
      contextRef="i2f3a96a832ab4b0ca374599d1c3e9bce_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOmYwOWZlYWUyNmU5OTQ5Mzk4MDk5NmU5MjgzMzdkZDZiL3RhYmxlcmFuZ2U6ZjA5ZmVhZTI2ZTk5NDkzOTgwOTk2ZTkyODMzN2RkNmJfMjctMTMtMS0xLTQzNzM4_39d74a7e-0b30-4698-bb56-35621f9b8d9e"
      unitRef="usd">0</us-gaap:TreasuryStockRetiredCostMethodAmount>
    <us-gaap:AcceleratedShareRepurchaseProgramAdjustment
      contextRef="i543db287df984eccb3551d94073d122d_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOmYwOWZlYWUyNmU5OTQ5Mzk4MDk5NmU5MjgzMzdkZDZiL3RhYmxlcmFuZ2U6ZjA5ZmVhZTI2ZTk5NDkzOTgwOTk2ZTkyODMzN2RkNmJfMjgtNS0xLTEtNDM3Mzg_23595ba5-4142-483f-9b79-f10121625321"
      unitRef="usd">15679000</us-gaap:AcceleratedShareRepurchaseProgramAdjustment>
    <us-gaap:AcceleratedShareRepurchaseProgramAdjustment
      contextRef="i46cc59e8b81644bfa9c00742166adce3_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOmYwOWZlYWUyNmU5OTQ5Mzk4MDk5NmU5MjgzMzdkZDZiL3RhYmxlcmFuZ2U6ZjA5ZmVhZTI2ZTk5NDkzOTgwOTk2ZTkyODMzN2RkNmJfMjgtOS0xLTEtNDM3Mzg_164f4164-1181-4cd3-8720-b0604d8969d7"
      unitRef="usd">4331000</us-gaap:AcceleratedShareRepurchaseProgramAdjustment>
    <us-gaap:AcceleratedShareRepurchaseProgramAdjustment
      contextRef="i2f3a96a832ab4b0ca374599d1c3e9bce_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOmYwOWZlYWUyNmU5OTQ5Mzk4MDk5NmU5MjgzMzdkZDZiL3RhYmxlcmFuZ2U6ZjA5ZmVhZTI2ZTk5NDkzOTgwOTk2ZTkyODMzN2RkNmJfMjgtMTMtMS0xLTQzNzM4_f049c699-d689-4057-b669-82654230a43e"
      unitRef="usd">20010000</us-gaap:AcceleratedShareRepurchaseProgramAdjustment>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i5c1aea55f14840448c42fb7a08b519b6_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOmYwOWZlYWUyNmU5OTQ5Mzk4MDk5NmU5MjgzMzdkZDZiL3RhYmxlcmFuZ2U6ZjA5ZmVhZTI2ZTk5NDkzOTgwOTk2ZTkyODMzN2RkNmJfMjktNy0xLTEtNDM3Mzg_60ac6cd5-ce67-4aad-b805-0fe0e6e54fb7"
      unitRef="usd">123000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i2f3a96a832ab4b0ca374599d1c3e9bce_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOmYwOWZlYWUyNmU5OTQ5Mzk4MDk5NmU5MjgzMzdkZDZiL3RhYmxlcmFuZ2U6ZjA5ZmVhZTI2ZTk5NDkzOTgwOTk2ZTkyODMzN2RkNmJfMjktMTMtMS0xLTQzNzM4_7fc5e4ff-44d6-4dbf-ae4c-2d01f0a50588"
      unitRef="usd">123000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:DividendsCommonStockCash
      contextRef="i46cc59e8b81644bfa9c00742166adce3_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOmYwOWZlYWUyNmU5OTQ5Mzk4MDk5NmU5MjgzMzdkZDZiL3RhYmxlcmFuZ2U6ZjA5ZmVhZTI2ZTk5NDkzOTgwOTk2ZTkyODMzN2RkNmJfMzAtOS0xLTEtNDM3Mzg_e1c995b7-5257-4f92-b1ff-7db45fe1c3c8"
      unitRef="usd">18170000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="i2f3a96a832ab4b0ca374599d1c3e9bce_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOmYwOWZlYWUyNmU5OTQ5Mzk4MDk5NmU5MjgzMzdkZDZiL3RhYmxlcmFuZ2U6ZjA5ZmVhZTI2ZTk5NDkzOTgwOTk2ZTkyODMzN2RkNmJfMzAtMTMtMS0xLTQzNzM4_6628677b-04df-4a07-a71c-6f0290697039"
      unitRef="usd">18170000</us-gaap:DividendsCommonStockCash>
    <us-gaap:CommonStockSharesIssued
      contextRef="i86b6fd23b7b042e2ba7777c1c5d29391_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOmYwOWZlYWUyNmU5OTQ5Mzk4MDk5NmU5MjgzMzdkZDZiL3RhYmxlcmFuZ2U6ZjA5ZmVhZTI2ZTk5NDkzOTgwOTk2ZTkyODMzN2RkNmJfMzItMS0xLTEtNDM3Mzg_1a1a1dc6-904f-4c3d-bfa3-a4a4a2f749d5"
      unitRef="shares">10929000</us-gaap:CommonStockSharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="i86b6fd23b7b042e2ba7777c1c5d29391_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOmYwOWZlYWUyNmU5OTQ5Mzk4MDk5NmU5MjgzMzdkZDZiL3RhYmxlcmFuZ2U6ZjA5ZmVhZTI2ZTk5NDkzOTgwOTk2ZTkyODMzN2RkNmJfMzItMy0xLTEtNDM3Mzg_edb4567d-c0a6-44a6-b52f-5c71e7d65990"
      unitRef="usd">11000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i0c74a76f5cb04d3896ad8481dd40c875_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOmYwOWZlYWUyNmU5OTQ5Mzk4MDk5NmU5MjgzMzdkZDZiL3RhYmxlcmFuZ2U6ZjA5ZmVhZTI2ZTk5NDkzOTgwOTk2ZTkyODMzN2RkNmJfMzItNS0xLTEtNDM3Mzg_7de96e79-d3c4-4e2b-a108-1e292790964c"
      unitRef="usd">18617000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ib4e37db708e64812ac81e983938b61df_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOmYwOWZlYWUyNmU5OTQ5Mzk4MDk5NmU5MjgzMzdkZDZiL3RhYmxlcmFuZ2U6ZjA5ZmVhZTI2ZTk5NDkzOTgwOTk2ZTkyODMzN2RkNmJfMzItNy0xLTEtNDM3Mzg_d8082385-98f9-45eb-a1d0-9353c8104f22"
      unitRef="usd">391000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i45eff40e381645728b84813044e661c6_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOmYwOWZlYWUyNmU5OTQ5Mzk4MDk5NmU5MjgzMzdkZDZiL3RhYmxlcmFuZ2U6ZjA5ZmVhZTI2ZTk5NDkzOTgwOTk2ZTkyODMzN2RkNmJfMzItOS0xLTEtNDM3Mzg_2469cd4f-2ee4-46fe-9776-eb05c671da45"
      unitRef="usd">131503000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i82d77786c5f844c8a6ad979988ec850e_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOmYwOWZlYWUyNmU5OTQ5Mzk4MDk5NmU5MjgzMzdkZDZiL3RhYmxlcmFuZ2U6ZjA5ZmVhZTI2ZTk5NDkzOTgwOTk2ZTkyODMzN2RkNmJfMzItMTEtMS0xLTQzNzM4_2ba6cb03-b8cd-4324-9996-4e85942088fc"
      unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i5de311f5948148cda49342e2cea83715_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOmYwOWZlYWUyNmU5OTQ5Mzk4MDk5NmU5MjgzMzdkZDZiL3RhYmxlcmFuZ2U6ZjA5ZmVhZTI2ZTk5NDkzOTgwOTk2ZTkyODMzN2RkNmJfMzItMTMtMS0xLTQzNzM4_f620b1e8-319e-47af-8c01-1bcbefc25fce"
      unitRef="usd">150522000</us-gaap:StockholdersEquity>
    <us-gaap:CommonStockSharesIssued
      contextRef="i1163d3352fc648fabd60e9dbcf073a70_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOjhhNjMyYmY5MWYyZDQwNTA4OTU4ZmM0YTliM2I0NTY3L3RhYmxlcmFuZ2U6OGE2MzJiZjkxZjJkNDA1MDg5NThmYzRhOWIzYjQ1NjdfMy0xLTEtMS00Mjc5Mg_6e17216c-cf7b-435d-8f43-f8ac4fc1cda4"
      unitRef="shares">11822000</us-gaap:CommonStockSharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="i1163d3352fc648fabd60e9dbcf073a70_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOjhhNjMyYmY5MWYyZDQwNTA4OTU4ZmM0YTliM2I0NTY3L3RhYmxlcmFuZ2U6OGE2MzJiZjkxZjJkNDA1MDg5NThmYzRhOWIzYjQ1NjdfMy0zLTEtMS00Mjc5Mg_a44e5146-0235-4c35-8d6f-1a918f05cd26"
      unitRef="usd">12000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="if34e8b84444d41ce8edf53d30fe4aa32_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOjhhNjMyYmY5MWYyZDQwNTA4OTU4ZmM0YTliM2I0NTY3L3RhYmxlcmFuZ2U6OGE2MzJiZjkxZjJkNDA1MDg5NThmYzRhOWIzYjQ1NjdfMy01LTEtMS00Mjc5Mg_384aecba-aaa3-48aa-bd08-47f5d70a0924"
      unitRef="usd">7842000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i19f7e6a88c8d41818d290843acae9d96_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOjhhNjMyYmY5MWYyZDQwNTA4OTU4ZmM0YTliM2I0NTY3L3RhYmxlcmFuZ2U6OGE2MzJiZjkxZjJkNDA1MDg5NThmYzRhOWIzYjQ1NjdfMy03LTEtMS00Mjc5Mg_da56578a-982a-4a9d-b6b8-1ae711266693"
      unitRef="usd">41000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i2b15d638707f47c0b49ae2a29db046e6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOjhhNjMyYmY5MWYyZDQwNTA4OTU4ZmM0YTliM2I0NTY3L3RhYmxlcmFuZ2U6OGE2MzJiZjkxZjJkNDA1MDg5NThmYzRhOWIzYjQ1NjdfMy05LTEtMS00Mjc5Mg_59c94016-2556-4d91-86d1-b9e738fbc80f"
      unitRef="usd">154351000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i52670ec43ed94ac3b4d465333938624b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOjhhNjMyYmY5MWYyZDQwNTA4OTU4ZmM0YTliM2I0NTY3L3RhYmxlcmFuZ2U6OGE2MzJiZjkxZjJkNDA1MDg5NThmYzRhOWIzYjQ1NjdfMy0xMS0xLTEtNDI3OTI_f05336d2-1224-4015-8435-1bd6c5fde69e"
      unitRef="usd">-5000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i03d902ffc72e4d98b5eeb6fb903f405b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOjhhNjMyYmY5MWYyZDQwNTA4OTU4ZmM0YTliM2I0NTY3L3RhYmxlcmFuZ2U6OGE2MzJiZjkxZjJkNDA1MDg5NThmYzRhOWIzYjQ1NjdfMy0xMy0xLTEtNDI3OTI_76b4ce07-000f-4997-aa07-955c0c4d3d2a"
      unitRef="usd">157246000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="id4f9149bb4104ee2963222e63eef1ac9_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOjhhNjMyYmY5MWYyZDQwNTA4OTU4ZmM0YTliM2I0NTY3L3RhYmxlcmFuZ2U6OGE2MzJiZjkxZjJkNDA1MDg5NThmYzRhOWIzYjQ1NjdfNC05LTEtMS00Mjc5Mg_927f2191-71a8-4e67-ab52-f72a5020f461"
      unitRef="usd">41063000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i68572f7de11f487eb008f9ea31479d93_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOjhhNjMyYmY5MWYyZDQwNTA4OTU4ZmM0YTliM2I0NTY3L3RhYmxlcmFuZ2U6OGE2MzJiZjkxZjJkNDA1MDg5NThmYzRhOWIzYjQ1NjdfNC0xMy0xLTEtNDI3OTI_9ec78792-7df3-4432-a5cc-9b0381c684ea"
      unitRef="usd">41063000</us-gaap:NetIncomeLoss>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod
      contextRef="i470e4e9ecca64945928eff798199788e_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOjhhNjMyYmY5MWYyZDQwNTA4OTU4ZmM0YTliM2I0NTY3L3RhYmxlcmFuZ2U6OGE2MzJiZjkxZjJkNDA1MDg5NThmYzRhOWIzYjQ1NjdfNS0xLTEtMS00Mjc5Mg_421132df-c984-456e-ac39-dcc49da9f31a"
      unitRef="shares">13000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
      contextRef="ia13ecf3f80ad40c2a77b77116d4ed43c_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOjhhNjMyYmY5MWYyZDQwNTA4OTU4ZmM0YTliM2I0NTY3L3RhYmxlcmFuZ2U6OGE2MzJiZjkxZjJkNDA1MDg5NThmYzRhOWIzYjQ1NjdfNS01LTEtMS00Mjc5Mg_79725253-d5e3-47b1-b43f-e44d45386c0e"
      unitRef="usd">2198000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
      contextRef="i68572f7de11f487eb008f9ea31479d93_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOjhhNjMyYmY5MWYyZDQwNTA4OTU4ZmM0YTliM2I0NTY3L3RhYmxlcmFuZ2U6OGE2MzJiZjkxZjJkNDA1MDg5NThmYzRhOWIzYjQ1NjdfNS0xMy0xLTEtNDI3OTI_d7755134-fc6f-4144-baa0-8bebc63ec5b0"
      unitRef="usd">2198000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i470e4e9ecca64945928eff798199788e_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOjhhNjMyYmY5MWYyZDQwNTA4OTU4ZmM0YTliM2I0NTY3L3RhYmxlcmFuZ2U6OGE2MzJiZjkxZjJkNDA1MDg5NThmYzRhOWIzYjQ1NjdfNi0xLTEtMS00Mjc5Mg_1fbc8e1d-bd11-4039-86b7-0b2cd0266ada"
      unitRef="shares">11000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="ia13ecf3f80ad40c2a77b77116d4ed43c_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOjhhNjMyYmY5MWYyZDQwNTA4OTU4ZmM0YTliM2I0NTY3L3RhYmxlcmFuZ2U6OGE2MzJiZjkxZjJkNDA1MDg5NThmYzRhOWIzYjQ1NjdfNi01LTEtMS00Mjc5Mg_6d3c0c74-5806-45d2-ab69-7c3d7f942443"
      unitRef="usd">481000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i68572f7de11f487eb008f9ea31479d93_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOjhhNjMyYmY5MWYyZDQwNTA4OTU4ZmM0YTliM2I0NTY3L3RhYmxlcmFuZ2U6OGE2MzJiZjkxZjJkNDA1MDg5NThmYzRhOWIzYjQ1NjdfNi0xMy0xLTEtNDI3OTI_a9affc05-531b-4e16-87e8-404dc48e0bd7"
      unitRef="usd">481000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation
      contextRef="i470e4e9ecca64945928eff798199788e_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOjhhNjMyYmY5MWYyZDQwNTA4OTU4ZmM0YTliM2I0NTY3L3RhYmxlcmFuZ2U6OGE2MzJiZjkxZjJkNDA1MDg5NThmYzRhOWIzYjQ1NjdfNy0xLTEtMS00Mjc5Mg_2e19acd9-10f2-4e25-8671-96cde4cc0fbe"
      unitRef="shares">7000</us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="ia13ecf3f80ad40c2a77b77116d4ed43c_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOjhhNjMyYmY5MWYyZDQwNTA4OTU4ZmM0YTliM2I0NTY3L3RhYmxlcmFuZ2U6OGE2MzJiZjkxZjJkNDA1MDg5NThmYzRhOWIzYjQ1NjdfNy01LTEtMS00Mjc5Mg_b18b87b0-78d1-4f2d-ae3a-985a35a27149"
      unitRef="usd">1807000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i2a8af11f752e4e7cb2dba522b9ad74d2_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOjhhNjMyYmY5MWYyZDQwNTA4OTU4ZmM0YTliM2I0NTY3L3RhYmxlcmFuZ2U6OGE2MzJiZjkxZjJkNDA1MDg5NThmYzRhOWIzYjQ1NjdfNy0xMS0xLTEtNDI3OTI_d9311e7c-6197-4894-99c9-0e950538afa9"
      unitRef="usd">0</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i68572f7de11f487eb008f9ea31479d93_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOjhhNjMyYmY5MWYyZDQwNTA4OTU4ZmM0YTliM2I0NTY3L3RhYmxlcmFuZ2U6OGE2MzJiZjkxZjJkNDA1MDg5NThmYzRhOWIzYjQ1NjdfNy0xMy0xLTEtNDI3OTI_1dd52895-5c3d-42d1-9644-b8e2a23d0456"
      unitRef="usd">1807000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i38351930dc7542bba71c26ab68521fec_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOjhhNjMyYmY5MWYyZDQwNTA4OTU4ZmM0YTliM2I0NTY3L3RhYmxlcmFuZ2U6OGE2MzJiZjkxZjJkNDA1MDg5NThmYzRhOWIzYjQ1NjdfOC0xMS0xLTEtNDI3OTI_f3b444fd-228b-422f-97e5-7a480ae50553"
      unitRef="usd">7500000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i68572f7de11f487eb008f9ea31479d93_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOjhhNjMyYmY5MWYyZDQwNTA4OTU4ZmM0YTliM2I0NTY3L3RhYmxlcmFuZ2U6OGE2MzJiZjkxZjJkNDA1MDg5NThmYzRhOWIzYjQ1NjdfOC0xMy0xLTEtNDI3OTI_8e61a680-2818-4388-be1e-2a29e24a10ac"
      unitRef="usd">7500000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i7ffa4de1d96a472385d9f446aded3673_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOjhhNjMyYmY5MWYyZDQwNTA4OTU4ZmM0YTliM2I0NTY3L3RhYmxlcmFuZ2U6OGE2MzJiZjkxZjJkNDA1MDg5NThmYzRhOWIzYjQ1NjdfOS03LTEtMS00Mjc5Mg_4ecd1543-4466-4bcf-b536-9544ed2702d0"
      unitRef="usd">62000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i68572f7de11f487eb008f9ea31479d93_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOjhhNjMyYmY5MWYyZDQwNTA4OTU4ZmM0YTliM2I0NTY3L3RhYmxlcmFuZ2U6OGE2MzJiZjkxZjJkNDA1MDg5NThmYzRhOWIzYjQ1NjdfOS0xMy0xLTEtNDI3OTI_4012f26a-1457-4c51-b00e-5f9e6ab895bf"
      unitRef="usd">62000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:DividendsCommonStockCash
      contextRef="id4f9149bb4104ee2963222e63eef1ac9_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOjhhNjMyYmY5MWYyZDQwNTA4OTU4ZmM0YTliM2I0NTY3L3RhYmxlcmFuZ2U6OGE2MzJiZjkxZjJkNDA1MDg5NThmYzRhOWIzYjQ1NjdfMTAtOS0xLTEtNDI3OTI_7a5a5aec-279b-48e3-b807-dca5022a6b8b"
      unitRef="usd">16852000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="i68572f7de11f487eb008f9ea31479d93_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOjhhNjMyYmY5MWYyZDQwNTA4OTU4ZmM0YTliM2I0NTY3L3RhYmxlcmFuZ2U6OGE2MzJiZjkxZjJkNDA1MDg5NThmYzRhOWIzYjQ1NjdfMTAtMTMtMS0xLTQyNzky_097f125e-aee1-4052-9a55-181d0ba8d4be"
      unitRef="usd">16852000</us-gaap:DividendsCommonStockCash>
    <us-gaap:CommonStockSharesIssued
      contextRef="i926bcd92e3394962b4b7831cda0ea157_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOjhhNjMyYmY5MWYyZDQwNTA4OTU4ZmM0YTliM2I0NTY3L3RhYmxlcmFuZ2U6OGE2MzJiZjkxZjJkNDA1MDg5NThmYzRhOWIzYjQ1NjdfMTItMS0xLTEtNDI3OTI_b1600ddb-4a1a-4a86-90c2-53e7a0844fe1"
      unitRef="shares">11839000</us-gaap:CommonStockSharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="i926bcd92e3394962b4b7831cda0ea157_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOjhhNjMyYmY5MWYyZDQwNTA4OTU4ZmM0YTliM2I0NTY3L3RhYmxlcmFuZ2U6OGE2MzJiZjkxZjJkNDA1MDg5NThmYzRhOWIzYjQ1NjdfMTItMy0xLTEtNDI3OTI_73f61d9b-dbf8-47d0-874f-98bb73daf310"
      unitRef="usd">12000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i593139faed924dd193120eb4e1bcaeec_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOjhhNjMyYmY5MWYyZDQwNTA4OTU4ZmM0YTliM2I0NTY3L3RhYmxlcmFuZ2U6OGE2MzJiZjkxZjJkNDA1MDg5NThmYzRhOWIzYjQ1NjdfMTItNS0xLTEtNDI3OTI_663e531d-0cea-4254-9154-c60e3deea4ed"
      unitRef="usd">8714000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i4149861d44464055b0906f38bd8c72e2_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOjhhNjMyYmY5MWYyZDQwNTA4OTU4ZmM0YTliM2I0NTY3L3RhYmxlcmFuZ2U6OGE2MzJiZjkxZjJkNDA1MDg5NThmYzRhOWIzYjQ1NjdfMTItNy0xLTEtNDI3OTI_828bbb44-65d4-4333-b23c-e87b839077d0"
      unitRef="usd">103000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i53d4071f311c4bc6a78da6c7fb1ca3da_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOjhhNjMyYmY5MWYyZDQwNTA4OTU4ZmM0YTliM2I0NTY3L3RhYmxlcmFuZ2U6OGE2MzJiZjkxZjJkNDA1MDg5NThmYzRhOWIzYjQ1NjdfMTItOS0xLTEtNDI3OTI_30c79db2-5d1d-4695-af14-75e826d08599"
      unitRef="usd">178562000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i432fec2efa784910b40e24a63bb087c5_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOjhhNjMyYmY5MWYyZDQwNTA4OTU4ZmM0YTliM2I0NTY3L3RhYmxlcmFuZ2U6OGE2MzJiZjkxZjJkNDA1MDg5NThmYzRhOWIzYjQ1NjdfMTItMTEtMS0xLTQyNzky_8a93a26e-9495-49e3-9653-a00d50ed3674"
      unitRef="usd">-12500000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i36a8ff01ce244ad6a7aaa930257b4d4f_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOjhhNjMyYmY5MWYyZDQwNTA4OTU4ZmM0YTliM2I0NTY3L3RhYmxlcmFuZ2U6OGE2MzJiZjkxZjJkNDA1MDg5NThmYzRhOWIzYjQ1NjdfMTItMTMtMS0xLTQyNzky_2cf3fc6a-8a52-451f-924d-3a37ca881d77"
      unitRef="usd">174891000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="ia82656c7830f478dbef5fdc6935f568d_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOjhhNjMyYmY5MWYyZDQwNTA4OTU4ZmM0YTliM2I0NTY3L3RhYmxlcmFuZ2U6OGE2MzJiZjkxZjJkNDA1MDg5NThmYzRhOWIzYjQ1NjdfMTMtOS0xLTEtNDI3OTI_4e34005e-7701-4cff-8036-c04036af32b0"
      unitRef="usd">46963000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i8148576927e64d0f8fda8e31eb6b529b_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOjhhNjMyYmY5MWYyZDQwNTA4OTU4ZmM0YTliM2I0NTY3L3RhYmxlcmFuZ2U6OGE2MzJiZjkxZjJkNDA1MDg5NThmYzRhOWIzYjQ1NjdfMTMtMTMtMS0xLTQyNzky_57ce80a9-02e0-4451-a619-8b72d786cb56"
      unitRef="usd">46963000</us-gaap:NetIncomeLoss>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod
      contextRef="i02db23a8737b4985815005662095656a_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOjhhNjMyYmY5MWYyZDQwNTA4OTU4ZmM0YTliM2I0NTY3L3RhYmxlcmFuZ2U6OGE2MzJiZjkxZjJkNDA1MDg5NThmYzRhOWIzYjQ1NjdfMTQtMS0xLTEtNDI3OTI_a75fae58-8f3a-4cbb-9db2-a75098fecf30"
      unitRef="shares">10000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
      contextRef="i9224eb8da52e48a886d66dcac0ff9f06_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOjhhNjMyYmY5MWYyZDQwNTA4OTU4ZmM0YTliM2I0NTY3L3RhYmxlcmFuZ2U6OGE2MzJiZjkxZjJkNDA1MDg5NThmYzRhOWIzYjQ1NjdfMTQtNS0xLTEtNDI3OTI_4756ea88-1de7-416a-977f-d390af5ab237"
      unitRef="usd">1697000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
      contextRef="ia82656c7830f478dbef5fdc6935f568d_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOjhhNjMyYmY5MWYyZDQwNTA4OTU4ZmM0YTliM2I0NTY3L3RhYmxlcmFuZ2U6OGE2MzJiZjkxZjJkNDA1MDg5NThmYzRhOWIzYjQ1NjdfMTQtOS0xLTEtNDI3OTI_59f340a7-d517-4df4-8a94-5d4c1d1dd276"
      unitRef="usd">142000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
      contextRef="i8148576927e64d0f8fda8e31eb6b529b_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOjhhNjMyYmY5MWYyZDQwNTA4OTU4ZmM0YTliM2I0NTY3L3RhYmxlcmFuZ2U6OGE2MzJiZjkxZjJkNDA1MDg5NThmYzRhOWIzYjQ1NjdfMTQtMTMtMS0xLTQyNzky_180036ff-cb95-4b2b-b397-2403c3232357"
      unitRef="usd">1839000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i02db23a8737b4985815005662095656a_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOjhhNjMyYmY5MWYyZDQwNTA4OTU4ZmM0YTliM2I0NTY3L3RhYmxlcmFuZ2U6OGE2MzJiZjkxZjJkNDA1MDg5NThmYzRhOWIzYjQ1NjdfMTUtMS0xLTEtNDI3OTI_8456f6b6-c28a-4eaf-a9b8-5d52080b42a0"
      unitRef="shares">3000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i9224eb8da52e48a886d66dcac0ff9f06_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOjhhNjMyYmY5MWYyZDQwNTA4OTU4ZmM0YTliM2I0NTY3L3RhYmxlcmFuZ2U6OGE2MzJiZjkxZjJkNDA1MDg5NThmYzRhOWIzYjQ1NjdfMTUtNS0xLTEtNDI3OTI_c8621a9d-5f79-4a1d-9a57-862c5e2f18f7"
      unitRef="usd">221000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i8148576927e64d0f8fda8e31eb6b529b_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOjhhNjMyYmY5MWYyZDQwNTA4OTU4ZmM0YTliM2I0NTY3L3RhYmxlcmFuZ2U6OGE2MzJiZjkxZjJkNDA1MDg5NThmYzRhOWIzYjQ1NjdfMTUtMTMtMS0xLTQyNzky_85c7b0f7-83fc-4e16-875c-6275c2b1b603"
      unitRef="usd">221000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i9224eb8da52e48a886d66dcac0ff9f06_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOjhhNjMyYmY5MWYyZDQwNTA4OTU4ZmM0YTliM2I0NTY3L3RhYmxlcmFuZ2U6OGE2MzJiZjkxZjJkNDA1MDg5NThmYzRhOWIzYjQ1NjdfMTYtNS0xLTEtNDI3OTI_c54dca5d-4f53-4e5a-9b12-378346be85a9"
      unitRef="usd">26000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i8148576927e64d0f8fda8e31eb6b529b_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOjhhNjMyYmY5MWYyZDQwNTA4OTU4ZmM0YTliM2I0NTY3L3RhYmxlcmFuZ2U6OGE2MzJiZjkxZjJkNDA1MDg5NThmYzRhOWIzYjQ1NjdfMTYtMTMtMS0xLTQyNzky_f69f2338-bf36-4323-9d85-910a653a5923"
      unitRef="usd">26000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i7a3770d9964c4b419436e67fc0ef4044_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOjhhNjMyYmY5MWYyZDQwNTA4OTU4ZmM0YTliM2I0NTY3L3RhYmxlcmFuZ2U6OGE2MzJiZjkxZjJkNDA1MDg5NThmYzRhOWIzYjQ1NjdfMTctNy0xLTEtNDI3OTI_86b28cb2-04b5-4f82-a809-8497ff9d8a26"
      unitRef="usd">-28000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i8148576927e64d0f8fda8e31eb6b529b_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOjhhNjMyYmY5MWYyZDQwNTA4OTU4ZmM0YTliM2I0NTY3L3RhYmxlcmFuZ2U6OGE2MzJiZjkxZjJkNDA1MDg5NThmYzRhOWIzYjQ1NjdfMTctMTMtMS0xLTQyNzky_a6e4510b-64a5-4738-9895-a9dd9a936fa7"
      unitRef="usd">-28000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i581ec4205b3c47a0a164d6c0e54036f6_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOjhhNjMyYmY5MWYyZDQwNTA4OTU4ZmM0YTliM2I0NTY3L3RhYmxlcmFuZ2U6OGE2MzJiZjkxZjJkNDA1MDg5NThmYzRhOWIzYjQ1NjdfMTgtMTEtMS0xLTQyNzky_ff4c3d39-be03-4db6-b858-4dc1de5c08b3"
      unitRef="usd">12230000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i8148576927e64d0f8fda8e31eb6b529b_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOjhhNjMyYmY5MWYyZDQwNTA4OTU4ZmM0YTliM2I0NTY3L3RhYmxlcmFuZ2U6OGE2MzJiZjkxZjJkNDA1MDg5NThmYzRhOWIzYjQ1NjdfMTgtMTMtMS0xLTQyNzky_15387783-eb9b-4f7a-8c95-69c7673fac8f"
      unitRef="usd">12230000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockSharesRetired
      contextRef="i02db23a8737b4985815005662095656a_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOjhhNjMyYmY5MWYyZDQwNTA4OTU4ZmM0YTliM2I0NTY3L3RhYmxlcmFuZ2U6OGE2MzJiZjkxZjJkNDA1MDg5NThmYzRhOWIzYjQ1NjdfMTktMS0xLTEtNDI3OTI_889a1443-8f74-4447-b3e9-b0d7aa56b59c"
      unitRef="shares">114000</us-gaap:TreasuryStockSharesRetired>
    <us-gaap:TreasuryStockRetiredCostMethodAmount
      contextRef="ia82656c7830f478dbef5fdc6935f568d_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOjhhNjMyYmY5MWYyZDQwNTA4OTU4ZmM0YTliM2I0NTY3L3RhYmxlcmFuZ2U6OGE2MzJiZjkxZjJkNDA1MDg5NThmYzRhOWIzYjQ1NjdfMTktOS0xLTEtNDI3OTI_96d794b8-c29c-4894-8175-7899baa92ae3"
      unitRef="usd">23383000</us-gaap:TreasuryStockRetiredCostMethodAmount>
    <us-gaap:TreasuryStockRetiredCostMethodAmount
      contextRef="i581ec4205b3c47a0a164d6c0e54036f6_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOjhhNjMyYmY5MWYyZDQwNTA4OTU4ZmM0YTliM2I0NTY3L3RhYmxlcmFuZ2U6OGE2MzJiZjkxZjJkNDA1MDg5NThmYzRhOWIzYjQ1NjdfMTktMTEtMS0xLTQyNzky_8744f85b-02fe-4054-9c19-e7fdf040cfb6"
      unitRef="usd">-23383000</us-gaap:TreasuryStockRetiredCostMethodAmount>
    <us-gaap:TreasuryStockRetiredCostMethodAmount
      contextRef="i8148576927e64d0f8fda8e31eb6b529b_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOjhhNjMyYmY5MWYyZDQwNTA4OTU4ZmM0YTliM2I0NTY3L3RhYmxlcmFuZ2U6OGE2MzJiZjkxZjJkNDA1MDg5NThmYzRhOWIzYjQ1NjdfMTktMTMtMS0xLTQyNzky_7b834c0f-1d20-44cc-a7be-e9a047ad2c92"
      unitRef="usd">0</us-gaap:TreasuryStockRetiredCostMethodAmount>
    <us-gaap:DividendsCommonStockCash
      contextRef="ia82656c7830f478dbef5fdc6935f568d_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOjhhNjMyYmY5MWYyZDQwNTA4OTU4ZmM0YTliM2I0NTY3L3RhYmxlcmFuZ2U6OGE2MzJiZjkxZjJkNDA1MDg5NThmYzRhOWIzYjQ1NjdfMjAtOS0xLTEtNDI3OTI_6f405db2-c33d-4c85-a6cb-b7c658bfd16c"
      unitRef="usd">16941000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="i8148576927e64d0f8fda8e31eb6b529b_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOjhhNjMyYmY5MWYyZDQwNTA4OTU4ZmM0YTliM2I0NTY3L3RhYmxlcmFuZ2U6OGE2MzJiZjkxZjJkNDA1MDg5NThmYzRhOWIzYjQ1NjdfMjAtMTMtMS0xLTQyNzky_5488036d-6351-49e7-b851-c46d605da42e"
      unitRef="usd">16941000</us-gaap:DividendsCommonStockCash>
    <us-gaap:CommonStockSharesIssued
      contextRef="i9e9dcffbe0354e98962551a32828abc2_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOjhhNjMyYmY5MWYyZDQwNTA4OTU4ZmM0YTliM2I0NTY3L3RhYmxlcmFuZ2U6OGE2MzJiZjkxZjJkNDA1MDg5NThmYzRhOWIzYjQ1NjdfMjItMS0xLTEtNDI3OTI_9e9f49b4-2755-45bc-b05f-1297ca4d4405"
      unitRef="shares">11738000</us-gaap:CommonStockSharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="i9e9dcffbe0354e98962551a32828abc2_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOjhhNjMyYmY5MWYyZDQwNTA4OTU4ZmM0YTliM2I0NTY3L3RhYmxlcmFuZ2U6OGE2MzJiZjkxZjJkNDA1MDg5NThmYzRhOWIzYjQ1NjdfMjItMy0xLTEtNDI3OTI_e8202447-42af-4e50-b299-502ad46b9a84"
      unitRef="usd">12000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="idfb0b0b879244ae7862113b2345aa1e6_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOjhhNjMyYmY5MWYyZDQwNTA4OTU4ZmM0YTliM2I0NTY3L3RhYmxlcmFuZ2U6OGE2MzJiZjkxZjJkNDA1MDg5NThmYzRhOWIzYjQ1NjdfMjItNS0xLTEtNDI3OTI_9063bdc2-e034-4e01-80b8-c6d28eb900e6"
      unitRef="usd">10606000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i9cea7aaedf6e484b95020ab9ac02f011_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOjhhNjMyYmY5MWYyZDQwNTA4OTU4ZmM0YTliM2I0NTY3L3RhYmxlcmFuZ2U6OGE2MzJiZjkxZjJkNDA1MDg5NThmYzRhOWIzYjQ1NjdfMjItNy0xLTEtNDI3OTI_b072803f-d2c6-40a1-ba03-eeb953cc4e96"
      unitRef="usd">75000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ic4a2d943c8664242a544b6294ec6c7c8_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOjhhNjMyYmY5MWYyZDQwNTA4OTU4ZmM0YTliM2I0NTY3L3RhYmxlcmFuZ2U6OGE2MzJiZjkxZjJkNDA1MDg5NThmYzRhOWIzYjQ1NjdfMjItOS0xLTEtNDI3OTI_78d5fcbd-842f-4468-b0da-faad88c378d2"
      unitRef="usd">185343000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ib6dc7945bf0e400099cdcc1fed80fb2c_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOjhhNjMyYmY5MWYyZDQwNTA4OTU4ZmM0YTliM2I0NTY3L3RhYmxlcmFuZ2U6OGE2MzJiZjkxZjJkNDA1MDg5NThmYzRhOWIzYjQ1NjdfMjItMTEtMS0xLTQyNzky_753574d2-557d-4cf3-983a-3283e003f329"
      unitRef="usd">-1347000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i059d81e5005e42788c673ccfaf1058e5_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOjhhNjMyYmY5MWYyZDQwNTA4OTU4ZmM0YTliM2I0NTY3L3RhYmxlcmFuZ2U6OGE2MzJiZjkxZjJkNDA1MDg5NThmYzRhOWIzYjQ1NjdfMjItMTMtMS0xLTQyNzky_05148221-7bbc-4d3f-84c1-0afc8ca674c2"
      unitRef="usd">194689000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="i73d2ec22c05b4c4fbe6a550f139a59ae_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOjhhNjMyYmY5MWYyZDQwNTA4OTU4ZmM0YTliM2I0NTY3L3RhYmxlcmFuZ2U6OGE2MzJiZjkxZjJkNDA1MDg5NThmYzRhOWIzYjQ1NjdfMjMtOS0xLTEtNDM3NjE_be4bb976-0245-4b6d-8beb-d1c804b1ecff"
      unitRef="usd">41982000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i3bb5592686d74afab4f7004818fd6f9b_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOjhhNjMyYmY5MWYyZDQwNTA4OTU4ZmM0YTliM2I0NTY3L3RhYmxlcmFuZ2U6OGE2MzJiZjkxZjJkNDA1MDg5NThmYzRhOWIzYjQ1NjdfMjMtMTMtMS0xLTQzNzYx_14384877-d1af-45ee-b3fe-03a5ee8a07c3"
      unitRef="usd">41982000</us-gaap:NetIncomeLoss>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod
      contextRef="ibd26354982214044ae591432e82c800d_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOjhhNjMyYmY5MWYyZDQwNTA4OTU4ZmM0YTliM2I0NTY3L3RhYmxlcmFuZ2U6OGE2MzJiZjkxZjJkNDA1MDg5NThmYzRhOWIzYjQ1NjdfMjQtMS0xLTEtNDM3NjE_e61ba505-6c9e-4f81-a728-70cdbc18f27c"
      unitRef="shares">1000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
      contextRef="i1aab3bd0f0be43baa5e0bc44e70a5a28_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOjhhNjMyYmY5MWYyZDQwNTA4OTU4ZmM0YTliM2I0NTY3L3RhYmxlcmFuZ2U6OGE2MzJiZjkxZjJkNDA1MDg5NThmYzRhOWIzYjQ1NjdfMjQtNS0xLTEtNDM3NjE_4fdf4926-dc6b-4468-9e66-7c8c44eb8535"
      unitRef="usd">2269000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
      contextRef="i3bb5592686d74afab4f7004818fd6f9b_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOjhhNjMyYmY5MWYyZDQwNTA4OTU4ZmM0YTliM2I0NTY3L3RhYmxlcmFuZ2U6OGE2MzJiZjkxZjJkNDA1MDg5NThmYzRhOWIzYjQ1NjdfMjQtMTMtMS0xLTQzNzYx_ce96420a-f8d8-45c4-b0da-acbf30043ada"
      unitRef="usd">2269000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="ibd26354982214044ae591432e82c800d_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOjhhNjMyYmY5MWYyZDQwNTA4OTU4ZmM0YTliM2I0NTY3L3RhYmxlcmFuZ2U6OGE2MzJiZjkxZjJkNDA1MDg5NThmYzRhOWIzYjQ1NjdfMjUtMS0xLTEtNDM3NjE_0fa6fb94-53c0-47a9-aaad-53c4dd2e24ba"
      unitRef="shares">3000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i1aab3bd0f0be43baa5e0bc44e70a5a28_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOjhhNjMyYmY5MWYyZDQwNTA4OTU4ZmM0YTliM2I0NTY3L3RhYmxlcmFuZ2U6OGE2MzJiZjkxZjJkNDA1MDg5NThmYzRhOWIzYjQ1NjdfMjUtNS0xLTEtNDM3NjE_581764d5-c17e-4f7c-9d22-14c1938554e5"
      unitRef="usd">109000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i3bb5592686d74afab4f7004818fd6f9b_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOjhhNjMyYmY5MWYyZDQwNTA4OTU4ZmM0YTliM2I0NTY3L3RhYmxlcmFuZ2U6OGE2MzJiZjkxZjJkNDA1MDg5NThmYzRhOWIzYjQ1NjdfMjUtMTMtMS0xLTQzNzYx_7e00b702-1746-45ff-9225-8cbef1f36bf2"
      unitRef="usd">109000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation
      contextRef="ibd26354982214044ae591432e82c800d_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOjhhNjMyYmY5MWYyZDQwNTA4OTU4ZmM0YTliM2I0NTY3L3RhYmxlcmFuZ2U6OGE2MzJiZjkxZjJkNDA1MDg5NThmYzRhOWIzYjQ1NjdfMjYtMS0xLTEtNDM3NjE_1b75dc0f-f0aa-4bf0-97c0-38fb39542e7e"
      unitRef="shares">1000</us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i1aab3bd0f0be43baa5e0bc44e70a5a28_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOjhhNjMyYmY5MWYyZDQwNTA4OTU4ZmM0YTliM2I0NTY3L3RhYmxlcmFuZ2U6OGE2MzJiZjkxZjJkNDA1MDg5NThmYzRhOWIzYjQ1NjdfMjYtNS0xLTEtNDM3NjE_ccb1a974-c9a4-48b9-bb43-6492886ca96a"
      unitRef="usd">34000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i3bb5592686d74afab4f7004818fd6f9b_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOjhhNjMyYmY5MWYyZDQwNTA4OTU4ZmM0YTliM2I0NTY3L3RhYmxlcmFuZ2U6OGE2MzJiZjkxZjJkNDA1MDg5NThmYzRhOWIzYjQ1NjdfMjYtMTMtMS0xLTQzNzYx_d819ddfa-1e47-4956-a2ce-6c8be0e42e42"
      unitRef="usd">34000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i4218dcf5ff3845e68993eb267c5fbe10_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOjhhNjMyYmY5MWYyZDQwNTA4OTU4ZmM0YTliM2I0NTY3L3RhYmxlcmFuZ2U6OGE2MzJiZjkxZjJkNDA1MDg5NThmYzRhOWIzYjQ1NjdfMjctNy0xLTEtNDM3NjE_4f751b11-a794-4bb1-a78c-456f98ac7985"
      unitRef="usd">47000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i3bb5592686d74afab4f7004818fd6f9b_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOjhhNjMyYmY5MWYyZDQwNTA4OTU4ZmM0YTliM2I0NTY3L3RhYmxlcmFuZ2U6OGE2MzJiZjkxZjJkNDA1MDg5NThmYzRhOWIzYjQ1NjdfMjctMTMtMS0xLTQzNzYx_a43d6d09-609b-4c91-8dc3-0b9953e64f1c"
      unitRef="usd">47000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i64699db86ad54ac8a14806cd578d3cf7_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOjhhNjMyYmY5MWYyZDQwNTA4OTU4ZmM0YTliM2I0NTY3L3RhYmxlcmFuZ2U6OGE2MzJiZjkxZjJkNDA1MDg5NThmYzRhOWIzYjQ1NjdfMjgtMTEtMS0xLTQzNzYx_5f71d076-785f-433f-9b01-b59c6d64d8e1"
      unitRef="usd">26270000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i3bb5592686d74afab4f7004818fd6f9b_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOjhhNjMyYmY5MWYyZDQwNTA4OTU4ZmM0YTliM2I0NTY3L3RhYmxlcmFuZ2U6OGE2MzJiZjkxZjJkNDA1MDg5NThmYzRhOWIzYjQ1NjdfMjgtMTMtMS0xLTQzNzYx_90078394-5b04-436d-b3ed-fd6d10ce52fb"
      unitRef="usd">26270000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockSharesRetired
      contextRef="ibd26354982214044ae591432e82c800d_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOjhhNjMyYmY5MWYyZDQwNTA4OTU4ZmM0YTliM2I0NTY3L3RhYmxlcmFuZ2U6OGE2MzJiZjkxZjJkNDA1MDg5NThmYzRhOWIzYjQ1NjdfMjktMS0xLTEtNDM3NjE_85b6a957-98d5-4ca6-9c3e-7e0220c926d4"
      unitRef="shares">123000</us-gaap:TreasuryStockSharesRetired>
    <us-gaap:TreasuryStockRetiredCostMethodAmount
      contextRef="i73d2ec22c05b4c4fbe6a550f139a59ae_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOjhhNjMyYmY5MWYyZDQwNTA4OTU4ZmM0YTliM2I0NTY3L3RhYmxlcmFuZ2U6OGE2MzJiZjkxZjJkNDA1MDg5NThmYzRhOWIzYjQ1NjdfMjktOS0xLTEtNDM3NjE_f83e60a4-509e-4aa6-8f2d-fe48412a0de9"
      unitRef="usd">27617000</us-gaap:TreasuryStockRetiredCostMethodAmount>
    <us-gaap:TreasuryStockRetiredCostMethodAmount
      contextRef="i64699db86ad54ac8a14806cd578d3cf7_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOjhhNjMyYmY5MWYyZDQwNTA4OTU4ZmM0YTliM2I0NTY3L3RhYmxlcmFuZ2U6OGE2MzJiZjkxZjJkNDA1MDg5NThmYzRhOWIzYjQ1NjdfMjktMTEtMS0xLTQzNzYx_38fe1ee3-1bbe-4004-8f9a-1f672c027686"
      unitRef="usd">-27617000</us-gaap:TreasuryStockRetiredCostMethodAmount>
    <us-gaap:DividendsCommonStockCash
      contextRef="i73d2ec22c05b4c4fbe6a550f139a59ae_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOjhhNjMyYmY5MWYyZDQwNTA4OTU4ZmM0YTliM2I0NTY3L3RhYmxlcmFuZ2U6OGE2MzJiZjkxZjJkNDA1MDg5NThmYzRhOWIzYjQ1NjdfMzAtOS0xLTEtNDM3NjE_6c5824aa-0ad4-45e1-99b5-d359124a2d92"
      unitRef="usd">16553000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="i3bb5592686d74afab4f7004818fd6f9b_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOjhhNjMyYmY5MWYyZDQwNTA4OTU4ZmM0YTliM2I0NTY3L3RhYmxlcmFuZ2U6OGE2MzJiZjkxZjJkNDA1MDg5NThmYzRhOWIzYjQ1NjdfMzAtMTMtMS0xLTQzNzYx_de518e62-38b9-4af2-b7ec-f67c0b40aff3"
      unitRef="usd">16553000</us-gaap:DividendsCommonStockCash>
    <us-gaap:CommonStockSharesIssued
      contextRef="ib9edd1f9ecfe40139a3c3fbfe3370644_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOjhhNjMyYmY5MWYyZDQwNTA4OTU4ZmM0YTliM2I0NTY3L3RhYmxlcmFuZ2U6OGE2MzJiZjkxZjJkNDA1MDg5NThmYzRhOWIzYjQ1NjdfMzItMS0xLTEtNDM3NjE_26133a95-0415-48f1-a3a3-5ae78d9bedf8"
      unitRef="shares">11618000</us-gaap:CommonStockSharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="ib9edd1f9ecfe40139a3c3fbfe3370644_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOjhhNjMyYmY5MWYyZDQwNTA4OTU4ZmM0YTliM2I0NTY3L3RhYmxlcmFuZ2U6OGE2MzJiZjkxZjJkNDA1MDg5NThmYzRhOWIzYjQ1NjdfMzItMy0xLTEtNDM3NjE_c80ad748-de5c-4ef8-8cf3-f4fa9c9fd63f"
      unitRef="usd">12000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i25169b23871e46eca074903e07db728c_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOjhhNjMyYmY5MWYyZDQwNTA4OTU4ZmM0YTliM2I0NTY3L3RhYmxlcmFuZ2U6OGE2MzJiZjkxZjJkNDA1MDg5NThmYzRhOWIzYjQ1NjdfMzItNS0xLTEtNDM3NjE_d27cb3d6-424f-4af8-9c1d-fd9d940f24b3"
      unitRef="usd">12950000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i9c3f2304fd3c47c18b9051b19c7301ea_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOjhhNjMyYmY5MWYyZDQwNTA4OTU4ZmM0YTliM2I0NTY3L3RhYmxlcmFuZ2U6OGE2MzJiZjkxZjJkNDA1MDg5NThmYzRhOWIzYjQ1NjdfMzItNy0xLTEtNDM3NjE_5c610781-d0a5-47a3-aa6b-894f83de1fbd"
      unitRef="usd">122000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i00844f75496c44e194d293f567033a2d_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOjhhNjMyYmY5MWYyZDQwNTA4OTU4ZmM0YTliM2I0NTY3L3RhYmxlcmFuZ2U6OGE2MzJiZjkxZjJkNDA1MDg5NThmYzRhOWIzYjQ1NjdfMzItOS0xLTEtNDM3NjE_59bfbd9b-22d5-4da7-95d9-dfed30420a76"
      unitRef="usd">183155000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i0e33dd9737fd44d6ab51db5290fd1254_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOjhhNjMyYmY5MWYyZDQwNTA4OTU4ZmM0YTliM2I0NTY3L3RhYmxlcmFuZ2U6OGE2MzJiZjkxZjJkNDA1MDg5NThmYzRhOWIzYjQ1NjdfMzItMTEtMS0xLTQzNzYx_4a24ad3c-11ad-4c46-9e24-004bb8b5d8e8"
      unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ifb5de6f6a1b842d59a7c6674c3095ce8_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18yOC9mcmFnOmQyZGU5ZGY1NzFjNTRhM2VhZjY3NDgxZTczMzViZjZiL3RhYmxlOjhhNjMyYmY5MWYyZDQwNTA4OTU4ZmM0YTliM2I0NTY3L3RhYmxlcmFuZ2U6OGE2MzJiZjkxZjJkNDA1MDg5NThmYzRhOWIzYjQ1NjdfMzItMTMtMS0xLTQzNzYx_91b8af7a-bbf6-4311-b68b-5991968cde17"
      unitRef="usd">196239000</us-gaap:StockholdersEquity>
    <us-gaap:SignificantAccountingPoliciesTextBlock
      contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18zNC9mcmFnOjZhODRjZTVmYjIzMjQzYzc4ODU0YjM0OGZjZDc5ZDBmL3RleHRyZWdpb246NmE4NGNlNWZiMjMyNDNjNzg4NTRiMzQ4ZmNkNzlkMGZfMzUwNg_6ba77f91-2500-46fc-ad2a-73e18d0edbd2">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Basis of Presentation -&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The accompanying unaudited condensed consolidated financial statements of Medifast, Inc. and its wholly-owned subsidiaries (&#x201c;Medifast,&#x201d; the &#x201c;Company,&#x201d; &#x201c;we,&#x201d; &#x201c;us,&#x201d; or &#x201c;our&#x201d;) included herein have been prepared in accordance with generally accepted accounting principles in the United States of America (&#x201c;GAAP&#x201d;) for interim reporting and pursuant to the rules and regulations of the Securities and Exchange Commission (the &#x201c;SEC&#x201d;). Accordingly, certain information and notes that are normally required by GAAP have been condensed or omitted. However, in the opinion of management, all adjustments consisting of normal, recurring adjustments considered necessary for a fair presentation of the financial position and results of operations have been included and management believes the disclosures that are made are adequate to make the information presented not misleading. The condensed consolidated balance sheet at December&#160;31, 2021 has been derived from the audited consolidated financial statements at that date included in the Company&#x2019;s Annual Report on Form 10-K for the fiscal year ended December&#160;31, 2021 (&#x201c;2021 Form 10-K&#x201d;).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The results of operations for the three and nine months ended September 30, 2022 are not necessarily indicative of results that may be expected for the fiscal year ending December&#160;31, 2022. The accompanying unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto, which are included in the 2021 Form 10-K.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Presentation of Financial Statements -&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The unaudited condensed consolidated financial statements included herein include the accounts of the Company. All significant intercompany accounts and transactions have been eliminated.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Reclassification -&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Certain amounts reported for prior periods have been reclassified to be consistent with the current period presentation. No reclassification in the condensed consolidated financial statements had a material impact on the presentation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Use of Estimates&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; - The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and reported amounts of revenue and expenses during the reporting period. Actual results could differ materially from those estimates.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Accounting Pronouncements Adopted in 2022&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March 2020, the FASB issued Accounting Standards Update (&#x201c;ASU&#x201d;) 2020-04, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting&lt;/span&gt;, which provides optional guidance for a limited time to ease the potential burden in accounting for reference rate reform. The new guidance provides optional expedients and exceptions for applying accounting principles under GAAP to contracts, hedging relationships and other transactions affected by reference rate reform if certain criteria are met and to other derivative instruments if there is a change to the interest rates used for discounting, margining or contract price alignment. These amendments are effective immediately and may be applied prospectively to contract modifications made and hedging relationships entered into or evaluated on or before December 31, 2022. We adopted Topic 848 beginning in the first quarter of fiscal 2022 without any material impact on the Company's financial position and results of operations.</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock
      contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18zNC9mcmFnOjZhODRjZTVmYjIzMjQzYzc4ODU0YjM0OGZjZDc5ZDBmL3RleHRyZWdpb246NmE4NGNlNWZiMjMyNDNjNzg4NTRiMzQ4ZmNkNzlkMGZfMzUwNw_815bd213-7ed7-43d5-9393-bffdb596264c">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Basis of Presentation -&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The accompanying unaudited condensed consolidated financial statements of Medifast, Inc. and its wholly-owned subsidiaries (&#x201c;Medifast,&#x201d; the &#x201c;Company,&#x201d; &#x201c;we,&#x201d; &#x201c;us,&#x201d; or &#x201c;our&#x201d;) included herein have been prepared in accordance with generally accepted accounting principles in the United States of America (&#x201c;GAAP&#x201d;) for interim reporting and pursuant to the rules and regulations of the Securities and Exchange Commission (the &#x201c;SEC&#x201d;). Accordingly, certain information and notes that are normally required by GAAP have been condensed or omitted. However, in the opinion of management, all adjustments consisting of normal, recurring adjustments considered necessary for a fair presentation of the financial position and results of operations have been included and management believes the disclosures that are made are adequate to make the information presented not misleading. The condensed consolidated balance sheet at December&#160;31, 2021 has been derived from the audited consolidated financial statements at that date included in the Company&#x2019;s Annual Report on Form 10-K for the fiscal year ended December&#160;31, 2021 (&#x201c;2021 Form 10-K&#x201d;).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The results of operations for the three and nine months ended September 30, 2022 are not necessarily indicative of results that may be expected for the fiscal year ending December&#160;31, 2022. The accompanying unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto, which are included in the 2021 Form 10-K.&lt;/span&gt;&lt;/div&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock
      contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18zNC9mcmFnOjZhODRjZTVmYjIzMjQzYzc4ODU0YjM0OGZjZDc5ZDBmL3RleHRyZWdpb246NmE4NGNlNWZiMjMyNDNjNzg4NTRiMzQ4ZmNkNzlkMGZfMzUwMg_7ce8e168-831d-4a3d-8876-9b5106f0074f">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Presentation of Financial Statements -&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The unaudited condensed consolidated financial statements included herein include the accounts of the Company. All significant intercompany accounts and transactions have been eliminated.&lt;/span&gt;</us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock>
    <us-gaap:PriorPeriodReclassificationAdjustmentDescription
      contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18zNC9mcmFnOjZhODRjZTVmYjIzMjQzYzc4ODU0YjM0OGZjZDc5ZDBmL3RleHRyZWdpb246NmE4NGNlNWZiMjMyNDNjNzg4NTRiMzQ4ZmNkNzlkMGZfMzUwMw_4c875417-4495-42db-98cb-a052f6017f7e">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Reclassification -&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Certain amounts reported for prior periods have been reclassified to be consistent with the current period presentation. No reclassification in the condensed consolidated financial statements had a material impact on the presentation.&lt;/span&gt;</us-gaap:PriorPeriodReclassificationAdjustmentDescription>
    <us-gaap:UseOfEstimates
      contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18zNC9mcmFnOjZhODRjZTVmYjIzMjQzYzc4ODU0YjM0OGZjZDc5ZDBmL3RleHRyZWdpb246NmE4NGNlNWZiMjMyNDNjNzg4NTRiMzQ4ZmNkNzlkMGZfMzUwNA_2c1d04ec-f2e6-4066-8eb9-89d2d588568c">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Use of Estimates&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; - The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and reported amounts of revenue and expenses during the reporting period. Actual results could differ materially from those estimates.&lt;/span&gt;</us-gaap:UseOfEstimates>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18zNC9mcmFnOjZhODRjZTVmYjIzMjQzYzc4ODU0YjM0OGZjZDc5ZDBmL3RleHRyZWdpb246NmE4NGNlNWZiMjMyNDNjNzg4NTRiMzQ4ZmNkNzlkMGZfMzUwNQ_b9fce907-3645-49fe-92d7-487ae3066112">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Accounting Pronouncements Adopted in 2022&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March 2020, the FASB issued Accounting Standards Update (&#x201c;ASU&#x201d;) 2020-04, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting&lt;/span&gt;, which provides optional guidance for a limited time to ease the potential burden in accounting for reference rate reform. The new guidance provides optional expedients and exceptions for applying accounting principles under GAAP to contracts, hedging relationships and other transactions affected by reference rate reform if certain criteria are met and to other derivative instruments if there is a change to the interest rates used for discounting, margining or contract price alignment. These amendments are effective immediately and may be applied prospectively to contract modifications made and hedging relationships entered into or evaluated on or before December 31, 2022. We adopted Topic 848 beginning in the first quarter of fiscal 2022 without any material impact on the Company's financial position and results of operations.</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:InventoryDisclosureTextBlock
      contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18zNy9mcmFnOjAwNzc4OWM5YjcxZjRlYjU5NzA5ZDZhMjhjMzdmZDZmL3RleHRyZWdpb246MDA3Nzg5YzliNzFmNGViNTk3MDlkNmEyOGMzN2ZkNmZfOTIw_9f0e58f5-e5f3-4e9d-8748-66d2d2cf24ea">INVENTORIES&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventories consist principally of raw materials, non-food finished goods and packaged meal replacements held in the Company&#x2019;s warehouses and outsourced distribution centers. Inventories are stated at the lower of cost or net realizable value, utilizing the first-in, first-out method. The cost of finished goods includes the cost of raw materials, packaging supplies, direct and indirect labor and other indirect manufacturing costs. On a quarterly basis, management reviews inventories for unsalable or obsolete inventories.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The Company donated inventory with an aggregate cost of $1.1&#160;million and $10.5&#160;million to Ukrainian refugees and those in need in Ukraine, increasing selling, general and administrative (&#x201c;SG&amp;amp;A&#x201d;) expenses during the three and nine months ended &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;September&#160;30, 2022. The donations were made to two 501(c)(3) organizations that are coordinating the distribution throughout refugee camps in Europe and in Ukraine.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventories consisted of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.549%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.638%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 1.37pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;11,989&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 1.37pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;15,196&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Packaging&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;3,078&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;3,641&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Non-food finished goods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;10,455&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;15,991&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;122,227&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;152,687&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Reserve for obsolete inventory&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;(2,470)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;(7,472)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1.37pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;145,279&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1.37pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;180,043&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:InventoryDisclosureTextBlock>
    <us-gaap:NoncashContributionExpense
      contextRef="i2f3a96a832ab4b0ca374599d1c3e9bce_D20220701-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18zNy9mcmFnOjAwNzc4OWM5YjcxZjRlYjU5NzA5ZDZhMjhjMzdmZDZmL3RleHRyZWdpb246MDA3Nzg5YzliNzFmNGViNTk3MDlkNmEyOGMzN2ZkNmZfNjAz_ca2382c4-b472-4ef2-9b44-1e9f4ee16570"
      unitRef="usd">1100000</us-gaap:NoncashContributionExpense>
    <us-gaap:NoncashContributionExpense
      contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18zNy9mcmFnOjAwNzc4OWM5YjcxZjRlYjU5NzA5ZDZhMjhjMzdmZDZmL3RleHRyZWdpb246MDA3Nzg5YzliNzFmNGViNTk3MDlkNmEyOGMzN2ZkNmZfNzY5NjU4MTM5NTY4Ng_167cbb33-8e7d-4b58-a646-0c57d8f8127c"
      unitRef="usd">10500000</us-gaap:NoncashContributionExpense>
    <dei:DocumentPeriodEndDate
      contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18zNy9mcmFnOjAwNzc4OWM5YjcxZjRlYjU5NzA5ZDZhMjhjMzdmZDZmL3RleHRyZWdpb246MDA3Nzg5YzliNzFmNGViNTk3MDlkNmEyOGMzN2ZkNmZfOTg5NTYwNDY1MTMzMQ_75cfbe1e-17ec-4442-ae34-fd999dbe9ec2">2022-09-30</dei:DocumentPeriodEndDate>
    <us-gaap:ScheduleOfInventoryCurrentTableTextBlock
      contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18zNy9mcmFnOjAwNzc4OWM5YjcxZjRlYjU5NzA5ZDZhMjhjMzdmZDZmL3RleHRyZWdpb246MDA3Nzg5YzliNzFmNGViNTk3MDlkNmEyOGMzN2ZkNmZfOTE5_70d50061-93c9-45ed-ab5f-a0b1e5f48c43">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventories consisted of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.549%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.638%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 1.37pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;11,989&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 1.37pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;15,196&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Packaging&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;3,078&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;3,641&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Non-food finished goods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;10,455&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;15,991&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;122,227&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;152,687&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Reserve for obsolete inventory&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;(2,470)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;(7,472)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1.37pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;145,279&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1.37pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;180,043&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
    <dei:DocumentPeriodEndDate
      contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18zNy9mcmFnOjAwNzc4OWM5YjcxZjRlYjU5NzA5ZDZhMjhjMzdmZDZmL3RhYmxlOmQzNDEzZDg0OTk5YTRhY2M5MWZmZjBkZDJlODkwMGFhL3RhYmxlcmFuZ2U6ZDM0MTNkODQ5OTlhNGFjYzkxZmZmMGRkMmU4OTAwYWFfMC0xLTEtMS00Mjc5Mg_75cfbe1e-17ec-4442-ae34-fd999dbe9ec2">2022-09-30</dei:DocumentPeriodEndDate>
    <us-gaap:InventoryRawMaterials
      contextRef="i5de311f5948148cda49342e2cea83715_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18zNy9mcmFnOjAwNzc4OWM5YjcxZjRlYjU5NzA5ZDZhMjhjMzdmZDZmL3RhYmxlOmQzNDEzZDg0OTk5YTRhY2M5MWZmZjBkZDJlODkwMGFhL3RhYmxlcmFuZ2U6ZDM0MTNkODQ5OTlhNGFjYzkxZmZmMGRkMmU4OTAwYWFfMi0xLTEtMS00Mjc5Mg_dc7aa0ce-f386-42f2-a208-f3ec769f095c"
      unitRef="usd">11989000</us-gaap:InventoryRawMaterials>
    <us-gaap:InventoryRawMaterials
      contextRef="i47f09f18839440ffae0cf05a475aa7fe_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18zNy9mcmFnOjAwNzc4OWM5YjcxZjRlYjU5NzA5ZDZhMjhjMzdmZDZmL3RhYmxlOmQzNDEzZDg0OTk5YTRhY2M5MWZmZjBkZDJlODkwMGFhL3RhYmxlcmFuZ2U6ZDM0MTNkODQ5OTlhNGFjYzkxZmZmMGRkMmU4OTAwYWFfMi0zLTEtMS00Mjc5Mg_55ee2620-e5c2-4ef6-9104-7e171fda8837"
      unitRef="usd">15196000</us-gaap:InventoryRawMaterials>
    <us-gaap:RetailRelatedInventoryPackagingAndOtherSupplies
      contextRef="i5de311f5948148cda49342e2cea83715_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18zNy9mcmFnOjAwNzc4OWM5YjcxZjRlYjU5NzA5ZDZhMjhjMzdmZDZmL3RhYmxlOmQzNDEzZDg0OTk5YTRhY2M5MWZmZjBkZDJlODkwMGFhL3RhYmxlcmFuZ2U6ZDM0MTNkODQ5OTlhNGFjYzkxZmZmMGRkMmU4OTAwYWFfMy0xLTEtMS00Mjc5Mg_db3bc9fb-2fb2-407c-8ac6-dc66965c39e0"
      unitRef="usd">3078000</us-gaap:RetailRelatedInventoryPackagingAndOtherSupplies>
    <us-gaap:RetailRelatedInventoryPackagingAndOtherSupplies
      contextRef="i47f09f18839440ffae0cf05a475aa7fe_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18zNy9mcmFnOjAwNzc4OWM5YjcxZjRlYjU5NzA5ZDZhMjhjMzdmZDZmL3RhYmxlOmQzNDEzZDg0OTk5YTRhY2M5MWZmZjBkZDJlODkwMGFhL3RhYmxlcmFuZ2U6ZDM0MTNkODQ5OTlhNGFjYzkxZmZmMGRkMmU4OTAwYWFfMy0zLTEtMS00Mjc5Mg_9f5f81a1-4e9d-4764-9817-07ca336d8633"
      unitRef="usd">3641000</us-gaap:RetailRelatedInventoryPackagingAndOtherSupplies>
    <med:InventoryNonFoodFinishedGoods
      contextRef="i5de311f5948148cda49342e2cea83715_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18zNy9mcmFnOjAwNzc4OWM5YjcxZjRlYjU5NzA5ZDZhMjhjMzdmZDZmL3RhYmxlOmQzNDEzZDg0OTk5YTRhY2M5MWZmZjBkZDJlODkwMGFhL3RhYmxlcmFuZ2U6ZDM0MTNkODQ5OTlhNGFjYzkxZmZmMGRkMmU4OTAwYWFfNC0xLTEtMS00Mjc5Mg_6e38f0b1-c4b4-4b7b-a7f4-18a277b3776e"
      unitRef="usd">10455000</med:InventoryNonFoodFinishedGoods>
    <med:InventoryNonFoodFinishedGoods
      contextRef="i47f09f18839440ffae0cf05a475aa7fe_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18zNy9mcmFnOjAwNzc4OWM5YjcxZjRlYjU5NzA5ZDZhMjhjMzdmZDZmL3RhYmxlOmQzNDEzZDg0OTk5YTRhY2M5MWZmZjBkZDJlODkwMGFhL3RhYmxlcmFuZ2U6ZDM0MTNkODQ5OTlhNGFjYzkxZmZmMGRkMmU4OTAwYWFfNC0zLTEtMS00Mjc5Mg_8ff2fd9d-5bc1-4c86-860f-ea8acd0b1177"
      unitRef="usd">15991000</med:InventoryNonFoodFinishedGoods>
    <us-gaap:InventoryFinishedGoods
      contextRef="i5de311f5948148cda49342e2cea83715_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18zNy9mcmFnOjAwNzc4OWM5YjcxZjRlYjU5NzA5ZDZhMjhjMzdmZDZmL3RhYmxlOmQzNDEzZDg0OTk5YTRhY2M5MWZmZjBkZDJlODkwMGFhL3RhYmxlcmFuZ2U6ZDM0MTNkODQ5OTlhNGFjYzkxZmZmMGRkMmU4OTAwYWFfNS0xLTEtMS00Mjc5Mg_2a60ecba-7dc8-4efe-864c-715fe7831841"
      unitRef="usd">122227000</us-gaap:InventoryFinishedGoods>
    <us-gaap:InventoryFinishedGoods
      contextRef="i47f09f18839440ffae0cf05a475aa7fe_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18zNy9mcmFnOjAwNzc4OWM5YjcxZjRlYjU5NzA5ZDZhMjhjMzdmZDZmL3RhYmxlOmQzNDEzZDg0OTk5YTRhY2M5MWZmZjBkZDJlODkwMGFhL3RhYmxlcmFuZ2U6ZDM0MTNkODQ5OTlhNGFjYzkxZmZmMGRkMmU4OTAwYWFfNS0zLTEtMS00Mjc5Mg_746733fd-aed3-442f-87de-27a96e7b95fe"
      unitRef="usd">152687000</us-gaap:InventoryFinishedGoods>
    <us-gaap:InventoryValuationReserves
      contextRef="i5de311f5948148cda49342e2cea83715_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18zNy9mcmFnOjAwNzc4OWM5YjcxZjRlYjU5NzA5ZDZhMjhjMzdmZDZmL3RhYmxlOmQzNDEzZDg0OTk5YTRhY2M5MWZmZjBkZDJlODkwMGFhL3RhYmxlcmFuZ2U6ZDM0MTNkODQ5OTlhNGFjYzkxZmZmMGRkMmU4OTAwYWFfNi0xLTEtMS00Mjc5Mg_71842c3a-d91b-478c-af1e-efe3a156d97f"
      unitRef="usd">2470000</us-gaap:InventoryValuationReserves>
    <us-gaap:InventoryValuationReserves
      contextRef="i47f09f18839440ffae0cf05a475aa7fe_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18zNy9mcmFnOjAwNzc4OWM5YjcxZjRlYjU5NzA5ZDZhMjhjMzdmZDZmL3RhYmxlOmQzNDEzZDg0OTk5YTRhY2M5MWZmZjBkZDJlODkwMGFhL3RhYmxlcmFuZ2U6ZDM0MTNkODQ5OTlhNGFjYzkxZmZmMGRkMmU4OTAwYWFfNi0zLTEtMS00Mjc5Mg_d50d9962-341f-4b1f-9b90-3faaa3efd9e1"
      unitRef="usd">7472000</us-gaap:InventoryValuationReserves>
    <us-gaap:InventoryNet
      contextRef="i5de311f5948148cda49342e2cea83715_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18zNy9mcmFnOjAwNzc4OWM5YjcxZjRlYjU5NzA5ZDZhMjhjMzdmZDZmL3RhYmxlOmQzNDEzZDg0OTk5YTRhY2M5MWZmZjBkZDJlODkwMGFhL3RhYmxlcmFuZ2U6ZDM0MTNkODQ5OTlhNGFjYzkxZmZmMGRkMmU4OTAwYWFfNy0xLTEtMS00Mjc5Mg_2ad80d04-1667-4efb-afa8-87ff8bd98aba"
      unitRef="usd">145279000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="i47f09f18839440ffae0cf05a475aa7fe_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM18zNy9mcmFnOjAwNzc4OWM5YjcxZjRlYjU5NzA5ZDZhMjhjMzdmZDZmL3RhYmxlOmQzNDEzZDg0OTk5YTRhY2M5MWZmZjBkZDJlODkwMGFhL3RhYmxlcmFuZ2U6ZDM0MTNkODQ5OTlhNGFjYzkxZmZmMGRkMmU4OTAwYWFfNy0zLTEtMS00Mjc5Mg_bc4d3b64-8bf5-47ef-8c89-9a8a182d3bc2"
      unitRef="usd">180043000</us-gaap:InventoryNet>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180MC9mcmFnOmU3ZDQ0NTc2ZmI2ZDQ5MWJiMmYwMmVlNDZhMDFkNDY5L3RleHRyZWdpb246ZTdkNDQ1NzZmYjZkNDkxYmIyZjAyZWU0NmEwMWQ0NjlfODg3_50e38cde-06d6-4db6-8fe6-dc5cec059fed">EARNINGS PER SHARE&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic earnings per share (&#x201c;EPS&#x201d;) computations are calculated utilizing the weighted average number of shares of the Company&#x2019;s common stock outstanding during the periods presented. Diluted EPS is calculated utilizing the weighted average number of shares of the Company&#x2019;s common stock outstanding adjusted for the effect of dilutive common stock equivalents.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table sets forth the computation of basic and diluted EPS (in thousands, except per share data):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.329%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.361%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.361%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.364%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.366%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three months ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nine months ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Numerator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;36,155&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;41,982&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;117,050&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;130,008&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Denominator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Weighted average shares of common stock outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,964&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11,692&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11,290&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11,739&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Effect of dilutive common stock equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;93&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Weighted average shares of common stock outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11,042&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11,785&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11,369&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11,840&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Earnings per share - basic&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10.37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11.07&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Earnings per share - diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10.30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10.98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The calculation of diluted EPS excluded 10 thousand and 0 thousand antidilutive restricted stock awards for the three months ended September 30, 2022 and 2021, respectively, and 3 thousand and 0 thousand antidilutive restricted stock awards for the nine months ended September 30, 2022 and 2021, respectively. EPS is computed independently for each of the periods presented above, and accordingly, the sum of the quarterly earnings per common share may not equal the year-to-date total computed.&lt;/span&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180MC9mcmFnOmU3ZDQ0NTc2ZmI2ZDQ5MWJiMmYwMmVlNDZhMDFkNDY5L3RleHRyZWdpb246ZTdkNDQ1NzZmYjZkNDkxYmIyZjAyZWU0NmEwMWQ0NjlfODg4_6ad920e3-2b73-4113-8807-631587c18527">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table sets forth the computation of basic and diluted EPS (in thousands, except per share data):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.329%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.361%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.361%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.364%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.366%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three months ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nine months ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Numerator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;36,155&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;41,982&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;117,050&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;130,008&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Denominator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Weighted average shares of common stock outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,964&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11,692&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11,290&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11,739&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Effect of dilutive common stock equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;93&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Weighted average shares of common stock outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11,042&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11,785&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11,369&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11,840&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Earnings per share - basic&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10.37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11.07&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Earnings per share - diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10.30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10.98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLoss
      contextRef="i2f3a96a832ab4b0ca374599d1c3e9bce_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180MC9mcmFnOmU3ZDQ0NTc2ZmI2ZDQ5MWJiMmYwMmVlNDZhMDFkNDY5L3RhYmxlOjRkMzFjYzhhNTgxMTQwMThhMmQ3OTdlNDYyZGZjZTQyL3RhYmxlcmFuZ2U6NGQzMWNjOGE1ODExNDAxOGEyZDc5N2U0NjJkZmNlNDJfNC0xLTEtMS00Mjc5Mg_a8dda91d-2175-496c-9f08-a26d7da54d28"
      unitRef="usd">36155000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i3bb5592686d74afab4f7004818fd6f9b_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180MC9mcmFnOmU3ZDQ0NTc2ZmI2ZDQ5MWJiMmYwMmVlNDZhMDFkNDY5L3RhYmxlOjRkMzFjYzhhNTgxMTQwMThhMmQ3OTdlNDYyZGZjZTQyL3RhYmxlcmFuZ2U6NGQzMWNjOGE1ODExNDAxOGEyZDc5N2U0NjJkZmNlNDJfNC0zLTEtMS00Mjc5Mg_1debcfff-fbe8-498c-aa9f-09b9030d2bca"
      unitRef="usd">41982000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180MC9mcmFnOmU3ZDQ0NTc2ZmI2ZDQ5MWJiMmYwMmVlNDZhMDFkNDY5L3RhYmxlOjRkMzFjYzhhNTgxMTQwMThhMmQ3OTdlNDYyZGZjZTQyL3RhYmxlcmFuZ2U6NGQzMWNjOGE1ODExNDAxOGEyZDc5N2U0NjJkZmNlNDJfNC01LTEtMS00Mjc5Mg_80832123-86c4-453b-95cf-1adedabcc4d8"
      unitRef="usd">117050000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ic431430d1ab24120b4507025a722d73a_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180MC9mcmFnOmU3ZDQ0NTc2ZmI2ZDQ5MWJiMmYwMmVlNDZhMDFkNDY5L3RhYmxlOjRkMzFjYzhhNTgxMTQwMThhMmQ3OTdlNDYyZGZjZTQyL3RhYmxlcmFuZ2U6NGQzMWNjOGE1ODExNDAxOGEyZDc5N2U0NjJkZmNlNDJfNC03LTEtMS00Mjc5Mg_613b68c5-10ac-4dab-8b25-62d4a8bef4e3"
      unitRef="usd">130008000</us-gaap:NetIncomeLoss>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i2f3a96a832ab4b0ca374599d1c3e9bce_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180MC9mcmFnOmU3ZDQ0NTc2ZmI2ZDQ5MWJiMmYwMmVlNDZhMDFkNDY5L3RhYmxlOjRkMzFjYzhhNTgxMTQwMThhMmQ3OTdlNDYyZGZjZTQyL3RhYmxlcmFuZ2U6NGQzMWNjOGE1ODExNDAxOGEyZDc5N2U0NjJkZmNlNDJfNy0xLTEtMS00Mjc5Mg_f898d3ca-f97f-4e85-983a-deb6e6fd412c"
      unitRef="shares">10964000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i3bb5592686d74afab4f7004818fd6f9b_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180MC9mcmFnOmU3ZDQ0NTc2ZmI2ZDQ5MWJiMmYwMmVlNDZhMDFkNDY5L3RhYmxlOjRkMzFjYzhhNTgxMTQwMThhMmQ3OTdlNDYyZGZjZTQyL3RhYmxlcmFuZ2U6NGQzMWNjOGE1ODExNDAxOGEyZDc5N2U0NjJkZmNlNDJfNy0zLTEtMS00Mjc5Mg_4a9b94b8-a6e9-4989-b54c-3efaffe200c8"
      unitRef="shares">11692000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180MC9mcmFnOmU3ZDQ0NTc2ZmI2ZDQ5MWJiMmYwMmVlNDZhMDFkNDY5L3RhYmxlOjRkMzFjYzhhNTgxMTQwMThhMmQ3OTdlNDYyZGZjZTQyL3RhYmxlcmFuZ2U6NGQzMWNjOGE1ODExNDAxOGEyZDc5N2U0NjJkZmNlNDJfNy01LTEtMS00Mjc5Mg_5b0062bc-29de-40ee-8380-519244f7cbfc"
      unitRef="shares">11290000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ic431430d1ab24120b4507025a722d73a_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180MC9mcmFnOmU3ZDQ0NTc2ZmI2ZDQ5MWJiMmYwMmVlNDZhMDFkNDY5L3RhYmxlOjRkMzFjYzhhNTgxMTQwMThhMmQ3OTdlNDYyZGZjZTQyL3RhYmxlcmFuZ2U6NGQzMWNjOGE1ODExNDAxOGEyZDc5N2U0NjJkZmNlNDJfNy03LTEtMS00Mjc5Mg_53a9fe20-f7b4-440a-932c-59fe5edf5cf4"
      unitRef="shares">11739000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="i2f3a96a832ab4b0ca374599d1c3e9bce_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180MC9mcmFnOmU3ZDQ0NTc2ZmI2ZDQ5MWJiMmYwMmVlNDZhMDFkNDY5L3RhYmxlOjRkMzFjYzhhNTgxMTQwMThhMmQ3OTdlNDYyZGZjZTQyL3RhYmxlcmFuZ2U6NGQzMWNjOGE1ODExNDAxOGEyZDc5N2U0NjJkZmNlNDJfOC0xLTEtMS00Mjc5Mg_6a0de0de-fab0-4cae-82ad-552f5a70b41d"
      unitRef="shares">78000</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="i3bb5592686d74afab4f7004818fd6f9b_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180MC9mcmFnOmU3ZDQ0NTc2ZmI2ZDQ5MWJiMmYwMmVlNDZhMDFkNDY5L3RhYmxlOjRkMzFjYzhhNTgxMTQwMThhMmQ3OTdlNDYyZGZjZTQyL3RhYmxlcmFuZ2U6NGQzMWNjOGE1ODExNDAxOGEyZDc5N2U0NjJkZmNlNDJfOC0zLTEtMS00Mjc5Mg_df0307f9-622a-4ac8-ab10-5e30d5e46899"
      unitRef="shares">93000</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180MC9mcmFnOmU3ZDQ0NTc2ZmI2ZDQ5MWJiMmYwMmVlNDZhMDFkNDY5L3RhYmxlOjRkMzFjYzhhNTgxMTQwMThhMmQ3OTdlNDYyZGZjZTQyL3RhYmxlcmFuZ2U6NGQzMWNjOGE1ODExNDAxOGEyZDc5N2U0NjJkZmNlNDJfOC01LTEtMS00Mjc5Mg_5b5e228f-5242-4640-9db4-207ba80f67f7"
      unitRef="shares">79000</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="ic431430d1ab24120b4507025a722d73a_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180MC9mcmFnOmU3ZDQ0NTc2ZmI2ZDQ5MWJiMmYwMmVlNDZhMDFkNDY5L3RhYmxlOjRkMzFjYzhhNTgxMTQwMThhMmQ3OTdlNDYyZGZjZTQyL3RhYmxlcmFuZ2U6NGQzMWNjOGE1ODExNDAxOGEyZDc5N2U0NjJkZmNlNDJfOC03LTEtMS00Mjc5Mg_0351cfe9-84ff-4c38-9be2-dc18f8defeae"
      unitRef="shares">101000</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i2f3a96a832ab4b0ca374599d1c3e9bce_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180MC9mcmFnOmU3ZDQ0NTc2ZmI2ZDQ5MWJiMmYwMmVlNDZhMDFkNDY5L3RhYmxlOjRkMzFjYzhhNTgxMTQwMThhMmQ3OTdlNDYyZGZjZTQyL3RhYmxlcmFuZ2U6NGQzMWNjOGE1ODExNDAxOGEyZDc5N2U0NjJkZmNlNDJfOS0xLTEtMS00Mjc5Mg_84cb14e3-f772-485f-8732-41831c32018f"
      unitRef="shares">11042000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i3bb5592686d74afab4f7004818fd6f9b_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180MC9mcmFnOmU3ZDQ0NTc2ZmI2ZDQ5MWJiMmYwMmVlNDZhMDFkNDY5L3RhYmxlOjRkMzFjYzhhNTgxMTQwMThhMmQ3OTdlNDYyZGZjZTQyL3RhYmxlcmFuZ2U6NGQzMWNjOGE1ODExNDAxOGEyZDc5N2U0NjJkZmNlNDJfOS0zLTEtMS00Mjc5Mg_2aff0e75-9228-4ea3-9954-217c28edb259"
      unitRef="shares">11785000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180MC9mcmFnOmU3ZDQ0NTc2ZmI2ZDQ5MWJiMmYwMmVlNDZhMDFkNDY5L3RhYmxlOjRkMzFjYzhhNTgxMTQwMThhMmQ3OTdlNDYyZGZjZTQyL3RhYmxlcmFuZ2U6NGQzMWNjOGE1ODExNDAxOGEyZDc5N2U0NjJkZmNlNDJfOS01LTEtMS00Mjc5Mg_7427627c-dd54-4194-a276-a986871df6e4"
      unitRef="shares">11369000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ic431430d1ab24120b4507025a722d73a_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180MC9mcmFnOmU3ZDQ0NTc2ZmI2ZDQ5MWJiMmYwMmVlNDZhMDFkNDY5L3RhYmxlOjRkMzFjYzhhNTgxMTQwMThhMmQ3OTdlNDYyZGZjZTQyL3RhYmxlcmFuZ2U6NGQzMWNjOGE1ODExNDAxOGEyZDc5N2U0NjJkZmNlNDJfOS03LTEtMS00Mjc5Mg_9b818bfe-be63-4fa5-9c90-f2a88eb256e3"
      unitRef="shares">11840000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareBasic
      contextRef="i2f3a96a832ab4b0ca374599d1c3e9bce_D20220701-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180MC9mcmFnOmU3ZDQ0NTc2ZmI2ZDQ5MWJiMmYwMmVlNDZhMDFkNDY5L3RhYmxlOjRkMzFjYzhhNTgxMTQwMThhMmQ3OTdlNDYyZGZjZTQyL3RhYmxlcmFuZ2U6NGQzMWNjOGE1ODExNDAxOGEyZDc5N2U0NjJkZmNlNDJfMTEtMS0xLTEtNDI3OTI_0e9d8a51-1252-4b35-aa02-03fc84b667a5"
      unitRef="usdPerShare">3.30</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i3bb5592686d74afab4f7004818fd6f9b_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180MC9mcmFnOmU3ZDQ0NTc2ZmI2ZDQ5MWJiMmYwMmVlNDZhMDFkNDY5L3RhYmxlOjRkMzFjYzhhNTgxMTQwMThhMmQ3OTdlNDYyZGZjZTQyL3RhYmxlcmFuZ2U6NGQzMWNjOGE1ODExNDAxOGEyZDc5N2U0NjJkZmNlNDJfMTEtMy0xLTEtNDI3OTI_1b2a2beb-1da2-487d-9b9c-63582e545254"
      unitRef="usdPerShare">3.59</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180MC9mcmFnOmU3ZDQ0NTc2ZmI2ZDQ5MWJiMmYwMmVlNDZhMDFkNDY5L3RhYmxlOjRkMzFjYzhhNTgxMTQwMThhMmQ3OTdlNDYyZGZjZTQyL3RhYmxlcmFuZ2U6NGQzMWNjOGE1ODExNDAxOGEyZDc5N2U0NjJkZmNlNDJfMTEtNS0xLTEtNDI3OTI_af82b6ad-081a-4e4a-8ad6-3849c0b87c39"
      unitRef="usdPerShare">10.37</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="ic431430d1ab24120b4507025a722d73a_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180MC9mcmFnOmU3ZDQ0NTc2ZmI2ZDQ5MWJiMmYwMmVlNDZhMDFkNDY5L3RhYmxlOjRkMzFjYzhhNTgxMTQwMThhMmQ3OTdlNDYyZGZjZTQyL3RhYmxlcmFuZ2U6NGQzMWNjOGE1ODExNDAxOGEyZDc5N2U0NjJkZmNlNDJfMTEtNy0xLTEtNDI3OTI_64243f66-c29f-4d53-b182-a9cbd7e97946"
      unitRef="usdPerShare">11.07</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i2f3a96a832ab4b0ca374599d1c3e9bce_D20220701-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180MC9mcmFnOmU3ZDQ0NTc2ZmI2ZDQ5MWJiMmYwMmVlNDZhMDFkNDY5L3RhYmxlOjRkMzFjYzhhNTgxMTQwMThhMmQ3OTdlNDYyZGZjZTQyL3RhYmxlcmFuZ2U6NGQzMWNjOGE1ODExNDAxOGEyZDc5N2U0NjJkZmNlNDJfMTMtMS0xLTEtNDI3OTI_d9d05442-ccfa-4851-8aaf-83277780d6c7"
      unitRef="usdPerShare">3.27</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i3bb5592686d74afab4f7004818fd6f9b_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180MC9mcmFnOmU3ZDQ0NTc2ZmI2ZDQ5MWJiMmYwMmVlNDZhMDFkNDY5L3RhYmxlOjRkMzFjYzhhNTgxMTQwMThhMmQ3OTdlNDYyZGZjZTQyL3RhYmxlcmFuZ2U6NGQzMWNjOGE1ODExNDAxOGEyZDc5N2U0NjJkZmNlNDJfMTMtMy0xLTEtNDI3OTI_22ec0c3e-593d-4696-841a-b59c2befff96"
      unitRef="usdPerShare">3.56</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180MC9mcmFnOmU3ZDQ0NTc2ZmI2ZDQ5MWJiMmYwMmVlNDZhMDFkNDY5L3RhYmxlOjRkMzFjYzhhNTgxMTQwMThhMmQ3OTdlNDYyZGZjZTQyL3RhYmxlcmFuZ2U6NGQzMWNjOGE1ODExNDAxOGEyZDc5N2U0NjJkZmNlNDJfMTMtNS0xLTEtNDI3OTI_7fd300b9-0cbf-4c57-944b-f8b3eeecba9f"
      unitRef="usdPerShare">10.30</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ic431430d1ab24120b4507025a722d73a_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180MC9mcmFnOmU3ZDQ0NTc2ZmI2ZDQ5MWJiMmYwMmVlNDZhMDFkNDY5L3RhYmxlOjRkMzFjYzhhNTgxMTQwMThhMmQ3OTdlNDYyZGZjZTQyL3RhYmxlcmFuZ2U6NGQzMWNjOGE1ODExNDAxOGEyZDc5N2U0NjJkZmNlNDJfMTMtNy0xLTEtNDI3OTI_acdf8146-9734-4b7b-b8de-afb060d105f5"
      unitRef="usdPerShare">10.98</us-gaap:EarningsPerShareDiluted>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i8c40ccc203fe40598b003eaa16fd683f_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180MC9mcmFnOmU3ZDQ0NTc2ZmI2ZDQ5MWJiMmYwMmVlNDZhMDFkNDY5L3RleHRyZWdpb246ZTdkNDQ1NzZmYjZkNDkxYmIyZjAyZWU0NmEwMWQ0NjlfNTM5_985a5274-4b6e-401e-881c-f055fbfca57f"
      unitRef="shares">10000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i44833e234c5b420caed39d2dbc002f2b_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180MC9mcmFnOmU3ZDQ0NTc2ZmI2ZDQ5MWJiMmYwMmVlNDZhMDFkNDY5L3RleHRyZWdpb246ZTdkNDQ1NzZmYjZkNDkxYmIyZjAyZWU0NmEwMWQ0NjlfNTQ2_7df40e27-c439-4475-8978-05d80f8acb64"
      unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ide51255203a64d54b830864bda6b2f1f_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180MC9mcmFnOmU3ZDQ0NTc2ZmI2ZDQ5MWJiMmYwMmVlNDZhMDFkNDY5L3RleHRyZWdpb246ZTdkNDQ1NzZmYjZkNDkxYmIyZjAyZWU0NmEwMWQ0NjlfNjIz_110290db-f0c9-4e6f-a82e-b1924c919b8a"
      unitRef="shares">3000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i873b1283e7f24f0c80ef84c8a9e20c76_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180MC9mcmFnOmU3ZDQ0NTc2ZmI2ZDQ5MWJiMmYwMmVlNDZhMDFkNDY5L3RleHRyZWdpb246ZTdkNDQ1NzZmYjZkNDkxYmIyZjAyZWU0NmEwMWQ0NjlfNjMw_50aaed34-54ae-4e4b-8da7-c6405f9fbf55"
      unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
      contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RleHRyZWdpb246ZTVhOGVlNTZmNGM1NDhmNzhjYjViOTk0YzJmYjU5OGRfNDczMQ_2556d421-d3a5-4193-a119-1218b92c632b">SHARE-BASED COMPENSATION&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Stock Options&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has issued non-qualified and incentive stock options to employees and non-employee directors. The fair value of these options are estimated on the date of grant using the Black-Scholes option pricing model, which requires estimates of the expected term of the option, the risk-free interest rate, the expected volatility of the price of the Company&#x2019;s common stock, and dividend yield. Options outstanding as of September&#160;30, 2022 generally vest over a period of three years and expire ten years from the date of grant. The exercise price of these options ranges from $26.52 to $66.68. Due to the Company&#x2019;s lack of option exercise history on the date of grant, the expected term is calculated using the simplified method defined as the midpoint &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;between the vesting period and the contractual term of each option. The risk free interest rate is based on the U.S. Treasury yield curve in effect on the date of grant that most closely corresponds to the expected term of the option. The expected volatility is based on the historical volatility of the Company&#x2019;s common stock over the period of time equivalent to the expected term for each award. The dividend yield is computed as the annualized dividend rate at the grant date divided by the strike price of the stock option. For the nine months ended September 30, 2022 and 2021, the Company did not grant stock options. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table is a summary of our stock option activity (in thousands, except per share data):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:32.525%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.056%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nine months ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;Awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted-Average Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted-Average Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Outstanding at beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;54.98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;48.19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;49.69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Outstanding at end of the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;54.98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;47.66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Exercisable at end of the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;52.76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;42.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of September&#160;30, 2022, the weighted-average remaining contractual life for outstanding stock options was 55 months with an aggregate intrinsic value of $1.8 million and the weighted-average remaining contractual life for exercisable stock options was 53 months with an aggregate intrinsic value of $1.5 million. The unrecognized compensation expense calculated under the fair value method for stock options expected to vest as of September&#160;30, 2022 was less than &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$0.1 million&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and is expected to be recognized over a weighted-average period of &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4 months&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. For the nine months ended September 30, 2022, there was no exercise activity of stock options. For the nine months ended September 30, 2021, the Company received $0.8 million in cash proceeds from the exercise of stock options. The total intrinsic value for stock options exercised during the nine months ended September 30, 2021 was $3.3 million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Restricted Stock&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has issued restricted stock to employees and non-employee directors generally with vesting terms up to five years after the date of grant. The fair value of the restricted stock is equal to the market price of the Company&#x2019;s common stock on the date of grant. Expense for restricted stock is amortized ratably over the vesting period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes our restricted stock activity (in thousands, except per share data):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:33.549%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.344%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.617%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-bottom:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;Nine months ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;Weighted-Average Grant Date Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;Weighted-Average Grant Date Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Outstanding at beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;183.51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;116.06&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;176.60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;266.99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(19)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;156.16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(26)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;116.62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;186.53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;166.02&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Outstanding at end of the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;187.83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;183.04&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company withheld approximately 8 thousand and 7 thousand shares of the Company&#x2019;s common stock to cover minimum tax liability withholding obligations upon the vesting of shares of restricted stock for the nine months ended September 30, 2022 and 2021, respectively. The total fair value of restricted stock awards vested during the nine months ended September 30, 2022 and 2021 was $3&#160;million and $7&#160;million, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Market and Performance-based Share Awards&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has issued market and performance-based share awards to certain key executives who were granted deferred shares and may earn between 0% and 250% of the target number depending upon both the Company&#x2019;s total stockholder return &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(&#x201c;TSR&#x201d;) and the Company&#x2019;s performance against predetermined performance goals over a three-year performance period after the date of grant. Market and performance-based share awards that are tied to the Company&#x2019;s TSR are valued using the Monte Carlo method and are recognized ratably as expense over the award&#x2019;s performance period. The fair value of the performance-based share awards is equal to the market price of the Company&#x2019;s common stock on the date of grant adjusted by expected level of achievement over the performance period. Expense for performance-based share awards is amortized ratably over the performance period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Share-based compensation expense is recorded in selling, general, and administrative expense in the accompanying Condensed Consolidated Statements of Income. The total expenses during the three months ended September 30, 2022 and 2021 are as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.268%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.623%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-bottom:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;Three months ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;Share-Based Compensation Expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;Share-Based Compensation Expense&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Options and restricted stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,392&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,116&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Market and performance-based share awards granted in 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;438&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Performance-based share awards granted in 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;654&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;309&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Performance-based share awards granted in 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;479&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;479&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Performance-based share awards granted in 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;365&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total share-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,963&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,269&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The total expenses during the nine months ended September 30, 2022 and 2021 are as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.268%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.623%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-bottom:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;Nine months ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;Share-Based Compensation Expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;Share-Based Compensation Expense&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Options and restricted stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,789&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,175&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Market and performance-based share awards granted in 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;950&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Performance-based share awards granted in 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,941&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;666&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Performance-based share awards granted in 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,423&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,329&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Performance-based share awards granted in 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,443&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total share-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,103&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,613&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The total income tax benefit recognized in the accompanying Condensed Consolidated Statements of Income for restricted stock awards was &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$0.4 million&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and $0.1 million for the three months ended September 30, 2022 and 2021, respectively, and &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$1.2&#160;million&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and $2.3&#160;million for the nine months ended September 30, 2022 and 2021, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There was $7.6 million of total unrecognized compensation cost related to restricted stock awards as of September&#160;30, 2022, which is expected to be recognized over a weighted-average period of 23 months. There was $7.9 million of unrecognized compensation costs related to the 66 thousand market and performance-based shares presented in the table above as of September&#160;30, 2022, which is expected to be recognized over a weighted-average period of 23 months.&lt;/span&gt;&lt;/div&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <dei:DocumentPeriodEndDate
      contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RleHRyZWdpb246ZTVhOGVlNTZmNGM1NDhmNzhjYjViOTk0YzJmYjU5OGRfNDcw_75cfbe1e-17ec-4442-ae34-fd999dbe9ec2">2022-09-30</dei:DocumentPeriodEndDate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="if96bd90ed63041fc85fb7929f8aa69cf_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RleHRyZWdpb246ZTVhOGVlNTZmNGM1NDhmNzhjYjViOTk0YzJmYjU5OGRfNTA1_94e305a9-6fe1-4337-9a4e-c9870f3b63d1">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="if96bd90ed63041fc85fb7929f8aa69cf_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RleHRyZWdpb246ZTVhOGVlNTZmNGM1NDhmNzhjYjViOTk0YzJmYjU5OGRfNTE5_163d5d78-f841-4a4d-bc4c-9860d302b5e1">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
      contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RleHRyZWdpb246ZTVhOGVlNTZmNGM1NDhmNzhjYjViOTk0YzJmYjU5OGRfNTk0_a378676a-04bf-4ad9-a5d1-2f7bbdda230a"
      unitRef="usdPerShare">26.52</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
      contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RleHRyZWdpb246ZTVhOGVlNTZmNGM1NDhmNzhjYjViOTk0YzJmYjU5OGRfNjAw_b66c2f56-78e4-468f-969b-6db5fa498211"
      unitRef="usdPerShare">66.68</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="ic431430d1ab24120b4507025a722d73a_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RleHRyZWdpb246ZTVhOGVlNTZmNGM1NDhmNzhjYjViOTk0YzJmYjU5OGRfMTMyNw_1bf0f332-04cb-4043-812e-c95846601198"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RleHRyZWdpb246ZTVhOGVlNTZmNGM1NDhmNzhjYjViOTk0YzJmYjU5OGRfMTMyNw_f0d2c5a6-f684-4d50-9c42-4c5ccede2126"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
      contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RleHRyZWdpb246ZTVhOGVlNTZmNGM1NDhmNzhjYjViOTk0YzJmYjU5OGRfNDczNQ_61425146-3753-49b2-8bea-22201f854684">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table is a summary of our stock option activity (in thousands, except per share data):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:32.525%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.056%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nine months ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;Awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted-Average Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted-Average Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Outstanding at beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;54.98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;48.19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;49.69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Outstanding at end of the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;54.98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;47.66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Exercisable at end of the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;52.76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;42.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i47f09f18839440ffae0cf05a475aa7fe_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RhYmxlOjQ0Y2Q2NDFjNjQ4OTQyMzI4NmI1MDE0NTEwOGU5Mzk2L3RhYmxlcmFuZ2U6NDRjZDY0MWM2NDg5NDIzMjg2YjUwMTQ1MTA4ZTkzOTZfNC0xLTEtMS00Mjc5Mg_df4af431-4ca7-4e31-9a7c-f361c4e9bd55"
      unitRef="shares">33000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="i47f09f18839440ffae0cf05a475aa7fe_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RhYmxlOjQ0Y2Q2NDFjNjQ4OTQyMzI4NmI1MDE0NTEwOGU5Mzk2L3RhYmxlcmFuZ2U6NDRjZDY0MWM2NDg5NDIzMjg2YjUwMTQ1MTA4ZTkzOTZfNC0zLTEtMS00Mjc5Mg_8e441d83-6d10-4420-a329-282c7e55b7ef"
      unitRef="usdPerShare">54.98</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i03d902ffc72e4d98b5eeb6fb903f405b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RhYmxlOjQ0Y2Q2NDFjNjQ4OTQyMzI4NmI1MDE0NTEwOGU5Mzk2L3RhYmxlcmFuZ2U6NDRjZDY0MWM2NDg5NDIzMjg2YjUwMTQ1MTA4ZTkzOTZfNC01LTEtMS00Mjc5Mg_ae18ad6d-b5a2-4446-b7d7-9c290f70c09a"
      unitRef="shares">61000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="i03d902ffc72e4d98b5eeb6fb903f405b_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RhYmxlOjQ0Y2Q2NDFjNjQ4OTQyMzI4NmI1MDE0NTEwOGU5Mzk2L3RhYmxlcmFuZ2U6NDRjZDY0MWM2NDg5NDIzMjg2YjUwMTQ1MTA4ZTkzOTZfNC03LTEtMS00Mjc5Mg_2433cf72-10a5-4b7c-b5f4-c8c92640147c"
      unitRef="usdPerShare">48.19</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RhYmxlOjQ0Y2Q2NDFjNjQ4OTQyMzI4NmI1MDE0NTEwOGU5Mzk2L3RhYmxlcmFuZ2U6NDRjZDY0MWM2NDg5NDIzMjg2YjUwMTQ1MTA4ZTkzOTZfNS0xLTEtMS00Mjc5Mg_a53879c3-74c7-47e7-a133-744f815be9d2"
      unitRef="shares">0</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RhYmxlOjQ0Y2Q2NDFjNjQ4OTQyMzI4NmI1MDE0NTEwOGU5Mzk2L3RhYmxlcmFuZ2U6NDRjZDY0MWM2NDg5NDIzMjg2YjUwMTQ1MTA4ZTkzOTZfNS0zLTEtMS00Mjc5Mg_3674ed8c-1a3f-4a8b-983e-a1f9ce5bf21f"
      unitRef="usdPerShare">0</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="ic431430d1ab24120b4507025a722d73a_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RhYmxlOjQ0Y2Q2NDFjNjQ4OTQyMzI4NmI1MDE0NTEwOGU5Mzk2L3RhYmxlcmFuZ2U6NDRjZDY0MWM2NDg5NDIzMjg2YjUwMTQ1MTA4ZTkzOTZfNS01LTEtMS00Mjc5Mg_c9f06ad3-341a-47d2-8cc7-8a7c985eb9c4"
      unitRef="shares">16000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="ic431430d1ab24120b4507025a722d73a_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RhYmxlOjQ0Y2Q2NDFjNjQ4OTQyMzI4NmI1MDE0NTEwOGU5Mzk2L3RhYmxlcmFuZ2U6NDRjZDY0MWM2NDg5NDIzMjg2YjUwMTQ1MTA4ZTkzOTZfNS03LTEtMS00Mjc5Mg_f64fc654-51f8-428f-ad8a-13662bc5f7eb"
      unitRef="usdPerShare">49.69</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i5de311f5948148cda49342e2cea83715_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RhYmxlOjQ0Y2Q2NDFjNjQ4OTQyMzI4NmI1MDE0NTEwOGU5Mzk2L3RhYmxlcmFuZ2U6NDRjZDY0MWM2NDg5NDIzMjg2YjUwMTQ1MTA4ZTkzOTZfNy0xLTEtMS00Mjc5Mg_a346decc-260c-4d51-ad19-d64cfb2ab36b"
      unitRef="shares">33000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="i5de311f5948148cda49342e2cea83715_I20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RhYmxlOjQ0Y2Q2NDFjNjQ4OTQyMzI4NmI1MDE0NTEwOGU5Mzk2L3RhYmxlcmFuZ2U6NDRjZDY0MWM2NDg5NDIzMjg2YjUwMTQ1MTA4ZTkzOTZfNy0zLTEtMS00Mjc5Mg_f46ba585-a128-44cf-954b-ec7f5f77b1b2"
      unitRef="usdPerShare">54.98</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="ifb5de6f6a1b842d59a7c6674c3095ce8_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RhYmxlOjQ0Y2Q2NDFjNjQ4OTQyMzI4NmI1MDE0NTEwOGU5Mzk2L3RhYmxlcmFuZ2U6NDRjZDY0MWM2NDg5NDIzMjg2YjUwMTQ1MTA4ZTkzOTZfNy01LTEtMS00Mjc5Mg_c88b15aa-4927-46bf-8cc1-89d63c1407a7"
      unitRef="shares">45000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="ifb5de6f6a1b842d59a7c6674c3095ce8_I20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RhYmxlOjQ0Y2Q2NDFjNjQ4OTQyMzI4NmI1MDE0NTEwOGU5Mzk2L3RhYmxlcmFuZ2U6NDRjZDY0MWM2NDg5NDIzMjg2YjUwMTQ1MTA4ZTkzOTZfNy03LTEtMS00Mjc5Mg_c3e7c97c-b575-47ac-9b99-8cae8a67c927"
      unitRef="usdPerShare">47.66</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="i5de311f5948148cda49342e2cea83715_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RhYmxlOjQ0Y2Q2NDFjNjQ4OTQyMzI4NmI1MDE0NTEwOGU5Mzk2L3RhYmxlcmFuZ2U6NDRjZDY0MWM2NDg5NDIzMjg2YjUwMTQ1MTA4ZTkzOTZfOC0xLTEtMS00Mjc5Mg_88222748-15db-4085-b792-b9d6bb2b84ee"
      unitRef="shares">28000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="i5de311f5948148cda49342e2cea83715_I20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RhYmxlOjQ0Y2Q2NDFjNjQ4OTQyMzI4NmI1MDE0NTEwOGU5Mzk2L3RhYmxlcmFuZ2U6NDRjZDY0MWM2NDg5NDIzMjg2YjUwMTQ1MTA4ZTkzOTZfOC0zLTEtMS00Mjc5Mg_db667807-e687-472c-951a-884bc8261d78"
      unitRef="usdPerShare">52.76</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="ifb5de6f6a1b842d59a7c6674c3095ce8_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RhYmxlOjQ0Y2Q2NDFjNjQ4OTQyMzI4NmI1MDE0NTEwOGU5Mzk2L3RhYmxlcmFuZ2U6NDRjZDY0MWM2NDg5NDIzMjg2YjUwMTQ1MTA4ZTkzOTZfOC01LTEtMS00Mjc5Mg_6350c4dc-f0f6-4015-beb3-4036c7e7f9df"
      unitRef="shares">35000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="ifb5de6f6a1b842d59a7c6674c3095ce8_I20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RhYmxlOjQ0Y2Q2NDFjNjQ4OTQyMzI4NmI1MDE0NTEwOGU5Mzk2L3RhYmxlcmFuZ2U6NDRjZDY0MWM2NDg5NDIzMjg2YjUwMTQ1MTA4ZTkzOTZfOC03LTEtMS00Mjc5Mg_b7a7a3f5-67e7-44f6-a6f7-b17471a88a01"
      unitRef="usdPerShare">42.00</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <dei:DocumentPeriodEndDate
      contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RleHRyZWdpb246ZTVhOGVlNTZmNGM1NDhmNzhjYjViOTk0YzJmYjU5OGRfMTQ2Mg_75cfbe1e-17ec-4442-ae34-fd999dbe9ec2">2022-09-30</dei:DocumentPeriodEndDate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RleHRyZWdpb246ZTVhOGVlNTZmNGM1NDhmNzhjYjViOTk0YzJmYjU5OGRfMTU0OA_b928dda8-7fe3-43e6-9b04-980b42d2d41c">P55M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="i5de311f5948148cda49342e2cea83715_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RleHRyZWdpb246ZTVhOGVlNTZmNGM1NDhmNzhjYjViOTk0YzJmYjU5OGRfMTU4OA_34f4725b-6b9c-4ed9-b5ab-aa5f1321db5d"
      unitRef="usd">1800000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
      contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RleHRyZWdpb246ZTVhOGVlNTZmNGM1NDhmNzhjYjViOTk0YzJmYjU5OGRfMTY3Nw_94386346-b3f3-450d-b4a9-9f2548c1f604">P53M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
      contextRef="i5de311f5948148cda49342e2cea83715_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RleHRyZWdpb246ZTVhOGVlNTZmNGM1NDhmNzhjYjViOTk0YzJmYjU5OGRfMTcxNw_412c3ad4-69d1-4a92-a982-d67465156632"
      unitRef="usd">1500000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
    <dei:DocumentPeriodEndDate
      contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RleHRyZWdpb246ZTVhOGVlNTZmNGM1NDhmNzhjYjViOTk0YzJmYjU5OGRfMTgzOQ_75cfbe1e-17ec-4442-ae34-fd999dbe9ec2">2022-09-30</dei:DocumentPeriodEndDate>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="ie17f9491af104b57837e5277e79f0dee_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RleHRyZWdpb246ZTVhOGVlNTZmNGM1NDhmNzhjYjViOTk0YzJmYjU5OGRfMTg0Ng_3f729c7d-68ab-4df3-8f79-f9c2cffe6b8a"
      unitRef="usd">100000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="if96bd90ed63041fc85fb7929f8aa69cf_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RleHRyZWdpb246ZTVhOGVlNTZmNGM1NDhmNzhjYjViOTk0YzJmYjU5OGRfMTkxNg_885a0792-cbc5-4eb9-b166-a30428c230e6">P4M</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="ic431430d1ab24120b4507025a722d73a_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RleHRyZWdpb246ZTVhOGVlNTZmNGM1NDhmNzhjYjViOTk0YzJmYjU5OGRfMjAxNA_e4a6443a-ddd2-4faf-a357-3c4559c33ed5"
      unitRef="usd">800000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="ic431430d1ab24120b4507025a722d73a_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RleHRyZWdpb246ZTVhOGVlNTZmNGM1NDhmNzhjYjViOTk0YzJmYjU5OGRfMjE0Mg_d4289b88-c736-4cfa-a938-8e90f8cc464b"
      unitRef="usd">3300000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="id337c0920a144e0c91a6bed2853c1d7b_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RleHRyZWdpb246ZTVhOGVlNTZmNGM1NDhmNzhjYjViOTk0YzJmYjU5OGRfMjI3OA_b3350ab7-ee49-48f0-ac6a-51317d2af41c">P5Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock
      contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RleHRyZWdpb246ZTVhOGVlNTZmNGM1NDhmNzhjYjViOTk0YzJmYjU5OGRfNDczNA_7c63ddf4-700c-4619-b596-93de537ab2fd">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes our restricted stock activity (in thousands, except per share data):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:33.549%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.344%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.617%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-bottom:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;Nine months ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;Weighted-Average Grant Date Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;Weighted-Average Grant Date Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Outstanding at beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;183.51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;116.06&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;176.60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;266.99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(19)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;156.16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(26)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;116.62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;186.53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;166.02&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Outstanding at end of the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;187.83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;183.04&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="ia06f0db3dd8146e097bef1502f9f86af_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RhYmxlOjgxZTI1OTgxMWNmYzQwYTdiZGFlNmIyYjk4ZWIyZjk5L3RhYmxlcmFuZ2U6ODFlMjU5ODExY2ZjNDBhN2JkYWU2YjJiOThlYjJmOTlfNC0xLTEtMS00Mjc5Mg_d595c726-acf1-4e3e-b0c3-784dab6f3076"
      unitRef="shares">44000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="ia06f0db3dd8146e097bef1502f9f86af_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RhYmxlOjgxZTI1OTgxMWNmYzQwYTdiZGFlNmIyYjk4ZWIyZjk5L3RhYmxlcmFuZ2U6ODFlMjU5ODExY2ZjNDBhN2JkYWU2YjJiOThlYjJmOTlfNC0zLTEtMS00Mjc5Mg_7f9edb34-af44-4abe-9433-50c7a9b3574f"
      unitRef="usdPerShare">183.51</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i64e1421ab00c4da49c0547bb9f5f234a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RhYmxlOjgxZTI1OTgxMWNmYzQwYTdiZGFlNmIyYjk4ZWIyZjk5L3RhYmxlcmFuZ2U6ODFlMjU5ODExY2ZjNDBhN2JkYWU2YjJiOThlYjJmOTlfNC01LTEtMS00Mjc5Mg_3703c266-48e3-49f6-a682-175667ddb093"
      unitRef="shares">50000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i64e1421ab00c4da49c0547bb9f5f234a_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RhYmxlOjgxZTI1OTgxMWNmYzQwYTdiZGFlNmIyYjk4ZWIyZjk5L3RhYmxlcmFuZ2U6ODFlMjU5ODExY2ZjNDBhN2JkYWU2YjJiOThlYjJmOTlfNC03LTEtMS00Mjc5Mg_1306ea4a-471f-4431-aa6f-5699f98c26c6"
      unitRef="usdPerShare">116.06</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="id337c0920a144e0c91a6bed2853c1d7b_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RhYmxlOjgxZTI1OTgxMWNmYzQwYTdiZGFlNmIyYjk4ZWIyZjk5L3RhYmxlcmFuZ2U6ODFlMjU5ODExY2ZjNDBhN2JkYWU2YjJiOThlYjJmOTlfNS0xLTEtMS00Mjc5Mg_2f27d00f-0633-4e6f-b508-0fe01a1127be"
      unitRef="shares">38000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="id337c0920a144e0c91a6bed2853c1d7b_D20220101-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RhYmxlOjgxZTI1OTgxMWNmYzQwYTdiZGFlNmIyYjk4ZWIyZjk5L3RhYmxlcmFuZ2U6ODFlMjU5ODExY2ZjNDBhN2JkYWU2YjJiOThlYjJmOTlfNS0zLTEtMS00Mjc5Mg_ceb745e2-9701-49ca-b621-38a011c84a8f"
      unitRef="usdPerShare">176.60</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="if58da46cc9354a8eadc10f9e4f114ac2_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RhYmxlOjgxZTI1OTgxMWNmYzQwYTdiZGFlNmIyYjk4ZWIyZjk5L3RhYmxlcmFuZ2U6ODFlMjU5ODExY2ZjNDBhN2JkYWU2YjJiOThlYjJmOTlfNS01LTEtMS00Mjc5Mg_b56152d0-6baa-42c3-ad09-d99d3d1829d4"
      unitRef="shares">21000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="if58da46cc9354a8eadc10f9e4f114ac2_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RhYmxlOjgxZTI1OTgxMWNmYzQwYTdiZGFlNmIyYjk4ZWIyZjk5L3RhYmxlcmFuZ2U6ODFlMjU5ODExY2ZjNDBhN2JkYWU2YjJiOThlYjJmOTlfNS03LTEtMS00Mjc5Mg_efc71e8c-b6bb-4dba-b346-67d4e718b5a4"
      unitRef="usdPerShare">266.99</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="id337c0920a144e0c91a6bed2853c1d7b_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RhYmxlOjgxZTI1OTgxMWNmYzQwYTdiZGFlNmIyYjk4ZWIyZjk5L3RhYmxlcmFuZ2U6ODFlMjU5ODExY2ZjNDBhN2JkYWU2YjJiOThlYjJmOTlfNi0xLTEtMS00Mjc5Mg_a47644ff-c1a8-489b-a98d-08436969fd68"
      unitRef="shares">19000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="id337c0920a144e0c91a6bed2853c1d7b_D20220101-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RhYmxlOjgxZTI1OTgxMWNmYzQwYTdiZGFlNmIyYjk4ZWIyZjk5L3RhYmxlcmFuZ2U6ODFlMjU5ODExY2ZjNDBhN2JkYWU2YjJiOThlYjJmOTlfNi0zLTEtMS00Mjc5Mg_6d0d70a2-b95b-4388-90ae-9ff46b1768dc"
      unitRef="usdPerShare">156.16</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="if58da46cc9354a8eadc10f9e4f114ac2_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RhYmxlOjgxZTI1OTgxMWNmYzQwYTdiZGFlNmIyYjk4ZWIyZjk5L3RhYmxlcmFuZ2U6ODFlMjU5ODExY2ZjNDBhN2JkYWU2YjJiOThlYjJmOTlfNi01LTEtMS00Mjc5Mg_025d2a99-de2f-4241-be10-f7204ef2e777"
      unitRef="shares">26000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="if58da46cc9354a8eadc10f9e4f114ac2_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RhYmxlOjgxZTI1OTgxMWNmYzQwYTdiZGFlNmIyYjk4ZWIyZjk5L3RhYmxlcmFuZ2U6ODFlMjU5ODExY2ZjNDBhN2JkYWU2YjJiOThlYjJmOTlfNi03LTEtMS00Mjc5Mg_9c803b11-489d-4347-9a07-43935587484e"
      unitRef="usdPerShare">116.62</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="id337c0920a144e0c91a6bed2853c1d7b_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RhYmxlOjgxZTI1OTgxMWNmYzQwYTdiZGFlNmIyYjk4ZWIyZjk5L3RhYmxlcmFuZ2U6ODFlMjU5ODExY2ZjNDBhN2JkYWU2YjJiOThlYjJmOTlfNy0xLTEtMS00Mjc5Mg_4d020f67-9111-4981-a919-599f267b386f"
      unitRef="shares">1000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="id337c0920a144e0c91a6bed2853c1d7b_D20220101-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RhYmxlOjgxZTI1OTgxMWNmYzQwYTdiZGFlNmIyYjk4ZWIyZjk5L3RhYmxlcmFuZ2U6ODFlMjU5ODExY2ZjNDBhN2JkYWU2YjJiOThlYjJmOTlfNy0zLTEtMS00Mjc5Mg_fddf1473-fe2b-46bf-99d6-4d1a535a244e"
      unitRef="usdPerShare">186.53</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="if58da46cc9354a8eadc10f9e4f114ac2_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RhYmxlOjgxZTI1OTgxMWNmYzQwYTdiZGFlNmIyYjk4ZWIyZjk5L3RhYmxlcmFuZ2U6ODFlMjU5ODExY2ZjNDBhN2JkYWU2YjJiOThlYjJmOTlfNy01LTEtMS00Mjc5Mg_9c67c21a-0b91-4b53-8242-896e05d8e46e"
      unitRef="shares">3000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="if58da46cc9354a8eadc10f9e4f114ac2_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RhYmxlOjgxZTI1OTgxMWNmYzQwYTdiZGFlNmIyYjk4ZWIyZjk5L3RhYmxlcmFuZ2U6ODFlMjU5ODExY2ZjNDBhN2JkYWU2YjJiOThlYjJmOTlfNy03LTEtMS00Mjc5Mg_ce916734-d773-4cad-b57f-7b7c645bfbf7"
      unitRef="usdPerShare">166.02</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="iee1cf11574cc42609fde6f9c8aee4073_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RhYmxlOjgxZTI1OTgxMWNmYzQwYTdiZGFlNmIyYjk4ZWIyZjk5L3RhYmxlcmFuZ2U6ODFlMjU5ODExY2ZjNDBhN2JkYWU2YjJiOThlYjJmOTlfOC0xLTEtMS00Mjc5Mg_77990c43-e02c-4238-b7d9-1b363f5bb263"
      unitRef="shares">62000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="iee1cf11574cc42609fde6f9c8aee4073_I20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RhYmxlOjgxZTI1OTgxMWNmYzQwYTdiZGFlNmIyYjk4ZWIyZjk5L3RhYmxlcmFuZ2U6ODFlMjU5ODExY2ZjNDBhN2JkYWU2YjJiOThlYjJmOTlfOC0zLTEtMS00Mjc5Mg_893bb141-63eb-4230-9c5d-3c020e53e690"
      unitRef="usdPerShare">187.83</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="ic65b09ecdbb7426eb38e93fcf8817112_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RhYmxlOjgxZTI1OTgxMWNmYzQwYTdiZGFlNmIyYjk4ZWIyZjk5L3RhYmxlcmFuZ2U6ODFlMjU5ODExY2ZjNDBhN2JkYWU2YjJiOThlYjJmOTlfOC01LTEtMS00Mjc5Mg_665346ba-3e5e-4d86-9e2d-24f8ffd87102"
      unitRef="shares">42000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="ic65b09ecdbb7426eb38e93fcf8817112_I20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RhYmxlOjgxZTI1OTgxMWNmYzQwYTdiZGFlNmIyYjk4ZWIyZjk5L3RhYmxlcmFuZ2U6ODFlMjU5ODExY2ZjNDBhN2JkYWU2YjJiOThlYjJmOTlfOC03LTEtMS00Mjc5Mg_76352906-6156-4278-853b-aac4f6909d4d"
      unitRef="usdPerShare">183.04</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation
      contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RleHRyZWdpb246ZTVhOGVlNTZmNGM1NDhmNzhjYjViOTk0YzJmYjU5OGRfMjYzOA_1e851a60-984e-4f73-9b15-9dcc64bbd15a"
      unitRef="shares">8000</us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation>
    <us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation
      contextRef="ic431430d1ab24120b4507025a722d73a_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RleHRyZWdpb246ZTVhOGVlNTZmNGM1NDhmNzhjYjViOTk0YzJmYjU5OGRfMjY0NQ_3081a035-d016-4aca-9e5f-4b8719654382"
      unitRef="shares">7000</us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
      contextRef="id337c0920a144e0c91a6bed2853c1d7b_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RleHRyZWdpb246ZTVhOGVlNTZmNGM1NDhmNzhjYjViOTk0YzJmYjU5OGRfMjkwMA_a87bd3a8-22dc-4e7d-be5f-b7879db911dc"
      unitRef="usd">3000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
      contextRef="if58da46cc9354a8eadc10f9e4f114ac2_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RleHRyZWdpb246ZTVhOGVlNTZmNGM1NDhmNzhjYjViOTk0YzJmYjU5OGRfMjkwNw_d7b71e7c-4868-451a-8df2-de1913e15bc6"
      unitRef="usd">7000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <med:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesEarnedPercentage
      contextRef="if99f41a5e55c4b58ab6b630db3712adb_D20220101-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RleHRyZWdpb246ZTVhOGVlNTZmNGM1NDhmNzhjYjViOTk0YzJmYjU5OGRfMzExMg_19df983e-de59-4d31-be18-dff0a67f7de5"
      unitRef="number">0</med:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesEarnedPercentage>
    <med:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesEarnedPercentage
      contextRef="i0ecdbda19ca5476b9e392faeaca89725_D20220101-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RleHRyZWdpb246ZTVhOGVlNTZmNGM1NDhmNzhjYjViOTk0YzJmYjU5OGRfMzExOQ_f7e791f2-3292-4a9b-86bb-cbf7b40ec743"
      unitRef="number">2.50</med:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesEarnedPercentage>
    <med:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesEarnedPerformancePeriod
      contextRef="id883036fe81d4fbd9ce98760bd9584d6_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RleHRyZWdpb246ZTVhOGVlNTZmNGM1NDhmNzhjYjViOTk0YzJmYjU5OGRfNDczNg_91a2c218-38f2-4fa0-8d08-0e208feddf71">P3Y</med:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesEarnedPerformancePeriod>
    <us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock
      contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RleHRyZWdpb246ZTVhOGVlNTZmNGM1NDhmNzhjYjViOTk0YzJmYjU5OGRfNDczMg_24f29885-14ed-4fe7-8917-d0007f1770fd">The total expenses during the three months ended September 30, 2022 and 2021 are as follows (in thousands):&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.268%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.623%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-bottom:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;Three months ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;Share-Based Compensation Expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;Share-Based Compensation Expense&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Options and restricted stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,392&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,116&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Market and performance-based share awards granted in 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;438&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Performance-based share awards granted in 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;654&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;309&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Performance-based share awards granted in 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;479&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;479&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Performance-based share awards granted in 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;365&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total share-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,963&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,269&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The total expenses during the nine months ended September 30, 2022 and 2021 are as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.268%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.623%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-bottom:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;Nine months ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;Share-Based Compensation Expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;Share-Based Compensation Expense&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Options and restricted stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,789&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,175&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Market and performance-based share awards granted in 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;950&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Performance-based share awards granted in 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,941&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;666&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Performance-based share awards granted in 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,423&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,329&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Performance-based share awards granted in 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,443&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total share-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,103&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,613&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="ibadc66af627d4a50adc5b6a3602689c5_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RhYmxlOmFhMDU2MTczZDc1ZTQwZjNhZjUzZWYwYzZhYzdlODAzL3RhYmxlcmFuZ2U6YWEwNTYxNzNkNzVlNDBmM2FmNTNlZjBjNmFjN2U4MDNfMy0xLTEtMS00Mjc5Mg_74d3f8dc-5579-411b-94d5-2b256cef64e9"
      unitRef="shares">90000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ibadc66af627d4a50adc5b6a3602689c5_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RhYmxlOmFhMDU2MTczZDc1ZTQwZjNhZjUzZWYwYzZhYzdlODAzL3RhYmxlcmFuZ2U6YWEwNTYxNzNkNzVlNDBmM2FmNTNlZjBjNmFjN2U4MDNfMy0zLTEtMS00Mjc5Mg_97e8f84e-253d-4046-9a38-ac390e9a7733"
      unitRef="usd">1392000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i12f18bce76824fa181f9d54c1673be9d_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RhYmxlOmFhMDU2MTczZDc1ZTQwZjNhZjUzZWYwYzZhYzdlODAzL3RhYmxlcmFuZ2U6YWEwNTYxNzNkNzVlNDBmM2FmNTNlZjBjNmFjN2U4MDNfMy01LTEtMS00Mjc5Mg_5f5c26c5-df83-44d5-a947-c77e02441358"
      unitRef="shares">89000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i12f18bce76824fa181f9d54c1673be9d_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RhYmxlOmFhMDU2MTczZDc1ZTQwZjNhZjUzZWYwYzZhYzdlODAzL3RhYmxlcmFuZ2U6YWEwNTYxNzNkNzVlNDBmM2FmNTNlZjBjNmFjN2U4MDNfMy03LTEtMS00Mjc5Mg_380348b6-98f8-491a-86f7-1399e44da202"
      unitRef="usd">1116000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i95d94f4202144399b49c964c8368ac37_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RhYmxlOmFhMDU2MTczZDc1ZTQwZjNhZjUzZWYwYzZhYzdlODAzL3RhYmxlcmFuZ2U6YWEwNTYxNzNkNzVlNDBmM2FmNTNlZjBjNmFjN2U4MDNfNC0xLTEtMS00Mjc5Mg_a0f6dc91-90ad-4a0d-9ef2-cde42a9f8544"
      unitRef="shares">25000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i95d94f4202144399b49c964c8368ac37_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RhYmxlOmFhMDU2MTczZDc1ZTQwZjNhZjUzZWYwYzZhYzdlODAzL3RhYmxlcmFuZ2U6YWEwNTYxNzNkNzVlNDBmM2FmNTNlZjBjNmFjN2U4MDNfNC0zLTEtMS00Mjc5Mg_5cee9fac-75c5-4cec-a15d-a528a103cd9a"
      unitRef="usd">438000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i0901c79f16de41bea38c2f269bd6bd08_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RhYmxlOmFhMDU2MTczZDc1ZTQwZjNhZjUzZWYwYzZhYzdlODAzL3RhYmxlcmFuZ2U6YWEwNTYxNzNkNzVlNDBmM2FmNTNlZjBjNmFjN2U4MDNfNC01LTEtMS00Mjc5Mg_d3873803-d82e-4fc9-bf19-d1715f4cff2a"
      unitRef="shares">0</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i0901c79f16de41bea38c2f269bd6bd08_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RhYmxlOmFhMDU2MTczZDc1ZTQwZjNhZjUzZWYwYzZhYzdlODAzL3RhYmxlcmFuZ2U6YWEwNTYxNzNkNzVlNDBmM2FmNTNlZjBjNmFjN2U4MDNfNC03LTEtMS00Mjc5Mg_bfda1a8e-08f8-4853-a5dc-de437b80fb07"
      unitRef="usd">0</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i0a41616804a64fe39e2eb14b59e5df17_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RhYmxlOmFhMDU2MTczZDc1ZTQwZjNhZjUzZWYwYzZhYzdlODAzL3RhYmxlcmFuZ2U6YWEwNTYxNzNkNzVlNDBmM2FmNTNlZjBjNmFjN2U4MDNfNS0xLTEtMS00Mjc5Mg_3380fd8c-4e19-4276-a55c-8fed064a08c3"
      unitRef="shares">15000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i0a41616804a64fe39e2eb14b59e5df17_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RhYmxlOmFhMDU2MTczZDc1ZTQwZjNhZjUzZWYwYzZhYzdlODAzL3RhYmxlcmFuZ2U6YWEwNTYxNzNkNzVlNDBmM2FmNTNlZjBjNmFjN2U4MDNfNS0zLTEtMS00Mjc5Mg_0eb3e3a6-1efe-451d-bb25-3bd18d1b720a"
      unitRef="usd">654000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="ie5d960394d1f4239b6b22f78b99ccbfd_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RhYmxlOmFhMDU2MTczZDc1ZTQwZjNhZjUzZWYwYzZhYzdlODAzL3RhYmxlcmFuZ2U6YWEwNTYxNzNkNzVlNDBmM2FmNTNlZjBjNmFjN2U4MDNfNS01LTEtMS00Mjc5Mg_14202fa6-3e4a-4bef-a3e9-d86163ddf547"
      unitRef="shares">14000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ie5d960394d1f4239b6b22f78b99ccbfd_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RhYmxlOmFhMDU2MTczZDc1ZTQwZjNhZjUzZWYwYzZhYzdlODAzL3RhYmxlcmFuZ2U6YWEwNTYxNzNkNzVlNDBmM2FmNTNlZjBjNmFjN2U4MDNfNS03LTEtMS00Mjc5Mg_26649ef7-6e2c-4511-8ef6-56d1d39bdb3b"
      unitRef="usd">309000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="ia7b71491bfda423a9b849e5ba3c9591d_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RhYmxlOmFhMDU2MTczZDc1ZTQwZjNhZjUzZWYwYzZhYzdlODAzL3RhYmxlcmFuZ2U6YWEwNTYxNzNkNzVlNDBmM2FmNTNlZjBjNmFjN2U4MDNfNi0xLTEtMS00Mjc5Mg_fc8828a6-b45d-4f4a-a6e6-e8140a724959"
      unitRef="shares">26000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ia7b71491bfda423a9b849e5ba3c9591d_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RhYmxlOmFhMDU2MTczZDc1ZTQwZjNhZjUzZWYwYzZhYzdlODAzL3RhYmxlcmFuZ2U6YWEwNTYxNzNkNzVlNDBmM2FmNTNlZjBjNmFjN2U4MDNfNi0zLTEtMS00Mjc5Mg_7c21ac31-b22d-4b0c-a052-179bdf645c58"
      unitRef="usd">479000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i840318db555b44f1929d580be8e92f97_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RhYmxlOmFhMDU2MTczZDc1ZTQwZjNhZjUzZWYwYzZhYzdlODAzL3RhYmxlcmFuZ2U6YWEwNTYxNzNkNzVlNDBmM2FmNTNlZjBjNmFjN2U4MDNfNi01LTEtMS00Mjc5Mg_130ab120-5903-4433-9779-48080564ab77"
      unitRef="shares">26000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i840318db555b44f1929d580be8e92f97_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RhYmxlOmFhMDU2MTczZDc1ZTQwZjNhZjUzZWYwYzZhYzdlODAzL3RhYmxlcmFuZ2U6YWEwNTYxNzNkNzVlNDBmM2FmNTNlZjBjNmFjN2U4MDNfNi03LTEtMS00Mjc5Mg_a622c4f7-0ae6-4342-85f5-301a92fec8b0"
      unitRef="usd">479000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i86506a2c9bb242aab0a78a2c5c61556e_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RhYmxlOmFhMDU2MTczZDc1ZTQwZjNhZjUzZWYwYzZhYzdlODAzL3RhYmxlcmFuZ2U6YWEwNTYxNzNkNzVlNDBmM2FmNTNlZjBjNmFjN2U4MDNfNy0xLTEtMS00Mjc5Mg_2abb1fa7-1210-4571-a729-544dc7ac5646"
      unitRef="shares">0</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i86506a2c9bb242aab0a78a2c5c61556e_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RhYmxlOmFhMDU2MTczZDc1ZTQwZjNhZjUzZWYwYzZhYzdlODAzL3RhYmxlcmFuZ2U6YWEwNTYxNzNkNzVlNDBmM2FmNTNlZjBjNmFjN2U4MDNfNy0zLTEtMS00Mjc5Mg_b7be531c-39bf-4e12-b982-8ab0d628f9b2"
      unitRef="usd">0</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i9f1fb4440c1a44f78177fa769579f56b_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RhYmxlOmFhMDU2MTczZDc1ZTQwZjNhZjUzZWYwYzZhYzdlODAzL3RhYmxlcmFuZ2U6YWEwNTYxNzNkNzVlNDBmM2FmNTNlZjBjNmFjN2U4MDNfNy01LTEtMS00Mjc5Mg_cc1d8700-fdfc-49e5-b771-65aa94ed97b6"
      unitRef="shares">16000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i9f1fb4440c1a44f78177fa769579f56b_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RhYmxlOmFhMDU2MTczZDc1ZTQwZjNhZjUzZWYwYzZhYzdlODAzL3RhYmxlcmFuZ2U6YWEwNTYxNzNkNzVlNDBmM2FmNTNlZjBjNmFjN2U4MDNfNy03LTEtMS00Mjc5Mg_f734f226-d9c8-4610-86c1-cb4b71b93485"
      unitRef="usd">365000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i2f3a96a832ab4b0ca374599d1c3e9bce_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RhYmxlOmFhMDU2MTczZDc1ZTQwZjNhZjUzZWYwYzZhYzdlODAzL3RhYmxlcmFuZ2U6YWEwNTYxNzNkNzVlNDBmM2FmNTNlZjBjNmFjN2U4MDNfOC0xLTEtMS00Mjc5Mg_9611d214-eff9-4cc3-837b-a5c3cabf4226"
      unitRef="shares">156000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i2f3a96a832ab4b0ca374599d1c3e9bce_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RhYmxlOmFhMDU2MTczZDc1ZTQwZjNhZjUzZWYwYzZhYzdlODAzL3RhYmxlcmFuZ2U6YWEwNTYxNzNkNzVlNDBmM2FmNTNlZjBjNmFjN2U4MDNfOC0zLTEtMS00Mjc5Mg_eafd2f69-954e-49d0-a76c-37bf08f6fa9d"
      unitRef="usd">2963000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i3bb5592686d74afab4f7004818fd6f9b_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RhYmxlOmFhMDU2MTczZDc1ZTQwZjNhZjUzZWYwYzZhYzdlODAzL3RhYmxlcmFuZ2U6YWEwNTYxNzNkNzVlNDBmM2FmNTNlZjBjNmFjN2U4MDNfOC01LTEtMS00Mjc5Mg_4edd1849-836d-4ae7-ad1e-d811cb2e6b5b"
      unitRef="shares">145000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i3bb5592686d74afab4f7004818fd6f9b_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RhYmxlOmFhMDU2MTczZDc1ZTQwZjNhZjUzZWYwYzZhYzdlODAzL3RhYmxlcmFuZ2U6YWEwNTYxNzNkNzVlNDBmM2FmNTNlZjBjNmFjN2U4MDNfOC03LTEtMS00Mjc5Mg_e64431d2-7056-4317-9305-615e9de55ced"
      unitRef="usd">2269000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="ic07f86d9e5da4afd87e67a65fb6f4791_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RhYmxlOjE4YjcxMDc0MDM5NzRhYWNiNzcxODY4YTFlOWJiMjE0L3RhYmxlcmFuZ2U6MThiNzEwNzQwMzk3NGFhY2I3NzE4NjhhMWU5YmIyMTRfMy0xLTEtMS00Mjc5Mg_05eafedb-7b5f-4137-bf14-35e24f98e956"
      unitRef="shares">90000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ic07f86d9e5da4afd87e67a65fb6f4791_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RhYmxlOjE4YjcxMDc0MDM5NzRhYWNiNzcxODY4YTFlOWJiMjE0L3RhYmxlcmFuZ2U6MThiNzEwNzQwMzk3NGFhY2I3NzE4NjhhMWU5YmIyMTRfMy0zLTEtMS00Mjc5Mg_0b9ba415-bf02-4521-bf51-6f0d3e0c5cf3"
      unitRef="usd">3789000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="ie5f97af31c054e3788ba0bc81976a278_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RhYmxlOjE4YjcxMDc0MDM5NzRhYWNiNzcxODY4YTFlOWJiMjE0L3RhYmxlcmFuZ2U6MThiNzEwNzQwMzk3NGFhY2I3NzE4NjhhMWU5YmIyMTRfMy01LTEtMS00Mjc5Mg_e7467861-8212-45fe-bf60-5ba6f865e825"
      unitRef="shares">89000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ie5f97af31c054e3788ba0bc81976a278_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RhYmxlOjE4YjcxMDc0MDM5NzRhYWNiNzcxODY4YTFlOWJiMjE0L3RhYmxlcmFuZ2U6MThiNzEwNzQwMzk3NGFhY2I3NzE4NjhhMWU5YmIyMTRfMy03LTEtMS00Mjc5Mg_86abb033-ff4a-415f-a320-e4146a1059f2"
      unitRef="usd">3175000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="icf2b50e3ab554624b26461e34b8f1ca1_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RhYmxlOjE4YjcxMDc0MDM5NzRhYWNiNzcxODY4YTFlOWJiMjE0L3RhYmxlcmFuZ2U6MThiNzEwNzQwMzk3NGFhY2I3NzE4NjhhMWU5YmIyMTRfNC0xLTEtMS00Mjc5Mg_53ed1076-cfd9-44b5-adce-c3810b682b6d"
      unitRef="shares">25000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="icf2b50e3ab554624b26461e34b8f1ca1_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RhYmxlOjE4YjcxMDc0MDM5NzRhYWNiNzcxODY4YTFlOWJiMjE0L3RhYmxlcmFuZ2U6MThiNzEwNzQwMzk3NGFhY2I3NzE4NjhhMWU5YmIyMTRfNC0zLTEtMS00Mjc5Mg_eefbe617-fa06-4d61-a6fe-8bbb64bb5942"
      unitRef="usd">950000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i69d71c00111f4c31a670e455a0400e4b_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RhYmxlOjE4YjcxMDc0MDM5NzRhYWNiNzcxODY4YTFlOWJiMjE0L3RhYmxlcmFuZ2U6MThiNzEwNzQwMzk3NGFhY2I3NzE4NjhhMWU5YmIyMTRfNC01LTEtMS00Mjc5Mg_39f341b3-0c69-4f28-83c9-2d0923740fa3"
      unitRef="shares">0</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i69d71c00111f4c31a670e455a0400e4b_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RhYmxlOjE4YjcxMDc0MDM5NzRhYWNiNzcxODY4YTFlOWJiMjE0L3RhYmxlcmFuZ2U6MThiNzEwNzQwMzk3NGFhY2I3NzE4NjhhMWU5YmIyMTRfNC03LTEtMS00Mjc5Mg_d6c3fc8a-df55-4b63-ae9d-fc4bfef01d34"
      unitRef="usd">0</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i8836599f5719436f91aef628c5b33be0_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RhYmxlOjE4YjcxMDc0MDM5NzRhYWNiNzcxODY4YTFlOWJiMjE0L3RhYmxlcmFuZ2U6MThiNzEwNzQwMzk3NGFhY2I3NzE4NjhhMWU5YmIyMTRfNS0xLTEtMS00Mjc5Mg_44b745e8-ae0a-4406-bb50-5e0d1ef063bd"
      unitRef="shares">15000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i8836599f5719436f91aef628c5b33be0_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RhYmxlOjE4YjcxMDc0MDM5NzRhYWNiNzcxODY4YTFlOWJiMjE0L3RhYmxlcmFuZ2U6MThiNzEwNzQwMzk3NGFhY2I3NzE4NjhhMWU5YmIyMTRfNS0zLTEtMS00Mjc5Mg_ced2c7b1-f208-4728-b6a9-82eeea7acba1"
      unitRef="usd">1941000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="if982f76b88b6470b88a0ed0c16c942e8_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RhYmxlOjE4YjcxMDc0MDM5NzRhYWNiNzcxODY4YTFlOWJiMjE0L3RhYmxlcmFuZ2U6MThiNzEwNzQwMzk3NGFhY2I3NzE4NjhhMWU5YmIyMTRfNS01LTEtMS00Mjc5Mg_d306dee7-5cf0-4aff-963b-48a5e757c7a3"
      unitRef="shares">14000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="if982f76b88b6470b88a0ed0c16c942e8_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RhYmxlOjE4YjcxMDc0MDM5NzRhYWNiNzcxODY4YTFlOWJiMjE0L3RhYmxlcmFuZ2U6MThiNzEwNzQwMzk3NGFhY2I3NzE4NjhhMWU5YmIyMTRfNS03LTEtMS00Mjc5Mg_f2e682f4-ecb9-4292-98ac-d483fd91a78f"
      unitRef="usd">666000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="iaf70d20a80bb4d1aa9e3337f77338213_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RhYmxlOjE4YjcxMDc0MDM5NzRhYWNiNzcxODY4YTFlOWJiMjE0L3RhYmxlcmFuZ2U6MThiNzEwNzQwMzk3NGFhY2I3NzE4NjhhMWU5YmIyMTRfNi0xLTEtMS00Mjc5Mg_0eaaf040-9ee1-43c2-8239-c7d1fe405189"
      unitRef="shares">26000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="iaf70d20a80bb4d1aa9e3337f77338213_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RhYmxlOjE4YjcxMDc0MDM5NzRhYWNiNzcxODY4YTFlOWJiMjE0L3RhYmxlcmFuZ2U6MThiNzEwNzQwMzk3NGFhY2I3NzE4NjhhMWU5YmIyMTRfNi0zLTEtMS00Mjc5Mg_dfd7c578-2457-4489-b73b-95f1fddda9b0"
      unitRef="usd">1423000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="iec911248646e4fb08207555f658d9df7_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RhYmxlOjE4YjcxMDc0MDM5NzRhYWNiNzcxODY4YTFlOWJiMjE0L3RhYmxlcmFuZ2U6MThiNzEwNzQwMzk3NGFhY2I3NzE4NjhhMWU5YmIyMTRfNi01LTEtMS00Mjc5Mg_9eb5c25c-f2dd-452d-afe7-b60df9b48011"
      unitRef="shares">26000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="iec911248646e4fb08207555f658d9df7_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RhYmxlOjE4YjcxMDc0MDM5NzRhYWNiNzcxODY4YTFlOWJiMjE0L3RhYmxlcmFuZ2U6MThiNzEwNzQwMzk3NGFhY2I3NzE4NjhhMWU5YmIyMTRfNi03LTEtMS00Mjc5Mg_7f57153f-7490-4b77-ad0c-cc5c4206be69"
      unitRef="usd">1329000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i2b5cd09c8d0d42ac95d3ad2f1003faf4_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RhYmxlOjE4YjcxMDc0MDM5NzRhYWNiNzcxODY4YTFlOWJiMjE0L3RhYmxlcmFuZ2U6MThiNzEwNzQwMzk3NGFhY2I3NzE4NjhhMWU5YmIyMTRfNy0xLTEtMS00Mjc5Mg_db694037-0e3f-4168-b558-74e7ac22db3e"
      unitRef="shares">0</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i2b5cd09c8d0d42ac95d3ad2f1003faf4_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RhYmxlOjE4YjcxMDc0MDM5NzRhYWNiNzcxODY4YTFlOWJiMjE0L3RhYmxlcmFuZ2U6MThiNzEwNzQwMzk3NGFhY2I3NzE4NjhhMWU5YmIyMTRfNy0zLTEtMS00Mjc5Mg_3616fdc3-4009-47d5-9c95-03a361818c4b"
      unitRef="usd">0</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i22b57c2d55054a9da3152d65a3fac12e_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RhYmxlOjE4YjcxMDc0MDM5NzRhYWNiNzcxODY4YTFlOWJiMjE0L3RhYmxlcmFuZ2U6MThiNzEwNzQwMzk3NGFhY2I3NzE4NjhhMWU5YmIyMTRfNy01LTEtMS00Mjc5Mg_6e276cb5-4a38-4b40-8545-ace69c3b5a83"
      unitRef="shares">16000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i22b57c2d55054a9da3152d65a3fac12e_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RhYmxlOjE4YjcxMDc0MDM5NzRhYWNiNzcxODY4YTFlOWJiMjE0L3RhYmxlcmFuZ2U6MThiNzEwNzQwMzk3NGFhY2I3NzE4NjhhMWU5YmIyMTRfNy03LTEtMS00Mjc5Mg_86ff94f2-1a6a-4e01-bc96-15fe7f0701aa"
      unitRef="usd">1443000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RhYmxlOjE4YjcxMDc0MDM5NzRhYWNiNzcxODY4YTFlOWJiMjE0L3RhYmxlcmFuZ2U6MThiNzEwNzQwMzk3NGFhY2I3NzE4NjhhMWU5YmIyMTRfOC0xLTEtMS00Mjc5Mg_271fa0f8-3834-49dd-8a27-3fc41b1c1279"
      unitRef="shares">156000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RhYmxlOjE4YjcxMDc0MDM5NzRhYWNiNzcxODY4YTFlOWJiMjE0L3RhYmxlcmFuZ2U6MThiNzEwNzQwMzk3NGFhY2I3NzE4NjhhMWU5YmIyMTRfOC0zLTEtMS00Mjc5Mg_c829340d-8c45-4d1f-9b71-b06d5e63272e"
      unitRef="usd">8103000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="ic431430d1ab24120b4507025a722d73a_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RhYmxlOjE4YjcxMDc0MDM5NzRhYWNiNzcxODY4YTFlOWJiMjE0L3RhYmxlcmFuZ2U6MThiNzEwNzQwMzk3NGFhY2I3NzE4NjhhMWU5YmIyMTRfOC01LTEtMS00Mjc5Mg_3c3184c0-70bd-4c68-bfcc-aaeaca2691bc"
      unitRef="shares">145000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ic431430d1ab24120b4507025a722d73a_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RhYmxlOjE4YjcxMDc0MDM5NzRhYWNiNzcxODY4YTFlOWJiMjE0L3RhYmxlcmFuZ2U6MThiNzEwNzQwMzk3NGFhY2I3NzE4NjhhMWU5YmIyMTRfOC03LTEtMS00Mjc5Mg_e7e529dd-a043-4f63-ae53-6c5955437aca"
      unitRef="usd">6613000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
      contextRef="i0d192144959640fd8d222d1f8b709e6b_D20220701-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RleHRyZWdpb246ZTVhOGVlNTZmNGM1NDhmNzhjYjViOTk0YzJmYjU5OGRfNDI4MQ_7f2bc6f4-f92f-4d9b-8fef-30dc04cb3583"
      unitRef="usd">400000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
      contextRef="i2fe34b3f982747e1929ba94579cd75e3_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RleHRyZWdpb246ZTVhOGVlNTZmNGM1NDhmNzhjYjViOTk0YzJmYjU5OGRfNDI4OA_c1efa8b8-cd19-4e61-b758-6104aa873909"
      unitRef="usd">100000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
      contextRef="id337c0920a144e0c91a6bed2853c1d7b_D20220101-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RleHRyZWdpb246ZTVhOGVlNTZmNGM1NDhmNzhjYjViOTk0YzJmYjU5OGRfNDMyOA_7c86e615-24e9-4ca5-adf7-06bf606f01a2"
      unitRef="usd">1200000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
      contextRef="if58da46cc9354a8eadc10f9e4f114ac2_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RleHRyZWdpb246ZTVhOGVlNTZmNGM1NDhmNzhjYjViOTk0YzJmYjU5OGRfNDMzNQ_9c104a32-fb57-4972-999e-77b53b8a227d"
      unitRef="usd">2300000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions
      contextRef="iee1cf11574cc42609fde6f9c8aee4073_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RleHRyZWdpb246ZTVhOGVlNTZmNGM1NDhmNzhjYjViOTk0YzJmYjU5OGRfNDM4Mg_05ec13d0-233b-4c43-bbf8-55c4093706dd"
      unitRef="usd">7600000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions>
    <dei:DocumentPeriodEndDate
      contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RleHRyZWdpb246ZTVhOGVlNTZmNGM1NDhmNzhjYjViOTk0YzJmYjU5OGRfNDQ2Ng_75cfbe1e-17ec-4442-ae34-fd999dbe9ec2">2022-09-30</dei:DocumentPeriodEndDate>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="id337c0920a144e0c91a6bed2853c1d7b_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RleHRyZWdpb246ZTVhOGVlNTZmNGM1NDhmNzhjYjViOTk0YzJmYjU5OGRfNDUzOQ_ba454560-9be1-4ab3-8110-a966d950c4bc">P23M</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions
      contextRef="i6694abec73714bcba4d3d84d55594c48_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RleHRyZWdpb246ZTVhOGVlNTZmNGM1NDhmNzhjYjViOTk0YzJmYjU5OGRfNDU1Mw_04b607cf-164f-40ac-a878-549300b59465"
      unitRef="usd">7900000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="id883036fe81d4fbd9ce98760bd9584d6_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RleHRyZWdpb246ZTVhOGVlNTZmNGM1NDhmNzhjYjViOTk0YzJmYjU5OGRfNDYwNg_6e3fca99-89bd-4dfd-b099-45b76fce9277"
      unitRef="shares">66000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <dei:DocumentPeriodEndDate
      contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RleHRyZWdpb246ZTVhOGVlNTZmNGM1NDhmNzhjYjViOTk0YzJmYjU5OGRfNDY1Ng_75cfbe1e-17ec-4442-ae34-fd999dbe9ec2">2022-09-30</dei:DocumentPeriodEndDate>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="id883036fe81d4fbd9ce98760bd9584d6_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180My9mcmFnOmU1YThlZTU2ZjRjNTQ4Zjc4Y2I1Yjk5NGMyZmI1OThkL3RleHRyZWdpb246ZTVhOGVlNTZmNGM1NDhmNzhjYjViOTk0YzJmYjU5OGRfNDcyOQ_5749dbf2-5c3f-4c2f-92f0-60ed344a2d64">P23M</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:LesseeOperatingLeasesTextBlock
      contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180Ni9mcmFnOjZjNzYyOWQ3ZTg4MTQ1MmVhNDBhY2E4OTgzMjc1ZWIxL3RleHRyZWdpb246NmM3NjI5ZDdlODgxNDUyZWE0MGFjYTg5ODMyNzVlYjFfMTM3OA_d300f593-e246-4781-b44c-bff7db94dfe7">LEASES&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Operating Leases&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has operating leases for office and warehouse space and certain equipment. In certain of the Company&#x2019;s lease agreements, the rental payments are adjusted periodically based on defined terms within the lease. The Company did not have any finance leases as of September&#160;30, 2022 and 2021, respectively, or for the nine-month periods then ended, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our leases relating to office and warehouse space have lease terms of 18 months to 126 months. Our leases relating to equipment have lease terms of 24 months to 203 months, with certain of them having automatic renewal clauses.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s warehouse agreements also contain non-lease components, in the form of payments towards variable logistics services and labor charges, which the Company is obligated to pay based on the services consumed by it. Such amounts are not included in the measurement of the lease liability but are. recognized as expenses when they are incurred.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The operating lease expense was $1.7&#160;million and $1.4&#160;million for the three months ended September 30, 2022 and 2021, respectively, and $5.2 million and $3.8 million for the nine months ended September 30, 2022 and 2021, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Supplemental cash flow information related to the Company&#x2019;s operating leases was as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.245%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:63.780%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.905%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.420%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;Nine months ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Cash paid for amounts included in the measurements of lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Operating cash flow used in operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,413&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,175&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Right-of-use assets obtained in exchange for lease obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;103&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,745&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of September&#160;30, 2022, the weighted average remaining lease term was 60 months and the weighted average discount rate was 2.1%.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the maturity of the Company&#x2019;s operating lease liabilities as of September&#160;30, 2022 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.660%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:81.385%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.415%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;2022 (excluding the nine months ended September&#160;30, 2022)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,787&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,241&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,693&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,825&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,412&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Total lease payments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;29,118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Less: imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,418)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Total &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;27,700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeasesTextBlock>
    <dei:DocumentPeriodEndDate
      contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180Ni9mcmFnOjZjNzYyOWQ3ZTg4MTQ1MmVhNDBhY2E4OTgzMjc1ZWIxL3RleHRyZWdpb246NmM3NjI5ZDdlODgxNDUyZWE0MGFjYTg5ODMyNzVlYjFfMzAy_75cfbe1e-17ec-4442-ae34-fd999dbe9ec2">2022-09-30</dei:DocumentPeriodEndDate>
    <us-gaap:LesseeOperatingLeaseTermOfContract
      contextRef="ice458ff158834dc8b920eafada15a08c_I20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180Ni9mcmFnOjZjNzYyOWQ3ZTg4MTQ1MmVhNDBhY2E4OTgzMjc1ZWIxL3RleHRyZWdpb246NmM3NjI5ZDdlODgxNDUyZWE0MGFjYTg5ODMyNzVlYjFfNDQ1_931ba815-c75d-4474-8619-8d0002017107">P18M</us-gaap:LesseeOperatingLeaseTermOfContract>
    <us-gaap:LesseeOperatingLeaseTermOfContract
      contextRef="ic37ce3f978074bddbfb14a6e5f911b56_I20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180Ni9mcmFnOjZjNzYyOWQ3ZTg4MTQ1MmVhNDBhY2E4OTgzMjc1ZWIxL3RleHRyZWdpb246NmM3NjI5ZDdlODgxNDUyZWE0MGFjYTg5ODMyNzVlYjFfNDUx_86c8f90f-7672-4503-b4ab-0c0ac573e418">P126M</us-gaap:LesseeOperatingLeaseTermOfContract>
    <us-gaap:LesseeOperatingLeaseTermOfContract
      contextRef="i0399caeb91d24d5b95af603648d72cb4_I20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180Ni9mcmFnOjZjNzYyOWQ3ZTg4MTQ1MmVhNDBhY2E4OTgzMjc1ZWIxL3RleHRyZWdpb246NmM3NjI5ZDdlODgxNDUyZWE0MGFjYTg5ODMyNzVlYjFfNTA4_f23c619b-a95a-435d-9066-7e82f10241b8">P24M</us-gaap:LesseeOperatingLeaseTermOfContract>
    <us-gaap:LesseeOperatingLeaseTermOfContract
      contextRef="ie6bff7e9e26a4002b1c59b59832b37a2_I20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180Ni9mcmFnOjZjNzYyOWQ3ZTg4MTQ1MmVhNDBhY2E4OTgzMjc1ZWIxL3RleHRyZWdpb246NmM3NjI5ZDdlODgxNDUyZWE0MGFjYTg5ODMyNzVlYjFfNTE0_6adbd560-312d-4127-b1d0-207a0b8975fc">P203M</us-gaap:LesseeOperatingLeaseTermOfContract>
    <us-gaap:OperatingLeaseExpense
      contextRef="i2f3a96a832ab4b0ca374599d1c3e9bce_D20220701-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180Ni9mcmFnOjZjNzYyOWQ3ZTg4MTQ1MmVhNDBhY2E4OTgzMjc1ZWIxL3RleHRyZWdpb246NmM3NjI5ZDdlODgxNDUyZWE0MGFjYTg5ODMyNzVlYjFfOTU3_6f60918e-68ab-4d6e-aef2-685b3ede1225"
      unitRef="usd">1700000</us-gaap:OperatingLeaseExpense>
    <us-gaap:OperatingLeaseExpense
      contextRef="i3bb5592686d74afab4f7004818fd6f9b_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180Ni9mcmFnOjZjNzYyOWQ3ZTg4MTQ1MmVhNDBhY2E4OTgzMjc1ZWIxL3RleHRyZWdpb246NmM3NjI5ZDdlODgxNDUyZWE0MGFjYTg5ODMyNzVlYjFfOTY0_6c117fb5-7362-43d4-8b33-6af74d75c936"
      unitRef="usd">1400000</us-gaap:OperatingLeaseExpense>
    <us-gaap:OperatingLeaseExpense
      contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180Ni9mcmFnOjZjNzYyOWQ3ZTg4MTQ1MmVhNDBhY2E4OTgzMjc1ZWIxL3RleHRyZWdpb246NmM3NjI5ZDdlODgxNDUyZWE0MGFjYTg5ODMyNzVlYjFfMTAwNA_026471a8-44f3-4b39-9aee-719d567cdbbf"
      unitRef="usd">5200000</us-gaap:OperatingLeaseExpense>
    <us-gaap:OperatingLeaseExpense
      contextRef="ic431430d1ab24120b4507025a722d73a_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180Ni9mcmFnOjZjNzYyOWQ3ZTg4MTQ1MmVhNDBhY2E4OTgzMjc1ZWIxL3RleHRyZWdpb246NmM3NjI5ZDdlODgxNDUyZWE0MGFjYTg5ODMyNzVlYjFfMTAxMQ_b6cf2386-e622-427f-a464-87f2d4404f89"
      unitRef="usd">3800000</us-gaap:OperatingLeaseExpense>
    <us-gaap:LeaseCostTableTextBlock
      contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180Ni9mcmFnOjZjNzYyOWQ3ZTg4MTQ1MmVhNDBhY2E4OTgzMjc1ZWIxL3RleHRyZWdpb246NmM3NjI5ZDdlODgxNDUyZWE0MGFjYTg5ODMyNzVlYjFfMTM3Ng_fdeba23f-6724-4a55-8e5b-74f7e40761b0">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Supplemental cash flow information related to the Company&#x2019;s operating leases was as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.245%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:63.780%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.905%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.420%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;Nine months ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Cash paid for amounts included in the measurements of lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Operating cash flow used in operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,413&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,175&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Right-of-use assets obtained in exchange for lease obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;103&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,745&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LeaseCostTableTextBlock>
    <us-gaap:OperatingLeasePayments
      contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180Ni9mcmFnOjZjNzYyOWQ3ZTg4MTQ1MmVhNDBhY2E4OTgzMjc1ZWIxL3RhYmxlOjRmMDc1MzA0YzljMjRlYjQ5NjI1ZGY4NzQwMDNlYjNjL3RhYmxlcmFuZ2U6NGYwNzUzMDRjOWMyNGViNDk2MjVkZjg3NDAwM2ViM2NfNC0xLTEtMS00Mjc5Mg_5bcb3fa4-989c-484d-b18d-eaf41724e9e5"
      unitRef="usd">5413000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments
      contextRef="ic431430d1ab24120b4507025a722d73a_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180Ni9mcmFnOjZjNzYyOWQ3ZTg4MTQ1MmVhNDBhY2E4OTgzMjc1ZWIxL3RhYmxlOjRmMDc1MzA0YzljMjRlYjQ5NjI1ZGY4NzQwMDNlYjNjL3RhYmxlcmFuZ2U6NGYwNzUzMDRjOWMyNGViNDk2MjVkZjg3NDAwM2ViM2NfNC0zLTEtMS00Mjc5Mg_b7cb3856-6b8b-4852-80e2-336977a9295d"
      unitRef="usd">3175000</us-gaap:OperatingLeasePayments>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180Ni9mcmFnOjZjNzYyOWQ3ZTg4MTQ1MmVhNDBhY2E4OTgzMjc1ZWIxL3RhYmxlOjRmMDc1MzA0YzljMjRlYjQ5NjI1ZGY4NzQwMDNlYjNjL3RhYmxlcmFuZ2U6NGYwNzUzMDRjOWMyNGViNDk2MjVkZjg3NDAwM2ViM2NfNy0xLTEtMS00Mjc5Mg_ec6a4ceb-ad03-4661-a647-02a63fb32e1c"
      unitRef="usd">103000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="ic431430d1ab24120b4507025a722d73a_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180Ni9mcmFnOjZjNzYyOWQ3ZTg4MTQ1MmVhNDBhY2E4OTgzMjc1ZWIxL3RhYmxlOjRmMDc1MzA0YzljMjRlYjQ5NjI1ZGY4NzQwMDNlYjNjL3RhYmxlcmFuZ2U6NGYwNzUzMDRjOWMyNGViNDk2MjVkZjg3NDAwM2ViM2NfNy0zLTEtMS00Mjc5Mg_e2db2261-a90a-4da4-8ced-a83e9ead9420"
      unitRef="usd">9745000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <dei:DocumentPeriodEndDate
      contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180Ni9mcmFnOjZjNzYyOWQ3ZTg4MTQ1MmVhNDBhY2E4OTgzMjc1ZWIxL3RleHRyZWdpb246NmM3NjI5ZDdlODgxNDUyZWE0MGFjYTg5ODMyNzVlYjFfMTE2Mw_75cfbe1e-17ec-4442-ae34-fd999dbe9ec2">2022-09-30</dei:DocumentPeriodEndDate>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="i5de311f5948148cda49342e2cea83715_I20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180Ni9mcmFnOjZjNzYyOWQ3ZTg4MTQ1MmVhNDBhY2E4OTgzMjc1ZWIxL3RleHRyZWdpb246NmM3NjI5ZDdlODgxNDUyZWE0MGFjYTg5ODMyNzVlYjFfMTIxMw_ab063b99-9764-44e1-a343-051c68d4d732">P60M</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="i5de311f5948148cda49342e2cea83715_I20220930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180Ni9mcmFnOjZjNzYyOWQ3ZTg4MTQ1MmVhNDBhY2E4OTgzMjc1ZWIxL3RleHRyZWdpb246NmM3NjI5ZDdlODgxNDUyZWE0MGFjYTg5ODMyNzVlYjFfMTI1OQ_c67727b8-87c4-4888-8e7b-48c6b758034b"
      unitRef="number">0.021</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock
      contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180Ni9mcmFnOjZjNzYyOWQ3ZTg4MTQ1MmVhNDBhY2E4OTgzMjc1ZWIxL3RleHRyZWdpb246NmM3NjI5ZDdlODgxNDUyZWE0MGFjYTg5ODMyNzVlYjFfMTM3Nw_6c69329f-61ea-4de2-9569-fb421b80fd67">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the maturity of the Company&#x2019;s operating lease liabilities as of September&#160;30, 2022 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.660%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:81.385%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.415%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;2022 (excluding the nine months ended September&#160;30, 2022)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,787&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,241&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,693&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,825&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,412&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Total lease payments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;29,118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Less: imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,418)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Total &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;27,700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <dei:DocumentPeriodEndDate
      contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180Ni9mcmFnOjZjNzYyOWQ3ZTg4MTQ1MmVhNDBhY2E4OTgzMjc1ZWIxL3RleHRyZWdpb246NmM3NjI5ZDdlODgxNDUyZWE0MGFjYTg5ODMyNzVlYjFfMTM1Ng_75cfbe1e-17ec-4442-ae34-fd999dbe9ec2">2022-09-30</dei:DocumentPeriodEndDate>
    <dei:DocumentPeriodEndDate
      contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180Ni9mcmFnOjZjNzYyOWQ3ZTg4MTQ1MmVhNDBhY2E4OTgzMjc1ZWIxL3RhYmxlOjgwNTVlOTdiYTU1ODQ3NDFhNjZlMGU2ODNmOTY5NjA3L3RhYmxlcmFuZ2U6ODA1NWU5N2JhNTU4NDc0MWE2NmUwZTY4M2Y5Njk2MDdfMC0wLTEtMS00Mjc5Mi90ZXh0cmVnaW9uOmRmOGZkODZlMDg3OTQ1NmQ5NTBkNDYxOGI2NGZhMzNiXzM5_75cfbe1e-17ec-4442-ae34-fd999dbe9ec2">2022-09-30</dei:DocumentPeriodEndDate>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
      contextRef="i5de311f5948148cda49342e2cea83715_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180Ni9mcmFnOjZjNzYyOWQ3ZTg4MTQ1MmVhNDBhY2E4OTgzMjc1ZWIxL3RhYmxlOjgwNTVlOTdiYTU1ODQ3NDFhNjZlMGU2ODNmOTY5NjA3L3RhYmxlcmFuZ2U6ODA1NWU5N2JhNTU4NDc0MWE2NmUwZTY4M2Y5Njk2MDdfMC0xLTEtMS00Mjc5Mg_2a6fe753-6ad6-4de2-a39c-19af125669a8"
      unitRef="usd">1787000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="i5de311f5948148cda49342e2cea83715_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180Ni9mcmFnOjZjNzYyOWQ3ZTg4MTQ1MmVhNDBhY2E4OTgzMjc1ZWIxL3RhYmxlOjgwNTVlOTdiYTU1ODQ3NDFhNjZlMGU2ODNmOTY5NjA3L3RhYmxlcmFuZ2U6ODA1NWU5N2JhNTU4NDc0MWE2NmUwZTY4M2Y5Njk2MDdfMS0xLTEtMS00Mjc5Mg_c02ed2fc-a1e9-46af-85d8-c47727858094"
      unitRef="usd">6241000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
      contextRef="i5de311f5948148cda49342e2cea83715_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180Ni9mcmFnOjZjNzYyOWQ3ZTg4MTQ1MmVhNDBhY2E4OTgzMjc1ZWIxL3RhYmxlOjgwNTVlOTdiYTU1ODQ3NDFhNjZlMGU2ODNmOTY5NjA3L3RhYmxlcmFuZ2U6ODA1NWU5N2JhNTU4NDc0MWE2NmUwZTY4M2Y5Njk2MDdfMi0xLTEtMS00Mjc5Mg_15d49a83-3962-4cc0-bf4e-31075fe9235f"
      unitRef="usd">5693000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree
      contextRef="i5de311f5948148cda49342e2cea83715_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180Ni9mcmFnOjZjNzYyOWQ3ZTg4MTQ1MmVhNDBhY2E4OTgzMjc1ZWIxL3RhYmxlOjgwNTVlOTdiYTU1ODQ3NDFhNjZlMGU2ODNmOTY5NjA3L3RhYmxlcmFuZ2U6ODA1NWU5N2JhNTU4NDc0MWE2NmUwZTY4M2Y5Njk2MDdfMy0xLTEtMS00Mjc5Mg_80fe46ce-c601-4e6a-93d0-fe61d33599a0"
      unitRef="usd">5825000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour
      contextRef="i5de311f5948148cda49342e2cea83715_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180Ni9mcmFnOjZjNzYyOWQ3ZTg4MTQ1MmVhNDBhY2E4OTgzMjc1ZWIxL3RhYmxlOjgwNTVlOTdiYTU1ODQ3NDFhNjZlMGU2ODNmOTY5NjA3L3RhYmxlcmFuZ2U6ODA1NWU5N2JhNTU4NDc0MWE2NmUwZTY4M2Y5Njk2MDdfNC0xLTEtMS00Mjc5Mg_6bdc1fc0-7bd6-41cf-983e-2d621fb0888a"
      unitRef="usd">4160000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <med:LesseeOperatingLeaseLiabilityPaymentsDueYearFiveAndAfterYearFive
      contextRef="i5de311f5948148cda49342e2cea83715_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180Ni9mcmFnOjZjNzYyOWQ3ZTg4MTQ1MmVhNDBhY2E4OTgzMjc1ZWIxL3RhYmxlOjgwNTVlOTdiYTU1ODQ3NDFhNjZlMGU2ODNmOTY5NjA3L3RhYmxlcmFuZ2U6ODA1NWU5N2JhNTU4NDc0MWE2NmUwZTY4M2Y5Njk2MDdfNS0xLTEtMS00Mjc5Mg_45bbe327-3469-4a4d-85b3-3d2a055803f8"
      unitRef="usd">5412000</med:LesseeOperatingLeaseLiabilityPaymentsDueYearFiveAndAfterYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="i5de311f5948148cda49342e2cea83715_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180Ni9mcmFnOjZjNzYyOWQ3ZTg4MTQ1MmVhNDBhY2E4OTgzMjc1ZWIxL3RhYmxlOjgwNTVlOTdiYTU1ODQ3NDFhNjZlMGU2ODNmOTY5NjA3L3RhYmxlcmFuZ2U6ODA1NWU5N2JhNTU4NDc0MWE2NmUwZTY4M2Y5Njk2MDdfNi0xLTEtMS00Mjc5Mg_0bd10d80-cfd8-4945-a0fa-bdd198b5a630"
      unitRef="usd">29118000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
      contextRef="i5de311f5948148cda49342e2cea83715_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180Ni9mcmFnOjZjNzYyOWQ3ZTg4MTQ1MmVhNDBhY2E4OTgzMjc1ZWIxL3RhYmxlOjgwNTVlOTdiYTU1ODQ3NDFhNjZlMGU2ODNmOTY5NjA3L3RhYmxlcmFuZ2U6ODA1NWU5N2JhNTU4NDc0MWE2NmUwZTY4M2Y5Njk2MDdfNy0xLTEtMS00Mjc5Mg_44fd135a-1c48-4cb6-af9d-0b72c5f8d2be"
      unitRef="usd">1418000</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability
      contextRef="i5de311f5948148cda49342e2cea83715_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180Ni9mcmFnOjZjNzYyOWQ3ZTg4MTQ1MmVhNDBhY2E4OTgzMjc1ZWIxL3RhYmxlOjgwNTVlOTdiYTU1ODQ3NDFhNjZlMGU2ODNmOTY5NjA3L3RhYmxlcmFuZ2U6ODA1NWU5N2JhNTU4NDc0MWE2NmUwZTY4M2Y5Njk2MDdfOC0xLTEtMS00Mjc5Mg_e924dfa4-f3e2-4742-9935-2b871ddff178"
      unitRef="usd">27700000</us-gaap:OperatingLeaseLiability>
    <us-gaap:ComprehensiveIncomeNoteTextBlock
      contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180OS9mcmFnOjIwOGNhNTFjMWEzNTQyZjdiY2UzYWQ3NDNlY2FlZDQwL3RleHRyZWdpb246MjA4Y2E1MWMxYTM1NDJmN2JjZTNhZDc0M2VjYWVkNDBfMTgw_00dffdc8-348f-4f87-98b6-5620426cfffa">ACCUMULATED OTHER COMPREHENSIVE INCOME&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table sets forth the components of accumulated other comprehensive income, net of tax where applicable (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.345%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:64.909%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.047%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.138%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;September 30,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;December 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Foreign currency translation&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;391&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Unrealized gains on investment securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Accumulated other comprehensive income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;391&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ComprehensiveIncomeNoteTextBlock>
    <us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock
      contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180OS9mcmFnOjIwOGNhNTFjMWEzNTQyZjdiY2UzYWQ3NDNlY2FlZDQwL3RleHRyZWdpb246MjA4Y2E1MWMxYTM1NDJmN2JjZTNhZDc0M2VjYWVkNDBfMTgx_6d87997c-5f1e-42ec-a010-223e889ffb55">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table sets forth the components of accumulated other comprehensive income, net of tax where applicable (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.345%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:64.909%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.047%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.138%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;September 30,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;December 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Foreign currency translation&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;391&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Unrealized gains on investment securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Accumulated other comprehensive income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;391&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
    <dei:DocumentPeriodEndDate
      contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180OS9mcmFnOjIwOGNhNTFjMWEzNTQyZjdiY2UzYWQ3NDNlY2FlZDQwL3RhYmxlOmZhZGMxM2Q5ZGZkNzQxMWVhYzY1YWUyYWY2ZmU5OTgwL3RhYmxlcmFuZ2U6ZmFkYzEzZDlkZmQ3NDExZWFjNjVhZTJhZjZmZTk5ODBfMC0xLTEtMS00Mjc5Mg_75cfbe1e-17ec-4442-ae34-fd999dbe9ec2">2022-09-30</dei:DocumentPeriodEndDate>
    <us-gaap:StockholdersEquity
      contextRef="i9072f45fffaa474fb85e95c07d3eeec4_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180OS9mcmFnOjIwOGNhNTFjMWEzNTQyZjdiY2UzYWQ3NDNlY2FlZDQwL3RhYmxlOmZhZGMxM2Q5ZGZkNzQxMWVhYzY1YWUyYWY2ZmU5OTgwL3RhYmxlcmFuZ2U6ZmFkYzEzZDlkZmQ3NDExZWFjNjVhZTJhZjZmZTk5ODBfMi0xLTEtMS00Mjc5Mg_ede97284-e5e5-4139-a4ef-b540f3a91984"
      unitRef="usd">391000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="if1f1d1f963874bf9a839c3e7d4c9af87_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180OS9mcmFnOjIwOGNhNTFjMWEzNTQyZjdiY2UzYWQ3NDNlY2FlZDQwL3RhYmxlOmZhZGMxM2Q5ZGZkNzQxMWVhYzY1YWUyYWY2ZmU5OTgwL3RhYmxlcmFuZ2U6ZmFkYzEzZDlkZmQ3NDExZWFjNjVhZTJhZjZmZTk5ODBfMi0zLTEtMS00Mjc5Mg_af67e46c-2083-49f3-bcb8-182eeed93fcd"
      unitRef="usd">90000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i097ff6133d214f6bb8b7dc45eed5eed7_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180OS9mcmFnOjIwOGNhNTFjMWEzNTQyZjdiY2UzYWQ3NDNlY2FlZDQwL3RhYmxlOmZhZGMxM2Q5ZGZkNzQxMWVhYzY1YWUyYWY2ZmU5OTgwL3RhYmxlcmFuZ2U6ZmFkYzEzZDlkZmQ3NDExZWFjNjVhZTJhZjZmZTk5ODBfMy0xLTEtMS00Mjc5Mg_f5c7103e-4cb2-4d4e-b480-1316f5b61538"
      unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i8729459526e94e28ad22588635f7ca5e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180OS9mcmFnOjIwOGNhNTFjMWEzNTQyZjdiY2UzYWQ3NDNlY2FlZDQwL3RhYmxlOmZhZGMxM2Q5ZGZkNzQxMWVhYzY1YWUyYWY2ZmU5OTgwL3RhYmxlcmFuZ2U6ZmFkYzEzZDlkZmQ3NDExZWFjNjVhZTJhZjZmZTk5ODBfMy0zLTEtMS00Mjc5Mg_184bf122-2a64-4df7-9669-868105e025b6"
      unitRef="usd">21000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ib4e37db708e64812ac81e983938b61df_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180OS9mcmFnOjIwOGNhNTFjMWEzNTQyZjdiY2UzYWQ3NDNlY2FlZDQwL3RhYmxlOmZhZGMxM2Q5ZGZkNzQxMWVhYzY1YWUyYWY2ZmU5OTgwL3RhYmxlcmFuZ2U6ZmFkYzEzZDlkZmQ3NDExZWFjNjVhZTJhZjZmZTk5ODBfNC0xLTEtMS00Mjc5Mg_fcfee315-a02c-42c4-8496-fc18b6a2edcb"
      unitRef="usd">391000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="id19243f3c67e4c9db2d2085c6f295c96_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM180OS9mcmFnOjIwOGNhNTFjMWEzNTQyZjdiY2UzYWQ3NDNlY2FlZDQwL3RhYmxlOmZhZGMxM2Q5ZGZkNzQxMWVhYzY1YWUyYWY2ZmU5OTgwL3RhYmxlcmFuZ2U6ZmFkYzEzZDlkZmQ3NDExZWFjNjVhZTJhZjZmZTk5ODBfNC0zLTEtMS00Mjc5Mg_d4497dfb-d4f1-4373-a657-07e63b074de8"
      unitRef="usd">111000</us-gaap:StockholdersEquity>
    <us-gaap:FinancialInstrumentsDisclosureTextBlock
      contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM181Mi9mcmFnOmRiNzNlZjJjZDg0YzRhYzlhNDNiYTIzNmFkNTU3NDNiL3RleHRyZWdpb246ZGI3M2VmMmNkODRjNGFjOWE0M2JhMjM2YWQ1NTc0M2JfMTUxMA_44e3751a-24a0-4ee7-bea2-60c99280b9ef">FINANCIAL INSTRUMENTS&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain financial assets and liabilities are accounted for at fair value, which is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The following fair value hierarchy prioritizes the inputs used to measure fair value:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:18pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level 1 &#x2013; Quoted prices are available in active markets for identical assets or liabilities as of the reporting date. Active markets are those in which transactions for the asset or liability occur in sufficient frequency and volume to provide pricing information on an ongoing basis.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:18pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level 2 &#x2013; Pricing inputs are other than quoted prices in active markets included in Level 1, which are either directly or indirectly observable as of the reporting date. Level 2 includes those financial instruments that are valued using models or other valuation methodologies.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:18pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level 3 &#x2013; Pricing inputs include significant inputs that are generally less observable from objective sources. These inputs may be used with internally developed methodologies that result in management&#x2019;s best estimate of fair value from the perspective of a market participant.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables present the Company&#x2019;s cash and financial assets that are measured at fair value on a recurring basis for each of the hierarchy levels (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.800%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.605%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;Unrealized Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;Accrued Interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;Estimated Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;Cash &amp;amp; Cash&lt;br/&gt;Equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;Investment&lt;br/&gt;Securities&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;69,710&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;69,710&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;69,710&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Level 1:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Money market accounts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;69,710&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;69,710&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;69,710&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.800%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.605%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;Unrealized Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;Accrued Interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;Estimated Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;Cash &amp;amp; Cash&lt;br/&gt;Equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;Investment&lt;br/&gt;Securities&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;94,824&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;94,824&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;94,824&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Level 1:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Money market accounts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,359&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,359&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,359&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Government &amp;amp; agency securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,401&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,413&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,413&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,760&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,772&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,359&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,413&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Level 2:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Municipal bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,880&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,948&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,948&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;109,464&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;109,544&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;104,183&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,361&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;The Company had no realized gain or loss for the three months ended September&#160;30, 2022. The company had a realized loss of $0.2 million for the nine months ended September 30, 2022. There was no realized gain or losses for the three and nine months ended September&#160;30, 2021.</us-gaap:FinancialInstrumentsDisclosureTextBlock>
    <us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock
      contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM181Mi9mcmFnOmRiNzNlZjJjZDg0YzRhYzlhNDNiYTIzNmFkNTU3NDNiL3RleHRyZWdpb246ZGI3M2VmMmNkODRjNGFjOWE0M2JhMjM2YWQ1NTc0M2JfMTUxMQ_24428ba5-d9ec-4c07-af93-045c570827c4">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables present the Company&#x2019;s cash and financial assets that are measured at fair value on a recurring basis for each of the hierarchy levels (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.800%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.605%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;Unrealized Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;Accrued Interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;Estimated Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;Cash &amp;amp; Cash&lt;br/&gt;Equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;Investment&lt;br/&gt;Securities&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;69,710&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;69,710&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;69,710&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Level 1:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Money market accounts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;69,710&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;69,710&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;69,710&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.800%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.605%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;Unrealized Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;Accrued Interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;Estimated Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;Cash &amp;amp; Cash&lt;br/&gt;Equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;Investment&lt;br/&gt;Securities&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;94,824&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;94,824&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;94,824&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Level 1:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Money market accounts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,359&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,359&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,359&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Government &amp;amp; agency securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,401&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,413&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,413&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,760&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,772&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,359&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,413&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Level 2:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Municipal bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,880&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,948&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,948&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;109,464&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;109,544&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;104,183&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,361&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock>
    <dei:DocumentPeriodEndDate
      contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM181Mi9mcmFnOmRiNzNlZjJjZDg0YzRhYzlhNDNiYTIzNmFkNTU3NDNiL3RhYmxlOjZlMmY0MTM2NDc5MTQyMGNhZjFjODNhN2E0Y2M0NjNjL3RhYmxlcmFuZ2U6NmUyZjQxMzY0NzkxNDIwY2FmMWM4M2E3YTRjYzQ2M2NfMC0xLTEtMS00Mjc5Mg_75cfbe1e-17ec-4442-ae34-fd999dbe9ec2">2022-09-30</dei:DocumentPeriodEndDate>
    <us-gaap:MarketableSecurities
      contextRef="i2441f967061c4361b6837702e3fee167_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM181Mi9mcmFnOmRiNzNlZjJjZDg0YzRhYzlhNDNiYTIzNmFkNTU3NDNiL3RhYmxlOjZlMmY0MTM2NDc5MTQyMGNhZjFjODNhN2E0Y2M0NjNjL3RhYmxlcmFuZ2U6NmUyZjQxMzY0NzkxNDIwY2FmMWM4M2E3YTRjYzQ2M2NfMy0xLTEtMS00Mjc5Mg_90e400a4-988f-4755-9097-e079670cafa8"
      unitRef="usd">69710000</us-gaap:MarketableSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="i2441f967061c4361b6837702e3fee167_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM181Mi9mcmFnOmRiNzNlZjJjZDg0YzRhYzlhNDNiYTIzNmFkNTU3NDNiL3RhYmxlOjZlMmY0MTM2NDc5MTQyMGNhZjFjODNhN2E0Y2M0NjNjL3RhYmxlcmFuZ2U6NmUyZjQxMzY0NzkxNDIwY2FmMWM4M2E3YTRjYzQ2M2NfMy03LTEtMS00Mjc5Mg_ca5c02ea-b7dc-43fd-858b-b9592e72c4f6"
      unitRef="usd">69710000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i2441f967061c4361b6837702e3fee167_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM181Mi9mcmFnOmRiNzNlZjJjZDg0YzRhYzlhNDNiYTIzNmFkNTU3NDNiL3RhYmxlOjZlMmY0MTM2NDc5MTQyMGNhZjFjODNhN2E0Y2M0NjNjL3RhYmxlcmFuZ2U6NmUyZjQxMzY0NzkxNDIwY2FmMWM4M2E3YTRjYzQ2M2NfMy05LTEtMS00Mjc5Mg_a4c5e897-7529-44fe-a9da-cf94da3300f3"
      unitRef="usd">69710000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:MarketableSecurities
      contextRef="iea299389245a4a8b89c2066eaf7399d6_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM181Mi9mcmFnOmRiNzNlZjJjZDg0YzRhYzlhNDNiYTIzNmFkNTU3NDNiL3RhYmxlOjZlMmY0MTM2NDc5MTQyMGNhZjFjODNhN2E0Y2M0NjNjL3RhYmxlcmFuZ2U6NmUyZjQxMzY0NzkxNDIwY2FmMWM4M2E3YTRjYzQ2M2NfNi0xLTEtMS00Mjc5Mg_8da15f63-596c-49da-82da-cf643e196209"
      unitRef="usd">0</us-gaap:MarketableSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="iea299389245a4a8b89c2066eaf7399d6_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM181Mi9mcmFnOmRiNzNlZjJjZDg0YzRhYzlhNDNiYTIzNmFkNTU3NDNiL3RhYmxlOjZlMmY0MTM2NDc5MTQyMGNhZjFjODNhN2E0Y2M0NjNjL3RhYmxlcmFuZ2U6NmUyZjQxMzY0NzkxNDIwY2FmMWM4M2E3YTRjYzQ2M2NfNi03LTEtMS00Mjc5Mg_21e67820-0642-46a9-a110-89d4fe4890ab"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="iea299389245a4a8b89c2066eaf7399d6_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM181Mi9mcmFnOmRiNzNlZjJjZDg0YzRhYzlhNDNiYTIzNmFkNTU3NDNiL3RhYmxlOjZlMmY0MTM2NDc5MTQyMGNhZjFjODNhN2E0Y2M0NjNjL3RhYmxlcmFuZ2U6NmUyZjQxMzY0NzkxNDIwY2FmMWM4M2E3YTRjYzQ2M2NfNi05LTEtMS00Mjc5Mg_92d5b9c1-d555-473b-90ff-a931091784c5"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:MarketableSecurities
      contextRef="i5de311f5948148cda49342e2cea83715_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM181Mi9mcmFnOmRiNzNlZjJjZDg0YzRhYzlhNDNiYTIzNmFkNTU3NDNiL3RhYmxlOjZlMmY0MTM2NDc5MTQyMGNhZjFjODNhN2E0Y2M0NjNjL3RhYmxlcmFuZ2U6NmUyZjQxMzY0NzkxNDIwY2FmMWM4M2E3YTRjYzQ2M2NfMTMtMS0xLTEtNDI3OTI_0507db72-f148-4200-ba1c-71af0a8b35db"
      unitRef="usd">69710000</us-gaap:MarketableSecurities>
    <us-gaap:MarketableSecuritiesUnrealizedGainLoss
      contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM181Mi9mcmFnOmRiNzNlZjJjZDg0YzRhYzlhNDNiYTIzNmFkNTU3NDNiL3RhYmxlOjZlMmY0MTM2NDc5MTQyMGNhZjFjODNhN2E0Y2M0NjNjL3RhYmxlcmFuZ2U6NmUyZjQxMzY0NzkxNDIwY2FmMWM4M2E3YTRjYzQ2M2NfMTMtMy0xLTEtNDI3OTI_4efaf19f-83bf-4ecb-b082-fc2538b65672"
      unitRef="usd">0</us-gaap:MarketableSecuritiesUnrealizedGainLoss>
    <us-gaap:InterestReceivable
      contextRef="i5de311f5948148cda49342e2cea83715_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM181Mi9mcmFnOmRiNzNlZjJjZDg0YzRhYzlhNDNiYTIzNmFkNTU3NDNiL3RhYmxlOjZlMmY0MTM2NDc5MTQyMGNhZjFjODNhN2E0Y2M0NjNjL3RhYmxlcmFuZ2U6NmUyZjQxMzY0NzkxNDIwY2FmMWM4M2E3YTRjYzQ2M2NfMTMtNS0xLTEtNDI3OTI_1e2b9dad-47ca-434d-9c87-7e42935703f9"
      unitRef="usd">0</us-gaap:InterestReceivable>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="i5de311f5948148cda49342e2cea83715_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM181Mi9mcmFnOmRiNzNlZjJjZDg0YzRhYzlhNDNiYTIzNmFkNTU3NDNiL3RhYmxlOjZlMmY0MTM2NDc5MTQyMGNhZjFjODNhN2E0Y2M0NjNjL3RhYmxlcmFuZ2U6NmUyZjQxMzY0NzkxNDIwY2FmMWM4M2E3YTRjYzQ2M2NfMTMtNy0xLTEtNDI3OTI_eac82e54-5a07-42dc-aaba-64e1cf44c727"
      unitRef="usd">69710000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i5de311f5948148cda49342e2cea83715_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM181Mi9mcmFnOmRiNzNlZjJjZDg0YzRhYzlhNDNiYTIzNmFkNTU3NDNiL3RhYmxlOjZlMmY0MTM2NDc5MTQyMGNhZjFjODNhN2E0Y2M0NjNjL3RhYmxlcmFuZ2U6NmUyZjQxMzY0NzkxNDIwY2FmMWM4M2E3YTRjYzQ2M2NfMTMtOS0xLTEtNDI3OTI_fe8aaf5e-50f5-4b80-bfe6-2a6cd6d4303d"
      unitRef="usd">69710000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:InvestmentOwnedAtFairValue
      contextRef="i5de311f5948148cda49342e2cea83715_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM181Mi9mcmFnOmRiNzNlZjJjZDg0YzRhYzlhNDNiYTIzNmFkNTU3NDNiL3RhYmxlOjZlMmY0MTM2NDc5MTQyMGNhZjFjODNhN2E0Y2M0NjNjL3RhYmxlcmFuZ2U6NmUyZjQxMzY0NzkxNDIwY2FmMWM4M2E3YTRjYzQ2M2NfMTMtMTEtMS0xLTQyNzky_e7479859-ceaf-43b1-9523-ad1997e1bd76"
      unitRef="usd">0</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:MarketableSecurities
      contextRef="i1ce2f0d8655c4a7da2f77d8aa8960f46_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM181Mi9mcmFnOmRiNzNlZjJjZDg0YzRhYzlhNDNiYTIzNmFkNTU3NDNiL3RhYmxlOjU1YzA1N2VlYjgwNTQxN2ViYTgxYTBmMzRhZjM1N2NiL3RhYmxlcmFuZ2U6NTVjMDU3ZWViODA1NDE3ZWJhODFhMGYzNGFmMzU3Y2JfMy0xLTEtMS00Mjc5Mg_de71eada-1f44-49ff-9dfb-f8c7d58bb1fc"
      unitRef="usd">94824000</us-gaap:MarketableSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="i1ce2f0d8655c4a7da2f77d8aa8960f46_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM181Mi9mcmFnOmRiNzNlZjJjZDg0YzRhYzlhNDNiYTIzNmFkNTU3NDNiL3RhYmxlOjU1YzA1N2VlYjgwNTQxN2ViYTgxYTBmMzRhZjM1N2NiL3RhYmxlcmFuZ2U6NTVjMDU3ZWViODA1NDE3ZWJhODFhMGYzNGFmMzU3Y2JfMy03LTEtMS00Mjc5Mg_542807ab-e4ef-4834-974c-28e1ee576517"
      unitRef="usd">94824000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i1ce2f0d8655c4a7da2f77d8aa8960f46_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM181Mi9mcmFnOmRiNzNlZjJjZDg0YzRhYzlhNDNiYTIzNmFkNTU3NDNiL3RhYmxlOjU1YzA1N2VlYjgwNTQxN2ViYTgxYTBmMzRhZjM1N2NiL3RhYmxlcmFuZ2U6NTVjMDU3ZWViODA1NDE3ZWJhODFhMGYzNGFmMzU3Y2JfMy05LTEtMS00Mjc5Mg_1e848bd9-1f98-4c0c-b24c-e10537ceeac8"
      unitRef="usd">94824000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:MarketableSecurities
      contextRef="i1b9d5d43ca6d4d0a8b8eba73d75d9cd6_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM181Mi9mcmFnOmRiNzNlZjJjZDg0YzRhYzlhNDNiYTIzNmFkNTU3NDNiL3RhYmxlOjU1YzA1N2VlYjgwNTQxN2ViYTgxYTBmMzRhZjM1N2NiL3RhYmxlcmFuZ2U6NTVjMDU3ZWViODA1NDE3ZWJhODFhMGYzNGFmMzU3Y2JfNi0xLTEtMS00Mjc5Mg_57cda507-3d91-43d1-ab7b-5b51179510b7"
      unitRef="usd">9359000</us-gaap:MarketableSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="i1b9d5d43ca6d4d0a8b8eba73d75d9cd6_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM181Mi9mcmFnOmRiNzNlZjJjZDg0YzRhYzlhNDNiYTIzNmFkNTU3NDNiL3RhYmxlOjU1YzA1N2VlYjgwNTQxN2ViYTgxYTBmMzRhZjM1N2NiL3RhYmxlcmFuZ2U6NTVjMDU3ZWViODA1NDE3ZWJhODFhMGYzNGFmMzU3Y2JfNi03LTEtMS00Mjc5Mg_e2f59884-cefa-4414-a660-4ab5871b61c7"
      unitRef="usd">9359000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i1b9d5d43ca6d4d0a8b8eba73d75d9cd6_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM181Mi9mcmFnOmRiNzNlZjJjZDg0YzRhYzlhNDNiYTIzNmFkNTU3NDNiL3RhYmxlOjU1YzA1N2VlYjgwNTQxN2ViYTgxYTBmMzRhZjM1N2NiL3RhYmxlcmFuZ2U6NTVjMDU3ZWViODA1NDE3ZWJhODFhMGYzNGFmMzU3Y2JfNi05LTEtMS00Mjc5Mg_45c2e1c6-e29b-41a0-9ed0-186004c67bd3"
      unitRef="usd">9359000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:MarketableSecurities
      contextRef="i8dd60027e0b14536ba3bfa6e34c9dfae_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM181Mi9mcmFnOmRiNzNlZjJjZDg0YzRhYzlhNDNiYTIzNmFkNTU3NDNiL3RhYmxlOjU1YzA1N2VlYjgwNTQxN2ViYTgxYTBmMzRhZjM1N2NiL3RhYmxlcmFuZ2U6NTVjMDU3ZWViODA1NDE3ZWJhODFhMGYzNGFmMzU3Y2JfNy0xLTEtMS00Mjc5Mg_3ede47c1-d478-467d-bec2-24b39a1f1978"
      unitRef="usd">1401000</us-gaap:MarketableSecurities>
    <us-gaap:MarketableSecuritiesUnrealizedGainLoss
      contextRef="i23259e7a55774035a3ea3e0ab04e7338_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM181Mi9mcmFnOmRiNzNlZjJjZDg0YzRhYzlhNDNiYTIzNmFkNTU3NDNiL3RhYmxlOjU1YzA1N2VlYjgwNTQxN2ViYTgxYTBmMzRhZjM1N2NiL3RhYmxlcmFuZ2U6NTVjMDU3ZWViODA1NDE3ZWJhODFhMGYzNGFmMzU3Y2JfNy0zLTEtMS00Mjc5Mg_50b0b8d8-3acc-454f-9e15-3f8c403743de"
      unitRef="usd">12000</us-gaap:MarketableSecuritiesUnrealizedGainLoss>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="i8dd60027e0b14536ba3bfa6e34c9dfae_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM181Mi9mcmFnOmRiNzNlZjJjZDg0YzRhYzlhNDNiYTIzNmFkNTU3NDNiL3RhYmxlOjU1YzA1N2VlYjgwNTQxN2ViYTgxYTBmMzRhZjM1N2NiL3RhYmxlcmFuZ2U6NTVjMDU3ZWViODA1NDE3ZWJhODFhMGYzNGFmMzU3Y2JfNy03LTEtMS00Mjc5Mg_c1a54c0a-b065-4946-b82b-04dbc36b469e"
      unitRef="usd">1413000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:InvestmentOwnedAtFairValue
      contextRef="i8dd60027e0b14536ba3bfa6e34c9dfae_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM181Mi9mcmFnOmRiNzNlZjJjZDg0YzRhYzlhNDNiYTIzNmFkNTU3NDNiL3RhYmxlOjU1YzA1N2VlYjgwNTQxN2ViYTgxYTBmMzRhZjM1N2NiL3RhYmxlcmFuZ2U6NTVjMDU3ZWViODA1NDE3ZWJhODFhMGYzNGFmMzU3Y2JfNy0xMS0xLTEtNDI3OTI_0c9d4b97-b789-40fc-8707-966c77b934b4"
      unitRef="usd">1413000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:MarketableSecurities
      contextRef="if41dd7900bc54c728b2f679f78ab8cf8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM181Mi9mcmFnOmRiNzNlZjJjZDg0YzRhYzlhNDNiYTIzNmFkNTU3NDNiL3RhYmxlOjU1YzA1N2VlYjgwNTQxN2ViYTgxYTBmMzRhZjM1N2NiL3RhYmxlcmFuZ2U6NTVjMDU3ZWViODA1NDE3ZWJhODFhMGYzNGFmMzU3Y2JfOC0xLTEtMS00Mjc5Mg_7be77ad3-5acd-4708-8eb7-800db76352fc"
      unitRef="usd">10760000</us-gaap:MarketableSecurities>
    <us-gaap:MarketableSecuritiesUnrealizedGainLoss
      contextRef="i64b67de4322349efbcaab405308f4973_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM181Mi9mcmFnOmRiNzNlZjJjZDg0YzRhYzlhNDNiYTIzNmFkNTU3NDNiL3RhYmxlOjU1YzA1N2VlYjgwNTQxN2ViYTgxYTBmMzRhZjM1N2NiL3RhYmxlcmFuZ2U6NTVjMDU3ZWViODA1NDE3ZWJhODFhMGYzNGFmMzU3Y2JfOC0zLTEtMS00Mjc5Mg_8987d768-931c-452f-8c41-3e3e06eb4f4b"
      unitRef="usd">12000</us-gaap:MarketableSecuritiesUnrealizedGainLoss>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="if41dd7900bc54c728b2f679f78ab8cf8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM181Mi9mcmFnOmRiNzNlZjJjZDg0YzRhYzlhNDNiYTIzNmFkNTU3NDNiL3RhYmxlOjU1YzA1N2VlYjgwNTQxN2ViYTgxYTBmMzRhZjM1N2NiL3RhYmxlcmFuZ2U6NTVjMDU3ZWViODA1NDE3ZWJhODFhMGYzNGFmMzU3Y2JfOC03LTEtMS00Mjc5Mg_f5e0d2a3-3124-4dbb-941e-6751dd9c3f9e"
      unitRef="usd">10772000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="if41dd7900bc54c728b2f679f78ab8cf8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM181Mi9mcmFnOmRiNzNlZjJjZDg0YzRhYzlhNDNiYTIzNmFkNTU3NDNiL3RhYmxlOjU1YzA1N2VlYjgwNTQxN2ViYTgxYTBmMzRhZjM1N2NiL3RhYmxlcmFuZ2U6NTVjMDU3ZWViODA1NDE3ZWJhODFhMGYzNGFmMzU3Y2JfOC05LTEtMS00Mjc5Mg_0e66d66d-cafb-4f1b-aaee-aa81c71584e2"
      unitRef="usd">9359000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:InvestmentOwnedAtFairValue
      contextRef="if41dd7900bc54c728b2f679f78ab8cf8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM181Mi9mcmFnOmRiNzNlZjJjZDg0YzRhYzlhNDNiYTIzNmFkNTU3NDNiL3RhYmxlOjU1YzA1N2VlYjgwNTQxN2ViYTgxYTBmMzRhZjM1N2NiL3RhYmxlcmFuZ2U6NTVjMDU3ZWViODA1NDE3ZWJhODFhMGYzNGFmMzU3Y2JfOC0xMS0xLTEtNDI3OTI_cfbcb98f-f458-4b03-a303-4e8c07c67091"
      unitRef="usd">1413000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:MarketableSecurities
      contextRef="i51ae42d5ac59407da626249ef44365c7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM181Mi9mcmFnOmRiNzNlZjJjZDg0YzRhYzlhNDNiYTIzNmFkNTU3NDNiL3RhYmxlOjU1YzA1N2VlYjgwNTQxN2ViYTgxYTBmMzRhZjM1N2NiL3RhYmxlcmFuZ2U6NTVjMDU3ZWViODA1NDE3ZWJhODFhMGYzNGFmMzU3Y2JfMTEtMS0xLTEtNDI3OTI_f2c4b5b2-cd52-417c-80b6-4ce6d296ac3a"
      unitRef="usd">3880000</us-gaap:MarketableSecurities>
    <us-gaap:MarketableSecuritiesUnrealizedGainLoss
      contextRef="i89429fed7a924252aaa74342106dea93_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM181Mi9mcmFnOmRiNzNlZjJjZDg0YzRhYzlhNDNiYTIzNmFkNTU3NDNiL3RhYmxlOjU1YzA1N2VlYjgwNTQxN2ViYTgxYTBmMzRhZjM1N2NiL3RhYmxlcmFuZ2U6NTVjMDU3ZWViODA1NDE3ZWJhODFhMGYzNGFmMzU3Y2JfMTEtMy0xLTEtNDI3OTI_274ad5d2-eeac-4e63-a288-53103af5794e"
      unitRef="usd">9000</us-gaap:MarketableSecuritiesUnrealizedGainLoss>
    <us-gaap:InterestReceivable
      contextRef="i51ae42d5ac59407da626249ef44365c7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM181Mi9mcmFnOmRiNzNlZjJjZDg0YzRhYzlhNDNiYTIzNmFkNTU3NDNiL3RhYmxlOjU1YzA1N2VlYjgwNTQxN2ViYTgxYTBmMzRhZjM1N2NiL3RhYmxlcmFuZ2U6NTVjMDU3ZWViODA1NDE3ZWJhODFhMGYzNGFmMzU3Y2JfMTEtNS0xLTEtNDI3OTI_47f910b4-72f3-4caa-a139-e8b7e04c9f88"
      unitRef="usd">59000</us-gaap:InterestReceivable>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="i51ae42d5ac59407da626249ef44365c7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM181Mi9mcmFnOmRiNzNlZjJjZDg0YzRhYzlhNDNiYTIzNmFkNTU3NDNiL3RhYmxlOjU1YzA1N2VlYjgwNTQxN2ViYTgxYTBmMzRhZjM1N2NiL3RhYmxlcmFuZ2U6NTVjMDU3ZWViODA1NDE3ZWJhODFhMGYzNGFmMzU3Y2JfMTEtNy0xLTEtNDI3OTI_53056c29-04c7-4218-8780-d833a0d86afc"
      unitRef="usd">3948000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:InvestmentOwnedAtFairValue
      contextRef="i51ae42d5ac59407da626249ef44365c7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM181Mi9mcmFnOmRiNzNlZjJjZDg0YzRhYzlhNDNiYTIzNmFkNTU3NDNiL3RhYmxlOjU1YzA1N2VlYjgwNTQxN2ViYTgxYTBmMzRhZjM1N2NiL3RhYmxlcmFuZ2U6NTVjMDU3ZWViODA1NDE3ZWJhODFhMGYzNGFmMzU3Y2JfMTEtMTEtMS0xLTQyNzky_313517a9-8a31-46c3-91eb-e79567b2e846"
      unitRef="usd">3948000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:MarketableSecurities
      contextRef="i47f09f18839440ffae0cf05a475aa7fe_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM181Mi9mcmFnOmRiNzNlZjJjZDg0YzRhYzlhNDNiYTIzNmFkNTU3NDNiL3RhYmxlOjU1YzA1N2VlYjgwNTQxN2ViYTgxYTBmMzRhZjM1N2NiL3RhYmxlcmFuZ2U6NTVjMDU3ZWViODA1NDE3ZWJhODFhMGYzNGFmMzU3Y2JfMTMtMS0xLTEtNDI3OTI_94ccf7c7-1c45-4334-86c0-81c587e29245"
      unitRef="usd">109464000</us-gaap:MarketableSecurities>
    <us-gaap:MarketableSecuritiesUnrealizedGainLoss
      contextRef="ifaa46d08341a4f5db42a3cfd1e77e968_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM181Mi9mcmFnOmRiNzNlZjJjZDg0YzRhYzlhNDNiYTIzNmFkNTU3NDNiL3RhYmxlOjU1YzA1N2VlYjgwNTQxN2ViYTgxYTBmMzRhZjM1N2NiL3RhYmxlcmFuZ2U6NTVjMDU3ZWViODA1NDE3ZWJhODFhMGYzNGFmMzU3Y2JfMTMtMy0xLTEtNDI3OTI_7b96912b-f804-40fe-8b5a-5c80a24d6b1d"
      unitRef="usd">21000</us-gaap:MarketableSecuritiesUnrealizedGainLoss>
    <us-gaap:InterestReceivable
      contextRef="i47f09f18839440ffae0cf05a475aa7fe_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM181Mi9mcmFnOmRiNzNlZjJjZDg0YzRhYzlhNDNiYTIzNmFkNTU3NDNiL3RhYmxlOjU1YzA1N2VlYjgwNTQxN2ViYTgxYTBmMzRhZjM1N2NiL3RhYmxlcmFuZ2U6NTVjMDU3ZWViODA1NDE3ZWJhODFhMGYzNGFmMzU3Y2JfMTMtNS0xLTEtNDI3OTI_7625e43b-55db-4922-a15d-5e395a1582dc"
      unitRef="usd">59000</us-gaap:InterestReceivable>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="i47f09f18839440ffae0cf05a475aa7fe_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM181Mi9mcmFnOmRiNzNlZjJjZDg0YzRhYzlhNDNiYTIzNmFkNTU3NDNiL3RhYmxlOjU1YzA1N2VlYjgwNTQxN2ViYTgxYTBmMzRhZjM1N2NiL3RhYmxlcmFuZ2U6NTVjMDU3ZWViODA1NDE3ZWJhODFhMGYzNGFmMzU3Y2JfMTMtNy0xLTEtNDI3OTI_c48f4f76-1634-410d-a43b-c26fef844beb"
      unitRef="usd">109544000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i47f09f18839440ffae0cf05a475aa7fe_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM181Mi9mcmFnOmRiNzNlZjJjZDg0YzRhYzlhNDNiYTIzNmFkNTU3NDNiL3RhYmxlOjU1YzA1N2VlYjgwNTQxN2ViYTgxYTBmMzRhZjM1N2NiL3RhYmxlcmFuZ2U6NTVjMDU3ZWViODA1NDE3ZWJhODFhMGYzNGFmMzU3Y2JfMTMtOS0xLTEtNDI3OTI_14304120-dea1-4d52-9d65-123a2e001074"
      unitRef="usd">104183000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:InvestmentOwnedAtFairValue
      contextRef="i47f09f18839440ffae0cf05a475aa7fe_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM181Mi9mcmFnOmRiNzNlZjJjZDg0YzRhYzlhNDNiYTIzNmFkNTU3NDNiL3RhYmxlOjU1YzA1N2VlYjgwNTQxN2ViYTgxYTBmMzRhZjM1N2NiL3RhYmxlcmFuZ2U6NTVjMDU3ZWViODA1NDE3ZWJhODFhMGYzNGFmMzU3Y2JfMTMtMTEtMS0xLTQyNzky_07897d3b-4feb-4f28-b536-df8058aad6c9"
      unitRef="usd">5361000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:DebtAndEquitySecuritiesRealizedGainLoss
      contextRef="i2f3a96a832ab4b0ca374599d1c3e9bce_D20220701-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM181Mi9mcmFnOmRiNzNlZjJjZDg0YzRhYzlhNDNiYTIzNmFkNTU3NDNiL3RleHRyZWdpb246ZGI3M2VmMmNkODRjNGFjOWE0M2JhMjM2YWQ1NTc0M2JfMzI5ODUzNDg4NTUwNQ_dcabff13-a4e1-4a66-b2dd-f4217c20d8a6"
      unitRef="usd">0</us-gaap:DebtAndEquitySecuritiesRealizedGainLoss>
    <dei:DocumentPeriodEndDate
      contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM181Mi9mcmFnOmRiNzNlZjJjZDg0YzRhYzlhNDNiYTIzNmFkNTU3NDNiL3RleHRyZWdpb246ZGI3M2VmMmNkODRjNGFjOWE0M2JhMjM2YWQ1NTc0M2JfMTQ0OQ_75cfbe1e-17ec-4442-ae34-fd999dbe9ec2">2022-09-30</dei:DocumentPeriodEndDate>
    <us-gaap:DebtAndEquitySecuritiesRealizedGainLoss
      contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM181Mi9mcmFnOmRiNzNlZjJjZDg0YzRhYzlhNDNiYTIzNmFkNTU3NDNiL3RleHRyZWdpb246ZGI3M2VmMmNkODRjNGFjOWE0M2JhMjM2YWQ1NTc0M2JfMzI5ODUzNDg4NTUwNw_c9eb2a5e-85b5-4915-bc59-5f8484c1b5d6"
      unitRef="usd">-200000</us-gaap:DebtAndEquitySecuritiesRealizedGainLoss>
    <us-gaap:DebtAndEquitySecuritiesRealizedGainLoss
      contextRef="i3bb5592686d74afab4f7004818fd6f9b_D20210701-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM181Mi9mcmFnOmRiNzNlZjJjZDg0YzRhYzlhNDNiYTIzNmFkNTU3NDNiL3RleHRyZWdpb246ZGI3M2VmMmNkODRjNGFjOWE0M2JhMjM2YWQ1NTc0M2JfMTQ1Ng_0142c2a9-3775-4039-a0f6-ec597b132caa"
      unitRef="usd">0</us-gaap:DebtAndEquitySecuritiesRealizedGainLoss>
    <us-gaap:DebtAndEquitySecuritiesRealizedGainLoss
      contextRef="ic431430d1ab24120b4507025a722d73a_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM181Mi9mcmFnOmRiNzNlZjJjZDg0YzRhYzlhNDNiYTIzNmFkNTU3NDNiL3RleHRyZWdpb246ZGI3M2VmMmNkODRjNGFjOWE0M2JhMjM2YWQ1NTc0M2JfMTQ1Ng_2f7c2163-8175-4d65-86bd-655c417c4561"
      unitRef="usd">0</us-gaap:DebtAndEquitySecuritiesRealizedGainLoss>
    <us-gaap:DebtDisclosureTextBlock
      contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM181NS9mcmFnOjFjMWU2MTk4MjE1NzRmNmJiNjU5YmU0YTI1ODljMjRkL3RleHRyZWdpb246MWMxZTYxOTgyMTU3NGY2YmI2NTliZTRhMjU4OWMyNGRfMzQ0MA_dc1f7c99-e347-49f6-8226-748f36a04323">DEBT&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Credit Agreement&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;On April&#160;13, 2021, the Company and certain of its subsidiaries (collectively, the &#x201c;Guarantors&#x201d;) entered into a credit agreement (the &#x201c;Credit Agreement&#x201d;) among the Company, the Guarantors, the lenders party thereto and Citibank, N.A., in its capacity as administrative agent. On May&#160;31, 2022, the Credit Agreement was amended to increase the borrowing capacity and convert the interest rate to be based on Secured Overnight Financing Rate (&#x201c;SOFR&#x201d;), from London Inter-Bank Offered Rate (LIBOR) (the &#x201c;Amended Credit Agreement&#x201d;).  The Amended Credit Agreement provides for a $225.0 million senior secured revolving credit facility with a $20.0 million letter of credit sublimit. The Amended Credit Agreement also provides for an uncommitted incremental facility that permits the Company, subject to certain conditions, to increase the senior secured revolving credit facility by up to $100.0 million. The Amended Credit Agreement matures on April&#160;13, 2026.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s obligations under the Amended Credit Agreement are guaranteed by the Guarantors. The obligations of the Company and the Guarantors are secured by first-priority liens on substantially all of the assets of the Company and the Guarantors, subject to certain exceptions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under the Amended Credit Agreement, the Company will pay to the administrative agent for the account of each revolving lender a commitment fee on a quarterly basis based on amounts committed but unused under the revolving facility from 0.20% to 0.40% per annum depending on the Company&#x2019;s Total Net Leverage Ratio (as defined in the Amended Credit Agreement). The Company is also obligated to pay the administrative agent customary fees for credit facilities of this size and type.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revolving borrowings under the Amended Credit Agreement bear interest at a rate per annum equal to (i) the Term SOFR Rate for the interest period plus the Applicable Rate (as defined in the Amended Credit Agreement) based on the Company&#x2019;s Total Net Leverage Ratio or (ii) the Alternate Base Rate (as defined in the Amended Credit Agreement) as in effect from time to time plus the Applicable Rate based on the Company&#x2019;s Total Net Leverage Ratio. As of September&#160;30, 2022, the Applicable Rate for Term SOFR Loans is 1.25% per annum and the Applicable Rate for ABR Loans is 0.25% per annum. SOFR based loans also include a Credit Spread Adjustment based on the duration of the borrowing.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Amended Credit Agreement contains affirmative and negative covenants customarily applicable to senior secured credit facilities, including covenants that, among other things, limit or restrict the ability of the Company and its subsidiaries, subject to negotiated exceptions, to incur additional indebtedness and additional liens on their assets, engage in mergers or acquisitions or dispose of assets, pay dividends or make other distributions, voluntarily prepay other indebtedness, enter into transactions with affiliated persons, make investments and change the nature of their businesses. The Amended Credit Agreement also contains customary events of default, subject to thresholds and grace periods, including, among others, payment default, covenant default, cross default to other material indebtedness and judgment default. In addition, the Amended Credit Agreement requires the Company to maintain a Total Net Leverage Ratio of no more than 2.75 to 1.00 and an Interest Coverage Ratio of at least 3.50 to 1.00.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has no borrowings outstanding under the Amended Credit Agreement as of September&#160;30, 2022.&lt;/span&gt;&lt;/div&gt;</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="ib975abad8363400482246009fad4070e_I20220531"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM181NS9mcmFnOjFjMWU2MTk4MjE1NzRmNmJiNjU5YmU0YTI1ODljMjRkL3RleHRyZWdpb246MWMxZTYxOTgyMTU3NGY2YmI2NTliZTRhMjU4OWMyNGRfNTc3_96abdc8c-a3bb-4049-949e-31a99f5085e5"
      unitRef="usd">225000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i9f7c21a6e6a1463a8de2e4295c68b795_I20220531"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM181NS9mcmFnOjFjMWU2MTk4MjE1NzRmNmJiNjU5YmU0YTI1ODljMjRkL3RleHRyZWdpb246MWMxZTYxOTgyMTU3NGY2YmI2NTliZTRhMjU4OWMyNGRfNjI4_4a9ab666-e013-473a-9419-f67bdfcdf444"
      unitRef="usd">20000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <med:LineOfCreditFacilityAccordionFeatureIncreaseLimit
      contextRef="i9f7c21a6e6a1463a8de2e4295c68b795_I20220531"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM181NS9mcmFnOjFjMWU2MTk4MjE1NzRmNmJiNjU5YmU0YTI1ODljMjRkL3RleHRyZWdpb246MWMxZTYxOTgyMTU3NGY2YmI2NTliZTRhMjU4OWMyNGRfODY0_6a7958c4-5708-4e65-b62c-5ffbead9bc1d"
      unitRef="usd">100000000</med:LineOfCreditFacilityAccordionFeatureIncreaseLimit>
    <us-gaap:LineOfCreditFacilityCommitmentFeePercentage
      contextRef="ibea5baeea8b840488104a7e63ceeb4bc_D20220531-20220531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM181NS9mcmFnOjFjMWU2MTk4MjE1NzRmNmJiNjU5YmU0YTI1ODljMjRkL3RleHRyZWdpb246MWMxZTYxOTgyMTU3NGY2YmI2NTliZTRhMjU4OWMyNGRfMTQzMA_6e560b9b-6f9d-4ff3-b239-3cb3a9a4a998"
      unitRef="number">0.0020</us-gaap:LineOfCreditFacilityCommitmentFeePercentage>
    <us-gaap:LineOfCreditFacilityCommitmentFeePercentage
      contextRef="ie586fdb4b2b04c1f83bcdaff0af594c8_D20220531-20220531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM181NS9mcmFnOjFjMWU2MTk4MjE1NzRmNmJiNjU5YmU0YTI1ODljMjRkL3RleHRyZWdpb246MWMxZTYxOTgyMTU3NGY2YmI2NTliZTRhMjU4OWMyNGRfMTQzNg_47a9f450-7e3f-4d14-9413-b92abec89790"
      unitRef="number">0.0040</us-gaap:LineOfCreditFacilityCommitmentFeePercentage>
    <dei:DocumentPeriodEndDate
      contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM181NS9mcmFnOjFjMWU2MTk4MjE1NzRmNmJiNjU5YmU0YTI1ODljMjRkL3RleHRyZWdpb246MWMxZTYxOTgyMTU3NGY2YmI2NTliZTRhMjU4OWMyNGRfMjEyMQ_75cfbe1e-17ec-4442-ae34-fd999dbe9ec2">2022-09-30</dei:DocumentPeriodEndDate>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i56c008dd01b046dda5a8ab4c98daf9d7_D20220101-20220930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM181NS9mcmFnOjFjMWU2MTk4MjE1NzRmNmJiNjU5YmU0YTI1ODljMjRkL3RleHRyZWdpb246MWMxZTYxOTgyMTU3NGY2YmI2NTliZTRhMjU4OWMyNGRfMjE2OA_7ba55af0-07d4-4805-83d5-c0f2a3b7799f"
      unitRef="number">0.0125</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i761b85a615a044a28a135126fe49dca4_D20220101-20220930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM181NS9mcmFnOjFjMWU2MTk4MjE1NzRmNmJiNjU5YmU0YTI1ODljMjRkL3RleHRyZWdpb246MWMxZTYxOTgyMTU3NGY2YmI2NTliZTRhMjU4OWMyNGRfMjIyMg_14a88f9a-26bc-463f-9cb3-189371a38f68"
      unitRef="number">0.0025</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <med:MaximumTotalNetLeverageRatio
      contextRef="i1572f54925ef49918ea7d21b949a4e18_I20220531"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM181NS9mcmFnOjFjMWU2MTk4MjE1NzRmNmJiNjU5YmU0YTI1ODljMjRkL3RleHRyZWdpb246MWMxZTYxOTgyMTU3NGY2YmI2NTliZTRhMjU4OWMyNGRfMzI4OQ_91b7c93a-6e36-4377-9795-bc6baaa7b46b"
      unitRef="number">2.75</med:MaximumTotalNetLeverageRatio>
    <med:MinimumInterestCoverageRatio
      contextRef="i1572f54925ef49918ea7d21b949a4e18_I20220531"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM181NS9mcmFnOjFjMWU2MTk4MjE1NzRmNmJiNjU5YmU0YTI1ODljMjRkL3RleHRyZWdpb246MWMxZTYxOTgyMTU3NGY2YmI2NTliZTRhMjU4OWMyNGRfMzM0MQ_6c4d6410-814b-48a4-8b29-ea3d1d0af64e"
      unitRef="number">3.50</med:MinimumInterestCoverageRatio>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i116efaf8269843e38b3d65a462979897_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM181NS9mcmFnOjFjMWU2MTk4MjE1NzRmNmJiNjU5YmU0YTI1ODljMjRkL3RleHRyZWdpb246MWMxZTYxOTgyMTU3NGY2YmI2NTliZTRhMjU4OWMyNGRfMzI5ODUzNDg4Njc3Ng_e5afd223-f776-4519-8f78-8a4357d31ef9"
      unitRef="usd">0</us-gaap:DebtInstrumentCarryingAmount>
    <dei:DocumentPeriodEndDate
      contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM181NS9mcmFnOjFjMWU2MTk4MjE1NzRmNmJiNjU5YmU0YTI1ODljMjRkL3RleHRyZWdpb246MWMxZTYxOTgyMTU3NGY2YmI2NTliZTRhMjU4OWMyNGRfMzQzNw_75cfbe1e-17ec-4442-ae34-fd999dbe9ec2">2022-09-30</dei:DocumentPeriodEndDate>
    <us-gaap:RepurchaseAgreementsResaleAgreementsSecuritiesBorrowedAndSecuritiesLoanedDisclosureTextBlock
      contextRef="ia2bf050e1630451bb448780754fc1e01_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM181OC9mcmFnOjZjOWI1YzJiNDVmMjQ5ZmZhM2QzZjQ1NTRlZWM5NWU0L3RleHRyZWdpb246NmM5YjVjMmI0NWYyNDlmZmEzZDNmNDU1NGVlYzk1ZTRfMTA0OQ_39cb802d-3e10-4570-b7f8-7894bad1cd36">ACCELERATED SHARE REPURCHASE (&#x201c;ASR&#x201d;) PROGRAMIn the second quarter of fiscal 2022, the Company entered into an ASR agreement with JPMorgan Chase, National Association ("JPMorgan Chase") to purchase shares of its common stock from JPMorgan Chase for an aggregate purchase price of $100.0&#160;million. Pursuant to the ASR program, the Company received an initial delivery of approximately 480&#160;thousand shares of common stock based on the closing price of the common stock on May 31, 2022. Approximately 91&#160;thousand additional shares of the Company's common stock were delivered upon termination of the agreement on August 8, 2022. The final number of shares delivered to the Company under the ASR agreement was based on the average of the daily volume-weighted average trading prices of the Company&#x2019;s common stock during the term of the ASR program, less a discount.</us-gaap:RepurchaseAgreementsResaleAgreementsSecuritiesBorrowedAndSecuritiesLoanedDisclosureTextBlock>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1
      contextRef="i9c92e926af9e4d908021e1a185782db8_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM181OC9mcmFnOjZjOWI1YzJiNDVmMjQ5ZmZhM2QzZjQ1NTRlZWM5NWU0L3RleHRyZWdpb246NmM5YjVjMmI0NWYyNDlmZmEzZDNmNDU1NGVlYzk1ZTRfMjg4_0a1dc973-1ebf-4670-a956-d2515ed00358"
      unitRef="usd">100000000</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i0b400b25989d44b2afb02aff99c3fc41_D20220531-20220531"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM181OC9mcmFnOjZjOWI1YzJiNDVmMjQ5ZmZhM2QzZjQ1NTRlZWM5NWU0L3RleHRyZWdpb246NmM5YjVjMmI0NWYyNDlmZmEzZDNmNDU1NGVlYzk1ZTRfMzc5_105fe2f2-fb07-4021-a9c9-e5c3431e5ca3"
      unitRef="shares">480000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i614062ec1b3741b0a8c6fc4b23ffa70c_D20220808-20220808"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM4YWU0MTNiM2ZmMzRkNTY5NzY1MDJjNTg1ZmE2YWIzL3NlYzpjOGFlNDEzYjNmZjM0ZDU2OTc2NTAyYzU4NWZhNmFiM181OC9mcmFnOjZjOWI1YzJiNDVmMjQ5ZmZhM2QzZjQ1NTRlZWM5NWU0L3RleHRyZWdpb246NmM5YjVjMmI0NWYyNDlmZmEzZDNmNDU1NGVlYzk1ZTRfNzY5NjU4MTM5NTk5OQ_57b8da93-a2c2-4df8-89f3-c77d1410e30e"
      unitRef="shares">91000</us-gaap:TreasuryStockSharesAcquired>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>49
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M?P%*DEP6\2C4FF>0]\J3R!I/8M^P\?8!HA*U0<JU+-N,V]OC]EIQSX5B\0]
M]&J+4^H[GGV"L2YF8==S73-(?P_2?\>Y0/29>H6-CYF&";[5QWQ3A.L92J%
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M4B(I'M><@=>U 'Q?":'>!OJ^<7^_//@?4$L#!!0    ( '2&8U5+B% :O@(
M &0'   8    >&PO=V]R:W-H965T<R]S:&5E=#4N>&ULK95=3]LP%(;_BI5-
M$TBL^>C'@+612EL$$H.*LNUBVH6;G#863IS93@O[]3MVTJCM AW2;A+;.>^;
MYYPXQ_VUD(\J =#D*>69&CB)UOFYZZHH@92JEL@APR<+(5.J<2J7KLHET-B*
M4NX&GM=S4\HR)^S;M:D,^Z+0G&4PE405:4KE\P5PL1XXOK-9N&?+1)L%-^SG
M= DST%_SJ<296[O$+(5,,9$1"8N!,_3/1ST3;P.^,5BKK3$QF<R%>#23ZWC@
M> 8(.$3:.%"\K6 $G!LCQ/A5>3KU*XUP>[QQO[2Y8RYSJF D^'<6ZV3@G#HD
MA@4MN+X7ZRNH\ND:OTAP9:]D7<5Z#HD*I45:B9$@95EYIT]5';8$?N<%05 )
M@G\5M"M!VR9:DMFTQE33L"_%FD@3C6YF8&MCU9@-R\Q7G&F)3QGJ=#BZNQU/
M;F>3,<'1[.[F>CQ\P,G%\&9X.YJ0V=5D\C C1U,J(=,):!91?DP^DO?$)2K!
M5;6YL8P\)*)0-(M5W]7(9M[@1A7'1<D1O, Q@[Q%VMX)";P@:)"/7I>/(4*Y
M;^7^KMS%BM1E">JR!-:O_1*.IAIPLVHB%N22932+&.5D*A2SN^_'<*ZTQ#WX
MLRG5TKO3[&W^RW.5TP@&#OYX"N0*G/##.[_G?6Y*_#^9[92A79>A_9I[.!)I
MBMGB+HP>3TA.)5E17@ YPH\="\ZI5"0'66Z!XZ92E/ZGUM]TE%7HM3P//]%J
M.\=#43OPG1J^\P;X:I?20B="LM\0VR3*U4;RTKR[Q82=T?/VR ]%[9!W:_+N
M&\B94L5AW.Y?(+YW%ISMX39$^=VS3C-NK\;MO0$7CPJEL0FP;'F(N=?(?+K'
MW!"%S.T]9G>K!YKSYPN52Y8IPF&!.J_U"0UDV=/+B1:Y;8MSH;')VF&"QR!(
M$X#/%T+HS<1TVOI@#?\ 4$L#!!0    ( '2&8U5ZV>,NT@8  % <   8
M>&PO=V]R:W-H965T<R]S:&5E=#8N>&ULK5EM<YLX$/XK&E_GIIVI:R3QYESB
M&<=.IIEIDTR=7#\K(-NZ J* \W*__E9 P :AM#?^$@-9+<^N=O?91:=/,ON1
M;SDOT',<)?G9:%L4Z<EDD@=;'K/\DTQY O]9RRQF!=QFFTF>9IR%Y:(XFA#+
M<B<Q$\EH=EH^N\UFIW)71"+AMQG*=W',LI=S'LFGLQ$>O3[X)C;;0CV8S$Y3
MMN$K7MRGMQG<31HMH8AYD@N9H(ROST9S?+*@MEI02OPM^%.^=XV4*0]2_E W
M5^'9R%*(>,2#0JE@\//(%SR*E"; \;-6.FK>J1;N7[]JORR-!V,>6,X7,OHN
MPF)[-O)'*.1KMHN*;_+I,Z\-<I2^0$9Y^1<]U;+6" 6[O)!QO1@0Q"*I?MES
M[8B]!:!'OX#4"TAW@3VP@-8+:&EHA:PT:\D*-CO-Y!/*E#1H4Q>E;\K58(U(
MU#:NB@S^*V!=,5O<7"\OKE<72P17JYLO5\OY'=RL[N#GZ\7UW0K=7*+%?/49
M77ZY^;Y"[^^OY_?+*Y#Y@,;H?K5$[]]]0.^02-#=5NYREH3YZ:0 9$K_)*A1
MG%<HR "**?HJDV*;HXLDY.'A^@E8U)A%7LTZ)T:%*YY^0M3ZB(A%B ;/XM>7
M8P,<VGB9EOKH@+Z;E&>L$,D&S578BD)PK9<J+;9>B\KHDSQE 3\;0<KF/'OD
MH]F??V#7^DMGXI&4'1AL-P;;)NVS:RA (@EDS'5F5FO=<JVJ,X\SC#W+L4XG
MC_L&:,2H95E^(W8 S6F@.<:]F(?_0%I!)2IR5$@H18%, A%QE#28U?. Y5N4
M9O)10$2BAQ<DFSUDQCUTCKF'1U)VX"BW<91KW,,E!Z6!8%6Y34+$8ID5XM_R
M@<[R2IVSMU^^1=S.IO:%J.=Z^BWU&J2>.=ID,B[W*^)0T1%_!I++M9'G]=YN
M>W8W[OI"U!F*.K^!Z!LAKK8LXV-%."&"$%, !_WH]_V(+=H!V1=R74SU(*<-
MR*D1Y'QO@Y%<0_CS6.QB!'<B>>15UJ"<![ML,/RG/5S8[D#OBWB6'CBV6AJS
MW@C6-<\R<.YK!K-G/;Y:S_[;Q]BSNV&J$1O"N$>UV%AY%EN6;+BBRKU:DN<<
M"I%*KTBP!Q&5CCW1(L?'K"S'TG;H"]+Z@ACWZPKB*2ED-A!%]>J#'+0]MQM)
M&K&QYQ)%^=JM:OD:&]D1X+51]%'E0<I$J 5*^\$\=;HP^T)#P=02+#8S[&V%
MZ;7852$DBRW/H&V$3(!$K6)+B]KN9ZGO3[NP^U)CQYK: ]!; L9&VIK=E"@-
MZ)S^>WW'[GE5(T;I=* &XI;VL)GWYD$@=ZH[2-D+>X#&H.2^(,AVO'6W%G>?
MV\80BT[/KWTYFWCV  GBE@7Q&S0(#4Q)@VL8SOY7[X+[U(=MXE/<M4 C9\'D
M.!0:+4MBWU@BKTJ:>;M1QD:V_>U:>"1MAT:WK(O-M+MB=9#!5%HSJV+?7Z9<
MW"=4A^SU5+61&BF\EU2'<U9+O,1,O+>[+-BJKJOL%U2@%2^E,?SG3J0*O0XR
MT;"PY^(N9IT8))0_A+JE8F*DMTZJ[/*R<:@]_G::U,H/8='>_*(3@U;#'JC]
MI"5/0HQ9<BD2!C/+FUE"C!S\NUER+&V'1K>43,R4?).JMC2'"LRS0.1588.;
M8*<^!%7\%PJ86*"KT'O#Q,*UB7T1'^.![6JIFKP]#.>J_\]AVDSK? G16F;#
M;2K1<"]VK&X#I!7SA^8ITE(T,5/T0N5&*!2!)*%B0N@T8"C."QG\V,HHY ,N
MUE"R0]VIWX6MD;-=?[ :M=Q-S-R]4@#WO*Q'J>%IK-BK!U,C:+N6-93 +5.3
MWV'JU_*S;M+ZC?+39U^H*P[I%R"-X)1.K:&(;FF:F*?92YEQL4GJ3C-X02*&
MS-=7^OZ@2J;=:4LCA.F0EUM>)69>7?(@*S\(@&]+;ZL245XH;GH$UDWT#2CI
M4^68VK;7G<%U<E-B#60?;3F5FCEU,006C=$#WX@D44$"A N-- +&%5([F] ^
M>V++QG[7#)V<2STRT$G3EF6IF65-=G UKJQ-Z/OLZ4X]W(UQC1B&60&[ ^!;
MDJ5FDEWMTC3BJH%A$93"/(ADOLO*/J=-79%4)RG 3-J9G1Z5@8^E[= C>Q^Q
M?WTH1D,#,>U3* QE5C?C-6(VI/S X$Y;KJ5FKETVG!7R(&+U%Z%H%U8EEG5F
M.ZT%FN_.4#6[XZ=.S*-.M[9.]LYF8IYMRB.K')4PJO.,YFES+#8O#X,ZS\_Q
MR:(ZW&K55&=M7UD&-2%'$5^#2NN3!U[-JN.KZJ:0:7D"]""+0L;EY98S('$E
M /]?2UF\WJ@7-(>(L_\ 4$L#!!0    ( '2&8U7LXIM$1Q(  *G1   8
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MQJJ>S9*V([X/EJLV^+*]?#=M.V^FI&>($[?B,+1?4#KBC?O.WI35*,OME(:
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M<^6V0/?_'U:K]N[+1<?_O%K_MK-Q^7]02P,$%     @ =(9C59:'[V=D!@
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M [+=U=X-O&GB=;HT'I=S_*SP-\0V;, Z'.6W@W# [O]J\0]02P,$%     @
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MVS86_2L8U=M)9F1:)"5:2FS/V$G:YB&))T[3AYU]@$A(XIHD% "TK/WU>RY
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MEN[;,)VK3-8-D<U=U>E5:DKGNNFN&G:W:NST5(?OMPK7=\SZ6\H8X\E_2YN
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MF=OA0G#T[S0!O\^D-/4#;=#\%X2K_P-02P,$%     @ =(9C53[XD:TE!0
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M8UKVJ*P!?5]):?:"#5#]/KI_ 5!+ P04    " !TAF-5[HO(SFH%   L#0
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ME_0Y@Y8%:+\P=*LT$S;0?B!-_P%02P,$%     @ =(9C5=QL!4\+!P  EQ(
M !D   !X;"]W;W)K<VAE971S+W-H965T,34N>&ULG5A=<]LV%OTK&+7;<694
MBJ+M)$ULSTA.LYN9I,[8:?>ATP>0A"0D(,  H!7MK]]S 9*B5,EV^F+SXW[?
M<P^N>+$V]HM;">'9MTII=SE:>5^_FDQ<L1(5=XFIA<:;A;$5][BURXFKK>!E
M4*K4)$O3YY.*2SVZN@C//MJK"]-X);7X:)EKJHK;S5PHL[X<34?=@UNY7'EZ
M,+FZJ/E2W G_>_W1XF[26REE);231C,K%I>CV?35_(SD@\ ?4JS=X)I1)KDQ
M7^CF77DY2BD@H43AR0+'OWMQ+90B0PCC:VMSU+LDQ>%U9_UMR!VYY-R):Z/^
M*TN_NAR]'+%2+'BC_*U9_T>T^9R3O<(H%_ZR=93-7HQ8T3AOJE89$512Q__\
M6UN'@<++](A"UBID(>[H*$3YAGM^=6'-FEF2AC6Z"*D&;00G-37ESEN\E=#S
M5V]^G7^ZF'A8HOM)T6K-HU9V1.L7]L%HOW+L5UV*<E=_@@CZ,+(NC'GVH,$[
M42?L-!VS+,VR!^R=]FF=!GNGQ](2N6=OI"N4<8T5[,]9[KP%!/XZE&RT=7;8
M%HW%*U?S0ER.@'LG[+T87?WTP_1Y^OJ!2,_Z2,\>LGZT 8]KL6LK2NG9;&F%
MP)QX=J/9K+92L>EIJ.1TS/Q*L&M3U5QO&-<E*X3U&%5F%DQZAUG,G2PEMU(X
M=@(PA6FY%VH357_ZX666I:__W7#+M3?6A0?3U\\8_ GX9Q*/&6=%C(7WL9P,
MU/<#[8WPRNCE,,;H=>LNWBL!F%G':F[]AIY804Z1SK7T,N?ZRYC]ELR2,:()
M:14<_9*0Y8[Q$F,CJ?N4&")$  F5Z@/?L--IA%Q;J/V"KDF_(N\E@T>ID28H
M( CGQJ+5$O%OO5&!C;Y'C8.(##5RGL&W( .Y"!12,O#1G2@:*N -Q#5Q!WLK
M-=<%6;PE^9.V>G<W;V^[BHW9PIJ*O3>ZA(EW9/_G.?)G-XM%:$?4?/]N?G/[
M;*<'LS:-8[U(V"<('Y-BM37WL@1(< Z@W3]FV7F2@I"4(FYU0DL\=VU*5MP;
M=1]*$^TL4!]%%5I+OPKJZ4!;"8\\")*M.%"I9"7](S%QY<Q>8)HUNC 5='W
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M;XKPF('+R?(![,\-Z+A>L(+VIYW3?P%02P,$%     @ =(9C543?\&F[ @
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M+W-H965T,C$N>&ULC5;;;MLX$/V5@5IT$T"-+K[&M0TDV11;H-D&=;9]*/I
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M<VAE971S+W-H965T,C(N>&ULC55M;]HP$/XKIVRJ6@DU+]"N4$ "RE2DOJE
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M./]VX8&NYE1E6)67LV&A+$V:<IG2:$?M'.A\J93],!Q!_;/H_P502P,$%
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M=0//NW1+3)B3Q%:W$$G,:T4)@X5 LBY++'Y/@?)F[/C.3K$DFT(9A9O$%=[
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MENOV!M0.2Z;3K4RGWH9=+Y><+HFD:H1+GBE#DZ 'DJ^'B%)'F'7&3J!6!GN
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M;:(^1H!K _7_DC&Y&^@%JL^;\']02P,$%     @ =(9C5:B ^-:> P  '@T
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M7=& )UI?G,ULTW@GOM\\FI]20Z[[YV^8NIM_8'K%R9X"EP09G0W)7;KND/7
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MOQVV6>C7&H19H.<7G*MMQSP@[?N?_0%02P,$%     @ =(9C5;\+.'2/!
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M$'@:<013 !HP)([M>W#G?12MWE/1^O][H]]02P,$%     @ =(9C59>*NQS
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M81HE!J0'0'IGA/SD&9 ^ .F?!?(AF 1)&"$#\@J O#HCY$$DKP'(ZW-VMV]
MW@"0-^>$O#(@;P'(6[N0V6(Z#=*/:#9"6?R8Q*,X#)(<!6$X6R1Y;$"^!2#?
MVH6,DV64Y+,TCC(#Z X NK,+% 5I$B>/&9I'*<K&01J9N;H/)>N^Y?YL8"X?
M@F[83>=Z  9Y/#/3M O*Q+)-)I%&,WO1A:SA6M:&'N:+Z6+2SLM9/M:=V<0L
MC<8Z;/'RH%,A;[B6Q3&*$YU\XV""XB3+TX76;GX00\@7KF5A#*.'W&2!M.!:
M]H+NSV@2I5V>;68"2J/Y(@W'>M"ABU=?:Z[>F:R0'5S+>@ S[X%H7<@/KF5!
M&+D77>@O94;D:Y,-TH)KV0M_IN&CB) H7,NF.)6/?X*:7\^0-CS+VNC2\K'H
M>9 M/,NV //SP1SQP,6'98T<S<]'@PE9Q+-LD8.9/"0*4W8(!UG$LVR1(U/Y
M$H6\W-:J:6QB0H+Q+ OF*&:"A<#-1H*YA/,@MWBVW7(JZW2P)B;D%L_VXN,T
M9J9X86)"FO$L:P; 3(E4)B:D&N]<JM'1K,O2W .!5./_']68T^98-O(A[_C_
M9972!FZ[9:1IC1D*L=R@$>,[$Q/RCF_9.[\P1[6J!4'39O.T+M&$8$E0:&*"
MVUZ6Q0-;W-RM\2$%^985=-SBEUVWX\K$A!3D6U;0*<R?T\G$A!3D6U90LRS\
M^R2'[.-;M@^X6#S<,X;LX[?VZ>W_":S(FE9DE>A'2%U?8%;,!6H.W6['U76S
M'EG7C(6Z;E9-.%[M?S'L?X]\^ %02P,$%     @ =(9C5;>]PDN! 0  *1<
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M2=8/K9=__9^X79-:E<W!GW4_XV=?4$L! A0#%     @ =(9C50=!36*!
ML0   !               ( !     &1O8U!R;W!S+V%P<"YX;6Q02P$"% ,4
M    " !TAF-5(#45$>X    K @  $0              @ &O    9&]C4')O
M<',O8V]R92YX;6Q02P$"% ,4    " !TAF-5F5R<(Q &  "<)P  $P
M        @ ', 0  >&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0    ( '2&
M8U5=*AE6Q 4  ,0>   8              " @0T(  !X;"]W;W)K<VAE971S
M+W-H965T,2YX;6Q02P$"% ,4    " !TAF-5ZT! *R,&  #R'   &
M        @($'#@  >&PO=V]R:W-H965T<R]S:&5E=#(N>&UL4$L! A0#%
M  @ =(9C5>P_V9^X P  ;@T  !@              ("!8!0  'AL+W=O<FMS
M:&5E=',O<VAE970S+GAM;%!+ 0(4 Q0    ( '2&8U6NJ?/,_04  &L6   8
M              " @4X8  !X;"]W;W)K<VAE971S+W-H965T-"YX;6Q02P$"
M% ,4    " !TAF-52XA0&KX"  !D!P  &               @(&!'@  >&PO
M=V]R:W-H965T<R]S:&5E=#4N>&UL4$L! A0#%     @ =(9C57K9XR[2!@
M4!P  !@              ("!=2$  'AL+W=O<FMS:&5E=',O<VAE970V+GAM
M;%!+ 0(4 Q0    ( '2&8U7LXIM$1Q(  *G1   8              " @7TH
M  !X;"]W;W)K<VAE971S+W-H965T-RYX;6Q02P$"% ,4    " !TAF-5EH?O
M9V0&  #>#P  &               @('Z.@  >&PO=V]R:W-H965T<R]S:&5E
M=#@N>&UL4$L! A0#%     @ =(9C50CW<LE\!   :PD  !@
M ("!E$$  'AL+W=O<FMS:&5E=',O<VAE970Y+GAM;%!+ 0(4 Q0    ( '2&
M8U7W-XIH*@0  &H*   9              " @49&  !X;"]W;W)K<VAE971S
M+W-H965T,3 N>&UL4$L! A0#%     @ =(9C5=*;HACS"0  CB   !D
M         ("!ITH  'AL+W=O<FMS:&5E=',O<VAE970Q,2YX;6Q02P$"% ,4
M    " !TAF-5/OB1K24%  "8#   &0              @('15   >&PO=V]R
M:W-H965T<R]S:&5E=#$R+GAM;%!+ 0(4 Q0    ( '2&8U4XY>U>V0(  $H&
M   9              " @2U:  !X;"]W;W)K<VAE971S+W-H965T,3,N>&UL
M4$L! A0#%     @ =(9C5>Z+R,YJ!0  + T  !D              ("!/5T
M 'AL+W=O<FMS:&5E=',O<VAE970Q-"YX;6Q02P$"% ,4    " !TAF-5W&P%
M3PL'  "7$@  &0              @('>8@  >&PO=V]R:W-H965T<R]S:&5E
M=#$U+GAM;%!+ 0(4 Q0    ( '2&8U7HT4LXF ,  #,(   9
M  " @2!J  !X;"]W;W)K<VAE971S+W-H965T,38N>&UL4$L! A0#%     @
M=(9C5>WG@&BI!@  YA$  !D              ("![VT  'AL+W=O<FMS:&5E
M=',O<VAE970Q-RYX;6Q02P$"% ,4    " !TAF-51-_P:;L"  "W!0  &0
M            @('/=   >&PO=V]R:W-H965T<R]S:&5E=#$X+GAM;%!+ 0(4
M Q0    ( '2&8U6Y$DMQ1 ,  "D'   9              " @<%W  !X;"]W
M;W)K<VAE971S+W-H965T,3DN>&UL4$L! A0#%     @ =(9C581/:+ZT!
M@@X  !D              ("!/'L  'AL+W=O<FMS:&5E=',O<VAE970R,"YX
M;6Q02P$"% ,4    " !TAF-58R-],H #  !*"   &0              @($G
M@   >&PO=V]R:W-H965T<R]S:&5E=#(Q+GAM;%!+ 0(4 Q0    ( '2&8U41
ME1-!Y (  #@&   9              " @=Z#  !X;"]W;W)K<VAE971S+W-H
M965T,C(N>&UL4$L! A0#%     @ =(9C5<-YW'NN P  SP@  !D
M     ("!^88  'AL+W=O<FMS:&5E=',O<VAE970R,RYX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( '2&8U77% %V= ,  .H,   9              "
M@:B>  !X;"]W;W)K<VAE971S+W-H965T,C@N>&UL4$L! A0#%     @ =(9C
M5:B ^-:> P  '@T  !D              ("!4Z(  'AL+W=O<FMS:&5E=',O
M<VAE970R.2YX;6Q02P$"% ,4    " !TAF-5"^(>7DX%  !:(P  &0
M        @($HI@  >&PO=V]R:W-H965T<R]S:&5E=#,P+GAM;%!+ 0(4 Q0
M   ( '2&8U76:=9._@,  ) :   9              " @:VK  !X;"]W;W)K
M<VAE971S+W-H965T,S$N>&UL4$L! A0#%     @ =(9C5:\UY?0C P  L@@
M !D              ("!XJ\  'AL+W=O<FMS:&5E=',O<VAE970S,BYX;6Q0
M2P$"% ,4    " !TAF-5>UY.H>T"   +"   &0              @($\LP
M>&PO=V]R:W-H965T<R]S:&5E=#,S+GAM;%!+ 0(4 Q0    ( '2&8U6_"SAT
MCP0  ( B   9              " @6"V  !X;"]W;W)K<VAE971S+W-H965T
M,S0N>&UL4$L! A0#%     @ =(9C57D(;(7-!0  LR(  !D
M ("!)KL  'AL+W=O<FMS:&5E=',O<VAE970S-2YX;6Q02P$"% ,4    " !T
MAF-5Y#2(4IH"  #(!P  &0              @($JP0  >&PO=V]R:W-H965T
M<R]S:&5E=#,V+GAM;%!+ 0(4 Q0    ( '2&8U5&8C5J;00  +X8   9
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M  !X;"]W;W)K8F]O:RYX;6Q02P$"% ,4    " !TAF-5M[W"2X$!   I%P
M&@              @ &+TP  >&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-0
M2P$"% ,4    " !TAF-58]:*%)L!  "4%P  $P              @ %$U0
I6T-O;G1E;G1?5'EP97-=+GAM;%!+!08     +@ N 'D,   0UP     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.2.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>154</ContextCount>
  <ElementCount>205</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>32</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>4</UnitCount>
  <MyReports>
    <Report instance="med-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medifast1.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="med-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>0000002 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF INCOME (UNAUDITED)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEUNAUDITED</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF INCOME (UNAUDITED)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="med-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>0000003 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (UNAUDITED)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUNAUDITED</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (UNAUDITED)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="med-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>0000004 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED</Role>
      <ShortName>CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="med-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>0000005 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical</Role>
      <ShortName>CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="med-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>0000006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="med-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>0000007 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (UNAUDITED)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYUNAUDITED</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (UNAUDITED)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="med-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>0000008 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medifast1.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="med-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>0000009 - Disclosure - INVENTORIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medifast1.com/role/INVENTORIES</Role>
      <ShortName>INVENTORIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="med-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>0000010 - Disclosure - EARNINGS PER SHARE</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medifast1.com/role/EARNINGSPERSHARE</Role>
      <ShortName>EARNINGS PER SHARE</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="med-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>0000011 - Disclosure - SHARE-BASED COMPENSATION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medifast1.com/role/SHAREBASEDCOMPENSATION</Role>
      <ShortName>SHARE-BASED COMPENSATION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="med-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>0000012 - Disclosure - LEASES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medifast1.com/role/LEASES</Role>
      <ShortName>LEASES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="med-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>0000013 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE INCOME</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medifast1.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOME</Role>
      <ShortName>ACCUMULATED OTHER COMPREHENSIVE INCOME</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="med-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>0000014 - Disclosure - FINANCIAL INSTRUMENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medifast1.com/role/FINANCIALINSTRUMENTS</Role>
      <ShortName>FINANCIAL INSTRUMENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="med-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>0000015 - Disclosure - DEBT</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medifast1.com/role/DEBT</Role>
      <ShortName>DEBT</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="med-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>0000016 - Disclosure - ACCELERATED SHARE REPURCHASE ("ASR") PROGRAM</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medifast1.com/role/ACCELERATEDSHAREREPURCHASEASRPROGRAM</Role>
      <ShortName>ACCELERATED SHARE REPURCHASE ("ASR") PROGRAM</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="med-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>0000017 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medifast1.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="med-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>0000018 - Disclosure - INVENTORIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medifast1.com/role/INVENTORIESTables</Role>
      <ShortName>INVENTORIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.medifast1.com/role/INVENTORIES</ParentRole>
      <Position>18</Position>
    </Report>
    <Report instance="med-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>0000019 - Disclosure - EARNINGS PER SHARE (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medifast1.com/role/EARNINGSPERSHARETables</Role>
      <ShortName>EARNINGS PER SHARE (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.medifast1.com/role/EARNINGSPERSHARE</ParentRole>
      <Position>19</Position>
    </Report>
    <Report instance="med-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>0000020 - Disclosure - SHARE-BASED COMPENSATION (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONTables</Role>
      <ShortName>SHARE-BASED COMPENSATION (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.medifast1.com/role/SHAREBASEDCOMPENSATION</ParentRole>
      <Position>20</Position>
    </Report>
    <Report instance="med-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>0000021 - Disclosure - LEASES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medifast1.com/role/LEASESTables</Role>
      <ShortName>LEASES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.medifast1.com/role/LEASES</ParentRole>
      <Position>21</Position>
    </Report>
    <Report instance="med-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>0000022 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE INCOME (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medifast1.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMETables</Role>
      <ShortName>ACCUMULATED OTHER COMPREHENSIVE INCOME (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.medifast1.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOME</ParentRole>
      <Position>22</Position>
    </Report>
    <Report instance="med-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>0000023 - Disclosure - FINANCIAL INSTRUMENTS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medifast1.com/role/FINANCIALINSTRUMENTSTables</Role>
      <ShortName>FINANCIAL INSTRUMENTS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.medifast1.com/role/FINANCIALINSTRUMENTS</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="med-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>0000024 - Disclosure - INVENTORIES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medifast1.com/role/INVENTORIESDetails</Role>
      <ShortName>INVENTORIES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.medifast1.com/role/INVENTORIESTables</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="med-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>0000025 - Disclosure - EARNINGS PER SHARE - Computation of Basic and Diluted EPS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medifast1.com/role/EARNINGSPERSHAREComputationofBasicandDilutedEPSDetails</Role>
      <ShortName>EARNINGS PER SHARE - Computation of Basic and Diluted EPS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="med-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>0000026 - Disclosure - EARNINGS PER SHARE - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medifast1.com/role/EARNINGSPERSHARENarrativeDetails</Role>
      <ShortName>EARNINGS PER SHARE - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>26</Position>
    </Report>
    <Report instance="med-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>0000027 - Disclosure - SHARE-BASED COMPENSATION - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails</Role>
      <ShortName>SHARE-BASED COMPENSATION - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>27</Position>
    </Report>
    <Report instance="med-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>0000028 - Disclosure - SHARE-BASED COMPENSATION - Stock Options Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONStockOptionsActivityDetails</Role>
      <ShortName>SHARE-BASED COMPENSATION - Stock Options Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>28</Position>
    </Report>
    <Report instance="med-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>0000029 - Disclosure - SHARE-BASED COMPENSATION - Restricted Stock Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONRestrictedStockActivityDetails</Role>
      <ShortName>SHARE-BASED COMPENSATION - Restricted Stock Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>29</Position>
    </Report>
    <Report instance="med-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>0000030 - Disclosure - SHARE-BASED COMPENSATION - Summary of Performance-based Share Awards (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONSummaryofPerformancebasedShareAwardsDetails</Role>
      <ShortName>SHARE-BASED COMPENSATION - Summary of Performance-based Share Awards (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>30</Position>
    </Report>
    <Report instance="med-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>0000031 - Disclosure - LEASES - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medifast1.com/role/LEASESNarrativeDetails</Role>
      <ShortName>LEASES - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>31</Position>
    </Report>
    <Report instance="med-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>0000032 - Disclosure - LEASES - Supplemental Cash Flow Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medifast1.com/role/LEASESSupplementalCashFlowInformationDetails</Role>
      <ShortName>LEASES - Supplemental Cash Flow Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>32</Position>
    </Report>
    <Report instance="med-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>0000033 - Disclosure - LEASES - Future Minimum Lease Commitments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medifast1.com/role/LEASESFutureMinimumLeaseCommitmentsDetails</Role>
      <ShortName>LEASES - Future Minimum Lease Commitments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>33</Position>
    </Report>
    <Report instance="med-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>0000034 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE INCOME - Accumulated Other Comprehensive Income (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medifast1.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMEAccumulatedOtherComprehensiveIncomeDetails</Role>
      <ShortName>ACCUMULATED OTHER COMPREHENSIVE INCOME - Accumulated Other Comprehensive Income (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>34</Position>
    </Report>
    <Report instance="med-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>0000035 - Disclosure - FINANCIAL INSTRUMENTS - Cash and Financial Assets That are Measured at Fair Value on a Recurring Basis for Each of the Hierarchy Levels (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medifast1.com/role/FINANCIALINSTRUMENTSCashandFinancialAssetsThatareMeasuredatFairValueonaRecurringBasisforEachoftheHierarchyLevelsDetails</Role>
      <ShortName>FINANCIAL INSTRUMENTS - Cash and Financial Assets That are Measured at Fair Value on a Recurring Basis for Each of the Hierarchy Levels (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>35</Position>
    </Report>
    <Report instance="med-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>0000036 - Disclosure - FINANCIAL INSTRUMENTS - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medifast1.com/role/FINANCIALINSTRUMENTSNarrativeDetails</Role>
      <ShortName>FINANCIAL INSTRUMENTS - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>36</Position>
    </Report>
    <Report instance="med-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>0000037 - Disclosure - DEBT - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medifast1.com/role/DEBTNarrativeDetails</Role>
      <ShortName>DEBT - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>37</Position>
    </Report>
    <Report instance="med-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>0000038 - Disclosure - ACCELERATED SHARE REPURCHASE ("ASR") PROGRAM (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medifast1.com/role/ACCELERATEDSHAREREPURCHASEASRPROGRAMDetails</Role>
      <ShortName>ACCELERATED SHARE REPURCHASE ("ASR") PROGRAM (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.medifast1.com/role/ACCELERATEDSHAREREPURCHASEASRPROGRAM</ParentRole>
      <Position>38</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-Q" original="med-20220930.htm">med-20220930.htm</File>
    <File>med-20220930.xsd</File>
    <File>med-20220930_cal.xml</File>
    <File>med-20220930_def.xml</File>
    <File>med-20220930_lab.xml</File>
    <File>med-20220930_pre.xml</File>
    <File>med-20220930xexx311.htm</File>
    <File>med-20220930xexx312.htm</File>
    <File>med-20220930xexx321.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="612">http://fasb.org/us-gaap/2021-01-31</BaseTaxonomy>
    <BaseTaxonomy items="47">http://xbrl.sec.gov/dei/2021q4</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>54
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "med-20220930.htm": {
   "axisCustom": 0,
   "axisStandard": 11,
   "contextCount": 154,
   "dts": {
    "calculationLink": {
     "local": [
      "med-20220930_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "med-20220930_def.xml"
     ]
    },
    "inline": {
     "local": [
      "med-20220930.htm"
     ]
    },
    "labelLink": {
     "local": [
      "med-20220930_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "med-20220930_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "med-20220930.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd",
      "https://xbrl.sec.gov/country/2021/country-2021.xsd",
      "https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd"
     ]
    }
   },
   "elementCount": 309,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2021q4": 5,
    "total": 5
   },
   "keyCustom": 10,
   "keyStandard": 195,
   "memberCustom": 10,
   "memberStandard": 21,
   "nsprefix": "med",
   "nsuri": "http://www.medifast1.com/20220930",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "med-20220930.htm",
      "contextRef": "ia2bf050e1630451bb448780754fc1e01_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0000001 - Document - Cover",
     "role": "http://www.medifast1.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "med-20220930.htm",
      "contextRef": "ia2bf050e1630451bb448780754fc1e01_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "med-20220930.htm",
      "contextRef": "ia2bf050e1630451bb448780754fc1e01_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000010 - Disclosure - EARNINGS PER SHARE",
     "role": "http://www.medifast1.com/role/EARNINGSPERSHARE",
     "shortName": "EARNINGS PER SHARE",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "med-20220930.htm",
      "contextRef": "ia2bf050e1630451bb448780754fc1e01_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "med-20220930.htm",
      "contextRef": "ia2bf050e1630451bb448780754fc1e01_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000011 - Disclosure - SHARE-BASED COMPENSATION",
     "role": "http://www.medifast1.com/role/SHAREBASEDCOMPENSATION",
     "shortName": "SHARE-BASED COMPENSATION",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "med-20220930.htm",
      "contextRef": "ia2bf050e1630451bb448780754fc1e01_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "med-20220930.htm",
      "contextRef": "ia2bf050e1630451bb448780754fc1e01_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000012 - Disclosure - LEASES",
     "role": "http://www.medifast1.com/role/LEASES",
     "shortName": "LEASES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "med-20220930.htm",
      "contextRef": "ia2bf050e1630451bb448780754fc1e01_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "med-20220930.htm",
      "contextRef": "ia2bf050e1630451bb448780754fc1e01_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ComprehensiveIncomeNoteTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000013 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE INCOME",
     "role": "http://www.medifast1.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOME",
     "shortName": "ACCUMULATED OTHER COMPREHENSIVE INCOME",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "med-20220930.htm",
      "contextRef": "ia2bf050e1630451bb448780754fc1e01_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ComprehensiveIncomeNoteTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "med-20220930.htm",
      "contextRef": "ia2bf050e1630451bb448780754fc1e01_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FinancialInstrumentsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000014 - Disclosure - FINANCIAL INSTRUMENTS",
     "role": "http://www.medifast1.com/role/FINANCIALINSTRUMENTS",
     "shortName": "FINANCIAL INSTRUMENTS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "med-20220930.htm",
      "contextRef": "ia2bf050e1630451bb448780754fc1e01_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FinancialInstrumentsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "med-20220930.htm",
      "contextRef": "ia2bf050e1630451bb448780754fc1e01_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000015 - Disclosure - DEBT",
     "role": "http://www.medifast1.com/role/DEBT",
     "shortName": "DEBT",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "med-20220930.htm",
      "contextRef": "ia2bf050e1630451bb448780754fc1e01_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "med-20220930.htm",
      "contextRef": "ia2bf050e1630451bb448780754fc1e01_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RepurchaseAgreementsResaleAgreementsSecuritiesBorrowedAndSecuritiesLoanedDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000016 - Disclosure - ACCELERATED SHARE REPURCHASE (\"ASR\") PROGRAM",
     "role": "http://www.medifast1.com/role/ACCELERATEDSHAREREPURCHASEASRPROGRAM",
     "shortName": "ACCELERATED SHARE REPURCHASE (\"ASR\") PROGRAM",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "med-20220930.htm",
      "contextRef": "ia2bf050e1630451bb448780754fc1e01_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RepurchaseAgreementsResaleAgreementsSecuritiesBorrowedAndSecuritiesLoanedDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "med-20220930.htm",
      "contextRef": "ia2bf050e1630451bb448780754fc1e01_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000017 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)",
     "role": "http://www.medifast1.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "med-20220930.htm",
      "contextRef": "ia2bf050e1630451bb448780754fc1e01_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "med-20220930.htm",
      "contextRef": "ia2bf050e1630451bb448780754fc1e01_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000018 - Disclosure - INVENTORIES (Tables)",
     "role": "http://www.medifast1.com/role/INVENTORIESTables",
     "shortName": "INVENTORIES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "med-20220930.htm",
      "contextRef": "ia2bf050e1630451bb448780754fc1e01_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "med-20220930.htm",
      "contextRef": "ia2bf050e1630451bb448780754fc1e01_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000019 - Disclosure - EARNINGS PER SHARE (Tables)",
     "role": "http://www.medifast1.com/role/EARNINGSPERSHARETables",
     "shortName": "EARNINGS PER SHARE (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "med-20220930.htm",
      "contextRef": "ia2bf050e1630451bb448780754fc1e01_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "med-20220930.htm",
      "contextRef": "i2f3a96a832ab4b0ca374599d1c3e9bce_D20220701-20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000002 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF INCOME (UNAUDITED)",
     "role": "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEUNAUDITED",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF INCOME (UNAUDITED)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "med-20220930.htm",
      "contextRef": "i2f3a96a832ab4b0ca374599d1c3e9bce_D20220701-20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "med-20220930.htm",
      "contextRef": "ia2bf050e1630451bb448780754fc1e01_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000020 - Disclosure - SHARE-BASED COMPENSATION (Tables)",
     "role": "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONTables",
     "shortName": "SHARE-BASED COMPENSATION (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "med-20220930.htm",
      "contextRef": "ia2bf050e1630451bb448780754fc1e01_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "med-20220930.htm",
      "contextRef": "ia2bf050e1630451bb448780754fc1e01_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000021 - Disclosure - LEASES (Tables)",
     "role": "http://www.medifast1.com/role/LEASESTables",
     "shortName": "LEASES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "med-20220930.htm",
      "contextRef": "ia2bf050e1630451bb448780754fc1e01_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "med-20220930.htm",
      "contextRef": "ia2bf050e1630451bb448780754fc1e01_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000022 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE INCOME (Tables)",
     "role": "http://www.medifast1.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMETables",
     "shortName": "ACCUMULATED OTHER COMPREHENSIVE INCOME (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "med-20220930.htm",
      "contextRef": "ia2bf050e1630451bb448780754fc1e01_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "med-20220930.htm",
      "contextRef": "ia2bf050e1630451bb448780754fc1e01_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000023 - Disclosure - FINANCIAL INSTRUMENTS (Tables)",
     "role": "http://www.medifast1.com/role/FINANCIALINSTRUMENTSTables",
     "shortName": "FINANCIAL INSTRUMENTS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "med-20220930.htm",
      "contextRef": "ia2bf050e1630451bb448780754fc1e01_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "med-20220930.htm",
      "contextRef": "i2f3a96a832ab4b0ca374599d1c3e9bce_D20220701-20220930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NoncashContributionExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000024 - Disclosure - INVENTORIES (Details)",
     "role": "http://www.medifast1.com/role/INVENTORIESDetails",
     "shortName": "INVENTORIES (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "med-20220930.htm",
      "contextRef": "i2f3a96a832ab4b0ca374599d1c3e9bce_D20220701-20220930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NoncashContributionExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "med-20220930.htm",
      "contextRef": "i2f3a96a832ab4b0ca374599d1c3e9bce_D20220701-20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000025 - Disclosure - EARNINGS PER SHARE - Computation of Basic and Diluted EPS (Details)",
     "role": "http://www.medifast1.com/role/EARNINGSPERSHAREComputationofBasicandDilutedEPSDetails",
     "shortName": "EARNINGS PER SHARE - Computation of Basic and Diluted EPS (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "med-20220930.htm",
      "contextRef": "i2f3a96a832ab4b0ca374599d1c3e9bce_D20220701-20220930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "med-20220930.htm",
      "contextRef": "i8c40ccc203fe40598b003eaa16fd683f_D20220701-20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000026 - Disclosure - EARNINGS PER SHARE - Narrative (Details)",
     "role": "http://www.medifast1.com/role/EARNINGSPERSHARENarrativeDetails",
     "shortName": "EARNINGS PER SHARE - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "med-20220930.htm",
      "contextRef": "i8c40ccc203fe40598b003eaa16fd683f_D20220701-20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "med-20220930.htm",
      "contextRef": "ia2bf050e1630451bb448780754fc1e01_D20220101-20220930",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000027 - Disclosure - SHARE-BASED COMPENSATION - Narrative (Details)",
     "role": "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails",
     "shortName": "SHARE-BASED COMPENSATION - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "med-20220930.htm",
      "contextRef": "ia2bf050e1630451bb448780754fc1e01_D20220101-20220930",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "med-20220930.htm",
      "contextRef": "i47f09f18839440ffae0cf05a475aa7fe_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000028 - Disclosure - SHARE-BASED COMPENSATION - Stock Options Activity (Details)",
     "role": "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONStockOptionsActivityDetails",
     "shortName": "SHARE-BASED COMPENSATION - Stock Options Activity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "med-20220930.htm",
      "contextRef": "i47f09f18839440ffae0cf05a475aa7fe_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "med-20220930.htm",
      "contextRef": "ia06f0db3dd8146e097bef1502f9f86af_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000029 - Disclosure - SHARE-BASED COMPENSATION - Restricted Stock Activity (Details)",
     "role": "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONRestrictedStockActivityDetails",
     "shortName": "SHARE-BASED COMPENSATION - Restricted Stock Activity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "med-20220930.htm",
      "contextRef": "ia06f0db3dd8146e097bef1502f9f86af_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "med-20220930.htm",
      "contextRef": "i2f3a96a832ab4b0ca374599d1c3e9bce_D20220701-20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000003 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (UNAUDITED)",
     "role": "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUNAUDITED",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (UNAUDITED)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "med-20220930.htm",
      "contextRef": "i2f3a96a832ab4b0ca374599d1c3e9bce_D20220701-20220930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "med-20220930.htm",
      "contextRef": "i2f3a96a832ab4b0ca374599d1c3e9bce_D20220701-20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000030 - Disclosure - SHARE-BASED COMPENSATION - Summary of Performance-based Share Awards (Details)",
     "role": "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONSummaryofPerformancebasedShareAwardsDetails",
     "shortName": "SHARE-BASED COMPENSATION - Summary of Performance-based Share Awards (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "med-20220930.htm",
      "contextRef": "i2f3a96a832ab4b0ca374599d1c3e9bce_D20220701-20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "med-20220930.htm",
      "contextRef": "i2f3a96a832ab4b0ca374599d1c3e9bce_D20220701-20220930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000031 - Disclosure - LEASES - Narrative (Details)",
     "role": "http://www.medifast1.com/role/LEASESNarrativeDetails",
     "shortName": "LEASES - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "med-20220930.htm",
      "contextRef": "i2f3a96a832ab4b0ca374599d1c3e9bce_D20220701-20220930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "med-20220930.htm",
      "contextRef": "ia2bf050e1630451bb448780754fc1e01_D20220101-20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeasePayments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000032 - Disclosure - LEASES - Supplemental Cash Flow Information (Details)",
     "role": "http://www.medifast1.com/role/LEASESSupplementalCashFlowInformationDetails",
     "shortName": "LEASES - Supplemental Cash Flow Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "med-20220930.htm",
      "contextRef": "ia2bf050e1630451bb448780754fc1e01_D20220101-20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeasePayments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "med-20220930.htm",
      "contextRef": "i5de311f5948148cda49342e2cea83715_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000033 - Disclosure - LEASES - Future Minimum Lease Commitments (Details)",
     "role": "http://www.medifast1.com/role/LEASESFutureMinimumLeaseCommitmentsDetails",
     "shortName": "LEASES - Future Minimum Lease Commitments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "med-20220930.htm",
      "contextRef": "i5de311f5948148cda49342e2cea83715_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "med-20220930.htm",
      "contextRef": "i5de311f5948148cda49342e2cea83715_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquity",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000034 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE INCOME - Accumulated Other Comprehensive Income (Details)",
     "role": "http://www.medifast1.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMEAccumulatedOtherComprehensiveIncomeDetails",
     "shortName": "ACCUMULATED OTHER COMPREHENSIVE INCOME - Accumulated Other Comprehensive Income (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "med-20220930.htm",
      "contextRef": "i9072f45fffaa474fb85e95c07d3eeec4_I20220930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "med-20220930.htm",
      "contextRef": "i5de311f5948148cda49342e2cea83715_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MarketableSecurities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000035 - Disclosure - FINANCIAL INSTRUMENTS - Cash and Financial Assets That are Measured at Fair Value on a Recurring Basis for Each of the Hierarchy Levels (Details)",
     "role": "http://www.medifast1.com/role/FINANCIALINSTRUMENTSCashandFinancialAssetsThatareMeasuredatFairValueonaRecurringBasisforEachoftheHierarchyLevelsDetails",
     "shortName": "FINANCIAL INSTRUMENTS - Cash and Financial Assets That are Measured at Fair Value on a Recurring Basis for Each of the Hierarchy Levels (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "med-20220930.htm",
      "contextRef": "i5de311f5948148cda49342e2cea83715_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MarketableSecurities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "med-20220930.htm",
      "contextRef": "i2f3a96a832ab4b0ca374599d1c3e9bce_D20220701-20220930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtAndEquitySecuritiesRealizedGainLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000036 - Disclosure - FINANCIAL INSTRUMENTS - Narrative (Details)",
     "role": "http://www.medifast1.com/role/FINANCIALINSTRUMENTSNarrativeDetails",
     "shortName": "FINANCIAL INSTRUMENTS - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "med-20220930.htm",
      "contextRef": "i2f3a96a832ab4b0ca374599d1c3e9bce_D20220701-20220930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtAndEquitySecuritiesRealizedGainLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "med-20220930.htm",
      "contextRef": "i1572f54925ef49918ea7d21b949a4e18_I20220531",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "med:MaximumTotalNetLeverageRatio",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000037 - Disclosure - DEBT - Narrative (Details)",
     "role": "http://www.medifast1.com/role/DEBTNarrativeDetails",
     "shortName": "DEBT - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "med-20220930.htm",
      "contextRef": "i1572f54925ef49918ea7d21b949a4e18_I20220531",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "med:MaximumTotalNetLeverageRatio",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "med-20220930.htm",
      "contextRef": "i9c92e926af9e4d908021e1a185782db8_I20220630",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockRepurchaseProgramAuthorizedAmount1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000038 - Disclosure - ACCELERATED SHARE REPURCHASE (\"ASR\") PROGRAM (Details)",
     "role": "http://www.medifast1.com/role/ACCELERATEDSHAREREPURCHASEASRPROGRAMDetails",
     "shortName": "ACCELERATED SHARE REPURCHASE (\"ASR\") PROGRAM (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "med-20220930.htm",
      "contextRef": "i9c92e926af9e4d908021e1a185782db8_I20220630",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockRepurchaseProgramAuthorizedAmount1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "med-20220930.htm",
      "contextRef": "i5de311f5948148cda49342e2cea83715_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000004 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)",
     "role": "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED",
     "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "med-20220930.htm",
      "contextRef": "i5de311f5948148cda49342e2cea83715_I20220930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:ShortTermInvestments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:CommonStockParOrStatedValuePerShare",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "med-20220930.htm",
      "contextRef": "i5de311f5948148cda49342e2cea83715_I20220930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000005 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "role": "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical",
     "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:CommonStockParOrStatedValuePerShare",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "med-20220930.htm",
      "contextRef": "i5de311f5948148cda49342e2cea83715_I20220930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "med-20220930.htm",
      "contextRef": "ia2bf050e1630451bb448780754fc1e01_D20220101-20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)",
     "role": "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "med-20220930.htm",
      "contextRef": "ia2bf050e1630451bb448780754fc1e01_D20220101-20220930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:DepreciationDepletionAndAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "med-20220930.htm",
      "contextRef": "i1163d3352fc648fabd60e9dbcf073a70_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockSharesIssued",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000007 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (UNAUDITED)",
     "role": "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYUNAUDITED",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (UNAUDITED)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "med-20220930.htm",
      "contextRef": "id4f9149bb4104ee2963222e63eef1ac9_D20210101-20210331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "med-20220930.htm",
      "contextRef": "ia2bf050e1630451bb448780754fc1e01_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000008 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES",
     "role": "http://www.medifast1.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "med-20220930.htm",
      "contextRef": "ia2bf050e1630451bb448780754fc1e01_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "med-20220930.htm",
      "contextRef": "ia2bf050e1630451bb448780754fc1e01_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000009 - Disclosure - INVENTORIES",
     "role": "http://www.medifast1.com/role/INVENTORIES",
     "shortName": "INVENTORIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "med-20220930.htm",
      "contextRef": "ia2bf050e1630451bb448780754fc1e01_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 32,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.medifast1.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.medifast1.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.medifast1.com/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.medifast1.com/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.medifast1.com/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.medifast1.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r404"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report",
        "terseLabel": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.medifast1.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r405"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.medifast1.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.medifast1.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.medifast1.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.medifast1.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.medifast1.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.medifast1.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r402"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.medifast1.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.medifast1.com/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.medifast1.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r402"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.medifast1.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.medifast1.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r402"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.medifast1.com/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.medifast1.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r413"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.medifast1.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r402"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.medifast1.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r402"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.medifast1.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r402"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.medifast1.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r402"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.medifast1.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.medifast1.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r401"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.medifast1.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r403"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.medifast1.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.medifast1.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "med_AdjustmentsToPaidInCapitalShareRepurchasesNotYetSettled": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Adjustments To Paid In Capital, Share Repurchases Not Yet Settled",
        "label": "Adjustments To Paid In Capital, Share Repurchases Not Yet Settled",
        "negatedTerseLabel": "Stock repurchases, not yet settled"
       }
      }
     },
     "localname": "AdjustmentsToPaidInCapitalShareRepurchasesNotYetSettled",
     "nsuri": "http://www.medifast1.com/20220930",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "med_AmortizationOfPremiumOnInvestmentSecurities": {
     "auth_ref": [],
     "calculation": {
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The expense charged against amortization of premium on investment securities.",
        "label": "Amortization of Premium on Investment Securities",
        "terseLabel": "Amortization of premium on investment securities"
       }
      }
     },
     "localname": "AmortizationOfPremiumOnInvestmentSecurities",
     "nsuri": "http://www.medifast1.com/20220930",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "med_CashAndCashEquivalentsAndMarketableSecuritiesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "N/A",
        "label": "Cash And Cash Equivalents And Marketable securities [Line Items]",
        "terseLabel": "Cash And Cash Equivalents And Marketable securities [Line Items]"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAndMarketableSecuritiesLineItems",
     "nsuri": "http://www.medifast1.com/20220930",
     "presentation": [
      "http://www.medifast1.com/role/FINANCIALINSTRUMENTSCashandFinancialAssetsThatareMeasuredatFairValueonaRecurringBasisforEachoftheHierarchyLevelsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "med_CashAndCashEquivalentsAndMarketableSecuritiesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "N/A",
        "label": "Cash And Cash Equivalents And Marketable securities [Table]",
        "terseLabel": "Cash And Cash Equivalents And Marketable securities [Table]"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAndMarketableSecuritiesTable",
     "nsuri": "http://www.medifast1.com/20220930",
     "presentation": [
      "http://www.medifast1.com/role/FINANCIALINSTRUMENTSCashandFinancialAssetsThatareMeasuredatFairValueonaRecurringBasisforEachoftheHierarchyLevelsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "med_CreditAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Credit Agreement [Member]",
        "label": "Credit Agreement [Member]",
        "terseLabel": "Credit Agreement"
       }
      }
     },
     "localname": "CreditAgreementMember",
     "nsuri": "http://www.medifast1.com/20220930",
     "presentation": [
      "http://www.medifast1.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "med_DenominatorAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Denominator [Abstract]",
        "label": "Denominator [Abstract]",
        "verboseLabel": "Denominator:"
       }
      }
     },
     "localname": "DenominatorAbstract",
     "nsuri": "http://www.medifast1.com/20220930",
     "presentation": [
      "http://www.medifast1.com/role/EARNINGSPERSHAREComputationofBasicandDilutedEPSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "med_GovernmentAgencySecuritiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Government Agency Securities [Member]",
        "label": "Government Agency Securities [Member]",
        "terseLabel": "Government &amp; agency securities"
       }
      }
     },
     "localname": "GovernmentAgencySecuritiesMember",
     "nsuri": "http://www.medifast1.com/20220930",
     "presentation": [
      "http://www.medifast1.com/role/FINANCIALINSTRUMENTSCashandFinancialAssetsThatareMeasuredatFairValueonaRecurringBasisforEachoftheHierarchyLevelsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "med_GrantedIn2019Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Granted In 2019",
        "label": "Granted In 2019 [Member]",
        "terseLabel": "Granted In 2019"
       }
      }
     },
     "localname": "GrantedIn2019Member",
     "nsuri": "http://www.medifast1.com/20220930",
     "presentation": [
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONSummaryofPerformancebasedShareAwardsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "med_GrantedIn2020Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Granted In 2020",
        "label": "Granted In 2020 [Member]",
        "terseLabel": "Granted In 2020"
       }
      }
     },
     "localname": "GrantedIn2020Member",
     "nsuri": "http://www.medifast1.com/20220930",
     "presentation": [
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONSummaryofPerformancebasedShareAwardsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "med_GrantedIn2021Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Granted In 2021",
        "label": "Granted In 2021 [Member]",
        "terseLabel": "Granted In 2021"
       }
      }
     },
     "localname": "GrantedIn2021Member",
     "nsuri": "http://www.medifast1.com/20220930",
     "presentation": [
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONSummaryofPerformancebasedShareAwardsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "med_GrantedIn2022Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Granted In 2022",
        "label": "Granted In 2022 [Member]",
        "terseLabel": "Granted In 2022"
       }
      }
     },
     "localname": "GrantedIn2022Member",
     "nsuri": "http://www.medifast1.com/20220930",
     "presentation": [
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONSummaryofPerformancebasedShareAwardsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "med_InventoryNonFoodFinishedGoods": {
     "auth_ref": [],
     "calculation": {
      "http://www.medifast1.com/role/INVENTORIESDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before last-in first-out (LIFO) and valuation reserves of (Non-food) merchandise or goods held by the entity that are readily available for sale.",
        "label": "Inventory Non Food Finished Goods",
        "verboseLabel": "Non-food finished goods"
       }
      }
     },
     "localname": "InventoryNonFoodFinishedGoods",
     "nsuri": "http://www.medifast1.com/20220930",
     "presentation": [
      "http://www.medifast1.com/role/INVENTORIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "med_LesseeOperatingLeaseLiabilityPaymentsDueYearFiveAndAfterYearFive": {
     "auth_ref": [],
     "calculation": {
      "http://www.medifast1.com/role/LEASESFutureMinimumLeaseCommitmentsDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee Operating Lease Liability Payments Due Year Five And After Year Five",
        "label": "Lessee Operating Lease Liability Payments Due Year Five And After Year Five",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFiveAndAfterYearFive",
     "nsuri": "http://www.medifast1.com/20220930",
     "presentation": [
      "http://www.medifast1.com/role/LEASESFutureMinimumLeaseCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "med_LineOfCreditFacilityAccordionFeatureIncreaseLimit": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line of credit facility, accordion feature, increase limit, subject to certain conditions by obtaining additional commitments from existing and/or new lenders.",
        "label": "Line of Credit Facility, Accordion Feature, Increase Limit",
        "terseLabel": "Accordion feature, increase limit"
       }
      }
     },
     "localname": "LineOfCreditFacilityAccordionFeatureIncreaseLimit",
     "nsuri": "http://www.medifast1.com/20220930",
     "presentation": [
      "http://www.medifast1.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "med_MarketAndPerformanceSharesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Market And Performance Shares",
        "label": "Market And Performance Shares [Member]",
        "terseLabel": "Market and Performance-Based Shares"
       }
      }
     },
     "localname": "MarketAndPerformanceSharesMember",
     "nsuri": "http://www.medifast1.com/20220930",
     "presentation": [
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONSummaryofPerformancebasedShareAwardsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "med_MaximumTotalNetLeverageRatio": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum ratio as of any date, of (a) Total Net Funded Indebtedness on such date to (b) Consolidated EBITDA for the Reference Period ended on such date under credit facility.",
        "label": "Maximum Total Net Leverage Ratio",
        "terseLabel": "Maximum Total Net Leverage Ratio"
       }
      }
     },
     "localname": "MaximumTotalNetLeverageRatio",
     "nsuri": "http://www.medifast1.com/20220930",
     "presentation": [
      "http://www.medifast1.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "med_MinimumInterestCoverageRatio": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Minimum Interest Coverage Ratio",
        "label": "Minimum Interest Coverage Ratio",
        "terseLabel": "Minimum Interest Coverage Ratio"
       }
      }
     },
     "localname": "MinimumInterestCoverageRatio",
     "nsuri": "http://www.medifast1.com/20220930",
     "presentation": [
      "http://www.medifast1.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "med_NumeratorAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Numerator [Abstract]",
        "label": "Numerator [Abstract]",
        "verboseLabel": "Numerator:"
       }
      }
     },
     "localname": "NumeratorAbstract",
     "nsuri": "http://www.medifast1.com/20220930",
     "presentation": [
      "http://www.medifast1.com/role/EARNINGSPERSHAREComputationofBasicandDilutedEPSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "med_OperatingLeaseArrangementForEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the operating lease arrangement for equipment.",
        "label": "Operating Lease Arrangement For Equipment [Member]",
        "terseLabel": "Operating Lease Arrangement for Equipment"
       }
      }
     },
     "localname": "OperatingLeaseArrangementForEquipmentMember",
     "nsuri": "http://www.medifast1.com/20220930",
     "presentation": [
      "http://www.medifast1.com/role/LEASESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "med_OperatingLeaseArrangementForRealEstateMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the operating lease arrangement for real estate.",
        "label": "Operating Lease Arrangement For Real Estate [Member]",
        "terseLabel": "Operating Lease Arrangement for Real Estate"
       }
      }
     },
     "localname": "OperatingLeaseArrangementForRealEstateMember",
     "nsuri": "http://www.medifast1.com/20220930",
     "presentation": [
      "http://www.medifast1.com/role/LEASESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "med_OperatingLeaseExpenseNonCash": {
     "auth_ref": [],
     "calculation": {
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating Lease, Expense, Non-Cash",
        "label": "Operating Lease, Expense, Non-Cash",
        "terseLabel": "Non-cash lease expense"
       }
      }
     },
     "localname": "OperatingLeaseExpenseNonCash",
     "nsuri": "http://www.medifast1.com/20220930",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "med_OptionsAndRestrictedStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Options And Restricted Stock",
        "label": "Options And Restricted Stock [Member]",
        "terseLabel": "Options And Restricted Stock"
       }
      }
     },
     "localname": "OptionsAndRestrictedStockMember",
     "nsuri": "http://www.medifast1.com/20220930",
     "presentation": [
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONSummaryofPerformancebasedShareAwardsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "med_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesEarnedPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-Based Compensation Arrangement By Share-Based Payment Award, Number Of Additional Shares Earned, Percentage",
        "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Number Of Additional Shares Earned, Percentage",
        "terseLabel": "Additional performance-based shares, percentage"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesEarnedPercentage",
     "nsuri": "http://www.medifast1.com/20220930",
     "presentation": [
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "med_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesEarnedPerformancePeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-Based Compensation Arrangement By Share-Based Payment Award, Number Of Additional Shares Earned, Performance Period",
        "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Number Of Additional Shares Earned, Performance Period",
        "terseLabel": "Performance period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesEarnedPerformancePeriod",
     "nsuri": "http://www.medifast1.com/20220930",
     "presentation": [
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r185",
      "r216",
      "r235",
      "r236",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r356",
      "r388",
      "r389",
      "r399",
      "r400"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/DEBTNarrativeDetails",
      "http://www.medifast1.com/role/LEASESNarrativeDetails",
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r185",
      "r216",
      "r235",
      "r236",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r356",
      "r388",
      "r389",
      "r399",
      "r400"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/DEBTNarrativeDetails",
      "http://www.medifast1.com/role/LEASESNarrativeDetails",
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r185",
      "r216",
      "r226",
      "r235",
      "r236",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r356",
      "r388",
      "r389",
      "r399",
      "r400"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/DEBTNarrativeDetails",
      "http://www.medifast1.com/role/LEASESNarrativeDetails",
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r185",
      "r216",
      "r226",
      "r235",
      "r236",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r356",
      "r388",
      "r389",
      "r399",
      "r400"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Range [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/DEBTNarrativeDetails",
      "http://www.medifast1.com/role/LEASESNarrativeDetails",
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AcceleratedShareRepurchaseProgramAdjustment": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount needed to adjust previously recorded stockholders' equity balances to the actual aggregate amounts paid, whether in cash or other consideration, to acquire all of the shares purchased under an Accelerated Share Repurchase arrangement.",
        "label": "Accelerated Share Repurchase Program, Adjustment",
        "terseLabel": "Settlement of accelerated share repurchase agreement"
       }
      }
     },
     "localname": "AcceleratedShareRepurchaseProgramAdjustment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]",
        "terseLabel": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r33"
     ],
     "calculation": {
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.",
        "label": "Accounts Payable and Accrued Liabilities, Current",
        "terseLabel": "Accounts payable and accrued expenses"
       }
      }
     },
     "localname": "AccountsPayableAndAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember": {
     "auth_ref": [
      "r44",
      "r45",
      "r46",
      "r50",
      "r57",
      "r58",
      "r59"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), attributable to parent.",
        "label": "AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-sale, Parent [Member]",
        "terseLabel": "Unrealized gains on investment securities"
       }
      }
     },
     "localname": "AccumulatedNetUnrealizedInvestmentGainLossMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMEAccumulatedOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Line Items]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMEAccumulatedOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r21",
      "r48",
      "r49",
      "r50",
      "r378",
      "r394",
      "r395"
     ],
     "calculation": {
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Accumulated other comprehensive income"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": {
     "auth_ref": [
      "r57",
      "r58",
      "r297",
      "r298",
      "r299",
      "r300",
      "r301",
      "r303"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss).",
        "label": "Accumulated Other Comprehensive Income (Loss) [Table]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Table]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMEAccumulatedOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r47",
      "r50",
      "r57",
      "r58",
      "r59",
      "r93",
      "r94",
      "r95",
      "r286",
      "r390",
      "r391",
      "r414"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Accumulated Other Comprehensive Income"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMEAccumulatedOtherComprehensiveIncomeDetails",
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYUNAUDITED"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedTranslationAdjustmentMember": {
     "auth_ref": [
      "r43",
      "r50",
      "r57",
      "r58",
      "r59",
      "r286",
      "r298",
      "r299",
      "r300",
      "r301",
      "r303"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) resulting from foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to the parent.",
        "label": "Accumulated Foreign Currency Adjustment Attributable to Parent [Member]",
        "terseLabel": "Foreign currency translation"
       }
      }
     },
     "localname": "AccumulatedTranslationAdjustmentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMEAccumulatedOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdditionalPaidInCapital": {
     "auth_ref": [
      "r19",
      "r266",
      "r324"
     ],
     "calculation": {
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.",
        "label": "Additional Paid in Capital",
        "terseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapital",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r93",
      "r94",
      "r95",
      "r263",
      "r264",
      "r265",
      "r291"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional Paid-In Capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYUNAUDITED"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease to equity for grantee's tax withholding obligation for award under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Decrease for Tax Withholding Obligation",
        "negatedLabel": "Net shares repurchased for taxes"
       }
      }
     },
     "localname": "AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) to additional paid-in capital (APIC) for recognition and exercise of award under share-based payment arrangement.",
        "label": "APIC, Share-based Payment Arrangement, Recognition and Exercise",
        "terseLabel": "Share-based compensation"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net income to cash provided by operating activities"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "auth_ref": [
      "r238",
      "r259",
      "r267"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.",
        "label": "Share-based Payment Arrangement, Expense",
        "terseLabel": "Share-Based Compensation Expense"
       }
      }
     },
     "localname": "AllocatedShareBasedCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONSummaryofPerformancebasedShareAwardsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r114"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "verboseLabel": "Anti-dilutive awards"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/EARNINGSPERSHARENarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "auth_ref": [
      "r114"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of antidilutive security.",
        "label": "Antidilutive Securities [Axis]",
        "terseLabel": "Antidilutive Securities [Axis]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/EARNINGSPERSHARENarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "auth_ref": [
      "r114"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.",
        "label": "Antidilutive Securities, Name [Domain]",
        "terseLabel": "Antidilutive Securities, Name [Domain]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/EARNINGSPERSHARENarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ArrangementsAndNonarrangementTransactionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Domain]",
        "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative [Domain]"
       }
      }
     },
     "localname": "ArrangementsAndNonarrangementTransactionsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/LEASESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r88",
      "r133",
      "r136",
      "r142",
      "r154",
      "r171",
      "r172",
      "r173",
      "r174",
      "r175",
      "r176",
      "r177",
      "r178",
      "r179",
      "r180",
      "r181",
      "r283",
      "r287",
      "r295",
      "r322",
      "r324",
      "r359",
      "r377"
     ],
     "calculation": {
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "TOTAL ASSETS"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "ASSETS"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r6",
      "r8",
      "r42",
      "r88",
      "r154",
      "r171",
      "r172",
      "r173",
      "r174",
      "r175",
      "r176",
      "r177",
      "r178",
      "r179",
      "r180",
      "r181",
      "r283",
      "r287",
      "r295",
      "r322",
      "r324"
     ],
     "calculation": {
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "Current Assets"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent": {
     "auth_ref": [
      "r148",
      "r161"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as current.",
        "label": "Debt Securities, Available-for-sale, Current",
        "terseLabel": "Estimated Fair Value"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtSecuritiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/FINANCIALINSTRUMENTSCashandFinancialAssetsThatareMeasuredatFairValueonaRecurringBasisforEachoftheHierarchyLevelsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AwardDateAxis": {
     "auth_ref": [
      "r239",
      "r261"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by date or year award under share-based payment arrangement is granted.",
        "label": "Award Date [Axis]",
        "terseLabel": "Award Date [Axis]"
       }
      }
     },
     "localname": "AwardDateAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONSummaryofPerformancebasedShareAwardsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AwardDateDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date or year award under share-based payment arrangement is granted.",
        "label": "Award Date [Domain]",
        "terseLabel": "Award Date [Domain]"
       }
      }
     },
     "localname": "AwardDateDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONSummaryofPerformancebasedShareAwardsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r239",
      "r261"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type [Axis]"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails",
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONRestrictedStockActivityDetails",
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONSummaryofPerformancebasedShareAwardsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BaseRateMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Minimum rate investor will accept.",
        "label": "Base Rate [Member]",
        "terseLabel": "Base Rate"
       }
      }
     },
     "localname": "BaseRateMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "terseLabel": "Basis of Presentation"
       }
      }
     },
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r3",
      "r30",
      "r82"
     ],
     "calculation": {
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash &amp; Cash Equivalents",
        "verboseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED",
      "http://www.medifast1.com/role/FINANCIALINSTRUMENTSCashandFinancialAssetsThatareMeasuredatFairValueonaRecurringBasisforEachoftheHierarchyLevelsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r77",
      "r82",
      "r84"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "periodEndLabel": "Cash and cash equivalents - end of period",
        "periodStartLabel": "Cash and cash equivalents - beginning of the period"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r77",
      "r296"
     ],
     "calculation": {
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Decrease in cash and cash equivalents"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashMember": {
     "auth_ref": [
      "r10"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits.",
        "label": "Cash [Member]",
        "terseLabel": "Cash"
       }
      }
     },
     "localname": "CashMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/FINANCIALINSTRUMENTSCashandFinancialAssetsThatareMeasuredatFairValueonaRecurringBasisforEachoftheHierarchyLevelsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockDividendsPerShareDeclared": {
     "auth_ref": [
      "r223"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate dividends declared during the period for each share of common stock outstanding.",
        "label": "Common Stock, Dividends, Per Share, Declared",
        "verboseLabel": "Cash dividends declared per share (in dollars per share)"
       }
      }
     },
     "localname": "CommonStockDividendsPerShareDeclared",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEUNAUDITED"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r93",
      "r94",
      "r291"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYUNAUDITED"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r18"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common stock, par value (in dollars per share)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r18"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common stock, shares authorized (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r18"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "periodEndLabel": "Balance (in shares)",
        "periodStartLabel": "Balance (in shares)",
        "terseLabel": "Common stock, issued (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical",
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYUNAUDITED"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r18",
      "r218"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding",
        "terseLabel": "Common stock, outstanding (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r18",
      "r324"
     ],
     "calculation": {
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "verboseLabel": "Common stock, par value $0.001 per share: 20,000 shares authorized; 10,929 and 11,594 issued and 10,928 and 11,593 outstanding at September\u00a030, 2022 and December\u00a031, 2021, respectively"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r53",
      "r55",
      "r56",
      "r64",
      "r369",
      "r384"
     ],
     "calculation": {
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUNAUDITED": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Comprehensive income"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNoteTextBlock": {
     "auth_ref": [
      "r63",
      "r72",
      "r368",
      "r383"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.",
        "label": "Comprehensive Income (Loss) Note [Text Block]",
        "terseLabel": "ACCUMULATED OTHER COMPREHENSIVE INCOME"
       }
      }
     },
     "localname": "ComprehensiveIncomeNoteTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CostOfRevenue": {
     "auth_ref": [
      "r68",
      "r88",
      "r154",
      "r171",
      "r172",
      "r173",
      "r175",
      "r176",
      "r177",
      "r178",
      "r179",
      "r180",
      "r181",
      "r295"
     ],
     "calculation": {
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEUNAUDITED": {
       "order": 2.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate cost of goods produced and sold and services rendered during the reporting period.",
        "label": "Cost of Revenue",
        "verboseLabel": "Cost of sales"
       }
      }
     },
     "localname": "CostOfRevenue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CreditFacilityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Axis]",
        "terseLabel": "Credit Facility [Axis]"
       }
      }
     },
     "localname": "CreditFacilityAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CreditFacilityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Domain]",
        "terseLabel": "Credit Facility [Domain]"
       }
      }
     },
     "localname": "CreditFacilityDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtAndEquitySecuritiesRealizedGainLoss": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of realized gain (loss) on investment in debt and equity securities.",
        "label": "Debt and Equity Securities, Realized Gain (Loss)",
        "negatedTerseLabel": "Realized loss or gains"
       }
      }
     },
     "localname": "DebtAndEquitySecuritiesRealizedGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/FINANCIALINSTRUMENTSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]",
        "terseLabel": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "auth_ref": [
      "r86",
      "r188",
      "r189",
      "r190",
      "r191",
      "r192",
      "r193",
      "r194",
      "r199",
      "r206",
      "r207",
      "r209",
      "r215"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.",
        "label": "Debt Disclosure [Text Block]",
        "terseLabel": "DEBT"
       }
      }
     },
     "localname": "DebtDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/DEBT"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r13",
      "r15",
      "r16",
      "r87",
      "r91",
      "r182",
      "r183",
      "r184",
      "r185",
      "r186",
      "r187",
      "r189",
      "r195",
      "r196",
      "r197",
      "r198",
      "r200",
      "r201",
      "r202",
      "r203",
      "r204",
      "r205",
      "r211",
      "r212",
      "r213",
      "r214",
      "r306",
      "r360",
      "r361",
      "r375"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument.",
        "label": "Debt Instrument, Basis Spread on Variable Rate",
        "terseLabel": "Applicable Rate"
       }
      }
     },
     "localname": "DebtInstrumentBasisSpreadOnVariableRate1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentCarryingAmount": {
     "auth_ref": [
      "r16",
      "r210",
      "r361",
      "r375"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.",
        "label": "Long-term Debt, Gross",
        "terseLabel": "Borrowings"
       }
      }
     },
     "localname": "DebtInstrumentCarryingAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r36",
      "r87",
      "r91",
      "r182",
      "r183",
      "r184",
      "r185",
      "r186",
      "r187",
      "r189",
      "r195",
      "r196",
      "r197",
      "r198",
      "r200",
      "r201",
      "r202",
      "r203",
      "r204",
      "r205",
      "r211",
      "r212",
      "r213",
      "r214",
      "r306"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]",
        "terseLabel": "Debt Instrument, Name [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r36",
      "r87",
      "r91",
      "r182",
      "r183",
      "r184",
      "r185",
      "r186",
      "r187",
      "r189",
      "r195",
      "r196",
      "r197",
      "r198",
      "r200",
      "r201",
      "r202",
      "r203",
      "r204",
      "r205",
      "r208",
      "r211",
      "r212",
      "r213",
      "r214",
      "r219",
      "r220",
      "r221",
      "r222",
      "r304",
      "r305",
      "r306",
      "r307",
      "r374"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-term Debt Instruments [Table]",
        "terseLabel": "Schedule of Long-term Debt Instruments [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredIncomeTaxAssetsNet": {
     "auth_ref": [
      "r269",
      "r270"
     ],
     "calculation": {
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.",
        "label": "Deferred Income Tax Assets, Net",
        "terseLabel": "Deferred tax assets"
       }
      }
     },
     "localname": "DeferredIncomeTaxAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r80",
      "r89",
      "r272",
      "r276",
      "r277",
      "r278"
     ],
     "calculation": {
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Income Tax Expense (Benefit)",
        "terseLabel": "Deferred income taxes"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r80",
      "r131"
     ],
     "calculation": {
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
        "label": "Depreciation, Depletion and Amortization",
        "terseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "auth_ref": [
      "r268"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement [Text Block]",
        "verboseLabel": "SHARE-BASED COMPENSATION"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATION"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Payment Arrangement [Abstract]",
        "terseLabel": "Share-based Payment Arrangement [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock": {
     "auth_ref": [
      "r239",
      "r261"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of share-based payment arrangement.",
        "label": "Disclosure of Share-based Compensation Arrangements by Share-based Payment Award [Table Text Block]",
        "terseLabel": "Disclosure of Share-based Compensation Arrangements by Share-based Payment Award"
       }
      }
     },
     "localname": "DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DividendsCash": {
     "auth_ref": [
      "r223",
      "r373"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of paid and unpaid cash dividends declared for classes of stock, for example, but not limited to, common and preferred.",
        "label": "Dividends, Cash",
        "verboseLabel": "Dividends declared included in accounts payable"
       }
      }
     },
     "localname": "DividendsCash",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DividendsCommonStockCash": {
     "auth_ref": [
      "r223"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of paid and unpaid common stock dividends declared with the form of settlement in cash.",
        "label": "Dividends, Common Stock, Cash",
        "negatedLabel": "Cash dividends declared to stockholders"
       }
      }
     },
     "localname": "DividendsCommonStockCash",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]",
        "terseLabel": "Earnings Per Share [Abstract]"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r65",
      "r98",
      "r99",
      "r100",
      "r101",
      "r102",
      "r107",
      "r109",
      "r111",
      "r112",
      "r113",
      "r117",
      "r118",
      "r292",
      "r293",
      "r370",
      "r385"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "terseLabel": "Earnings per share - basic (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEUNAUDITED",
      "http://www.medifast1.com/role/EARNINGSPERSHAREComputationofBasicandDilutedEPSDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareBasicAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Basic [Abstract]",
        "verboseLabel": "Basic earnings per share"
       }
      }
     },
     "localname": "EarningsPerShareBasicAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEUNAUDITED",
      "http://www.medifast1.com/role/EARNINGSPERSHAREComputationofBasicandDilutedEPSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r65",
      "r98",
      "r99",
      "r100",
      "r101",
      "r102",
      "r109",
      "r111",
      "r112",
      "r113",
      "r117",
      "r118",
      "r292",
      "r293",
      "r370",
      "r385"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "verboseLabel": "Earnings per share - diluted (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEUNAUDITED",
      "http://www.medifast1.com/role/EARNINGSPERSHAREComputationofBasicandDilutedEPSDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDilutedAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Diluted [Abstract]",
        "verboseLabel": "Diluted earnings per share"
       }
      }
     },
     "localname": "EarningsPerShareDilutedAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEUNAUDITED",
      "http://www.medifast1.com/role/EARNINGSPERSHAREComputationofBasicandDilutedEPSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r114",
      "r115",
      "r116",
      "r119"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "verboseLabel": "EARNINGS PER SHARE"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/EARNINGSPERSHARE"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r296"
     ],
     "calculation": {
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 4.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "terseLabel": "Foreign currency impact"
       }
      }
     },
     "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": {
     "auth_ref": [
      "r260"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount",
        "terseLabel": "Employee service share based compensation nonvested awards total compensation cost not yet recognized (less than)"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "auth_ref": [
      "r260"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition",
        "terseLabel": "Compensation cost recognition weighted average period"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions": {
     "auth_ref": [
      "r260"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost to be recognized for nonvested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount",
        "terseLabel": "Unrecognized compensation costs"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense": {
     "auth_ref": [
      "r259"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax benefit for recognition of expense of award under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Expense, Tax Benefit",
        "terseLabel": "Total income tax benefit recognized related to restricted stock awards"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeStockOptionMember": {
     "auth_ref": [
      "r258"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.",
        "label": "Share-based Payment Arrangement, Option [Member]",
        "terseLabel": "Stock Options"
       }
      }
     },
     "localname": "EmployeeStockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Abstract]"
       }
      }
     },
     "localname": "EquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r0",
      "r57",
      "r58",
      "r59",
      "r93",
      "r94",
      "r95",
      "r97",
      "r103",
      "r105",
      "r120",
      "r155",
      "r218",
      "r223",
      "r263",
      "r264",
      "r265",
      "r273",
      "r274",
      "r291",
      "r297",
      "r298",
      "r299",
      "r300",
      "r301",
      "r303",
      "r390",
      "r391",
      "r392",
      "r414"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMEAccumulatedOtherComprehensiveIncomeDetails",
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYUNAUDITED"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EurodollarMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate based on U.S. dollar denominated deposits at foreign banks or foreign branches of U.S. banks.",
        "label": "Eurodollar [Member]",
        "terseLabel": "Eurodollar"
       }
      }
     },
     "localname": "EurodollarMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r197",
      "r211",
      "r212",
      "r227",
      "r228",
      "r229",
      "r230",
      "r231",
      "r232",
      "r233",
      "r234",
      "r294",
      "r328",
      "r329",
      "r330"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/FINANCIALINSTRUMENTSCashandFinancialAssetsThatareMeasuredatFairValueonaRecurringBasisforEachoftheHierarchyLevelsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r197",
      "r227",
      "r228",
      "r233",
      "r234",
      "r294",
      "r328"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Level 1:"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/FINANCIALINSTRUMENTSCashandFinancialAssetsThatareMeasuredatFairValueonaRecurringBasisforEachoftheHierarchyLevelsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r197",
      "r211",
      "r212",
      "r227",
      "r228",
      "r233",
      "r234",
      "r294",
      "r329"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Level 2:"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/FINANCIALINSTRUMENTSCashandFinancialAssetsThatareMeasuredatFairValueonaRecurringBasisforEachoftheHierarchyLevelsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r197",
      "r211",
      "r212",
      "r227",
      "r228",
      "r229",
      "r230",
      "r231",
      "r232",
      "r233",
      "r234",
      "r328",
      "r329",
      "r330"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/FINANCIALINSTRUMENTSCashandFinancialAssetsThatareMeasuredatFairValueonaRecurringBasisforEachoftheHierarchyLevelsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FinancialInstrumentAxis": {
     "auth_ref": [
      "r149",
      "r150",
      "r151",
      "r152",
      "r153",
      "r156",
      "r157",
      "r158",
      "r159",
      "r160",
      "r162",
      "r163",
      "r164",
      "r165",
      "r208",
      "r217",
      "r290",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350",
      "r351",
      "r352",
      "r353",
      "r354",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of financial instrument.",
        "label": "Financial Instrument [Axis]",
        "terseLabel": "Financial Instrument [Axis]"
       }
      }
     },
     "localname": "FinancialInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/FINANCIALINSTRUMENTSCashandFinancialAssetsThatareMeasuredatFairValueonaRecurringBasisforEachoftheHierarchyLevelsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FinancialInstrumentsDisclosureTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for financial instruments. This disclosure includes, but is not limited to, fair value measurements of short and long term marketable securities, international currencies forward contracts, and auction rate securities. Financial instruments may include hedging and non-hedging currency exchange instruments, derivatives, securitizations and securities available for sale at fair value. Also included are investment results, realized and unrealized gains and losses as well as impairments and risk management disclosures.",
        "label": "Financial Instruments Disclosure [Text Block]",
        "verboseLabel": "FINANCIAL INSTRUMENTS"
       }
      }
     },
     "localname": "FinancialInstrumentsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/FINANCIALINSTRUMENTS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GrossProfit": {
     "auth_ref": [
      "r67",
      "r88",
      "r133",
      "r135",
      "r138",
      "r141",
      "r143",
      "r154",
      "r171",
      "r172",
      "r173",
      "r175",
      "r176",
      "r177",
      "r178",
      "r179",
      "r180",
      "r181",
      "r295"
     ],
     "calculation": {
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEUNAUDITED": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.",
        "label": "Gross Profit",
        "totalLabel": "Gross profit"
       }
      }
     },
     "localname": "GrossProfit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [
      "r61",
      "r133",
      "r135",
      "r138",
      "r141",
      "r143",
      "r358",
      "r366",
      "r371",
      "r386"
     ],
     "calculation": {
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEUNAUDITED": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "totalLabel": "Income from operations before income taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r90",
      "r104",
      "r105",
      "r132",
      "r271",
      "r275",
      "r279",
      "r387"
     ],
     "calculation": {
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEUNAUDITED": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "terseLabel": "Provision for income taxes"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxesPaidNet": {
     "auth_ref": [
      "r83"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.",
        "label": "Income Taxes Paid, Net",
        "terseLabel": "Income taxes paid"
       }
      }
     },
     "localname": "IncomeTaxesPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": {
     "auth_ref": [
      "r79"
     ],
     "calculation": {
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.",
        "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities",
        "terseLabel": "Accounts payable and accrued expenses"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "auth_ref": [
      "r79"
     ],
     "calculation": {
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Inventories",
        "negatedLabel": "Inventories"
       }
      }
     },
     "localname": "IncreaseDecreaseInInventories",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Change in operating assets and liabilities:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingAssets": {
     "auth_ref": [
      "r79"
     ],
     "calculation": {
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in operating assets classified as other.",
        "label": "Increase (Decrease) in Other Operating Assets",
        "negatedLabel": "Other assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherOperatingAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
     "auth_ref": [
      "r79"
     ],
     "calculation": {
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.",
        "label": "Increase (Decrease) in Prepaid Expense and Other Assets",
        "negatedLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInPrepaidTaxes": {
     "auth_ref": [
      "r79"
     ],
     "calculation": {
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) of consideration paid in advance for income and other taxes that provide economic benefits in future periods.",
        "label": "Increase (Decrease) in Prepaid Taxes",
        "negatedTerseLabel": "Income taxes, prepaid"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidTaxes",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYUNAUDITED"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InterestIncomeExpenseNonoperatingNet": {
     "auth_ref": [],
     "calculation": {
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEUNAUDITED": {
       "order": 1.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net amount of nonoperating interest income (expense).",
        "label": "Interest Income (Expense), Nonoperating, Net",
        "verboseLabel": "Interest expense"
       }
      }
     },
     "localname": "InterestIncomeExpenseNonoperatingNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestReceivable": {
     "auth_ref": [
      "r41"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of interest earned but not received. Also called accrued interest or accrued interest receivable.",
        "label": "Interest Receivable",
        "terseLabel": "Accrued Interest"
       }
      }
     },
     "localname": "InterestReceivable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/FINANCIALINSTRUMENTSCashandFinancialAssetsThatareMeasuredatFairValueonaRecurringBasisforEachoftheHierarchyLevelsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Inventory Disclosure [Abstract]",
        "terseLabel": "Inventory Disclosure [Abstract]"
       }
      }
     },
     "localname": "InventoryDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_InventoryDisclosureTextBlock": {
     "auth_ref": [
      "r167"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.",
        "label": "Inventory Disclosure [Text Block]",
        "verboseLabel": "INVENTORIES"
       }
      }
     },
     "localname": "InventoryDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/INVENTORIES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InventoryFinishedGoods": {
     "auth_ref": [
      "r38"
     ],
     "calculation": {
      "http://www.medifast1.com/role/INVENTORIESDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer.",
        "label": "Inventory, Finished Goods, Gross",
        "terseLabel": "Finished goods"
       }
      }
     },
     "localname": "InventoryFinishedGoods",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/INVENTORIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r4",
      "r40",
      "r324"
     ],
     "calculation": {
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://www.medifast1.com/role/INVENTORIESDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Net",
        "terseLabel": "Inventories",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED",
      "http://www.medifast1.com/role/INVENTORIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryRawMaterials": {
     "auth_ref": [
      "r39"
     ],
     "calculation": {
      "http://www.medifast1.com/role/INVENTORIESDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before valuation and LIFO reserves of raw materials expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Raw Materials, Gross",
        "terseLabel": "Raw materials"
       }
      }
     },
     "localname": "InventoryRawMaterials",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/INVENTORIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryValuationReserves": {
     "auth_ref": [
      "r40",
      "r166"
     ],
     "calculation": {
      "http://www.medifast1.com/role/INVENTORIESDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of valuation reserve for inventory.",
        "label": "Inventory Valuation Reserves",
        "negatedLabel": "Reserve for obsolete inventory"
       }
      }
     },
     "localname": "InventoryValuationReserves",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/INVENTORIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentOwnedAtFairValue": {
     "auth_ref": [
      "r396",
      "r397",
      "r398"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of the investment at close of period. For schedules of investments that are categorized, the value would be aggregated by category. For investment in and advances to affiliates, if operations of any controlled companies are different in character from those of the company, group such affiliates within divisions and by type of activities.",
        "label": "Investment Owned, at Fair Value",
        "terseLabel": "Investment Securities"
       }
      }
     },
     "localname": "InvestmentOwnedAtFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/FINANCIALINSTRUMENTSCashandFinancialAssetsThatareMeasuredatFairValueonaRecurringBasisforEachoftheHierarchyLevelsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentsAllOtherInvestmentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investments, All Other Investments [Abstract]",
        "terseLabel": "Investments, All Other Investments [Abstract]"
       }
      }
     },
     "localname": "InvestmentsAllOtherInvestmentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_LeaseCostTableTextBlock": {
     "auth_ref": [
      "r318"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.",
        "label": "Lease, Cost [Table Text Block]",
        "terseLabel": "Summary of Supplemental Cash Flow Information"
       }
      }
     },
     "localname": "LeaseCostTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/LEASESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LeasesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases [Abstract]",
        "terseLabel": "Leases [Abstract]"
       }
      }
     },
     "localname": "LeasesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeaseDescriptionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Lessee, Lease, Description [Line Items]",
        "terseLabel": "Lessee, Lease, Description [Line Items]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/LEASESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeaseDescriptionTable": {
     "auth_ref": [
      "r313"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about lessee's leases.",
        "label": "Lessee, Lease, Description [Table]",
        "terseLabel": "Lessee, Lease, Description [Table]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/LEASESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "auth_ref": [
      "r319"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.",
        "label": "Lessee, Operating Lease, Liability, Maturity [Table Text Block]",
        "terseLabel": "Summary of Maturity of the Company's Operating Lease Liabilities"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/LEASESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r319"
     ],
     "calculation": {
      "http://www.medifast1.com/role/LEASESFutureMinimumLeaseCommitmentsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.medifast1.com/role/LEASESFutureMinimumLeaseCommitmentsDetails_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.",
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "totalLabel": "Total lease payments"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/LEASESFutureMinimumLeaseCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r319"
     ],
     "calculation": {
      "http://www.medifast1.com/role/LEASESFutureMinimumLeaseCommitmentsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year One",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/LEASESFutureMinimumLeaseCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [
      "r319"
     ],
     "calculation": {
      "http://www.medifast1.com/role/LEASESFutureMinimumLeaseCommitmentsDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/LEASESFutureMinimumLeaseCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r319"
     ],
     "calculation": {
      "http://www.medifast1.com/role/LEASESFutureMinimumLeaseCommitmentsDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/LEASESFutureMinimumLeaseCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r319"
     ],
     "calculation": {
      "http://www.medifast1.com/role/LEASESFutureMinimumLeaseCommitmentsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/LEASESFutureMinimumLeaseCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear": {
     "auth_ref": [
      "r319"
     ],
     "calculation": {
      "http://www.medifast1.com/role/LEASESFutureMinimumLeaseCommitmentsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year.",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year",
        "terseLabel": "2022 (excluding the nine months ended September\u00a030, 2022)"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/LEASESFutureMinimumLeaseCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [
      "r319"
     ],
     "calculation": {
      "http://www.medifast1.com/role/LEASESFutureMinimumLeaseCommitmentsDetails_1": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.",
        "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
        "negatedLabel": "Less: imputed interest"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/LEASESFutureMinimumLeaseCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseTermOfContract": {
     "auth_ref": [
      "r312"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lessee, Operating Lease, Term of Contract",
        "terseLabel": "Lease term"
       }
      }
     },
     "localname": "LesseeOperatingLeaseTermOfContract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/LEASESNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "auth_ref": [
      "r321"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.",
        "label": "Lessee, Operating Leases [Text Block]",
        "verboseLabel": "LEASES"
       }
      }
     },
     "localname": "LesseeOperatingLeasesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/LEASES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LetterOfCreditMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A document typically issued by a financial institution which acts as a guarantee of payment to a beneficiary, or as the source of payment for a specific transaction (for example, wiring funds to a foreign exporter if and when specified merchandise is accepted pursuant to the terms of the letter of credit).",
        "label": "Letter of Credit [Member]",
        "terseLabel": "Letter of Credit"
       }
      }
     },
     "localname": "LetterOfCreditMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r34",
      "r88",
      "r137",
      "r154",
      "r171",
      "r172",
      "r173",
      "r175",
      "r176",
      "r177",
      "r178",
      "r179",
      "r180",
      "r181",
      "r284",
      "r287",
      "r288",
      "r295",
      "r322",
      "r323"
     ],
     "calculation": {
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r24",
      "r88",
      "r154",
      "r295",
      "r324",
      "r362",
      "r380"
     ],
     "calculation": {
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "LIABILITIES AND STOCKHOLDERS' EQUITY"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r35",
      "r88",
      "r154",
      "r171",
      "r172",
      "r173",
      "r175",
      "r176",
      "r177",
      "r178",
      "r179",
      "r180",
      "r181",
      "r284",
      "r287",
      "r288",
      "r295",
      "r322",
      "r323",
      "r324"
     ],
     "calculation": {
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "terseLabel": "Current Liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCreditFacilityCommitmentFeePercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The fee, expressed as a percentage of the line of credit facility, for the line of credit facility regardless of whether the facility has been used.",
        "label": "Line of Credit Facility, Commitment Fee Percentage",
        "terseLabel": "Commitment fee percentage"
       }
      }
     },
     "localname": "LineOfCreditFacilityCommitmentFeePercentage",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "auth_ref": [
      "r32"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "terseLabel": "Credit facility maximum borrowing capacity"
       }
      }
     },
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LinesOfCreditCurrent": {
     "auth_ref": [
      "r13",
      "r360"
     ],
     "calculation": {
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The carrying value as of the balance sheet date of the current portion of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.",
        "label": "Line of Credit, Current",
        "terseLabel": "Revolving credit facility"
       }
      }
     },
     "localname": "LinesOfCreditCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MarketableSecurities": {
     "auth_ref": [
      "r365"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in marketable security.",
        "label": "Marketable Securities",
        "terseLabel": "Cost"
       }
      }
     },
     "localname": "MarketableSecurities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/FINANCIALINSTRUMENTSCashandFinancialAssetsThatareMeasuredatFairValueonaRecurringBasisforEachoftheHierarchyLevelsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MarketableSecuritiesUnrealizedGainLoss": {
     "auth_ref": [
      "r66"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrealized gain (loss) on investment in marketable security.",
        "label": "Marketable Securities, Unrealized Gain (Loss)",
        "terseLabel": "Unrealized Gains"
       }
      }
     },
     "localname": "MarketableSecuritiesUnrealizedGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/FINANCIALINSTRUMENTSCashandFinancialAssetsThatareMeasuredatFairValueonaRecurringBasisforEachoftheHierarchyLevelsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MoneyMarketFundsMember": {
     "auth_ref": [
      "r227"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fund that invests in short-term money-market instruments, for example, but not limited to, commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and other highly liquid securities.",
        "label": "Money Market Funds [Member]",
        "terseLabel": "Money market accounts"
       }
      }
     },
     "localname": "MoneyMarketFundsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/FINANCIALINSTRUMENTSCashandFinancialAssetsThatareMeasuredatFairValueonaRecurringBasisforEachoftheHierarchyLevelsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MunicipalBondsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long-term debt securities issued by state, city or local governments or the agencies operated by state, city or local governments.",
        "label": "Municipal Bonds [Member]",
        "terseLabel": "Municipal bonds"
       }
      }
     },
     "localname": "MunicipalBondsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/FINANCIALINSTRUMENTSCashandFinancialAssetsThatareMeasuredatFairValueonaRecurringBasisforEachoftheHierarchyLevelsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r77"
     ],
     "calculation": {
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash flow used in financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "verboseLabel": "Financing Activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r77"
     ],
     "calculation": {
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash flow used in investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "Investing Activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r77",
      "r78",
      "r81"
     ],
     "calculation": {
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash flow provided by operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Operating Activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r2",
      "r51",
      "r54",
      "r59",
      "r62",
      "r81",
      "r88",
      "r96",
      "r98",
      "r99",
      "r100",
      "r101",
      "r104",
      "r105",
      "r110",
      "r133",
      "r135",
      "r138",
      "r141",
      "r143",
      "r154",
      "r171",
      "r172",
      "r173",
      "r175",
      "r176",
      "r177",
      "r178",
      "r179",
      "r180",
      "r181",
      "r293",
      "r295",
      "r367",
      "r382"
     ],
     "calculation": {
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUNAUDITED": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      },
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEUNAUDITED": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "terseLabel": "Net income",
        "totalLabel": "Net income",
        "verboseLabel": "Net income"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED",
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYUNAUDITED",
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUNAUDITED",
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEUNAUDITED",
      "http://www.medifast1.com/role/EARNINGSPERSHAREComputationofBasicandDilutedEPSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "verboseLabel": "Accounting Pronouncements Adopted in 2022"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NoncashContributionExpense": {
     "auth_ref": [
      "r81"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Noncash charitable contributions made by the entity during the period.",
        "label": "Noncash Contribution Expense",
        "terseLabel": "Donated inventory"
       }
      }
     },
     "localname": "NoncashContributionExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/INVENTORIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NonoperatingIncomeExpense": {
     "auth_ref": [
      "r70"
     ],
     "calculation": {
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEUNAUDITED": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).",
        "label": "Nonoperating Income (Expense)",
        "totalLabel": "Total other (expense) income"
       }
      }
     },
     "localname": "NonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NonoperatingIncomeExpenseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Nonoperating Income (Expense) [Abstract]",
        "terseLabel": "Other income (expense)"
       }
      }
     },
     "localname": "NonoperatingIncomeExpenseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEUNAUDITED"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r133",
      "r135",
      "r138",
      "r141",
      "r143"
     ],
     "calculation": {
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEUNAUDITED": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "totalLabel": "Income from operations"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseExpense": {
     "auth_ref": [
      "r310"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating lease expense. Excludes sublease income.",
        "label": "Operating Lease, Expense",
        "verboseLabel": "Operating lease expense"
       }
      }
     },
     "localname": "OperatingLeaseExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/LEASESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Operating Lease, Liability, Payment, Due [Abstract]",
        "terseLabel": "Lessee, Operating Lease, Liability, Payment, Due [Abstract]"
       }
      }
     },
     "localname": "OperatingLeaseLiabilitiesPaymentsDueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/LEASESFutureMinimumLeaseCommitmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingLeaseLiability": {
     "auth_ref": [
      "r309"
     ],
     "calculation": {
      "http://www.medifast1.com/role/LEASESFutureMinimumLeaseCommitmentsDetails_1": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.",
        "label": "Operating Lease, Liability",
        "terseLabel": "Total"
       }
      }
     },
     "localname": "OperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/LEASESFutureMinimumLeaseCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r309"
     ],
     "calculation": {
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease, Liability, Current",
        "terseLabel": "Current lease obligations"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r309"
     ],
     "calculation": {
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "terseLabel": "Lease obligations, net of current lease obligations"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasePayments": {
     "auth_ref": [
      "r311",
      "r314"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.",
        "label": "Operating Lease, Payments",
        "terseLabel": "Cash paid for amounts included in the measurements of lease liabilities - Operating cash flow used in operating leases"
       }
      }
     },
     "localname": "OperatingLeasePayments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/LEASESSupplementalCashFlowInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r308"
     ],
     "calculation": {
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "terseLabel": "Right-of-use assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r317",
      "r320"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average discount rate for operating lease calculated at point in time.",
        "label": "Operating Lease, Weighted Average Discount Rate, Percent",
        "terseLabel": "Weighted average discount rate"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/LEASESSupplementalCashFlowInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r316",
      "r320"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Operating Lease, Weighted Average Remaining Lease Term",
        "terseLabel": "Weighted average remaining lease term"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/LEASESSupplementalCashFlowInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r92",
      "r106",
      "r128",
      "r289"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the general note to the financial statements for the reporting entity which may include, descriptions of the basis of presentation, business description, significant accounting policies, consolidations, reclassifications, new pronouncements not yet adopted and changes in accounting principles.",
        "label": "Organization, Consolidation, Basis of Presentation, Business Description and Accounting Policies [Text Block]",
        "verboseLabel": "Presentation of Financial Statements"
       }
      }
     },
     "localname": "OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r31"
     ],
     "calculation": {
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Other assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent": {
     "auth_ref": [
      "r281",
      "r282",
      "r285"
     ],
     "calculation": {
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUNAUDITED": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments, of appreciation (loss) in value of unsold available-for-sale securities, attributable to parent entity. Excludes amounts related to other than temporary impairment (OTTI) loss.",
        "label": "Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, Net of Tax, Portion Attributable to Parent",
        "terseLabel": "Unrealized losses on investment securities"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent": {
     "auth_ref": [
      "r281",
      "r282",
      "r285"
     ],
     "calculation": {
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUNAUDITED": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent",
        "terseLabel": "Foreign currency translation"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]",
        "verboseLabel": "Other comprehensive income (loss), net of tax:"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUNAUDITED"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent": {
     "auth_ref": [
      "r52",
      "r55",
      "r281",
      "r282",
      "r285"
     ],
     "calculation": {
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUNAUDITED": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of other comprehensive income (loss) attributable to parent entity.",
        "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent",
        "terseLabel": "Other comprehensive Income (loss)",
        "totalLabel": "Other comprehensive income (loss), net of tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYUNAUDITED",
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r71"
     ],
     "calculation": {
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEUNAUDITED": {
       "order": 2.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income (Expense)",
        "verboseLabel": "Other income (expense)"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRepurchaseOfCommonStock": {
     "auth_ref": [
      "r76"
     ],
     "calculation": {
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow to reacquire common stock during the period.",
        "label": "Payments for Repurchase of Common Stock",
        "negatedLabel": "Stock repurchases"
       }
      }
     },
     "localname": "PaymentsForRepurchaseOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRepurchaseOfOtherEquity": {
     "auth_ref": [
      "r76"
     ],
     "calculation": {
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow to reacquire equity classified as other.",
        "label": "Payments for Repurchase of Other Equity",
        "negatedLabel": "Net shares repurchased for taxes"
       }
      }
     },
     "localname": "PaymentsForRepurchaseOfOtherEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDividends": {
     "auth_ref": [
      "r76"
     ],
     "calculation": {
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash outflow in the form of capital distributions and dividends to common shareholders, preferred shareholders and noncontrolling interests.",
        "label": "Payments of Dividends",
        "negatedLabel": "Cash dividends paid to stockholders"
       }
      }
     },
     "localname": "PaymentsOfDividends",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r74"
     ],
     "calculation": {
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Purchase of property and equipment"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PerformanceSharesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement awarded for meeting performance target.",
        "label": "Performance Shares [Member]",
        "terseLabel": "Performance-Based Shares"
       }
      }
     },
     "localname": "PerformanceSharesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails",
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONSummaryofPerformancebasedShareAwardsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r6",
      "r28",
      "r29"
     ],
     "calculation": {
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense and Other Assets, Current",
        "terseLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidTaxes": {
     "auth_ref": [
      "r5",
      "r7",
      "r168",
      "r169"
     ],
     "calculation": {
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for income and other taxes that provide economic benefits within a future period of one year or the normal operating cycle, if longer.",
        "label": "Prepaid Taxes",
        "terseLabel": "Income taxes, prepaid"
       }
      }
     },
     "localname": "PrepaidTaxes",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PriorPeriodReclassificationAdjustmentDescription": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error.",
        "label": "Reclassification, Comparability Adjustment [Policy Text Block]",
        "verboseLabel": "Reclassification"
       }
      }
     },
     "localname": "PriorPeriodReclassificationAdjustmentDescription",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ProceedsFromSaleOfShortTermInvestments": {
     "auth_ref": [
      "r73"
     ],
     "calculation": {
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from sales of all investments, including securities and other assets, having ready marketability and intended by management to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term.",
        "label": "Proceeds from Sale of Short-term Investments",
        "terseLabel": "Sale and maturities of investment securities"
       }
      }
     },
     "localname": "ProceedsFromSaleOfShortTermInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromStockOptionsExercised": {
     "auth_ref": [
      "r75",
      "r262"
     ],
     "calculation": {
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement.",
        "label": "Proceeds from Stock Options Exercised",
        "terseLabel": "Proceeds from stock options exercised",
        "verboseLabel": "Options exercised by executives and directors"
       }
      }
     },
     "localname": "ProceedsFromStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED",
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r11",
      "r12",
      "r170",
      "r324",
      "r372",
      "r381"
     ],
     "calculation": {
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "terseLabel": "Property, plant and equipment - net of accumulated depreciation"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepurchaseAgreementsResaleAgreementsSecuritiesBorrowedAndSecuritiesLoanedDisclosureTextBlock": {
     "auth_ref": [
      "r355"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for repurchase agreements (also known as repos), resale agreements (also known as reverse repurchase agreements or reverse repos), securities borrowed transactions, and securities loaned transactions.",
        "label": "Repurchase Agreements, Resale Agreements, Securities Borrowed, and Securities Loaned Disclosure [Text Block]",
        "terseLabel": "ACCELERATED SHARE REPURCHASE (\"ASR\") PROGRAM"
       }
      }
     },
     "localname": "RepurchaseAgreementsResaleAgreementsSecuritiesBorrowedAndSecuritiesLoanedDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/ACCELERATEDSHAREREPURCHASEASRPROGRAM"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RestrictedStockMember": {
     "auth_ref": [
      "r114"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock including a provision that prohibits sale or substantive sale of an equity instrument for a specified period of time or until specified performance conditions are met.",
        "label": "Restricted Stock [Member]",
        "terseLabel": "Restricted Stock"
       }
      }
     },
     "localname": "RestrictedStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/EARNINGSPERSHARENarrativeDetails",
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails",
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONRestrictedStockActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetailRelatedInventoryPackagingAndOtherSupplies": {
     "auth_ref": [
      "r40"
     ],
     "calculation": {
      "http://www.medifast1.com/role/INVENTORIESDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of items used in storage, presentation or transportation of physical goods that are targeted for sale to end users.",
        "label": "Retail Related Inventory, Packaging and Other Supplies",
        "terseLabel": "Packaging"
       }
      }
     },
     "localname": "RetailRelatedInventoryPackagingAndOtherSupplies",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/INVENTORIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r20",
      "r223",
      "r266",
      "r324",
      "r379",
      "r393",
      "r395"
     ],
     "calculation": {
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Retained earnings"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r0",
      "r93",
      "r94",
      "r95",
      "r97",
      "r103",
      "r105",
      "r155",
      "r263",
      "r264",
      "r265",
      "r273",
      "r274",
      "r291",
      "r390",
      "r392"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Retained Earnings"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYUNAUDITED"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Revenues": {
     "auth_ref": [
      "r60",
      "r88",
      "r129",
      "r130",
      "r134",
      "r139",
      "r140",
      "r144",
      "r145",
      "r146",
      "r154",
      "r171",
      "r172",
      "r173",
      "r175",
      "r176",
      "r177",
      "r178",
      "r179",
      "r180",
      "r181",
      "r295",
      "r371"
     ],
     "calculation": {
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEUNAUDITED": {
       "order": 1.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).",
        "label": "Revenues",
        "verboseLabel": "Revenue"
       }
      }
     },
     "localname": "Revenues",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevolvingCreditFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.",
        "label": "Revolving Credit Facility [Member]",
        "terseLabel": "Senior Secured Revolving Credit Facility"
       }
      }
     },
     "localname": "RevolvingCreditFacilityMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": {
     "auth_ref": [
      "r315",
      "r320"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability.",
        "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability",
        "verboseLabel": "Right-of-use assets obtained in exchange for lease obligations - Operating leases"
       }
      }
     },
     "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/LEASESSupplementalCashFlowInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r50",
      "r302",
      "r303"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss).",
        "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Schedule of Accumulated Other Comprehensive Income"
       }
      }
     },
     "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMETables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation of available-for-sale securities from cost basis to fair value.",
        "label": "Schedule of Available-for-sale Securities Reconciliation [Table Text Block]",
        "terseLabel": "Schedule of Cash and Financial Assets that are Measured at Fair Value on a Recurring Basis for each of the Hierarchy Levels"
       }
      }
     },
     "localname": "ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/FINANCIALINSTRUMENTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r113"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "terseLabel": "Schedule of the Computation of Basic and Diluted EPS"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/EARNINGSPERSHARETables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": {
     "auth_ref": [
      "r9",
      "r25",
      "r26",
      "r27"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.",
        "label": "Schedule of Inventory, Current [Table Text Block]",
        "terseLabel": "Schedule of Inventories"
       }
      }
     },
     "localname": "ScheduleOfInventoryCurrentTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/INVENTORIESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock": {
     "auth_ref": [
      "r249"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the changes in outstanding nonvested restricted stock units.",
        "label": "Schedule of Nonvested Restricted Stock Units Activity [Table Text Block]",
        "terseLabel": "Summary of Restricted Stock Activity"
       }
      }
     },
     "localname": "ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r239",
      "r261"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]",
        "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails",
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONRestrictedStockActivityDetails",
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONSummaryofPerformancebasedShareAwardsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "auth_ref": [
      "r243",
      "r254",
      "r256"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.",
        "label": "Share-based Payment Arrangement, Option, Activity [Table Text Block]",
        "terseLabel": "Summary of Stock Option Activity"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r69"
     ],
     "calculation": {
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEUNAUDITED": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.",
        "label": "Selling, General and Administrative Expense",
        "verboseLabel": "Selling, general, and administrative"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r79"
     ],
     "calculation": {
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Noncash Expense",
        "terseLabel": "Share-based compensation"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "auth_ref": [
      "r240"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period",
        "verboseLabel": "Award vesting period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": {
     "auth_ref": [
      "r248"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period",
        "negatedTerseLabel": "Forfeited (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONRestrictedStockActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r253"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value",
        "terseLabel": "Forfeited (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONRestrictedStockActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "auth_ref": [
      "r251"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "terseLabel": "Granted (in shares)",
        "verboseLabel": "Shares granted in period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails",
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONRestrictedStockActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r251"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Granted (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONRestrictedStockActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "auth_ref": [
      "r250"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
        "periodEndLabel": "Outstanding at end of period (in shares)",
        "periodStartLabel": "Outstanding at beginning of period (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONRestrictedStockActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]",
        "terseLabel": "Shares"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONRestrictedStockActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r250"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value",
        "periodEndLabel": "Outstanding at end of period (in dollars per share)",
        "periodStartLabel": "Outstanding at beginning of period (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONRestrictedStockActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]",
        "terseLabel": "Weighted-Average Grant Date Fair Value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONRestrictedStockActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": {
     "auth_ref": [
      "r252"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period",
        "negatedLabel": "Vested (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONRestrictedStockActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue": {
     "auth_ref": [
      "r255"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value",
        "terseLabel": "Share-based compensation arrangement, fair value of awards vested"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r252"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Vested (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONRestrictedStockActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails",
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONRestrictedStockActivityDetails",
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONSummaryofPerformancebasedShareAwardsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": {
     "auth_ref": [
      "r246"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number",
        "verboseLabel": "Shares, Exercisable at end of the period (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONStockOptionsActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": {
     "auth_ref": [
      "r246"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price",
        "verboseLabel": "Weighted-Average Exercise Price, Exercisable at end of the period (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONStockOptionsActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue": {
     "auth_ref": [
      "r255"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value",
        "terseLabel": "Intrinsic value of options exercised"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross number of share options (or share units) granted during the period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross",
        "terseLabel": "Share-based compensation arrangement by share-based payment award, options, grants in period, gross"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": {
     "auth_ref": [
      "r261"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value",
        "terseLabel": "Aggregate intrinsic value of options outstanding"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "auth_ref": [
      "r245",
      "r261"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options outstanding, including both vested and non-vested options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number",
        "periodEndLabel": "Shares, Outstanding at end of the period (in shares)",
        "periodStartLabel": "Shares, Outstanding at beginning of period (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONStockOptionsActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]",
        "terseLabel": "Awards"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONStockOptionsActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r244"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "periodEndLabel": "Weighted-Average Exercise Price, Outstanding at end of the period (in dollars per share)",
        "periodStartLabel": "Weighted-Average Exercise Price, Outstanding at beginning of period (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONStockOptionsActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]",
        "terseLabel": "Weighted-Average Exercise Price"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONStockOptionsActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod": {
     "auth_ref": [
      "r261"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued under share-based payment arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period",
        "verboseLabel": "Share-based compensation (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYUNAUDITED"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r237",
      "r242"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Award Type [Domain]",
        "terseLabel": "Equity Award [Domain]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails",
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONRestrictedStockActivityDetails",
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONSummaryofPerformancebasedShareAwardsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price",
        "verboseLabel": "Weighted-Average Exercise Price, Exercised (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONStockOptionsActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit": {
     "auth_ref": [
      "r258"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The floor of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range.",
        "label": "Share-based Payment Arrangement, Option, Exercise Price Range, Lower Range Limit",
        "verboseLabel": "Share-based compensation, shares authorized under stock option plans, exercise price range, lower range limit (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit": {
     "auth_ref": [
      "r258"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The ceiling of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range.",
        "label": "Share-based Payment Arrangement, Option, Exercise Price Range, Upper Range Limit",
        "verboseLabel": "Share-based compensation, shares authorized under stock option plans, exercise price range, upper range limit (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod": {
     "auth_ref": [
      "r241"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period",
        "terseLabel": "Award expiration period"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": {
     "auth_ref": [
      "r261"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value",
        "terseLabel": "Aggregate intrinsic value of options exercisable"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": {
     "auth_ref": [
      "r261"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term",
        "terseLabel": "Weighted-average remaining contractual life of options exercisable"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "auth_ref": [
      "r257"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term",
        "terseLabel": "Weighted-average remaining contractual life of options outstanding"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares used to settle grantee's tax withholding obligation for award under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Shares Withheld for Tax Withholding Obligation",
        "negatedLabel": "Net shares repurchased for taxes (in shares)",
        "terseLabel": "Shares withheld for employee taxes"
       }
      }
     },
     "localname": "SharesPaidForTaxWithholdingForShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYUNAUDITED",
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShortTermInvestments": {
     "auth_ref": [
      "r14",
      "r363",
      "r364",
      "r376"
     ],
     "calculation": {
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.",
        "label": "Short-term Investments",
        "terseLabel": "Investment securities"
       }
      }
     },
     "localname": "ShortTermInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r85",
      "r92"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.",
        "label": "Significant Accounting Policies [Text Block]",
        "verboseLabel": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r0",
      "r37",
      "r57",
      "r58",
      "r59",
      "r93",
      "r94",
      "r95",
      "r97",
      "r103",
      "r105",
      "r120",
      "r155",
      "r218",
      "r223",
      "r263",
      "r264",
      "r265",
      "r273",
      "r274",
      "r291",
      "r297",
      "r298",
      "r299",
      "r300",
      "r301",
      "r303",
      "r390",
      "r391",
      "r392",
      "r414"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMEAccumulatedOtherComprehensiveIncomeDetails",
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYUNAUDITED"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYUNAUDITED",
      "http://www.medifast1.com/role/EARNINGSPERSHARENarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]",
        "terseLabel": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]",
        "terseLabel": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r93",
      "r94",
      "r95",
      "r120",
      "r357"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYUNAUDITED",
      "http://www.medifast1.com/role/EARNINGSPERSHARENarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": {
     "auth_ref": [
      "r17",
      "r18",
      "r218",
      "r223"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture",
        "terseLabel": "Shares"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONSummaryofPerformancebasedShareAwardsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r17",
      "r18",
      "r218",
      "r223",
      "r247"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period",
        "negatedLabel": "Shares, Exercised (in shares)",
        "terseLabel": "Options exercised by executives and directors (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYUNAUDITED",
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONStockOptionsActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": {
     "auth_ref": [
      "r37",
      "r218",
      "r223"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued as a result of the exercise of stock options.",
        "label": "Stock Issued During Period, Value, Stock Options Exercised",
        "terseLabel": "Options exercised by executives and directors"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchaseProgramAuthorizedAmount1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stock repurchase plan authorized.",
        "label": "Stock Repurchase Program, Authorized Amount",
        "terseLabel": "Repurchase amount"
       }
      }
     },
     "localname": "StockRepurchaseProgramAuthorizedAmount1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/ACCELERATEDSHAREREPURCHASEASRPROGRAMDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r18",
      "r22",
      "r23",
      "r88",
      "r147",
      "r154",
      "r295",
      "r324"
     ],
     "calculation": {
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "periodEndLabel": "Balance",
        "periodStartLabel": "Balance",
        "terseLabel": "Accumulated other comprehensive income",
        "totalLabel": "Total stockholders' equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMEAccumulatedOtherComprehensiveIncomeDetails",
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED",
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "terseLabel": "Stockholders' Equity"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Cash Flow Information [Abstract]",
        "terseLabel": "Supplemental disclosure of cash flow information:"
       }
      }
     },
     "localname": "SupplementalCashFlowInformationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": {
     "auth_ref": [
      "r149",
      "r150",
      "r151",
      "r152",
      "r153",
      "r208",
      "r217",
      "r290",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350",
      "r351",
      "r352",
      "r353",
      "r354",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms.",
        "label": "Financial Instruments [Domain]",
        "terseLabel": "Financial Instruments [Domain]"
       }
      }
     },
     "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/FINANCIALINSTRUMENTSCashandFinancialAssetsThatareMeasuredatFairValueonaRecurringBasisforEachoftheHierarchyLevelsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockCommonMember": {
     "auth_ref": [
      "r225"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Previously issued common shares repurchased by the issuing entity and held in treasury.",
        "label": "Treasury Stock, Common [Member]",
        "terseLabel": "Treasury Stock"
       }
      }
     },
     "localname": "TreasuryStockCommonMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYUNAUDITED"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockRetiredCostMethodAmount": {
     "auth_ref": [
      "r18",
      "r218",
      "r224"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease of par value, additional paid in capital (APIC) and retained earnings of common and preferred stock retired from treasury when treasury stock is accounted for under the cost method.",
        "label": "Treasury Stock, Retired, Cost Method, Amount",
        "negatedTerseLabel": "Treasury stock retired from stock repurchases"
       }
      }
     },
     "localname": "TreasuryStockRetiredCostMethodAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TreasuryStockSharesAcquired": {
     "auth_ref": [
      "r18",
      "r218",
      "r223"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares that have been repurchased during the period and are being held in treasury.",
        "label": "Treasury Stock, Shares, Acquired",
        "terseLabel": "Initial amount received (in shares)"
       }
      }
     },
     "localname": "TreasuryStockSharesAcquired",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/ACCELERATEDSHAREREPURCHASEASRPROGRAMDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockSharesRetired": {
     "auth_ref": [
      "r18",
      "r218",
      "r223"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common and preferred stock retired from treasury during the period.",
        "label": "Treasury Stock, Shares, Retired",
        "negatedTerseLabel": "Treasury stock retired from stock repurchases (in shares)"
       }
      }
     },
     "localname": "TreasuryStockSharesRetired",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYUNAUDITED"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockValueAcquiredCostMethod": {
     "auth_ref": [
      "r218",
      "r223",
      "r225"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.",
        "label": "Treasury Stock, Value, Acquired, Cost Method",
        "negatedLabel": "Treasury stock from stock repurchases"
       }
      }
     },
     "localname": "TreasuryStockValueAcquiredCostMethod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TypeOfArrangementAxis": {
     "auth_ref": [
      "r280"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]",
        "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]"
       }
      }
     },
     "localname": "TypeOfArrangementAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/LEASESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r121",
      "r122",
      "r123",
      "r124",
      "r125",
      "r126",
      "r127"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "verboseLabel": "Use of Estimates"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_VariableRateAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of variable rate.",
        "label": "Variable Rate [Axis]",
        "terseLabel": "Variable Rate [Axis]"
       }
      }
     },
     "localname": "VariableRateAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VariableRateDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index.",
        "label": "Variable Rate [Domain]",
        "terseLabel": "Variable Rate [Domain]"
       }
      }
     },
     "localname": "VariableRateDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment": {
     "auth_ref": [
      "r113"
     ],
     "calculation": {
      "http://www.medifast1.com/role/EARNINGSPERSHAREComputationofBasicandDilutedEPSDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation.",
        "label": "Weighted Average Number Diluted Shares Outstanding Adjustment",
        "terseLabel": "Effect of dilutive common stock equivalents (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberDilutedSharesOutstandingAdjustment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/EARNINGSPERSHAREComputationofBasicandDilutedEPSDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r108",
      "r113"
     ],
     "calculation": {
      "http://www.medifast1.com/role/EARNINGSPERSHAREComputationofBasicandDilutedEPSDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "terseLabel": "Diluted (in shares)",
        "totalLabel": "Weighted average shares of common stock outstanding (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEUNAUDITED",
      "http://www.medifast1.com/role/EARNINGSPERSHAREComputationofBasicandDilutedEPSDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]",
        "verboseLabel": "Weighted average shares outstanding -"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEUNAUDITED"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r107",
      "r113"
     ],
     "calculation": {
      "http://www.medifast1.com/role/EARNINGSPERSHAREComputationofBasicandDilutedEPSDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Basic (in shares)",
        "verboseLabel": "Weighted average shares of common stock outstanding (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEUNAUDITED",
      "http://www.medifast1.com/role/EARNINGSPERSHAREComputationofBasicandDilutedEPSDetails"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 4
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=124429488&loc=d3e326-107755"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "250",
   "URI": "http://asc.fasb.org/topic&trid=2122394"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1448-109256"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1505-109256"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1252-109256"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1337-109256"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e3842-109258"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e4984-109258"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "http://asc.fasb.org/topic&trid=2144383"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "275",
   "URI": "http://asc.fasb.org/topic&trid=2134479"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(2))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9031-108599"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9054-108599"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=124260329&loc=d3e26626-111562"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27232-111563"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=SL120269820-111563"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "321",
   "URI": "http://asc.fasb.org/extlink&oid=123583765&loc=SL75117539-209714"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "321",
   "URI": "http://asc.fasb.org/extlink&oid=123583765&loc=SL75117539-209714"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "321",
   "URI": "http://asc.fasb.org/extlink&oid=123583765&loc=SL75117539-209714"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919244-210447"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919253-210447"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919258-210447"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919230-210447"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124258926&loc=SL82898722-210454"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922895-210455"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922900-210455"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121590138&loc=SL82922954-210456"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.BB)",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "330",
   "URI": "http://asc.fasb.org/topic&trid=2126998"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "340",
   "URI": "http://asc.fasb.org/extlink&oid=123349782&loc=d3e5879-108316"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "340",
   "URI": "http://asc.fasb.org/extlink&oid=6387103&loc=d3e6435-108320"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "http://asc.fasb.org/topic&trid=2208564"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21463-112644"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21475-112644"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21506-112644"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21521-112644"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21538-112644"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=SL79508275-113901"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.F)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "http://asc.fasb.org/topic&trid=2228938"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e31917-109318"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(c))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(7))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "808",
   "URI": "http://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569616-111683"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569643-111683"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "810",
   "URI": "http://asc.fasb.org/topic&trid=2197479"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123477628&loc=d3e90205-114008"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.1)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.17)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918638-209977"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918673-209980"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918673-209980"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(1)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(2)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(3)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(4)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918701-209980"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "53",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/subtopic&trid=77888251"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(i)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(ii)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19,20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=66007379&loc=d3e113888-111728"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=109249958&loc=SL34722452-111729"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)(i)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(5)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(6)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(7)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(b)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "860",
   "URI": "http://asc.fasb.org/topic&trid=2197590"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "http://asc.fasb.org/extlink&oid=123353855&loc=SL119991595-234733"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "http://asc.fasb.org/extlink&oid=123384075&loc=d3e41242-110953"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(4))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(5))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.4)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(15))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "405",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=6957935&loc=d3e64057-112817"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(1)(g))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117819544-158441"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "210",
   "Subparagraph": "(b)",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=99383244&loc=d3e12121-115841"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13D(Column C))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=SL120429264-123010"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "http://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "http://asc.fasb.org/extlink&oid=123360121&loc=d3e27327-108691"
  },
  "r401": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r402": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r403": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r404": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a"
  },
  "r405": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r406": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1402"
  },
  "r407": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(1)"
  },
  "r408": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)"
  },
  "r409": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(3)"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.8)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r410": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(i)"
  },
  "r411": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(ii)"
  },
  "r412": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(iii)"
  },
  "r413": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.9)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a),(b),(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e637-108580"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e681-108580"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)(4)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669686-108580"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e557-108580"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(1))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(10))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(21))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(7)(c))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1,2)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6787-107765"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "220",
   "URI": "http://asc.fasb.org/topic&trid=2134417"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3179-108585"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3521-108585"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6801-107765"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3044-108585"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4297-108586"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=SL98516268-108586"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18726-107790"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(c))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(f))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "http://asc.fasb.org/topic&trid=2122369"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>55
<FILENAME>0001628280-22-028255-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001628280-22-028255-xbrl.zip
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M%MO8#!DCBB..GNH8'!5F8-GHVV6I2X0H$6**\8T2(::!$*,1#FJ29EQQY'#
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MD=B$92*V8_D[ZTG0H'4&&&EL&;@FNS1PK?H7NDD0JEY^OUXN-*FU)LL1D80
MB0 5GCCJ#:$4G!6.,Q_4VKH%V2&]?$KN@[.]WL./QZ7(9])DHHQ*G[]>.,LU
M<E_/-7KJ9DG+;.#E3! ;P]AT6YPE>IVE?54KI2VDNJ*Y/A<.0&I-'(ALI2@F
MB8G6$9ZLA,P>P#<C6Z$/MP>KZF7HK#JW3"*J.M^3.L\3#RLB9.Z?F0;(2(!!
M-@U*?S.FC5=>2"VQS,I0?2&@0^K<JM?!=H5[7)W,O#^:NL,V:,:7)?6K-]IC
M87D>BH-4>+H;>%K,B9 L.*ZY(8@H2;:%+#%,)I(8YB-'""\*V^#<]J59Q*=S
M+7F H[2CO:3K)*%[A)NV.%*%F[N"FX4!S1*]TCH0@Y"-&Q,UL<YP8KQ06G $
M#WIM75#5-VIQ2G.%FZZWKN_T-1YE?=YU[K31<;Z;TW[O^- 54CN,34G7<9.@
M0WI#;#KKN!!.CDX.FT8Z$8_'&>2:7B,UY';G3K:9?%X5Z62C_.6Y;&HJ89NU
M_+/#Y\LVDZ"=1<V)XZ7'FF24&)DM<Q,=E4HIRH-96Y>FSVA;$^M6E%<^:D5N
MS[U6%?F>%'F^8[907 7!26 R4\FBS9[Q2(!J8ZAPV@%F159])MJ:1-2UH%['
M2<B;\CT9)7(RP1J]NQ]BL9O1*%.XX?N?T4VPD<!N^F6"C8E; :D]0-I:8!:!
M:\]DY"1&S,P"J"$^2"!21Z#@A!*L>/IMW[!;5Q?5P%UG-;DM9E$U^?XT>8Y:
MH(<H.0]$"\B$@J,C7L;2CTW9:$Q@(93)KM '>6L;H:,QNXY3BR:(W4*H[E$C
M46N<XB)C8&<T#-5-WC8";2]P"<&#I\ 4L8)E! I&$B]\(@I]/D:LTE+*S"5X
M7]DN&3?52]%1+E$U^,XU>(Y#J&1D2L$3FBP28$D5#@%9H1%$TMH(4YHP]4&U
M-=&P>B>6HA";F##K02S51M4[<3],XGS-9W5>^^[C&295@Z9-,'J]0"> JB!T
M)A%@4R#@!"7>*D$")F,9%3Q3B@)&+=0E5<]$9[6X+391M?B>M'B.4ACNN%>!
M$VY*Q .H)@9=)%RE9$R,AI8IR= 'ND*9Q!V=J73;G)J;6C@WN$8K?<N[=(>M
MUK5U/;=\=W_CY][5C<]7N%/IU:F;CZ)3:<>2X.N1VMZ1&A:(L544%;>6! ^9
M'1M%B:-<$!I <$3+F&5KZX*KOI"+CK;5R4?M'BNOX/<HP:_=E/P*?JV"WYP]
MD4+2VCI)= B!0"Q=2Y0.1 4J+,J !E(&/VOZ&0 K^'7<-OC*Z-X.V0<WO<LG
M, WIYZV-'[=^WMK?>KDWFVRYO_OB__Z]^_/FRS=[_]-[^?J7K?VW=5;2*N4J
M?'U6TL\#YP>'7^^+6@<FK4[+FMDIM!%"?I[II'?L3IL9IJ74QH4P/L&+;C:/
MR/*O,TKNP?(_VU.O9EMJ8Q@W9AOJ$H34:M6V&?*'Q6*AZ)#'J!3)!#@SY)0H
M\3[39.V,U J3H5#2<,#T&7^$.;T5IAXE3+5FHU>8>B"8FC/DP1G//0J2]S$2
M\%P2+X4E*C*1G$A!65=Z#(F^H%V"J9:,@!LC3C.&_IZ9(O_,%&_R]0W^.3K\
M,S];+XPQ#J:]Y$+1I-//XFF>H29*WA'S^CG?Q&0WO6@6_TKLJO,4OA.V%@NF
MDBN#F*(CWAI&('I&7&",T!2LQ4!1E7E,+0U4J%G.G57>MOA(5=Z[5-XYSF%E
MAE>O.%':E_SFJ(F/F7A$*3A7"9,S[4U#Z6B&\VIXJ,[]CX>ECK W\OFVFB8O
M-=WY?HNQSZVBTVH3M8Y/BQ54O)A$25*BO$XEN)EM(B4,T2%2%;T"66HX59]=
M$=I<><=-U>0[+<:NFGRGFKQ0C1V4=]Z2H&PV$QS-9@+3902D"RHH"2&*HLF2
M/]IIT5U/<OVB@?+A#>*<M:WIO3@SJAOV[H!JL<K*4^JU%X*D1&D&*G#$B%2B
M1?D(2M'3",4-*Z'/Y>+HAM7)IUI605?(S_)T0:<])TP%G3L%G?FB,&6$<2!)
MD-024#R##DA!9(S!!1F#+G8.4[9O!*^@4SLJ=S6+K\/.M$O[]>=Y)UK_O)=R
M:-7-]A3\_G?L9JN=3N[B!'J[&,8+5#$9+6'-"62,(SXY33Q0IX)'J3U=6^>L
M+_6MZY)K%*^SVGS'KK:JS7>DS?.Y1"B-CT )3\X38)83[[TCUH5(.34:#&9M
M5OW\0X>T>56[##ST;;1VPX^K:K]Q:-[6D7FV $_7IW 'CLP*_NV!_Q\+5$[[
M#/(L,2("DP1X3,09#\1(F[A1$7RI"&5:]LT5^>ZKXTQ85C-7*)S[=-'F#CR8
M%6U:19LYJNF!<:DH)3%F@@D0&7%:<Y*XH"I81U4Q')G-:"-7V75Y7VC3M>+T
M3E_C478ZO9K-[DU'X8^#T6'>?9/_Z94)19?J";KD3NZ02WJ9FI+S:Y]=@I3/
M/V>\N:<'R/I\,3HZ&I4_FJ7>[QV[<>]/=WB"O;]][2Q]A>.] S?&5L[4K9V?
MY@_5V4TU._&5&^^.]Z9EZ."OY<8N_O39>4KK>?KM\_33UG3[Q1?GZ9_Q7[]"
M_/=_#M_QPS_]A]''G7_]],?;#^_I6_Y6Y+6ANYOAT^YF7K%\;SO\UP^[FZ]A
M^U_;;/=7<[J[\;NDW#IN!''-;%81-3%.(4F,!JED,%+KKQ.R:S;1]YF!=1.M
MXB:*#!-(4<856$4@)$V<4C2S.VXU\_F]@&OK]!FE5[53FWNA=XR9S12Q/N]=
MN^^:]R=WY'FXM..:[379.)D>C,89C&.U#3JZ#6F9,ZVXTB9Z$F)(!#1(8EVR
M!#/&Z1BDL!J_@F57[JFV[,NZIU9S3WGO\OG(/+'"94#ST1";H)BKWB:)VBL*
M:^N<]C.[NP&VS?98SWT6_@_?J/&M%E=+S-P\%#/OR!FV-9F<5*QI$VNVOX4U
M;.>WUV+WMRVZ_=NO'[;S,Y=KOMW_S]&[S2W8V0SR[8>7[-W^P<'V3X;^SGQ,
M*//IA=Y% GD?E/'42"237%(5K:1Q;9W1OKW""]\TH.K(R59W6J=WVL?MU[^'
MO)=X9N/$&YY/-<L5,98EPD!8&9/ST;&\UU@_X]#B7ALT OZ.+7=GX+9[,IU,
M\_UDN*_[KJ/[[G3G]>\"(PL^[S:J1)FQ:1BQ-F::KF,4$21-]ASC%@=D=0GC
MZH;K_H;[E.D[]49)X(%XJ5Q)4]3$YD.6,&9$LII%8^(9T"W6$?9&%U*^!4VO
M#O15H.EN>HXM.R='^0KA2R1QW&?@H,B4H""9]P!&&ZHEI,"0LM\WFZ.+T3(P
M^/P,FX%(Q,'SS5'(5QU.7^4KC^++8=QT4_P2.6)^A624F1Z47R/1G9)3=&."
MPPH=-X".U]^ CN.#=QDRWGYZ?;J[^3+_WFNZ\R&OQ?ZO@YVCUS1_GN9GI]L?
MW@UV,C;\KF5('AD2IC$0@&SR.Q1 4K3YQ/)H,?"U]3T\GN*1Q_$L."QHOU>D
M?XXD9SMI=G)M8KC\4=9\-'_-I\DQ9L#Y$P]KPZ_[22V[=)PW<81Z2B^K:O.C
M!D4^254V5JDKGE>I//$! J&9:WDMA?(.RC';H=SA6@G0S4J JINWU<VYA"N'
MTF0A&$)32>\T8(CGV=9/+@%FX&0"2\+58JY59_/Z'U6[KHU\RV6YW6'OV TB
M&0Q[P1T/INZP=NJZZX[KGY?^55[YK>&+V;I7@[X]./IE@2I(KYTM\5G%@BJ-
M?12QP2<24&5+BAHI>*$*IJ^8[E!GG]JCJYMTH>KP?>CP'*5@5@0NO2 F!$X
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M\="5"L@?_AK$Z<$Y/%WZK3,9THM?<3[?P<GT^E_IP%(SF>\)YHHZ+WTM=]L
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MM7 -(+%S0&(5D!X.D#[- 9*5CJ'4D1A4@@ SD5B1\<EQ)S&?*DXP7LJ%RK2
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MX;"^AL6<B_^MZ18=5>R'3;=80IW3X"-&\@G'HZK)RVKR'.&PW%D095(X%4"
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M+HP+U)NU==OGM".=#Y] CXH7U[&B'NEY?#\8#DM\=I1ZTP/L'3?Z]+3*]Y9
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MY^965+IC5)HSLX20RJ*FQ MTI?$G(]8+()$BUS0:&WE86P?6%Y1W")6>5*_
MS^VLBN8<NG%3E5YR@V;EZ2Z$_*33P@9/7;:,OM/JG3WA51;6S>RO1XC<=[!
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M$LE05R:[<*>UUYHQ%0$CB+ T#&_$#R>3:=/2;7]TT:6@-"G8&IYU)V@0UR]
M]3"^_(CC,)C@;FK"6KO'Y?5**]M$ZODD9VTUEUP*$B5F5JD](QY$(EARU:4P
M*E!<6^=]9DT%Z]6"@0K654I52E5*3T=*#^D)J\2GV\1GP9\6M9:2"2 IJ$2
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M5N"/$=^<)!Y_#?L@1/W^)C"I7NNXZC#9"<4WFF2C.P?[RD<-2Z*19B0@;EE
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ME"5Y[A#V,!&'T?GF&1S;J(YPY[;%!:_FP*O=*WHR6!PB_!^(E,.(>PNDA-J
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M (CIR 2U*>&H!#+@T2 >+4/&")Z/-'NJ8W!4F'I?1-_Y#',!B.<)$ ^5&U$
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MK[TR3Y=>\M-Z3D\<+J^D2C$2#Z H%/>>4XE-RBVSC=<V1HX5NZ;'43G:_"1
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MC@AD@O>2.Q>(L"OK5W1Z'7?EJIHNSLG8[]A1M4C%?4H%;K[?9U@3BYE  1,
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MX.3F[UA_V(+7664NGN^J)]H:34(.1_[Z.>Q1MS>X-(\_N_C3<T@K'!D]NY\
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MCTVO&F%:L]0E+,7+:9:.YCXC+,?608[GQ-I8$"$<AS-5F?3 4FK[8HA]JOR
M!5J:M^/>G#4[G^4"OPS1U.TDXW74O]1,-<F>K8BS->X"G;LUA"%+0O2A_72W
M[\9H-Y<A@;V>WX4E+1((6M@D@0)>1KPY)^?!#$CH_7(4\HJUCCXIX:(--!"J
M@B.<<T8,&#DD>L!>;X,.#I2#*7"62#M!SPG55&?Y;*MQ=MQVQXTV .Y7!-.2
M'FR8=X3TOP#^FD:)9<$3 [^;HX##6^#0OD<AMU) [PBJ2K)[T1]4?\+OT07R
M VQW3_UXD CPER.XM]\.7GVRA@LN9$:TQ=XCQN:DH#0C1DOIM<@<QV#2K$/!
MA+8J2;[=N)V<DU+#LX)3N:+P!%B%SWW!O1!" RX6M9Q[J$1%FV>?,FYEIEPD
M5/)(>&8< =,>Y!R' \UP7H84*.<NUM3.R[FK)=QP7L2A?GFS0+@OBCS+90P%
M]3Q:KUW0A9(9_"2 #N7-,Q97DM[.8&!Z1\E[_*_SV5?^,>?XIT1:>_\9MT?G
M^ST0TDE:7B"UEUCN.MSOE7CVJ$,_/T!X'\Y:6&R11V>T)H7&T+B/GM@,?N7"
M*AGAB)E2V.OM(MV-COOC(5H?W>_.+QLV3N$_85*"G%Q1&#AI& O"M%:K-HPN
MZ$-4JVZ#3K5:M1$$Y\Y!K0(#'N@J,B(<UF8[%HEF,2,R"S[GW# O^55JU:*_
M8W4H-NTK>@8XS6T>8P[JD]1*BHPY48AH)&ASG[A\LIEN$[72;2*V?Q9T3ACC
M[S <AG  C A[V3OZ.P!3# _A"?_J@'%\S^3::E?D>O+Q!.YY?O#^5?[Q\(@W
M#U_19O?=<6OW7\<?V!X_.#SZUCQQ]./[_:_+Y-KJ-O/6R;[XN.L[![M'7T$I
M@\_VLN;+%R<?#H_$P6[SO/7M7>?#R8O8/&SF!SO8W3B+0N<DP/6$JX(2V%E'
M;(S*6PV"-*A2@0(2!+1 /A>ND!+T/&T-3K)C!><R2)=)K:VR+#YI!%!&3F'G
M0;$)3Y[]O;?S9N_-,L$O$OH2G9=G\?T'+2Z,.>85-RYCEG) =ELPY2G8H\8I
MS@4LY0I.N">RGY)CHZ3'!^GO;#PO<RD:QZ@#3=^HD]XH^8'[,8(L2LH5")R
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M.+^$*IFN4OWFKJHD;S:[Q-AAOS,>77[)A?2:NY>'%#/E*%O:G;G_'D_]QJ=
ME<0.@OE,3(3%/C6=,W,^?/+'HM 'B3^_@9>]^YQRP.BVO"H_-,:?]NZE3@(\
MVA\D.G@*BE48X+=@.69CUM(X'B#P_-?WNQ2I)\]2[C(J.%@5BB&A__G#/%MU
MP"N;Q%RCZ<O=MQ6:&BU-,QH/X-\Z/_OLDW12YTQ'(FE &R,PHH$B2+2<45MD
MT4MU@_SLS5'/#U/Y*"97IZKY1,Y5I\!AF=Q54<%EG6R62Q;GTK[JAC(;1LEK
M[RKX</+QU;:4V6WR\0NZG1<_(<5=;G-ZO=O>=9YI.KM["'6EPJ3?PE=,+DU@
MM+*8J4:3G^"[.SIK';[K'!SZ]H?#M_1@]U7>VGUQW#KYV&F^A&?NMKH'N-:3
MG7S9=W>PNT-;[]^*%OOKN'4(:\+1A^_W6*O[]NSCX0?>9'C=9];<];'Y/#M;
M\-VU=?;Q_QUGKONN9][K\4'W=??@Y<?/![OPW-VC_ #6WNJ^$JW#?WUN[7[X
M>O!RG[5>?CQN?FNU_]^WIE@OEOV^I+9=TQ?X^,,'CS(Z<#NWPL6@P)4:]"1/
MK/0_@80[B"_:Z%?X )CQ*\0$[@Q7EB.FS,@8%,X_-5Z6^KK)M2-4FTB9D%(;
M;"JUI8K+.C#\")?\8/+88\YI J[*+\U,8C=[U0<^Z_Z>06EW'%KPY,.ST/D2
MFDG%JB%I;9#TY@(DN8P%SZ(CAN((/6DB*80OB./H:"U$D6F.$YH9O^A2O?=\
MUL=<Y 8\Q6\%2=?5 &M(NCXDH69T>-:OD6AM2-2^@$14> [Z3TYRC3V*G,N(
MC3R0G(*I'(-FN< 6,UM2KRNAK%:.KHM$HE:.-@F)L/M6C45KPZ*+J:U%%@.7
M+A G,XJCM0W1.&PR!DE]G@NM38985+ -K/)YY%J1K+6B#<*B%_UQ[3-:&Q2M
M*(26UCL:01E2%GU&U$6BBSP0YB6CT69%49@GS_@6G65!U6K174!1FM:9TF!J
MY>@G 5(W^)N!4?M+V.GY'3R4R>\U.*T-G"YZC[BP-N1,D9Q+3;CAGF K89)[
M9C*!Z7BQ*+LT7&P,^N#UI(=1JID&$599,)-.[+>L++BZ"]7C#35>__5KX+Z=
M)EF#]-I ^J)C+;.>9K[(B(N^(%QS04P6#;'>4UU8820<XS.FMRB]V,CWATJ1
MOL\QM7YY*7 C[SQMM+NGXW(Z,N@T83CZM73-WS8-L][V)I4CP>]]=?#5G=1^
ML :PM0'816\<Y]'37!A"'0< <U82$[4GF57,B5AX9@.F3? 5^/5[K6#>B8*Y
M]F+56N=<U_YL-,+? \#_PM7P=P/A!Q>]F$$S[K&=8\P#(UQQ1K3.!6&V4-3[
M&*G"B7IJ2V7K<F.NCX-^8JW\#XVCU]<81W]/0[CE3Y\]CQ4_@W <>L/VE[#?
M<_UN:/5'&U,1=O!FPJ?[9P<O6\ S+TZ 7[ZU#E^=?SP!_F-OOWUXC_P']V8O
M.A]W7YTMU]$T3W8X\#)MOF]^_8!U,KM_=8'_3CX>MHX_(O^Q=R<?WK_[##P?
MFX='9Y^R##C)NX+DO(B$QT(1,/ D$9)EG$D'^HU9'O$N90B*YS+74G)A;!&-
M*$)A'!R/]<8OUX_M/'_^MOGV[YW#O=W&P>&_]UXWGA\T_WF]]^^]UIO]=WN-
M_1;\OG>+V?3?7<C/+CM\XXZ#'W?"0=QQ;MP=IY$@!Z/C,%A!:W_WA\.-*D&\
M!X+[^DGZ0FFM'!&1!@+"V!$#>TP8RT-1Z!BM$(^F #%U.@0=850.HYQ-O,1R
M0C,CF48?:29]/B4:[$X/5+/5Z(5RIJ3YBC,B!Z%A3D\[($'P 0^F;$UNY[<<
M(\.W=:9_1ME:QM5/&"/#,_DSQLC0O+B3,3(7O[KI8SW8G$U0%].M!>%+U;_[
M\?CCR^;7)GLE/K[\^+GU[=77YOMWQQ]@;;#F\P_O/\"*WPHP&\Z65?^/W1>?
M/WS;^_9QM_/Y8Q?OO_?UX_L7)ZV3=\<?#_\Z_GCRL?OQ\+,X0*EP4?6_83E<
M&A1D!W\\6U4-=XWNL8^5*7:#J_:'3O=G(X;?W/7DFU]V[,V+_@!^[372+.F>
M.V^,!G"S3E*A?ZAZ\E$ZT!ZE"TQGBD4NT(XS7/%H"Q&T<)GR>0C!\>NZP-Z,
MP& Y[G> PX9[_QEO4C/<!R'E+@99@P]:L8*3(((@G.::&!XBL8)G./:<ZH(_
M>9;K'ZZB6F.2WAWUNJVQ9G->[098$VFDGD8M\T)Q&[$T1[L\*,^=-K%0"6LH
M93FML>;G8LUR:UD3I<+R!+!PBIQP'7-BG2T(+1A( :_SZ/R39[K.![Y3]>QM
M;Q!@%=^";QR9=F_80,=F[TL8CM#@; R#PXY55\T=?)0I'#= G$RK&"7-<\\H
MC]+:PBKON ":QO^K']%NYBW\V/X://D6!OT:B6Z"1!<S,Z)PBF9YP*0,1KCG
M@5A>9(3F5$9A)15Y\>19ZLK&_MR@#.!U#XWYU3FW4$QSH0630?/ "N,9$T4A
M<Q&5,R+4NL)=<>BRKD +T-TH8X09[*#LHR):2DT*6=!,A(P!ESYYQAYA<X>'
MD3VU<ZVX49U=56=7_60(MSSDREN5%4'R@C+C"AHTV'QY 7+<Q]JU="<0OJ("
M-+H80DXQ:Y\YPIGCI.!:DN@H'(UAP3N[3M?2_2=.;<H0IAHE:Y1<1$E/->-Y
MS!UZ8)SVEGF6%<+)R+1P6M:*[EVAY+*BZSG7RD=+/(^4\%SEQ$BA2*:"S&VF
MN _86Y$^'I3\R>FE@FUN>JGZZ>FE+]H]TW-MT]GO#4>#<5FHV!ZZ3G\X'FQ*
MTA]M3K+!NZ_;K6^MSL>3OTX^[AYE'[X!;WWK' ./MC\<[G^#[\-SWR+/MI>3
M_CZ^W,^;[%VWV6U]/MA]?=)Z^>+D +NUL[^.FR=-6-LKVCK$Y+^_8O/P[=?F
MSB>.NJ*@AC!N,L)#4,0&PXC,G-:LR*P.<3G/-#.@H6A0601UW 551*NEL$6N
M)#.4V>4TP1?[K9W6\_V=OQO[K3>'K]\V]UJ';VZ15OK]YRZNDWM/#6!)*&S.
M,RV*$/$J2@L&K,+E TE@? [(8=J]1IS0\614,XY$6IB&@#F(KBII2S.;S:@1
M37O0^&(ZX[#5.#MNN^-&>PCR+*89SZ8<P7 *!Q#@)_CZ67_<\0V+X[5< *O5
M-T;]QC!TX*&]\KD-N.^I::</4MI"!$O73!=RCH.CX;L),CM59D,EC6T8G870
M:\!6?X8;G1J$Q#9L*;[,J)P&$0QR9?*S8_K6=F,Q?W/V.HWC=AB8@3L^Q_7W
MT2'_+93OT^Z=CN&6XV&Y_.J><]=>.R%S@NX$-<"GM-@DNO@[? F=!FTDGRS]
ML_%JW,=S3X=9$<,7T^ZD?%(\$X<3CZJ]3]FOP%6PS2B4IL._!RO&:^".#L)I
M?Y"&<)2'LK-X,WS8Z+@_3 \JJ6SNW,N'X6VF!#2CEKYSXP%>-AS'"-2 !Q\'
MX3_CE!>#)/ZEWP&,P(,\'?2_P)K3*^):VKTR%H"TU2^IKG?4QT^L&;:'VX_G
ME-GTE/^9OGNB<=SYTMD$[-MK_&>!!BZ>>KN'PP_*Z>X5_4Q@ >\4VNE6O@W<
M/P+F11KIS7ZS\ Y?$CU=3AF3]59/&E9T,0.O]DP*EY"##TY<Z8%C\4;=O@^=
M1(SEF^&'Y2%W ]S-P\X? 7D^HN/-+SO>:A<;0UAI&]@#H'+RT73OCD(/@+ #
M!]0)P^'\*<5!OPN_GX22"(;]\0#((D'J<(J277..>)_ \@S.OZQ/[Z4;>EQ=
M_Q0^6=CY\MF#,!QW<#EPBYXY2I@]G=ICPW $:L (S*91FE\U!]QI64GN@,ET
M6BT.$^]7"(9ZU-M5H][RI=VI1[W]LJ/>OJOL+BO'@F9><6VUR;F5T>142A:U
MY(8++O5=UFA-U)07_<$;TPEOIOD5KV%306J MH ONDE%6O=CK[WZQ#AGA36"
M>(TI^"Y3V$ A)W *3JBL8,KQQU*F-9P,BELY%\Z9X7'2#R_815/)6"G^?M$.
M2JHBVC?CP6"J*R85-1C0@RJ]9F9==% (#A],21= ]G:6W6H4&1/;17;YQ[<N
MD\JVA;[=A+.K/\L+7B^V7FR]V&Q;9FN9]??]JIX'6G-5%R*N4XNI>I!\[#2[
M'V!M3=;:=:)Y^.J\^;)U_/$$M)C=UG&+[64?6#-KG;1.EB-$K>[;\X\GK[XV
MOWW(6M\^?VWM[I]]8"^ZS?=-WF1[^8?#UR<?OKUB<.<U%2*N',FWJNCN3@K>
M-IUG4D+3\_X53>K67$[X2+9L+G/\)6:.U]MWH^W;<6Z ?L#][[5(K+=OU?;M
M5?XVWW@!UDXJ+7Z'%D^]C3?#/;0L_[?IGO[9P!_3/F)F!UB/JUHNU[MYY6[N
M3PMGTD:^65T\\TM7O-?/>]C/NZ..!;"<^\EL3RA8MR7X%4J%&>=8**PR21W/
M);6RR)7*6,AC  /YVH5[S13)0Q_F#/ ?1%O.AV$27ZS?TUF PS><Z (;!BHA
MB,ZT(B%3>)S.1!Q(+?66HIM435PW+OCET*BJ(:UIKJ:YFN9JFGNT-'</6M?E
MF12[P8YFOSU/?<<>QJB+AZ*0Y4L*F3/"P0D:@ITO",\C#E0K++%::!84<SS*
M6B&K@>K^7^T>@ H]"CL]C__,>59W1L_-8' .NY;<UC4\K1&>Q'+G*>Y$*,!
M5()IPGD,Q&AOB(N:>Y/G61;S&IYJ>+K_5[MWW?T6L8G;]Q^J[U'?XS'?X[''
M2JJJJJ?7B1+?5&K5]ZCOL?'WN*/^H/?&X,U^+YQ/*M6J<NNZ$>AE!F,P3.N\
MT(P+PTUA"^U8)F4P4>5:>[F^>.+FM0)]$*;ABBG3A3=41)D3H:4C'*W"@B73
M4/(\4"WAO.I6H ^4=V]G3=6G5)]2?4H;( =_*,)3B\C;BLCEX ZC0:J"9223
MG!$NC2:&THP4VO,8>*$S8VL16;/U3XR'U,Q\6V9>#H5HYH75CA(OA"!<Y9;H
M+$9B=$XS357!G:B9^8$R\[UK4M_QATS*_H&DPM4'6W_S87ZS)H!?_)LU ?SB
MWZP)X!?_9DT O_@WUY)"LL;(W;4ZFM]W>+%>9+W(A[_(-<7#KS\#Z]XBXX?]
MD>G<U,3^[O"%1YR*>:LMV&AORPU<I\*'G-(H-"\H+YPW7.><!>:"*7)%15UI
MO GN4K@_NDI3B@!\+S\XW/^4B0S'BS$2X> (9UE&K*&.*&IB9@J;"V_7E3I^
M&Q:Y9W]JC7@UXJU$O%OU&;PI],TZD&$#LK_[PSI-:FTX>+Z(@SQ$$ZF.I,AM
M)#PX2VQ6 "PZ)G#4HI"*K3MN5 -A#80/'@C7I?I-V@2^3K.*$ =KK%L3UK66
M=#X:F-7>>,*5,X3GW!/M"D54X$SG0F5Y7'M.:(UU-=;56%>W=M@ -%S2_()Q
M!0N"$V$R!1:P=\08:XCD@;K(N5-,U19P#88U&/X<,*S;1]PY!!XL*80Q%,9$
M$8C(HB#<%AFQ,4C"C'1>>IYGN:\AL(; &@)_ENT[::M]<-;#F6[8\KU.$U^K
MOZ],$P?8>W4.WS__%!17NA":P&%%,((M)5JPG!A/M5:!6J_D@S2"5\R?KR>:
M/:+I4/5BZ\4^M,76$\VNGFBV&UPUW(JFX5:T'F95#[.JAUEMSO;5PZSJ85;W
MOXWU,*MZF%7]O/IY]3"K>IC5HV@'? -?*W6!Q<P74@C'C?*&1:5\84RA919Y
MV9V#4I;3.L5\E:OU+?WP;8>VV+O.AY.CL];AJZ_P,WS_Z.N'PW_A6H_A^?#Y
M[)JIJ_7PW4ES]VW^\?V[]L$NW&-W#W[^Z_A@]\5Q\^6';ZV7+^#ZM_D']M>J
M858^*!J,-X1&S@G7,1+MHR6Q<,J+PEH:W9-GFF\5C-?-R6LT>FCM16J:JVFN
MIKF:YAX.S=V#UE5G/-Z?0K;<[U!P5F3*6!)XB(07.2=:<4=8$6@(0DE!5:V0
MU4!U_Z]V#T!59R/>-3PM=W"DH>"%]1KL15T0[C)'+ -X"C03N0(2-JZHX:F&
MI_M_M7O7W>MA5O4]ZGNLZ1Z//592#[.J[_%+WZ,>9C7_XH^R0?A-#$:KO? \
M=T9Z[K'541&L4;E7PFOGZWCB1MB'*R9:">6\$9DBN=>4\-Q38JRR1%A!J=*"
M9A;=5UNYT'5__X?%OO?>W[\^I?J4'LDIW8,HK(,\]R<EEX,\@46ABX(3%Z(A
MG%-.C)09X<:*0E$KJ:NE9,W9=51D0_EY.2K"A6.!.DD"TY9P:C*B@\\(+626
M<2>5]7G-SP^2G^]=GWKLGL^7?5A)#PL]JN(9<Q1Z[KPQ7%WQ<5V"NVY$;N,(
M[@8"I/ >\(6ID%G*12ZMR6TT,N3<:1]-J+TD&R$O+F9=Y\$'KG .(E<%X5)Y
M8H-CA'&;:T,CU:IX\HQN\8P^OB!ZS;X5^[*<"1V4$4(IGN7"Y '^EQF;\:#R
MO$A=JNFD2_4M^7A5E^J:>6_"O-^679R9S6SA"Y(;YP@7/(*R1P7)8^'@&!7/
M?0#F937G/BS.O?>$D?J4-E,]JCUG]P>^RYXS1XW@+C/$9E(0KKDDMF"69-Q;
M!T?,I0Y)<Z)YC;\/B[-K_'T(IW0/^'O=!HPUU/Z8D7IA^A0<$[=:$:L*37@6
M'2E4IHB6TBEE=<XMWSRL_=%$HA]Q;UYK9N&CY/7(J?=*9YEU INR%Y9%J714
MA;&%BT7MBMH$+C]X?L$5I6Q0ROB<".-PYDA6D")818HL\U;)7#!L $"S+277
MW%WZ^USR@ (;OR[G2VZE\H'GC.5<AVB=,99G(L^*R+7*:R_61O#]LA>KT(7R
M2A9$YQ2]6"R2PG%*\I"'3 ;+([?K\&+5//]0>/Z'(IWU^6[\^=Z#-E=[SNX/
M\)<]9U&$S#.3DYPR3KBWEFA. Y%*P&%KE\?D.0-%3]6@7X/"SP.%.EWMKJ%@
M.5TM"U)Z^!]Q)EK"([7$F!#@/P5UBHJ"![;>=+4:"6HDJ!V[]^7R67;L.C#2
MK2XBB5P4A-LL)R:'__!0N$PYJ3)-U^38O2O^7TNSA376N%[KA>^[$+=>9+W(
MA[_(QUXY7K:&8+=K#7%=?:>^1WV/3;W'8Z^ :(*J[=JGIM.P_9ZORQTN'>A)
M3>#,"^.$YIGR1C+),.3$>2Z%4W6,>1,,CMDLS[D1QLQQ*RPCS@M&.%6.%)F5
MA+L@/=/2N-P\>99O%<4/QYCK?+"-Y=]"<Z9C\,IHQIE@QAC%<\YH)GTPNHX4
M;PKWGB]R+U/<>.$9P>Z>A >9$\.*@HB<9KF)0FD>GCS[85=AS;D;R[GKDKR3
M 7VO@POM+\BX-7/>D#E;2Z*5JZAI9CE1+.8@4(TAAN::A,*JD'&G8U$\>?;C
MCOR:.Q\]=];1^OODZR6A*_),2,<T 1Y6!)2D@A2JR(@O\MQ@*W6#>9GYEN9%
MS=H/B[7K0I>'<$KWHA[5\= [,7"F+HI7YZUOG\\_Y307%,Q24IB<$BY=3C0-
ME@2EA526A8++S0/;36LP__/B2_4BZT76BUQ_2"3!CM@6&QP<.>R/3*>>(GSE
M&SX6/8JKF.E(BR+7G&<QFI"YF G#E3!&Q;J?U89H4,T+ 1[-G8L*#%7JN" \
MSSDII,M(09TH5&":<8')Y7J+RWHN5(U'#P./HC%<^JS(.34\"F\Y,[F+G@:E
M@I9U@ZY-0:,EWYFR6FK*<(IYQK%Q02"%%88(5V2&<2\M]4^>L4?86Z\&HD<)
M1.M2C.KXVP]CS7+\34DF L\M$2 ?"->,$4.%)R+D6L!/!?/N<<;?:JRIL::.
M)FXH2BUI1(X7D4<E"95@FG&:>6(0M!R3,<2"<QML:9\)7MMG-53]6E!55R3?
M.4 =+*E1E.<9IRR##364<$P3UEX* H=G6,C QE;8:R[C6[38I&YS-4#5 '47
M=EN=&' GCJ3EQ(!,%5KY')LD!/P/*X@5N20^%IDHC/'2:;#NMG*Y2<ZD2Q(#
MQ!6) 3<)8\ZBE3DLT/?'H.3?)J9:/[-^YO6?F8CZC^0\AW]]^\NS"<>UQET
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M5,@CX9YR--?@P#4S-KA"*YWA6?-59WV*,-*#4X7S. 540;:'\QZMT/)2:PL
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M;\&]EQ &X">E:@(J=%'UPMSP*F(%"LFI*9-\$%EFYD!J]H=7SXYAM&#^;#=
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M]V]ELE,:!H^I75\=; MB$JJ? %S#WZ\]J09>NDS>7JP/A)?OF--A>#KYX4]
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M*2<]8^IZJJ>WO?E>4NG(LF2KKM[_2OAY$\DPM--HNZZD,#OC)[[<-8H2R+,
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MDF"TH)IK!=UE!K(FD%_N=L5=WHN-3=W=9&,#O((]W'ULZGX>%PN=4]W"<T(
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MJ4437[;\;5YRQHB!I]2M24XY&I XHR,YBU$8C(N7X]K"7DSB$ 0$H6\"8<K
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M(TET;!*U[L"2).J#?RVI=$F"1-[U6YHQ]5[.I^K9K!\)K 2V;\#*^51/3(O
MN>ER/-5S\".G4\DQ.'(Z50?1**=32;&4TZFZA4,YG4I.IY(GF\6F7<=6!_MV
MW\FS^9*#3[[I*T-7'<.2XZDD\_:/>5W;5G5OS_*YY&#)P2??],#U5$^7'"PY
MN*\<+,=320[N-P=W6 =?P.$J.9[JU7O#,56S-0?*OO8C4XDB94FD;A-I8*JN
MV38C)ZET;"IYJJVWG=(@J=0'UUY2Z<)DZ0)J?W)&5=YZ;*L#74Y ZC:1;-5U
MY&&8;M/(\E3+D</>ND\D5TZIZC:1Y)FE/E#IU*)T 8G42YU291BNJCLRX]-M
M*CFJ.Y SD+I-(\,TU:$AJ=1Q*EFZJNM#2:5.4TGF3OM I9/+DIQ5)6=5]4A<
M=,V2^9!NTTC76L\:E20ZNA@-)8TZ3R.OK5\@:=0''UM2Z:(D:65>E7#6X(_B
MU?D4*FK?-5<1B>?#@\GCH9%FZ$]AS13G\MXH?TRY(K[$_6L&NV1W7/%S3YJ<
MYU2)%UF:L0C1I"Q2^'T0*1D\!^@8+T)JIE7B"?XJY4J4']U6)D'$HG' 0F7&
M6;K A= 5QP=3-N,*2^G?&R]O_5(EX?,X07B7#C^; :FS5%OUH)$H@?_75\%X
MR+AM6"-K,K%LWQEX[L#1S;$S="9LP$;6/X?FJVY2<N.\/%'RU^#?B\ /LD<Z
M+_Z!S8,,\/Z%I_$B&5<:2#JXH0W6-$S8$++EAW@&;WY4I@RE.![_.8U#GR<I
MJ63WG<)AS[!C8(+7A@,NJ9!_ "9$WD!$/,3)G\@_XQPA^%77T:RU;V;+:3WB
MDV*D$?+H&*%(@+D>@FRJO(9?U[WIM6&YFKZQ[H]\7%W6$). 5.#8=,['& N&
MCQK)X&O'7'\^XIGB\W$"TL.1^[?@(.&3$-9+ 0[#U8S5=0*Q5-Y1A,U%*#01
MCBR:Q32RB#>,= *$35)X=/0("YNZIBO%FB21N!3('K#8%$!,"W',Z9:#2!B$
M]PCP!;(<")U78<2E8*\A81H8-/ !)HC@6> K6:SDN][M#2GHE# L]$L,?R0%
MGK($>)*-Q7@.GZ?C)!@M50NN9^KO/L2 C@@W"/^BPQ8,E<O7#/ZB81X(QH<I
MB^Y@S_#HUQJZ_$3OHP6-=XCZ<.$7+PK27&-IRJ>H@O6A0+I:W>(2*4SY]X*!
MEDO"QQ)!@O>U@5W1?'/V2 ,3 1^_Q_?K*\<K7(3/)WP<)SYB"WY8 F/F+* I
M_ST-0E33 'R&[X0UQL V0;00RKP$9I[$=PF;$8E'/ SX/3WV "0&&88?TL5D
M$HP#0*$2E@H+EO,!JEC%[XY!T\RQ#\Y'0P) @=T (X(O FDJ%AN!?L<MKD 2
M%ZBB]P,6EFPD)&R#:5@Z5>E/XHY[%A)M\>D@NN=B<(N2\O$B";* IZ4L^N(@
MR6M#]S1'>5+:$;37 T]SE:<5CJ;T3U5C39BPF!/.1W61G[(!W8O2=B\0"&*0
M(Q 5BJVO*P%$E&&;=;IA9XU5D&9#F[98Q8"M!(#O $4M 24=(< ,E:M1T8'%
M=A3*ZW$A&4NU0%P497'RJ(Q8B%R<JKC(AITHUPF0^3GI//YMCBI(L*-08<"'
M"7(D" 7/4#6"0\K"\+&BI!F XB](O:UJ?;6J%0L^3AL 'X.KR^#O'&K0*QP6
M8N,QN51JKLV0MJ#)-7/#V AP<S!)WP^<S3V7"Y8:BT;=C,?)@B_W#^J'ET).
M@,(GA),%8"2,%SX9Z 6Q6L;'TPBX_NX1+3X;!:'@.]1ZBSEJ7'IL#MN*8#$(
M!Q[ I/L@W_CPCAQ6XU+V1D(+/UKHMS7I? #6>&UJ]C.$K^HND3"[SUC.Z+4R
M+%"=1T';%.'06/=(!>XV'-4]%*%G:=YS*/ '>BNE@D(6J:A&879?NVLTWL$W
M_#]K/AN$Y5R !0J AV@[BO"SLHIRE7MHMU^_Y*[5FQ6OX_5@?;>HSI <FRYE
MU0_2E'^4 ("'-2O!A1<I["[AY/>!$IW#V[[!_C/PVQ5[J,.7XD6*K\ZCU@<.
M$/O@_$ PNW0LP8D G[)PX'!Q8>QOB3W"X@&*95;?X1F;KV"HN,<<GO#1R[M=
MW '+%SZ><(IF\Y!G?',+?12ICV 5%TFZ0!D*P%R,%BE\)TT5&HC&[QY7'>89
MPW ('#KT!'V?*F^ 8N("9,J*9U)Z>JOBN>(NDB7"R&JRR!8)%^ODZU,P /80
MB!8]DG,-GNED0<)4/6M,$2B^/HP?Z*UU2J'9KN38L+%:N%E++,>6?_=JY:E\
MZ+F^?(2-()A99,V/;(P$/ '%<0YS99:P*'Q6_IPF!31S=L>O1Z"8_KQF$P#V
MAH4/[#%]]7:5K8&GJPALVGN%_4'O#2AWVK#WR>3%]BZDSL>0C#)<-Z0813WX
M>]896)1IPB=_??67I_-H[JOW?XAP=(+1="9F8;+W=03N@S+Z&<4Z"V9D^<3?
M55T!0>0"=!)8F1BWBLE/-@9=(20P%6&L4,\47:([6N@S3?DX05<W7<Q0^?LX
M^_$1'-?Q=#5M@0H.3"PX^^C1YFE07&@CVY64BA"!#""8)G\>OEZDSC#I,LK(
MR:8('6)NB$!2!(VH761@0<NAO0ZR//^1+$U**A)C>48+T2*T,$CD^O9[Z#I_
M OL*'D\HO K#*A)X5:JC1B]B)L MVJAT,4H#/P _"4"Y F##(MNG5C--OX!#
MP#!$3$MWAO0N>0Z(204<+S!A2VQC8CL/5O+7BP67*XF?0T[DHRCQ$7^3<**,
MKWP 6HQ8]*>J_*[=:BJ% UE* =.8$LCIVKQ1>#EY#H"*W]CC2FZCR%4)(&]+
M(-%%83/A5<)K2_\1OSR*$XB[<C[-7XD(C",LL0A.)1R 3X/V/3>K(W*7@=F_
M?OKYBRK,ZZ\??_CT1;FJ(/0V?^DZ1 5ZA6EO^E:1P4C)48!0W30W E>0C0 ^
MI+00+)'P^SB\I]V(Q2:PI1 W15*!:^CK2X!KEGN!^3/ +6$ PO4$="Q,XS40
MP=F.A&!FQ#-CX92 W)5PD,H!/V2&5%[A&WCMOW*1+=@7W50AJ^H&X7;>.<0T
MB[F(8?3US3^Q18ST 0[@GLDD2&8Y_P%[1/Q._#".[SDX3\BQH!CB/!0!ISD,
MQF52< 4@\NAN5].;JUFW57'&<@/HP9)/TTITLKY5*C(PD35!K1Z0@A6D#\-"
M&Z".70*^?TW*V:$F=:("U$? JV)IRM_!Q&1@?4K"P2_"XN<?@W0<QGDI<!0O
M,E HR9\0,7\)TC_[9QMRX!, 'HPK\<?2[,,^L=X)I@\DA+05\T'!@2Q5,FVS
M? 5R&2AMG024)B2K3WQ5T83B*XSRW!B\%\$E1=!BJ=70Q8_AF2C.A%$1)@4X
M.;@G<L!K0(? AB*(<010JXX&!DN4REM6<D$TLV0AS#XE$A)&B4#4"V#^%R(F
MP7@-HHYM,4UGB5K%'Q 5HK\X%59L5B%W?>*TAEKY0TA7BE]AX3$%A)2_7-4F
MFH(>8/[$VEJ45ZAJY)K%B^\L:X:S&;Q )!+P^XLH *+-0E+1AOZ=X,N0@U^2
M;BE*K*I'#)=G!!-9%OQHPH)$0=>7%QIO0WF2B[%N(>-%Z)?<C.GK"$$N/4<J
MX1/@Y+\@L\(Z^6/$UA2:T]K+2!N0M@B%CUH&W6GN1(!5@0<$W<BY!GX+)F X
M(JRTHA5",'!+G+Y)^9B<PA5Y75I)=$B0DLN"44]Y/LD#@!'G$5J_D@H%>P/&
M<*-5(2#9P)P(Z#BP>O75K_VMW;!7'1AD &V-@MPD#H7T?T[B,??1WO6/*7YC
M$3C^(N^YK/@@#WR8!GRB_/0-]#UI^T]8U<6*#T87]-G/I<'(/U-)9A8D>["5
M/$ZNM/ (><-2&V;V\E^"FXO6B<H]Q=2^(MCU2U^"G,82Y?,2Y:JH=8'Q$HG8
M+XL0L&-8[-IPKO@;^K;A^/E/2Q_O=IS1HWD HZZ7QM<KMI]V@H9ZG\2&\CI6
M1%\G)1I$J)?%_O*0W<]55KZR*!4LTL+HBP:"M*R+3[!&CU9X,0)'?W4W"C4<
M8)4?=T,@I2G^DS(-"?"$3\"6;51L#"[^TFQ@Q9IR'6@X6!J ._U#$8U1-T.%
MG$ FW(K .%;X$G_I$@L/.B#-@G8$_/4@G2[3Y*9N6,I'-'R8L<TEB4([PWA'
M']R)PL#/"1 'TQV4U!"XR6T4A4)DA[[.L7N#:GN?DCL6!?\OOY8EYZX_P$CZ
M#^Q1/)7BY!TUUW$%YR,Q\\Z-TMBMMQ'L2/J2P95\'331<20*GV6; ]GBG.%(
M+$2/![F6@+78IS B*7:\["3ILGZI5YB5!IH-DN,>*TKD"^T1"-GE7>YO6H/"
MA\BQ,*YB8>E[)P46E*LMBFVRHM@F:XKM3;7:/0'.A76+JM1:$7"M$X[XG_91
MP(_:(?>G5,H()A6F?E3"X$]4&%F\^8#:;K^R,K*LC%C-E9'=72O/>"7+*1=8
M3LD9GS3D!H$V+P0[OF%X@F2?05$I'S\JGR@K\7'I-.T;8WAV_V(,0U-^Y7>@
M'RFXX%2=Z:5=K*19\GQ^M:ZVDIYFRCV64D2S-Z9T[X2W25T1 8#'$N%O"70(
M8X7)-X['" H/"GQ1,"[)(QB<!2;BBEQ%67\37NUB'D>UGAZF&P *\-/4LAFO
MZKE3=FZ9B [9@XKYBC(+5_3$%JXD@% %FJH@(0MF::5EEE4J:7G^L$A-B+I-
MF>Z85":;JQ4S6A@Y--%EUZVF_&?\ + D:NZ+EHN$Q%M%"G#,(@$YE@7]@.(W
M<N7S@D$FNM=%<H9V&V#M$YQI2L4W^<Q/ EUF6-;2.&/*_8Q6G1"!EXH[0K$'
M,!:U2&)2,BF\YSQ.6$03=@\*!H$$6-#V%Z%E1&'4#'--*ZC8.X_AN3W4,;<:
MY>25GV'W<=)/_;)+2HN8'S<Z$1M5L)$6>!DX''A(V!M5R7%2Z!'J$/X9Q%XQ
M].O_VILQP&GJ>#W'Q+ZXA-\%J:A)?V6AZ.03IQL@5BA[XU%Y_4/HU-PN[<PT
MI]HA9@X2Y7.U0W%C7RWV0*?_EB$&W=B!A7\V3_E-\8]W?I#.0_9X$T0$$3WT
M;M4]JQD*06(E/LX];L_5AKJ+3G<^V"-_\0ZWW7O:T!SL=-M]N\\LS]WKR:W
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MWSVCF=_Y$?G-H2'+F=[YL0,QMJ<6RN7Q(7$>"(?US(-DJ5G%N2&QAUGL!Y,
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M C3AP6KX5J$(_T81\J0XTL!$U>ASD;^2@N0(@G!O))'>4F(UM81;F<%Z*3%
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MQC8.[WNHAA0C5>! -0/4FZDZKSQZ"[Z'_:+&O?RQAZ6P([#:N$@UAF8*(7'
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MY\+/HX0(FQ+KMIK.2A:KV9CU6R5SV>>]=UR4UN]\@2Z.414CJ8 )Q$"B+XT
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MHZXX+)Y]7GX$Q/#+#_\'4$L#!!0    ( '2&8U6"W8*7#R8  (JB 0 4
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M"9_=H-E+ZLP9(QMOM9[%"TCC7KFH_2&1AXMDGG:= <5X5BR1D!0&.V)27)J
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M@KD"7&L!E%8#Y&L]_NQH,%G.AJ7!Y!_CO@VF37B-R,#(##:$!K\NQ?9(3XY
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M!CIU>=>-Z#OYD)M'S<KZ) F+A,8H@B@DVESG,89,<@5QP)1VSW 09E9<<&R
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M0)909LY$ DBB,(8ASDB<D@3'<;Q,P;NW(]R.HEA]#MLI>O=#I.-4-%*LA;X
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M-;H;(<%?>T;7H8!*/R@/5#3E_E$"V1RU\D=:/)@2[ \TGRU*0!W?<T\5$3L
MVE8TQ>%IPQ5*<5=QJSA*A]L[>LEZJ1'YM,JF6C_T^IL)Z)+"Y$ 8F_6E;$2Y
MIH4IJ6GBP.K-P;?##ZCVCWB8<4Y$"E.LEQ24) HRA#@,.,I4QA1*[5:3 60=
MW0JT(>D&%7;:Y.MSBBU]\W%,7-_K6K<Y<_?9^T?3KXO?H[S#[@CT#_S>!L(
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M*O=NJ]'GFMH#P<,,Q1*&+)(0I7$$,T40%!%-)*5!E))A.D.?I<;8S(!CY34
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MGV7Y.!>73^:(8)((D@98FTF8J @BTR2!$9E $B>,AR*A-)5+FKRW-YELQN[
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MDK_2:;4QY]=TLIBS,XPHOS/Q3N;4,IEAWZ8":SUZMJOL@>S?PK*0Y?UM+7O
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MV+R%39DK_YIN".M:[M<"<[M%Q3>2/2\%F^*:3LJ-P!6>ES9X=J@(; ^0Y\K
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M?&WL^&[D+\,@,0K>FZX?"')>H?%_ROO:7K=Q+,WO\RL$[&*F"KB<)252)&>
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MF/7ZE5FKU;RR55XL] NEEH\++]]'=[/RN>.[CF><H,)0HP'*C0*8:0N<%2&
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MV,Q+"]XNML5*8O=IER .W7$E F[HO=,19O/%OL!+\DJW0: DWNE<&G'D/4N
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MS<%]1;&VK_O:I;<U^7FS7/UJOC6-:ZI:H-N@EIDM1 %UZ<Q$B N 2R@!EZ8
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M9]]&</FSKU/(?_T3_B4I.J5.T/+"_W'Q=[]>O_?;%&8(E06?'_ 'RS\O+]F
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MVP=)!9 :K;:Q2A"I)<I6HG]J<%DE';,.3_;*V?:XM@I3_0:EM3?E-K#0S+)
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M'YR#IJAQ/F? Q>:1*ZX<\4("L4SB5J XLR%6@>)J]#69I]892NZ/<^E:92T
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M U:O*\)_2D(#YR. !(SB)(.2NI"(E3P0801XFURRXD6OME=S&E %Y_TLR[5
MU\[YP7/">;1Y]6/U#$_**-/H(H.%9#@*"AT7Q[5"%R:Y*)5BQK0V[FX3/E_-
MN443Z[,_"/Y7\E8'%((,+GB2H] +<1#OA2?*>F],\ J%\^HWS9=P=M+$HNP!
M=*_OM.5)T<0,V4/*!,4@4#398D0=#8&<,^?@,ZV4B;HC!E_-R<Q+6(\U0/?B
M\H#N#*>LE0KTS&MJ9@.MPV$;"4&.0F;9,A+!9"*CHL3Y)/$KQ LMMU.ISG#V
MGA.".AL?Y&RF5@0@22"?D@E&+,<5FU30(0:>,JO40; K%EYTVL\Z^+UGU'L!
M00/G@+='M5-!03 7B4ME*G5.@5@=@3AGHE>4H8-8)_"X14;/9VK]0&'2E5X:
M -7F@GMB'K'V6J'4$#H<'3>IF2%.*46T-*94CV9KZFQ/-;CI%^);@*NS$Z..
M--T VA\>M.YYQGA:8F!!J47WG2L2F'4D^*@M8TSY2J;T07(:OZ:HCI))URIK
M '<=%,0D:[.(RA"5;5GZL32.1".@E?;.Z,1E;"RYY,-:,T=?P'ST;9R$'2/@
M)6/^V2JLJUK)F]D],D#FRFF2F (BK1+$BXS*D50X3Z7(OK&#OXWX;'QWZ!C%
M.ROLVQI2_S46W#)W32J3)<N9,"C9GII'$H!+8C+J-(1L,V^L0F1=%E_H,ML!
MSG>_)#< W<O)%.FJ%)EY:WQ QYIEZ= WT<4W0>D 39IK* ,!&QLO5*6D_;]7
M9)N0>]7;X^T^@H.D8J0 D6A6P@111J,[BB8K. 8<5:AT8RDA:W+X0G-"7M-2
MW )R+[M<[5G)H-XR#&\*)WAE8TE;2]9S%(YQQ"<GB8B1.RFT$ZW5^Z_/Y M-
M"WE-2W([X&V[*D]?P#YYUZ.G@:O$K26&R42DRI&@/Z%07& 3_DHK^=(6YB9A
M9'N-FU_3LMP&="\]=W)UX=Q);UMX^N_0KESUP[ZI:&&2XB*C-0LB$.E2Z03,
M/3$Q"PS%HXVM#5RO(X@7&I*^F+/8:J!\U='HZN(;!$VYBAZ--024F?6)6 .)
M>,^2 99<B"\M4EV=^U=_Q%MO^31H"M;"\G^YX^'GQ6>Y9BE%=-D@""*]<R2$
M4.J]* -%3=*5YI8V(X(7NIO_E[('-5']JIV"V^>%SPLN^N"RPRA):HU1$C6"
M.(R.2(S@I/0V4N5>F#E84P2O_I#[%9B#FJA^U>9@>59YCJA^7FK2FZ"YR21D
M7*_2ZY)KR0S).2<>;?81>LKFW@G_K_YH_148@FIX?M568(WH"I1E!O]'C$^:
M2"D2">A.$6,4./!>!YE?F WH^*3@)9_BOP(+4 G+G=X [&ANP_G9F9_^G.0;
MP\D659@+R5Y,BNE\CL,:[ZPZUV%3WMLHZQ9,>.H,)5%(2:21AGCI!8G&8 "K
MC3:QSL7*:RGK%C$XSAT:(^HXD38Q8EF DIQ&,\I0.U9IF_KOLNXU\5NOK'L=
M$#3@W]VN\$3B HM(;70:G5,M<9]541$:5?0B^HA!ZW^7=5>!PI-EW>OHI0%0
MU2GC9-D+ [QT*_;H.%F-CA/&449ER1/GN/Q["@)>>%GW6N#:25GW&IKN>=;S
MY12O<7JX4MARL(DB%X*SLB<%W),R1Z]6)$<!**3LG_%Y5WA-XY?)U3$PJ:.0
MGK'UT4__"?,BFNMP8B''V9*71*54@&&PX-80Z1.&D@Z_*JQP\"%JIE< UW/O
M:?QJ<I?HZE0E#6S4C[&AF<JZ^"O<<5.FT$02HN1$9PG4):9BK#-]91L(]G<=
MMBL(=JFV!M"WD$XY'5NX(<);'U5@Q)29IC)2A999"!*H-Y8;3AFKV%+JDHS7
MTBUBZ]AC([VT!*KE.LO4,%IDD$0Y,/;>$8=VF02NHJ8T6Y;KI!;=(:0!CW\S
ME3X&C@WDV[-#M3B-+S?VQ05:FDQ#DW.J]$VU%LG7M)AA'8G+&GW#1*.59@4?
MZH%'-Z+P3=0TZ4YF#:F<+<FG D)R"@A-RA?3J% *)1D#5T16+.I,W9HJ9RUX
MRC54OHG,&E(Y79+/A%+.92 VYW+ISARQH!C1.EECF0A2R#553EOP3&NH?!.9
MM:-RYI;D<ZYRYJ:,AC6E75;2A1%!#!@J X#,-JZG\LM']YN24T'E&\FL 5>O
M@QHDSP,R)3C)7LFRE0'Q25$B@(*7Q@?ZLOO:U8N)FXA4=HR %C#_Y#3A!\4Q
M$#9&ICUZ:;Q4@M,<B94JDPS@F 5ON:5U0+X^L8T?97>,I[5&16^OW ;PNS=:
M?&:9$W./G?T?Y4L84.H]>I;H:G(?\1^7RDE6)C90F<"D%'2='F^KT=?XD7A=
ME%9086? [#K)[</^WLG^R:%'V<Z'WV'SS+5''M1-.MHJ5':48_8!4-_7.3?)
M2&:]9D0)DX@4&>-"*36).@1DWVK%H,HZO4W'ME;I \QF (MGOH-9G X7MX@7
M_HGG7N@ BCC.$,=9 T:]KAQ^\!@21L(1ZN3$/$%4O[OD%ABX:TNZ$GR/.]ML
M.A\<%\N[.%J-@+8SV$Q,-"6]ETLT> IYT)$QSZPTJW6GP*?>0 I^=Q<EMU[;
M-QXZ4N)D6XFV (/+$S.5*:51D.A]F509%?&">I)"8;U<QMT]9=P6"'T>.V^A
MLKM*WT!^/:O]XW \/#L_NSPW<U9Y#H:41'_T>X(B-CI*P*O,HP<5S4I]I592
M_*U7]ZSZ310WZ4**?:O?_[A!N,\B>W2C"605D'W@Q')EB,C.<B.,"WRE:^S5
MU'_SU?T$)9VI?V,I-A#5EA2/HWPC KN8EZ.1&M".9):+8X2[H-><$IZ,YQ9D
MC*%.A[D'R>DW9NW:1^A.\@W Y^9AZ=XX'4[&_OHGI_C5#/WLDM9XF67&8Y8R
M4X)Q-*Z.:#B&UF@K&8L1 W>5;*QT.K(>H?VZI1U X^[)1T4]]9[(#.7P8/QE
ML41O,/I^,CT&/]J?H>(N;7P21C"!EEU:ZH@,T1"?(A!KC+$FEX%(J]R@K_/.
MGK,I:BI^L@,M-(RN4ES[K7Q]Z4"DF*26"5T]APLT9%VZ22O"E$E,1JD5I5N"
MZ\XK>T[;: !;V^B@@?WS8>?B^K0[<\L\%8$D$]'!<!B98E0!!&,)QHP%[FV=
M_?(9POJ]PJWEDG6IC6; =7OUG,+TK-2HCI<GH#([I]$(@S(8K"9IB:?(6W(Y
M19:SM['.]*_G:6OQ9'!#*#P(L\[TT@#2;O-R>8^69 @0(./F;G !.I'+HK1$
M&J$C?A6$K7/_\" Y+4:1W>!I>^EO#*'O, V3'=QCGIQ_^S9:[/E^]-;/OKX?
M3?XX&"]*2<H;MKW=7/'Q7=YY;L)1I9M0)X3P6I.D+^!!B8\V$!8S;IP6Q>7J
ME"=W>Q-Z>Q5<]E@8:$9]\J5&B9<1+Q0!$!#Z1(?@:(*<6*Z3)_<P/7WO:AMK
M_FFCLY&X&]BXCDO3HZ/\&<,*M,_SHX"K;EQR2_=_Q*\ES, 0XS:G'X8^#$?#
M^<^!SS1(QE!Z,:*!-<BTE0"X6[/ N B2\CKU.5L0W?<FV!G\=J6X#G?&KDS;
MG4Y=QU"RJ6_ZD6R0/1>1,D^L9@I7H=!E<'BI@>#,Q\0X2F '1N]Y2ON.(RN9
MPXY5U("A?)*_TOYH<CZ>'_LY?()I1-$/("I+'3!B)& $P[(DSFM.8G(&Y9E"
M5'4*L=>EM-^BB%U!<%L5-9[G^/Z\-#%=7L0O^'\[.3L;SA=.R;;1P4H/[S(V
M6)^;.I%!##F+"&B>3$: !%_ZZWA+F)0A&>ZYLW6ZF=>,#"[]@"',+KW6=^=P
MQ;-SDBL: H%2,H:,>A*B<>66+0AMN*509R#P.E0V%46L@Y*G;5:'JFE@RWSH
MF._*";WD[\(U0'T=Y?=HHOWH'^"G S3W*<FLT/BC7R"3%Z5KK,1M0 H=LA%<
MU>DHL3G-_4*R'HY6.+NMH-27 E\4ZR'N/:=_P.@[?)R,YU]G@\RX2E%&XG2I
MT B6D5*84;H=,PF,41'J%&UM2G&_07%;T-U6H2\(N&51GOXQ&03TJ1583F3F
MCD@0D03F&;$.J'0,F-*UO)RU".TW5FX.IINH[Z6A$^$& TT9F$"!9$L%[AL1
M&0RE3S"G$?EF@>8Z<T36)K7?4+I-A*ZMPA>&T?>3\^D@:I?!*A1?#L@5T$!\
M:;+"DE0Y.>H#JY,OO"ZE_8ZD:!*A:RNPYXR\M7@;?B\-#/<ROOKR^X'16OO@
M49P!2HT/Q7C5F4QRUDYKE+E0SYT+=4''2E#4+Q:*.U?5"[*; PC L[6:Z%"&
MJ;NHB#76X\+3"6*42M$Z5X>K4K@2.,V+!6=5A6T.Q,G<C^H#\?,X+2\#(.W_
MB/C1O;/RW4!%GZU"^V\,[@32YTP\<$HB<\I;&YV$'@*AQ\A=":+V=4.T$U6N
MCU=W@=<Q?"G--"K<+U[?U4=&G4Z6DA1+J0 $14H[+\*4I2K)Z(6MDYRT30*%
M>_&HZT(=K^#*<'#'Z>WXTG# =GYM>)>CJXO#7S<6Y][;MY\_?OZP=[K_[NCT
M]_WC,ECL>/_W_<.3@[_M'QSBM_M[,9Z?G2]F(2T&T)6N.U/X"N,9>GD'8WS4
M%@UJNGU_-PJI*)..KGI7>/V'R6QV"/.C?.I_7%F5X(2V8"SA+)5.BS$1;UDY
M&P[X\Y!,KN0D;$CPUA6NJ[WVHOC$R."4"H9D6IH,&X?FL4Q2<(%K@UYBH*K.
M;K4.E3T7).X =_>J7VOIL(&8\Z34518+?S'JL[ V&2\J\A;]TCG7MF0Y\@RA
M=#@J?5$Q@/;,9&,PH-&R3J#Y)%DO H$;H.%>4\2N5-, SN[P<-G#-VBFC;(D
M,X'^H)2NE*T8DJP"9D+R]&Y[ZH[P]2 Y/;?@[$[=DZYEWP" ;BR[16WPZ$(Q
MZ?^>S^8W"GA]4DE'DX@0%A=<J0_V(E&BM3<,7)39UZE(7(V^?B'6 1 >WQJ[
MTDI;6$-'XO-X"GXT_%<I#RC#K@M?OZ'@BI5?\A=,\,B')1;*8 B@L>3F^#)_
MJ,@/;*HT07A=2OO-5:F*O^XUU182'W,VEHR) )!$4@02!2)5+H7KR1.?I;?&
M*ZLK;:4KD]AO DI5['6HFY<!NK*B/EQ7'P=JL@Z":(9<29,X*0V%2-3,ZR0P
MQG*]!O4?UNH[4:_AR:XBAZH*; "@BW;Q7R<C5-?L8ET/DE,A1!=(HF5.#],>
M_6.NB3*<,Z<R9:E.EM-]6EY$>+JA[A_JV[^Y(IH]XG]_<+AW^/9@[\/!X<GI
M\>>/^X>G)Z7*WH_3^^'8C^/0CQ:%H[/3KWZ.>OD(?G:.U/OY>S^<_LV/SF$R
M]L<0SZ=EG,$;/QO.\F2Z[^/724:U_#Z$*?+]]><'^ ZC+4J,^J*TFW/N)N3<
MT8GXM<LYVQN-%FOOYH^N#B(5QO$L 6$&W<Y%:Q8K 5T#)8Q0)H;HZQBJU>C;
M)K6J:&YOG,I_BC'X[D=PT=KK8GIPV=9.BJ865X[+=DL"F*!<D)2$+0,9.7&X
MO1&9@6OA*/IGXID5L-F;^S72%;!R,W&JLB(:\ "N5O^;GU=?WE[KBU,SC7)C
M64<")="3.DH2DF6$V2@$.M_ ?9WN':O1UP\(=X&0275UM03"Y:ZT6+SW^;N<
M>\V- Z$-"5*5X=?H(CF0Z-!3D$(KER+PNEA<A<Q^[6(-G#P&Q<Z5UA(B#\;?
MSN>SA<0N)YF"3C$FG0ESR>&JM9IXJQ7)V@L;%$HN5,;??:(:05OW4'@,=%OJ
MI5&(7<Y'!@_*0;+$Q(A;!'.4.$8S"3;)S"&; )6WV_M$]7ODTR_$-M%+"Q"[
M#/T.QN@(GU]W,,\\<&4-,=[3TIL5S3Y%KKP2G/F0.;-UCK@?(:@?:/7AOG6@
MD 9PM;BAQ#<709W ]/LP#L=?2HW]/>YFI87^[.%?+=>J")DEP1T1!C V\R")
M!0=$HO.1E V&FSJVKDLN>MY_NX#5W;$8?>FX 7P7<W#9*UUZ'02WA(N2O)T<
M&GM'!1%!:RY=B"K5,977-/0\ Z,W'$PZ44H#</HX&<//BPWE_?DX7=Z@.YZI
MC":03)$!::4G7AM-G+!)F9A#3'6*=1^FIU__KAF8=:"LG@MS?YM\A^EXL0E\
M@7'\>>W 7*9N!,O14TTD4B;1@Q% + WHQDBKT&].E-L[ >R#9\7/O:??-(7>
M =6Y*EJP9.=CE.,W/WHSN5X:0HE(0<@R1*2XP3(0+X(C8*V5-!@(ODZ3K(>H
MZ;?U1>^@ZTQ1/=NPM>*RZRMX%F/B)>Y7BW++A&QZZS31:*!#D(EEF5:P;)N]
MO1][M\,H=D>*:<'./<#,@(-/C/M 0N!EI)$5Q":T2CE8I:4)SLHZN:D/4?-"
M;KPV1,!=:[:M.AJ%U'6:[65R[8!GB(Y)11@K7'$;B0OXK0#0N TH9W*=IGVK
MT?="3NKJP6Y+E34 Q(,Q/@MF\V.(@&(LFT'D04$I(_ 9'5#)E24^"4^BA6R3
MSRZ).K4>]VEY(9MH-P#;4A4-@&GONQ^."N'O)],3?U-"[R#,K[][>SXM\A^H
M1+VC#MD3$<-H[1CQ&.>0*+RFGN(_E>;HK4EH/V%$3S"LJ<0&,/J(1.=O_73Z
M$^.SQ67?@(9$%4T8;87$B32Q+#POT8K+1%-*-E<\Z'V6O'[ZY?6$Q^X5U@ *
MK],2C_X80]J[SKL=9)T-: ](NA)$*HS*<&5)HKVWQBJE'*O3ZOYQFOIIBM?;
M-MR):EY4$OYA&1$\'W[?HM_+2H^ME][^- <[SD7'<%,;]/DY6(L[HI7$ES01
MC$>-35;$F.NX-75ST2_?4MP 7($7A2G7J^_X;B0D9)0L*4HT!%\F_9;NS^5R
M#J3CWDN;>)VK_!4)?!FYZFM@Z:XEJZ&H;=O2G5:V;N_VWYQV8,T>?$PWUNMY
M"CNR5D7]9<#4:%)2Y*X0Q7..X)D@PKOB*;F$_CHXP@4&FN!#$I4JFA^FIPMK
M='U;<G&<3;,3RL5 C 9)I,2(V5N,HE,"RJ/%W5_78_$.,?U:F0XP\)!5V4;@
M#7C?MUFX: 23A$=AH)](,[IVWF 4&Z4@Y=:-LNBLDO4VJPWR'ZLB9BOU/@F7
MM67='%H._1DLKV23LD[RDD$GRND<PQTTJ!"($UHQY7'7-'7ZRCU&44O(65_3
M3P)G0['W?7&-KQO.][Y, 6ZT[<F9>RDDD"!]L;XF$LN#)2(87&>*\Z#D,_[)
MHP]O"0*;ZFS2I0 ;," 73+SW<=&M=[$P0%,NI6($?%9H49TE =U\DJ0!:7 /
MEI5:>]RGI=],OZZWFRUEW1Q:ENM'!DZM0HC3HE;I:)GSA<(Q9=(7RL9J7><B
M^"%J^K4QVVKX2<#\_]5=36\C-PR]][\(T+=&EP+>U-LMD'8#)^W5H"@I"9!D
M%A-GV_WWI6([&WM3PQG/8-2+ <. 1?$]220EDCW470%E%NEK>_?U]N%Z=S+;
MW5((E[)S+*.$4B5.,3 ^,5IEP!U@XB.51C@H5DTDZH-Z.Q8$%?#I/*U6I4WF
M>BZ;.3CAC,G6,A*6CO 0R6=,#3+2$!ESU@H-:10:O27-M.P9$.P?^DJ<J/D)
MV?/8K98+>+A.SWNR:5"CYYH)9QM&*\BQP!T9@,(F$=&(>)R%0__ZBBKT;9\F
M.\-.^\I\*&.FOR9K@'_+6A4T.BU+Q^E,)C^0Q-PF@BV@RFB2^=['?A@"3+DU
MG #9/N@]]#<Q[)OF%AO!.;EBY742BS:5S'LP+,C&,2]]2AFTD?JH]V-' ;\S
M],30]P&N'4*+4\,/_[P2'*TS3C26.>=+[4]TM.$%+*_*>3 H /A14;'CX'\]
M]#2>[&#P]]9B!1;C7]#=EN-N :NTJ24C,Z#7#'TNK2LU,-H3$VMT1NTQB2#'
M>42Z+\FT*4!#AS=.TG-E/-EX7<):]%%YEHG;3%M!7A<-3;@2Z]$B!#&.7_&C
M+--Z%:=A>X H/11= 57F3UT;V[L[Z+;9D=I#)$^(Q1 =T[SQ+ 3KF0!E8]!&
M23_.=<N^)/70I ^R^UTL3E%S!33Y (_/JMAF-7*!UD=D6>62'$F;:Y T#RL5
M>.V]23A..:Y=.:8-J@],D1-47 %!=H_@\Y<WHL!34%BBQ,X2SQUMK%Z:R*R6
M.5N;<L!Q$I7_0Z!IFZ"/>^W?3^L5D*<(OHW&O83YUH;ZA[;KVK]+$!"^T"^K
M;TNO9*G&G5F..93XL66--XY%2+Y)47)4X[PA>8^4-5T0]Z3%?LQT+(PF?CSP
MUKQFB 01@?4Q06DK^ML#=NM>L/>WJR6'1J/BB2@"AK38E(HD*K*8M ,7N8?]
M?*HW'Q:\>^":KI!/X]3X>J]T4_O>D_9C2A>IPX+@=5I::&PRG!:(0UOZ#B0&
M)CMF1"FB29_2CU.6Z!U"UA3T'V]+&P*A"LBWJZ[GS@*7) O$SP^OS5:Q!%I0
M&#69&[ET:HG"LN"#H8V;G%^AO70X3ES@6 EKBBP-0[M1L)GX%-U8 E?M"N[^
M2*M2P+6C9;,H0"U!",\Q<V8;25Y1I"F064L.;^.Y#]Z)J,41!^:A,6HRZT\_
M&P?3YM2L6-^U;%/NS]K7\Y!T;DL))=,F9Z:-<LQS *:X4]$FD=W^8ZNW67%@
MC&DR*D=CQ5#:K.Y\VB89S^[;IX?2[CIG:.BL#8Y#J<>@6,"(+%FP2CDKHQ@G
ML^^05$=QR?T?N#0X!M4FX<[.SN;G\\7L:O[+Y:?98KZ87_RY./LTNYS/+A<7
MB\^_+F:_]\]>>\^_#Y/4UGL^ ^6ZK7,<7_*;N+-H92"V9;*$-0*Q)4OZ,"B)
ME+3QC%32?%>.01KR+=*7IPYOR-F\Z-KK#NYG3ZN;MBL9G.L5(98^*@Y9*X9$
M?IHN&N9%]$QF94!Z0->,4XOL2 %K:,_<BQMO-N8;&) *SKRK[KF-PK?GZ5W>
MD%8?9TA:(TF6J1$J"!$95^7B(/G,&FO(T=0F-TWBAJMQ+E0."%5#N^5!^#24
MXL<_YS8_E(] S/_YIW\!4$L#!!0    ( '2&8U6JVB',MP<  %(F   7
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M0=G]L6%I;07@!4S%9;$ANE:5AM1Q5T^HK&P)3+M0C:2IL2(8$.K3B2Q09&A
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M7=[)M**3%/8A;C"V/=@)^>F1]+?^=5)IXK=9XW@*/I-;WRNM0!<27'?5A2=
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M&>5$C0RW7J5<5;X^XME7(F2.Y;^2MT7^Y>W+]EJ\"-*OI([^!E!+ 0(4 Q0
M   ( '2&8U7%JZ#W@&D! )':$@ 0              "  0    !M960M,C R
M,C Y,S N:'1M4$L! A0#%     @ =(9C5?%"&0T'"P  'V4  !
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M2P$"% ,4    " !TAF-5DWT1VIE3  !&P , %               @ &?/P(
M;65D+3(P,C(P.3,P7W!R92YX;6Q02P$"% ,4    " !TAF-5JMHAS+<'  !2
M)@  %P              @ %JDP( ;65D+3(P,C(P.3,P>&5X>#,Q,2YH=&U0
M2P$"% ,4    " !TAF-5VTC !JP'  #U)0  %P              @ %6FP(
M;65D+3(P,C(P.3,P>&5X>#,Q,BYH=&U02P$"% ,4    " !TAF-5'A"D:BP%
M  #M&@  %P              @ $WHP( ;65D+3(P,C(P.3,P>&5X>#,R,2YH
8=&U02P4&      D "0!3 @  F*@"

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
